PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Brink, R				Brink, Robert			LOX-1 Unlocks Human Plasma Cell Potential	IMMUNITY			English	Editorial Material							DENDRITIC CELLS; ANTIBODY-RESPONSES; B-CELLS; ACTIVATION; EXPANSION; APRIL	Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is best known for promoting atherosclerosis. In this issue of Immunity, Joo et al. (2014) find that dendritic cells triggered through LOX-1 can directly support plasmablast production via the production of the cytokines APRIL and BAFF.	[Brink, Robert] St Vincents Hosp, Garvan Inst Med Res, Immunol Div, Darlinghurst, NSW 2010, Australia; [Brink, Robert] UNSW Australia, St Vincents Clin Sch, Darlinghurst, NSW 2010, Australia	Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of New South Wales Sydney	Brink, R (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Immunol Div, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	r.brink@garvan.org.au	Brink, Robert/B-7910-2010	Brink, Robert/0000-0002-9586-3655				Caminschi I, 2012, TRENDS IMMUNOL, V33, P71, DOI 10.1016/j.it.2011.10.007; Chan TD, 2009, J IMMUNOL, V183, P3139, DOI 10.4049/jimmunol.0901690; Huysamen C, 2009, FEMS MICROBIOL LETT, V290, P121, DOI 10.1111/j.1574-6968.2008.01418.x; Joo H, 2014, IMMUNITY, V41, P592, DOI 10.1016/j.immuni.2014.09.009; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; MacLennan ICM, 2002, IMMUNITY, V17, P235, DOI 10.1016/S1074-7613(02)00398-9; Mehta JL, 2007, CIRC RES, V100, P1634, DOI 10.1161/CIRCRESAHA.107.149724; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Teichmann LL, 2010, IMMUNITY, V33, P967, DOI 10.1016/j.immuni.2010.11.025	10	3	3	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2014	41	4					507	508		10.1016/j.immuni.2014.09.019	http://dx.doi.org/10.1016/j.immuni.2014.09.019			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3HY	25367564	Bronze			2022-12-18	WOS:000345504300002
J	Mackay, LK; Carbone, FR				Mackay, Laura K.; Carbone, Francis R.			CD4 Helpers Put Tissue-Resident Memory Cells in Their Place	IMMUNITY			English	Editorial Material							CD8(+) T-CELLS; INFECTION; VIRUS	The regulation of tissue-resident memory cell development is poorly understood. In this issue of Immunity, Laidlaw et al. (2014) demonstrate that CD4(+) T cells promote development of lung-resident memory cells by limiting T-bet expression and directing CD8(+) T cells to the airway epithelium.	[Mackay, Laura K.; Carbone, Francis R.] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic 3010, Australia	University of Melbourne	Carbone, FR (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic 3010, Australia.	fcarbone@unimelb.edu.au	Carbone, Francis/ABF-2141-2020; Mackay, Laura K/HGC-6580-2022	Mackay, Laura K/0000-0002-8496-6632				Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Laidlaw BJ, 2014, IMMUNITY, V41, P633, DOI 10.1016/j.immuni.2014.09.007; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Sheridan BS, 2014, IMMUNITY, V40, P747, DOI 10.1016/j.immuni.2014.03.007; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Slutter B, 2013, IMMUNITY, V39, P939, DOI 10.1016/j.immuni.2013.09.013; Zhang N, 2012, NAT IMMUNOL, V13, P667, DOI 10.1038/ni.2319	10	3	4	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2014	41	4					514	+		10.1016/j.immuni.2014.09.018	http://dx.doi.org/10.1016/j.immuni.2014.09.018			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3HY	25367567	Bronze			2022-12-18	WOS:000345504300005
J	Monack, DM				Monack, Denise M.			The Battle in the Gut	IMMUNITY			English	Editorial Material							HOST-DEFENSE; GROWTH; IL-22	Our molecular understanding of how pathogen-microbiota-immune system interactions influence disease outcomes is limited. In this issue of Immunity, Behnsen et al. (2014) report that the cytokine interleukin-22, which usually plays a protective role, promotes pathogen colonization by suppressing related commensal bacteria.	Stanford Univ, Dept Microbiol & Immunol, Stanford Sch Med, Stanford, CA 94305 USA	Stanford University	Monack, DM (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford Sch Med, Stanford, CA 94305 USA.	dmonack@stanford.edu		Monack, Denise/0000-0003-3804-2209				Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Behnsen J, 2014, IMMUNITY, V40, P262, DOI 10.1016/j.immuni.2014.01.003; Kinnebrew MA, 2010, J INFECT DIS, V201, P534, DOI 10.1086/650203; Liu JZ, 2012, CELL HOST MICROBE, V11, P227, DOI 10.1016/j.chom.2012.01.017; Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011; Rutz S, 2013, IMMUNOL REV, V252, P116, DOI 10.1111/imr.12027; Sansonetti PJ, 2011, MUCOSAL IMMUNOL, V4, P8, DOI 10.1038/mi.2010.77; Stelter C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020749; Winter SE, 2013, EMBO REP, V14, P319, DOI 10.1038/embor.2013.27; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	10	3	3	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2014	40	2					173	175		10.1016/j.immuni.2014.01.007	http://dx.doi.org/10.1016/j.immuni.2014.01.007			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB2QQ	24560194	Bronze			2022-12-18	WOS:000331637600004
J	Zhang, R; Turka, LA				Zhang, Ruan; Turka, Laurence A.			A Breath of Fresh Aire	IMMUNITY			English	Editorial Material							T-CELL ANERGY; TOLERANCE		[Zhang, Ruan] Massachusetts Gen Hosp, Transplantat Biol Res Ctr, Boston, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Zhang, R (corresponding author), Massachusetts Gen Hosp, Transplantat Biol Res Ctr, 149 13th St,Room 5101, Boston, MA 02129 USA.	rzhang5@partners.org						Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Chiodetti L, 2006, J IMMUNOL, V176, P2279, DOI 10.4049/jimmunol.176.4.2279; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Gardner JM, 2013, IMMUNITY, V39, P560, DOI 10.1016/j.immuni.2013.08.005; Li XC, 2001, IMMUNITY, V14, P407, DOI 10.1016/S1074-7613(01)00121-2; Mueller DL, 2004, NAT IMMUNOL, V5, P883, DOI 10.1038/ni1106; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Schwartz RH, 1996, J EXP MED, V184, P1, DOI 10.1084/jem.184.1.1; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035	9	3	3	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2013	39	3					427	429		10.1016/j.immuni.2013.08.022	http://dx.doi.org/10.1016/j.immuni.2013.08.022			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UM	24054325	Bronze			2022-12-18	WOS:000330949600006
J	Randolph, GJ				Randolph, Gwendalyn J.			Macrophages in Marseille	IMMUNITY			English	News Item								Immunology has recently witnessed several new developments in understanding the biology of macrophages. These exciting developments were the focus of a conference in Marseille, France, in January 2013. This conference is summarized here.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Randolph, GJ (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	grandolph@path.wustl.edu							0	3	3	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2013	38	4					619	621		10.1016/j.immuni.2013.04.002	http://dx.doi.org/10.1016/j.immuni.2013.04.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RP	23601676	Bronze			2022-12-18	WOS:000330942100001
J	Newell, EW; Sigel, N; Bendall, SC; Nolan, GP; Davis, MM				Newell, Evan W.; Sigel, Natalia; Bendall, Sean C.; Nolan, Garry P.; Davis, Mark M.			Cytometry by Time-of-Flight Shows Combinatorial Cytokine Expression and Virus-Specific Cell Niches within a Continuum of CD8(+) T Cell Phenotypes (vol 36, pg 142, 2012)	IMMUNITY			English	Correction												mmdavis@stanford.edu	Newell, Evan W/F-9711-2012; Bendall, Sean/AGG-0126-2022; Nolan, Garry/AAE-7903-2019	Newell, Evan W/0000-0002-2889-243X; 				Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002	1	3	3	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN 24	2013	38	1					198	199		10.1016/j.immuni.2012.12.002	http://dx.doi.org/10.1016/j.immuni.2012.12.002			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	079TQ		Green Accepted, Bronze			2022-12-18	WOS:000314195500021
J	Blander, JM				Blander, J. Magarian			Designing a Type I Interferon Signaling Phagosome	IMMUNITY			English	Editorial Material							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PHAGOCYTOSIS	Circulating immune complexes trigger type I interferons exacerbating disease in systemic lupus erythematosus. In this issue of Immunity, Henault et al. (2012) show that Fc gamma-receptor, Toll-like receptor 9, and LC3 conspire to mold phagosomes into type I interferon signaling platforms.	Mt Sinai Sch Med, Inst Immunol, Dept Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Blander, JM (corresponding author), Mt Sinai Sch Med, Inst Immunol, Dept Med, New York, NY 10029 USA.	julie.blander@mssm.edu		Blander, Julie Magarian/0000-0001-9207-1700				Elkon KB, 2012, CURR OPIN IMMUNOL, V24, P665, DOI 10.1016/j.coi.2012.08.004; Florey O, 2011, NAT CELL BIOL, V13, P1335, DOI 10.1038/ncb2363; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Henault J, 2012, IMMUNITY, V37, P986, DOI 10.1016/j.immuni.2012.09.014; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Martinez J, 2011, P NATL ACAD SCI USA, V108, P17396, DOI 10.1073/pnas.1113421108; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029; TUNG KSK, 1981, CLIN EXP IMMUNOL, V43, P615; Underhill DM, 2012, NAT REV IMMUNOL, V12, P492, DOI 10.1038/nri3244	10	3	3	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	DEC 14	2012	37	6					947	949		10.1016/j.immuni.2012.11.009	http://dx.doi.org/10.1016/j.immuni.2012.11.009			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057PH	23244713	Bronze			2022-12-18	WOS:000312575000001
J	Klein, L; Jovanovic, K				Klein, Ludger; Jovanovic, Ksenija			Regulatory T Cell Differentiation: Turning Harmful into Useful	IMMUNITY			English	Editorial Material							THYMIC SELECTION	In this issue of Immunity, Lee et al. (2012) demonstrate a surprisingly broad "window of opportunity" for regulatory T (Treg) cell induction and provide evidence for an avidity model of Treg cell differentiation versus deletion.	[Klein, Ludger; Jovanovic, Ksenija] Univ Munich, Inst Immunol, D-80336 Munich, Germany	University of Munich	Klein, L (corresponding author), Univ Munich, Inst Immunol, Goethestr 31, D-80336 Munich, Germany.	ludger.klein@med.lmu.de	Klein, Ludger/G-8785-2011	Klein, Ludger/0000-0003-2054-071X				Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Hinterberger M, 2010, NAT IMMUNOL, V11, P512, DOI 10.1038/ni.1874; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; Lee HM, 2012, IMMUNITY, V37, P475, DOI 10.1016/j.immuni.2012.07.009; Leung MWL, 2009, J EXP MED, V206, P2121, DOI 10.1084/jem.20091033; Moon JJ, 2011, P NATL ACAD SCI USA, V108, P14602, DOI 10.1073/pnas.1109806108; Seddon B, 2000, IMMUNOL TODAY, V21, P95, DOI 10.1016/S0167-5699(99)01559-5; Simons DM, 2010, J LEUKOCYTE BIOL, V88, P1099, DOI 10.1189/jlb.0310183; VONBOEHMER H, 1989, IMMUNOL TODAY, V10, P57, DOI 10.1016/0167-5699(89)90307-1	10	3	3	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP 21	2012	37	3					441	443		10.1016/j.immuni.2012.09.002	http://dx.doi.org/10.1016/j.immuni.2012.09.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	011XG	22999949	Bronze			2022-12-18	WOS:000309199000006
J	Rodewald, HR				Rodewald, Hans-Reimer			A Game of Kit and Mouse: The Kit Is Still in the Bag Response	IMMUNITY			English	Letter							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MAST-CELLS; MICE		German Canc Res Ctr, Div Cellular Immunol, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Rodewald, HR (corresponding author), German Canc Res Ctr, Div Cellular Immunol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	hr.rodewald@dkfz.de						Bennett JL, 2009, J IMMUNOL, V182, P5507, DOI 10.4049/jimmunol.0801485; Brown MA, 2012, IMMUNITY, V36, P891, DOI 10.1016/j.immuni.2012.05.004; Dudeck A, 2011, IMMUNITY, V34, P973, DOI 10.1016/j.immuni.2011.03.028; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Li HM, 2011, J IMMUNOL, V187, P274, DOI 10.4049/jimmunol.1003603; Mancardi DA, 2011, J IMMUNOL, V186, P1899, DOI 10.4049/jimmunol.1003642; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; Piconese S, 2011, LAB INVEST, V91, P627, DOI 10.1038/labinvest.2011.3; Sayed BA, 2011, J IMMUNOL, V186, P3294, DOI 10.4049/jimmunol.1003574; Secor VH, 2000, J EXP MED, V191, P813, DOI 10.1084/jem.191.5.813	10	3	3	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 29	2012	36	6					893	894		10.1016/j.immuni.2012.06.004	http://dx.doi.org/10.1016/j.immuni.2012.06.004			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	969ZE		Bronze			2022-12-18	WOS:000306097100004
J	Chatila, TA; Williams, CB				Chatila, Talal A.; Williams, Calvin B.			Foxp3: Shades of Tolerance	IMMUNITY			English	Editorial Material							REGULATORY T-CELLS		[Chatila, Talal A.] Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Chatila, Talal A.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Williams, Calvin B.] Med Coll Wisconsin, Rheumatol Sect, Dept Pediat, Milwaukee, WI 53226 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Medical College of Wisconsin	Chatila, TA (corresponding author), Childrens Hosp, Div Immunol, 300 Longwood Ave, Boston, MA 02115 USA.	talal.chatila@childrens.harvard.edu		Williams, Calvin/0000-0002-5492-8475; Chatila, Talal/0000-0001-7439-2762	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085090] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI085090] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bettini ML, 2012, IMMUNITY, V36, P717, DOI 10.1016/j.immuni.2012.03.020; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Darce J, 2012, IMMUNITY, V36, P731, DOI 10.1016/j.immuni.2012.04.007; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Haribhai D, 2011, IMMUNITY, V35, P109, DOI 10.1016/j.immuni.2011.03.029; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Li B, 2007, INT IMMUNOL, V19, P825, DOI 10.1093/intimm/dxm043; Torgerson TR, 2007, J ALLERGY CLIN IMMUN, V120, P744, DOI 10.1016/j.jaci.2007.08.044; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	10	3	4	1	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY 25	2012	36	5					693	694		10.1016/j.immuni.2012.05.011	http://dx.doi.org/10.1016/j.immuni.2012.05.011			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	954VL	22633453	Green Accepted, Bronze			2022-12-18	WOS:000304976000001
J	Koyasu, S; Moro, K				Koyasu, Shigeo; Moro, Kazuyo			Natural "Helper" Cells in the Lung: Good or Bad Help?	IMMUNITY			English	Editorial Material							INNATE LYMPHOID-CELLS; IMMUNITY; INFLAMMATION	The natural helper (NH) cell comprises a newly identified Th2 cell-type innate lymphocyte population. In this issue of Immunity, Halim et al. (2012) provide evidence that NH cells reside in the lung and play a critical role in protease allergen-induced airway inflammation.	[Koyasu, Shigeo; Moro, Kazuyo] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 1608582, Japan; [Koyasu, Shigeo; Moro, Kazuyo] RIKEN Res Ctr Allergy & Immunol RCAI, Lab Immune Cell Syst, Kanagawa 2300045, Japan; [Koyasu, Shigeo] JSPS, Res Ctr Sci Syst, Tokyo 1028472, Japan; [Moro, Kazuyo] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Tokyo 1020076, Japan	Keio University; RIKEN; Japan Society for the Promotion of Science; Japan Science & Technology Agency (JST)	Koyasu, S (corresponding author), Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 1608582, Japan.	koyasu@z3.keio.jp	Koyasu, Shigeo/J-5583-2015; Moro, Kazuyo/A-5987-2016	Koyasu, Shigeo/0000-0001-9585-3038; Moro, Kazuyo/0000-0002-7377-1303	Grants-in-Aid for Scientific Research [22689013] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Reed CE, 2004, J ALLERGY CLIN IMMUN, V114, P997, DOI 10.1016/j.jaci.2004.07.060; Saenz SA, 2010, TRENDS IMMUNOL, V31, P407, DOI 10.1016/j.it.2010.09.001; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Yasuda K, 2012, P NATL ACAD SCI USA, V109, P3451, DOI 10.1073/pnas.1201042109	10	3	4	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAR 23	2012	36	3					317	319		10.1016/j.immuni.2012.03.001	http://dx.doi.org/10.1016/j.immuni.2012.03.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	915ST	22444628	Bronze			2022-12-18	WOS:000302048400004
J	Haining, WN				Haining, W. Nicholas			The Numerology of T Cell Functional Diversity	IMMUNITY			English	Editorial Material							GENE-EXPRESSION; DIFFERENTIATION; HETEROGENEITY; MEMORY	Memory T cells are heterogeneous in phenotype and function. In this issue of Immunity, Newell et al. (2012) use a new flow cytometry platform to show that the functional heterogeneity of the human T cell compartment is even greater than previously thought.	[Haining, W. Nicholas] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Haining, W. Nicholas] Harvard Univ, Sch Med, Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Haining, W. Nicholas] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Haining, WN (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, 44 Binney St, Boston, MA 02115 USA.	nicholas_haining@dfci.harvard.edu			NIAID NIH HHS [R01 AI091493-03, U19 AI082630-02, R01 AI091493, U19 AI082630] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091493, U19AI082630] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Flatz L, 2011, P NATL ACAD SCI USA, V108, P5724, DOI 10.1073/pnas.1013084108; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Ma C, 2011, NAT MED, V17, P738, DOI 10.1038/nm.2375; McKinstry KK, 2010, IMMUNOLOGY, V130, P1, DOI 10.1111/j.1365-2567.2010.03259.x; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050	10	3	3	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN 27	2012	36	1					10	12		10.1016/j.immuni.2012.01.006	http://dx.doi.org/10.1016/j.immuni.2012.01.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	885GG	22284416	Green Accepted, Bronze			2022-12-18	WOS:000299766000005
J	Ballesteros-Tato, A; Randall, TD				Ballesteros-Tato, Andre; Randall, Troy D.			Memory: The Incomplete Unhappening of Differentiation	IMMUNITY			English	Editorial Material							T-CELLS; EFFECTOR; BET	The signals that regulate the differentiation of central and effector memory T cells remain unclear. In this issue of Immunity, Pepper et al. (2011) and Marshall et al. (2011) implicate the differential expression of transcription factors in driving memory subtypes.	[Ballesteros-Tato, Andre; Randall, Troy D.] Univ Rochester, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA	University of Rochester	Randall, TD (corresponding author), Univ Rochester, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA.	troy_randall@urmc.rochester.edu		Ballesteros-Tato, Andre/0000-0002-4833-593X				Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Marshall HD, 2011, IMMUNITY, V35, P633, DOI 10.1016/j.immuni.2011.08.016; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Soares H, 2007, J EXP MED, V204, P1095, DOI 10.1084/jem.20070176	10	3	3	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT 28	2011	35	4					496	498		10.1016/j.immuni.2011.10.001	http://dx.doi.org/10.1016/j.immuni.2011.10.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	843FM	22035843	Bronze			2022-12-18	WOS:000296657700008
J	Saito, T				Saito, Takashi			Nanocluster Formation: More with Memory	IMMUNITY			English	Editorial Material							CELL-RECEPTOR MICROCLUSTERS; T-CELLS; ACTIVATION	The molecular basis of quicker and stronger responses by memory T cells is elusive. In this issue of Immunity, Kumar et al. (2011) demonstrate that more T cell receptor nanoclusters are present on memory cells than naive T cells before antigen stimulation, suggesting a basis for quick memory response.	[Saito, Takashi] RIKEN Res Ctr Allergy & Immunol, Lab Cell Signaling, Kanagawa 2300045, Japan; [Saito, Takashi] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan	RIKEN; Osaka University	Saito, T (corresponding author), RIKEN Res Ctr Allergy & Immunol, Lab Cell Signaling, Kanagawa 2300045, Japan.	saito@rcai.riken.jp	Saito, Takashi/C-9684-2009	Saito, Takashi/0000-0001-9495-3547				Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Kumar R, 2011, IMMUNITY, V35, P375, DOI 10.1016/j.immuni.2011.08.010; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; MacLeod MKL, 2010, IMMUNOLOGY, V130, P10, DOI 10.1111/j.1365-2567.2010.03260.x; SCHAMEL WW, 2008, J EXP MED, V202, P493; Torres J, 2002, J MOL BIOL, V316, P375, DOI 10.1006/jmbi.2001.5268; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	9	3	3	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 23	2011	35	3					318	320		10.1016/j.immuni.2011.09.008	http://dx.doi.org/10.1016/j.immuni.2011.09.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	831RF	21943486	Bronze			2022-12-18	WOS:000295748100003
J	Erdman, LK; Kain, KC				Erdman, Laura K.; Kain, Kevin C.			Taking the STING Out of Malaria	IMMUNITY			English	Editorial Material							CEREBRAL MALARIA; RESPONSES; HEMOZOIN; DNA		[Erdman, Laura K.; Kain, Kevin C.] Univ Toronto, Univ Hlth Network, McLaughlin Rotman Ctr Global Hlth, Toronto, ON M5G 1L7, Canada	University of Toronto; University Health Network Toronto	Kain, KC (corresponding author), Univ Toronto, Univ Hlth Network, McLaughlin Rotman Ctr Global Hlth, Toronto, ON M5G 1L7, Canada.	kevin.kain@uhn.ca	Erdman, Laura/ABB-6936-2021	Erdman, Laura/0000-0001-8142-825X; Kain, Kevin/0000-0001-6068-1272				Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Lovegrove FE, 2007, AM J PATHOL, V171, P1894, DOI 10.2353/ajpath.2007.070630; Luty AJF, 2000, INFECT IMMUN, V68, P3909, DOI 10.1128/IAI.68.7.3909-3915.2000; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Sharma S, 2011, IMMUNITY, V35, P194, DOI 10.1016/j.immuni.2011.05.016; Shimosato T, 2006, CELL MICROBIOL, V8, P485, DOI 10.1111/j.1462-5822.2005.00640.x; Shio MT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000559; van der Heyde HC, 2006, TRENDS PARASITOL, V22, P503, DOI 10.1016/j.pt.2006.09.002; Vigario AM, 2007, J IMMUNOL, V178, P6416, DOI 10.4049/jimmunol.178.10.6416; Wu XZ, 2010, J IMMUNOL, V184, P4338, DOI 10.4049/jimmunol.0903824	10	3	3	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	AUG 26	2011	35	2					149	151		10.1016/j.immuni.2011.08.002	http://dx.doi.org/10.1016/j.immuni.2011.08.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	813SC	21867921	Bronze			2022-12-18	WOS:000294387900002
J	Franchi, L; Nunez, G				Franchi, Luigi; Nunez, Gabriel			A New Twist on the PYRIN Mediterranean Coast	IMMUNITY			English	Editorial Material							INFLAMMASOME; CASPASE-1; INTERACTS; PROTEIN; DOMAIN	Familial Mediterranean fever is caused by mutations of the PYRIN protein. Chea et al. (2011) provide evidence for a ASC protein-dependent pathway of caspase-1 activation in which gain-of-function PYRIN mutations lead to IL-1 beta cytokine overproduction and inflammatory disease.	[Franchi, Luigi; Nunez, Gabriel] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Franchi, Luigi; Nunez, Gabriel] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Nunez, G (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	bclx@umich.edu	Nuñez, Gabriel/A-7160-2014					Chae JJ, 2006, P NATL ACAD SCI USA, V103, P9982, DOI 10.1073/pnas.0602081103; Chae JJ, 2011, IMMUNITY, V34, P755, DOI 10.1016/j.immuni.2011.02.020; Chae JJ, 2003, MOL CELL, V11, P591, DOI 10.1016/S1097-2765(03)00056-X; Dowds TA, 2003, BIOCHEM BIOPH RES CO, V302, P575, DOI 10.1016/S0006-291X(03)00221-3; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Kastner DL, 2010, CELL, V140, P784, DOI 10.1016/j.cell.2010.03.002; Papin S, 2007, CELL DEATH DIFFER, V14, P1457, DOI 10.1038/sj.cdd.4402142; Seshadri S, 2007, J IMMUNOL, V179, P1274, DOI 10.4049/jimmunol.179.2.1274; Yu JW, 2007, MOL CELL, V28, P214, DOI 10.1016/j.molcel.2007.08.029; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734	10	3	3	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY 27	2011	34	5					695	697		10.1016/j.immuni.2011.05.004	http://dx.doi.org/10.1016/j.immuni.2011.05.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	775JV	21616439	Bronze			2022-12-18	WOS:000291456500007
J	Stewart, CA; Trinchieri, G				Stewart, C. Andrew; Trinchieri, Giorgio			At 17, In-10's Passion Need Not Inflame	IMMUNITY			English	Editorial Material							REGULATORY T-CELLS; INTERLEUKIN-10; SOCS3	In this issue of Immunity, Chaudhry et al. (2011) and Huber et al. (2011) report that control of Th17 cell responses during colonic inflammation requires direct signaling by IL-10 in regulatory T cells and Th17 cells.	[Stewart, C. Andrew; Trinchieri, Giorgio] NCI, Canc & Inflammat Program, Ctr Canc Res, NCI Frederick, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Trinchieri, G (corresponding author), NCI, Canc & Inflammat Program, Ctr Canc Res, NCI Frederick, Frederick, MD 21702 USA.	trinchig@mail.nih.gov	Stewart, Charles/G-2470-2012; Trinchieri, Giorgio/F-9369-2015	Trinchieri, Giorgio/0000-0001-5892-7464	NATIONAL CANCER INSTITUTE [ZIABC010793] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Huber S, 2011, IMMUNITY, V34, P554, DOI 10.1016/j.immuni.2011.01.020; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; Ma XJ, 2001, ADV IMMUNOL, V79, P55; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343	11	3	3	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR 22	2011	34	4					460	462		10.1016/j.immuni.2011.04.004	http://dx.doi.org/10.1016/j.immuni.2011.04.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	761AQ	21511180	Bronze			2022-12-18	WOS:000290367300005
J	Feau, S; Schoenberger, SP				Feau, Sonia; Schoenberger, Stephen P.			From the Loading Dock to the Boardroom: A New Job for Akt Kinase	IMMUNITY			English	Editorial Material							EFFECTOR	A new report in Immunity shows that, rather than driving the metabolic changes required for proliferation, Akt controls the gene expression programs that determine whether activated CD8(+) T cells differentiate into memory or effector cells.	[Feau, Sonia; Schoenberger, Stephen P.] La Jolla Inst Allergy & Immunol, Cellular Immunol Lab, La Jolla, CA 92037 USA	La Jolla Institute for Immunology	Schoenberger, SP (corresponding author), La Jolla Inst Allergy & Immunol, Cellular Immunol Lab, 9420 Athena Circle, La Jolla, CA 92037 USA.	sps@liai.org			NCI NIH HHS [R01 CA081261-06, R01 CA081261] Funding Source: Medline; NIAID NIH HHS [R01 AI076972, R01 AI076972-05] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA081261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076972] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BURGERING BM, 2008, J IMMUNOL, V27, P4161; Finlay D, 2010, ANN NY ACAD SCI, V1183, P149, DOI 10.1111/j.1749-6632.2009.05134.x; Hedrick SM, 2009, NAT IMMUNOL, V10, P1057, DOI 10.1038/ni.1784; Juntilla MA, 2008, IMMUNOL LETT, V116, P104, DOI 10.1016/j.imlet.2007.12.008; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Macintyre AN, 2011, IMMUNITY, V34, P224, DOI 10.1016/j.immuni.2011.01.012; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI200113296; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012	8	3	3	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 25	2011	34	2					141	143		10.1016/j.immuni.2011.02.013	http://dx.doi.org/10.1016/j.immuni.2011.02.013			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	729YD	21349425	Green Accepted, Bronze			2022-12-18	WOS:000287989500003
J	Guo, CG; Alt, FW; Giallourakis, C				Guo, Chunguang; Alt, Frederick W.; Giallourakis, Cosmas			PAIRing for Distal Igh Locus V(D)J Recombination	IMMUNITY			English	Editorial Material							HEAVY-CHAIN GENE; B-CELL; IMMUNOGLOBULIN; GENERATION; REPERTOIRE; SEGMENTS	In this issue of Immunity Ebert et al. (2011) defined the lineage- and stage-specific Pax5-dependent cis-sequences termed PAIR elements in the distal region of the mouse heavy chain immunoglobulin locus (Igh). These sequences may have a role in long-range IgH V(D)J recombination.	[Guo, Chunguang; Alt, Frederick W.; Giallourakis, Cosmas] Harvard Univ, Immune Dis Inst, Howard Hughes Med Inst, Childrens Hosp,Dept Genet,Med Sch, Boston, MA 02115 USA; [Giallourakis, Cosmas] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital	Alt, FW (corresponding author), Harvard Univ, Immune Dis Inst, Howard Hughes Med Inst, Childrens Hosp,Dept Genet,Med Sch, 300 Longwood Ave, Boston, MA 02115 USA.	alt@enders.tch.harvard.edu			NIAID NIH HHS [R01 AI020047] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020047] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Corcoran AE, 2010, SEMIN IMMUNOL, V22, P353, DOI 10.1016/j.smim.2010.08.001; Degner-Leisso SC, 2010, SEMIN IMMUNOL, V22, P346, DOI 10.1016/j.smim.2010.08.002; Ebert A, 2011, IMMUNITY, V34, P175, DOI 10.1016/j.immuni.2011.02.005; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Jhunjhunwala S, 2009, CELL, V138, P435, DOI 10.1016/j.cell.2009.07.016; MALYNN BA, 1990, J EXP MED, V171, P843, DOI 10.1084/jem.171.3.843; Subrahmanyam R, 2010, SEMIN IMMUNOL, V22, P337, DOI 10.1016/j.smim.2010.08.003; YANCOPOULOS GD, 1986, CELL, V44, P251, DOI 10.1016/0092-8674(86)90759-2; YANCOPOULOS GD, 1984, NATURE, V311, P727, DOI 10.1038/311727a0	10	3	3	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 25	2011	34	2					139	141		10.1016/j.immuni.2011.02.010	http://dx.doi.org/10.1016/j.immuni.2011.02.010			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	729YD	21349424	Bronze			2022-12-18	WOS:000287989500002
J	Hardt, WD				Hardt, Wolf-Dietrich			Infected Cell in Trouble: Bystander Cells Ring the Bell	IMMUNITY			English	Editorial Material							IMMUNE; RESPONSES	Infection with intracellular pathogens triggers cytokine production in the infected cells. In this issue of Immunity, Kasper et al. (2010) demonstrate that in certain infections, much of the response is mounted by noninfected neighboring cells.	Swiss Fed Inst Technol, D Biol, Inst Microbiol, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Hardt, WD (corresponding author), Swiss Fed Inst Technol, D Biol, Inst Microbiol, CH-8093 Zurich, Switzerland.	wolf-dietrich.hardt@micro.biol.ethz.ch		Hardt, Wolf-Dietrich/0000-0002-9892-6420				Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Dolowschiak T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001194; Eckmann L, 2005, SPRINGER SEMIN IMMUN, V27, P181, DOI 10.1007/s00281-005-0207-5; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Jones RM, 2008, CELL HOST MICROBE, V3, P233, DOI 10.1016/j.chom.2008.02.016; Kasper CA, 2010, IMMUNITY, V33, P804, DOI 10.1016/j.immuni.2010.10.015; Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102; Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; Ting JPY, 2010, SCIENCE, V327, P286, DOI 10.1126/science.1184004	10	3	3	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 24	2010	33	5					652	654		10.1016/j.immuni.2010.11.015	http://dx.doi.org/10.1016/j.immuni.2010.11.015			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	704VB	21094461	Bronze			2022-12-18	WOS:000286082600004
J	Huber, S; Flavell, RA				Huber, Samuel; Flavell, Richard A.			Checks and Balances: IL-23 in the Intestine	IMMUNITY			English	Editorial Material							INFLAMMATION; CELLS; COLITIS; DISEASE; TH17	In this issue of Immunity, Ahern et al. (2010) show that IL-23R signaling in CD4(+) T cells induces effector and suppresses regulatory CD4(+) T cells, which is critical for the development of intestinal, but not systemic, inflammation.	[Huber, Samuel; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	richard.flavell@yale.edu		Huber, Samuel/0000-0001-9325-8227	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Elson CO, 2007, GASTROENTEROLOGY, V132, P2359, DOI 10.1053/j.gastro.2007.03.104; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295	10	3	3	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 27	2010	33	2					150	152		10.1016/j.immuni.2010.08.005	http://dx.doi.org/10.1016/j.immuni.2010.08.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	647XU	20732638	Green Accepted, Bronze			2022-12-18	WOS:000281654900005
J	Luther, SA				Luther, Sanjiv A.			Plasma Cell Precursors: Long-Distance Travelers Looking for a Home	IMMUNITY			English	Editorial Material							LYMPH-NODE; MOTILITY	Little is known about the migration of plasma cell precursors to the lymph node medulla. In this issue of Immunity, Fooksman et al. (2010) propose that this migration is largely independent of chemotactic cues but follows a long linear walk of random orientation.	Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	University of Lausanne	Luther, SA (corresponding author), Univ Lausanne, Dept Biochem, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.	sluther@unil.ch	Luther, Sanjiv A/B-4380-2016; Luther, Sanjiv/AAP-6525-2020; , Sanjiv/B-4380-2016	Luther, Sanjiv A/0000-0002-8758-957X; Luther, Sanjiv/0000-0002-8758-957X; , Sanjiv/0000-0002-0614-561X				Angeli V, 2006, IMMUNITY, V24, P203, DOI 10.1016/j.immuni.2006.01.003; Bajenoff M, 2007, TRENDS IMMUNOL, V28, P346, DOI 10.1016/j.it.2007.06.005; Cahalan MD, 2008, ANNU REV IMMUNOL, V26, P585, DOI 10.1146/annurev.immunol.24.021605.090620; Cyster JG, 2003, IMMUNOL REV, V194, P48, DOI 10.1034/j.1600-065X.2003.00041.x; Fooksman DR, 2010, IMMUNITY, V33, P118, DOI 10.1016/j.immuni.2010.06.015; MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x; Mohr E, 2009, J IMMUNOL, V182, P2113, DOI 10.4049/jimmunol.0802771; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; Tarlinton D, 2008, CURR OPIN IMMUNOL, V20, P162, DOI 10.1016/j.coi.2008.03.016; Witt CM, 2005, PLOS BIOL, V3, P1062, DOI 10.1371/journal.pbio.0030160	10	3	3	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 23	2010	33	1					9	11		10.1016/j.immuni.2010.07.010	http://dx.doi.org/10.1016/j.immuni.2010.07.010			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	632JD	20643335	Bronze			2022-12-18	WOS:000280418100005
J	Podack, ER				Podack, Eckhard R.			How to Polymerize in Order to Survive	IMMUNITY			English	Editorial Material							NATURAL-KILLER-CELLS; MEMBRANE ATTACK; 9TH COMPONENT; T-CELLS; COMPLEMENT	Perforation of membranes and pore formation is mediated by polymerization of proteins of the immune system, complement C9 and Perforin, which share the conserved MACPF domain. In this issue of Immunity, Baran et al. (2009) identify the molecular mechanism initiating polymerization as charge interactions in the MACPF domain.	Univ Miami, Leonard Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA	University of Miami	Podack, ER (corresponding author), Univ Miami, Leonard Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA.	epodack@med.miami.edu						Baran K, 2009, IMMUNITY, V30, P684, DOI 10.1016/j.immuni.2009.03.016; BLUMENTHAL R, 1984, P NATL ACAD SCI-BIOL, V81, P5551, DOI 10.1073/pnas.81.17.5551; Hadders MA, 2007, SCIENCE, V317, P1552, DOI 10.1126/science.1147103; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; PODACK ER, 1982, P NATL ACAD SCI-BIOL, V79, P574, DOI 10.1073/pnas.79.2.574; PODACK ER, 1983, NATURE, V302, P442, DOI 10.1038/302442a0; Slade DJ, 2008, J MOL BIOL, V379, P331, DOI 10.1016/j.jmb.2008.03.061; Spielman J, 1998, J IMMUNOL, V161, P7063; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; YOUNG JDE, 1986, SCIENCE, V233, P184, DOI 10.1126/science.2425429	10	3	3	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY 22	2009	30	5					668	670		10.1016/j.immuni.2009.04.004	http://dx.doi.org/10.1016/j.immuni.2009.04.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	449UX	19464990	Bronze			2022-12-18	WOS:000266356900008
J	Allman, D; Calamito, M				Allman, David; Calamito, Marco			Instructing B Cell Fates on the Fringe	IMMUNITY			English	Editorial Material							MARGINAL-ZONE; POSITIVE SELECTION		[Allman, David; Calamito, Marco] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Allman, D (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	dallman@mail.med.upenn.edu			NIAID NIH HHS [R01 AI052861] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0; Pillai S, 2005, ANNU REV IMMUNOL, V23, P161, DOI 10.1146/annurev.immunol.23.021704.115728; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Stanley P, 2007, CURR OPIN STRUC BIOL, V17, P530, DOI 10.1016/j.sbi.2007.09.007; Tan JB, 2009, IMMUNITY, V30, P254, DOI 10.1016/j.immuni.2008.12.016; Thomas M, 2007, BLOOD, V109, P3342, DOI 10.1182/blood-2006-09-046698; Wen LJ, 2005, IMMUNITY, V23, P297, DOI 10.1016/j.immuni.2005.08.007	10	3	3	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	FEB 20	2009	30	2					175	177		10.1016/j.immuni.2009.01.003	http://dx.doi.org/10.1016/j.immuni.2009.01.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	412FT	19239900	Bronze			2022-12-18	WOS:000263710500004
J	Ziegler, SF				Ziegler, Steven F.			Regulatory T cells and inflammation: Better late than never	IMMUNITY			English	Editorial Material							AIRWAY INFLAMMATION; ASTHMA		Benaroya Res Inst, Program Immunol, Seattle, WA 98101 USA	Benaroya Research Institute	Ziegler, SF (corresponding author), Benaroya Res Inst, Program Immunol, Seattle, WA 98101 USA.	sziegler@benaroyaresearch.org						Akdis M, 2006, CURR OPIN IMMUNOL, V18, P738, DOI 10.1016/j.coi.2006.06.003; Hammad H, 2008, NAT REV IMMUNOL, V8, P193, DOI 10.1038/nri2275; Kearley J, 2005, J EXP MED, V202, P1539, DOI 10.1084/jem.20051166; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Umetsu DT, 2006, CURR OPIN IMMUNOL, V18, P727, DOI 10.1016/j.coi.2006.09.007; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Wilson MS, 2005, J EXP MED, V202, P1199, DOI 10.1084/jem.20042572; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	9	3	5	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 18	2008	29	1					5	7		10.1016/j.immuni.2008.07.001	http://dx.doi.org/10.1016/j.immuni.2008.07.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	329YB	18631450	Bronze			2022-12-18	WOS:000257905400003
J	Burkhardt, JK				Burkhardt, Janis K.			Integrins put the brakes on microcluster dynamics at the immunological synapse	IMMUNITY			English	Editorial Material							T-CELL-RECEPTOR; ACTIVATION	Integrin engagement costimulates T cell receptor signaling, but the underlying mechanisms are poorly understood. In this issue of Immunity, Nguyen et al. (2008) show that engagement of VLA-4 promotes sustained signaling by altering the dynamics of actin filaments and signaling molecules at the immunological synapse.	[Burkhardt, Janis K.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Burkhardt, Janis K.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania	Burkhardt, JK (corresponding author), Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	jburkhar@mail.med.upenn.edu		Burkhardt, Janis/0000-0002-8176-1375				Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Burkhardt JK, 2008, ANNU REV IMMUNOL, V26, P233, DOI 10.1146/annurev.immunol.26.021607.090347; Cemerski S, 2007, IMMUNITY, V26, P345, DOI 10.1016/j.immuni.2007.01.013; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Nguyen K, 2008, IMMUNITY, V28, P810, DOI 10.1016/j.immuni.2008.04.019; Seminario MC, 2008, IMMUNOL REV, V221, P90, DOI 10.1111/j.1600-065X.2008.00593.x; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	10	3	3	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2008	28	6					732	734		10.1016/j.immuni.2008.05.002	http://dx.doi.org/10.1016/j.immuni.2008.05.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	313SL	18549795	Bronze			2022-12-18	WOS:000256760200004
J	Guerra, N; Tan, YX; Joncker, NT; Choy, A; Gallardo, F; Xiong, N; Knoblaugh, S; Cado, D; Greenberg, NM; Raulet, DH				Guerra, Nadia; Tan, Ying Xim; Joncker, Nathalie T.; Choy, Augustine; Gallardo, Fermin; Xiong, Na; Knoblaugh, Susan; Cado, Dragana; Greenberg, Norman M.; Raulet, David H.			NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy (vol 28, pg 571, 2008)	IMMUNITY			English	Correction												raulet@berkeley.edu		Raulet, David/0000-0002-1257-8649				Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016	1	3	3	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY	2008	28	5					723	723		10.1016/j.immuni.2008.04.001	http://dx.doi.org/10.1016/j.immuni.2008.04.001			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	302XS		Bronze			2022-12-18	WOS:000256003900018
J	Gangloff, M; Gay, NJ				Gangloff, Monique; Gay, Nicholas J.			Baseless assumptions: Activation of TLR9 by DNA	IMMUNITY			English	Editorial Material							RECOGNITION		[Gangloff, Monique; Gay, Nicholas J.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Cambridge	Gangloff, M (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Rd, Cambridge CB2 1GA, England.	mg308@mole.bio.cam.ac.uk; njg11@mole.bio.cam.ac.uk		Gangloff, Monique/0000-0001-6131-0115				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Gay NJ, 2006, NAT REV IMMUNOL, V6, P693, DOI 10.1038/nri1916; Haas T, 2008, IMMUNITY, V28, P315, DOI 10.1016/j.immuni.2008.01.013; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Ranjith-Kumar CT, 2007, J BIOL CHEM, V282, P7668, DOI 10.1074/jbc.M610946200	9	3	3	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2008	28	3					293	294		10.1016/j.immuni.2008.02.009	http://dx.doi.org/10.1016/j.immuni.2008.02.009			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	276LH	18342000	Bronze			2022-12-18	WOS:000254142500003
J	Engelhardt, JJ; Krummel, MF				Engelhardt, John J.; Krummel, Matthew F.			The importance of prolonged binding to antigen-presenting cells for T cell fate decisions	IMMUNITY			English	Editorial Material							IMMUNOLOGICAL SYNAPSE; DENDRITIC CELLS; LYMPH-NODES; RESPONSES; ACTIVATION; THETA	How critical is it for T cells to stably arrest on antigen-presenting cells? In this issue of Immunity, Scholer et al. (2008) demonstrate profound effector and memory defects for CD8(+) T cells encountering "nonsticky" antigen-presenting cells lacking intercellular adhesion molecule-1.	[Engelhardt, John J.; Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Krummel, MF (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.	matthew.krummel@ucsf.edu						Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Friedman RS, 2006, NAT IMMUNOL, V7, P1101, DOI 10.1038/ni1384; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hugues S, 2007, NAT IMMUNOL, V8, P921, DOI 10.1038/ni1495; Marsland BJ, 2004, J EXP MED, V200, P181, DOI 10.1084/jem.20032229; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Scholer A, 2008, IMMUNITY, V28, P258, DOI 10.1016/j.immuni.2007.12.016; Sims TN, 2007, CELL, V129, P773, DOI 10.1016/j.cell.2007.03.037; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289	11	3	3	1	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	FEB	2008	28	2					143	145		10.1016/j.immuni.2008.01.006	http://dx.doi.org/10.1016/j.immuni.2008.01.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	264GH	18275826	Bronze			2022-12-18	WOS:000253275000004
J	Vyse, TJ				Vyse, Tim J.			Understanding lupus: Fishing genes out of mice and men	IMMUNITY			English	Editorial Material							ERYTHEMATOSUS; AUTOIMMUNITY	In this issue of Immunity, the Coronin-1A gene Coro1a, which regulates cytoskeletal structure, is shown by Haraldsson et al. (2007) to be a surprising disease-susceptibility gene that contributes to the spontaneous systemic autoimmunity in the MRL mouse, a model of systemic lupus erythematosus.	Univ London Imperial Coll Sci Technol & Med, Div Med, London SW7 2AZ, England	Imperial College London	Vyse, TJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Med, London SW7 2AZ, England.	t.vyse@imperial.ac.uk						COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; DEANE JA, 2007, CONTROL IMMUNITY, V27, P801; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Haraldsson MK, 2008, IMMUNITY, V28, P40, DOI 10.1016/j.immuni.2007.11.023; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Morel L, 2001, P NATL ACAD SCI USA, V98, P1787, DOI 10.1073/pnas.031336098; Vidal S, 1998, J CLIN INVEST, V101, P696, DOI 10.1172/JCI1817; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252	8	3	4	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN	2008	28	1					8	10		10.1016/j.immuni.2007.12.007	http://dx.doi.org/10.1016/j.immuni.2007.12.007			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	254ZU	18199411	Bronze			2022-12-18	WOS:000252627300003
J	Chang, JT; Reiner, SL				Chang, John T.; Reiner, Steven L.			Protection one cell thick	IMMUNITY			English	Editorial Material							T-CELLS; DIFFERENTIATION; EFFECTOR; CYCLE	Specific immunity is a layer of defense exquisitely broad, terrifyingly thin, and yet remarkably durable on challenge. In this issue of Immunity, Stemberger et al. (2007) now take this concept to its logical extreme by offering evidence that expenditure of a single lymphocyte yields its own replenishment.	[Chang, John T.; Reiner, Steven L.] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Chang, John T.; Reiner, Steven L.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Reiner, SL (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	sreiner@mail.med.upenn.edu		Chang, John/0000-0003-0873-6218				Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Catron DM, 2006, J EXP MED, V203, P1045, DOI 10.1084/jem.20051954; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; D'Souza WN, 2006, J IMMUNOL, V177, P777, DOI 10.4049/jimmunol.177.2.777; Hodgkin PD, 1996, J EXP MED, V184, P277, DOI 10.1084/jem.184.1.277; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Reiner SL, 2007, SCIENCE, V317, P622, DOI 10.1126/science.1143775; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012	9	3	3	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	DEC	2007	27	6					832	834		10.1016/j.immuni.2007.11.009	http://dx.doi.org/10.1016/j.immuni.2007.11.009			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	245AS	18093536	Bronze			2022-12-18	WOS:000251907300004
J	Tarlinton, D; Lew, A				Tarlinton, David; Lew, Andrew			Antigen to the node: B cells go native	IMMUNITY			English	Editorial Material							DENDRITIC CELLS; LYMPH-NODE; CONDUIT	The participation of B and T cells in an immune response requires their separate activation by different forms of the target antigen. In this issue of Immunity, Pape et al. (2007) describe antigen entry into the B cell areas in the lymph node without degradation or cellular assistance.	Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia	Walter & Eliza Hall Institute	Tarlinton, D (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Melbourne, Vic 3050, Australia.	tarlinton@wehi.edu.au	Lew, Andrew M/C-7248-2013	Lew, Andrew M/0000-0002-2198-8164; Tarlinton, David/0000-0001-9928-686X				Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Batista FD, 2000, EMBO J, V19, P513, DOI 10.1093/emboj/19.4.513; BEH KJ, 1985, IMMUNOLOGY, V54, P487; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Gretz JE, 1996, J IMMUNOL, V157, P495; Pape KA, 2007, IMMUNITY, V26, P491, DOI 10.1016/j.immuni.2007.02.011; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013	9	3	3	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2007	26	4					388	390		10.1016/j.immuni.2007.04.002	http://dx.doi.org/10.1016/j.immuni.2007.04.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	162YW	17459806	Bronze			2022-12-18	WOS:000246126400003
J	Honda, K; Takaoka, A; Taniguchi, T				Honda, Kenya; Takaoka, Akinori; Taniguchi, Tadatsugu			Type I interferon gene induction by the interferon regulatory factor family of transcription factors (vol 25, pg 349, 2006)	IMMUNITY			English	Correction												tada@m.u-tokyo.ac.jp						Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009	1	3	3	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2006	25	5					849	849		10.1016/j.immuni.2006.10.004	http://dx.doi.org/10.1016/j.immuni.2006.10.004			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	105WN		Bronze			2022-12-18	WOS:000242063100017
J	Wilson, CB; Schoenborn, J				Wilson, Christopher B.; Schoenborn, Jamie			BACing up the interferon-gamma locus	IMMUNITY			English	Editorial Material							IFN-GAMMA; EXPRESSION; ELEMENTS; DIFFERENTIATION; CELLS		Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Grad Program Mol & Cellular Biol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Wilson, CB (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.				NIAID NIH HHS [R01 AI071272-06A1] Funding Source: Medline; NICHD NIH HHS [R01 HD018184-27] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071272] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Chang SJ, 2005, P NATL ACAD SCI USA, V102, P17095, DOI 10.1073/pnas.0502129102; Cho JY, 2003, INT IMMUNOL, V15, P1149, DOI 10.1093/intimm/dxg113; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Lee DU, 2004, J BIOL CHEM, V279, P4802, DOI 10.1074/jbc.M307904200; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Shnyreva M, 2004, P NATL ACAD SCI USA, V101, P12622, DOI 10.1073/pnas.0400849101; Soutto M, 2002, J IMMUNOL, V169, P6664, DOI 10.4049/jimmunol.169.12.6664; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Zhu H, 2001, J IMMUNOL, V167, P855, DOI 10.4049/jimmunol.167.2.855	10	3	5	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2006	25	5					691	693		10.1016/j.immuni.2006.10.006	http://dx.doi.org/10.1016/j.immuni.2006.10.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	105WN	17098198	Green Accepted, Bronze			2022-12-18	WOS:000242063100001
J	Wraith, DC				Wraith, David C.			Avidity and the art of self non-self discrimination	IMMUNITY			English	Editorial Material							MIMICRY		Univ Bristol, Dept Cellular & Mol Med, Bristol BS8 1TD, Avon, England	University of Bristol	Wraith, DC (corresponding author), Univ Bristol, Dept Cellular & Mol Med, Bristol BS8 1TD, Avon, England.			Wraith, David/0000-0003-2147-5614	Wellcome Trust [074731] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Anderton SM, 2002, NAT REV IMMUNOL, V2, P487, DOI 10.1038/nri842; Anderton SM, 2006, TRENDS IMMUNOL, V27, P208, DOI 10.1016/j.it.2006.03.002; Benoist C, 2001, NAT IMMUNOL, V2, P797, DOI 10.1038/ni0901-797; Hemmer B, 2000, J NEUROIMMUNOL, V107, P148, DOI 10.1016/S0165-5728(00)00226-5; Horwitz MS, 1998, NAT MED, V4, P781, DOI 10.1038/nm0798-781; PIRCHER H, 1991, NATURE, V351, P482, DOI 10.1038/351482a0; Redmond WL, 2005, IMMUNITY, V22, P275, DOI 10.1016/j.immuni.2005.01.010; Su MA, 2004, CURR OPIN IMMUNOL, V16, P746, DOI 10.1016/j.coi.2004.09.009; Zehn D, 2006, IMMUNITY, V25, P261, DOI 10.1016/j.immuni.2006.06.009	9	3	3	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2006	25	2					191	193		10.1016/j.immuni.2006.08.004	http://dx.doi.org/10.1016/j.immuni.2006.08.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	077RM	16920637	Bronze			2022-12-18	WOS:000240047500005
J	Zheng, LX; Lenardo, M				Zheng, Lixin; Lenardo, Michael			T helper 2 cells' preferred way to die	IMMUNITY			English	Editorial Material							DEATH		NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Zheng, LX (corresponding author), NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000566, ZIAAI000717, Z01AI000566, Z01AI000717] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Devadas S, 2006, IMMUNITY, V25, P237, DOI 10.1016/j.immuni.2006.06.011; Farrar JD, 2002, J CLIN INVEST, V109, P431, DOI 10.1172/JCI200215093; Kagi D, 1996, ANNU REV IMMUNOL, V14, P207, DOI 10.1146/annurev.immunol.14.1.207; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; London CA, 1998, VET IMMUNOL IMMUNOP, V63, P37, DOI 10.1016/S0165-2427(98)00080-4; Oberg HH, 1997, CELL IMMUNOL, V181, P93, DOI 10.1006/cimm.1997.1200; Sharma V, 2006, J IMMUNOL, V176, P97, DOI 10.4049/jimmunol.176.1.97	7	3	3	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2006	25	2					187	188		10.1016/j.immuni.2006.08.006	http://dx.doi.org/10.1016/j.immuni.2006.08.006			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	077RM	16920635	Bronze			2022-12-18	WOS:000240047500003
J	Schlissel, MS; Kuo, TC				Schlissel, MS; Kuo, TC			AID for innate immunity to retroviral transformation	IMMUNITY			English	Editorial Material							CYTIDINE DEAMINASE AID; B-CELLS; ENZYME; VIRUS	AID is a cytidine deaminase essential for class switch recombination and somatic hypermutation during the humoral immune response. In this issue of Immunity, Gourzi et al. (2006) show that AID also plays a critical role in innate immunity to virally induced acute pro-B cell leukemia.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Schlissel, MS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA.							Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Gourzi P, 2006, IMMUNITY, V24, P779, DOI 10.1016/j.immuni.2006.03.021; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; ROSENBERG N, 1982, CURR TOP MICROBIOL, V101, P95; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Turelli P, 2005, SCIENCE, V307, P1061, DOI 10.1126/science.1105964; Unnikrishnan I, 1999, MOL CELL BIOL, V19, P4825, DOI 10.1128/mcb.19.7.4825	9	3	3	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2006	24	6					671	672		10.1016/j.immuni.2006.06.005	http://dx.doi.org/10.1016/j.immuni.2006.06.005			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057JN	16782023	Bronze			2022-12-18	WOS:000238592200005
J	Norbury, CC; Tewalt, EF				Norbury, CC; Tewalt, EF			Upstream toward the "DRiP"-ing source of the MHC class I pathway	IMMUNITY			English	Editorial Material							ANTIGEN-PROCESSING PATHWAY; CYTOTOXIC LYMPHOCYTES-T; DEGRADATION; MOLECULES; PEPTIDES; PROTEINS	MHC class I binding peptides are generated via cytosolic degradation of a previously undefined substrate. In this issue of Immunity, Kunisawa and Shastri (2006) isolate pre-degradation polypeptide intermediates bound to a cytosolic chaperone.	Penn State Univ, Milton S Hershey Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Norbury, CC (corresponding author), Penn State Univ, Milton S Hershey Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA.							ESQUIVEL F, 1992, J EXP MED, V175, P163, DOI 10.1084/jem.175.1.163; FALK K, 1990, NATURE, V348, P248, DOI 10.1038/348248a0; Kunisawa J, 2003, MOL CELL, V12, P565, DOI 10.1016/j.molcel.2003.08.009; Kunisawa J, 2006, IMMUNITY, V24, P523, DOI 10.1016/j.immuni.2006.03.015; Paz P, 1999, IMMUNITY, V11, P241, DOI 10.1016/S1074-7613(00)80099-0; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; Yewdell JW, 1996, J IMMUNOL, V157, P1823	9	3	4	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2006	24	5					503	506		10.1016/j.immuni.2006.05.007	http://dx.doi.org/10.1016/j.immuni.2006.05.007			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	048TT	16713966	Bronze			2022-12-18	WOS:000237970100005
J	Kaufmann, SHE; Englich, S; Grossman, ML				Kaufmann, SHE; Englich, S; Grossman, ML			Bringing immunology to the classroom	IMMUNITY			English	Letter									Max Planck Inst Infect Biol, European Fed Immunol Soc, D-10117 Berlin, Germany; Max Planck Inst Infect Biol, Dept Immunol, D-10117 Berlin, Germany	Max Planck Society; Max Planck Society	Kaufmann, SHE (corresponding author), Max Planck Inst Infect Biol, European Fed Immunol Soc, Schumannstr 21-22, D-10117 Berlin, Germany.	kaufmann@mpiib-berlin.mpg.de	; Kaufmann, Stefan HE/I-5454-2014	Grossman, Mary Louise/0000-0002-4600-7131; Kaufmann, Stefan HE/0000-0001-9866-8268					0	3	3	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2006	24	4					349	349		10.1016/j.immuni.2006.03.010	http://dx.doi.org/10.1016/j.immuni.2006.03.010			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	037NF	16618590	Bronze			2022-12-18	WOS:000237153000001
J	Goldrath, AW; Hedrick, SM				Goldrath, AW; Hedrick, SM			Central tolerance matters	IMMUNITY			English	Editorial Material							AIRE-DEFICIENT MICE; GENE-EXPRESSION; AUTOIMMUNITY; PROTEIN; THYMUS; CELLS	In this issue of Immunity, Anderson et al. provide another clue to the riddle that is Aire- why do human beings and mice lacking Aire develop diffuse and pathogenic autoimmunity? They find that Aire influences central tolerance not only by promoting the expression of peripheral self-proteins in thymic medullary epithelial cells (MECs) but also by furnishing these cells with the apparatus for effective antigen presentation (Anderson et al., 2005).	Univ Calif San Diego, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Goldrath, AW (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.		Hedrick, Stephen M/E-9171-2010	Goldrath, Ananda/0000-0002-5900-508X; Hedrick, Stephen/0000-0002-6345-8751				Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Gibson TJ, 1998, TRENDS BIOCHEM SCI, V23, P242, DOI 10.1016/S0968-0004(98)01231-6; Gotter J, 2004, CURR OPIN IMMUNOL, V16, P741, DOI 10.1016/j.coi.2004.08.004; Kuroda N, 2005, J IMMUNOL, V174, P1862, DOI 10.4049/jimmunol.174.4.1862; Liston A, 2004, J EXP MED, V200, P1015, DOI 10.1084/jem.20040581; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Ramsey C, 2002, HUM MOL GENET, V11, P397, DOI 10.1093/hmg/11.4.397; Uchida D, 2004, J EXP MED, V199, P167, DOI 10.1084/jem.20031291	10	3	3	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2005	23	2					113	114		10.1016/j.immuni.2005.08.004	http://dx.doi.org/10.1016/j.immuni.2005.08.004			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	962HM	16111630	Bronze			2022-12-18	WOS:000231721700002
J	Feuerer, M; Benoist, C; Mathis, D				Feuerer, M; Benoist, C; Mathis, D			Green T-R cells	IMMUNITY			English	Editorial Material							IMMUNOLOGICAL SELF-TOLERANCE; REGULATORY CELLS; FOXP3	Identification of the transcription factor Foxp3 as a "master regulator" of regulatory T (T-R) cells was a major discovery. A new study by Fontenot et al. (2005), reported in this issue of Immunity, provides novel insights into T-R cell biology by tracking their behavior in mice expressing a GFP-Foxp3 fusion-protein reporter.	Harvard Univ, Sch Med,Sect Immunol & Immunogenet, Brigham & Womens Hosp, Joslin Diabet Ctr,Dept Med, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Joslin Diabetes Center, Inc.	Feuerer, M (corresponding author), Harvard Univ, Sch Med,Sect Immunol & Immunogenet, Brigham & Womens Hosp, Joslin Diabet Ctr,Dept Med, 1 Joslin Pl, Boston, MA 02215 USA.							Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Liang S, 2005, J EXP MED, V201, P127, DOI 10.1084/jem.20041201; Ohashi PS, 2003, CURR OPIN IMMUNOL, V15, P668, DOI 10.1016/j.coi.2003.09.013; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Stock P, 2004, NAT IMMUNOL, V5, P1149, DOI 10.1038/ni1122; Van Parijs L, 1998, SCIENCE, V280, P243	12	3	3	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	2005	22	3					271	272		10.1016/j.immuni.2005.03.002	http://dx.doi.org/10.1016/j.immuni.2005.03.002			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	912UP	15780983	Bronze			2022-12-18	WOS:000228105700001
J	Pasare, C; Medzhitov, R				Pasare, C; Medzhitov, R			Toll-dependent control mechanisms of CD4 T cell activation (vol 21, pg 733, 2004)	IMMUNITY			English	Correction																		Pasare C, 2004, IMMUNITY, V21, P733, DOI 10.1016/j.immuni.2004.10.006	1	3	3	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	2005	22	3					397	398		10.1016/j.immuni.2005.03.001	http://dx.doi.org/10.1016/j.immuni.2005.03.001			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	912UP		Bronze			2022-12-18	WOS:000228105700013
J	Williams, MS; Henkart, PA				Williams, MS; Henkart, PA			Do cytotoxic lymphocytes kill via reactive oxygen species?	IMMUNITY			English	Editorial Material							CELL-DEATH; GRANZYME-B; APOPTOSIS; DAMAGE	A paper by Martinvalet et al. (2005) in this issue of Immunity examines the mechanisms used by granzyme A to kill target cells after its cytoplasmic injection by cytotoxic lymphocytes. They show that this protease induces mitochondrial damage and generation of reactive oxygen species that are necessary for cell death.	Univ Maryland, Sch Med, Dept Microbiol & Immunol, Rockville, MD 20855 USA; NCI, Expt Immunol Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Williams, MS (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Rockville, MD 20855 USA.							Adrain C, 2005, J BIOL CHEM, V280, P4663, DOI 10.1074/jbc.M410915200; Alimonti JB, 2001, J BIOL CHEM, V276, P6974, DOI 10.1074/jbc.M008444200; Fan ZS, 2003, NAT IMMUNOL, V4, P145, DOI 10.1038/ni885; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Johnson H, 2003, BLOOD, V101, P3093, DOI 10.1182/blood-2002-08-2485; Kagan VE, 2002, J IMMUNOL, V169, P487, DOI 10.4049/jimmunol.169.1.487; Martinvalet D, 2005, IMMUNITY, V22, P355, DOI 10.1016/j.immuni.2005.02.004; Sarin A, 1998, J IMMUNOL, V161, P2810; Sayers TJ, 2001, J IMMUNOL, V166, P765, DOI 10.4049/jimmunol.166.2.765; SHRESTA S, 1995, P NATL ACAD SCI USA, V92, P5679, DOI 10.1073/pnas.92.12.5679; Thomas DA, 2001, P NATL ACAD SCI USA, V98, P14985, DOI 10.1073/pnas.261581498	12	3	3	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2005	22	3					272	274		10.1016/j.immuni.2005.03.003	http://dx.doi.org/10.1016/j.immuni.2005.03.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	912UP	15780984	Bronze			2022-12-18	WOS:000228105700002
J	Woodland, DL; Blackman, MA				Woodland, DL; Blackman, MA			Immunity: It's in our bones	IMMUNITY			English	Editorial Material							MARROW; SITE; MIGRATION	Accumulating data suggest that the bone marrow is a reservoir for memory CD8(+) T cells. In this issue of Immunity, Mazo et al. (2005) show that bone marrow CD8(+) T cells are predominantly CCR7(+)/CD62L(+) "central memory" cells and describe specific signals that mediate their constitutive recruitment from the blood.	Trudeau Inst Inc, Saranac Lake, NY 12983 USA	Trudeau Institute	Woodland, DL (corresponding author), Trudeau Inst Inc, 154 Algonquin Ave, Saranac Lake, NY 12983 USA.							Becker TC, 2005, J IMMUNOL, V174, P1269, DOI 10.4049/jimmunol.174.3.1269; Berlin-Rufenach C, 1999, J EXP MED, V189, P1467, DOI 10.1084/jem.189.9.1467; Di Rosa F, 2003, IMMUNOLOGY, V108, P296, DOI 10.1046/j.1365-2567.2003.01593.x; Effros RB, 2004, EXP GERONTOL, V39, P517, DOI 10.1016/j.exger.2003.09.024; Feuerer M, 2003, NAT MED, V9, P1151, DOI 10.1038/nm914; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Mazo IB, 2005, IMMUNITY, V22, P259, DOI 10.1016/j.immuni.2005.01.008; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Tripp RA, 1997, J IMMUNOL, V158, P3716; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889	10	3	3	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2005	22	2					143	144		10.1016/j.immuni.2005.02.002	http://dx.doi.org/10.1016/j.immuni.2005.02.002			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	904PG	15723803	Bronze			2022-12-18	WOS:000227509600001
J	Ensminger, AW; Chess, A				Ensminger, AW; Chess, A			Bidirectional promoters regulate the monoallelically expressed Ly49 NK receptors	IMMUNITY			English	Editorial Material							GENE-EXPRESSION; IDENTIFICATION; INTERLEUKIN-2; TRANSGENES; CELLS	Members of the Ly49 gene family of natural killer (NK) cell receptors in mice are expressed in seemingly stochastic combinations such that each NK cell expresses a handful of family members. A transcriptional switch appears to establish this interesting pattern of expression.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Ensminger, AW (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.			Ensminger, Alexander/0000-0003-0824-3704				Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; HELD W, 1995, NATURE, V376, P355, DOI 10.1038/376355a0; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; JOHNSON AD, 1981, NATURE, V294, P217, DOI 10.1038/294217a0; Raulet DH, 2001, ANNU REV IMMUNOL, V19, P291, DOI 10.1146/annurev.immunol.19.1.291; Rhoades KL, 2000, CURR BIOL, V10, P789, DOI 10.1016/S0960-9822(00)00565-0; Saleh A, 2004, IMMUNITY, V21, P55, DOI 10.1016/j.immuni.2004.06.005; Saleh A, 2002, J IMMUNOL, V168, P5163, DOI 10.4049/jimmunol.168.10.5163; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; Tanamachi DM, 2004, J IMMUNOL, V172, P1074, DOI 10.4049/jimmunol.172.2.1074	11	3	3	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2004	21	1					2	3		10.1016/j.immuni.2004.07.001	http://dx.doi.org/10.1016/j.immuni.2004.07.001			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	842AU	15345214	Bronze			2022-12-18	WOS:000222975500002
J	Dittmer, U; Hasenkrug, KJ				Dittmer, U; Hasenkrug, KJ			Functional impairment of CD8+ T cells by regulatory T cells during persistent retroviral infection (vol 20, pg 293, 2004)	IMMUNITY			English	Correction									NIAID, Rocky Mt Labs, Persistent Viral Dis Lab, NIH, Hamilton, MT 59840 USA; Univ Klinikum, Inst Virol, D-45122 Essen, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Duisburg Essen	Hasenkrug, KJ (corresponding author), NIAID, Rocky Mt Labs, Persistent Viral Dis Lab, NIH, Hamilton, MT 59840 USA.	khasenkrug@niaid.nih.gov						Dittmer U, 2004, IMMUNITY, V20, P293, DOI 10.1016/S1074-7613(04)00054-8	1	3	3	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2004	20	5					653	653		10.1016/S1074-7613(04)00115-3	http://dx.doi.org/10.1016/S1074-7613(04)00115-3			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	823RX		Bronze			2022-12-18	WOS:000221631900015
J	Weinstein, IB; Li, HY				Weinstein, IB; Li, HY			Mast cells provide a "HINT" to the function of an exotic nucleotide	IMMUNITY			English	Editorial Material							HIT PROTEIN FAMILY; FHIT; KIN28; MICE	One or more members of the HIT (histidine triad) family of proteins is encoded in the genomes of diverse species, ranging from prokaryotes to humans. However, the precise cellular and biochemical functions of many of these proteins are largely enigmatic (Lima et al., 1997; Klein et al., 1998; Brenner, 2002). Therefore, the paper by Lee et al. in this issue of Immunity that ascribes a role for the histidine triad protein HINT (also designated HINT1) in regulating the activity of the microphthalmia transcription factor (MITF) is of great interest. Furthermore, this study implicates a role for an exotic endogenous nucleotide Ap(4)A in this process. This naturally occurring compound consists of two adenosines linked by four phosphate residues, and has been proposed as an intracellular and extracellular signaling molecule (Varshavsky, 1983).	Columbia Univ Coll Phys & Surg, New York, NY 10032 USA	Columbia University	Weinstein, IB (corresponding author), Columbia Univ Coll Phys & Surg, 630 W 168th St, New York, NY 10032 USA.							Bieganowski P, 2002, J BIOL CHEM, V277, P10852, DOI 10.1074/jbc.M111480200; Brenner C, 2002, BIOCHEMISTRY-US, V41, P9003, DOI 10.1021/bi025942q; Klein MG, 1998, EXP CELL RES, V244, P26, DOI 10.1006/excr.1998.4153; Korsisaari N, 2000, J BIOL CHEM, V275, P34837, DOI 10.1074/jbc.C000505200; Lima CD, 1997, SCIENCE, V278, P286, DOI 10.1126/science.278.5336.286; Razin E, 1999, J BIOL CHEM, V274, P34272, DOI 10.1074/jbc.274.48.34272; STEINGRIMSSON E, 1994, NAT GENET, V8, P256, DOI 10.1038/ng1194-256; Su T, 2003, P NATL ACAD SCI USA, V100, P7824, DOI 10.1073/pnas.1332160100; VARSHAVSKY A, 1983, CELL, V34, P711, DOI 10.1016/0092-8674(83)90526-3; Zanesi N, 2001, P NATL ACAD SCI USA, V98, P10250, DOI 10.1073/pnas.191345898	10	3	3	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2004	20	2					119	120		10.1016/S1074-7613(04)00029-9	http://dx.doi.org/10.1016/S1074-7613(04)00029-9			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EI	14975234	Bronze			2022-12-18	WOS:000221442400001
J	Waldmann, TA				Waldmann, TA			A novel means of favorably tipping the balance between cytopathic and regulatory T cells	IMMUNITY			English	Editorial Material							IL-2 RECEPTOR; ANTIBODIES		NCI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Waldmann, TA (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.		Waldmann, Thomas/AAT-5972-2021	Waldmann, Thomas/0000-0003-4500-6660	NATIONAL CANCER INSTITUTE [ZIASC004002, Z01SC004002] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		GuexCrosier Y, 1997, J IMMUNOL, V158, P452; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Lenardo MJ, 1996, J EXP MED, V183, P721, DOI 10.1084/jem.183.3.721; Leonard WJ, 2001, NAT REV IMMUNOL, V1, P200, DOI 10.1038/35105066; Shevach EM, 2001, J EXP MED, V193, pF41, DOI 10.1084/jem.193.11.F41; Waldmann TA, 1999, ANNU REV IMMUNOL, V17, P19, DOI 10.1146/annurev.immunol.17.1.19; Waldmann TA, 1998, CURR OPIN IMMUNOL, V10, P507, DOI 10.1016/S0952-7915(98)80215-X; Waldmann TA, 2001, IMMUNITY, V14, P105, DOI 10.1016/S1074-7613(09)00091-0; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	9	3	3	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2003	19	4					465	466		10.1016/S1074-7613(03)00273-5	http://dx.doi.org/10.1016/S1074-7613(03)00273-5			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	734JK	14563310	Bronze			2022-12-18	WOS:000186051900002
J	Staudt, LM; Flavell, RA				Staudt, LM; Flavell, RA			Genomics, genetics, and genes of the immune system	IMMUNITY			English	Editorial Material									NCI, Metab Branch, Ctr Canc Res, Bethesda, MD 20892 USA; Yale Univ, Immunobiol Sect, Howard Hughes Med Inst, Sch Med, New Haven, CT 06520 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute; Yale University	Staudt, LM (corresponding author), NCI, Metab Branch, Ctr Canc Res, Bethesda, MD 20892 USA.		Staudt, Louis/AAC-5324-2019						0	3	3	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2001	15	3			SI		335	336		10.1016/S1074-7613(01)00204-7	http://dx.doi.org/10.1016/S1074-7613(01)00204-7			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	476DW	11567624	Bronze			2022-12-18	WOS:000171211800001
J	Spiliotis, ET; Osorio, M; Zuniga, MC; Edidin, M				Spiliotis, ET; Osorio, M; Zuniga, MC; Edidin, M			Selective export of MHC class I molecules from the ER after their dissociation from TAP (vol 13, pg 841, 2000)	IMMUNITY			English	Correction									Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; Univ Calif Santa Cruz, Dept Biol, Santa Cruz, CA 95064 USA; Mayo Clin, Neuroimmunol Lab, Rochester, MN 55905 USA	Johns Hopkins University; University of California System; University of California Santa Cruz; Mayo Clinic	Spiliotis, ET (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.							Spiliotis ET, 2000, IMMUNITY, V13, P841, DOI 10.1016/S1074-7613(00)00081-9	1	3	3	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2001	14	2												1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	404HZ					2022-12-18	WOS:000167092500010
J	Fikrig, E; Barthold, SW; Sun, W; Feng, W; Telford, SR; Flavell, RA				Fikrig, E; Barthold, SW; Sun, W; Feng, W; Telford, SR; Flavell, RA			Borrelia burgdorferi p35 and p37 proteins, expressed in vivo, elicit protective immunity (vol 6, pg 531, 1997)	IMMUNITY			English	Correction																		Fikrig E, 1997, IMMUNITY, V6, P531, DOI 10.1016/S1074-7613(00)80341-6; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551	2	3	3	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	1998	9	5					U11	U11						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	144DK					2022-12-18	WOS:000077298300017
J	Gao, Y; Cai, C; Wullimann, D; Niessl, J; Rivera-Ballesteros, O; Chen, PR; Lange, J; Cuapio, A; Blennow, O; Hansson, L; Mielke, S; Nowak, P; Vesterbacka, J; Akber, M; Perez-Potti, A; Sekine, T; Muller, TR; Boulouis, C; Kammann, T; Parrot, T; Muvva, JR; Sobkowiak, M; Healy, K; Bogdanovic, G; Muschiol, S; Soderdahl, G; Osterborg, A; Hellgren, F; Grifoni, A; Weiskopf, D; Sette, A; Lore, K; Chen, MS; Ljungman, P; Sandberg, JK; Smith, CIE; Bergman, P; Ljunggren, HG; Aleman, S; Buggert, M				Gao, Yu; Cai, Curtis; Wullimann, David; Niessl, Julia; Rivera-Ballesteros, Olga; Chen, Puran; Lange, Joshua; Cuapio, Angelica; Blennow, Ola; Hansson, Lotta; Mielke, Stephan; Nowak, Piotr; Vesterbacka, Jan; Akber, Mira; Perez-Potti, Andre; Sekine, Takuya; Muller, Thomas R.; Boulouis, Caroline; Kammann, Tobias; Parrot, Tiphaine; Muvva, Jagadeeswara Rao; Sobkowiak, Michal; Healy, Katie; Bogdanovic, Gordana; Muschiol, Sandra; Soderdahl, Gunnar; Osterborg, Anders; Hellgren, Fredrika; Grifoni, Alba; Weiskopf, Daniela; Sette, Alessandro; Lore, Karin; Chen, Margaret Sallberg; Ljungman, Per; Sandberg, Johan K.; Smith, C. I. Edvard; Bergman, Peter; Ljunggren, Hans-Gustaf; Aleman, Soo; Buggert, Marcus			Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccination	IMMUNITY			English	Article							COVID-19; RESPONSES	Many immunocompromised patients mount suboptimal humoral immunity after SARS-CoV-2 mRNA vaccination. Here, we assessed the single-cell profile of SARS-CoV-2-specific T cells post-mRNA vaccination in healthy individuals and patients with various forms of immunodeficiencies. Impaired vaccine-induced cell-mediated immunity was observed in many immunocompromised patients, particularly in solid-organ transplant and chronic lymphocytic leukemia patients. Notably, individuals with an inherited lack of mature B cells, i.e., X-linked agammaglobulinemia (XLA) displayed highly functional spike-specific T cell responses. Single-cell RNA-sequencing further revealed that mRNA vaccination induced a broad functional spectrum of spike-specific CD4(+) and CD8(+) T cells in healthy individuals and patients with XLA. These responses were founded on polyclonal repertoires of CD4(+) T cells and robust expansions of oligoclonal effector-memory CD45RA(+) CD8(+) T cells with stem-like characteristics. Collectively, our data provide the functional continuum of SARS-CoV-2-specific T cell responses post-mRNA vaccination, highlighting that cell-mediated immunity is of variable functional quality across immunodeficiency syndromes.	[Gao, Yu; Cai, Curtis; Wullimann, David; Niessl, Julia; Rivera-Ballesteros, Olga; Chen, Puran; Lange, Joshua; Cuapio, Angelica; Akber, Mira; Perez-Potti, Andre; Sekine, Takuya; Muller, Thomas R.; Boulouis, Caroline; Kammann, Tobias; Parrot, Tiphaine; Muvva, Jagadeeswara Rao; Sandberg, Johan K.; Ljunggren, Hans-Gustaf; Buggert, Marcus] Karolinska Inst, Ctr Infect Med, Dept Med Huddinge, Stockholm, Sweden; [Blennow, Ola; Nowak, Piotr; Vesterbacka, Jan; Smith, C. I. Edvard; Bergman, Peter; Aleman, Soo] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Blennow, Ola; Soderdahl, Gunnar] Karolinska Univ Hosp, Dept Transplantat, Stockholm, Sweden; [Blennow, Ola; Soderdahl, Gunnar] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Hansson, Lotta; Osterborg, Anders] Karolinska Univ Hosp, Dept Hematol, Stockholm, Sweden; [Hansson, Lotta; Osterborg, Anders] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Mielke, Stephan] Karolinska Inst, Dept Lab Med Biomol & Cellular Med, Stockholm, Sweden; [Mielke, Stephan; Ljungman, Per; Smith, C. I. Edvard] Karolinska Univ Hosp Huddinge, Dept Cellular Therapy & Allogene Stem Cell Transp, Stockholm, Sweden; [Nowak, Piotr; Vesterbacka, Jan; Aleman, Soo] Karolinska Inst, Dept Med Huddinge, Infect Dis, Stockholm, Sweden; [Nowak, Piotr] Umea Univ, Lab Mol Infect Med Sweden MIMS, Umea, Sweden; [Sobkowiak, Michal; Healy, Katie; Chen, Margaret Sallberg] Karolinska Inst, Dept Dent Med, Stockholm, Sweden; [Bogdanovic, Gordana; Muschiol, Sandra] Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden; [Muschiol, Sandra] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Hellgren, Fredrika; Lore, Karin] Karolinska Inst, Karolinska Univ Hosp, Dept Med Solna, Stockholm, Sweden; [Grifoni, Alba; Weiskopf, Daniela; Sette, Alessandro] La Jolla Inst Immunol, Ctr Infect Dis & Vaccine Res, La Jolla, CA USA; [Sette, Alessandro] Univ Calif San Diego, Dept Med, Div Infect Dis & Global Publ Hlth, La Jolla, CA 92093 USA; [Ljungman, Per] Karolinska Inst, Dept Med Huddinge, Hematol, Stockholm, Sweden; [Bergman, Peter] Karolinska Inst, Dept Lab Med, Clin Microbiol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Umea University; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; La Jolla Institute for Immunology; University of California System; University of California San Diego; Karolinska Institutet; Karolinska Institutet	Buggert, M (corresponding author), Karolinska Inst, Ctr Infect Med, Dept Med Huddinge, Stockholm, Sweden.	marcus.buggert@ki.se	Sette, Alessandro/AFO-8916-2022; Blennow, Ola/HHR-9848-2022	Blennow, Ola/0000-0002-7167-7882; Cai, Curtis/0000-0002-3490-4361; Rivera Ballesteros, Olga/0000-0001-6949-4270; Mielke, Stephan/0000-0002-8325-9215; Cuapio, Angelica/0000-0002-9451-1914; Sobkowiak, Michal/0000-0003-2932-1994; Sallberg Chen, Margaret/0000-0002-3793-4064; Boulouis, Caroline/0000-0003-0562-5395	SciLifeLab National COVID-19 Research Program; Knut and Alice Wallenberg Foundation; Swedish Research Council; Region Stockholm; Nordstjernan AB; Karolinska Institutet; Swedish patient organizations of Primary Immunodeficiencies (PIO) and Hematology (Swedish Blood Cancer Foundation); Karolinska Institutet; European Research Council; Swedish Society of Medicine; Ake Wibergs Stiftelse; Swedish Cancer Society; Jonas Soderquist Stiftelse; Swedish Childhood Cancer Fund; NIH [75N9301900065]; EMBO postdoctoral fellowship [ALTF 1062-2020]; National Genomics Infrastructure in Stockholm - Science for Life Laboratory	SciLifeLab National COVID-19 Research Program; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Region Stockholm; Nordstjernan AB(HOGANAS ABStatisticon AB); Karolinska Institutet(Karolinska Institutet); Swedish patient organizations of Primary Immunodeficiencies (PIO) and Hematology (Swedish Blood Cancer Foundation); Karolinska Institutet(Karolinska Institutet); European Research Council(European Research Council (ERC)European Commission); Swedish Society of Medicine; Ake Wibergs Stiftelse; Swedish Cancer Society(Swedish Cancer Society); Jonas Soderquist Stiftelse; Swedish Childhood Cancer Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO postdoctoral fellowship(European Molecular Biology Organization (EMBO)); National Genomics Infrastructure in Stockholm - Science for Life Laboratory	This study has been funded by grants from the SciLife Lab National COVID-19 Research Program and financed by the Knut and Alice Wallenberg Foundation, the Swedish Research Council, Nordstjernan AB, Region Stockholm (Clinical research position-, ALF-, and CIMED grants), and a graduate student fellowship from Karolinska Institutet. In addition, the Swedish patient organizations of Primary Immuno deficiencies (PIO) and Hematology (Swedish Blood Cancer Foundation) provided grants. M.B. was supported by the Swedish Research Council, the Knut and Alice Wallenberg Foundation, the European Research Council, Karolinska Institutet, the Swedish Society of Medicine, the Swedish Cancer Society, the Swedish Childhood Cancer Fund, the Ake Wibergs Stiftelse, and the Jonas Soderquist Stiftelse. This work has partly been supported by NIH contract 75N9301900065 (A.S. and D. Weiskopf). J.N. was supported by an EMBO postdoctoral fellowship (ALTF 1062-2020). The authors acknowledge support from the National Genomics Infrastructure in Stockholm funded by Science for Life Laboratory, the Knut and Alice Wallenberg Foundation and the Swedish Research Council, and SNIC/Uppsala Multidisciplinary Center for Advanced Computational Science for assistance with massively parallel sequencing and access to the UPPMAX computational infrastructure.	Adamo S, 2022, NATURE, V602, P148, DOI 10.1038/s41586-021-04280-x; Apostolidis SA, 2021, NAT MED, V27, P1990, DOI 10.1038/s41591-021-01507-2; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Bange EM, 2021, NAT MED, V27, P1280, DOI 10.1038/s41591-021-01386-7; Bar-On YM, 2021, NEW ENGL J MED, V385, P1393, DOI 10.1056/NEJMoa2114255; Barda N, 2021, LANCET, V398, P2093, DOI 10.1016/S0140-6736(21)02249-2; Bergman P, 2021, EBIOMEDICINE, V74, DOI 10.1016/j.ebiom.2021.103705; Borcherding Nicholas, 2020, F1000Res, V9, P47, DOI 10.12688/f1000research.22139.1; Braun J, 2020, NATURE, V587, P270, DOI 10.1038/s41586-020-2598-9; Brown LAK, 2022, J ALLERGY CLIN IMMUN, V149, P557, DOI 10.1016/j.jaci.2021.10.031; Conway JR, 2017, BIOINFORMATICS, V33, P2938, DOI 10.1093/bioinformatics/btx364; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Embi PJ, 2021, MMWR-MORBID MORTAL W, V70, P1553, DOI 10.15585/mmwr.mm7044e3; Fung M, 2021, CLIN INFECT DIS, V72, P340, DOI 10.1093/cid/ciaa863; Gao Y, 2022, NAT MED, V28, P472, DOI 10.1038/s41591-022-01700-x; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Guerrera G, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl5344; Hao YH, 2021, CELL, V184, P3573, DOI 10.1016/j.cell.2021.04.048; Israelow B, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl4509; Kalimuddin S, 2021, MED-CAMBRIDGE, V2, P682, DOI 10.1016/j.medj.2021.04.003; Keeton R, 2022, NATURE, V603, P488, DOI 10.1038/s41586-022-04460-3; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Kiner E, 2021, NAT IMMUNOL, V22, P216, DOI 10.1038/s41590-020-00836-7; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Li FB, 2014, J IMMUNOL, V192, P3021, DOI 10.4049/jimmunol.1302934; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Liu JY, 2022, NATURE, V603, P493, DOI 10.1038/s41586-022-04465-y; Loyal L, 2021, SCIENCE, V374, P171, DOI 10.1126/science.abh1823; Marraco SAF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3700; Mateus J, 2021, SCIENCE, V374, P420, DOI 10.1126/science.abj9853; Mateus J, 2020, SCIENCE, V370, P89, DOI 10.1126/science.abd3871; McMahan K, 2021, NATURE, V590, DOI 10.1038/s41586-020-03041-6; Naaber P, 2021, LANCET REG HEALTH-EU, V10, DOI 10.1016/j.lanepe.2021.100208; Ng OW, 2016, VACCINE, V34, P2008, DOI 10.1016/j.vaccine.2016.02.063; Niessl J, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abk0894; Oberhardt V, 2021, NATURE, V597, P268, DOI 10.1038/s41586-021-03841-4; Painter MM, 2021, IMMUNITY, V54, P2133, DOI 10.1016/j.immuni.2021.08.001; Pimpinelli F, 2021, J HEMATOL ONCOL, V14, DOI 10.1186/s13045-021-01090-6; Planas D, 2022, NATURE, V602, P671, DOI 10.1038/s41586-021-04389-z; Planas D, 2021, NATURE, V596, P276, DOI 10.1038/s41586-021-03777-9; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Rahav G, 2021, ECLINICALMEDICINE, V41, DOI 10.1016/j.eclinm.2021.101158; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Sahin U, 2020, NATURE, V586, P594, DOI 10.1038/s41586-020-2814-7; Saini SK, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abf7550; Schulien I, 2021, NAT MED, V27, P78, DOI 10.1038/s41591-020-01143-2; Sekine T, 2020, CELL, V183, P158, DOI 10.1016/j.cell.2020.08.017; Shields AM, 2021, J ALLERGY CLIN IMMUN, V147, P870, DOI 10.1016/j.jaci.2020.12.620; Soresina A, 2020, PEDIAT ALLERG IMM-UK, V31, P565, DOI 10.1111/pai.13263; Szabo PA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12464-3; Tarke A, 2022, CELL, V185, P847, DOI 10.1016/j.cell.2022.01.015; Tartof SY, 2021, LANCET, V398, P1407, DOI 10.1016/S0140-6736(21)02183-8; Zhang JY, 2020, NAT IMMUNOL, V21, P1107, DOI 10.1038/s41590-020-0762-x	54	2	2	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 13	2022	55	9					1732	+		10.1016/j.immuni.2022.07.005	http://dx.doi.org/10.1016/j.immuni.2022.07.005			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	4X1ZN	35961317	Green Published, hybrid			2022-12-18	WOS:000860648000002
J	Aschman, T; Mothes, R; Heppner, FL; Radbruch, H				Aschman, Tom; Mothes, Ronja; Heppner, Frank L.; Radbruch, Helena			What SARS-CoV-2 does to our brains	IMMUNITY			English	Review							CENTRAL-NERVOUS-SYSTEM; INDUCED SICKNESS BEHAVIOR; ACUTE-PHASE RESPONSE; VIRUS-INFECTION; T-CELLS; COGNITIVE IMPAIRMENT; INTERSTITIAL FLUID; CHOROID-PLEXUS; TIME-COURSE; COVID-19	Neurological symptoms in SARS-CoV-2-infected patients have been reported, but their cause remains unclear. In theory, the neurological symptoms observed after SARS-CoV-2 infection could be (1) directly caused by the virus infecting brain cells, (2) indirectly by our body???s local or systemic immune response toward the virus, (3) by coincidental phenomena, or (4) a combination of these factors. As indisputable evidence of intact and replicating SARS-CoV-2 particles in the central nervous system (CNS) is currently lacking, we suggest focusing on the host???s immune reaction when trying to understand the neurocognitive symptoms associated with SARS-CoV-2 infection. In this perspective, we discuss the possible immune-mediated mechanisms causing functional or structural CNS alterations during acute infection as well as in the post-infectious context. We also review the available literature on CNS affection in the context of COVID-19 infection, as well as observations from animal studies on the molecular pathways involved in sickness behavior.	[Aschman, Tom; Mothes, Ronja; Heppner, Frank L.; Radbruch, Helena] Charite Univ Med Berlin, Charitepl 1, D-10117 Berlin, Germany; [Aschman, Tom; Mothes, Ronja; Heppner, Frank L.; Radbruch, Helena] Free Univ Berlin, Charitepl 1, D-10117 Berlin, Germany; [Aschman, Tom; Mothes, Ronja; Heppner, Frank L.; Radbruch, Helena] Humboldt Univ, Dept Neuropathol, Charitepl 1, D-10117 Berlin, Germany; [Heppner, Frank L.] NeuroCure, Cluster Excellence, Charitepl 1, D-10117 Berlin, Germany; [Heppner, Frank L.] German Ctr Neurodegenerat Dis DZNE Berlin, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Aschman, T; Heppner, FL; Radbruch, H (corresponding author), Charite Univ Med Berlin, Charitepl 1, D-10117 Berlin, Germany.; Aschman, T; Heppner, FL; Radbruch, H (corresponding author), Free Univ Berlin, Charitepl 1, D-10117 Berlin, Germany.; Aschman, T; Heppner, FL; Radbruch, H (corresponding author), Humboldt Univ, Dept Neuropathol, Charitepl 1, D-10117 Berlin, Germany.; Heppner, FL (corresponding author), NeuroCure, Cluster Excellence, Charitepl 1, D-10117 Berlin, Germany.; Heppner, FL (corresponding author), German Ctr Neurodegenerat Dis DZNE Berlin, D-10117 Berlin, Germany.	tom.aschman@charite.de; frank.heppner@charite.de; helena.radbruch@charite.de		Aschman, Tom/0000-0002-2101-6146; Radbruch, Helena/0000-0001-6941-3397; Heppner, Frank/0000-0001-9816-8917	Federal Ministry of Education and Research [NATON 01KX2121]; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy [EXC-2049 -390688087]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy(German Research Foundation (DFG))	This work was supported by the Federal Ministry of Education and Research within the framework of the network of university medicine (NATON 01KX2121). F.L.H. is funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy -EXC-2049 -390688087.	ACHESON ED, 1959, AM J MED, V26, P569, DOI 10.1016/0002-9343(59)90280-3; Ahn Grace E, 2012, Int J Clin Rheumtol, V7, P217; Alexopoulos H, 2020, NEUROL-NEUROIMMUNOL, V7, DOI 10.1212/NXI.0000000000000893; Altan-Bonnet N, 2016, CURR OPIN MICROBIOL, V32, P77, DOI 10.1016/j.mib.2016.05.004; Alvarez JI, 2011, BBA-MOL BASIS DIS, V1812, P252, DOI 10.1016/j.bbadis.2010.06.017; Ampie L, 2022, IMMUNITY, V55, P781, DOI 10.1016/j.immuni.2022.04.012; Armangue T, 2018, LANCET NEUROL, V17, P760, DOI 10.1016/S1474-4422(18)30244-8; Asadi-Pooya AA, 2020, SEIZURE-EUR J EPILEP, V79, P49, DOI 10.1016/j.seizure.2020.05.005; Aschman T, 2021, JAMA NEUROL, V78, P948, DOI 10.1001/jamaneurol.2021.2004; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Banks WA, 1995, NEUROIMMUNOMODULAT, V2, P241, DOI 10.1159/000097202; BANNISTER BA, 1988, POSTGRAD MED J, V64, P559, DOI 10.1136/pgmj.64.753.559; BARNETT EM, 1993, NEUROSCIENCE, V57, P1007, DOI 10.1016/0306-4522(93)90045-H; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; Bernard-Valnet R, 2021, NEUROL-NEUROIMMUNOL, V8, DOI 10.1212/NXI.0000000000001029; Biddle Chuck, 2006, AANA J, V74, P145; Bjornevik K, 2022, SCIENCE, V375, P296, DOI 10.1126/science.abj8222; Blank T, 2016, IMMUNITY, V44, P901, DOI 10.1016/j.immuni.2016.04.005; Bluthe RM, 1999, PSYCHONEUROENDOCRINO, V24, P301, DOI 10.1016/S0306-4530(98)00077-8; BLUTHE RM, 1994, CR ACAD SCI III-VIE, V317, P499; Bouayed J, 2021, BRAIN BEHAV IMMUN, V93, P4, DOI 10.1016/j.bbi.2020.12.028; Bouchard C, 1999, NEUROLOGY, V52, P498, DOI 10.1212/WNL.52.3.498; BRETDIBAT JL, 1995, BRAIN BEHAV IMMUN, V9, P242, DOI 10.1006/brbi.1995.1023; Brioschi S, 2021, SCIENCE, V373, P408, DOI 10.1126/science.abf9277; Cai RY, 2019, NAT NEUROSCI, V22, P317, DOI 10.1038/s41593-018-0301-3; CALDER BD, 1987, J ROY COLL GEN PRACT, V37, P11; Cape E, 2014, J PSYCHOSOM RES, V77, P219, DOI 10.1016/j.jpsychores.2014.06.014; CARDINALI DP, 1983, PSYCHONEUROENDOCRINO, V8, P3, DOI 10.1016/0306-4530(83)90038-0; Carfi A, 2020, JAMA-J AM MED ASSOC, V324, P603, DOI 10.1001/jama.2020.12603; Cavaillon JM, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201810128; Cevik M, 2021, LANCET MICROBE, V2, pE13, DOI 10.1016/S2666-5247(20)30172-5; Clay CC, 2007, J VIROL, V81, P12040, DOI 10.1128/JVI.00133-07; Cohen K, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj-2021-068414; CSERR HF, 1981, AM J PHYSIOL, V240, pF319, DOI 10.1152/ajprenal.1981.240.4.F319; Cugurra A, 2021, SCIENCE, V373, P409, DOI 10.1126/science.abf7844; Damkier HH, 2013, PHYSIOL REV, V93, P1847, DOI 10.1152/physrev.00004.2013; Dantzer R, 1999, NEUROREPORT, V10, P289, DOI 10.1097/00001756-199902050-00015; Daugherty SE, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1098; de Rooij SE, 2007, J PSYCHOSOM RES, V62, P521, DOI 10.1016/j.jpsychores.2006.11.013; Deigendesch N, 2020, ACTA NEUROPATHOL, V140, P583, DOI 10.1007/s00401-020-02213-y; Derk J, 2021, FRONT CELL NEUROSCI, V15, DOI 10.3389/fncel.2021.761506; Dittmayer C, 2020, LANCET, V396, pE64, DOI 10.1016/S0140-6736(20)32079-1; Ehler J, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1850-7; Engelhardt B, 2016, ACTA NEUROPATHOL, V132, P317, DOI 10.1007/s00401-016-1606-5; Engelhardt B, 2012, TRENDS IMMUNOL, V33, P579, DOI 10.1016/j.it.2012.07.004; Fajgenbaum DC, 2020, NEW ENGL J MED, V383, P2255, DOI 10.1056/NEJMra2026131; Filiano AJ, 2016, NATURE, V535, P425, DOI 10.1038/nature18626; FOLDI M, 1966, ACTA ANAT, V64, P498; Forrester JV, 2018, NAT REV NEUROSCI, V19, P655, DOI 10.1038/s41583-018-0070-8; Franke C, 2021, BRAIN BEHAV IMMUN, V93, P415, DOI 10.1016/j.bbi.2020.12.022; Galea I, 2007, J EXP MED, V204, P2023, DOI 10.1084/jem.20070064; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Goldsmith CS, 2020, LANCET, V395, pE99, DOI 10.1016/S0140-6736(20)31188-0; Gordon SM, 2004, INTENS CARE MED, V30, P1997, DOI 10.1007/s00134-004-2418-y; GROSS PM, 1987, J CEREBR BLOOD F MET, V7, P663, DOI 10.1038/jcbfm.1987.120; Haas J, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.618544; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; HASEK M, 1977, NATURE, V268, P68, DOI 10.1038/268068a0; Helms J, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03200-1; Heming M, 2021, IMMUNITY, V54, P164, DOI 10.1016/j.immuni.2020.12.011; Hepburn M, 2021, NEUROCRIT CARE, V34, P139, DOI 10.1007/s12028-020-01006-1; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; HOTCHIN NA, 1989, J INFECTION, V18, P143, DOI 10.1016/S0163-4453(89)91150-X; Howell OW, 2011, BRAIN, V134, P2755, DOI 10.1093/brain/awr182; Huang CL, 2021, LANCET, V397, P220, DOI 10.1016/S0140-6736(20)32656-8; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Janiaud P, 2021, CAN J CARDIOL, V37, P1353, DOI 10.1016/j.cjca.2021.05.009; Kanberg N, 2020, NEUROLOGY, V95, pE1754, DOI 10.1212/WNL.0000000000010111; Kaur C, 2017, HISTOL HISTOPATHOL, V32, P879, DOI 10.14670/HH-11-881; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Keddie S, 2021, BRAIN, V144, P682, DOI 10.1093/brain/awaa433; KIDA S, 1993, NEUROPATH APPL NEURO, V19, P480, DOI 10.1111/j.1365-2990.1993.tb00476.x; KIMURATAKEUCHI M, 1992, J INFECT DIS, V166, P1266, DOI 10.1093/infdis/166.6.1266; Kivisakk P, 2003, P NATL ACAD SCI USA, V100, P8389, DOI 10.1073/pnas.1433000100; Korin B, 2017, NAT NEUROSCI, V20, P1300, DOI 10.1038/nn.4610; KORN IL, 1981, EUR NEUROL, V20, P435; Krasemann S, 2022, MEDRXIV, DOI [10.1101/2022.01.13.22269205, DOI 10.1101/2022.01.13.22269205]; Krasemann S, 2022, STEM CELL REP, V17, P307, DOI 10.1016/j.stemcr.2021.12.011; Kunis G, 2013, BRAIN, V136, P3427, DOI 10.1093/brain/awt259; Lam MA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13455-4; LAYE S, 1994, MOL BRAIN RES, V27, P157, DOI 10.1016/0169-328X(94)90197-X; Lee DW, 2019, BIOL BLOOD MARROW TR, V25, P625, DOI 10.1016/j.bbmt.2018.12.758; Lemstra AW, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-4; Leuschen MP, 2004, MULT SCLER J, V10, P636, DOI 10.1191/1352458504ms1114oa; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Ma QL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01484-6; Maes M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-66; Mahmood SB, 2022, EGYPT J NEUROL PSYCH, V58, DOI 10.1186/s41983-022-00458-w; Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127; MASON DW, 1986, NEUROSCIENCE, V19, P685, DOI 10.1016/0306-4522(86)90292-7; Mastorakos P, 2021, NAT IMMUNOL, V22, P1280, DOI 10.1038/s41590-021-01012-1; Matschke J, 2020, LANCET NEUROL, V19, P919, DOI 10.1016/S1474-4422(20)30308-2; McGavern DB, 2011, NAT REV IMMUNOL, V11, P318, DOI 10.1038/nri2971; MEDAWAR PB, 1948, BRIT J EXP PATHOL, V29, P58; Mehandru S, 2022, NAT IMMUNOL, V23, P194, DOI 10.1038/s41590-021-01104-y; Meinhardt J, 2021, NAT NEUROSCI, V24, P168, DOI 10.1038/s41593-020-00758-5; Mendoza-Fernandez V, 2000, BRAIN RES, V885, P14, DOI 10.1016/S0006-8993(00)02877-8; Morgello S, 2020, J NEUROVIROL, V26, P459, DOI 10.1007/s13365-020-00868-7; Moriguchi T, 2020, INT J INFECT DIS, V94, P55, DOI 10.1016/j.ijid.2020.03.062; Morris AWJ, 2016, ACTA NEUROPATHOL, V131, P725, DOI 10.1007/s00401-016-1555-z; MOSES AV, 1993, P NATL ACAD SCI USA, V90, P10474, DOI 10.1073/pnas.90.22.10474; Mrdjen D, 2018, IMMUNITY, V48, P380, DOI 10.1016/j.immuni.2018.01.011; Muzambi R, 2021, LANCET HEALTH LONGEV, V2, pE426, DOI 10.1016/S2666-7568(21)00118-5; Neumann B, 2020, J NEUROL SCI, V418, DOI 10.1016/j.jns.2020.117090; Normandin E, 2021, J NEUROL SCI, V430, DOI 10.1016/j.jns.2021.120023; Odoardi F, 2012, NATURE, V488, P675, DOI 10.1038/nature11337; Oran DP, 2020, ANN INTERN MED, V173, P362, DOI 10.7326/M20-3012; PARISH JG, 1978, POSTGRAD MED J, V54, P711, DOI 10.1136/pgmj.54.637.711; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Placantonakis DG, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.587384; Poloni TE, 2021, BRAIN PATHOL, V31, DOI 10.1111/bpa.12997; Prinz M, 2021, ANNU REV IMMUNOL, V39, P251, DOI 10.1146/annurev-immunol-093019-110159; Pruss H, 2017, CURR OPIN NEUROL, V30, P327, DOI 10.1097/WCO.0000000000000445; Puelles VG, 2020, NEW ENGL J MED, V383, P590, DOI [10.1056/NEJMc2011400, 10.1056/NEJMc2013400]; Quan N, 1998, NEUROSCIENCE, V83, P281, DOI 10.1016/S0306-4522(97)00350-3; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Restivo DA, 2020, ANN INTERN MED, V173, P1027, DOI 10.7326/L20-0845; Romero-Sanchez CM, 2020, NEUROLOGY, V95, pE1060, DOI 10.1212/WNL.0000000000009937; Rustenhoven J, 2021, CELL, V184, P1000, DOI 10.1016/j.cell.2020.12.040; Schafflick D, 2021, NAT NEUROSCI, V24, P1225, DOI 10.1038/s41593-021-00880-y; Schlager C, 2016, NATURE, V530, P349, DOI 10.1038/nature16939; Schwabenland M, 2021, IMMUNITY, V54, P1594, DOI 10.1016/j.immuni.2021.06.002; Shakhar K, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002276; Shattuck EC, 2015, AM J PHYS ANTHROPOL, V157, P1, DOI 10.1002/ajpa.22698; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Smatti MK, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11080762; Sohal S, 2020, IDCases, V20, DOI 10.1016/j.idcr.2020.e00782; Solomon IH, 2020, NEW ENGL J MED, V383, P989, DOI 10.1056/NEJMc2019373; Song ER, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100288; Sonneville R, 2017, INTENS CARE MED, V43, P1075, DOI 10.1007/s00134-017-4807-z; Sparkman NL, 2006, J NEUROSCI, V26, P10709, DOI 10.1523/JNEUROSCI.3376-06.2006; Sriwastava S, 2021, J NEUROL, V268, P2690, DOI 10.1007/s00415-020-10263-1; Strazielle N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150945; STREILEIN JW, 1993, CURR OPIN IMMUNOL, V5, P428, DOI 10.1016/0952-7915(93)90064-Y; SZENTISTVANYI I, 1984, AM J PHYSIOL, V246, pF835, DOI 10.1152/ajprenal.1984.246.6.F835; Taga A, 2022, J PERIPHER NERV SYST, V27, P4, DOI 10.1111/jns.12482; Taquet M, 2021, LANCET PSYCHIAT, V8, P416, DOI 10.1016/S2215-0366(21)00084-5; Thakur KT, 2021, BRAIN, V144, P2696, DOI 10.1093/brain/awab148; Tsuda M, 2009, P NATL ACAD SCI USA, V106, P8032, DOI 10.1073/pnas.0810420106; Van Hook MJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232451; van Munster BC, 2008, J AM GERIATR SOC, V56, P1704, DOI 10.1111/j.1532-5415.2008.01851.x; van Ton AMP, 2020, BRAIN BEHAV IMMUN, V89, P656, DOI 10.1016/j.bbi.2020.06.027; VANDAM AM, 1992, BRAIN RES, V588, P291, DOI 10.1016/0006-8993(92)91588-6; Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047; von Bartheld CS, 2016, J COMP NEUROL, V524, P3865, DOI 10.1002/cne.24040; WIDNER H, 1988, SCAND J IMMUNOL, V28, P563, DOI 10.1111/j.1365-3083.1988.tb01488.x; Wislogki GB, 1936, AM J ANAT, V58, P421, DOI 10.1002/aja.1000580206; Witkowski M, 2021, NATURE, V600, P295, DOI 10.1038/s41586-021-04142-6; Woodruff MC, 2020, NAT IMMUNOL, V21, P1506, DOI 10.1038/s41590-020-00814-z; YTTERBERG SR, 1982, ARTHRITIS RHEUM, V25, P401, DOI 10.1002/art.1780250407; ZHANG ET, 1990, J ANAT, V170, P111; Zrzavy T, 2019, NEUROPATH APPL NEURO, V45, P278, DOI 10.1111/nan.12502	156	2	2	4	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 12	2022	55	7					1159	1172		10.1016/j.immuni.2022.06.013	http://dx.doi.org/10.1016/j.immuni.2022.06.013			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3G7UF	35777361	Green Published, Bronze			2022-12-18	WOS:000831554100009
J	Ignacio, A; Shah, K; Bernier-Latmani, J; Koller, Y; Coakley, G; Moyat, M; Hamelin, R; Armand, F; Wong, NC; Ramay, H; Thomson, CA; Burkhard, R; Wang, HZ; Dufour, A; Geuking, MB; McDonald, B; Petrova, TV; Harris, NL; McCoy, KD				Ignacio, Aline; Shah, Kathleen; Bernier-Latmani, Jeremiah; Koeller, Yasmin; Coakley, Gillian; Moyat, Mati; Hamelin, Romain; Armand, Florence; Wong, Nick C.; Ramay, Hena; Thomson, Carolyn A.; Burkhard, Regula; Wang, Haozhe; Dufour, Antoine; Geuking, Markus B.; McDonald, Braedon; Petrova, Tatiana, V; Harris, Nicola L.; McCoy, Kathy D.			Small intestinal resident eosinophils maintain gut homeostasis following microbial colonization	IMMUNITY			English	Article							BASEMENT-MEMBRANE; C/EBP-EPSILON; MACROPHAGES; MODEL; MOUSE; SIGNALS; MURINE; CELLS; IL-1; IDENTIFICATION	The intestine harbors a large population of resident eosinophils, yet the function of intestinal eosinophils has not been explored. Flow cytometry and whole-mount imaging identified eosinophils residing in the lamina propria along the length of the intestine prior to postnatal microbial colonization. Microscopy, transcriptomic analysis, and mass spectrometry of intestinal tissue revealed villus blunting, altered extracellular matrix, decreased epithelial cell turnover, increased gastrointestinal motility, and decreased lipid absorption in eosinophil-deficient mice. Mechanistically, intestinal epithelial cells released IL-33 in a microbiota-depen-dent manner, which led to eosinophil activation. The colonization of germ-free mice demonstrated that eosin-ophil activation in response to microbes regulated villous size alterations, macrophage maturation, epithelial barrier integrity, and intestinal transit. Collectively, our findings demonstrate a critical role for eosinophils in facilitating the mutualistic interactions between the host and microbiota and provide a rationale for the func-tional significance of their early life recruitment in the small intestine.	[Ignacio, Aline; Thomson, Carolyn A.; Dufour, Antoine; McCoy, Kathy D.] Univ Calgary, Cumming Sch Med, Snyder Inst Chron Dis, Dept Physiol & Pharmacol, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada; [Shah, Kathleen; Moyat, Mati; Harris, Nicola L.] Swiss Fed Inst Technol, Global Hlth Inst, CH-1015 Lausanne, Switzerland; [Shah, Kathleen] Francis Crick Inst, 1 Midland Rd, London NW1 1AT, England; [Bernier-Latmani, Jeremiah; Petrova, Tatiana, V] Univ Lausanne UNIL, Ludwig Inst Canc Res Lausanne, Dept Oncol, Chemin Boveresses 155, Epalinges, Switzerland; [Koeller, Yasmin] Univ Bern, Inselspital, Univ Klin Viszerale Chirurg & Med, Maurice Muller Labs,Dept Biomed Res, Murtenstr 35, CH-3008 Bern, Switzerland; [Coakley, Gillian; Moyat, Mati; Wang, Haozhe; Harris, Nicola L.] Monash Univ, Alfred Ctr, Cent Clin Sch, Dept Immunol & Pathol, Melbourne, Vic, Australia; [Hamelin, Romain; Armand, Florence] Fed Inst Technol, Prote Core Facil, CH-1015 Lausanne, Switzerland; [Wong, Nick C.] Monash Univ, Monash Bioinformat Platform, Clayton, Vic 3168, Australia; [Ramay, Hena] Univ Calgary, Int Microbiome Ctr, Cumming Sch Med, Calgary, AB, Canada; [Burkhard, Regula; Geuking, Markus B.] Univ Calgary, Cumming Sch Med, Snyder Inst Chron Dis, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Dufour, Antoine] Univ Calgary, McCaig Inst Bone & Joint Hlth, Calgary, AB T2N 4N1, Canada; [McDonald, Braedon] Univ Calgary, Cumming Sch Med, Dept Crit Care Med, Calgary, AB T2N 4A1, Canada; [Petrova, Tatiana, V] Swiss Fed Inst Technol Lausanne, Sch Life Sci, Swiss Inst Expt Canc Res, Route Cantonale, CH-1015 Lausanne, Switzerland	University of Calgary; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Francis Crick Institute; University of Bern; University Hospital of Bern; Monash University; Monash University; University of Calgary; University of Calgary; University of Calgary; University of Calgary; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	McCoy, KD (corresponding author), Univ Calgary, Cumming Sch Med, Snyder Inst Chron Dis, Dept Physiol & Pharmacol, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.; Harris, NL (corresponding author), Swiss Fed Inst Technol, Global Hlth Inst, CH-1015 Lausanne, Switzerland.; Harris, NL (corresponding author), Monash Univ, Alfred Ctr, Cent Clin Sch, Dept Immunol & Pathol, Melbourne, Vic, Australia.	nicola.harris@monash.edu; kathy.mccoy@ucalgary.ca		Burkhard, Regula/0000-0002-5117-0937; Bernier-Latmani, Jeremiah/0000-0002-6407-1049	So Paulo Research Foundation [2016/15882-7]; Eyes High Postdoctoral Fellowship from the University of Calgary; Swiss National Science Foundation [SNSF310030_134902, SNSF310030_156517, 31003A-156266]; European Research Council (ERC) [281785]; Canadian Institutes of Health Research (CIHR) [PJT-165930]; National Health and Medical Research Council (NHMRC) of Australia; NSERC Discovery Grant [DGECR-2019-00112]; Cumming School of Medicine, University of Calgary; Alberta Economic Development and Trade (AEDT) , Canada; Western Economic Diversification (WED)	So Paulo Research Foundation; Eyes High Postdoctoral Fellowship from the University of Calgary; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council (ERC)(European Research Council (ERC)European Commission); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Cumming School of Medicine, University of Calgary; Alberta Economic Development and Trade (AEDT) , Canada; Western Economic Diversification (WED)	We thank M. Dicay for performing Ussing Chamber experiments and S. Luther for providing Myd88-/-mice. A.I. was supported by a Fellowship from S?o Paulo Research Foundation (2016/15882-7) and an Eyes High Postdoctoral Fellowship from the University of Calgary. This work was supported by grants from the Swiss National Science Foundation (SNSF310030_134902 to K.D.M., SNSF310030_156517 to N.L.H., and 31003A-156266 to T.V.P.) and the Euro- pean Research Council (ERC, FP/2007-2013) Agreement no. 281785 to K.D.M. K.D.M. is also supported by a Canadian Institutes of Health Research (CIHR) grant (PJT-165930) . N.L.H. is supported by a National Health and Medical Research Council (NHMRC) of Australia SRF-B fellowship. A.D. was sup- ported by an NSERC Discovery Grant (DGECR-2019-00112) . The IMC is sup- ported by the Cumming School of Medicine, University of Calgary, Western Economic Diversification (WED) , and Alberta Economic Development and Trade (AEDT) , Canada. Graphical Abstract was created with BioRender.com .	Abdala-Valencia H, 2018, J LEUKOCYTE BIOL, V104, P95, DOI 10.1002/JLB.1MR1117-442RR; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Agace WW, 2017, IMMUNITY, V46, P532, DOI 10.1016/j.immuni.2017.04.004; Ahrends T, 2021, CELL, V184, P5715, DOI 10.1016/j.cell.2021.10.004; Allen IC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030612; Angulo EL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217807; Ansaldo E, 2019, SCIENCE, V364, P1179, DOI 10.1126/science.aaw7479; Arnold IC, 2018, J EXP MED, V215, P2055, DOI 10.1084/jem.20172049; Bain CC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02733; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Baril Jonathan-F, 2019, JMIR Cardio, V3, pe12122, DOI 10.2196/12122; Barker TH, 2017, MATRIX BIOL, V60-61, P1, DOI 10.1016/j.matbio.2017.04.003; Beller A, 2020, EUR J IMMUNOL, V50, P783, DOI 10.1002/eji.201948474; Bernier-Latmani J, 2016, NAT PROTOC, V11, P1617, DOI 10.1038/nprot.2016.092; Buonomo EL, 2016, CELL REP, V16, P432, DOI 10.1016/j.celrep.2016.06.007; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/nmeth.3869, 10.1038/NMETH.3869]; Carlens J, 2009, J IMMUNOL, V183, P5600, DOI 10.4049/jimmunol.0801581; CHEN Q, 2022, LIFE SCI ALLIANCE, V0005; Cherry WB, 2008, J ALLERGY CLIN IMMUN, V121, P1484, DOI 10.1016/j.jaci.2008.04.005; Chester D, 2017, MATRIX BIOL, V60-61, P124, DOI 10.1016/j.matbio.2016.08.004; Chiaranunt P, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.749708; Chu DK, 2014, J EXP MED, V211, P1657, DOI 10.1084/jem.20131800; Chu VT, 2014, IMMUNITY, V40, P582, DOI 10.1016/j.immuni.2014.02.014; Chumakov AM, 2004, ONCOGENE, V23, P3414, DOI 10.1038/sj.onc.1207126; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dey N, 2015, CELL, V163, P95, DOI 10.1016/j.cell.2015.08.059; Drake MG, 2018, J LEUKOCYTE BIOL, V104, P61, DOI 10.1002/JLB.3MR1117-426R; FitzPatrick RD, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.557960; Flood-Page P, 2003, J CLIN INVEST, V112, P1029, DOI 10.1172/JCI200317974; Fulkerson PC, 2006, P NATL ACAD SCI USA, V103, P16418, DOI 10.1073/pnas.0607863103; Goh YPS, 2013, P NATL ACAD SCI USA, V110, P9914, DOI 10.1073/pnas.1304046110; Gombart AF, 2003, BLOOD, V101, P3265, DOI 10.1182/blood-2002-04-1039; Gouon-Evans V, 2002, BREAST CANCER RES, V4, P155, DOI 10.1186/bcr441; Gouon-Evans V, 2000, DEVELOPMENT, V127, P2269; Grisaru-Tal S, 2020, NAT REV CANCER, V20, P594, DOI 10.1038/s41568-020-0283-9; Griseri T, 2015, IMMUNITY, V43, P187, DOI 10.1016/j.immuni.2015.07.008; Groulx JF, 2011, MATRIX BIOL, V30, P195, DOI 10.1016/j.matbio.2011.03.002; Gurtner A., 2021, BIORXIV; Hao ZY, 2001, J EXP MED, V194, P1151, DOI 10.1084/jem.194.8.1151; Hayes CL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32366-6; Heath JP, 1996, CELL BIOL INT, V20, P139, DOI 10.1006/cbir.1996.0018; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Huang L, 2016, TRENDS PARASITOL, V32, P798, DOI 10.1016/j.pt.2016.05.004; Hubbard B, 2014, MATRIX BIOL, V34, P124, DOI 10.1016/j.matbio.2013.10.006; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jacobs S, 2013, J HEALTH SERV RES PO, V18, P144, DOI 10.1177/1355819613476277; Jimenez-Saiz R, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00155; Johnston LK, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00051; Jung Y, 2015, MUCOSAL IMMUNOL, V8, P930, DOI 10.1038/mi.2014.123; Kang B, 2020, MUCOSAL IMMUNOL, V13, P216, DOI 10.1038/s41385-019-0228-3; Kato M, 1998, ANAT REC, V252, P418, DOI 10.1002/(SICI)1097-0185(199811)252:3<418::AID-AR10>3.0.CO;2-1; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Lee EH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28371-4; Li X, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/7894247; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Loffredo LF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61420-5; McGuire JK, 2003, AM J PATHOL, V162, P1831, DOI 10.1016/S0002-9440(10)64318-0; Mesnil C, 2016, J CLIN INVEST, V126, P3279, DOI 10.1172/JCI85664; Miguel RDV, 2017, P NATL ACAD SCI USA, V114, pE6892, DOI 10.1073/pnas.1621253114; Mishra A, 1999, J CLIN INVEST, V103, P1719, DOI 10.1172/JCI6560; Miyata J, 2013, J ALLERGY CLIN IMMUN, V131, P353, DOI 10.1016/j.jaci.2012.07.048; Muller PA, 2014, CELL, V158, P300, DOI 10.1016/j.cell.2014.04.050; Naba A, 2016, MATRIX BIOL, V49, P10, DOI 10.1016/j.matbio.2015.06.003; Naba A, 2015, JOVE-J VIS EXP, DOI 10.3791/53057; Nagase H, 2003, J IMMUNOL, V171, P3977, DOI 10.4049/jimmunol.171.8.3977; Nowicka Malgorzata, 2017, F1000Res, V6, P748, DOI 10.12688/f1000research.11622.3; Pinto SM, 2018, J CELL COMMUN SIGNAL, V12, P615, DOI 10.1007/s12079-018-0464-4; Plubell DL, 2017, MOL CELL PROTEOMICS, V16, P873, DOI 10.1074/mcp.M116.065524; Pope SM, 2005, J IMMUNOL, V175, P5341, DOI 10.4049/jimmunol.175.8.5341; PROCHAZKA M, 1992, P NATL ACAD SCI USA, V89, P3290, DOI 10.1073/pnas.89.8.3290; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Schinke T, 2004, BIOCHEM BIOPH RES CO, V314, P356, DOI 10.1016/j.bbrc.2003.12.100; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shah K, 2020, MUCOSAL IMMUNOL, V13, P574, DOI 10.1038/s41385-020-0281-y; Shaw TN, 2018, J EXP MED, V215, P1507, DOI 10.1084/jem.20180019; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; Sugawara R, 2016, J EXP MED, V213, P555, DOI 10.1084/jem.20141388; Suzukawa M, 2008, LAB INVEST, V88, P1245, DOI 10.1038/labinvest.2008.82; Swartz JM, 2004, J LEUKOCYTE BIOL, V76, P812, DOI 10.1189/jlb.0304182; Uderhardt S, 2017, J EXP MED, V214, P2121, DOI 10.1084/jem.20161070; Valencia HA, 2016, ALLERGY, V71, P267, DOI 10.1111/all.12776; van Tol EAF, 1999, AM J PHYSIOL-GASTR L, V277, pG245, DOI 10.1152/ajpgi.1999.277.1.G245; Vllasaliu D, 2014, EXP CELL RES, V323, P218, DOI 10.1016/j.yexcr.2014.02.022; Wang HZ, 2022, MUCOSAL IMMUNOL, V15, P27, DOI 10.1038/s41385-021-00443-1; Weller PF, 2017, NAT REV IMMUNOL, V17, P746, DOI 10.1038/nri.2017.95; Westermann S, 2022, J IMMUNOL, V208, P732, DOI 10.4049/jimmunol.2100184; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xenakis JJ, 2018, IMMUNOLOGY, V154, P298, DOI 10.1111/imm.12885; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Zeng MY, 2016, IMMUNITY, V44, P647, DOI 10.1016/j.immuni.2016.02.006; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	99	2	2	10	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 12	2022	55	7					1250	+		10.1016/j.immuni.2022.05.014	http://dx.doi.org/10.1016/j.immuni.2022.05.014			31	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3D3AD	35709757				2022-12-18	WOS:000829177900002
J	Parsa, R; London, M; de Castro, TBR; Reis, B; des Amorie, JB; Smith, JG; Mucida, D				Parsa, Roham; London, Mariya; de Castro, Tiago Bruno Rezende; Reis, Bernardo; des Amorie, Julian Buissant; Smith, Jason G.; Mucida, Daniel			Newly recruited intraepithelial Ly6A(+)CCR9(+)CD4(+) T cells protect against enteric viral infection	IMMUNITY			English	Article							NOROVIRUS INFECTION; TISSUE ADAPTATION; GAMMA; IMMUNITY; RECEPTOR; VIRUS; REPLICATION; MAINTENANCE; LYMPHOCYTES; SUFFICIENT	The intestinal epithelium comprises the body's largest surface exposed to viruses. Additionally, the gut epithelium hosts a large population of intraepithelial T lymphocytes, or IELs, although their role in resistance against viral infections remains elusive. By fate-mapping T cells recruited to the murine intestine, we observed an accumulation of newly recruited CD4(+) T cells after infection with murine norovirus CR6 and adenovirus type-2 (AdV), but not reovirus. CR6- and AdV-recruited intraepithelial CD4(+) T cells co-expressed Ly6A and chemokine receptor CCR9, exhibited T helper 1 and cytotoxic profiles, and conferred protection against AdV in vivo and in an organoid model in an IFN-gamma-dependent manner. Ablation of the T cell receptor (TCR) or the transcription factor ThPOK in CD4(+) T cells prior to AdV infection prevented viral control, while TCR ablation during infection did not impact viral clearance. These results uncover a protective role for intraepithelial Ly6A(+)CCR9(+)CD4(+ )T cells against enteric adenovirus.	[Parsa, Roham; London, Mariya; de Castro, Tiago Bruno Rezende; Reis, Bernardo; des Amorie, Julian Buissant; Mucida, Daniel] Rockefeller Univ, Lab Mucosal Immunol, New York, NY 10065 USA; [Mucida, Daniel] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [de Castro, Tiago Bruno Rezende] Rockefeller Univ, Lab Lymphocyte Dynam, New York, NY 10065 USA; [Smith, Jason G.] Univ Washington, Dept Microbiol, Sch Med, Seattle, WA 98109 USA; [London, Mariya] NYU, Grossman Sch Med, Dept Microbiol, 550 1St Ave, New York, NY 10016 USA; [des Amorie, Julian Buissant] Univ Utrecht, Univ Med Ctr Utrecht, Ctr Mol Med, Mol Canc Res, Utrecht, Netherlands	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; University of Washington; University of Washington Seattle; New York University; Utrecht University; Utrecht University Medical Center	Parsa, R; Mucida, D (corresponding author), Rockefeller Univ, Lab Mucosal Immunol, New York, NY 10065 USA.; Mucida, D (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.	rparsa@rockefeller.edu; mucida@rockefeller.edu	Parsa, Roham/AHA-7145-2022; de Castro, Tiago Bruno/G-9168-2017; Sgarbi Reis, Bernardo/E-3448-2012	Parsa, Roham/0000-0002-0864-6098; de Castro, Tiago Bruno/0000-0002-0359-0611; Sgarbi Reis, Bernardo/0000-0002-6841-116X; Mucida, Daniel/0000-0002-0000-0452; London, Mariya/0000-0002-9712-0070; Smith, Jason/0000-0001-6727-5269	Black Family Metastasis Center; Burroughs Wellcome Fund PATH Award; Mathers Foundation; Pershing Square Foundation; National Institutes of Health [R21AI144827, R01DK113375, R01DK093674]; Howard Hughes Medical Institute; Swedish Research Council; Sweden-America Foundation; FASI/FARE Consortium	Black Family Metastasis Center; Burroughs Wellcome Fund PATH Award(Burroughs Wellcome Fund); Mathers Foundation; Pershing Square Foundation(Pershing Square Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Swedish Research Council(Swedish Research CouncilEuropean Commission); Sweden-America Foundation; FASI/FARE Consortium	This work was supported by the Black Family Metastasis Center, the Burroughs Wellcome Fund PATH Award, the Mathers Foundation, the Pershing Square Foundation, the FASI/FARE Consortium, National Institutes of Health grants R21AI144827, R01DK113375, and R01DK093674, and the Howard Hughes Medical Institute (D.M.). R.P. was supported by the Swedish Research Council and The Sweden-America Foundation.	Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803; Bilate AM, 2020, IMMUNITY, V53, P1001, DOI 10.1016/j.immuni.2020.09.003; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Bouziat R, 2017, SCIENCE, V356, P44, DOI 10.1126/science.aah5298; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Brien JD, 2008, J IMMUNOL, V181, P8568, DOI 10.4049/jimmunol.181.12.8568; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Cervantes-Barragan L, 2017, SCIENCE, V357, P806, DOI 10.1126/science.aah5825; Christo SN, 2021, NAT IMMUNOL, V22, P1140, DOI 10.1038/s41590-021-01004-1; Ciucci T, 2019, IMMUNITY, V50, P91, DOI 10.1016/j.immuni.2018.12.019; Dash P, 2011, J CLIN INVEST, V121, P288, DOI 10.1172/JCI44752; Edelblum KL, 2015, GASTROENTEROLOGY, V148, P1417, DOI 10.1053/j.gastro.2015.02.053; Esterhazy D, 2019, NATURE, V569, P126, DOI 10.1038/s41586-019-1125-3; Faria AMC, 2017, J EXP MED, V214, P1211, DOI 10.1084/jem.20162014; Florsheim EB, 2021, CELL, V184, P1440, DOI 10.1016/j.cell.2020.12.007; Gounder AP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005474; Grau KR, 2017, NAT MICROBIOL, V2, P1586, DOI 10.1038/s41564-017-0057-7; Graziano VR, 2021, J VIROL, V95, DOI 10.1128/JVI.01652-20; Han A, 2014, NAT BIOTECHNOL, V32, P684, DOI 10.1038/nbt.2938; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; HOU S, 1992, J IMMUNOL, V149, P1319; Iliev ID, 2021, GASTROENTEROLOGY, V160, P1050, DOI 10.1053/j.gastro.2020.06.100; Jabri B, 2009, NAT REV IMMUNOL, V9, P858, DOI 10.1038/nri2670; Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960; Khatun A, 2021, J EXP MED, V218, DOI 10.1084/jem.20200650; Kiner E, 2021, NAT IMMUNOL, V22, P216, DOI 10.1038/s41590-020-00836-7; Kobayashi T, 2010, VIROLOGY, V398, P194, DOI 10.1016/j.virol.2009.11.037; Konkel JE, 2011, NAT IMMUNOL, V12, P312, DOI 10.1038/ni.1997; London M, 2021, NAT IMMUNOL, V22, P449, DOI 10.1038/s41590-021-00883-8; Lotem J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080467; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Masopust D, 2019, ANNU REV IMMUNOL, V37, P521, DOI 10.1146/annurev-immunol-042617-053214; McDonald BD, 2018, NAT REV IMMUNOL, V18, P514, DOI 10.1038/s41577-018-0013-7; Merkenschlager J, 2021, NATURE, V591, P458, DOI 10.1038/s41586-021-03187-x; Milner JJ, 2017, NATURE, V552, P253, DOI 10.1038/nature24993; MISTCHENKO AS, 1989, BIOCHEM PHARMACOL, V38, P1971, DOI 10.1016/0006-2952(89)90496-6; Mucida D, 2013, NAT IMMUNOL, V14, P281, DOI 10.1038/ni.2523; Nice TJ, 2015, SCIENCE, V347, P269, DOI 10.1126/science.1258100; Pimentel H, 2017, NAT METHODS, V14, P687, DOI 10.1038/nmeth.4324; Reis BS, 2014, IMMUNITY, V41, P244, DOI 10.1016/j.immuni.2014.06.017; Reis BS, 2013, NAT IMMUNOL, V14, P271, DOI 10.1038/ni.2518; Rogoz A, 2015, J IMMUNOL METHODS, V421, P89, DOI 10.1016/j.jim.2015.03.014; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sheridan BS, 2014, IMMUNITY, V40, P747, DOI 10.1016/j.immuni.2014.03.007; Strong DW, 2012, J VIROL, V86, P2950, DOI 10.1128/JVI.07038-11; Stuller KA, 2010, J IMMUNOL, V184, P3850, DOI 10.4049/jimmunol.0902935; Sujino T, 2016, SCIENCE, V352, P1581, DOI 10.1126/science.aaf3892; Swain SL, 2012, NAT REV IMMUNOL, V12, P136, DOI 10.1038/nri3152; TAKEUCHI A, 1976, INFECT IMMUN, V13, P569, DOI 10.1128/IAI.13.2.569-580.1976; Tanoue T, 2016, NAT REV IMMUNOL, V16, P295, DOI 10.1038/nri.2016.36; Tinevez JY, 2017, METHODS, V115, P80, DOI 10.1016/j.ymeth.2016.09.016; Tominaga K, 2000, INT IMMUNOL, V12, P151, DOI 10.1093/intimm/12.2.151; Trombetta J.J., 2014, CURR PROTOC MOL BIOL, V107, P1; Vacchio MS, 2014, NAT IMMUNOL, V15, P947, DOI 10.1038/ni.2960; van Konijnenburg DPH, 2017, CELL, V171, P783, DOI 10.1016/j.cell.2017.08.046; van Leeuwen EMM, 2004, J IMMUNOL, V173, P1834, DOI 10.4049/jimmunol.173.3.1834; Wilen CB, 2018, SCIENCE, V360, P204, DOI 10.1126/science.aar3799; Wilhelmi I, 2003, CLIN MICROBIOL INFEC, V9, P247, DOI 10.1046/j.1469-0691.2003.00560.x; Wilson SS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006446; Yoshimoto T, 1998, J IMMUNOL, V161, P3400; Zaunders JJ, 2004, BLOOD, V103, P2238, DOI 10.1182/blood-2003-08-2765	62	2	2	3	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 12	2022	55	7					1234	+		10.1016/j.immuni.2022.05.001	http://dx.doi.org/10.1016/j.immuni.2022.05.001			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3D3AD	35617965	Green Submitted			2022-12-18	WOS:000829177900001
J	Wang, YQ; Yuan, M; Lv, HB; Peng, J; Wilson, IA; Wu, NC				Wang, Yiquan; Yuan, Meng; Lv, Huibin; Peng, Jian; Wilson, Ian A.; Wu, Nicholas C.			A large-scale systematic survey reveals recurring molecular features of public antibody responses to SARS-CoV-2	IMMUNITY			English	Article							NEUTRALIZING ANTIBODIES; V(D)J RECOMBINATION; INFLUENZA-VIRUS; MECHANISMS; SPIKE; IDENTIFICATION; RECOGNITION; EPITOPES; DOMAIN	Global research to combat the COVID-19 pandemic has led to the isolation and characterization of thousands of human antibodies to the SARS-CoV-2 spike protein, providing an unprecedented opportunity to study the antibody response to a single antigen. Using the information derived from 88 research publications and 13 patents, we assembled a dataset of ???8,000 human antibodies to the SARS-CoV-2 spike protein from >200 donors. By analyzing immunoglobulin V and D gene usages, complementarity-determining region H3 sequences, and somatic hypermutations, we demonstrated that the common (public) responses to different domains of the spike protein were quite different. We further used these sequences to train a deep-learning model to accurately distinguish between the human antibodies to SARS-CoV-2 spike protein and those to influenza hemagglutinin protein. Overall, this study provides an informative resource for antibody research and enhances our molecular understanding of public antibody responses.	[Wang, Yiquan; Lv, Huibin; Wu, Nicholas C.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Yuan, Meng; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Lv, Huibin] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, HKU Pasteur Res Pole, Hong Kong, Peoples R China; [Peng, Jian] Univ Illinois, Dept Comp Sci, Urbana, IL 61801 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Wu, Nicholas C.] Univ Illinois, Ctr Biophys & Quantitat Biol, Urbana, IL 61801 USA; [Wu, Nicholas C.] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA; [Wu, Nicholas C.] Univ Illinois, Carle Illinois Coll Med, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; Scripps Research Institute; University of Hong Kong; University of Illinois System; University of Illinois Urbana-Champaign; Scripps Research Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Wu, NC (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.; Wu, NC (corresponding author), Univ Illinois, Ctr Biophys & Quantitat Biol, Urbana, IL 61801 USA.; Wu, NC (corresponding author), Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA.; Wu, NC (corresponding author), Univ Illinois, Carle Illinois Coll Med, Urbana, IL 61801 USA.	nicwu@illinois.edu		Wu, Nicholas/0000-0002-9078-6697	National Institutes of Health (NIH) [R00 AI139445, DP2 AT011966, R01 AI167910]; Bill and Melinda Gates Foundation [INV-004923]; Calmette and Yersin scholarship from the Pasteur International Network Association; Michelson Prizes for Human Immunology and Vaccine Research	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Calmette and Yersin scholarship from the Pasteur International Network Association; Michelson Prizes for Human Immunology and Vaccine Research	This work was supported by National Institutes of Health (NIH) R00 AI139445 (N.C.W.) , DP2 AT011966 (N.C.W.) , R01 AI167910 (N.C.W.) , the Michelson Pri-zes for Human Immunology and Vaccine Research (N.C.W.) , Bill and Melinda Gates Foundation INV-004923 (I.A.W.) , and a Calmette and Yersin scholarship from the Pasteur International Network Association (H.L.) . We thank Seth Zost for helpful discussion.	Abadi M, 2015, P 12 USENIX S OPERAT; Alvarez-Prado AF, 2018, J EXP MED, V215, P761, DOI 10.1084/jem.20171738; Anderson RJ, 2005, PROTEINS, V60, P679, DOI 10.1002/prot.20530; Andrews SF, 2018, CURR OPIN IMMUNOL, V53, P96, DOI 10.1016/j.coi.2018.04.009; [Anonymous], 2011, ICML, DOI [DOI 10.5555/3104482.3104565, 10.5555/3104482.3104565]; Zhou B, 2022, bioRxiv, DOI 10.1101/2022.01.05.475037; Barnes CO, 2020, NATURE, V588, P682, DOI 10.1038/s41586-020-2852-1; Benson DA, 2013, NUCLEIC ACIDS RES, V41, pD36, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkn723, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094]; Briney B, 2019, NATURE, V566, P393, DOI 10.1038/s41586-019-0879-y; Cao YL, 2020, CELL, V182, P73, DOI 10.1016/j.cell.2020.05.025; Cerutti G, 2021, CELL HOST MICROBE, V29, P819, DOI 10.1016/j.chom.2021.03.005; Chen EC, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109604; Chi XY, 2020, SCIENCE, V369, P650, DOI 10.1126/science.abc6952; Clark SA, 2021, CELL, V184, P2605, DOI 10.1016/j.cell.2021.03.027; Curtis NC, 2020, CURR OPIN SYST BIOL, V24, P93, DOI 10.1016/j.coisb.2020.10.008; Dejnirattisai W, 2021, CELL, V184, P2183, DOI 10.1016/j.cell.2021.02.032; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Dong JH, 2021, NAT MICROBIOL, V6, P1233, DOI 10.1038/s41564-021-00972-2; Dunand CJH, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0238; Dunbar J, 2016, BIOINFORMATICS, V32, P298, DOI 10.1093/bioinformatics/btv552; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Graham C, 2021, IMMUNITY, V54, P1276, DOI 10.1016/j.immuni.2021.03.023; Guo YC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02365; Hurlburt NK, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19231-9; Jackson KJL, 2014, CELL HOST MICROBE, V16, P105, DOI 10.1016/j.chom.2014.05.013; Joyce MG, 2016, CELL, V166, P609, DOI 10.1016/j.cell.2016.06.043; Jung D, 2004, CELL, V116, P299, DOI 10.1016/S0092-8674(04)00039-X; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim SI, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abd6990; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lang SS, 2017, CELL REP, V20, P2935, DOI 10.1016/j.celrep.2017.08.084; Lanzavecchia A, 2016, CURR OPIN IMMUNOL, V41, P62, DOI 10.1016/j.coi.2016.06.001; Li DP, 2022, ANNU REV MED, V73, P1, DOI 10.1146/annurev-med-042420-113838; Li DP, 2021, CELL, V184, P4203, DOI 10.1016/j.cell.2021.06.021; Li TT, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26539-7; Li WW, 2022, CELL REP, V38, DOI [10.1016/j.celrep.2021.110210, 10.1101/2021.08.02.454546]; Piccoli L, 2020, CELL, V183, P1024, DOI 10.1016/j.cell.2020.09.037; Pieper K, 2017, NATURE, V548, P597, DOI 10.1038/nature23670; Pinto D, 2021, SCIENCE, V373, P1109, DOI 10.1126/science.abj3321; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Raybould Matthew I J, 2021, Bioinformatics, V37, P734, DOI 10.1093/bioinformatics/btaa739; Reincke SM, 2022, SCIENCE, V375, P782, DOI 10.1126/science.abm5835; Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024; Robbiani Davide F, 2020, Nature, V584, P437, DOI [10.1101/2020.05.13.092619, 10.1038/s41586-020-2456-9]; Saito T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118432; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; Scheid JF, 2021, CELL, V184, P3205, DOI 10.1016/j.cell.2021.04.032; Schmitz AJ, 2021, IMMUNITY, V54, P2159, DOI [10.1016/j.immuni.2021.08.013, 10.1101/2021.03.24.436864]; Setliff I, 2018, CELL HOST MICROBE, V23, P845, DOI 10.1016/j.chom.2018.05.001; Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117; Shiakolas AR, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100313; Soto C, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-03649-5; Soto C, 2019, NATURE, V566, P398, DOI 10.1038/s41586-019-0934-8; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Starr TN, 2021, NATURE, V597, P97, DOI 10.1038/s41586-021-03807-6; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tan TJC, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24123-7; Tareen A, 2020, BIOINFORMATICS, V36, P2272, DOI 10.1093/bioinformatics/btz921; Thomson EC, 2021, CELL, V184, P1171, DOI 10.1016/j.cell.2021.01.037; Tong P, 2021, CELL, V184, P4969, DOI [10.1016/j.cell.2021.07.025, 10.1101/2021.03.10.434840]; Tortorici MA, 2020, SCIENCE, V370, P950, DOI 10.1126/science.abe3354; Truck J, 2015, J IMMUNOL, V194, P252, DOI 10.4049/jimmunol.1401405; Vaswani A, 2017, ADV NEUR IN, V30; Voss WN, 2021, SCIENCE, V372, P1108, DOI 10.1126/science.abg5268; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang LS, 2021, SCIENCE, V373, P759, DOI 10.1126/science.abh1766; Wec AZ, 2020, SCIENCE, V369, P731, DOI 10.1126/science.abc7424; Winters A, 2019, MABS-AUSTIN, V11, P1025, DOI 10.1080/19420862.2019.1624126; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Wu NC, 2020, PLOS PATHOG, V16, DOI [10.1371/journal.ppat.1009089, 10.1101/2020.09.21.305441]; Wu NC, 2020, CELL HOST MICROBE, V28, P434, DOI 10.1016/j.chom.2020.06.003; Wu NC, 2018, CELL HOST MICROBE, V24, P569, DOI 10.1016/j.chom.2018.09.010; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Yeap LS, 2015, CELL, V163, P1124, DOI 10.1016/j.cell.2015.10.042; Yu Guangchuang, 2020, Curr Protoc Bioinformatics, V69, pe96, DOI 10.1002/cpbi.96; Yuan M, 2021, BIOCHEM BIOPH RES CO, V538, P192, DOI 10.1016/j.bbrc.2020.10.012; Yuan M, 2020, SCIENCE, V369, P1119, DOI 10.1126/science.abd2321; Zhang Q, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24514-w; Zhou PP, 2022, SCI TRANSL MED, V14, DOI 10.1126/scitranslmed.abi9215; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	84	2	2	6	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 14	2022	55	6					1105	+		10.1016/j.immuni.2022.03.019	http://dx.doi.org/10.1016/j.immuni.2022.03.019			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3F2TY	35397794	Green Published, hybrid			2022-12-18	WOS:000830524400005
J	Fang, DF; Cui, KR; Cao, YQ; Zheng, MZ; Kawabe, T; Hu, GQ; Khillan, JS; Li, D; Zhong, C; Jankovic, D; Sher, A; Zhao, KJ; Zhu, JF				Fang, Difeng; Cui, Kairong; Cao, Yaqiang; Zheng, Mingzhu; Kawabe, Takeshi; Hu, Gangqing; Khillan, Jaspal S.; Li, Dan; Zhong, Chao; Jankovic, Dragana; Sher, Alan; Zhao, Keji; Zhu, Jinfang			Differential regulation of transcription factor T-bet induction during NK cell development and T helper-1 cell differentiation	IMMUNITY			English	Article							INNATE LYMPHOID-CELLS; IFN-GAMMA PRODUCTION; NATURAL-KILLER; TOXOPLASMA-GONDII; CUTTING EDGE; LINEAGE COMMITMENT; SPECIFIES LINEAGE; INTERFERON-GAMMA; MICE LACKING; HELPER T	Adaptive CD4(+) T helper cells and their innate counterparts, innate lymphoid cells, utilize an identical set of transcription factors (TFs) for their differentiation and functions. However, similarities and differences in the induction of these TFs in related lymphocytes are still elusive. Here, we show that T helper-1 (Th1) cells and natural killer (NK) cells displayed distinct epigenomes at the Tbx21 locus, which encodes T-bet, a critical TF for regulating type 1 immune responses. The initial induction of T-bet in NK precursors was dependent on the NK-specific DNase I hypersensitive site Tbx21-CNS-3, and the expression of the interleukin-18 (IL-18) receptor; IL-18 induced T-bet expression through the transcription factor RUNX3, which bound to Tbx21-CNS-3, By contrast, signal transducer and activator of transcription (STAT)-binding motifs within Tbx21-CNS-12 were critical for IL-12-induced T-bet expression during Th1 cell differentiation both in vitro and in vivo. Thus, type 1 innate and adaptive lymphocytes utilize distinct enhancer elements for their development and differentiation.	[Fang, Difeng; Zheng, Mingzhu; Li, Dan; Zhong, Chao; Zhu, Jinfang] NIAID, Mol & Cellular Immunoregulat Sect, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Cui, Kairong; Cao, Yaqiang; Hu, Gangqing; Zhao, Keji] NHLBI, Lab Epigenome Biol, NIH, Bldg 10, Bethesda, MD 20892 USA; [Zheng, Mingzhu] Southeast Univ, Dept Microbiol & Immunol, Jiangsu Prov Key Lab Crit Care Med, Sch Med, Nanjing 210009, Jiangsu, Peoples R China; [Kawabe, Takeshi; Sher, Alan] NIAID, Immunobiol Sect, Lab Parasit Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Kawabe, Takeshi] Tohoku Univ, Dept Microbiol & Immunol, Grad Sch Med, Sendai, Miyagi 9808575, Japan; [Hu, Gangqing] West Virginia Univ, Sch Med, Dept Microbiol Immunol & Cell Biol, Morgantown, WV 26506 USA; [Khillan, Jaspal S.] NIAID, Mouse Genet & Gene Modificat Sect, Comparat Med Branch, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Li, Dan] Soochow Univ, Dept Clin Lab, Affiliated Hosp 2, Suzhou 215004, Jiangsu, Peoples R China; [Zhong, Chao] Peking Univ, Sch Basic Med Sci, Inst Syst Biomed, Hlth Sci Ctr, Beijing 100191, Peoples R China; [Jankovic, Dragana] NIAID, Immunoparasitol Unit, Lab Parasit Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Southeast University - China; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Tohoku University; West Virginia University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Soochow University - China; Peking University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fang, DF; Zhu, JF (corresponding author), NIAID, Mol & Cellular Immunoregulat Sect, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	difeng.fang@nih.gov; jfzhu@niaid.nih.gov	FANG, DIFENG/G-7796-2018; Zhu, Jinfang/B-7574-2012; Cao, Yaqiang/ABC-3753-2021	FANG, DIFENG/0000-0003-2105-6743; Zhu, Jinfang/0000-0002-0117-4745; Cao, Yaqiang/0000-0002-4665-1517	Division of Intramural Research of the NIAID [1ZIA-AI-001169]; NHLBI [1ZIA-HL-006030]	Division of Intramural Research of the NIAID; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Drs. John J. O'Shea and Ronald N. Germain for their critical reading of the manuscript. We thank Steven L. Reiner for providing the Tbx21fl/fl mice, Takeshi Egawa and Dan R. Littman for providing the RUNX3-YFP mice, Juan Carlos Zuiga-PfluEurocker for providing OP9 and OP9-DL1 cell lines, Ke Weng and the NIAID Flow Cytometry Section for cell sorting, the NIH Tetramer Core Facility for the tetramer reagents, and the NHLBI DNA Sequencing Core facility for sequencing the ChIP-seq and DNase-seq libraries. This work is supported by the Division of Intramural Research of the NIAID (grant 1ZIA-AI-001169) and the NHLBI (grant 1ZIA-HL-006030) .	Abel AM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01869; Blanchard N, 2008, NAT IMMUNOL, V9, P937, DOI 10.1038/ni.1629; BROWN CR, 1990, J IMMUNOL, V145, P3438; Cao YQ, 2020, BIOINFORMATICS, V36, P666, DOI 10.1093/bioinformatics/btz651; Carotta S, 2011, BLOOD, V117, P5449, DOI 10.1182/blood-2010-11-318956; Chaix J, 2008, J IMMUNOL, V181, P1627, DOI 10.4049/jimmunol.181.3.1627; Chang DH, 2020, IMMUNITY, V53, P614, DOI 10.1016/j.immuni.2020.07.012; Chaves P, 2018, J IMMUNOL, V201, P3307, DOI 10.4049/jimmunol.1701675; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Christie D, 2014, CURR TOP MICROBIOL, V381, P125, DOI 10.1007/82_2014_372; Collins A, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90063; Colonna M, 2018, IMMUNITY, V48, P1104, DOI 10.1016/j.immuni.2018.05.013; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Daussy C, 2014, J EXP MED, V211, P563, DOI 10.1084/jem.20131560; DENKERS EY, 1993, J EXP MED, V178, P1465, DOI 10.1084/jem.178.5.1465; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Ebihara T, 2015, NAT IMMUNOL, V16, P1124, DOI 10.1038/ni.3272; Egawa T, 2008, NAT IMMUNOL, V9, P1131, DOI 10.1038/ni.1652; Fang DF, 2018, J EXP MED, V215, P2705, DOI 10.1084/jem.20180927; Fang DF, 2017, J EXP MED, V214, P1861, DOI 10.1084/jem.20170494; Fathman JW, 2011, BLOOD, V118, P5439, DOI 10.1182/blood-2011-04-348912; Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544; Gao YL, 2017, NAT IMMUNOL, V18, P1004, DOI 10.1038/ni.3800; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Grover HS, 2012, INFECT IMMUN, V80, P3279, DOI 10.1128/IAI.00425-12; Gury-BenAri M, 2016, CELL, V166, P1231, DOI 10.1016/j.cell.2016.07.043; Heinz S, 2012, CURR TOP MICROBIOL, V356, P1, DOI 10.1007/82_2011_142; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hoshino K, 1999, J IMMUNOL, V162, P5041; Hosoya-Ohmura S, 2011, MOL CELL BIOL, V31, P1894, DOI 10.1128/MCB.05065-11; Hu GQ, 2018, IMMUNITY, V48, P227, DOI 10.1016/j.immuni.2018.01.013; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Jin WF, 2015, NATURE, V528, P142, DOI 10.1038/nature15740; Kamimura Y, 2015, CELL REP, V10, P280, DOI 10.1016/j.celrep.2014.12.025; Kang J, 2015, ANNU REV IMMUNOL, V33, P505, DOI 10.1146/annurev-immunol-032414-112025; Kasal DN, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2106311118; Kawabe T, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam9304; Khan A, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1708-7; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Koues OI, 2016, CELL, V165, P1134, DOI 10.1016/j.cell.2016.04.014; Kugler DG, 2013, J EXP MED, V210, P1919, DOI 10.1084/jem.20122300; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lau CM, 2018, NAT IMMUNOL, V19, P963, DOI 10.1038/s41590-018-0176-1; Lazarevic V, 2011, NAT IMMUNOL, V12, P96, DOI 10.1038/ni.1969; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Levanon D, 2014, MOL CELL BIOL, V34, P1158, DOI 10.1128/MCB.01202-13; Lieberman LA, 2004, INFECT IMMUN, V72, P6729, DOI 10.1128/IAI.72.11.6729-6732.2004; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Madera S, 2018, J IMMUNOL, V200, P1977, DOI 10.4049/jimmunol.1700416; Maekawa Y, 2003, IMMUNITY, V19, P549, DOI 10.1016/S1074-7613(03)00270-X; Mantovani A, 2019, IMMUNITY, V50, P778, DOI 10.1016/j.immuni.2019.03.012; McFarland AP, 2021, IMMUNITY, V54, P1320, DOI 10.1016/j.immuni.2021.03.024; Minter LM, 2005, NAT IMMUNOL, V6, P680, DOI 10.1038/ni1209x; Moro K, 2015, NAT PROTOC, V10, P792, DOI 10.1038/nprot.2015.047; Muller AA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005723; Mujal AM, 2021, ANNU REV IMMUNOL, V39, P417, DOI 10.1146/annurev-immunol-101819-074948; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Ohno SI, 2008, INT IMMUNOL, V20, P71, DOI 10.1093/intimm/dxm120; Pak-Wittel M.A., 2014, CURR PROTOC IMMUNOL, V105; Park E, 2019, ELIFE, V8, DOI 10.7554/eLife.47605; PARKER SJ, 1991, CLIN EXP IMMUNOL, V84, P207, DOI 10.1111/j.1365-2249.1991.tb08150.x; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Perchet T, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01252; Pikovskaya O, 2016, J IMMUNOL, V196, P1449, DOI 10.4049/jimmunol.1502396; Rapp M, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan3796; Ratajczak MZ, 2020, LEUKEMIA, V34, P1512, DOI 10.1038/s41375-020-0827-8; Rogers JM, 2018, WIRES SYST BIOL MED, V10, DOI 10.1002/wsbm.1423; Scharton-Kersten T, 1998, J IMMUNOL, V160, P2565; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Sciume G, 2020, IMMUNITY, V53, P745, DOI 10.1016/j.immuni.2020.09.008; Seo W, 2017, SCI REP-UK, V7, DOI 10.1038/srep41351; Sharrock J., 2019, EMJ ALLERGY IMMUNOL, V4, P108; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Shih HY, 2014, IMMUNOL REV, V261, P23, DOI 10.1111/imr.12208; Silberstein L, 2016, CELL STEM CELL, V19, P530, DOI 10.1016/j.stem.2016.07.004; Simonetta F, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00241; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Stokic-Trtica V, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00813; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; Tominaga K, 2000, INT IMMUNOL, V12, P151, DOI 10.1093/intimm/12.2.151; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Waldmann TA, 1999, ANNU REV IMMUNOL, V17, P19, DOI 10.1146/annurev.immunol.17.1.19; Wang DN, 2020, CANCERS, V12, DOI 10.3390/cancers12061591; Wang Y, 2014, IMMUNITY, V40, P355, DOI 10.1016/j.immuni.2014.01.002; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Wu Y, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00930; Xu W, 2019, IMMUNITY, V50, P1054, DOI 10.1016/j.immuni.2019.02.022; Yagi R, 2010, IMMUNITY, V32, P507, DOI 10.1016/j.immuni.2010.04.004; Yang R, 2021, J EXP MED, V218, DOI 10.1084/jem.20202726; Yang R, 2020, CELL, V183, P1826, DOI 10.1016/j.cell.2020.10.046; Yang Y, 2007, BLOOD, V110, P2494, DOI 10.1182/blood-2006-11-058271; Yarovinsky F, 2014, NAT REV IMMUNOL, V14, P109, DOI 10.1038/nri3598; Yu F, 2018, J EXP MED, V215, P1813, DOI 10.1084/jem.20170155; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhong C, 2020, IMMUNITY, V52, P83, DOI 10.1016/j.immuni.2019.12.001; Zhu JF, 2012, IMMUNITY, V37, P660, DOI 10.1016/j.immuni.2012.09.007	103	2	2	6	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 12	2022	55	4					639	+		10.1016/j.immuni.2022.03.005	http://dx.doi.org/10.1016/j.immuni.2022.03.005			25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0W2LH	35381213				2022-12-18	WOS:000788864600010
J	Biram, A; Liu, JJ; Hezroni, H; Davidzohn, N; Schmiedel, D; Khatib-Massalha, E; Haddad, M; Grenov, A; Lebon, S; Salame, TM; Dezorella, N; Hoffman, D; Abou Karam, P; Biton, M; Lapidot, T; Bemark, M; Avraham, R; Jung, S; Shulman, Z				Biram, Adi; Liu, Jingjing; Hezroni, Hadas; Davidzohn, Natalia; Schmiedel, Dominik; Khatib-Massalha, Eman; Haddad, Montaser; Grenov, Amalie; Lebon, Sacha; Salame, Tomer Meir; Dezorella, Nili; Hoffman, Dotan; Abou Karam, Paula; Biton, Moshe; Lapidot, Tsvee; Bemark, Mats; Avraham, Roi; Jung, Steffen; Shulman, Ziv			Bacterial infection disrupts established germinal center reactions through monocyte recruitment and impaired metabolic adaptation	IMMUNITY			English	Article							B-CELLS; SALMONELLA INFECTION; RNA-SEQ; CENTER RESPONSES; DENDRITIC CELLS; CENTER HYPOXIA; EXPRESSION; LPS; TYPHIMURIUM; REVEALS	Consecutive exposures to different pathogens are highly prevalent and often alter the host immune response. However, it remains unknown how a secondary bacterial infection affects an ongoing adaptive immune response elicited against primary invading pathogens. We demonstrated that recruitment of Sca-1+ monocytes into lymphoid organs during Salmonella Typhimurium (STm) infection disrupted pre-existing germinal center (GC) reactions. GC responses induced by influenza, plasmodium, or commensals deteriorated following STm infection. GC disruption was independent of the direct bacterial interactions with B cells and instead was induced through recruitment of CCR2-dependent Sca-1(+) monocytes into the lymphoid organs. GC collapse was associated with impaired cellular respiration and was dependent on TNF alpha and IFN gamma, the latter of which was essential for Sca-1(+) monocyte differentiation. Monocyte recruitment and GC disruption also occurred during LPS-supplemented vaccination and Listeria monocytogenes infection. Thus, systemic activation of the innate immune response upon severe bacterial infection is induced at the expense of antibody-mediated immunity.	[Biram, Adi; Liu, Jingjing; Hezroni, Hadas; Davidzohn, Natalia; Schmiedel, Dominik; Khatib-Massalha, Eman; Haddad, Montaser; Grenov, Amalie; Lapidot, Tsvee; Jung, Steffen; Shulman, Ziv] Weizmann Inst Sci, Dept Immunol, IL-7610001 Rehovot, Israel; [Salame, Tomer Meir] Weizmann Inst Sci, Dept Life Sci Core Facil, IL-7610001 Rehovot, Israel; [Dezorella, Nili] Weizmann Inst Sci, Electron Microscopy Unit, IL-7610001 Rehovot, Israel; [Davidzohn, Natalia; Lebon, Sacha; Hoffman, Dotan; Biton, Moshe; Avraham, Roi] Weizmann Inst Sci, Dept Biol Regulat, IL-7610001 Rehovot, Israel; [Abou Karam, Paula] Weizmann Inst Sci, Dept Biomol Sci, IL-7610001 Rehovot, Israel; [Bemark, Mats] Univ Gothenburg, Inst Biomed, Dept Microbiol & Immunol, SE-40530 Gothenburg, Sweden	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; University of Gothenburg	Biram, A; Shulman, Z (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-7610001 Rehovot, Israel.	adi.biram@weizmann.ac.il; ziv.shulman@weizmann.ac.il	Jung, Steffen/K-1409-2012; Bemark, Mats/B-2578-2019	Jung, Steffen/0000-0003-4290-5716; Bemark, Mats/0000-0001-7416-9819; Grenov, Amalie/0000-0001-6310-565X; Salame, Tomer Meir/0000-0003-4260-8738; Davidzohn, Natalia/0000-0001-5611-3627; Hoffman, Dotan/0000-0002-7126-2943; Avraham, Roi/0000-0002-9098-3885	European Research Council (ERC) [677713]; Israel Science Foundation (ISF) [1090/18]; Morris Kahn Institute for Human Immunology; Azrieli Foundation; Ben B. and Joyce E. Eisenberg Foundation; Wolfson Family Charitable Trust; Wolfson Foundation	European Research Council (ERC)(European Research Council (ERC)European Commission); Israel Science Foundation (ISF)(Israel Science Foundation); Morris Kahn Institute for Human Immunology; Azrieli Foundation; Ben B. and Joyce E. Eisenberg Foundation; Wolfson Family Charitable Trust; Wolfson Foundation	We thank Dr. Elena Ainbinder and Dr. Yael Fried from the Stem Cells and Advanced Cell Technologies unit of the Weizmann Institute Life Science Core Facility for assistance with metabolism assays. Z.S. is supported by the European Research Council (ERC) grant no. 677713, Israel Science Foun-dation (ISF) grant no. 1090/18, and the Morris Kahn Institute for Human Immu-nology. We thank the Azrieli Foundation; Ben B. and Joyce E. Eisenberg Foun-dation; Wolfson Family Charitable Trust and Wolfson Foundation; and Elie Hirschfeld, Dr. Sarah Schlesinger, and Miel de Botton for their support. Z.S. is a member of the European Molecular Biology Organization (EMBO) Young Investigator Program.	Abbott RK, 2016, J IMMUNOL, V197, P4014, DOI 10.4049/jimmunol.1601401; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; Askenase MH, 2015, IMMUNITY, V42, P1130, DOI 10.1016/j.immuni.2015.05.011; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Bergqvist P, 2013, MUCOSAL IMMUNOL, V6, P122, DOI 10.1038/mi.2012.56; Biram A, 2019, NAT IMMUNOL, V20, P482, DOI 10.1038/s41590-019-0325-1; Bruhl H, 2007, ARTHRITIS RHEUM, V56, P2975, DOI 10.1002/art.22854; Bumann D, 2001, INFECT IMMUN, V69, P4618, DOI 10.1128/IAI.69.7.4618-4626.2001; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Caro-Maldonado A, 2014, J IMMUNOL, V192, P3626, DOI 10.4049/jimmunol.1302062; Chen C, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11121118; Cho SH, 2016, NATURE, V537, P234, DOI 10.1038/nature19334; Cunningham AF, 2007, J IMMUNOL, V178, P6200, DOI 10.4049/jimmunol.178.10.6200; Dasoveanu DC, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aaw0693; Denton AE, 2019, J EXP MED, V216, P621, DOI 10.1084/jem.20181216; Di Niro R, 2015, IMMUNITY, V43, P120, DOI 10.1016/j.immuni.2015.06.013; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunning J, 2020, MUCOSAL IMMUNOL, V13, P566, DOI 10.1038/s41385-020-0287-5; Elsner RA, 2020, IMMUNITY, V53, P1136, DOI 10.1016/j.immuni.2020.11.006; Elsner RA, 2019, CELL REP, V29, P2796, DOI 10.1016/j.celrep.2019.10.069; Elsner RA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004976; Ersching J, 2017, IMMUNITY, V46, P1045, DOI 10.1016/j.immuni.2017.06.005; Feldman C, 2021, PNEUMONIA, V13, DOI 10.1186/s41479-021-00083-w; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Fuhrmann DC, 2017, REDOX BIOL, V12, P208, DOI 10.1016/j.redox.2017.02.012; Gil-Cruz C, 2009, P NATL ACAD SCI USA, V106, P9803, DOI 10.1073/pnas.0812431106; Gitlin AD, 2015, SCIENCE, V349, P643, DOI 10.1126/science.aac4919; Glancy B, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.541040; Grainger JR, 2013, NAT MED, V19, P713, DOI 10.1038/nm.3189; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Kaneko Naoki, 2020, SSRN, P3652322, DOI [10.1016/j.cell.2020.08.025, 10.2139/ssrn.3652322]; Khatib-Massalha E, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17402-2; Kohen R, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2728-2; Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mack M, 2001, J IMMUNOL, V166, P4697, DOI 10.4049/jimmunol.166.7.4697; MacNamara KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028669; MacNamara KC, 2011, J IMMUNOL, V186, P1032, DOI 10.4049/jimmunol.1001893; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mastroeni Pietro, 2002, Current Molecular Medicine (Hilversum), V2, P393, DOI 10.2174/1566524023362492; McCarthy MK, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008292; McCullers JA, 2004, J INFECT DIS, V190, P519, DOI 10.1086/421525; McSorley SJ, 2002, IMMUNITY, V16, P365, DOI 10.1016/S1074-7613(02)00289-3; McSorley SJ, 2014, IMMUNOL REV, V260, P168, DOI 10.1111/imr.12184; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muri J, 2021, NAT REV IMMUNOL, V21, P363, DOI 10.1038/s41577-020-00478-8; Nanton MR, 2015, EUR J IMMUNOL, V45, P428, DOI 10.1002/eji.201444540; Nash A.A., 2015, MIMS PATHOGENESIS IN, P171, DOI [10.1016/B978-0-12-397188-3.00008-1, DOI 10.1016/B978-0-12-397188-3.00008-1]; Nothelfer K, 2015, NAT REV MICROBIOL, V13, P173, DOI 10.1038/nrmicro3415; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; OBRIEN AD, 1980, J IMMUNOL, V124, P20; Oxford JS, 2018, LANCET INFECT DIS, V18, pE348, DOI [10.1016/S1473-3099(18)30359-1, 10.1016/s1473-3099(18)30359-1]; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Perez-Lopez A, 2013, J IMMUNOL, V190, P1201, DOI 10.4049/jimmunol.1200415; Plecita-Hlavata L, 2016, INT J BIOCHEM CELL B, V80, P31, DOI 10.1016/j.biocel.2016.09.010; Popescu M, 2019, J IMMUNOL, V203, P2415, DOI 10.4049/jimmunol.1900484; Qureshi ST, 1996, GENOMICS, V31, P283, DOI 10.1006/geno.1996.0050; Racine R, 2010, J IMMUNOL, V184, P5085, DOI 10.4049/jimmunol.0902710; Reinecke F, 2009, BBA-MOL BASIS DIS, V1792, P1113, DOI 10.1016/j.bbadis.2009.04.003; Rhen M, 2019, J INNATE IMMUN, V11, P216, DOI 10.1159/000496370; Rosales-Reyes R, 2005, INFECT IMMUN, V73, P3937, DOI 10.1128/IAI.73.7.3937-3944.2005; Rosales-Reyes R, 2012, MICROB PATHOGENESIS, V52, P367, DOI 10.1016/j.micpath.2012.03.007; Ryg-Cornejo V, 2016, CELL REP, V14, P68, DOI 10.1016/j.celrep.2015.12.006; Sammicheli S, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah6789; Scarpulla R.C, 2013, MOL BIOL OXPHOS SYST; Schulke S, 2015, ALLERGY, V70, P1259, DOI 10.1111/all.12675; SECORD EA, 1995, AM J PATHOL, V147, P422; SEPPALA IJT, 1984, IMMUNOLOGY, V53, P827; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Souwer Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050667; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tam MA, 2008, IMMUNOL REV, V225, P140, DOI 10.1111/j.1600-065X.2008.00679.x; Tan Z, 2015, J BIOL CHEM, V290, P46, DOI 10.1074/jbc.M114.603589; Trivedi N, 2019, IMMUNITY, V51, P1088, DOI 10.1016/j.immuni.2019.10.004; Van Wyngene L, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708712; Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Weisel FJ, 2020, NAT IMMUNOL, V21, P331, DOI 10.1038/s41590-020-0598-4; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	84	2	2	3	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 8	2022	55	3					442	+		10.1016/j.immuni.2022.01.013	http://dx.doi.org/10.1016/j.immuni.2022.01.013			26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0Z4IZ	35182483				2022-12-18	WOS:000791044400010
J	Zindl, CL; Witte, SJ; Laufer, VA; Gao, M; Yue, ZL; Janowski, KM; Cai, BY; Frey, BF; Silberger, DJ; Harbour, SN; Singer, JR; Turner, H; Lund, FE; Vallance, BA; Rosenberg, AF; Schoeb, TR; Chen, JY; Hatton, RD; Weaver, CT				Zindl, Carlene L.; Witte, Steven J.; Laufer, Vincent A.; Gao, Min; Yue, Zongliang; Janowski, Karen M.; Cai, Baiyi; Frey, Blake F.; Silberger, Daniel J.; Harbour, Stacey N.; Singer, Jeffrey R.; Turner, Henrietta; Lund, Frances E.; Vallance, Bruce A.; Rosenberg, Alexander F.; Schoeb, Trenton R.; Chen, Jake Y.; Hatton, Robin D.; Weaver, Casey T.			A nonredundant role for T cell-derived interleukin 22 in antibacterial defense of colonic crypts	IMMUNITY			English	Article							INNATE LYMPHOID-CELLS; CITROBACTER-RODENTIUM INFECTION; INTESTINAL EPITHELIAL-CELLS; LIPOPOLYSACCHARIDE-BINDING PROTEIN; ENTEROPATHOGENIC ESCHERICHIA-COLI; LGR5(+) STEM-CELLS; IN-VIVO; ANTIMICROBIAL DEFENSE; MUCOSAL INFECTION; IL-22 PRODUCTION	Interleukin (IL)-22 is central to immune defense at barrier sites. We examined the contributions of innate lymphoid cell (ILC) and T cell-derived IL-22 during Citrobacter rodentium (C.r) infection using mice that both report Il22 expression and allow lineage-specific deletion. ILC-derived IL-22 activated STAT3 in C.r-colonized surface intestinal epithelial cells (IECs) but only temporally restrained bacterial growth. T cell-derived IL-22 induced a more robust and extensive activation of STAT3 in IECs, including IECs lining colonic crypts, and T cell-specific deficiency of IL-22 led to pathogen invasion of the crypts and increased mortality. This reflected a requirement for T cell-derived IL-22 for the expression of a host-protective transcriptomic program that included AMPs, neutrophil-recruiting chemokines, and mucin-related molecules, and it restricted IFNg-induced proinflammatory genes. Our findings demonstrate spatiotemporal differences in the production and action of IL-22 by ILCs and T cells during infection and reveal an indispensable role for IL-22-producing T cells in the protection of the intestinal crypts.	[Zindl, Carlene L.; Witte, Steven J.; Laufer, Vincent A.; Cai, Baiyi; Frey, Blake F.; Silberger, Daniel J.; Harbour, Stacey N.; Singer, Jeffrey R.; Turner, Henrietta; Hatton, Robin D.; Weaver, Casey T.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Witte, Steven J.; Laufer, Vincent A.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Gao, Min; Yue, Zongliang; Janowski, Karen M.; Schoeb, Trenton R.; Chen, Jake Y.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Gao, Min; Yue, Zongliang; Rosenberg, Alexander F.; Chen, Jake Y.] Univ Alabama Birmingham, Informat Inst, Birmingham, AL 35294 USA; [Lund, Frances E.; Rosenberg, Alexander F.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Vallance, Bruce A.] Univ British Columbia, Dept Pediat, Vancouver, BC V6H 3V4, Canada	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of British Columbia	Zindl, CL; Weaver, CT (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	carlenezindl@uabmc.edu; cweaver@uab.edu	Yue, Zongliang/AHE-3782-2022	Vallance, Bruce/0000-0003-1345-6747; Singer, Jeffrey/0000-0001-7033-3001; Yue, Zongliang/0000-0001-8290-123X; Zindl, Carlene/0000-0003-4841-3552	NIH; Crohn's and Colitis Foundation; NIH/NIAID; UAB Training Program in Immunologic Diseases and Basic Immunology; UAB MSTP training grant funds; NIH/NIDDK	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UAB Training Program in Immunologic Diseases and Basic Immunology; UAB MSTP training grant funds; NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank R.A. Kesterson and UAB TGEM core for ES cell microinjection, UAB CFAR core for cell sorting, UAB CPL for FFPE tissue processing, S. Williams and UAB HRIF core for assistance with confocal microscopy, UAB LCM core for LC imaging, and UAB SAIF core for animal imaging. This work was supported by grants from the NIH and Crohn's and Colitis Foundation (C.T.W.), T32 training grant funds from NIH/NIAID and the UAB Training Program in Immunologic Diseases and Basic Immunology (C.L.Z. and D.J.S.), UAB MSTP training grant funds (B.F.F. and J.R.S.), and NIH/NIDDK F30 grant (J.R.S.).	Aden K, 2018, J EXP MED, V215, P2868, DOI 10.1084/jem.20171029; Ahlfors H, 2014, J IMMUNOL, V193, P4602, DOI 10.4049/jimmunol.1401244; Akdis M, 2012, J ALLERGY CLIN IMMUN, V129, P1438, DOI 10.1016/j.jaci.2012.05.003; Allen A, 1998, INT J BIOCHEM CELL B, V30, P797, DOI 10.1016/S1357-2725(98)00028-4; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bando JK, 2016, NAT IMMUNOL, V17, P783, DOI 10.1038/ni.3484; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Benjamini Y., 1995, J R STAT SOC B, V57, P289; Berger CN, 2017, CELL METAB, V26, P738, DOI 10.1016/j.cmet.2017.09.003; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; Bergstrom KSB, 2008, INFECT IMMUN, V76, P796, DOI 10.1128/IAI.00093-07; Bergstrom KSB, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005108; Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902; Biton M, 2018, CELL, V175, P1307, DOI 10.1016/j.cell.2018.10.008; Bleich A, 2004, MAMM GENOME, V15, P865, DOI 10.1007/s00335-004-2392-2; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Borenshtein D, 2009, INFECT IMMUN, V77, P3639, DOI 10.1128/IAI.00225-09; BRANDTZAEG P, 1995, ADV EXP MED BIOL, V371, P201; Bry L, 2006, INFECT IMMUN, V74, P673, DOI 10.1128/IAI.74.1.673-681.2006; Bry L, 2004, J IMMUNOL, V172, P433, DOI 10.4049/jimmunol.172.1.433; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chan JM, 2013, INFECT IMMUN, V81, P4649, DOI 10.1128/IAI.00655-13; CHANG WWL, 1971, AM J ANAT, V131, P73, DOI 10.1002/aja.1001310105; Chen FD, 2016, J IMMUNOL, V196, P4390, DOI 10.4049/jimmunol.1501541; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; CLOHESSY PA, 1995, SCAND J IMMUNOL, V42, P551, DOI 10.1111/j.1365-3083.1995.tb03695.x; Collins JW, 2014, NAT REV MICROBIOL, V12, P612, DOI 10.1038/nrmicro3315; Colonna M, 2018, IMMUNITY, V48, P1104, DOI 10.1016/j.immuni.2018.05.013; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Croxen MA, 2013, CLIN MICROBIOL REV, V26, P822, DOI 10.1128/CMR.00022-13; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Donnenberg MS, 1997, TRENDS MICROBIOL, V5, P109, DOI 10.1016/S0966-842X(97)01000-7; DUC C, 1994, J CELL BIOL, V127, P1907, DOI 10.1083/jcb.127.6.1907; Frankel G, 1998, MOL MICROBIOL, V30, P911, DOI 10.1046/j.1365-2958.1998.01144.x; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Gronke K, 2019, NATURE, V566, P249, DOI 10.1038/s41586-019-0899-7; Guo YJ, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0230-z; Haber AL, 2017, NATURE, V551, P333, DOI 10.1038/nature24489; HARWIG SSL, 1995, J CLIN INVEST, V95, P603, DOI 10.1172/JCI117704; Hasegawa M, 2014, IMMUNITY, V41, P620, DOI 10.1016/j.immuni.2014.09.010; Hemrajani C, 2010, P NATL ACAD SCI USA, V107, P3129, DOI 10.1073/pnas.0911609106; Higgins LM, 1999, INFECT IMMUN, V67, P3031, DOI 10.1128/IAI.67.6.3031-3039.1999; Hopkins EGD, 2019, MBIO, V10, DOI 10.1128/mBio.00062-19; Hua GQ, 2012, GASTROENTEROLOGY, V143, P1266, DOI 10.1053/j.gastro.2012.07.106; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Huntington ND, 2016, CURR OPIN IMMUNOL, V38, P86, DOI 10.1016/j.coi.2015.11.008; Ignatiadis N, 2016, NAT METHODS, V13, P577, DOI [10.1038/NMETH.3885, 10.1038/nmeth.3885]; Kaiko GE, 2016, CELL, V165, P1708, DOI 10.1016/j.cell.2016.05.018; Kamada N, 2015, CELL HOST MICROBE, V17, P617, DOI 10.1016/j.chom.2015.04.001; Kim CJ, 2012, MUCOSAL IMMUNOL, V5, P670, DOI 10.1038/mi.2012.72; Kim M, 2010, CELL HOST MICROBE, V8, P20, DOI 10.1016/j.chom.2010.06.006; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Lee YS, 2015, INFECT IMMUN, V83, P3257, DOI 10.1128/IAI.00670-15; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li JL, 2016, J INVEST DERMATOL, V136, P416, DOI 10.1038/JID.2015.410; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Liang SC, 2010, J IMMUNOL, V185, P5531, DOI 10.4049/jimmunol.0904091; Liang YJ, 2017, ONCOTARGET, V8, P45566, DOI 10.18632/oncotarget.17269; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; Linden SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000617; Linden SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003952; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu Y, 2015, J IMMUNOL, V195, P4273, DOI 10.4049/jimmunol.1500939; LUSTER AD, 1987, J EXP MED, V166, P1084, DOI 10.1084/jem.166.4.1084; Ma CX, 2006, CELL MICROBIOL, V8, P1669, DOI 10.1111/j.1462-5822.2006.00741.x; Maaser C, 2004, INFECT IMMUN, V72, P3315, DOI 10.1128/IAI.72.6.3315-3324.2004; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Manitz MP, 2003, MOL CELL BIOL, V23, P1034, DOI 10.1128/MCB.23.3.1034-1043.2003; Martin BK, 1997, IMMUNITY, V6, P591, DOI 10.1016/S1074-7613(00)80347-7; Matsuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063053; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Miki T, 2012, J BIOL CHEM, V287, P34844, DOI 10.1074/jbc.M112.399998; Mostafavi S, 2016, CELL, V164, P564, DOI 10.1016/j.cell.2015.12.032; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Nougayrede JP, 2005, TRENDS MICROBIOL, V13, P103, DOI 10.1016/j.tim.2005.01.002; Okada T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2668; Okita Y, 2016, INFECT IMMUN, V84, P573, DOI 10.1128/IAI.01000-15; Papapietro O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2816; Pena-Muzenmayer G, 2005, J CELL SCI, V118, P4243, DOI 10.1242/jcs.02525; Pham TAN, 2014, CELL HOST MICROBE, V16, P504, DOI 10.1016/j.chom.2014.08.017; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; PUGIN J, 1993, P NATL ACAD SCI USA, V90, P2744, DOI 10.1073/pnas.90.7.2744; Rankin LC, 2016, NAT IMMUNOL, V17, P179, DOI 10.1038/ni.3332; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rothenberg ME, 2012, GASTROENTEROLOGY, V142, P1195, DOI 10.1053/j.gastro.2012.02.006; Sasaki N, 2016, P NATL ACAD SCI USA, V113, pE5399, DOI 10.1073/pnas.1607327113; Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; SCHLETTER J, 1995, INFECT IMMUN, V63, P2576, DOI 10.1128/IAI.63.7.2576-2580.1995; Sergushichev A., 2016, ALGORITHM FAST PRERA, DOI [10.1101/060012, DOI 10.1101/060012]; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Silberger DJ, 2017, MUCOSAL IMMUNOL, V10, P1108, DOI 10.1038/mi.2017.47; Simmons CP, 2003, INFECT IMMUN, V71, P5077, DOI 10.1128/IAI.71.9.5077-5086.2003; Sinclair JF, 2004, J BIOL CHEM, V279, P33751, DOI 10.1074/jbc.M401616200; Song C, 2015, J EXP MED, V212, P1869, DOI 10.1084/jem.20151403; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Sovran B, 2015, INFLAMM BOWEL DIS, V21, P531, DOI 10.1097/MIB.0000000000000319; Spehlmann ME, 2009, J IMMUNOL, V183, P3332, DOI 10.4049/jimmunol.0900600; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; Stelter C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020749; Stephens M, 2017, BIOSTATISTICS, V18, P275, DOI 10.1093/biostatistics/kxw041; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Thelemann C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086844; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Turner JE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003698; Vallance BA, 2002, INFECT IMMUN, V70, P2070, DOI 10.1128/IAI.70.4.2070-2081.2002; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Waldschmitt N, 2019, GUT, V68, P1190, DOI 10.1136/gutjnl-2018-316757; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wiles S, 2004, CELL MICROBIOL, V6, P963, DOI 10.1111/j.1462-5822.2004.00414.x; Wiles S, 2006, INFECT IMMUN, V74, P5391, DOI 10.1128/IAI.00848-06; Wittkopf N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118401; Wolk K, 2007, J IMMUNOL, V178, P5973, DOI 10.4049/jimmunol.178.9.5973; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Yamamoto K, 2015, J EXP MED, V212, P1901, DOI 10.1084/jem.20141904; Yue ZL, 2018, NUCLEIC ACIDS RES, V46, pD668, DOI 10.1093/nar/gkx1040; Yue ZL, 2015, BIOINFORMATICS, V31, P250, DOI 10.1093/bioinformatics/btv265; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zindl CL, 2013, P NATL ACAD SCI USA, V110, P12768, DOI 10.1073/pnas.1300318110	141	2	2	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 8	2022	55	3					494	+		10.1016/j.immuni.2022.02.003	http://dx.doi.org/10.1016/j.immuni.2022.02.003			30	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZQ5WU	35263568				2022-12-18	WOS:000767175700001
J	Frankel, TL; di Magliano, MP				Frankel, Timothy L.; di Magliano, Marina Pasca			Immune sensing of microbial metabolites: Action at the tumor	IMMUNITY			English	Editorial Material							ARYL-HYDROCARBON RECEPTOR	The microbiome affects establishment and growth of tumors as well as response to immune-based therapies. In this issue of Immunity, Hezaveh et al. (2022) reveal that metabolites of dietary tryptophan generated by the gut microbiota activate the aryl hydrocarbon receptor in myeloid cells, promoting an immune suppressive tumor microenvironment and facilitating pancreatic ductal adenocarcinoma growth.	[Frankel, Timothy L.; di Magliano, Marina Pasca] Univ Michigan, Dept Surg, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA; [Frankel, Timothy L.; di Magliano, Marina Pasca] Univ Michigan, Rogel Canc Ctr, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA; [di Magliano, Marina Pasca] Univ Michigan, Dept Cell & Dev Biol, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	di Magliano, MP (corresponding author), Univ Michigan, Dept Surg, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.; di Magliano, MP (corresponding author), Univ Michigan, Rogel Canc Ctr, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.; di Magliano, MP (corresponding author), Univ Michigan, Dept Cell & Dev Biol, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	marinapa@med.umich.edu			NIH/NCI [U01 CA224145, R01 R01 CA151588]	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to thank Katelyn L. Donahue for the artwork. Work in the MPdM and TLF labora-tories is supported in part by NIH/NCI U01 CA224145 and R01 R01 CA151588.	Belcheva A, 2014, CELL, V158, P288, DOI 10.1016/j.cell.2014.04.051; De Luca F, 2019, CLIN EXP IMMUNOL, V195, P74, DOI 10.1111/cei.13158; Durack J, 2019, J EXP MED, V216, P20, DOI 10.1084/jem.20180448; Goudot C, 2017, IMMUNITY, V47, P582, DOI 10.1016/j.immuni.2017.08.016; Hezaveh K, 2022, IMMUNITY, V55, P324, DOI 10.1016/j.immuni.2022.01.006; Neamah WH, 2019, J IMMUNOL, V203, P1830, DOI 10.4049/jimmunol.1900291; Platten M, 2019, NAT REV DRUG DISCOV, V18, P379, DOI 10.1038/s41573-019-0016-5; Plottel CS, 2011, CELL HOST MICROBE, V10, P324, DOI 10.1016/j.chom.2011.10.003; Pushalkar S, 2018, CANCER DISCOV, V8, P403, DOI 10.1158/2159-8290.CD-17-1134; Riquelme E, 2019, CELL, V178, P795, DOI 10.1016/j.cell.2019.07.008; Shinde R, 2018, NAT IMMUNOL, V19, P571, DOI 10.1038/s41590-018-0107-1; Stevens EA, 2009, IMMUNOLOGY, V127, P299, DOI 10.1111/j.1365-2567.2009.03054.x	12	2	2	5	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 8	2022	55	2					192	194		10.1016/j.immuni.2022.01.009	http://dx.doi.org/10.1016/j.immuni.2022.01.009			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YX7WH	35139348				2022-12-18	WOS:000754308000004
J	Koay, HF; Gherardin, NA; Nguyen, THO; Zhang, WJ; Habel, JR; Seneviratna, R; James, F; Holmes, NE; Smibert, OC; Gordon, CL; Trubiano, JA; Kedzierska, K; Godfrey, DI				Koay, Hui-Fern; Gherardin, Nicholas A.; Nguyen, Thi H. O.; Zhang, Wuji; Habel, Jennifer R.; Seneviratna, Rebecca; James, Fiona; Holmes, Natasha E.; Smibert, Olivia C.; Gordon, Claire L.; Trubiano, Jason A.; Kedzierska, Katherine; Godfrey, Dale I.			Are NKT cells a useful predictor of COVID-19 severity?	IMMUNITY			English	Letter									[Koay, Hui-Fern; Gherardin, Nicholas A.; Nguyen, Thi H. O.; Zhang, Wuji; Habel, Jennifer R.; Seneviratna, Rebecca; Gordon, Claire L.; Kedzierska, Katherine; Godfrey, Dale I.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia; [James, Fiona; Holmes, Natasha E.; Smibert, Olivia C.; Gordon, Claire L.] Austin Hlth, Dept Infect Dis, Heidelberg, Vic, Australia; [Holmes, Natasha E.] Univ Melbourne, Dept Crit Care, Parkville, Vic 3000, Australia; [Holmes, Natasha E.] Austin Hlth, Data Analyt Res & Evaluat DARE Ctr, Heidelberg, Vic 3084, Australia; [Holmes, Natasha E.] Univ Melbourne, Heidelberg, Vic 3084, Australia; [Holmes, Natasha E.; Trubiano, Jason A.] Austin Hlth, Ctr Antibiot Allergy & Res, Dept Infect Dis, Austin, Vic 3084, Australia; [Smibert, Olivia C.; Trubiano, Jason A.] Peter MacCallum Canc Ctr, Dept Infect Dis, Melbourne, Vic 3000, Australia; [Smibert, Olivia C.; Trubiano, Jason A.] Natl Ctr Infect Canc, Peter McCallum Canc Ctr, Melbourne, Vic 3000, Australia; [Trubiano, Jason A.] Univ Melbourne, Austin Hlth, Dept Med Austin Hlth, Heidelberg, Vic 3084, Australia; [Koay, Hui-Fern; Gordon, Claire L.] Austin Hlth, North Eastern Publ Hlth Unit, Heidelberg, Vic 3084, Australia	University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health	Koay, HF; Godfrey, DI (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia.	hf.koay@unimelb.edu.au; godfrey@unimelb.edu.au		Habel, Jennifer/0000-0003-0380-1527; Koay, Hui-Fern/0000-0002-3236-9609	Victorian Government MRFF award [2005544]; Australian National Health and Medical Research Council (NHMRC) [1173 871, 2008913]; NHMRC Early Career Fellowships [1160333, GNT1160963]; Australian Research Council DECRA [DE210100705]; NHMRC Emerging Leadership Level 1 Investigator Grant [1194036]; Melbourne International Research Scholarships (MIRS) from the University of Melbourne	Victorian Government MRFF award(Medical Research Future Fund (MRFF)); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Early Career Fellowships(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council DECRA(Australian Research Council); NHMRC Emerging Leadership Level 1 Investigator Grant(National Health and Medical Research Council (NHMRC) of Australia); Melbourne International Research Scholarships (MIRS) from the University of Melbourne	We acknowledge all DRASTIC (The use of cytokines as a preDictoR of disease Severity in criTically Ill Covid-patients) investigators from Austin Health and thank the participants involved. This work was supported by the Victorian Government MRFF award (#2005544) to K.K. and D.I.G. K.K. and D.I.G. were supported by the Australian National Health and Medical Research Council (NHMRC) Leadership Investigator Grants #1173 871 and #2008913, respectively; H.-F.K. and C.L.G. were supported by NHMRC Early Career Fellowships #1160333 and #GNT1160963 respectively; N.A.G. by an Australian Research Council DECRA (DE210100705), and T.H.O.N. by a NHMRC Emerging Leadership Level 1 Investigator Grant (#1194036). J.R.H. and W.Z. were supported by Melbourne International Research Scholarships (MIRS) from the University of Melbourne. Experiments conformed to the Declaration of Helsinki Principles and the Australian National Health and Medical Research Council Code of Practice. Written informed consent was obtained from all donors prior to the study. The study was approved by the Austin Health (HREC/63201/Austin-2020) and the University of Melbourne (#2057366.1 and #2056901.1) Human Research Ethics Committees.	Godfrey DI, 2015, NAT IMMUNOL, V16, P1114, DOI 10.1038/ni.3298; Jouan Y, 2020, J EXP MED, V217, DOI 10.1084/jem.20200872; Kreutmair S, 2021, IMMUNITY, V54, P1578, DOI 10.1016/j.immuni.2021.05.002; Le Dieu R, 2007, BLOOD, V110, p538A; Lee PT, 2002, J CLIN INVEST, V110, P793, DOI 10.1172/JCI200215832; Mazzoni A, 2020, J CLIN INVEST, V130, P4694, DOI [10.1172/JCI138554, 10.1172/JCI138554.]; Parrot T, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abe1670; Van Acker HH, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00892; Zhang JY, 2020, NAT IMMUNOL, V21, P1107, DOI 10.1038/s41590-020-0762-x; Zingaropoli MA, 2021, CLIN IMMUNOL, V222, DOI 10.1016/j.clim.2020.108630	10	2	2	2	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 8	2022	55	2					185	187		10.1016/j.immuni.2022.01.005	http://dx.doi.org/10.1016/j.immuni.2022.01.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YX7WH	35104438	Bronze, Green Published			2022-12-18	WOS:000754308000001
J	Fauci, AS; Merad, M; Swaminathan, S; Hur, S; Topol, E; Fitzgerald, K; Sousa, CRE; Corbett, KS; Bauer, S				Fauci, Anthony S.; Merad, Miriam; Swaminathan, Soumya; Hur, Sun; Topol, Eric; Fitzgerald, Kate; Sousa, Caetano Reis e; Corbett, Kizzmekia S.; Bauer, Stefan			From mRNA sensing to vaccines	IMMUNITY			English	Editorial Material									[Fauci, Anthony S.] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Merad, Miriam] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Swaminathan, Soumya] WHO, Geneva, Switzerland; [Hur, Sun] Harvard Med Sch, Boston Childrens Hosp, Boston, MA 02115 USA; [Topol, Eric] Scripps Res, San Diego, CA USA; [Fitzgerald, Kate] Univ Massachusetts, Chan Med Sch, Amherst, MA 01003 USA; [Sousa, Caetano Reis e] Francis Crick Inst, London, England; [Corbett, Kizzmekia S.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Bauer, Stefan] Philipps Univ Marburg, Marburg, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Icahn School of Medicine at Mount Sinai; World Health Organization; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Massachusetts System; University of Massachusetts Amherst; Francis Crick Institute; Harvard University; Harvard T.H. Chan School of Public Health; Philipps University Marburg	Fauci, AS (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.			Bauer, Stefan/0000-0002-8462-1845; Topol, Eric/0000-0002-1478-4729					0	2	2	2	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2021	54	12					2676	2680						5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XQ6GW	34739870	Bronze, Green Published			2022-12-18	WOS:000731645300003
J	Lightman, SM; Peresie, JL; Carlson, LM; Holling, GA; Honikel, MM; Chavel, CA; Nemeth, MJ; Olejniczak, SH; Lee, KP				Lightman, Shivana M.; Peresie, Jennifer L.; Carlson, Louise M.; Holling, G. Aaron; Honikel, Mackenzie M.; Chavel, Colin A.; Nemeth, Michael J.; Olejniczak, Scott H.; Lee, Kelvin P.			Indoleamine 2,3-dioxygenase 1 is essential for sustaining durable antibody responses	IMMUNITY			English	Article							ARYL-HYDROCARBON RECEPTOR; PLASMA-CELL SURVIVAL; BONE-MARROW; DENDRITIC CELLS; HUMORAL IMMUNITY; T-CELLS; MAJOR SITE; MEMORY B; NICHE; DIFFERENTIATION	Humoral immunity is essential for protection against pathogens, emphasized by the prevention of 2-3 million deaths worldwide annually by childhood immunizations. Long-term protective immunity is dependent on the continual production of neutralizing antibodies by the subset of long-lived plasma cells (LLPCs). LLPCs are not intrinsically long-lived, but require interaction with LLPC niche stromal cells for survival. However, it remains unclear which and how these interactions sustain LLPC survival and long-term humoral immunity. We now have found that the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1) is required to sustain antibody responses and LLPC survival. Activation of IDO1 occurs upon the engagement of CD80/ CD86 on the niche dendritic cells by CD28 on LLPC. Kynurenine, the product of IDO1 catabolism, activates the aryl hydrocarbon receptor in LLPC, reinforcing CD28 expression and survival signaling. These findings expand the immune function of IDO1 and uncover a novel pathway for sustaining LLPC survival and humoral immunity.	[Lightman, Shivana M.; Peresie, Jennifer L.; Carlson, Louise M.; Holling, G. Aaron; Honikel, Mackenzie M.; Chavel, Colin A.; Nemeth, Michael J.; Olejniczak, Scott H.; Lee, Kelvin P.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14203 USA	Roswell Park Cancer Institute	Lee, KP (corresponding author), Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14203 USA.	kplee@iu.edu		Olejniczak, Scott/0000-0001-6857-5554; Holling, G. Aaron/0000-0001-5747-2592; Chavel, Colin/0000-0003-1458-8979; Lightman, Shivana/0000-0003-0810-6515; Honikel, Mackenzie/0000-0002-9480-3589	NIH [R01CA121044, R01AI100157, P30 CA016056, T32 CA085183, R00CA175189]; Roswell Park Alliance Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roswell Park Alliance Foundation	This research was supported by NIH grants R01CA121044, R01AI100157, P30 CA016056 (to K.P.L.) , T32 CA085183 (to S.M.L.) , and R00CA175189 (to S.H.O.) , and the Roswell Park Alliance Foundation (to M.J.N.) . CD80/CD86-/-BM was generously provided by Dr. Stephen Schoenberger.	Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Asghar K, 2015, EXP THER MED, V9, P901, DOI 10.3892/etm.2014.2146; Ball HJ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00485; Bemark M, 2011, J IMMUNOL, V186, P1399, DOI 10.4049/jimmunol.1002881; Bianchi-Smiraglia A, 2018, J CLIN INVEST, V128, P4682, DOI 10.1172/JCI70712; Boise LH, 2014, BLOOD, V124, P1873, DOI 10.1182/blood-2014-05-578732; Boomer JS, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002436; Bozec A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007764; Cassese G, 2001, EUR J IMMUNOL, V31, P2726, DOI 10.1002/1521-4141(200109)31:9<2726::AID-IMMU2726>3.0.CO;2-H; Chung YR, 2014, JOVE-J VIS EXP, DOI 10.3791/51660; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; de Vinuesa CG, 1999, EUR J IMMUNOL, V29, P3712; DiLillo DJ, 2008, J IMMUNOL, V180, P361, DOI 10.4049/jimmunol.180.1.361; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Hammarlund E, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01901-w; Han SS, 2003, J IMMUNOL, V170, P1267, DOI 10.4049/jimmunol.170.3.1267; Hwu P, 2000, J IMMUNOL, V164, P3596, DOI 10.4049/jimmunol.164.7.3596; Ibarrondo FJ, 2020, NEW ENGL J MED, V383, P1085, DOI 10.1056/NEJMc2025179; Jurgens B, 2009, BLOOD, V114, P3235, DOI 10.1182/blood-2008-12-195073; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Koorella C, 2014, J BIOL CHEM, V289, P7747, DOI 10.1074/jbc.M113.519686; Lam WY, 2018, TRENDS IMMUNOL, V39, P19, DOI 10.1016/j.it.2017.08.007; Lam WY, 2016, IMMUNITY, V45, P60, DOI 10.1016/j.immuni.2016.06.011; Lemke A, 2016, MUCOSAL IMMUNOL, V9, P83, DOI 10.1038/mi.2015.38; Li QS, 2016, J IMMUNOL, V197, P962, DOI 10.4049/jimmunol.1502615; Lightman SM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00965; MANKARIOUS S, 1988, J LAB CLIN MED, V112, P634; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Matino D, 2015, J CLIN INVEST, V125, P3766, DOI 10.1172/JCI81859; Mellor AL, 2001, NAT IMMUNOL, V2, P64, DOI 10.1038/83183; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Mellor AL, 2008, NAT REV IMMUNOL, V8, P74, DOI 10.1038/nri2233; Merlo LMF, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01861; Merlo LMF, 2016, J IMMUNOL, V196, P4487, DOI 10.4049/jimmunol.1600141; Merlo LMF, 2014, J IMMUNOL, V192, P2082, DOI 10.4049/jimmunol.1303012; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Moser K, 2006, CURR OPIN IMMUNOL, V18, P265, DOI 10.1016/j.coi.2006.03.004; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Murray ME, 2014, BLOOD, V123, P3770, DOI 10.1182/blood-2013-10-530964; Nair JR, 2011, J IMMUNOL, V187, P1243, DOI 10.4049/jimmunol.1100016; NEBERT DW, 1993, ANN NY ACAD SCI, V685, P624, DOI 10.1111/j.1749-6632.1993.tb35928.x; Nguyen DC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05853-7; Njau MN, 2012, J IMMUNOL, V189, P2758, DOI 10.4049/jimmunol.1102728; Peperzak V, 2013, NAT IMMUNOL, V14, P290, DOI 10.1038/ni.2527; Phan TG, 2006, J EXP MED, V203, P2419, DOI 10.1084/jem.20061254; Pioli PD, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02768; Piper CJM, 2019, CELL REP, V29, P1878, DOI 10.1016/j.celrep.2019.10.018; Pritz T, 2015, EUR J IMMUNOL, V45, P738, DOI 10.1002/eji.201444878; Quintana FJ, 2010, P NATL ACAD SCI USA, V107, P20768, DOI 10.1073/pnas.1009201107; Reynolds AE, 2015, J IMMUNOL, V194, P231, DOI 10.4049/jimmunol.1401203; Roush SW, 2007, JAMA-J AM MED ASSOC, V298, P2155, DOI 10.1001/jama.298.18.2155; Rozanski CH, 2015, J IMMUNOL, V194, P4717, DOI 10.4049/jimmunol.1402260; Rozanski CH, 2011, J EXP MED, V208, P1435, DOI 10.1084/jem.20110040; Sherr DH, 2013, SEMIN IMMUNOPATHOL, V35, P705, DOI 10.1007/s00281-013-0390-8; Shinde R, 2015, J IMMUNOL, V195, P2374, DOI 10.4049/jimmunol.1402854; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; SLIFKA MK, 1995, J VIROL, V69, P1895, DOI 10.1128/JVI.69.3.1895-1902.1995; Sze DMY, 2000, J EXP MED, V192, P813, DOI 10.1084/jem.192.6.813; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; Tellier J, 2014, EUR J IMMUNOL, V44, P2243, DOI 10.1002/eji.201444871; Turner JS, 2021, NATURE, V595, P421, DOI 10.1038/s41586-021-03647-4; Utley A, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107815; Vaidyanathan B, 2017, J EXP MED, V214, P197, DOI 10.1084/jem.20160789; Valor LM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183264; VanBlargan LA, 2016, MICROBIOL MOL BIOL R, V80, DOI 10.1128/MMBR.00024-15; Vogel CFA, 2013, IMMUNOL CELL BIOL, V91, P568, DOI 10.1038/icb.2013.43; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004; Wols HAM, 2002, J IMMUNOL, V169, P4213, DOI 10.4049/jimmunol.169.8.4213; World Health Organization, 2019, FACT SHEETS IMM COV; Yue EW, 2017, ACS MED CHEM LETT, V8, P486, DOI 10.1021/acsmedchemlett.6b00391; Zaretsky AG, 2017, CELL REP, V18, P1906, DOI 10.1016/j.celrep.2017.01.067; Zehentmeier S, 2014, EUR J IMMUNOL, V44, P2306, DOI 10.1002/eji.201344313; Zhu HB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08908-5	75	2	2	3	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2021	54	12					2772	+		10.1016/j.immuni.2021.10.005	http://dx.doi.org/10.1016/j.immuni.2021.10.005		DEC 2021	18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XQ6GW	34788602	Green Accepted			2022-12-18	WOS:000731645300015
J	Wan, SY; Ni, L; Zhao, XH; Liu, XD; Xu, W; Jin, W; Wang, XH; Dong, C				Wan, Siyuan; Ni, Lu; Zhao, Xiaohong; Liu, Xindong; Xu, Wei; Jin, Wei; Wang, Xiaohu; Dong, Chen			Costimulation molecules differentially regulate the ERK-Zfp831 axis to shape T follicular helper cell differentiation	IMMUNITY			English	Article							CXC CHEMOKINE RECEPTOR-5; CO-STIMULATION; BCL6 EXPRESSION; CUTTING EDGE; MAP KINASE; B-CELLS; ICOS; CD28; PHOSPHORYLATION; ACTIVATION	T follicular helper (Tfh) cells play essential roles in regulating humoral immunity, especially germinal center reactions. However, how CD4(+) T cells integrate the antigenic and costimulatory signals in Tfh cell development is still poorly understood. Here, we found that phorbol 12-myristate 13-acetate (PMA) + ionomycin (P+I) stimulation, together with interleukin-6 (1L-6), potently induce Tfh cell-like transcriptomic programs in vitro. The ERK kinase pathway was attenuated under P+I stimulation; ERK2 inhibition enhanced Tfh cell development in vitro and in vivo. We observed that inducible T cell costimulator (ICOS), but not CD28, lacked the ability to activate ERK, which was important in sustaining Tfh cell development. The transcription factor Zfp831, whose expression was repressed by ERK, promoted Tfh cell differentiation by directly upregulating the expression of the transcription factors Bcl6 and Tcf7. We have hence identified an ERK-Zfp831 axis, regulated by costimulation signaling, in critical regulation of Tfh cell development.	[Wan, Siyuan; Ni, Lu; Zhao, Xiaohong; Xu, Wei; Jin, Wei; Wang, Xiaohu; Dong, Chen] Tsinghua Univ, Inst Immunol, Beijing, Peoples R China; [Wan, Siyuan; Ni, Lu; Zhao, Xiaohong; Xu, Wei; Jin, Wei; Wang, Xiaohu; Dong, Chen] Tsinghua Univ, Sch Med, Beijing, Peoples R China; [Liu, Xindong] Third Mil Med Univ Army Med Univ, Southwest Hosp, Inst Pathol, Chongqing, Peoples R China; [Liu, Xindong] Third Mil Med Univ Army Med Univ, Southwest Hosp, Southwest Canc Ctr, Chongqing, Peoples R China; [Dong, Chen] Shanghai Jiao Tong Univ, Shanghai Immune Therapy Inst, Affiliated Renji Hosp, Sch Med, Shanghai, Peoples R China; [Jin, Wei] BeiGene Ltd, Beijing, Peoples R China	Tsinghua University; Tsinghua University; Army Medical University; Army Medical University; Shanghai Jiao Tong University	Dong, C (corresponding author), Tsinghua Univ, Inst Immunol, Beijing, Peoples R China.; Dong, C (corresponding author), Tsinghua Univ, Sch Med, Beijing, Peoples R China.	chendong@tsinghua.edu.cn	dong, chen/B-3181-2009	dong, chen/0000-0002-0084-9130	National Natural Science Foundation of China [31630022, 31821003, 31991173, 31991170, 32070889]; Beijing Municipal Science and Technology [Z181100001318007]; Shanghai Science and Technology Commission [21JC1404200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Technology; Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM))	We thank the animal facility at Tsinghua University for assistance in the gener-ation of Zfp831-/-and Zfp831FLAG mice and the core facility of Institute for Immunology, Tsinghua University (IITU) for flow cytometry sorting and data collecting. We thank Dr. Xiaoyu Hu (Tsinghua University) for Mapk1fl/fl and Mapk3-/-mice. We thank Dr. Haikun Wang (Institut Pasteur of Shanghai, Chi-nese Academy of Sciences) for Icos-/-mice. The work was supported in part by National Natural Science Foundation of China (31630022, 31821003, 31991173, and 31991170 to C.D. and 32070889 to X.W.) , Beijing Municipal Science and Technology (Z181100001318007 to C.D.) , and Shanghai Science and Technology Commission (21JC1404200 to C.D.) . C.D. is a FViL Investigator.	Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Akiba H, 2005, J IMMUNOL, V175, P2340, DOI 10.4049/jimmunol.175.4.2340; Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Bartleson JM, 2020, NAT IMMUNOL, V21, P1384, DOI 10.1038/s41590-020-0781-7; Batten M, 2010, J EXP MED, V207, P2895, DOI 10.1084/jem.20100064; Baumjohann D, 2011, J IMMUNOL, V187, P2089, DOI 10.4049/jimmunol.1101393; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Calvo CR, 1997, J EXP MED, V186, P1645, DOI 10.1084/jem.186.10.1645; Chang CF, 2012, J IMMUNOL, V189, P721, DOI 10.4049/jimmunol.1103015; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Choi YS, 2015, NAT IMMUNOL, V16, P980, DOI 10.1038/ni.3226; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Coquet JM, 2015, IMMUNOL CELL BIOL, V93, P780, DOI 10.1038/icb.2015.45; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Deng J, 2019, NAT REV RHEUMATOL, V15, P475, DOI 10.1038/s41584-019-0254-2; DiToro D, 2018, SCIENCE, V361, P1086, DOI 10.1126/science.aao2933; El-Brolosy MA, 2019, NATURE, V568, P193, DOI 10.1038/s41586-019-1064-z; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; FREEMAN GJ, 1995, IMMUNITY, V2, P523, DOI 10.1016/1074-7613(95)90032-2; Geng JL, 2019, J IMMUNOL, V202, P2991, DOI 10.4049/jimmunol.1801626; Gigoux M, 2009, P NATL ACAD SCI USA, V106, P20371, DOI 10.1073/pnas.0911573106; Greczmiel U, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam8686; Guedan S, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.96976; Harada Y, 2003, J EXP MED, V197, P257, DOI 10.1084/jem.20021305; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Kimura MY, 2007, J IMMUNOL, V178, P4926, DOI 10.4049/jimmunol.178.8.4926; Kimura MY, 2005, J EXP MED, V201, P397, DOI 10.1084/jem.20040733; Krishnamoorthy V, 2017, IMMUNITY, V47, P481, DOI 10.1016/j.immuni.2017.09.001; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; Lahmann A, 2019, J IMMUNOL, V202, P2229, DOI 10.4049/jimmunol.1801400; Liu XD, 2016, CELL REP, V14, P1735, DOI 10.1016/j.celrep.2016.01.038; Liu XD, 2014, NATURE, V507, P513, DOI 10.1038/nature12910; Liu XD, 2012, J EXP MED, V209, P1841, DOI 10.1084/jem.20120219; Ma ZP, 2019, NATURE, V568, P259, DOI 10.1038/s41586-019-1057-y; McDonald PW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10285; Niu HF, 1998, GENE DEV, V12, P1953, DOI 10.1101/gad.12.13.1953; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2012, J BIOL CHEM, V287, P11234, DOI 10.1074/jbc.M111.324046; Nurieva RI, 2011, IMMUNOL REV, V241, P133, DOI 10.1111/j.1600-065X.2011.01012.x; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Pedros C, 2016, NAT IMMUNOL, V17, P825, DOI 10.1038/ni.3463; Qi H, 2016, NAT REV IMMUNOL, V16, P612, DOI 10.1038/nri.2016.94; Rolf J, 2010, J IMMUNOL, V185, P4042, DOI 10.4049/jimmunol.1001730; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Rudd CE, 2003, NAT REV IMMUNOL, V3, P544, DOI 10.1038/nri1131; Sage PT, 2014, IMMUNITY, V41, P1026, DOI 10.1016/j.immuni.2014.12.005; Salek-Ardakani S, 2011, J IMMUNOL, V186, P5294, DOI 10.4049/jimmunol.1100406; Samuels IS, 2008, J NEUROSCI, V28, P6983, DOI 10.1523/JNEUROSCI.0679-08.2008; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Schneider H, 2002, J IMMUNOL, V169, P3475, DOI 10.4049/jimmunol.169.7.3475; SCHNEIDER H, 1995, EUR J IMMUNOL, V25, P1044, DOI 10.1002/eji.1830250428; Selcher JC, 2001, LEARN MEMORY, V8, P11, DOI 10.1101/lm.37001; Sengupta TK, 1998, P NATL ACAD SCI USA, V95, P11107, DOI 10.1073/pnas.95.19.11107; Slavik JM, 1999, J BIOL CHEM, V274, P3116, DOI 10.1074/jbc.274.5.3116; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Staton TL, 2011, NATURE, V472, P105, DOI 10.1038/nature09848; Stone EL, 2015, IMMUNITY, V42, P239, DOI 10.1016/j.immuni.2015.01.017; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Takagi T, 2001, NAT IMMUNOL, V2, P1048, DOI 10.1038/ni728; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Ueno H, 2019, CURR OPIN IMMUNOL, V59, P9, DOI 10.1016/j.coi.2019.02.007; Victora GD, 2012, BLOOD, V120, P2240, DOI 10.1182/blood-2012-03-415380; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; VYTHDREESE FA, 1995, EUR J IMMUNOL, V25, P3023, DOI 10.1002/eji.1830251106; Walker LSK, 2003, J IMMUNOL, V170, P91, DOI 10.4049/jimmunol.170.1.91; Wang XH, 2020, IMMUNITY, V52, P328, DOI 10.1016/j.immuni.2020.01.006; Weber JP, 2015, J EXP MED, V212, P217, DOI 10.1084/jem.20141432; Wing JB, 2014, IMMUNITY, V41, P1013, DOI 10.1016/j.immuni.2014.12.006; Xu LF, 2015, NAT IMMUNOL, V16, P991, DOI 10.1038/ni.3229; Xu W, 2019, IMMUNITY, V51, P826, DOI 10.1016/j.immuni.2019.10.006; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992	77	2	4	7	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2021	54	12					2740	+		10.1016/j.immuni.2021.09.018	http://dx.doi.org/10.1016/j.immuni.2021.09.018		DEC 2021	23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XQ6GW	34644536	Bronze			2022-12-18	WOS:000731645300013
J	Sanchez-David, RY; Maillard, PV				Sanchez-David, Raul Y.; Maillard, Pierre V.			Unlocking the therapeutic potential of antiviral RNAi	IMMUNITY			English	Editorial Material								RNA interference (RNAi) provides antiviral defense in many organisms, including plants, insects, and nematodes. In this issue of Immunity, Fang et al. (2021) utilize designer peptides targeting viral suppressors of RNAi to provide evidence for the relevance of RNAi to antiviral immunity in mammals, also revealing the potential of this approach toward antiviral therapy.	[Sanchez-David, Raul Y.; Maillard, Pierre V.] Queen Mary Univ London, Blizard Inst, Ctr Immunobiol, London E1 2AT, England	University of London; Queen Mary University London	Maillard, PV (corresponding author), Queen Mary Univ London, Blizard Inst, Ctr Immunobiol, London E1 2AT, England.	p.maillard@qmul.ac.uk	Maillard, Pierre V/V-4305-2019	Maillard, Pierre V/0000-0003-4611-388X	UK Research and Innovation Future Leaders Fellowship [MR/S034498/1]; Rising Stars Programme grant from the Barts Charity [MGU0459]	UK Research and Innovation Future Leaders Fellowship(UK Research & Innovation (UKRI)); Rising Stars Programme grant from the Barts Charity	P.V.M. and R.Y.S.-D. are funded through a UK Research and Innovation Future Leaders Fellowship (MR/S034498/1). P.V.M. is also funded by a Rising Stars Programme grant from the Barts Charity (MGU0459).	Fang Y, 2021, IMMUNITY, V54, P2231, DOI 10.1016/j.immuni.2021.08.027; Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930; Maillard PV, 2019, EMBO J, V38, DOI 10.15252/embj.2018100941; Poirier EZ, 2021, SCIENCE, V373, P231, DOI 10.1126/science.abg2264; Qian Q., 2019, J VIROL, V94, P1; Qiu Y, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax7989; Qiu Y, 2017, IMMUNITY, V46, P992, DOI 10.1016/j.immuni.2017.05.006; van der Veen AG, 2018, EMBO J, V37, DOI 10.15252/embj.201797479; Xu YP, 2019, CELL RES, V29, P265, DOI 10.1038/s41422-019-0152-9; Zhang YQ, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009790	10	2	2	8	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 12	2021	54	10					2180	2182		10.1016/j.immuni.2021.09.013	http://dx.doi.org/10.1016/j.immuni.2021.09.013		OCT 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WG2VB	34644551	Bronze			2022-12-18	WOS:000706854100004
J	Zillinger, T; Bartok, E				Zillinger, Thomas; Bartok, Eva			ADAR1 edits the SenZ and SenZ-ability of RNA	IMMUNITY			English	Editorial Material							MUTATIONS; DOMAIN; DSRNA	Some RNAs can assume a Z conformation, an unusual, left-handed turn. In this issue of Immunity, three studies report that mutations in the Za-RNA binding domain of the adenosine deaminase ADAR1 are sufficient to induce autoinflammatory disease in mice, which models human Aicardi-Goutie` res syndrome, highlighting the important role of Z-RNA editing in limiting innate immune recognition of endogenous RNA.	[Zillinger, Thomas; Bartok, Eva] Univ Hosp Bonn, Inst Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany; [Bartok, Eva] Inst Trop Med, Dept Biomed Sci, Unit Expt Immunol, B-2000 Antwerp, Belgium	University of Bonn; Institute of Tropical Medicine (ITM)	Bartok, E (corresponding author), Univ Hosp Bonn, Inst Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany.; Bartok, E (corresponding author), Inst Trop Med, Dept Biomed Sci, Unit Expt Immunol, B-2000 Antwerp, Belgium.	ebartok@uni-bonn.de	Bartok, Eva/AAM-6274-2020	Bartok, Eva/0000-0003-0556-1950; Zillinger, Thomas/0000-0002-0866-4835				Athanasiadis A, 2005, J MOL BIOL, V351, P496, DOI 10.1016/j.jmb.2005.06.028; Behrendt R, 2014, CLIN EXP IMMUNOL, V175, P9, DOI 10.1111/cei.12147; Chung HC, 2018, CELL, V172, P811, DOI 10.1016/j.cell.2017.12.038; Eisenberg E, 2018, NAT REV GENET, V19, P473, DOI 10.1038/s41576-018-0006-1; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Livingston JH, 2014, J MED GENET, V51, P76, DOI 10.1136/jmedgenet-2013-102038; Maurano Megan, 2021, Immunity, V54, P1948, DOI 10.1016/j.immuni.2021.07.001; Nakahama T, 2021, IMMUNITY, V54, P1976, DOI 10.1016/j.immuni.2021.08.022; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Schade M, 1999, EMBO J, V18, P470, DOI 10.1093/emboj/18.2.470; Tang QN, 2021, IMMUNITY, V54, P1961, DOI 10.1016/j.immuni.2021.08.011	12	2	2	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 14	2021	54	9					1909	1911		10.1016/j.immuni.2021.08.021	http://dx.doi.org/10.1016/j.immuni.2021.08.021		SEP 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UQ0VB	34525334	Bronze			2022-12-18	WOS:000695789800003
J	Mourcin, F; Verdiere, L; Roulois, D; Amin, R; Lamaison, C; Sibut, V; Thamphya, B; Pangault, C; Monvoisin, C; Huet, S; Seffals, M; Baulande, S; Mechta-Grigoriou, F; Legoix, P; Rossille, D; Guirriec, M; Leonard, S; Cartron, G; Salles, G; Fest, T; Tarte, K				Mourcin, Frederic; Verdiere, Lea; Roulois, David; Amin, Rada; Lamaison, Claire; Sibut, Vonick; Thamphya, Brice; Pangault, Celine; Monvoisin, Celine; Huet, Sarah; Seffals, Marine; Baulande, Sylvain; Mechta-Grigoriou, Fatima; Legoix, Patricia; Rossille, Delphine; Guirriec, Marion; Leonard, Simon; Cartron, Guillaume; Salles, Gilles; Fest, Thierry; Tarte, Karin			Follicular lymphoma triggers phenotypic and functional remodeling of the human lymphoid stromal cell landscape (vol 54, pg 1788, 2021)	IMMUNITY			English	Correction												karin.tarte@univ-rennes1.fr	Roulois, David/F-3732-2017; Amin, Rada/AAY-3950-2021; Pangault, Celine/C-3254-2017; tarte, karin/GXV-1815-2022; lamaison, claire/GVS-3267-2022; Salles, Gilles/Z-2336-2019	Roulois, David/0000-0002-8966-0608; Pangault, Celine/0000-0003-3978-2209; tarte, karin/0000-0002-6809-917X; lamaison, claire/0000-0003-1180-7902; Salles, Gilles/0000-0002-9541-8666				MOURCIN P, 2021, IMMUNITY, V54, P1788	1	2	2	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 10	2021	54	8					1901	1901		10.1016/j.immuni.2021.07.018	http://dx.doi.org/10.1016/j.immuni.2021.07.018		AUG 2021	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TZ6OI	34380065	Green Submitted, Bronze			2022-12-18	WOS:000684589700023
J	Roberto, MP; Varano, G; Vinas-Castells, R; Holmes, AB; Kumar, R; Pasqualucci, L; Farinha, P; Scott, DW; Dominguez-Sola, D				Roberto, Mark P.; Varano, Gabriele; Vinas-Castells, Rosa; Holmes, Antony B.; Kumar, Rahul; Pasqualucci, Laura; Farinha, Pedro; Scott, David W.; Dominguez-Sola, David			Mutations in the transcription factor FOXO1 mimic positive selection signals to promote germinal center B cell expansion and lymphomagenesis	IMMUNITY			English	Article							GENE-EXPRESSION; TUMOR-SUPPRESSOR; C-MYC; LYMPHOCYTE SUBSETS; DYNAMIC REGULATION; PROTEIN-KINASE; CENTER LIGHT; PI3 KINASE; T-CELL; ACTIVATION	The transcription factor forkhead box O1 (FOXO1), which instructs the dark zone program to direct germinal center (GC) polarity, is typically inactivated by phosphatidylinositol 3-kinase (PI3K) signals. Here, we investigated how FOXO1 mutations targeting this regulatory axis in GC-derived B cell non-Hodgkin lymphomas (B-NHLs) contribute to lymphomagenesis. Examination of primary B-NHL tissues revealed that FOXO1 mutations and PI3K pathway activity were not directly correlated. Human B cell lines bearing FOXO1 mutations exhibited hyperactivation of PI3K and Stress-activated protein kinase (SAPK)/Jun amino-terminal kinase (JNK) signaling, and increased cell survival under stress conditions as a result of alterations in FOXO1 transcriptional affinities and activation of transcriptional programs characteristic of GC-positive selection. When modeled in mice, FOXO1 mutations conferred competitive advantage to B cells in response to key T-dependent immune signals, disrupting GC homeostasis. FOXO1 mutant transcriptional signatures were prevalent in human B-NHL and predicted poor clinical outcomes. Thus, rather than enforcing FOXO1 constitutive activity, FOXO1 mutations enable co-option of GC-positive selection programs during the pathogenesis of GC-derived lymphomas.	[Roberto, Mark P.; Varano, Gabriele; Vinas-Castells, Rosa; Dominguez-Sola, David] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Dominguez-Sola, David] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Dominguez-Sola, David] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Dominguez-Sola, David] Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA; [Roberto, Mark P.; Dominguez-Sola, David] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Holmes, Antony B.; Kumar, Rahul; Pasqualucci, Laura] Columbia Univ, Inst Canc Genet, Med Ctr, New York, NY 10032 USA; [Pasqualucci, Laura] Columbia Univ, Dept Pathol, Med Ctr, New York, NY 10032 USA; [Pasqualucci, Laura] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Med Ctr, New York, NY 10032 USA; [Farinha, Pedro; Scott, David W.] British Columbia Canc, Ctr Lymphoid Canc, Vancouver, BC V5Z 1L3, Canada; [Varano, Gabriele] Univ Ferrara, Lab Adv Therapy Technol LTTA, Dept Translat Med, Ferrara, Italy; [Kumar, Rahul] Indian Inst Sci, Ctr Brain Res, Bengaluru, India	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Columbia University; Columbia University; Columbia University; University of Ferrara; Indian Institute of Science (IISC) - Bangalore	Dominguez-Sola, D (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA.; Dominguez-Sola, D (corresponding author), Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA.; Dominguez-Sola, D (corresponding author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA.; Dominguez-Sola, D (corresponding author), Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA.; Dominguez-Sola, D (corresponding author), Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA.	david.dominguez-sola@mssm.edu		Roberto, Mark/0000-0003-1723-8624; Farinha, Pedro/0000-0001-9364-9391; Dominguez-Sola, David/0000-0001-9569-8402	National Institutes of Health (NIH) [RO1-CA207963]; Louis Sklarow Memorial Trust; NIH/National Cancer Institute (NCI) Cancer Center Support Grant [P30-CA196521]; Tisch Cancer Institute; Next Generation Sequencing and Mouse Genetics and Gene Targeting Shared Resources at Mount Sinai. - (NIH) [R35-CA210105, P30-CA013696]; Lymphoma Research Foundation postdoctoral award; Ruth L. Kirchstein National Service Award (NRSA) Institutional Research Training Grant [T32-C078207]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louis Sklarow Memorial Trust; NIH/National Cancer Institute (NCI) Cancer Center Support Grant; Tisch Cancer Institute; Next Generation Sequencing and Mouse Genetics and Gene Targeting Shared Resources at Mount Sinai. - (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lymphoma Research Foundation postdoctoral award; Ruth L. Kirchstein National Service Award (NRSA) Institutional Research Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank D. Hasson (Icahn School of Medicine at Mount Sinai) for assistance in implementing next-generation sequencing protocols; G. Viavattene (Flow Cytometry core at Mount Sinai) and N. Terra (Dominguez-Sola lab) for invaluable technical assistance; P.J. Lehner and N.J. Matheson (University of Cambridge, United Kingdom) for sharing reagents and protocols for targeted cell isolation; Y. Tan and J.P. Mesirov (UCSD School of Medicine) for assistance with the Leading Edge Metanalysis pipeline; K. Kelley and P. Sanabria (Mouse Genetics and Gene Targeting CoRE, Mount Sinai) for assistance in generating Foxo1 mutant mice; R. Dalla-Favera (Columbia University Medical Center) for helpful scientific discussions; and E. Bernstein, E. Papapetrou, and P. Heeger (Icahn School of Medicine at Mount Sinai); K. Basso and A.F. Ferrando (Columbia University Medical Center); and Y. Takabatake for critically reading this manuscript. This study was supported by grants from the National Institutes of Health (NIH) RO1-CA207963 and the Louis Sklarow Memorial Trust (to D.D.-S.). Research was also funded in part through a NIH/National Cancer Institute (NCI) Cancer Center Support Grant (P30-CA196521) to the Tisch Cancer Institute and used the Flow Cytometry, Immunohistology, Next Generation Sequencing and Mouse Genetics and Gene Targeting Shared Resources at Mount Sinai. Additional funding support was provided by grant R35-CA210105 (NIH) and P30-CA013696 (NIH) (Herbert Irving Comprehensive Cancer Center, Columbia University). G.V. was supported by a Lymphoma Research Foundation postdoctoral award. M.P.R. was supported by a Ruth L. Kirchstein National Service Award (NRSA) Institutional Research Training Grant (T32-C078207).	Aggarwal M, 2009, LEUKEMIA LYMPHOMA, V50, P1699, DOI 10.1080/10428190903189035; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arthur SE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06354-3; Baffi TR, 2021, ANNU REV PHARMACOL, V61, P723, DOI 10.1146/annurev-pharmtox-031820-122108; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Basso K, 2004, BLOOD, V104, P4088, DOI 10.1182/blood-2003-12-4291; Basso K, 2015, NAT REV IMMUNOL, V15, P172, DOI 10.1038/nri3814; Basu S, 2013, J IMMUNOL METHODS, V396, P163, DOI 10.1016/j.jim.2013.07.008; Berberich I, 1996, EMBO J, V15, P92, DOI 10.1002/j.1460-2075.1996.tb00337.x; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bouska A, 2017, LEUKEMIA, V31, P83, DOI 10.1038/leu.2016.175; Brent MM, 2008, STRUCTURE, V16, P1407, DOI 10.1016/j.str.2008.06.013; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Cai ZM, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01007; Calado DP, 2012, NAT IMMUNOL, V13, P1092, DOI 10.1038/ni.2418; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Chaplin JW, 2011, J IMMUNOL, V187, P4199, DOI 10.4049/jimmunol.1100198; Chaveroux C, 2009, MOL CELL BIOL, V29, P6515, DOI 10.1128/MCB.00489-09; Chen J, 2010, EUR J IMMUNOL, V40, P1890, DOI 10.1002/eji.200939817; Chen MH, 2011, CANCER CELL, V20, P173, DOI 10.1016/j.ccr.2011.07.013; Compagno M, 2017, NATURE, V542, P489, DOI 10.1038/nature21406; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Dominguez-Sola D, 2017, METHODS MOL BIOL, V1623, P1, DOI 10.1007/978-1-4939-7095-7_1; Dominguez-Sola D, 2015, IMMUNITY, V43, P1064, DOI 10.1016/j.immuni.2015.10.015; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Egle A, 2004, BLOOD, V103, P2276, DOI 10.1182/blood-2003-07-2469; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Ennishi D, 2019, J CLIN ONCOL, V37, P190, DOI 10.1200/JCO.18.01583; Ersching J, 2017, IMMUNITY, V46, P1045, DOI 10.1016/j.immuni.2017.06.005; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Fruman DA, 2017, CELL, V170, P605, DOI 10.1016/j.cell.2017.07.029; Fuchs SY, 2000, J BIOL CHEM, V275, P12560, DOI 10.1074/jbc.275.17.12560; Fulda Simone, 2010, Int J Cell Biol, V2010, P370835, DOI 10.1155/2010/370835; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gallagher E, 2007, NAT IMMUNOL, V8, P57, DOI 10.1038/ni1421; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Godec J, 2016, IMMUNITY, V44, P194, DOI 10.1016/j.immuni.2015.12.006; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Grande BM, 2019, BLOOD, V133, P1313, DOI 10.1182/blood-2018-09-871418; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hotamisligil GS, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a006072; Huang CY, 2008, EUR J IMMUNOL, V38, P342, DOI 10.1002/eji.200737972; Huang E, 2003, NAT GENET, V34, P226, DOI 10.1038/ng1167; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Hubner A, 2012, P NATL ACAD SCI USA, V109, P12046, DOI 10.1073/pnas.1209660109; Inoue T, 2017, J EXP MED, V214, P1181, DOI 10.1084/jem.20161263; Jiang YW, 2017, CANCER DISCOV, V7, P38, DOI 10.1158/2159-8290.CD-16-0975; Kabrani E, 2018, BLOOD, V132, P2670, DOI 10.1182/blood-2018-06-856203; Langlet F, 2017, CELL, V171, P824, DOI 10.1016/j.cell.2017.09.045; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YY, 1996, J IMMUNOL, V157, P1440; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo W, 2018, IMMUNITY, V48, P313, DOI 10.1016/j.immuni.2018.01.008; MASON DY, 1992, INT IMMUNOL, V4, P163, DOI 10.1093/intimm/4.2.163; Matheson NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111437; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001; Mlynarczyk C, 2019, IMMUNOL REV, V288, P214, DOI 10.1111/imr.12755; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Morin RD, 2016, CLIN CANCER RES, V22, P2290, DOI 10.1158/1078-0432.CCR-15-2123; Morin RD, 2013, BLOOD, V122, P1256, DOI 10.1182/blood-2013-02-483727; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; Obsil T, 2011, BBA-MOL CELL RES, V1813, P1946, DOI 10.1016/j.bbamcr.2010.11.025; Ogata H, 2000, J EXP MED, V192, P23, DOI 10.1084/jem.192.1.23; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pasqualucci L, 2014, CELL REP, V6, P130, DOI 10.1016/j.celrep.2013.12.027; Pelossof R, 2017, NAT BIOTECHNOL, V35, P350, DOI 10.1038/nbt.3807; Petro JB, 2002, J BIOL CHEM, V277, P48009, DOI 10.1074/jbc.M200305200; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reese TA, 2016, CELL HOST MICROBE, V19, P713, DOI 10.1016/j.chom.2016.04.003; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Richter KN, 2018, EMBO J, V37, P139, DOI 10.15252/embj.201695709; Rickert RC, 2013, NAT REV IMMUNOL, V13, P578, DOI 10.1038/nri3487; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Sakata N, 1995, J BIOL CHEM, V270, P30823, DOI 10.1074/jbc.270.51.30823; Sander S, 2015, IMMUNITY, V43, P1075, DOI 10.1016/j.immuni.2015.10.021; Schmitz R, 2018, NEW ENGL J MED, V378, P1396, DOI 10.1056/NEJMoa1801445; Shaffer AL, 2012, ANNU REV IMMUNOL, V30, P565, DOI 10.1146/annurev-immunol-020711-075027; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Su TT, 2002, J IMMUNOL, V168, P2101, DOI 10.4049/jimmunol.168.5.2101; Su YW, 2011, P NATL ACAD SCI USA, V108, P1555, DOI 10.1073/pnas.1017729108; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szczepankiewicz BG, 2006, J MED CHEM, V49, P3563, DOI 10.1021/jm060199b; Teague BN, 2007, J IMMUNOL, V178, P7511, DOI 10.4049/jimmunol.178.12.7511; Teater M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02595-w; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trinh DL, 2013, BLOOD, V121, P3666, DOI 10.1182/blood-2013-01-479865; Tsai KL, 2007, NUCLEIC ACIDS RES, V35, P6984, DOI 10.1093/nar/gkm703; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Victora GD, 2014, CURR OPIN IMMUNOL, V28, P90, DOI 10.1016/j.coi.2014.02.010; Victora GD, 2012, BLOOD, V120, P2240, DOI 10.1182/blood-2012-03-415380; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vivanco I, 2007, CANCER CELL, V11, P555, DOI 10.1016/j.ccr.2007.04.021; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Xie LK, 2012, BLOOD, V119, P3503, DOI 10.1182/blood-2011-09-381905; Yusuf I, 2004, BLOOD, V104, P784, DOI 10.1182/blood-2003-09-3071; Zanella F, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-14; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou PX, 2019, BLOOD ADV, V3, P2118, DOI 10.1182/bloodadvances.2018029546	112	2	2	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 10	2021	54	8					1807	+		10.1016/j.immuni.2021.07.009	http://dx.doi.org/10.1016/j.immuni.2021.07.009		AUG 2021	32	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TZ6OI	34380064	Bronze, Green Accepted			2022-12-18	WOS:000684589700017
J	Wei, J; Ishizuka, JJ				Wei, Jessica; Ishizuka, Jeffrey J.			Going viral: HBV-specific CD8(+) tissue-resident memory T cells propagate anti-tumor immunity	IMMUNITY			English	Editorial Material							NASOPHARYNGEAL CARCINOMA	The nature of the epitopes recognized by tumor-infiltrating T cells is not clearly defined. In this issue of Immunity, Cheng et al. demonstrate that tissue-resident memory CD8(+) T cells specific for hepatitis B virus-derived antigens exhibit potent anti-tumor properties and correlate with relapse-free survival in patients with resected hepatocellular carcinoma.	[Wei, Jessica] Yale Sch Med, Dept Neurol, New Haven, CT USA; [Wei, Jessica] Yale Sch Med, Dept Immunobiol, New Haven, CT USA; [Wei, Jessica; Ishizuka, Jeffrey J.] Yale Canc Ctr, Dept Internal Med Oncol, Yale Sch Med, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Ishizuka, JJ (corresponding author), Yale Canc Ctr, Dept Internal Med Oncol, Yale Sch Med, New Haven, CT 06520 USA.	jeffrey.ishizuka@yale.edu			Yale Cancer Center; Yale School of Medicine	Yale Cancer Center; Yale School of Medicine	J.J.I. was supported by funding from the Yale Cancer Center and Yale School of Medicine.	Benechet AP, 2019, NATURE, V574, P200, DOI 10.1038/s41586-019-1620-6; Cheng Y, 2021, IMMUNITY, V54, P1825, DOI 10.1016/j.immuni.2021.06.013; Cheng Y, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau6905; Comoli P, 2005, J CLIN ONCOL, V23, P8942, DOI 10.1200/JCO.2005.02.6195; International Agency for Research onCancer, 2020, LIVER; Rosato PC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08534-1; Sefrin JP, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01962; Straathof KCM, 2005, BLOOD, V105, P1898, DOI 10.1182/blood-2004-07-2975; Wang T, 2020, PHARMACOL RES, V159, DOI 10.1016/j.phrs.2020.104876; Yau T, 2020, JAMA ONCOL, V6, DOI 10.1001/jamaoncol.2020.4564	10	2	2	3	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 10	2021	54	8					1630	1632		10.1016/j.immuni.2021.07.014	http://dx.doi.org/10.1016/j.immuni.2021.07.014		AUG 2021	4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TZ6OI	34380061	Bronze			2022-12-18	WOS:000684589700004
J	Flayer, CH; Sokol, CL				Flayer, Cameron H.; Sokol, Caroline L.			No pain, no gain: Sensory neurons heal a sunburn	IMMUNITY			English	Editorial Material							MIGRATION; INJURY; SKIN	In a recent issue of Nature, Hoeffel et al. describe a novel pathway of sterile tissue repair utilizing a mouse model of sunburn. This wound healing pathway is coordinated by sensory neuron-derived TAFA4 that induces IL-10 production from Tim4(+) dermal macrophages to prevent sustained inflammation and the emergence of tissue fibrosis.	[Flayer, Cameron H.; Sokol, Caroline L.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Sokol, CL (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA.	clsokol@mgh.harvard.edu			NIH [K08AI121421, T32HL116275]; Massachusetts General Hospital Transformative Scholar Award; AAAAI Foundation; Food Allergy Science Initiative	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts General Hospital Transformative Scholar Award; AAAAI Foundation; Food Allergy Science Initiative	This work was supported by NIH K08AI121421 (to C.L.S.) and T32HL116275 (to C.H.F.), a Massachusetts General Hospital Transformative Scholar Award (to C.L.S.), an AAAAI Foundation and Dr. Donald Y. M. Leung/JACI Editors Faculty Development Award (to C.L.S.), and the Food Allergy Science Initiative (to C.L.S.). BioRender was used to generate Figure 1.	Baral P, 2018, NAT MED, V24, P417, DOI 10.1038/nm.4501; Clydesdale GJ, 2001, IMMUNOL CELL BIOL, V79, P547, DOI 10.1046/j.1440-1711.2001.01047.x; Delfini MC, 2013, CELL REP, V5, P378, DOI 10.1016/j.celrep.2013.09.013; Hoeffel G, 2021, NATURE, V594, P94, DOI 10.1038/s41586-021-03563-7; Lopes DM, 2016, CNS NEUROSCI THER, V22, P118, DOI 10.1111/cns.12444; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Perner C, 2020, IMMUNITY, V53, P1063, DOI 10.1016/j.immuni.2020.10.001; Sharma N, 2020, NATURE, V577, P392, DOI 10.1038/s41586-019-1900-1; Wang WY, 2015, CELL MOL IMMUNOL, V12, P615, DOI 10.1038/cmi.2014.61; Zhang SQ, 2021, CELL, V184, P2151, DOI 10.1016/j.cell.2021.03.002	10	2	2	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 13	2021	54	7					1374	1376		10.1016/j.immuni.2021.06.011	http://dx.doi.org/10.1016/j.immuni.2021.06.011		JUL 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TI4ZW	34260885	Bronze, Green Accepted			2022-12-18	WOS:000672812100005
J	Huang, X; Ferris, ST; Kim, S; Choudhary, MNK; Belk, JA; Fan, CX; Qi, YY; Sudan, R; Xia, Y; Desai, P; Chen, J; Ly, N; Shi, QM; Bagadia, P; Liu, TT; Guilliams, M; Egawa, T; Colonna, M; Diamond, MS; Murphy, TL; Satpathy, AT; Wang, T; Murphy, KM				Huang, Xiao; Ferris, Stephen T.; Kim, Sunkyung; Choudhary, Mayank N. K.; Belk, Julia A.; Fan, Changxu; Qi, Yanyan; Sudan, Raki; Xia, Yu; Desai, Pritesh; Chen, Jing; Ly, Nghi; Shi, Quanming; Bagadia, Prachi; Liu, Tiantian; Guilliams, Martin; Egawa, Takeshi; Colonna, Marco; Diamond, Michael S.; Murphy, Theresa L.; Satpathy, Ansuman T.; Wang, Ting; Murphy, Kenneth M.			Differential usage of transcriptional repressor Zeb2 enhancers distinguishes adult and embryonic hematopoiesis	IMMUNITY			English	Article							SMAD-INTERACTING PROTEIN-1; PERIPHERAL LYMPHOID ORGANS; DENDRITIC CELL; YOLK-SAC; TERMINAL DIFFERENTIATION; PHENOTYPIC ROBUSTNESS; MYELOID PROGENITORS; FETAL LIVER; IN-VITRO; T-BET	The transcriptional repressor ZEB2 regulates development of many cell fates among somatic, neural, and hematopoietic lineages, but the basis for its requirement in these diverse lineages is unclear. Here, we identified a 400-basepair (bp) region located 165 kilobases (kb) upstream of the Zeb2 transcriptional start site (TSS) that binds the E proteins at several E-box motifs and was active in hematopoietic lineages. Germline deletion of this 400-bp region (Zeb2(Delta-165)mice) specifically prevented Zeb2 expression in hematopoietic stem cell (HSC)-derived lineages. Zeb2(Delta-165) mice lacked development of plasmacytoid dendritic cells (pDCs), monocytes, and B cells. All macrophages in Zeb2(Delta-165) mice were exclusively of embryonic origin. Using single-cell chromatin profiling, we identified a second Zeb2 enhancer located at +164-kb that was selectively active in embryonically derived lineages, but not HSC-derived ones. Thus, Zeb2 expression in adult, but not embryonic, hematopoiesis is selectively controlled by the -165-kb Zeb2 enhancer.	[Huang, Xiao; Ferris, Stephen T.; Kim, Sunkyung; Sudan, Raki; Xia, Yu; Chen, Jing; Liu, Tiantian; Egawa, Takeshi; Colonna, Marco; Diamond, Michael S.; Murphy, Theresa L.; Murphy, Kenneth M.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA; [Choudhary, Mayank N. K.; Fan, Changxu; Wang, Ting] Washington Univ, Dept Genet, Sch Med, St Louis, MO 63110 USA; [Belk, Julia A.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Qi, Yanyan; Ly, Nghi; Shi, Quanming; Satpathy, Ansuman T.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Desai, Pritesh; Diamond, Michael S.] Washington Univ, Dept Med, Sch Med, St Louis, MO 63110 USA; [Bagadia, Prachi] Amgen Inc, Dept Oncol, 1120 Vet Blvd, San Francisco, CA 94080 USA; [Guilliams, Martin] VIB Inflammat Res Ctr, Unit Immunoregulat & Mucosal Immunol, B-9052 Ghent, Belgium; [Guilliams, Martin] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Diamond, Michael S.] Washington Univ, Dept Mol Microbiol, Sch Med, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, Sch Med, St Louis, MO 63110 USA; [Choudhary, Mayank N. K.; Fan, Changxu; Wang, Ting] Washington Univ, Edison Family Ctr Genome Sci & Syst Biol, Sch Med, St Louis, MO 63110 USA; [Wang, Ting] Washington Univ, McDonnell Genome Inst, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Stanford University; Stanford University; Washington University (WUSTL); Amgen; Flanders Institute for Biotechnology (VIB); Ghent University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Murphy, KM (corresponding author), Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA.	kmurphy@wustl.edu	Sudan, Raki/AFK-6979-2022; Guilliams, Martin/N-7803-2013; Huang, Xiao/GPF-9961-2022	Guilliams, Martin/0000-0003-3525-7570; Huang, Xiao/0000-0002-2754-5225; Xia, Yu/0000-0002-6397-1205; Belk, Julia/0000-0003-4724-6158; Desai, Pritesh/0000-0002-4697-9475; Chen, Jing/0000-0002-5998-6930	National Cancer Institute's Cancer Center support grant [P30 CA91842]; Institute of Clinical and Translational Sciences/Clinical and Translational Science Award from the National Center for Research Resourcess (NCRR) [UL1TR000448]; NIH Roadmap for Medical Research; NIH [R01AI150297, K08CA230188, R01AI130152]; Parker Institute for Cancer Immunotherapy; Cancer Research Institute; Burroughs Wellcome Fund; Leukemia and Lymphoma Society	National Cancer Institute's Cancer Center support grant; Institute of Clinical and Translational Sciences/Clinical and Translational Science Award from the National Center for Research Resourcess (NCRR); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker Institute for Cancer Immunotherapy; Cancer Research Institute; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society)	We thank the Genome Technology Access Center in the Department of Genetics at Washington University School of Medicine for help with genomic analysis, which is supported by the National Cancer Institute's Cancer Center support grant (P30 CA91842) to the Siteman Cancer Center and by the Institute of Clinical and Translational Sciences/Clinical and Translational Science Award grant (UL1TR000448) from the National Center for Research Resourcess (NCRR) and NIH Roadmap for Medical Research. This publication is solely the responsibility of the authors and does not necessarily represent the official view of the NCRR or NIH. This work benefitted from data assembled by the ImmGen Consortium (Heng et al., 2008). This work was supported by NIH (R01AI150297 to K.M.M.) A.T.S. was supported by a Bridge Scholar Award from the Parker Institute for Cancer Immunotherapy, a Technology Impact Award from the Cancer Research Institute, a Career Award for Medical Scientists from the Burroughs Wellcome Fund, and NIH (K08CA230188). T.E. was supported by a Scholar Award from the Leukemia and Lymphoma Society and NIH (R01AI130152).	Bagadia P, 2019, NAT IMMUNOL, V20, P1174, DOI 10.1038/s41590-019-0449-3; Bagadia P, 2019, ANNU REV CELL DEV BI, V35, P381, DOI 10.1146/annurev-cellbio-100818-125403; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bruttger J, 2015, IMMUNITY, V43, P92, DOI 10.1016/j.immuni.2015.06.012; Calero-Nieto FJ, 2014, EMBO J, V33, P1212, DOI 10.1002/embj.201386825; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Choudhary MNK, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-019-1916-8; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Delconte RB, 2016, IMMUNITY, V44, P103, DOI 10.1016/j.immuni.2015.12.007; Denecker G, 2014, CELL DEATH DIFFER, V21, P1250, DOI 10.1038/cdd.2014.44; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dominguez CX, 2015, J EXP MED, V212, P2041, DOI 10.1084/jem.20150186; Durai V, 2019, NAT IMMUNOL, V20, P1161, DOI 10.1038/s41590-019-0450-x; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Frame JM, 2013, BLOOD CELL MOL DIS, V51, P220, DOI 10.1016/j.bcmd.2013.09.006; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Gautam S, 2019, NAT IMMUNOL, V20, P337, DOI 10.1038/s41590-018-0311-z; Gautier EL, 2013, BLOOD, V122, P2714, DOI 10.1182/blood-2013-01-478206; Ghosh HS, 2014, J EXP MED, V211, P1623, DOI 10.1084/jem.20132121; Gibbings SL, 2015, BLOOD, V126, P1357, DOI 10.1182/blood-2015-01-624809; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Goossens S, 2011, BLOOD, V117, P5620, DOI 10.1182/blood-2010-08-300236; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Grajales-Reyes GE, 2015, NAT IMMUNOL, V16, P708, DOI 10.1038/ni.3197; Granja JM, 2020, ARCHR INTEGRATIVE SC, DOI [10.1101/2020.04.28.066498, DOI 10.1101/2020.04.28.066498]; Guan TX, 2018, J EXP MED, V215, P1153, DOI 10.1084/jem.20171352; Hegarty SV, 2015, PROG NEUROBIOL, V132, P81, DOI 10.1016/j.pneurobio.2015.07.001; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Higashi Y, 2002, GENESIS, V32, P82, DOI 10.1002/gene.10048; Hoeffel G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00486; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Hoppe PS, 2016, NATURE, V535, P299, DOI 10.1038/nature18320; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Iavarone A, 2004, NATURE, V432, P1040, DOI 10.1038/nature03068; Iwata A, 2017, NAT IMMUNOL, V18, P563, DOI 10.1038/ni.3714; Jackson JT, 2011, EMBO J, V30, P2690, DOI 10.1038/emboj.2011.163; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Koenis DS, 2018, CELL REP, V24, P2127, DOI 10.1016/j.celrep.2018.07.065; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lavin Y, 2013, CANCER IMMUNOL RES, V1, P201, DOI 10.1158/2326-6066.CIR-13-0117; Li J, 2017, BLOOD, V129, P460, DOI 10.1182/blood-2016-05-714659; Lin Y, 2014, STEM CELLS DEV, V23, P1168, DOI 10.1089/scd.2013.0536; Liu ZY, 2019, CELL, V178, P1509, DOI 10.1016/j.cell.2019.08.009; Long HK, 2016, CELL, V167, P1170, DOI 10.1016/j.cell.2016.09.018; Luyten A, 2014, GENE DEV, V28, P1827, DOI 10.1101/gad.240101.114; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; MOORE MAS, 1970, BRIT J HAEMATOL, V18, P279, DOI 10.1111/j.1365-2141.1970.tb01443.x; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Nishizaki Y, 2014, GENESIS, V52, P56, DOI 10.1002/dvg.22726; Omilusik KD, 2018, J EXP MED, V215, P773, DOI 10.1084/jem.20171584; Omilusik KD, 2015, J EXP MED, V212, P2027, DOI 10.1084/jem.20150194; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Osterwalder M, 2018, NATURE, V554, P239, DOI 10.1038/nature25461; Palis J, 1999, DEVELOPMENT, V126, P5073; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Remacle JE, 1999, EMBO J, V18, P5073, DOI 10.1093/emboj/18.18.5073; Rodrigues PF, 2018, NAT IMMUNOL, V19, P711, DOI 10.1038/s41590-018-0136-9; Sakai M, 2019, IMMUNITY, V51, P655, DOI 10.1016/j.immuni.2019.09.002; Sanborn AL, 2015, P NATL ACAD SCI USA, V112, pE6456, DOI 10.1073/pnas.1518552112; Satpathy AT, 2019, NAT BIOTECHNOL, V37, P925, DOI 10.1038/s41587-019-0206-z; Sawai CM, 2016, IMMUNITY, V45, P597, DOI 10.1016/j.immuni.2016.08.007; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Scott CL, 2019, TRENDS IMMUNOL, V40, P431, DOI 10.1016/j.it.2019.03.001; Scott CL, 2018, IMMUNITY, V49, P312, DOI 10.1016/j.immuni.2018.07.004; Scott CL, 2016, J EXP MED, V213, P897, DOI 10.1084/jem.20151715; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Steininger A, 2011, J EXP MED, V208, P1585, DOI 10.1084/jem.20101785; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; Stier MT, 2018, J EXP MED, V215, P263, DOI 10.1084/jem.20170449; Theisen DJ, 2018, SCIENCE, V362, P694, DOI 10.1126/science.aat5030; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017; Van de Putte T, 2003, AM J HUM GENET, V72, P465, DOI 10.1086/346092; van Grunsven LA, 2003, J BIOL CHEM, V278, P26135, DOI 10.1074/jbc.M300597200; van Helden MJ, 2015, J EXP MED, V212, P2015, DOI 10.1084/jem.20150809; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Verykokakis M, 2014, IMMUNOL REV, V261, P177, DOI 10.1111/imr.12203; Wu J, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108395; Wu XD, 2016, P NATL ACAD SCI USA, V113, P14775, DOI 10.1073/pnas.1611408114; Xu W, 2019, IMMUNITY, V50, P1054, DOI 10.1016/j.immuni.2019.02.022; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yoshida H, 2019, CELL, V176, P897, DOI 10.1016/j.cell.2018.12.036; Zhang N, 2019, J EXP MED, V216, P1291, DOI 10.1084/jem.20182024	90	2	2	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 13	2021	54	7					1417	+		10.1016/j.immuni.2021.04.015	http://dx.doi.org/10.1016/j.immuni.2021.04.015			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TI4ZW	34004142	Green Accepted, Bronze			2022-12-18	WOS:000672812100009
J	Wegner, J; Kirchhoff, A; Schlee, M				Wegner, Julia; Kirchhoff, Alexander; Schlee, Martin			DPP9 holds all the CARD8s for inflammasome regulation	IMMUNITY			English	Editorial Material								CARD8 senses pathogen-associated protease activity and assembles a pyroptosis-inducing inflammasome, but detailed regulatory mechanisms have remained elusive. In this issue of Immunity, Sharif et al. use cryo-EM and biochemical assays to unveil how DPP9 sequesters the inflammasome-forming C-terminal fragment of CARD8 to suppress its activation.	[Wegner, Julia; Kirchhoff, Alexander; Schlee, Martin] Univ Hosp Bonn, Dept Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany	University of Bonn	Schlee, M (corresponding author), Univ Hosp Bonn, Dept Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany.	martin.schlee@uni-bonn.de		Schlee, Martin/0000-0003-3671-7639; Kirchhoff, Alexander/0000-0002-8796-1829; Wegner, Julia/0000-0001-8103-8040				Chui AJ, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108264; Fenini G, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21134788; Griswold AR, 2019, ACS CHEM BIOL, V14, P2424, DOI 10.1021/acschembio.9b00462; Hollingsworth LR, 2021, NATURE, V592, P778, DOI 10.1038/s41586-021-03350-4; Huang MH, 2021, NATURE, V592, P773, DOI 10.1038/s41586-021-03320-w; Johnson DC, 2018, NAT MED, V24, P1151, DOI 10.1038/s41591-018-0082-y; Linder A, 2020, EMBO J, V39, DOI 10.15252/embj.2020105071; Sandstrom A, 2019, SCIENCE, V364, P42, DOI 10.1126/science.aau1330; Sharif H, 2021, IMMUNITY, V54, P1392, DOI 10.1016/j.immuni.2021.04.024; Zhong FL, 2018, J BIOL CHEM, V293, P18864, DOI 10.1074/jbc.RA118.004350	10	2	2	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 13	2021	54	7					1363	1365		10.1016/j.immuni.2021.06.005	http://dx.doi.org/10.1016/j.immuni.2021.06.005		JUL 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TI4ZW	34260881	Bronze			2022-12-18	WOS:000672812100002
J	Bajpai, G; Nahrendorf, M				Bajpai, Geetika; Nahrendorf, Matthias			Infectious and lifestyle modifiers of immunity and host resilience	IMMUNITY			English	Review							ADIPOSE-TISSUE MACROPHAGES; STRESS ACCELERATES ATHEROSCLEROSIS; CHEMOKINE RECEPTOR EXPRESSION; ACUTE PSYCHOLOGICAL STRESS; HEMATOPOIETIC STEM-CELLS; LOW-GRADE INFLAMMATION; VIRUS INFECTION; NK CELLS; EPIGENETIC MODIFICATIONS; CARDIOVASCULAR-DISEASE	The interindividual heterogeneity of the immune system likely determines the personal risk for acquiring infections and developing diseases with inflammatory components. In addition to genetic factors, the immune system's heterogeneity is driven by diverging exposures of leukocytes and their progenitors to infections, vaccinations, and health behavior, including lifestyle-related stimuli such as diet, physical inactivity, and psychosocial stress. We review how such experiences alter immune cell responses to concurrent and subsequent challenges, leading to either improved host resilience or disease susceptibility due to a muted or overzealous immune system, with a primary focus on the contribution of innate immune cells. We explore the involvement of diverse mechanisms, including trained immunity, and their relevance for infections and cardiovascular disease, as these prevalent conditions are heavily influenced by immune cell abundance and phenotypic adaptions. Understanding the mechanistic bases of immune modulations by prior or co-exposures may lead to new therapies targeting dysfunctional inflammation.	[Bajpai, Geetika; Nahrendorf, Matthias] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Bajpai, Geetika; Nahrendorf, Matthias] Harvard Med Sch, Boston, MA 02115 USA; [Bajpai, Geetika; Nahrendorf, Matthias] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Nahrendorf, Matthias] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Nahrendorf, Matthias] Univ Hosp Wuerzburg, Dept Internal Med 1, Wurzburg, Germany	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Wurzburg	Nahrendorf, M (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA.; Nahrendorf, M (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Nahrendorf, M (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA.; Nahrendorf, M (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA.; Nahrendorf, M (corresponding author), Univ Hosp Wuerzburg, Dept Internal Med 1, Wurzburg, Germany.	mnahrendorf@mgh.harvard.edu			NIH [HL139598, HL142494, HL131478]; MGH Research Scholar Program	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MGH Research Scholar Program	The authors are funded by the NIH (HL139598, HL142494, HL131478) and the MGH Research Scholar Program. We acknowledge Kaley Joyes (Massachusetts General Hospital, Boston, MA, USA) for editing the manuscript.	Abubakar I, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17370; Afari ME, 2016, EXPERT REV CARDIOVAS, V14, P573, DOI 10.1586/14779072.2016.1154788; Arts RJW, 2016, CELL METAB, V24, P807, DOI 10.1016/j.cmet.2016.10.008; Bajpai G, 2019, CIRC RES, V124, P263, DOI 10.1161/CIRCRESAHA.118.314028; Beis D, 2018, PSYCHOSOM MED, V80, P649, DOI 10.1097/PSY.0000000000000620; Bekkering S, 2016, ATHEROSCLEROSIS, V254, P228, DOI 10.1016/j.atherosclerosis.2016.10.019; Bekkering S, 2014, ARTERIOSCL THROM VAS, V34, P1731, DOI 10.1161/ATVBAHA.114.303887; Bickett TE, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01202; Bosch JA, 2003, BRAIN BEHAV IMMUN, V17, P251, DOI 10.1016/S0889-1591(03)00054-0; Brodin P, 2017, NAT REV IMMUNOL, V17, P21, DOI 10.1038/nri.2016.125; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Caprara GV, 2017, IMMUNOL LETT, V188, P13, DOI 10.1016/j.imlet.2017.05.012; Chaussee MS, 2011, VACCINE, V29, P3773, DOI 10.1016/j.vaccine.2011.03.031; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Christ A, 2018, CELL, V172, P162, DOI 10.1016/j.cell.2017.12.013; Cirovic B, 2020, CELL HOST MICROBE, V28, P322, DOI 10.1016/j.chom.2020.05.014; Coulombe F, 2009, J EXP MED, V206, P1709, DOI 10.1084/jem.20081779; Cui JF, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002572; Davis FM, 2019, ARTERIOSCL THROM VAS, V39, P2353, DOI 10.1161/ATVBAHA.119.312754; Davis FM, 2019, ARTERIOSCL THROM VAS, V39, P623, DOI 10.1161/ATVBAHA.118.312135; Dhabhar FS, 2012, PSYCHONEUROENDOCRINO, V37, P1345, DOI 10.1016/j.psyneuen.2012.05.008; Dhabhar FS, 2009, NEUROIMMUNOMODULAT, V16, P300, DOI 10.1159/000216188; DHABHAR FS, 1995, J IMMUNOL, V154, P5511; Dimsdale JE, 2008, J AM COLL CARDIOL, V51, P1237, DOI 10.1016/j.jacc.2007.12.024; Doherty DG, 2016, J AUTOIMMUN, V66, P60, DOI 10.1016/j.jaut.2015.08.020; Drewry AM, 2014, SHOCK, V42, P383, DOI 10.1097/SHK.0000000000000234; Duque GA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00491; Dye C, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0365; Eguchi M, 2012, J CELL MOL MED, V16, P2925, DOI 10.1111/j.1582-4934.2012.01613.x; Engler H, 2004, J NEUROIMMUNOL, V148, P106, DOI 10.1016/j.jneuroim.2003.11.011; Feng XJ, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00210; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Fischer IP, 2018, INT J OBESITY, V42, P507, DOI 10.1038/ijo.2017.224; Franca CN, 2017, CLIN SCI, V131, P1215, DOI 10.1042/CS20170009; Friedrich K, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01874; Frodermann V, 2019, NAT MED, V25, P1761, DOI 10.1038/s41591-019-0633-x; Garcia-Sastre A, 2011, VIRUS RES, V162, P12, DOI 10.1016/j.virusres.2011.10.017; Gideon A., 2020, J CLIN ENDOCR METAB, V105, P762, DOI DOI 10.1210/clinem/dgz190; Goodier MR, 2016, J IMMUNOL, V197, P313, DOI 10.4049/jimmunol.1502049; GRAY HG, 1989, POULTRY SCI, V68, P1710, DOI 10.3382/ps.0681710; Grzelak AK, 2017, COMPARATIVE MED, V67, P263; Guan XR, 2012, INFLAMM RES, V61, P591, DOI 10.1007/s00011-012-0449-3; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Gyawali B, 2019, SAGE OPEN MED, V7, DOI 10.1177/2050312119835043; Hansel A, 2010, NEUROSCI BIOBEHAV R, V35, P115, DOI 10.1016/j.neubiorev.2009.12.012; Haidari M, 2010, ATHEROSCLEROSIS, V208, P90, DOI 10.1016/j.atherosclerosis.2009.07.028; Handy DE, 2011, CIRCULATION, V123, P2145, DOI 10.1161/CIRCULATIONAHA.110.956839; Harkins JM, 2004, J NUTR, V134, P2673, DOI 10.1093/jn/134.10.2673; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Heidt T, 2014, NAT MED, V20, P754, DOI 10.1038/nm.3589; Heikkinen T, 2013, PEDIATR INFECT DIS J, V32, P669, DOI 10.1097/INF.0b013e3182840fe7; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Hoyer FF, 2019, IMMUNITY, V51, P899, DOI 10.1016/j.immuni.2019.10.010; Hsu SY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002869; Huaman MA, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.607957; Hulsmans M, 2017, CELL, V169, P510, DOI 10.1016/j.cell.2017.03.050; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; Jordan S, 2019, CELL, V178, P1102, DOI 10.1016/j.cell.2019.07.050; Jost S, 2011, IMMUNOLOGY, V132, P516, DOI 10.1111/j.1365-2567.2010.03394.x; Kalafati L, 2020, CELL, V183, P771, DOI 10.1016/j.cell.2020.09.058; Kaufmann E, 2018, CELL, V172, P176, DOI 10.1016/j.cell.2017.12.031; Keustermans GC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17195-3; Khan N, 2020, CELL, V183, P752, DOI 10.1016/j.cell.2020.09.062; Kleinnijenhuis J, 2014, CLIN IMMUNOL, V155, P213, DOI 10.1016/j.clim.2014.10.005; Kleinnijenhuis J, 2014, J INNATE IMMUN, V6, P152, DOI 10.1159/000355628; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; Kloner RA, 1997, J AM COLL CARDIOL, V30, P1174, DOI 10.1016/S0735-1097(97)00281-7; Kratz M, 2014, CELL METAB, V20, P614, DOI 10.1016/j.cmet.2014.08.010; Krinninger P, 2014, J CLIN ENDOCR METAB, V99, P2500, DOI 10.1210/jc.2013-2611; Kumari M, 2003, STRESS, V6, P297, DOI 10.1080/10253890310001619461; Lamb DJ, 1999, ATHEROSCLEROSIS, V143, P105, DOI 10.1016/S0021-9150(98)00284-6; Lavine KJ, 2018, J AM COLL CARDIOL, V72, P2213, DOI 10.1016/j.jacc.2018.08.2149; Lee SE, 2008, VACCINE, V26, P3383, DOI 10.1016/j.vaccine.2008.04.041; Lin TK, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.010739; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Maachi M, 2004, INT J OBESITY, V28, P993, DOI 10.1038/sj.ijo.0802718; Mangtani P, 2014, CLIN INFECT DIS, V58, P470, DOI 10.1093/cid/cit790; Marsland AL, 2017, BRAIN BEHAV IMMUN, V64, P208, DOI 10.1016/j.bbi.2017.01.011; MasucciMagoulas L, 1997, SCIENCE, V275, P391, DOI 10.1126/science.275.5298.391; McAlpine CS, 2019, NATURE, V566, P383, DOI 10.1038/s41586-019-0948-2; McDonald JU, 2017, IMMUNOLOGY, V151, P451, DOI 10.1111/imm.12742; Mina MJ, 2019, SCIENCE, V366, P599, DOI 10.1126/science.aay6485; Mitroulis I, 2018, CELL, V172, P147, DOI 10.1016/j.cell.2017.11.034; Molina-Serrano D, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00192; Nagareddy PR, 2014, CELL METAB, V19, P821, DOI 10.1016/j.cmet.2014.03.029; Nagareddy PR, 2013, CELL METAB, V17, P695, DOI 10.1016/j.cmet.2013.04.001; NALIBOFF BD, 1991, PSYCHOSOM MED, V53, P121, DOI 10.1097/00006842-199103000-00002; Naslund C., 1932, VACCINATION PREVENTA; Nelson RH, 2013, PRIMARY CARE, V40, P195, DOI 10.1016/j.pop.2012.11.003; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Nicolas-Avila JA, 2020, CELL, V183, P94, DOI 10.1016/j.cell.2020.08.031; OLD LJ, 1959, NATURE, V184, P291, DOI 10.1038/184291a0; Poirier P, 2006, ARTERIOSCL THROM VAS, V26, P968, DOI 10.1161/01.ATV.0000216787.85457.f3; Poitou C, 2011, ARTERIOSCL THROM VAS, V31, P2322, DOI 10.1161/ATVBAHA.111.230979; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Priem B, 2020, CELL, V183, P786, DOI 10.1016/j.cell.2020.09.059; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Rajalingam D, 2020, BMC NEUROSCI, V21, DOI 10.1186/s12868-020-00574-4; Rogawski E, 2014, HEART, V100, P517, DOI 10.1136/heartjnl-2013-305406; Rohleder N, 2014, PSYCHOSOM MED, V76, P181, DOI 10.1097/PSY.0000000000000049; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Rosenman KD, 1996, NEW ENGL J MED, V334, P1673; Russell K, 2018, VACCINE, V36, P1272, DOI 10.1016/j.vaccine.2018.01.045; Saeedi P, 2019, DIABETES RES CLIN PR, V157, DOI 10.1016/j.diabres.2019.107843; Saklayen MG, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0812-z; Sanchez-Sarmiento AM, 2015, AM J PRIMATOL, V77, P246, DOI 10.1002/ajp.22327; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; SCHEDLOWSKI M, 1993, J CLIN IMMUNOL, V13, P344, DOI 10.1007/BF00920243; Schipper HS, 2012, DIABETOLOGIA, V55, P2800, DOI 10.1007/s00125-012-2641-y; Schmitz J, 2016, MOL METAB, V5, P328, DOI 10.1016/j.molmet.2015.12.001; Shirai T, 2016, J EXP MED, V213, P337, DOI 10.1084/jem.20150900; Siasos G, 2012, CURR TOP MED CHEM, V12, P1132, DOI 10.2174/1568026611208011132; Singhal G, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00270; Slifka MK, 2003, J CLIN INVEST, V111, P805, DOI 10.1172/JCI200313603; Sohrabi Y, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00353; Song H, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1255; Stensballe LG, 2005, VACCINE, V23, P1251, DOI 10.1016/j.vaccine.2004.09.006; Steptoe A, 2007, BRAIN BEHAV IMMUN, V21, P901, DOI 10.1016/j.bbi.2007.03.011; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Sugisaki K, 1998, J LEUKOCYTE BIOL, V63, P440, DOI 10.1002/jlb.63.4.440; Sullivan PW, 2008, QUAL LIFE RES, V17, P1063, DOI 10.1007/s11136-008-9385-7; Tietge UJF, 2014, CURR OPIN LIPIDOL, V25, P94, DOI 10.1097/MOL.0000000000000051; Ulloa L, 2005, TRENDS MOL MED, V11, P56, DOI 10.1016/j.molmed.2004.12.007; van Dam AD, 2016, ATHEROSCLEROSIS, V251, P6, DOI 10.1016/j.atherosclerosis.2016.05.031; van der Heijden CDCC, 2020, CIRC RES, V127, P269, DOI 10.1161/CIRCRESAHA.119.315800; van der Valk FM, 2016, CIRCULATION, V134, P611, DOI 10.1161/CIRCULATIONAHA.116.020838; Varol C, 2015, ANNU REV IMMUNOL, V33, P643, DOI 10.1146/annurev-immunol-032414-112220; Wagstaffe HR, 2019, J IMMUNOL, V203, P1609, DOI 10.4049/jimmunol.1801648; Walker AMN, 2016, DIABETES VASC DIS RE, V13, P331, DOI 10.1177/1479164116653342; Wang A, 2016, CELL, V166, P1512, DOI 10.1016/j.cell.2016.07.026; Wang YL, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1054-3; Wendeln AC, 2018, NATURE, V556, P332, DOI 10.1038/s41586-018-0023-4; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046; Wohleb ES, 2017, PROG NEURO-PSYCHOPH, V79, P40, DOI 10.1016/j.pnpbp.2016.04.013; Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001; Yanagi Y, 2002, VIROLOGY, V299, P155, DOI 10.1006/viro.2002.1471; Yoshimura A, 2015, OBESITY FACTS, V8, P1, DOI 10.1159/000373881; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731; Zaldivar F, 2006, INT J OBESITY, V30, P906, DOI 10.1038/sj.ijo.0803227; Zeyda M, 2007, INT J OBESITY, V31, P1420, DOI 10.1038/sj.ijo.0803632; Zhang T, 2010, THROMB RES, V126, P386, DOI 10.1016/j.thromres.2010.07.022; Zhu J, 2014, ARCH MED SCI, V10, P855, DOI 10.5114/aoms.2014.46206	143	2	2	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 8	2021	54	6					1110	1122		10.1016/j.immuni.2021.05.011	http://dx.doi.org/10.1016/j.immuni.2021.05.011		JUN 2021	13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SP7ZL	34107270	Bronze			2022-12-18	WOS:000659882900006
J	Bou-Tayeh, B; Miller, ML				Bou-Tayeh, Berna; Miller, Martin L.			Ovarian tumors orchestrate distinct cellular compositions	IMMUNITY			English	Editorial Material								The determinants of T cell infiltration in tumors remain largely unknown. In a recent issue of Cancer Cell, Hornburg et al. use single-cell RNA sequencing to characterize the cellular compartments of the ovarian cancer microenvironment and shed light on how tumor, immune, and stromal cells interact and shape T cell infiltration.	[Bou-Tayeh, Berna; Miller, Martin L.] Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 0RE, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Miller, ML (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 0RE, England.	martin.miller@cruk.cam.ac.uk						Desbois M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19408-2; Galon J, 2019, NAT REV DRUG DISCOV, V18, P197, DOI 10.1038/s41573-018-0007-y; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Hornburg M., 2021, CANCER CELL, V39; Izar B, 2020, NAT MED, V26, P1271, DOI 10.1038/s41591-020-0926-0; Jimenez-Sanchez A, 2020, NAT GENET, V52, P582, DOI 10.1038/s41588-020-0630-5; Jimenez-Sanchez A, 2017, CELL, V170, P927, DOI 10.1016/j.cell.2017.07.025; Leone RD, 2020, NAT REV CANCER, V20, P516, DOI 10.1038/s41568-020-0273-y; Zhang AW, 2018, CELL, V173, P1755, DOI 10.1016/j.cell.2018.03.073; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	10	2	2	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 8	2021	54	6					1107	1109		10.1016/j.immuni.2021.05.014	http://dx.doi.org/10.1016/j.immuni.2021.05.014		JUN 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SP7ZL	34107269	Bronze			2022-12-18	WOS:000659882900005
J	Sorini, C; Villablanca, EJ				Sorini, Chiara; Villablanca, Eduardo J.			ILC damage, and I'll repair it	IMMUNITY			English	Editorial Material								In this issue of Immunity, Wang et al. report that the recognition of lysophosphatidyl serine via the receptor GPR43 confers type 3 innate lymphoid cells with the capacity to sense damage-induced cell death, which in turn triggers interleukin-22-dependent tissue repair.	[Sorini, Chiara; Villablanca, Eduardo J.] Karolinska Inst, Div Immunol & Allergy, Dept Med Solna, S-17176 Stockholm, Sweden; [Sorini, Chiara; Villablanca, Eduardo J.] Univ Hosp Solna, S-17176 Stockholm, Sweden	Karolinska Institutet	Villablanca, EJ (corresponding author), Karolinska Inst, Div Immunol & Allergy, Dept Med Solna, S-17176 Stockholm, Sweden.; Villablanca, EJ (corresponding author), Univ Hosp Solna, S-17176 Stockholm, Sweden.	eduardo.villablanca@ki.se	Sorini, Chiara/M-5837-2015; Villablanca, Eduardo/E-1380-2016	Sorini, Chiara/0000-0002-6803-8377; Villablanca, Eduardo/0000-0001-9522-9729				Makide K, 2014, J LIPID RES, V55, P1986, DOI 10.1194/jlr.R046920; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Ouyang WJ, 2019, IMMUNITY, V50, P871, DOI 10.1016/j.immuni.2019.03.020; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Wang XQ, 2021, IMMUNITY, V54, P1123, DOI 10.1016/j.immuni.2021.05.007; Zou J, 2018, CELL HOST MICROBE, V23, P41, DOI 10.1016/j.chom.2017.11.003	6	2	2	2	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 8	2021	54	6					1097	1099		10.1016/j.immuni.2021.05.015	http://dx.doi.org/10.1016/j.immuni.2021.05.015		JUN 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SP7ZL	34107265	Bronze			2022-12-18	WOS:000659882900001
J	Choi, G; Kim, BS; Chang, JH; Chung, Y				Choi, Garam; Kim, Byung-Seok; Chang, Jae-Hoon; Chung, Yeonseok			Defining the role of transforming growth factor b1 in Foxp3(+) T regulatory cells	IMMUNITY			English	Letter							MICE		[Choi, Garam; Kim, Byung-Seok; Chung, Yeonseok] Seoul Natl Univ, Pharmaceut Sci Res Inst, Coll Pharm, Lab Immune Regulat, Seoul 08826, South Korea; [Kim, Byung-Seok] Incheon Natl Univ, Div Life Sci, Coll Life Sci & Bioengn, Incheon 22012, South Korea; [Chang, Jae-Hoon] Yeungnam Univ, Coll Pharm, Gyongsan 38541, Gyeongbuk, South Korea	Seoul National University (SNU); Incheon National University; Yeungnam University	Chung, Y (corresponding author), Seoul Natl Univ, Pharmaceut Sci Res Inst, Coll Pharm, Lab Immune Regulat, Seoul 08826, South Korea.	yeonseok@snu.ac.kr			National Research Foundation of Korea [2020R1A3B207889011]	National Research Foundation of Korea(National Research Foundation of Korea)	Funding for this study was provided by the National Research Foundation of Korea 2020R1A3B207889011 (Y.C).	Azhar M, 2009, GENESIS, V47, P423, DOI 10.1002/dvg.20516; Gutcher I, 2011, IMMUNITY, V34, P396, DOI 10.1016/j.immuni.2011.03.005; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Turner JA, 2020, IMMUNITY, V53, P1202, DOI [10.1016/j.immuni.2020.10.002, 10.1016/j.immuni.2020.11.011]; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062	10	2	2	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 9	2021	54	3					393	394		10.1016/j.immuni.2021.02.008	http://dx.doi.org/10.1016/j.immuni.2021.02.008		MAR 2021	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RU	33691125				2022-12-18	WOS:000627409300003
J	Cresswell, P				Cresswell, Peter			Nilabh Shastri (1952-2021) Obituary	IMMUNITY			English	Biographical-Item									[Cresswell, Peter] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Yale University	Cresswell, P (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	peter.cresswell@yale.edu							0	2	2	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 9	2021	54	3					389	390		10.1016/j.immuni.2021.02.006	http://dx.doi.org/10.1016/j.immuni.2021.02.006		MAR 2021	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RU	33691123	Bronze			2022-12-18	WOS:000627409300001
J	Nabekura, T; Shibuya, A				Nabekura, Tsukasa; Shibuya, Akira			ILC1: guardians of the oral mucosa against enemy viruses	IMMUNITY			English	Editorial Material							NK CELLS; IL-12	Type 1 innate lymphoid cells (ILC1s) regulate inflammation in the tissues; however, their role in anti-viral immunity remains largely unknown. In this issue of Immunity, Shannon et al. report that ILC1s invoke an antiviral effect by producing interferon (IFN)gamma at homeostasis, thereby limiting viral replication in the oral mucosa.	[Nabekura, Tsukasa; Shibuya, Akira] Univ Tsukuba, Tsukuba Adv Res Alliance, Life Sci Ctr Survival Dynam, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan; [Nabekura, Tsukasa; Shibuya, Akira] Univ Tsukuba, Fac Med, Dept Immunol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan; [Nabekura, Tsukasa; Shibuya, Akira] Univ Tsukuba, R&D Ctr Innovat Drug Discovery, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba	Shibuya, A (corresponding author), Univ Tsukuba, Tsukuba Adv Res Alliance, Life Sci Ctr Survival Dynam, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.; Shibuya, A (corresponding author), Univ Tsukuba, Fac Med, Dept Immunol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.; Shibuya, A (corresponding author), Univ Tsukuba, R&D Ctr Innovat Drug Discovery, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	ashibuya@md.tsukuba.ac.jp						[Anonymous], 2020, IMMUNITY; Huang Ni, 2020, medRxiv, DOI 10.1101/2020.10.26.20219089; Lim AI, 2016, J EXP MED, V213, P569, DOI 10.1084/jem.20151750; Nabekura T, 2021, BIOMED J, V44, P115, DOI 10.1016/j.bj.2020.10.001; Novelli F, 2004, CYTOKINE GROWTH F R, V15, P367, DOI 10.1016/j.cytogfr.2004.03.009; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Seillet C, 2016, CURR TOP MICROBIOL, V395, P37, DOI 10.1007/82_2015_474; Spits H, 2016, NAT IMMUNOL, V17, P758, DOI 10.1038/ni.3482; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Weizman OE, 2017, CELL, V171, P795, DOI 10.1016/j.cell.2017.09.052	10	2	2	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 9	2021	54	2					196	198		10.1016/j.immuni.2021.01.002	http://dx.doi.org/10.1016/j.immuni.2021.01.002		FEB 2021	4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RE	33567258	Green Published, Bronze			2022-12-18	WOS:000627407700003
J	Zheng, LT; Zhang, ZM				Zheng, Liangtao; Zhang, Zemin			Decoding the genetic basis of anti-tumor immunity	IMMUNITY			English	Editorial Material							CELLS	Substantial variations of tumor immune properties exist among cancer patients, but the contributing factors underlying those variations are poorly understood. In this issue of Immunity, Sayaman et al. uncover associations between germline genetic variants and tumor immune properties, revealing candidate causal genes.	[Zheng, Liangtao; Zhang, Zemin] Peking Univ, Peking Tsinghua Ctr Life Sci, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China; [Zhang, Zemin] Peking Univ, BIOPIC, Beijing Adv Innovat Ctr Genom, Sch Life Sci, Beijing 100871, Peoples R China	Peking University; Peking University	Zhang, ZM (corresponding author), Peking Univ, Peking Tsinghua Ctr Life Sci, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China.; Zhang, ZM (corresponding author), Peking Univ, BIOPIC, Beijing Adv Innovat Ctr Genom, Sch Life Sci, Beijing 100871, Peoples R China.	zemin@pku.edu.cn			National Natural Science Foundation of China [81988101, 91742203, 91942307, 31530036]; Beijing Municipal Science and Technology Project of China [Z201100005320014]; Beijing Advanced Innovation Center for Genomics	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Technology Project of China; Beijing Advanced Innovation Center for Genomics	The Zhang laboratory is supported by the National Natural Science Foundation of China (81988101, 91742203, 91942307, and 31530036), the Beijing Municipal Science and Technology Project of China (Z201100005320014), and the Beijing Advanced Innovation Center for Genomics.	Benci JL, 2019, CELL, V178, P933, DOI 10.1016/j.cell.2019.07.019; Hollern DP, 2019, CELL, V179, P1191, DOI 10.1016/j.cell.2019.10.028; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Li HJ, 2019, CELL, V176, P775, DOI 10.1016/j.cell.2018.11.043; Lim YW, 2018, P NATL ACAD SCI USA, V115, pE11701, DOI 10.1073/pnas.1804506115; Sayaman RW, 2021, IMMUNITY, V54, P367, DOI 10.1016/j.immuni.2021.01.011; Shahamatdar S, 2020, CELL REP, V30, P2900, DOI 10.1016/j.celrep.2020.02.039; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Thorsson V, 2019, IMMUNITY, V51, P411, DOI 10.1016/j.immuni.2019.08.004; Zhang YY, 2020, CELL MOL IMMUNOL, V17, P807, DOI 10.1038/s41423-020-0488-6	10	2	2	2	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 9	2021	54	2					199	201		10.1016/j.immuni.2021.01.005	http://dx.doi.org/10.1016/j.immuni.2021.01.005		FEB 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RE	33567259	Bronze			2022-12-18	WOS:000627407700004
J	Brown, H; Esterhazy, D				Brown, Hailey; Esterhazy, Daria			Paying a Price Twice: Dose-Dependent Effects of Treg Cell-Derived TGF-beta on Tolerance	IMMUNITY			English	Editorial Material								Although many immune cells can secrete TGF-beta, whether all sources of TGF-beta are functionally equivalent is unknown. In this issue, Turner et al. uncover the importance of T regulatory (Treg) cell-intrinsic Tgfb1 gene dose in the prevention of autoimmunity and allergic disease.	[Brown, Hailey; Esterhazy, Daria] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Esterhazy, Daria] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Brown, H (corresponding author), Univ Chicago, Comm Immunol, Chicago, IL 60637 USA.	haileybrown@uchicago.edu						Abdel-Gadir A, 2019, NAT MED, V25, P1164, DOI 10.1038/s41591-019-0461-z; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Frischmeyer-Guerrerio PA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006448; Gomez G, 2005, J IMMUNOL, V174, P5987, DOI 10.4049/jimmunol.174.10.5987; Gutcher I, 2011, IMMUNITY, V34, P396, DOI 10.1016/j.immuni.2011.03.005; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Turner JA, 2020, IMMUNITY, V53, P1202, DOI [10.1016/j.immuni.2020.10.002, 10.1016/j.immuni.2020.11.011]	10	2	2	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2020	53	6					1128	1130		10.1016/j.immuni.2020.11.008	http://dx.doi.org/10.1016/j.immuni.2020.11.008			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9JT	33326762	Bronze			2022-12-18	WOS:000599363300003
J	Cleveland, SB; Huseby, ES				Cleveland, Sarah B.; Huseby, Eric S.			Resolving the Instructions for alpha beta T Cell Development	IMMUNITY			English	Editorial Material							CD4; DIFFERENTIATION	In this issue of Immunity, Chopp et. al. use single-cell transcriptomics and epigenomics in mice and human samples to delineate developmental trajectories of alpha beta T cell subsets and refine the kinetic selection model of CD4(+) and CD8(+) T cell lineage commitment.	[Cleveland, Sarah B.; Huseby, Eric S.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Huseby, ES (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA.	eric.huseby@umassmed.edu			UMMS Initiative for Maximizing Student Development [T32 GM135751]; US National Institutes of Health [AI143976, AR071269]	UMMS Initiative for Maximizing Student Development; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	S.B.C. is supported by the UMMS Initiative for Maximizing Student Development (T32 GM135751). E.S.H. is supported by the US National Institutes of Health (AI143976, AR071269).	Chopp LB, 2020, IMMUNITY, V53, P1182, DOI 10.1016/j.immuni.2020.10.024; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Itano A, 2000, IMMUNITY, V12, P383, DOI 10.1016/S1074-7613(00)80190-9; Mingueneau M, 2013, NAT IMMUNOL, V14, P619, DOI 10.1038/ni.2590; Owen DL, 2019, J IMMUNOL, V203, P2031, DOI 10.4049/jimmunol.1900662; Park JE, 2020, SCIENCE, V367, P868, DOI 10.1126/science.aay3224; Park JH, 2010, NAT IMMUNOL, V11, P257, DOI 10.1038/ni.1840; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Taniuchi I, 2018, ANNU REV IMMUNOL, V36, P579, DOI 10.1146/annurev-immunol-042617-053411; Yui MA, 2014, NAT REV IMMUNOL, V14, P529, DOI 10.1038/nri3702	10	2	2	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2020	53	6					1126	1128		10.1016/j.immuni.2020.11.014	http://dx.doi.org/10.1016/j.immuni.2020.11.014			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9JT	33326761	Bronze, Green Accepted			2022-12-18	WOS:000599363300002
J	Knudsen, NH; Manguso, RT				Knudsen, Nelson H.; Manguso, Robert T.			Tumor-Derived PGE2 Gives NK Cells a Headache	IMMUNITY			English	Editorial Material								Tumors use active immunosuppressive mechanisms to evade immune recognition and shape the local inflammatory environment. In this issue of Immunity, Bonavita et al. report that tumor-derived PGE2 blocks early activation of natural killer cells and interferes with subsequent adaptive immune cell recruitment to the tumor.	[Knudsen, Nelson H.; Manguso, Robert T.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; [Knudsen, Nelson H.; Manguso, Robert T.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Manguso, RT (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA.; Manguso, RT (corresponding author), Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA.	rmanguso@broadinstitute.org						Bonavita E, 2020, IMMUNITY, V53, P1215, DOI 10.1016/j.immuni.2020.10.020; Chen JH, 2015, NAT MED, V21, P327, DOI 10.1038/nm.3831; Holt D, 2011, CANCER IMMUNOL IMMUN, V60, P1577, DOI 10.1007/s00262-011-1064-9; Inada M, 2015, J BIOL CHEM, V290, P29781, DOI 10.1074/jbc.M115.669481; LINNEMEYER PA, 1993, J IMMUNOL, V150, P3747; Lopez-Soto A, 2017, CANCER CELL, V32, P135, DOI 10.1016/j.ccell.2017.06.009; O'Sullivan T, 2012, J EXP MED, V209, P1869, DOI 10.1084/jem.20112738; SCHULTZ RM, 1978, SCIENCE, V202, P320, DOI 10.1126/science.694537; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015	9	2	2	2	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2020	53	6					1131	1132		10.1016/j.immuni.2020.11.018	http://dx.doi.org/10.1016/j.immuni.2020.11.018			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9JT	33326763	Bronze			2022-12-18	WOS:000599363300004
J	Chandra, A; Goldman, N; Vahedi, G				Chandra, Aditi; Goldman, Naomi; Vahedi, Golnaz			Foxp3 Re-distributes Its Heavy Lifting	IMMUNITY			English	Editorial Material							REGULATORY T-CELLS	Understanding the mechanisms that establish regulatory T (Treg) cell identity is central to understanding Treg cell function. van der Veeken et al. now show that the lineage-determining transcription factor Foxp3 establishes Treg-cell-specific chromatin architecture indirectly, mostly by decreasing the expression of other transcriptional regulators, including TCF1.	[Chandra, Aditi; Goldman, Naomi; Vahedi, Golnaz] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA; [Chandra, Aditi; Goldman, Naomi; Vahedi, Golnaz] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Chandra, Aditi; Goldman, Naomi; Vahedi, Golnaz] Univ Penn, Epigenet Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Chandra, Aditi; Goldman, Naomi; Vahedi, Golnaz] Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Vahedi, G (corresponding author), Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA.; Vahedi, G (corresponding author), Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA.; Vahedi, G (corresponding author), Univ Penn, Epigenet Inst, Perelman Sch Med, Philadelphia, PA 19104 USA.; Vahedi, G (corresponding author), Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA.	vahedi@pennmedicine.upenn.edu		Chandra, Aditi/0000-0002-2053-163X				[Anonymous], IMMUNITY, V48, P243; Delacher M, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101127; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Samstein RM, 2012, CELL, V150, P29, DOI 10.1016/j.cell.2012.05.031; Scott-Browne JP, 2016, IMMUNITY, V45, P1327, DOI 10.1016/j.immuni.2016.10.028; Skene PJ, 2017, ELIFE, V6, DOI 10.7554/eLife.21856; van der Veeken J, 2020, IMMUNITY, V53, P971, DOI 10.1016/j.immuni.2020.10.010; Xing SJ, 2019, J EXP MED, V216, P847, DOI 10.1084/jem.20182010	8	2	2	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2020	53	5					895	897		10.1016/j.immuni.2020.10.021	http://dx.doi.org/10.1016/j.immuni.2020.10.021			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9ED	33207211	Bronze			2022-12-18	WOS:000599348200001
J	Kinsella, RL; Stallings, CL				Kinsella, Rachel L.; Stallings, Christina L.			A Flexible and Deadly Way to Control Salmonella Infection	IMMUNITY			English	Editorial Material								Although programmed cell death can control intracellular bacterial replication, the role of cell death during systemic Salmonella infection remained elusive. In this issue of Immunity, Doerflinger et al. discover a critical but overlapping role for cell death associated caspases during Salmonella infection.	[Kinsella, Rachel L.; Stallings, Christina L.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Stallings, CL (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	stallings@wustl.edu						[Anonymous], TITLE ERROR, DOI 10.1016/j.bbi.2019.12.019; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Gram AM, 2019, EMBO J, V38, DOI 10.15252/embj.2019102065; Kupz A, 2014, INFECT IMMUN, V82, P4997, DOI 10.1128/IAI.02192-14; Legrand AJ, 2019, MOL CELL, V76, P232, DOI 10.1016/j.molcel.2019.09.006; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Negroni A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/250762	8	2	2	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2020	53	3					471	473		10.1016/j.immuni.2020.08.009	http://dx.doi.org/10.1016/j.immuni.2020.08.009			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NO9KZ	32937145	Bronze			2022-12-18	WOS:000569806100001
J	Chapman, NM; Gottschalk, S; Chi, HB				Chapman, Nicole M.; Gottschalk, Stephen; Chi, Hongbo			Preventing Ubiquitination Improves CAR T Cell Therapy via 'CAR Merry-Go-Around'	IMMUNITY			English	Editorial Material								Chimeric antigen receptor (CAR) T cells are potent drivers of antitumor immunity, but promoting durable CAR T cell responses remains challenging. In this issue of Immunity, Li et al. (2020) show that blockade of CAR ubiquitination induces CAR recycling to the cell surface, leading to increased CAR T cell cytotoxicity and longevity by amplifying 41BB-dependent signaling and mitochondrial metabolism.	[Chapman, Nicole M.; Chi, Hongbo] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Gottschalk, Stephen] St Jude Childrens Res Hosp, Dept Bone Marrow Transplantat & Cellular Therapy, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Chi, HB (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA.; Gottschalk, S (corresponding author), St Jude Childrens Res Hosp, Dept Bone Marrow Transplantat & Cellular Therapy, Memphis, TN 38105 USA.	stephen.gottschalk@stjude.org; hongbo.chi@stjude.org	Chi, Hongbo/M-9397-2018; Keerthi, Dinesh/ABH-1420-2020	Chi, Hongbo/0000-0002-9997-2496; 				Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Chapman NM, 2020, NAT REV IMMUNOL, V20, P55, DOI 10.1038/s41577-019-0203-y; Geltink RIK, 2017, CELL, V171, P385, DOI 10.1016/j.cell.2017.08.018; Li W., 2020, IMMUNITY; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Menk AV, 2018, J EXP MED, V215, P1091, DOI 10.1084/jem.20171068; Rafiq S, 2020, NAT REV CLIN ONCOL, V17, P147, DOI 10.1038/s41571-019-0297-y; Tyrakis PA, 2016, NATURE, V540, P236, DOI 10.1038/nature20165; Wei J, 2019, NATURE, V576, P471, DOI 10.1038/s41586-019-1821-z; Yang CW, 2016, CELL, V164, P141, DOI 10.1016/j.cell.2015.11.052	10	2	2	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2020	53	2					243	245		10.1016/j.immuni.2020.07.023	http://dx.doi.org/10.1016/j.immuni.2020.07.023			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NC4NX	32814023	Bronze			2022-12-18	WOS:000561190600005
J	Hendricks, MR; Savan, R				Hendricks, Matthew R.; Savan, Ram			Interferon-lambda at the Center of the Storm	IMMUNITY			English	Editorial Material							INFECTION	Type I and III interferons (IFNs) drive effective antiviral functions but differentially affect tissue homeostasis. Using mouse models of severe inflammation, Broggi et al. and Major et al. report in Science that type III IFNs disrupt epithelial cell proliferation and differentiation in the lung.	[Hendricks, Matthew R.; Savan, Ram] Univ Washington, Dept Immunol, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle	Savan, R (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98109 USA.	savanram@uw.edu		Savan, Ram/0000-0002-3087-1355				Broggi A, 2020, SCIENCE, V369, P706, DOI 10.1126/science.abc3545; Broggi A, 2017, NAT IMMUNOL, V18, P1084, DOI 10.1038/ni.3821; Forero A, 2019, IMMUNITY, V51, P451, DOI 10.1016/j.immuni.2019.07.007; Galani IE, 2017, IMMUNITY, V46, P875, DOI 10.1016/j.immuni.2017.04.025; Hemann EA, 2019, NAT IMMUNOL, V20, P1035, DOI 10.1038/s41590-019-0408-z; Hemann EA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01707; Klinkhammer J, 2018, ELIFE, V7, DOI 10.7554/eLife.33354; Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304; Major J, 2020, SCIENCE, V369, P712, DOI 10.1126/science.abc2061; McFarland AP, 2014, NAT IMMUNOL, V15, P72, DOI 10.1038/ni.2758; Nice TJ, 2015, SCIENCE, V347, P269, DOI 10.1126/science.1258100; Wells AI, 2018, TRENDS IMMUNOL, V39, P848, DOI 10.1016/j.it.2018.08.008	12	2	2	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2020	53	2					245	247		10.1016/j.immuni.2020.07.024	http://dx.doi.org/10.1016/j.immuni.2020.07.024			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NC4NX	32814024	Green Published, Bronze			2022-12-18	WOS:000561190600006
J	Garcia, PAA; Berger, SL				Garcia, Paula A. Agudelo; Berger, Shelley L.			Genetics Meets Epigenetics in Treg Cells and Autoimmunity	IMMUNITY			English	Editorial Material								Most autoimmunity-associated SNPs in the genome map to noncoding regulatory regions in T cells, but the nature of underlying epigenetic mechanisms and any normal purpose in T cell differentiation remain unclear. In this issue of Immunity, Ohkura et al. establish that crucial SNPs linked to autoimmune disease are enriched in DNA regions of CpG demethylation that govern Treg cell development and function.	[Garcia, Paula A. Agudelo; Berger, Shelley L.] Univ Penn, Epigenet Inst, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Garcia, Paula A. Agudelo; Berger, Shelley L.] Univ Penn, Epigenet Inst, Dept Genet, Philadelphia, PA 19104 USA; [Garcia, Paula A. Agudelo; Berger, Shelley L.] Univ Penn, Dept Biol, Epigenet Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Berger, SL (corresponding author), Univ Penn, Epigenet Inst, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.; Berger, SL (corresponding author), Univ Penn, Epigenet Inst, Dept Genet, Philadelphia, PA 19104 USA.; Berger, SL (corresponding author), Univ Penn, Dept Biol, Epigenet Inst, Philadelphia, PA 19104 USA.	bergers@pennmedicine.upenn.edu			NIH/NCI [R01 CA 78831]	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Work in S.L.B.'s lab receives support from the NIH/NCI R01 CA 78831.	Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Kitagawa Y, 2017, NAT IMMUNOL, V18, P173, DOI 10.1038/ni.3646; Ohkura N, 2020, IMMUNITY, V52, P1119, DOI 10.1016/j.immuni.2020.04.006; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010	7	2	2	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2020	52	6					897	899		10.1016/j.immuni.2020.05.009	http://dx.doi.org/10.1016/j.immuni.2020.05.009			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MA4MT	32553177	Bronze, Green Accepted			2022-12-18	WOS:000541890000005
J	Buechler, MB; Turley, SJ				Buechler, Matthew B.; Turley, Shannon J.			Neutrophils Follow Stromal Omens to Limit Peritoneal Inflammation	IMMUNITY			English	Editorial Material								The omentum, an adipose tissue rich in fat-associated lymphoid clusters in the peritoneal cavity, is associated with immune surveillance and protection against peritoneal contaminants. In this issue of Immunity, Jackson-Jones et al. reveal how omental stromal cells regulate neutrophil trafficking to control peritonitis.	[Buechler, Matthew B.; Turley, Shannon J.] Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA	Roche Holding; Genentech	Turley, SJ (corresponding author), Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA.	turley.shannon@gene.com		Buechler, Matthew/0000-0003-1902-622X				Benezech C, 2015, NAT IMMUNOL, V16, P819, DOI 10.1038/ni.3215; Buechler MB, 2019, IMMUNITY, V51, P119, DOI 10.1016/j.immuni.2019.05.010; Di Nicola V, 2019, REGEN THER, V11, P182, DOI 10.1016/j.reth.2019.07.008; Jackson-Jones LH, 2020, IMMUNITY, V52, P700, DOI 10.1016/j.immuni.2020.03.011; MCLACHLIN AD, 1973, AM J SURG, V125, P134, DOI 10.1016/0002-9610(73)90018-4; Meza-Perez S, 2017, TRENDS IMMUNOL, V38, P526, DOI 10.1016/j.it.2017.03.002; Morison R, 1906, Br Med J, V1, P76; Rangel-Moreno J, 2009, IMMUNITY, V30, P731, DOI 10.1016/j.immuni.2009.03.014; Wang J, 2016, CELL, V165, P668, DOI 10.1016/j.cell.2016.03.009; Zhang N, 2019, J EXP MED, V216, P1291, DOI 10.1084/jem.20182024	10	2	2	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 14	2020	52	4					578	580		10.1016/j.immuni.2020.03.015	http://dx.doi.org/10.1016/j.immuni.2020.03.015			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LE5TM	32294403	Bronze			2022-12-18	WOS:000526782600003
J	Cao, W; Kayama, H; Chen, ML; Delmas, A; Sun, A; Kim, SY; Rangarajan, ES; McKevitt, K; Beck, AP; Jackson, CB; Crynen, G; Oikonomopoulos, A; Lacey, PN; Martinez, GJ; Izard, T; Lorenz, RG; Rodriguez-Palacios, A; Cominelli, F; Abreu, MT; Hommes, DW; Koralov, SB; Takeda, K; Sundrud, MS				Cao, Wei; Kayama, Hisako; Chen, Mei Lan; Delmas, Amber; Sun, Amy; Kim, Sang Yong; Rangarajan, Erumbi S.; McKevitt, Kelly; Beck, Amanda P.; Jackson, Cody B.; Crynen, Gogce; Oikonomopoulos, Angelos; Lacey, Precious N.; Martinez, Gustavo J.; Izard, Tina; Lorenz, Robin G.; Rodriguez-Palacios, Alex; Cominelli, Fabio; Abreu, Maria T.; Hommes, Daniel W.; Koralov, Sergei B.; Takeda, Kiyoshi; Sundrud, Mark S.			The Xenobiotic Transporter Mdr1 Enforces T Cell Homeostasis in the Presence of Intestinal Bile Acids (vol 47, pg 1182, 2017)	IMMUNITY			English	Correction												msundrud@scripps.edu	Jackson, Cody/ACN-5204-2022; Lorenz, Robin G/AAJ-1499-2021	Jackson, Cody/0000-0002-0686-9423; Lorenz, Robin G/0000-0002-2514-9819; Koralov, Sergei/0000-0002-4843-3791; Kim, Sang Yong/0000-0001-7326-7505; Crynen, Gogce/0000-0001-6066-9900	NIAID NIH HHS [R21 AI119728, R01 AI143821] Funding Source: Medline; NIDDK NIH HHS [R01 DK055812] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Cao W, 2017, IMMUNITY, V47, P1182, DOI 10.1016/j.immuni.2017.11.012	1	2	2	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2020	52	3					571	571						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KV6NX	32187521	Bronze, Green Accepted			2022-12-18	WOS:000520600200017
J	Fung, C; Howitt, MR				Fung, Connie; Howitt, Michael R.			A Tuft Act to Follow: Leukotrienes Take the Stage in Anti-worm Immunity	IMMUNITY			English	Editorial Material							CELLS	Tuft cells are specialized taste-chemosensory cells that detect the presence of intestinal parasites and orchestrate type 2 immunity. In this issue of Immunity, McGinty et al. discover that parasitic worms, but not commensal protists, stimulate tuft cells to release cysteinyl leukotrienes to amplify anti-helminth immunity in the small intestine.	[Fung, Connie; Howitt, Michael R.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Stanford University	Howitt, MR (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	mhowitt@stanford.edu		Fung, Connie/0000-0003-1693-5719	Stanford School of Medicine Dean's Postdoctoral Fellowship; Jacob Churg Award; National Institutes of Health (NIH) [K01DK113041]	Stanford School of Medicine Dean's Postdoctoral Fellowship; Jacob Churg Award; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Thank you to the Howitt lab for helping brainstorm many terrible puns for the title of this preview. This work was supported by the Stanford School of Medicine Dean's Postdoctoral Fellowship (to C.F.), the Jacob Churg Award (to M.R.H.) and the National Institutes of Health (NIH) K01DK113041 (to M.R.H.).	Bezencon C, 2008, J COMP NEUROL, V509, P514, DOI 10.1002/cne.21768; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Haber AL, 2017, NATURE, V551, P333, DOI 10.1038/nature24489; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; McGinty JW, 2020, IMMUNITY, V52, P528, DOI 10.1016/j.immuni.2020.02.005; Nadjsombati MS, 2018, IMMUNITY, V49, P33, DOI 10.1016/j.immuni.2018.06.016; Schneider C, 2018, CELL, V174, P271, DOI 10.1016/j.cell.2018.05.014; Ualiyeva S, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aax7224; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161	9	2	2	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2020	52	3					426	428		10.1016/j.immuni.2020.02.011	http://dx.doi.org/10.1016/j.immuni.2020.02.011			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KV6NX	32187512	Bronze			2022-12-18	WOS:000520600200004
J	Hammad, H; Lambrecht, BN				Hammad, Hamida; Lambrecht, Bart N.			Rbm7 in Structural Cells: A NEAT Way to Control Fibrosis	IMMUNITY			English	Editorial Material								The initial molecular events and the cell type(s) responsible for the development of fibrosis are unclear. Fukushima, Satoh, et al. find that increased expression of the nuclear exosome targeting complex component Rbm7 in lung epithelial cells promotes the degradation of the long non-coding RNA NEAT1, impairs DNA repair, and triggers apoptosis. Dying epithelial cells release chemokines that recruit atypical monocytes, which drive tissue fibrosis.	[Hammad, Hamida; Lambrecht, Bart N.] VIB, Ctr Inflammat Res, Lab Mucosal Immunol & Immunoregulat, Ghent, Belgium; [Hammad, Hamida; Lambrecht, Bart N.] Univ Ghent, Dept Internal Med & Pediat, Ghent, Belgium; [Lambrecht, Bart N.] Erasmus MC, Dept Pulm Med, Rotterdam, Netherlands	Flanders Institute for Biotechnology (VIB); Ghent University; Erasmus University Rotterdam; Erasmus MC	Hammad, H (corresponding author), VIB, Ctr Inflammat Res, Lab Mucosal Immunol & Immunoregulat, Ghent, Belgium.; Hammad, H (corresponding author), Univ Ghent, Dept Internal Med & Pediat, Ghent, Belgium.	hamida.hammad@ugent.be	Lambrecht, Bart N/K-2484-2014	Lambrecht, Bart N/0000-0003-4376-6834				Adriaens C, 2016, NAT MED, V22, P861, DOI 10.1038/nm.4135; Fukushima K, 2020, IMMUNITY, V52, P542, DOI 10.1016/j.immuni.2020.02.007; Gibbons MA, 2011, AM J RESP CRIT CARE, V184, P569, DOI 10.1164/rccm.201010-1719OC; Griffiths K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20811-5; Kim KK, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1074-z; Lee JM, 2018, AM J RESP CELL MOL, V59, P215, DOI 10.1165/rcmb.2017-0034OC; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Reyfman PA, 2019, AM J RESP CRIT CARE, V199, P1517, DOI 10.1164/rccm.201712-2410OC; Satoh T, 2017, NATURE, V541, P96, DOI 10.1038/nature20611; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015	10	2	2	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2020	52	3					429	431		10.1016/j.immuni.2020.02.008	http://dx.doi.org/10.1016/j.immuni.2020.02.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KV6NX	32187513	Bronze			2022-12-18	WOS:000520600200005
J	Jensen, IJ; McGonagill, PW; Lefebvre, MN; Griffith, TS; Harty, JT; Badovinac, VP				Jensen, Isaac J. .; McGonagill, Patrick W.; Lefebvre, Mitchell N.; Griffith, Thomas S.; Harty, John T.; Badovinac, Vladimir P.			Worry and FRET: ROS Production Leads to Fluorochrome Tandem Degradation and impairs Interpretation of Flow Cytometric Results	IMMUNITY			English	Letter							DYES		[Harty, John T.; Badovinac, Vladimir P.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Harty, John T.; Badovinac, Vladimir P.] Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA 52242 USA; [McGonagill, Patrick W.] Univ Iowa, Dept Surg, Iowa City, IA 52242 USA; [Jensen, Isaac J. .; Lefebvre, Mitchell N.; Harty, John T.; Badovinac, Vladimir P.] Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA; [Griffith, Thomas S.] Univ Minnesota, Dept Urol, Minneapolis, MN USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Minnesota System; University of Minnesota Twin Cities	Badovinac, VP (corresponding author), Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA.; Badovinac, VP (corresponding author), Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA 52242 USA.; Badovinac, VP (corresponding author), Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA.	vladimir-badovinac@uiowa.edu	Griffith, Thomas/ABF-8225-2020	McGonagill, Patrick/0000-0001-8308-127X; LeFebvre, Mitchell/0000-0002-7641-7043; Badovinac, Vladimir/0000-0003-3180-2439; Jensen, Isaac/0000-0002-3107-3961	NIH [AI147064, GM113961, GM134880, AI114543, AI42767, AI85515, AI100527, GM115462, T32AI007511, T32AI007485]; Veterans Health Administration [I01BX001324]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Health Administration(US Department of Veterans Affairs)	Funding for this study was provided by NIH grants AI147064, GM113961, and GM134880 (V.P.B.); AI114543 (J.T.H. and V.P.B.); AI42767, AI85515, and AI100527 (J.T.H.); GM115462 (T.S.G.); and T32AI007511 and T32AI007485 to I. J.J. and Veterans Health Administration I01BX001324 to T.S.G.	Gerstner AOH, 2002, CYTOMETRY, V48, P115, DOI 10.1002/cyto.10119; Jensen IJ, 2018, J IMMUNOL, V200, P1543, DOI 10.4049/jimmunol.1701618; Le Roy C, 2009, CYTOM PART A, V75A, P882, DOI 10.1002/cyto.a.20774; Maecker HT, 2004, CYTOM PART A, V62A, P169, DOI 10.1002/cyto.a.20092; Morawski Peter A, 2019, Immunohorizons, V3, P585, DOI 10.4049/immunohorizons.1900080; Paredes RM, 2018, J IMMUNOL METHODS, V452, P32, DOI 10.1016/j.jim.2017.08.013; Postma NS, 1996, PHARM WORLD SCI, V18, P121, DOI 10.1007/BF00717727; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7	8	2	2	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2020	52	3					419	421		10.1016/j.immuni.2020.02.003	http://dx.doi.org/10.1016/j.immuni.2020.02.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KV6NX	32187510	Bronze, Green Accepted			2022-12-18	WOS:000520600200001
J	Zhou, L; Sonnenberg, GF				Zhou, Lei; Sonnenberg, Gregory F.			In Situ Support of ILC Precursors	IMMUNITY			English	Editorial Material								Innate lymphoid cells (ILCs) are tissue-resident lymphocytes that promote immunity to pathogens at mucosal barriers, but the mechanisms regulating their development within tissues remain poorly understood. In this issue of Immunity, Oherle et al. identify a niche in the neonatal airway where stromal cell-derived insulin-like growth factor 1 (IGF1) supports the proliferation of ILC precursors and protects from infection.	[Zhou, Lei; Sonnenberg, Gregory F.] Cornell Univ, Joan & Sanford I Weill Dept Med, Div Gastroenterol, Weill Cornell Med, New York, NY 10021 USA; [Zhou, Lei; Sonnenberg, Gregory F.] Cornell Univ, Dept Microbiol & Immunol, Weill Cornell Med, New York, NY 10021 USA; [Zhou, Lei; Sonnenberg, Gregory F.] Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Weill Cornell Med, New York, NY 10021 USA	Cornell University; Cornell University; Cornell University	Sonnenberg, GF (corresponding author), Cornell Univ, Joan & Sanford I Weill Dept Med, Div Gastroenterol, Weill Cornell Med, New York, NY 10021 USA.; Sonnenberg, GF (corresponding author), Cornell Univ, Dept Microbiol & Immunol, Weill Cornell Med, New York, NY 10021 USA.; Sonnenberg, GF (corresponding author), Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Weill Cornell Med, New York, NY 10021 USA.	gfsonnenberg@med.cornell.edu			Crohn's and Colitis Foundation fellowship [608975]; National Institutes of Health (NIH) [R01AI143842, R01AI123368, R01AI145989, R21CA249274, U01AI095608]; NIAID Mucosal Immunology Studies Team (MIST); Searle Scholars Program; American Asthma Foundation Scholar Award; Burroughs Wellcome Fund; Wade F.B. Thompson/Cancer Research Institute (CRI) CLIP Investigator grant; Meyer Cancer Center Collaborative Research Initiative; Roberts Institute for Research in IBD	Crohn's and Colitis Foundation fellowship; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID Mucosal Immunology Studies Team (MIST); Searle Scholars Program; American Asthma Foundation Scholar Award; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Wade F.B. Thompson/Cancer Research Institute (CRI) CLIP Investigator grant; Meyer Cancer Center Collaborative Research Initiative; Roberts Institute for Research in IBD	Research in the Sonnenberg Laboratory is supported by a Crohn's and Colitis Foundation fellowship to L.Z. (608975), the National Institutes of Health (NIH) to G.F.S. (R01AI143842, R01AI123368, R01AI145989, R21CA249274, and U01AI095608), the NIAID Mucosal Immunology Studies Team (MIST), the Searle Scholars Program, the American Asthma Foundation Scholar Award, an Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund, a Wade F.B. Thompson/Cancer Research Institute (CRI) CLIP Investigator grant, the Meyer Cancer Center Collaborative Research Initiative, Linda and Glenn Greenberg, and the Roberts Institute for Research in IBD. G.F.S. is a CRI Lloyd J. Old STAR.	Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Dahlgren MW, 2019, IMMUNITY, V50, P707, DOI 10.1016/j.immuni.2019.02.002; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Oherle K., 2020, DEV NEWBORN LUNGS IM, V52, P275; Sonnenberg GE, 2019, NAT REV IMMUNOL, V19, P599, DOI 10.1038/s41577-019-0194-8; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Torow N, 2017, J IMMUNOL, V198, P557, DOI 10.4049/jimmunol.1601253; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Zuklys S, 2016, NAT IMMUNOL, V17, P1206, DOI 10.1038/ni.3537	10	2	2	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 18	2020	52	2					207	209		10.1016/j.immuni.2020.01.011	http://dx.doi.org/10.1016/j.immuni.2020.01.011			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN8FZ	32075721	Bronze			2022-12-18	WOS:000515082000002
J	del Fresno, C; Sancho, D				del Fresno, Carlos; Sancho, David			Clec2d Joins the Cell Death Sensor Ranks	IMMUNITY			English	Editorial Material							OSTEOCLAST INHIBITORY LECTIN; FAMILY	Sensing tissue damage is an ancient function of immune cells that is central to the regulation of inflammation, tissue repair, and immunity. In this issue of Immunity, Lai et al. (2020) uncover a role for the C-type lectin receptor Clec2d as a sensor of cell death, which directly detects histones released during necrosis and thus contributes to inflammation and immunopathology.	[del Fresno, Carlos; Sancho, David] Ctr Nacl Invest Cardiovasc Carlos III CNIC, Immunobiol Lab, Madrid 28029, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Sancho, D (corresponding author), Ctr Nacl Invest Cardiovasc Carlos III CNIC, Immunobiol Lab, Madrid 28029, Spain.	dsancho@cnic.es	Sancho, David/D-3433-2009; Del Fresno, Carlos/ABD-7766-2020; Del Fresno Sánchez, CArlos/AAY-1525-2021	Sancho, David/0000-0003-2890-3984; Del Fresno, Carlos/0000-0003-1771-7254; 	AECC Foundation [INVES192DELF]; European Research Council (ERC) [725091]; European Commission [635122-PROCROP H2020]; Ministerio de Ciencia, Innovacion e Universidades (MICINN); Agencia Estatal de Investigacion; Fondo Europeo de Desarrollo Regional (FEDER) [SAF2016-79040-R]; Comunidad de Madrid [B2017/BMD-3733 Immunothercan-CM]; FIS-Instituto de Salud Carlos III; FEDER [RD16/0015/0018-REEM]; Acteria Foundation; Fundacio La Marato de TV3 [201723]; Instituto de Salud Carlos III (ISCIII); MICINN; Pro CNIC Foundation; Severo Ochoa Center of Excellence [SEV-2015-0505]; CNIC; Atresmedia	AECC Foundation; European Research Council (ERC)(European Research Council (ERC)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Ministerio de Ciencia, Innovacion e Universidades (MICINN); Agencia Estatal de Investigacion; Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); Comunidad de Madrid(Comunidad de Madrid); FIS-Instituto de Salud Carlos III(Instituto de Salud Carlos III); FEDER(European Commission); Acteria Foundation; Fundacio La Marato de TV3; Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Pro CNIC Foundation; Severo Ochoa Center of Excellence(Spanish Government); CNIC; Atresmedia	C.d.F. is supported by the AECC Foundation (INVES192DELF). Work in the DS laboratory is funded by the CNIC; the European Research Council (ERC 2016 Consolidator Grant 725091); the European Commission (635122-PROCROP H2020); Ministerio de Ciencia, Innovacion e Universidades (MICINN), Agencia Estatal de Investigacio n, and Fondo Europeo de Desarrollo Regional (FEDER) (SAF2016-79040-R); Comunidad de Madrid (B2017/BMD-3733 Immunothercan-CM); FIS-Instituto de Salud Carlos III, MICINN, and FEDER (RD16/0015/0018-REEM); the Acteria Foundation; Atresmedia (Constantes y Vitales prize); and Fundacio La Marato de TV3 (201723). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the MICINN, and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (SEV-2015-0505).	Gange CT, 2004, J BIOL CHEM, V279, P29043, DOI 10.1074/jbc.M312518200; Iizuka K, 2003, NAT IMMUNOL, V4, P801, DOI 10.1038/ni954; Kartsogiannis V, 2008, J BIOL CHEM, V283, P30850, DOI 10.1074/jbc.M801761200; Krenkel Oliver, 2014, Hepatobiliary Surg Nutr, V3, P331, DOI 10.3978/j.issn.2304-3881.2014.11.01; Lai JJ, 2020, IMMUNITY, V52, P123, DOI 10.1016/j.immuni.2019.11.013; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Silk E, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.52; Watson K, 1999, J BIOL CHEM, V274, P21707, DOI 10.1074/jbc.274.31.21707; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Zhou H, 2002, J BIOL CHEM, V277, P48808, DOI 10.1074/jbc.M209059200	10	2	2	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 14	2020	52	1					6	8		10.1016/j.immuni.2019.12.015	http://dx.doi.org/10.1016/j.immuni.2019.12.015			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KC7WX	31951550	Bronze			2022-12-18	WOS:000507384600003
J	Goto, A; Okado, K; Martins, N; Cai, H; Barbier, V; Lamiable, O; Troxler, L; Santiago, E; Kuhn, L; Paik, D; Silverman, N; Holleufer, A; Hartmann, R; Liu, JY; Peng, T; Hoffmann, JA; Meignin, C; Daeffler, L; Imler, JL				Goto, Akira; Okado, Kiyoshi; Martins, Nelson; Cai, Hua; Barbier, Vincent; Lamiable, Olivier; Troxler, Laurent; Santiago, Estelle; Kuhn, Lauriane; Paik, Donggi; Silverman, Neal; Holleufer, Andreas; Hartmann, Rune; Liu, Jiyong; Peng, Tao; Hoffmann, Jules A.; Meignin, Carine; Daeffler, Laurent; Imler, Jean-Luc			The Kinase IKK beta Regulates a STING- and NF-kappa B-Dependent Antiviral Response Pathway in Drosophila (vol 49, pg 225.e1, 2018)	IMMUNITY			English	Correction												goto@unistra.fr; jl.imler@unistra.fr	Daeffler, Laurent/S-6395-2019; Imler, Jean-Luc/GXH-4323-2022					Goto A, 2018, IMMUNITY, V49, P225, DOI 10.1016/j.immuni.2018.07.013	1	2	2	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 14	2020	52	1					200	200		10.1016/j.immuni.2019.12.009	http://dx.doi.org/10.1016/j.immuni.2019.12.009			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KC7WX	31940269	Bronze, Green Accepted, Green Submitted			2022-12-18	WOS:000507384600018
J	Zhou, W; Rothenberg, EV				Zhou, Wen; Rothenberg, Ellen V.			Building a Human Thymus: A Pointillist View	IMMUNITY			English	Editorial Material								In this issue of Immunity, Zeng et al. use single-cell RNA sequencing analyses of rare samples to shed light on the emergence of thymic stromal cell types, the first developing T lymphocytes, and their possible pre-thymic precursors in the early human fetus.	[Zhou, Wen; Rothenberg, Ellen V.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	California Institute of Technology	Rothenberg, EV (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	evroth@its.caltech.edu			US Public Health Service [R01 HD076915, R01 HL119102, R01 HD100039]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD100039, R01HD076915] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119102] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Relevant work in the Rothenberg group has been supported by grants from the US Public Health Service: R01 HD076915, R01 HL119102, and R01 HD100039.	Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Belyaev NN, 2012, IMMUNOGENETICS, V64, P591, DOI 10.1007/s00251-012-0620-6; Bornstein C, 2018, NATURE, V559, P622, DOI 10.1038/s41586-018-0346-1; Ha VL, 2017, LEUKEMIA, V31, P2503, DOI 10.1038/leu.2017.70; Kernfeld EM, 2018, IMMUNITY, V48, P1258, DOI 10.1016/j.immuni.2018.04.015; Ramond C, 2014, NAT IMMUNOL, V15, P27, DOI 10.1038/ni.2782; Wada H, 2008, NATURE, V452, P768, DOI 10.1038/nature06839; Yui MA, 2014, NAT REV IMMUNOL, V14, P529, DOI 10.1038/nri3702; Zeng Y, 2019, IMMUNITY, V51, P930, DOI 10.1016/j.immuni.2019.09.008; Zhou W, 2019, CELL SYST, V9, P321, DOI 10.1016/j.cels.2019.09.008	10	2	2	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 19	2019	51	5					788	790		10.1016/j.immuni.2019.10.003	http://dx.doi.org/10.1016/j.immuni.2019.10.003			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JO8FW	31747579	Green Accepted, Bronze			2022-12-18	WOS:000497811300004
J	Limjunyawong, N; Dong, XZ				Limjunyawong, Nathachit; Dong, Xinzhong			Spicy Immunity: Pain to Gain	IMMUNITY			English	Editorial Material							SENSORY NEURONS	The skin is densely innervated with nociceptive neurons specialized in detecting noxious and painful stimuli. In a recent issue of Cell, Cohen et al. report that activation of cutaneous nociceptive neurons leads to a nervereflex action that is sufficient to provide a danger signal that triggers regional immunity to fight a microbial challenge.	[Limjunyawong, Nathachit; Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Dong, XZ (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.; Dong, XZ (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA.	xdong2@jhmi.edu	Limjunyawong, Nathachit/GVS-1517-2022	Limjunyawong, Nathachit/0000-0002-9540-6171	NIH [R01NS054791]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054791] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Alan Scott and Dr. Dustin Green for editing and comments on the draft. X.D. is an investigator with the Howard Hughes Medical Institute. This work was supported by NIH R01NS054791.	Assas BM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00023; Baral P, 2018, NAT MED, V24, P417, DOI 10.1038/nm.4501; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Cohen JA, 2019, CELL, V178, P919, DOI 10.1016/j.cell.2019.06.022; Green DP, 2019, NEURON, V101, P412, DOI 10.1016/j.neuron.2019.01.012; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Kashem SW, 2015, IMMUNITY, V43, P515, DOI 10.1016/j.immuni.2015.08.016; Meixiong J, 2019, IMMUNITY, V50, P1163, DOI 10.1016/j.immuni.2019.03.013	8	2	2	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 17	2019	51	3					426	428		10.1016/j.immuni.2019.08.014	http://dx.doi.org/10.1016/j.immuni.2019.08.014			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY1XI	31533055	Bronze			2022-12-18	WOS:000486184600006
J	O'Neil, LJ; Kaplan, MJ				O'Neil, Liam J.; Kaplan, Mariana J.			NETched in Stone	IMMUNITY			English	Editorial Material							NEUTROPHIL EXTRACELLULAR TRAPS	Gallstone formation in adults is a common, yet incompletely understood disease process. In this issue, Munoz et al. (2019) report a pathogenic link between neutrophil extracellular traps (NETs) and the formation of gallstones.	[O'Neil, Liam J.; Kaplan, Mariana J.] NIAMSD, Syst Autoimmun Branch, Intramural Res Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Kaplan, MJ (corresponding author), NIAMSD, Syst Autoimmun Branch, Intramural Res Program, NIH, Bethesda, MD 20892 USA.	mariana.kaplan@nih.gov						Albrengues J, 2018, SCIENCE, V361, P1353, DOI 10.1126/science.aao4227; Blazkova J, 2017, J IMMUNOL, V198, P2479, DOI 10.4049/jimmunol.1601855; Chatfield SM, 2018, J IMMUNOL, V200, P1802, DOI 10.4049/jimmunol.1701382; Cho SK, 2018, BMC GASTROENTEROL, V18, DOI 10.1186/s12876-018-0748-4; Eruslanov EB, 2017, TRENDS CANCER, V3, P149, DOI 10.1016/j.trecan.2016.12.006; Gupta S, 2016, NAT REV NEPHROL, V12, P402, DOI 10.1038/nrneph.2016.71; Leppkes M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10973; Munoz LE, 2019, IMMUNITY, V51, P443, DOI 10.1016/j.immuni.2019.07.002; Shaffer EA, 2006, BEST PRACT RES CL GA, V20, P981, DOI 10.1016/j.bpg.2006.05.004; Warnatsch A, 2015, SCIENCE, V349, P316, DOI 10.1126/science.aaa8064	10	2	3	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 17	2019	51	3					413	414		10.1016/j.immuni.2019.08.015	http://dx.doi.org/10.1016/j.immuni.2019.08.015			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY1XI	31533050	Bronze			2022-12-18	WOS:000486184600001
J	Ji, LL; Hu, XY				Ji, Liangliang; Hu, Xiaoyu			Sweet Memories of 8 Empowered by Butyrate	IMMUNITY			English	Editorial Material							MICROBIOTA	Formation of memory T cells is coupled with changes of metabolic status, yet how environmental metabolites affect the transition remains largely unknown. In this issue of Immunity, Bachem et al. (2019) report that microbiota- derived butyrate enhances the memory potential of CD8(+) T cells via rewiring cellular metabolism.	[Ji, Liangliang; Hu, Xiaoyu] Tsinghua Univ, Inst Immunol, Beijing 100084, Peoples R China; [Ji, Liangliang; Hu, Xiaoyu] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Ji, Liangliang; Hu, Xiaoyu] Beijing Key Lab Immunol Res Chron Dis, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Hu, XY (corresponding author), Tsinghua Univ, Inst Immunol, Beijing 100084, Peoples R China.; Hu, XY (corresponding author), Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China.; Hu, XY (corresponding author), Beijing Key Lab Immunol Res Chron Dis, Beijing 100084, Peoples R China.	xiaoyuhu@tsinghua.edu.cn	Hu, Xiaoyu/D-5403-2017	Hu, Xiaoyu/0000-0002-4289-6998; Ji, Liangliang/0000-0001-8572-315X				Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Hand TW, 2012, SCIENCE, V337, P1553, DOI 10.1126/science.1220961; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Schulthess J, 2019, IMMUNITY, V50, P432, DOI 10.1016/j.immuni.2018.12.018; Tanaka K, 2007, J IMMUNOL, V178, P5209, DOI 10.4049/jimmunol.178.8.5209	9	2	2	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 20	2019	51	2					201	203		10.1016/j.immuni.2019.07.005	http://dx.doi.org/10.1016/j.immuni.2019.07.005			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS3XX	31433964	Bronze			2022-12-18	WOS:000482088500002
J	Thomson, CA; McCoy, KD				Thomson, Carolyn A.; McCoy, Kathy D.			Not All Lymph Nodes Are Created Equal	IMMUNITY			English	Editorial Material							T-CELLS	Appropriate priming of tolerogenic or effector immune responses is crucial for intestinal homeostasis. Recently in Nature, Esterhazy et al. (2019) reveal how compartmentalization of lymphatic drainage to functionally distinct lymph nodes facilitates the simultaneous induction of tolerogenic and effector responses.	[Thomson, Carolyn A.; McCoy, Kathy D.] Univ Calgary, Dept Physiol & Pharmacol, Snyder Inst Chron Dis, Cumming Sch Med, Calgary, AB, Canada	University of Calgary	McCoy, KD (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Snyder Inst Chron Dis, Cumming Sch Med, Calgary, AB, Canada.	kathy.mccoy@ucalgary.ca	McCoy, Kathy/ABD-5814-2021					Ahrendt M, 2008, J IMMUNOL, V181, P1898, DOI 10.4049/jimmunol.181.3.1898; CARTER PB, 1974, J EXP MED, V139, P1189, DOI 10.1084/jem.139.5.1189; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Esterhazy D, 2019, NATURE, V569, P126, DOI 10.1038/s41586-019-1125-3; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Hammerschmidt SI, 2008, J EXP MED, V205, P2483, DOI 10.1084/jem.20080039; Houston SA, 2016, MUCOSAL IMMUNOL, V9, P468, DOI 10.1038/mi.2015.77; TILNEY NL, 1971, J ANAT, V109, P369; Veenbergen S, 2016, MUCOSAL IMMUNOL, V9, P894, DOI 10.1038/mi.2015.118; Zhang ZD, 2016, IMMUNITY, V44, P330, DOI 10.1016/j.immuni.2016.01.004	10	2	2	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 16	2019	51	1					12	14		10.1016/j.immuni.2019.06.018	http://dx.doi.org/10.1016/j.immuni.2019.06.018			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	II9ZW	31315030	Bronze			2022-12-18	WOS:000475561000006
J	Bennett, L; Mumau, M; Speck, NA				Bennett, Laura; Mumau, Melanie; Speck, Nancy A.			Macrophages Fertilize the Soil to Promote Hematopoietic Cell Growth	IMMUNITY			English	Editorial Material							STEM	Inflammatory signals support the birth of hematopoietic stem cells in zebrafish embryos, but their cellular source in mammals is not known. In this issue, Mariani et al. (2019) report that macrophages are a primary source of pro-inflammatory signals that promote blood cell formation in mammalian embryos.	[Bennett, Laura; Mumau, Melanie; Speck, Nancy A.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Speck, NA (corresponding author), Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	nancyas@upenn.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007439] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL007439, R01 HL091724] Funding Source: Medline; NIDDK NIH HHS [T32 DK007780] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; Espin-Palazon R, 2014, CELL, V159, P1070, DOI 10.1016/j.cell.2014.10.031; Ley K, 2017, J IMMUNOL, V199, P2191, DOI 10.4049/jimmunol.1701135; Li Y, 2014, GENE DEV, V28, P2597, DOI 10.1101/gad.253302.114; Mariani S. A, 2019, IMMUNITY, P1439; Palis J, 2017, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00669; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Sawamiphak S, 2014, DEV CELL, V31, P640, DOI 10.1016/j.devcel.2014.11.007; Travnickova J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7227; Yokomizo T, 2010, DEVELOPMENT, V137, P3651, DOI 10.1242/dev.051094	10	2	2	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 18	2019	50	6					1342	1344		10.1016/j.immuni.2019.05.017	http://dx.doi.org/10.1016/j.immuni.2019.05.017			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7PZ	31216456	Bronze, Green Accepted			2022-12-18	WOS:000471876100004
J	Iram, T; Keller, A; Wyss-Coray, T				Iram, Tal; Keller, Andreas; Wyss-Coray, Tony			An 80,000-Piece Puzzle of Alzheimer's Disease	IMMUNITY			English	Editorial Material								To gain unfettered insight into one of the scourges of our aging societies, Mathys and colleagues in Nature (Mathys et al., 2019) illuminate the brain transcriptome of Alzheimer's disease at single-cell resolution. Their findings implicate oligodendrocytes, a cell type largely neglected in Alzheimer's disease research, and sex in the disease in intriguing ways.	[Iram, Tal; Keller, Andreas; Wyss-Coray, Tony] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Keller, Andreas] Saarland Univ, Clin Bioinformat, Saarbrucken, Germany; [Wyss-Coray, Tony] Vet Adm Palo Alto Healthcare Syst, Palo Alto, CA 94304 USA; [Wyss-Coray, Tony] Stanford Univ, Sch Med, Paul F Glenn Ctr Biol Aging, Stanford, CA 94305 USA; [Iram, Tal; Wyss-Coray, Tony] Stanford Univ, Wu Tsai Neurosci Inst, Stanford, CA 94305 USA	Stanford University; Saarland University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University	Wyss-Coray, T (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.; Wyss-Coray, T (corresponding author), Vet Adm Palo Alto Healthcare Syst, Palo Alto, CA 94304 USA.; Wyss-Coray, T (corresponding author), Stanford Univ, Sch Med, Paul F Glenn Ctr Biol Aging, Stanford, CA 94305 USA.; Wyss-Coray, T (corresponding author), Stanford Univ, Wu Tsai Neurosci Inst, Stanford, CA 94305 USA.	twc@stanford.edu	Iram, Tal/GSE-3876-2022; Keller, Andreas/ABB-6412-2021; Wyss-Coray, Tony/AAF-3380-2019	Keller, Andreas/0000-0002-5361-0895; Wyss-Coray, Tony/0000-0001-5893-0831				Bartzokis G, 2003, ARCH NEUROL-CHICAGO, V60, P393, DOI 10.1001/archneur.60.3.393; Bartzokis G, 2011, NEUROBIOL AGING, V32, P1341, DOI 10.1016/j.neurobiolaging.2009.08.007; Habib N, 2017, NAT METHODS, V14, P955, DOI [10.1038/NMETH.4407, 10.1038/nmeth.4407]; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Mathys H, 2019, NATURE, V570, P332, DOI 10.1038/s41586-019-1195-2; Mathys H, 2017, CELL REP, V21, P366, DOI 10.1016/j.celrep.2017.09.039; Mot AI, 2018, DIALOGUES CLIN NEURO, V20, P283, DOI 10.31887/DCNS.2018.20.4/knave; Olah M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02926-5; von Bartheld CS, 2016, J COMP NEUROL, V524, P3865, DOI 10.1002/cne.24040	9	2	2	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 18	2019	50	6					1349	1351		10.1016/j.immuni.2019.05.016	http://dx.doi.org/10.1016/j.immuni.2019.05.016			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7PZ	31216459	Bronze			2022-12-18	WOS:000471876100007
J	Lin, JB; Apte, RS				Lin, Jonathan B.; Apte, Rajendra S.			Visualizing the Heterogeneity of Retinal Microglia	IMMUNITY			English	Editorial Material							PHOTORECEPTOR DEGENERATION; PHAGOCYTOSIS; ACTIVATION; FATE	In this issue of Immunity, O'Koren et al. (2019) report that murine retinal microglia are long lived and are divided into two spatially and functionally distinct niches in the retina. In models of retinal neurodegeneration, retinal microglia migrate to the subretinal space, an inducible disease-associated niche, where they are neuroprotective.	[Lin, Jonathan B.; Apte, Rajendra S.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Apte, Rajendra S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Apte, Rajendra S.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Apte, RS (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.; Apte, RS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Apte, RS (corresponding author), Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63130 USA.	apte@wustl.edu			NIH [R01 EY019287, R21 EY026707, P30 EY002687, T32 GM007200, UL1 TR002345, TL1 TR002344]; Jeffrey Fort Innovation Fund; Starr Foundation; Research to Prevent Blindness; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002345, TL1TR002344] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY026707, R01EY019287, P30EY002687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007200] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jeffrey Fort Innovation Fund; Starr Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants R01 EY019287, R21 EY026707, and P30 EY002687; the Jeffrey Fort Innovation Fund; the Starr Foundation; and an unrestricted grant from Research to Prevent Blindness to the Department of Ophthalmology & Visual Sciences of Washington University School of Medicine. J.B.L. was supported by NIH grants T32 GM007200, UL1 TR002345, and TL1 TR002344. The authors thank Danyel Cavazos for help with scientific illustration.	Eandi CM, 2016, ELIFE, V5, DOI 10.7554/eLife.16490; Kelly J, 2007, J CLIN INVEST, V117, P3421, DOI 10.1172/JCI32430; Lin JB, 2018, EBIOMEDICINE, V32, P9, DOI 10.1016/j.ebiom.2018.05.035; Lin JB, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120157; Ma WX, 2013, NEUROBIOL AGING, V34, P2310, DOI 10.1016/j.neurobiolaging.2013.03.022; O'Koren EG, 2016, SCI REP-UK, V6, DOI 10.1038/srep20636; O'Koren EG, 2019, IMMUNITY, V50, P723, DOI 10.1016/j.immuni.2019.02.007; Sennlaub F, 2013, EMBO MOL MED, V5, P1775, DOI 10.1002/emmm.201302692; Zabel MK, 2016, GLIA, V64, P1479, DOI 10.1002/glia.23016; Zhao L, 2015, EMBO MOL MED, V7, P1179, DOI 10.15252/emmm.201505298	10	2	2	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 19	2019	50	3					544	546		10.1016/j.immuni.2019.02.017	http://dx.doi.org/10.1016/j.immuni.2019.02.017			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP4QH	30893583	Green Accepted, Bronze			2022-12-18	WOS:000461660500005
J	Ruotsalainen, J; Tuting, T				Ruotsalainen, Janne; Tueting, Thomas			Live or Let Die: T Cell Survival in Cancer Immunotherapy	IMMUNITY			English	Editorial Material							RESPONSES	Combination immune checkpoint blockade targeting CTLA-4 and PD-1 is thought to reinvigorate exhausted T cells better than monotherapies. In this issue of Immunity, Pai et al. (2019) show that, in the setting of low tumor burden, this combination regimen promotes interferon-gamma-dependent T cell hyperactivation and death and thus favors tumor progression.	[Ruotsalainen, Janne; Tueting, Thomas] Otto von Guericke Univ, Dept Dermatol, Lab Expt Dermatol, Magdeburg, Germany	Otto von Guericke University	Tuting, T (corresponding author), Otto von Guericke Univ, Dept Dermatol, Lab Expt Dermatol, Magdeburg, Germany.	thomas.tueting@med.ovgu.de	Tüting, Thomas/AAJ-3610-2021	Tüting, Thomas/0000-0001-7146-0934; Ruotsalainen, Janne/0000-0002-5312-5486				Berner V, 2007, NAT MED, V13, P354, DOI 10.1038/nm1554; Cristescu R, 2018, SCIENCE, V362, P197, DOI 10.1126/science.aar3593; Glodde N, 2017, IMMUNITY, V47, P789, DOI 10.1016/j.immuni.2017.09.012; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; LIU Y, 1990, Journal of Experimental Medicine, V172, P1735, DOI 10.1084/jem.172.6.1735; O'Donnell JS, 2019, NAT REV CLIN ONCOL, V16, P151, DOI 10.1038/s41571-018-0142-8; Pai CCS, 2019, IMMUNITY, V50, P477, DOI 10.1016/j.immuni.2019.01.006; Prabhu N, 2013, J VIROL, V87, P12510, DOI 10.1128/JVI.01776-13; Robert C, 2018, NAT MED, V24, P1645, DOI 10.1038/s41591-018-0250-0; Thommen DS, 2018, CANCER CELL, V33, P547, DOI 10.1016/j.ccell.2018.03.012	10	2	3	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 19	2019	50	2					280	282		10.1016/j.immuni.2019.01.016	http://dx.doi.org/10.1016/j.immuni.2019.01.016			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL8QC	30784574	Bronze			2022-12-18	WOS:000459006700004
J	Franco, F; Wenes, M; Ho, PC				Franco, Fabien; Wenes, Mathias; Ho, Ping-Chih			Sparks Fly in PGE2-Modulated Macrophage Polarization	IMMUNITY			English	Editorial Material							ACTIVATION; CELL	How macrophages convey extracellular signals by bridging metabolism and functions remains unclear. In this issue of Immunity, Sanin et al. (2018) report that prostaglandin E2 (PGE2) treatment in interleukin-4-activated macrophages suppresses mitochondrial membrane potential to control voltage-regulated genes involved in proliferation and immune responses.	[Franco, Fabien; Wenes, Mathias; Ho, Ping-Chih] Univ Lausanne, Dept Fundamental Oncol, Lausanne, Switzerland; [Franco, Fabien; Wenes, Mathias; Ho, Ping-Chih] Univ Lausanne, Ludwig Canc Res, Epalinges, Switzerland	University of Lausanne; University of Lausanne	Ho, PC (corresponding author), Univ Lausanne, Dept Fundamental Oncol, Lausanne, Switzerland.; Ho, PC (corresponding author), Univ Lausanne, Ludwig Canc Res, Epalinges, Switzerland.	ping-chih.ho@unil.ch		Wenes, Mathias/0000-0001-8478-8592				Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Chandel NS, 2015, CELL METAB, V22, P204, DOI 10.1016/j.cmet.2015.05.013; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Liu PS, 2017, NAT IMMUNOL, V18, P985, DOI 10.1038/ni.3796; Luan B, 2015, P NATL ACAD SCI USA, V112, P15642, DOI 10.1073/pnas.1519644112; Mills EL, 2018, NATURE, V556, P113, DOI 10.1038/nature25986; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Sanin DE, 2018, IMMUNITY, V49, P1021, DOI 10.1016/j.immuni.2018.10.011; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Tang T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04100-1; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986	11	2	3	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2018	49	6					987	989		10.1016/j.immuni.2018.12.002	http://dx.doi.org/10.1016/j.immuni.2018.12.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HE6VX	30566885	Bronze			2022-12-18	WOS:000453556500001
J	Deerhake, ME; Barclay, WE; Shinohara, ML				Deerhake, M. Elizabeth; Barclay, William E.; Shinohara, Mari L.			Are Neuropeptide-Reactive T Cells behind Narcolepsy?	IMMUNITY			English	Editorial Material								Researchers have previously hypothesized autoimmune origins for narcolepsy on the basis of its strong genetic association with an MHC class II allele. In a recent issue of Nature, Latorre et al. (2018) discovered that narcolepsy patients had autoreactive T cells specific to the neuronal antigen hypocretin, providing more evidence of the potential immune origin of the disease.	[Deerhake, M. Elizabeth; Barclay, William E.; Shinohara, Mari L.] Duke Univ, Dept Immunol, Sch Med, Durham, NC 27705 USA; [Shinohara, Mari L.] Duke Univ, Dept Mol Genet & Microbiol, Sch Med, Durham, NC 27705 USA	Duke University; Duke University	Shinohara, ML (corresponding author), Duke Univ, Dept Immunol, Sch Med, Durham, NC 27705 USA.; Shinohara, ML (corresponding author), Duke Univ, Dept Mol Genet & Microbiol, Sch Med, Durham, NC 27705 USA.	mari.shinohara@duke.edu	Deerhake, M. Elizabeth/AGE-0680-2022	Deerhake, M. Elizabeth/0000-0003-4061-5766; Shinohara, Mari/0000-0002-6808-9844	NIAID NIH HHS [T32 AI052077, F30 AI140497] Funding Source: Medline; NIGMS NIH HHS [T32 GM007171] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI052077, F30AI140497] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Latorre D, 2018, NATURE, V562, P63, DOI 10.1038/s41586-018-0540-1; Mignot E, 1997, SLEEP, V20, P1012; Mohan JF, 2012, NAT REV IMMUNOL, V12, P721, DOI 10.1038/nri3294; Nishino S, 2001, ANN NEUROL, V50, P381, DOI 10.1002/ana.1130; Nohynek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033536; Partinen M, 2014, LANCET NEUROL, V13, P600, DOI 10.1016/S1474-4422(14)70075-4; Spath S, 2017, IMMUNITY, V46, P245, DOI 10.1016/j.immuni.2017.01.007; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Wang CM, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00220	9	2	2	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2018	49	5					796	798		10.1016/j.immuni.2018.11.002	http://dx.doi.org/10.1016/j.immuni.2018.11.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HB1AY	30462995	Bronze			2022-12-18	WOS:000450752200006
J	Sanz-Moreno, V; Balkwill, FR				Sanz-Moreno, Victoria; Balkwill, Frances R.			Mets and NETs: The Awakening Force	IMMUNITY			English	Editorial Material							CANCER; METASTASIS; GROWTH; CELLS	In a recent study published in Science, Albrengues et al. (2018) unveil an intriguing mechanism whereby the release of neutrophil extra-cellular traps during chronic lung inflammation awakens dormant malignant cells and contributes to cancer progression.	[Sanz-Moreno, Victoria] Barts Canc Inst, Charterhouse Sq, London EC1M 6BQ, England; [Balkwill, Frances R.] Queen Mary Univ London, Charterhouse Sq, London EC1M 6BQ, England	University of London; Queen Mary University London; University of London; Queen Mary University London	Sanz-Moreno, V (corresponding author), Barts Canc Inst, Charterhouse Sq, London EC1M 6BQ, England.; Balkwill, FR (corresponding author), Queen Mary Univ London, Charterhouse Sq, London EC1M 6BQ, England.	v.sanz-moreno@qmul.ac.uk; f.balkwill@qmul.ac.uk		Sanz-Moreno, Victoria/0000-0002-5096-9456	Cancer Research UK [12065] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Albrengues J, 2018, SCIENCE, V361, P1353, DOI 10.1126/science.aao4227; Antonio N, 2015, EMBO J, V34, P2219, DOI 10.15252/embj.201490147; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Gay LJ, 2017, BBA-REV CANCER, V1868, P231, DOI 10.1016/j.bbcan.2017.05.002; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; O'Sullivan J, 2018, NAT REV GASTRO HEPAT, V15, P699, DOI 10.1038/s41575-018-0069-7; Orgaz JL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5255; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ruffell B, 2015, CANCER CELL, V27, P462, DOI 10.1016/j.ccell.2015.02.015; Wculek SK, 2015, NATURE, V528, P413, DOI 10.1038/nature16140	10	2	2	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2018	49	5					798	800		10.1016/j.immuni.2018.11.009	http://dx.doi.org/10.1016/j.immuni.2018.11.009			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HB1AY	30462996	Bronze			2022-12-18	WOS:000450752200007
J	Chauche, C; McSorley, HJ				Chauche, Caroline; McSorley, Henry J.			Basal Instinct: Persistence of Barrier Dysfunction	IMMUNITY			English	Editorial Material								In a recent issue of Nature, Ordovas-Montanes et al. (2018) used cutting-edge genomic, epigenetic, and interventional techniques to characterize the cellular ecosystem in allergic chronic rhinosinusitis. They showed that basal epithelial cells "remember'' type 2 inflammatory stimuli to maintain a chronic allergic disease phenotype.	[Chauche, Caroline; McSorley, Henry J.] Univ Edinburgh, Ctr Inflammat Res, Edinburgh EH16 4TJ, Midlothian, Scotland	University of Edinburgh	McSorley, HJ (corresponding author), Univ Edinburgh, Ctr Inflammat Res, Edinburgh EH16 4TJ, Midlothian, Scotland.	henry.mcsorley@ed.ac.uk		Chauche, Caroline/0000-0002-9127-4693; McSorley, Henry/0000-0003-1300-7407				Bachert C, 2016, JAMA-J AM MED ASSOC, V315, P469, DOI 10.1001/jama.2015.19330; Beyaz S, 2016, NATURE, V531, P53, DOI 10.1038/nature17173; Corren J, 2017, NEW ENGL J MED, V377, P936, DOI 10.1056/NEJMoa1704064; Hulse KE, 2015, CLIN EXP ALLERGY, V45, P328, DOI 10.1111/cea.12472; Kohanski MA, 2018, J ALLERGY CLIN IMMUN, V142, P460, DOI 10.1016/j.jaci.2018.03.019; Montoro DT, 2018, NATURE, V560, P319, DOI 10.1038/s41586-018-0393-7; Naik S, 2017, NATURE, V550, P475, DOI 10.1038/nature24271; Ordovas-Montanes J, 2018, NATURE, V560, P649, DOI 10.1038/s41586-018-0449-8; Plasschaert LW, 2018, NATURE, V560, P377, DOI 10.1038/s41586-018-0394-6; Xi Y, 2017, NAT CELL BIOL, V19, P904, DOI 10.1038/ncb3580	10	2	3	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2018	49	4					590	592		10.1016/j.immuni.2018.09.022	http://dx.doi.org/10.1016/j.immuni.2018.09.022			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX0FW	30332626	Green Submitted, Bronze			2022-12-18	WOS:000447386700006
J	Chen, JS; Eisenbarth, SC				Chen, Jennifer S.; Eisenbarth, Stephanie C.			Two-Factor Authentication for Type 2 Immunity	IMMUNITY			English	Editorial Material							DENDRITIC CELLS; T-CELLS	The initiation of type 2 responses is tightly regulated. In this issue of Immunity, Sokol et al. (2018) demonstrate that CCL8 is a critical signal that licenses dendritic cells to enter the lymph node parenchyma and induce Th2 differentiation after allergen exposure.	[Chen, Jennifer S.; Eisenbarth, Stephanie C.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA; [Chen, Jennifer S.; Eisenbarth, Stephanie C.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Chen, Jennifer S.; Eisenbarth, Stephanie C.] Yale Univ, Sch Med, Sect Rheumatol Allergy & Clin Immunol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Eisenbarth, SC (corresponding author), Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA.; Eisenbarth, SC (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.; Eisenbarth, SC (corresponding author), Yale Univ, Sch Med, Sect Rheumatol Allergy & Clin Immunol, New Haven, CT 06520 USA.	stephanie.eisenbarth@yale.edu		Chen, Jennifer/0000-0002-7808-2670				Braun A, 2011, NAT IMMUNOL, V12, P879, DOI 10.1038/ni.2085; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Leon B, 2012, NAT IMMUNOL, V13, P681, DOI 10.1038/ni.2309; Sokol CL, 2018, IMMUNITY, V49, P449, DOI 10.1016/j.immuni.2018.07.012; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Tomura M, 2008, P NATL ACAD SCI USA, V105, P10871, DOI 10.1073/pnas.0802278105	7	2	3	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2018	49	3					381	383		10.1016/j.immuni.2018.08.020	http://dx.doi.org/10.1016/j.immuni.2018.08.020			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GU0AK	30231976	Bronze			2022-12-18	WOS:000444909600003
J	Greene, TT; Labarta-Bajo, L; Zuniga, EI				Greene, Trever T.; Labarta-Bajo, Lara; Zuniga, Elina I.			Dangerously Fit: Extracellular ATP Aids Memory T Cell Metabolism	IMMUNITY			English	Editorial Material							INFECTION; P2X7	In a recent issue of Nature, Borges da Silva et al. (2018) reveal that P2RX7, a receptor for extracellular ATP, promotes CD8 T cell memory by enhancing metabolic fitness. This work links an ancient "danger'' signal with long-term immunity.	[Greene, Trever T.; Labarta-Bajo, Lara; Zuniga, Elina I.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Zuniga, EI (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	eizuniga@ucsd.edu	Labarta-Bajo, Lara/AAG-3648-2019	Labarta-Bajo, Lara/0000-0003-1812-6704				Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; da Silva HB, 2018, NATURE, V559, P264, DOI 10.1038/s41586-018-0282-0; Di Virgilio F, 2017, IMMUNITY, V47, P15, DOI 10.1016/j.immuni.2017.06.020; Hashimoto M, 2018, ANNU REV MED, V69, P301, DOI 10.1146/annurev-med-012017-043208; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Jameson SC, 2018, IMMUNITY, V48, P214, DOI 10.1016/j.immuni.2018.02.010; Marin TL, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aaf7478; Rissiek B, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00204; Vono M, 2013, P NATL ACAD SCI USA, V110, P21095, DOI 10.1073/pnas.1319784110; Zuniga EI, 2015, ANNU REV VIROL, V2, P573, DOI 10.1146/annurev-virology-100114-055226	10	2	2	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2018	49	2					208	210		10.1016/j.immuni.2018.08.009	http://dx.doi.org/10.1016/j.immuni.2018.08.009			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR1YX	30134200	Bronze			2022-12-18	WOS:000442354500007
J	Calcagno, N; Baufeld, C; Madore, C; Butovsky, O				Calcagno, Narghes; Baufeld, Caroline; Madore, Charlotte; Butovsky, Oleg			TREMendous 2 Be Social	IMMUNITY			English	Editorial Material							ALZHEIMERS-DISEASE; MICROGLIA; TREM2	TREM2 is known for its role in microglial phagocytosis and in neurodegenerative diseases. In this issue of Immunity, Filipello et al. (2018) show that microglial TREM2 is required for synaptic pruning in early development. TREM2-deficient mice show altered social behavior in adulthood, linking TREM2 to neurodevelopmental disease.	[Calcagno, Narghes; Baufeld, Caroline; Madore, Charlotte; Butovsky, Oleg] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA; [Butovsky, Oleg] Harvard Med Sch, Brigham & Womens Hosp, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Butovsky, O (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA.; Butovsky, O (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA.	obutovsky@rics.bwh.harvard.edu	Butovsky, Oleg/ABG-9086-2020; Madore, Charlotte/AAK-8735-2021	Butovsky, Oleg/0000-0003-0186-8867; Madore, Charlotte/0000-0002-0704-6496; Calcagno, Narghes/0000-0003-0615-891X	NINDS NIH HHS [R01 NS088137] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358; Filipello F, 2018, IMMUNITY, V48, P979, DOI 10.1016/j.immuni.2018.04.016; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Park HR, 2016, EXP NEUROBIOL, V25, P1, DOI 10.5607/en.2016.25.1.1; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Ulland TK, 2017, CELL, V170, P649, DOI 10.1016/j.cell.2017.07.023; Ulrich JD, 2017, NEURON, V94, P237, DOI 10.1016/j.neuron.2017.02.042; Yuan P, 2016, NEURON, V90, P724, DOI 10.1016/j.neuron.2016.05.003	10	2	2	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2018	48	5					842	843		10.1016/j.immuni.2018.04.034	http://dx.doi.org/10.1016/j.immuni.2018.04.034			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG1ZI	29768169	Bronze, Green Accepted			2022-12-18	WOS:000432488600004
J	Gerner, RR; Raffatellu, M				Gerner, Romana R.; Raffatellu, Manuela			A Worm's Gut Feelings: Neuronal Muscarinic and Epithelial Canonical Wnt Pathways Promote Antimicrobial Defense	IMMUNITY			English	Editorial Material							DISEASE; CATENIN	Molecular mechanisms connecting the gut-brain axis to immunity remain elusive. In this issue of Immunity, Labed et al. (2018) demonstrate that two evolutionarily conserved signaling mechanisms, the neuronal muscarinic and the epithelial Wnt pathways, together induce antimicrobial peptide expression that protects Caenorhabditis elegans against intestinal infection.	[Gerner, Romana R.; Raffatellu, Manuela] Univ Calif San Diego, Dept Pediat, Div Host Microbe Syst & Therapeut, La Jolla, CA 92093 USA; [Raffatellu, Manuela] Chiba Univ, UC San Diego Ctr Mucosal Immunol Allergy & Vaccin, La Jolla, CA 92093 USA; [Raffatellu, Manuela] Univ Calif San Diego, Ctr Microbiome Innovat, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Raffatellu, M (corresponding author), Univ Calif San Diego, Dept Pediat, Div Host Microbe Syst & Therapeut, La Jolla, CA 92093 USA.; Raffatellu, M (corresponding author), Chiba Univ, UC San Diego Ctr Mucosal Immunol Allergy & Vaccin, La Jolla, CA 92093 USA.; Raffatellu, M (corresponding author), Univ Calif San Diego, Ctr Microbiome Innovat, La Jolla, CA 92093 USA.	manuelar@ucsd.edu	Gerner, Romana R./AAE-6701-2020	Gerner, Romana R./0000-0003-2377-6509				Armbruster NS, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01204; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Sales ME, 2010, CURR OPIN INVEST DR, V11, P1239; Irazoqui JE, 2008, P NATL ACAD SCI USA, V105, P17469, DOI 10.1073/pnas.0809527105; Irazoqui JE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000982; Labed SA, 2018, IMMUNITY, V48, P963, DOI 10.1016/j.immuni.2018.04.017; McGhee James D, 2007, WormBook, P1; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	10	2	2	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2018	48	5					839	841		10.1016/j.immuni.2018.04.035	http://dx.doi.org/10.1016/j.immuni.2018.04.035			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG1ZI	29768168	Bronze			2022-12-18	WOS:000432488600003
J	Lewis, MD; Langhorne, J				Lewis, Matthew D.; Langhorne, Jean			A New Link between gamma delta T Cells and Myeloid Cells in Malaria?	IMMUNITY			English	Editorial Material							PLASMODIUM-FALCIPARUM; PFSPZ VACCINE; ALPHA-BETA; IMMUNITY; MEROZOITES; PROTECTION; INFECTION; MICE	In malaria, the immune responses leading to protective immunity versus immunopathology are unclear. Mamedov et al. (2018) identify a subset of clonally expanded gamma delta T cells in late-stage infection that produce M-CSF and may interact with myeloid cells to control recrudescent infection.	[Lewis, Matthew D.; Langhorne, Jean] Francis Crick Inst, 1 Midland Rd, London NW1 1AT, England	Francis Crick Institute	Langhorne, J (corresponding author), Francis Crick Inst, 1 Midland Rd, London NW1 1AT, England.	jean.langhorne@crick.ac.uk		Lewis, Matthew/0000-0003-4515-6896	UK Medical Research Council; Cancer Research UK; Wellcome Trust, UK	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Wellcome Trust, UK(Wellcome Trust)	We thank Yaw Bediako and Deirdre Cunningham for their helpful comments. The authors' laboratory is supported by the Francis Crick Institute, which receives its funding from the UK Medical Research Council, Cancer Research UK, and the Wellcome Trust, UK.	Costa G, 2011, BLOOD, V118, P6952, DOI 10.1182/blood-2011-08-376111; Fontana MF, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006046; Gupta P, 2016, CELL REP, V16, P1749, DOI 10.1016/j.celrep.2016.07.010; LANGHORNE J, 1995, INT IMMUNOL, V7, P1005, DOI 10.1093/intimm/7.6.1005; Lyke KE, 2017, P NATL ACAD SCI USA, V114, P2711, DOI 10.1073/pnas.1615324114; Mamedov MR, 2018, IMMUNITY, V48, P350, DOI 10.1016/j.immuni.2018.01.009; Osier FHA, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-108; Sissoko MS, 2017, LANCET INFECT DIS, V17, P498, DOI [10.1016/S1473-3099(17)30104-4, 10.1016/s1473-3099(17)30104-4]; TSUJI M, 1994, P NATL ACAD SCI USA, V91, P345, DOI 10.1073/pnas.91.1.345; Zaidi I, 2017, J IMMUNOL, V199, P3781, DOI 10.4049/jimmunol.1700314	10	2	2	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2018	48	2					193	195		10.1016/j.immuni.2018.02.003	http://dx.doi.org/10.1016/j.immuni.2018.02.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FW7ML	29466749	Bronze			2022-12-18	WOS:000425507800004
J	Gardner, A; Ruffell, B				Gardner, Alycia; Ruffell, Brian			moDCs, Less Problems	IMMUNITY			English	Editorial Material							DENDRITIC CELLS; CHEMOTHERAPY; TRAFFICKING; ACTIVATION; RESPONSES; IMMUNITY; THERAPY		[Gardner, Alycia; Ruffell, Brian] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA; [Ruffell, Brian] H Lee Moffitt Canc Ctr & Res Inst, Breast Oncol, Tampa, FL 33612 USA; [Gardner, Alycia] Univ S Florida, Canc Biol PhD Program, Tampa, FL 33620 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Ruffell, B (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA.; Ruffell, B (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Breast Oncol, Tampa, FL 33612 USA.	brian.ruffell@moffitt.org		Gardner, Alycia/0000-0003-2185-5174; Ruffell, Brian/0000-0002-3846-6872	Moffitt Cancer Center's Shula Breast Cancer Award; NCI/NIH grant [R00CA185325]; NATIONAL CANCER INSTITUTE [R00CA185325] Funding Source: NIH RePORTER	Moffitt Cancer Center's Shula Breast Cancer Award; NCI/NIH grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	B.R. is supported by Moffitt Cancer Center's Shula Breast Cancer Award and NCI/NIH grant R00CA185325. B.R. has a courtesy faculty appointment at the University of South Florida, Tampa, FL.	Gardner A, 2016, TRENDS IMMUNOL, V37, P855, DOI 10.1016/j.it.2016.09.006; Gasparini C, 2012, HUM IMMUNOL, V73, P342, DOI 10.1016/j.humimm.2012.01.018; Ma Y, 2013, IMMUNITY, V38, P729, DOI 10.1016/j.immuni.2013.03.003; Marigo I, 2016, CANCER CELL, V30, P377, DOI 10.1016/j.ccell.2016.08.004; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Roberts EW, 2016, CANCER CELL, V30, P324, DOI 10.1016/j.ccell.2016.06.003; Ruffell B, 2014, CANCER CELL, V26, P623, DOI 10.1016/j.ccell.2014.09.006; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Sharma MD, 2018, IMMUNITY, V48, P91, DOI 10.1016/j.immuni.2017.12.014; Spranger S, 2017, CANCER CELL, V31, P711, DOI 10.1016/j.ccell.2017.04.003	10	2	2	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2018	48	1					6	8		10.1016/j.immuni.2017.12.017	http://dx.doi.org/10.1016/j.immuni.2017.12.017			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FS9PW	29343441	Bronze			2022-12-18	WOS:000422751600003
J	Prabhu, S; Cockburn, IA; Vinuesa, CG				Prabhu, Savit; Cockburn, Ian A.; Vinuesa, Carola G.			HIV Immunogens: Affinity Is Key	IMMUNITY			English	Editorial Material							CENTER B-CELLS; ANTIBODIES		[Prabhu, Savit; Cockburn, Ian A.; Vinuesa, Carola G.] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol & Infect Dis, Canberra, ACT, Australia	Australian National University; John Curtin School of Medical Research	Vinuesa, CG (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol & Infect Dis, Canberra, ACT, Australia.	carola.vinuesa@anu.edu.au	Vinuesa, Carola G/B-1108-2010	Vinuesa, Carola G/0000-0001-9799-0298; Cockburn, Ian/0000-0001-8220-9294; Prabhu, Savit/0000-0003-3486-8951				Abbott RK, 2018, IMMUNITY, V48, P133, DOI 10.1016/j.immuni.2017.11.023; Briney B, 2016, CELL, V166, P1459, DOI 10.1016/j.cell.2016.08.005; Fisher CR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006469; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Jardine JG, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005815; Jardine JG, 2016, SCIENCE, V351, P1458, DOI 10.1126/science.aad9195; Phan TG, 2006, J EXP MED, V203, P2419, DOI 10.1084/jem.20061254; Zhang Y, 2013, J EXP MED, V210, P457, DOI 10.1084/jem.20120150	10	2	2	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2018	48	1					11	13		10.1016/j.immuni.2018.01.002	http://dx.doi.org/10.1016/j.immuni.2018.01.002			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FS9PW	29343432	Bronze			2022-12-18	WOS:000422751600005
J	Soukup, K; Joyce, JA				Soukup, Klara; Joyce, Johanna A.			A Long-Distance Relay-tionship between Tumor and Bone	IMMUNITY			English	Editorial Material							BREAST-CANCER METASTASIS; NEUTROPHILS; CELLS; MET		[Soukup, Klara; Joyce, Johanna A.] Univ Lausanne, Ludwig Inst Canc Res, Lausanne, Switzerland; [Soukup, Klara; Joyce, Johanna A.] Univ Lausanne, Dept Oncol, Lausanne, Switzerland	Ludwig Institute for Cancer Research; University of Lausanne; University of Lausanne	Joyce, JA (corresponding author), Univ Lausanne, Ludwig Inst Canc Res, Lausanne, Switzerland.; Joyce, JA (corresponding author), Univ Lausanne, Dept Oncol, Lausanne, Switzerland.	johanna@joycelab.org		Soukup, Klara/0000-0003-2764-4845	Ludwig Institute for Cancer Research; University of Lausanne; Breast Cancer Research Foundation; US National Cancer Institute [R01 CA181355]; Cancer Research UK IMAXT Grand Challenge Project; Swiss Cancer League [KFS 3990-08-2016]; Swiss Bridge Award; NATIONAL CANCER INSTITUTE [R01CA181355] Funding Source: NIH RePORTER	Ludwig Institute for Cancer Research; University of Lausanne; Breast Cancer Research Foundation; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK IMAXT Grand Challenge Project; Swiss Cancer League; Swiss Bridge Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research in the Joyce lab is supported by the Ludwig Institute for Cancer Research, University of Lausanne, Breast Cancer Research Foundation, US National Cancer Institute (R01 CA181355), Cancer Research UK IMAXT Grand Challenge Project, Swiss Cancer League (KFS 3990-08-2016), and the Swiss Bridge Award. We thank Sara Colomer-Lahiguera for her assistance with artwork.	Casbon AJ, 2015, P NATL ACAD SCI USA, V112, pE566, DOI 10.1073/pnas.1424927112; Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Engblom C, 2017, SCIENCE, V358, DOI 10.1126/science.aal5081; Fainsod-Levi T, 2017, CELL REP, V21, P2384, DOI 10.1016/j.celrep.2017.11.010; Finisguerra V, 2015, NATURE, V522, P349, DOI 10.1038/nature14407; Glodde N, 2017, IMMUNITY, V47, P789, DOI 10.1016/j.immuni.2017.09.012; Quail DF, 2017, NAT CELL BIOL, V19, P974, DOI 10.1038/ncb3578; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Wculek SK, 2015, NATURE, V528, P413, DOI 10.1038/nature16140	10	2	2	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2018	48	1					13	16		10.1016/j.immuni.2017.12.011	http://dx.doi.org/10.1016/j.immuni.2017.12.011			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FS9PW	29343434	Bronze			2022-12-18	WOS:000422751600006
J	Chennupati, V; Held, W				Chennupati, Vijaykumar; Held, Werner			Feeling Exhausted? Tuning Irf4 Energizes Dysfunctional T Cells	IMMUNITY			English	Editorial Material							EXPANSION; DIFFERENTIATION; INFECTION	The regulatory mechanisms governing T cell exhaustion remain incompletely understood. Man et al. (2017) and Wu et al. (2017) report that the T cell receptor responsive transcription factor Irf4 promotes T cell exhaustion in chronic viral infection but dampens exhaustion in response to tissue allografts.	[Chennupati, Vijaykumar; Held, Werner] Univ Lausanne, Dept Oncol, CH-1066 Epalinges, Switzerland	University of Lausanne	Held, W (corresponding author), Univ Lausanne, Dept Oncol, CH-1066 Epalinges, Switzerland.	werner.held@unil.ch			Swiss National Science Foundation [310030_159598]; Swiss Cancer Research [KFS-3601-02-2015]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer Research	W.H. is supported by grants from the Swiss National Science Foundation (310030_159598) and Swiss Cancer Research (KFS-3601-02-2015).	Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; Huber M, 2014, EUR J IMMUNOL, V44, P1886, DOI 10.1002/eji.201344279; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Man K, 2017, IMMUNITY, V47, P1129, DOI 10.1016/j.immuni.2017.11.021; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; Nayar R, 2014, J IMMUNOL, V192, P5881, DOI 10.4049/jimmunol.1303187; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wu J, 2017, IMMUNITY, V47, P1114, DOI 10.1016/j.immuni.2017.11.003; Yao SY, 2013, IMMUNITY, V39, P833, DOI 10.1016/j.immuni.2013.10.007	11	2	2	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2017	47	6					1009	1011		10.1016/j.immuni.2017.11.028	http://dx.doi.org/10.1016/j.immuni.2017.11.028			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FQ6PM	29262341	Bronze, Green Published			2022-12-18	WOS:000418486500003
J	Cheuk, S; Eidsmo, L				Cheuk, Stanley; Eidsmo, Liv			The Skinny on Fat Trm Cells	IMMUNITY			English	Editorial Material							MEMORY T-CELLS; TISSUE; TRIGGER	White adipose tissue (WAT) is exposed to pathogens that breach epithelial barriers, but the role of adipose T cells in immunity isn't clear. In this issue of Immunity, Han et al. (2017) find that WAT harbors a reservoir of memory T cells that provide antimicrobial immunity at the expense of lipid synthesis and metabolism.	[Cheuk, Stanley; Eidsmo, Liv] Karolinska Inst, Dept Med Solna, Dermatol & Venereol Unit, S-17176 Stockholm, Sweden; [Cheuk, Stanley; Eidsmo, Liv] Karolinska Univ, Dept Dermatol, Hosp Solna, S-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Eidsmo, L (corresponding author), Karolinska Inst, Dept Med Solna, Dermatol & Venereol Unit, S-17176 Stockholm, Sweden.; Eidsmo, L (corresponding author), Karolinska Univ, Dept Dermatol, Hosp Solna, S-17176 Stockholm, Sweden.	liv.eidsmo@ki.se	CHeuk, Stanley Sing Hoi/S-5871-2018; Cheuk, Stanley/P-1235-2019	CHeuk, Stanley Sing Hoi/0000-0002-2759-3884; Cheuk, Stanley/0000-0002-2759-3884; Eidsmo, Liv/0000-0001-9237-8374				Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803; Benezech C, 2015, NAT IMMUNOL, V16, P819, DOI 10.1038/ni.3215; Brestoff JR, 2015, CELL, V161, P146, DOI 10.1016/j.cell.2015.02.022; Cheuk S, 2017, IMMUNITY, V46, P287, DOI 10.1016/j.immuni.2017.01.009; Gerlach C, 2016, IMMUNITY, V45, P1270, DOI 10.1016/j.immuni.2016.10.018; Han SJ, 2017, IMMUNITY, V47, P1154, DOI 10.1016/j.immuni.2017.11.009; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Pan YD, 2017, NATURE, V543, P252, DOI 10.1038/nature21379; Park C. O., 2017, J ALLERGY CLIN IMMUN; Schenkel JM, 2014, SCIENCE, V346, P98, DOI 10.1126/science.1254536	10	2	2	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2017	47	6					1012	1014		10.1016/j.immuni.2017.12.003	http://dx.doi.org/10.1016/j.immuni.2017.12.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FQ6PM	29262342	Bronze			2022-12-18	WOS:000418486500004
J	Schmidt, FI; Latz, E				Schmidt, Florian I.; Latz, Eicke			CD14-New Tricks of an Old Acquaintance	IMMUNITY			English	Editorial Material							LPS-BINDING-PROTEIN; RECEPTOR	Zanoni et al. (2017) show that the LPS receptor CD14 promotes internalization of oxidized phospholipids, a hallmark of dying cells, triggering hyperactivation of dendritic cells and macrophages. Their findings reveal CD14 as a regulator of responses to infection and damage, relaying context-dependent signals that determine inflammatory cell fate decisions.	[Schmidt, Florian I.; Latz, Eicke] Univ Bonn, Univ Hosp, Inst Innate Immun, Bonn, Germany; [Latz, Eicke] Univ Massachusetts, Med Sch, Dept Infect Dis & Immunol, Worcester, MA 01655 USA; [Latz, Eicke] German Ctr Neurodegenerat Dis, Bonn, Germany	University of Bonn; University of Massachusetts System; University of Massachusetts Worcester; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Latz, E (corresponding author), Univ Bonn, Univ Hosp, Inst Innate Immun, Bonn, Germany.; Latz, E (corresponding author), Univ Massachusetts, Med Sch, Dept Infect Dis & Immunol, Worcester, MA 01655 USA.; Latz, E (corresponding author), German Ctr Neurodegenerat Dis, Bonn, Germany.	eicke.latz@uni-bonn.de	Schmidt, Florian Ingo/J-1672-2019; Schmidt, Florian/H-7372-2012; Latz, Eicke/H-3951-2014	Schmidt, Florian Ingo/0000-0002-9979-9769; Schmidt, Florian/0000-0002-9979-9769; Latz, Eicke/0000-0003-1488-5666	Emmy Noether Programme of the dgf; ERC consolidator grant InflammAct;  [SFB 57];  [SFB 83];  [SFB 1123]	Emmy Noether Programme of the dgf; ERC consolidator grant InflammAct; ; ; 	F.I.S. is funded by the Emmy Noether Programme of the dgf. E.L. is funded by the ERC consolidator grant InflammAct and by the SFBs 57, 83, 1123. E.L. is co-founder and consultant of IFM Therapeutics.	de Torre-Minguela C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00043; Erridge C, 2008, J BIOL CHEM, V283, P24748, DOI 10.1074/jbc.M800352200; Patel MN, 2017, TRENDS MOL MED, V23, P165, DOI 10.1016/j.molmed.2016.12.007; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Vanaja SK, 2016, CELL, V165, P1106, DOI 10.1016/j.cell.2016.04.015; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Zanoni I, 2017, IMMUNITY, V47, P697, DOI 10.1016/j.immuni.2017.09.010; Zanoni I, 2016, SCIENCE, V352, P1232, DOI 10.1126/science.aaf3036; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	9	2	3	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2017	47	4					606	608		10.1016/j.immuni.2017.10.003	http://dx.doi.org/10.1016/j.immuni.2017.10.003			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FJ9JE	29045891	Bronze			2022-12-18	WOS:000413091600003
J	Fan, ZC; Ley, K				Fan, Zhichao; Ley, Klaus			Developing Neutrophils Must Eat...Themselves!	IMMUNITY			English	Editorial Material							AUTOPHAGY	In this issue of Immunity, Riffelmacher et al. (2017) show that autophagy is necessary for the release of free fatty acids from intracellular stores within neutrophil precursor cells. This limits glycolysis, increases oxidative phosphorylation, and is essential for neutrophil maturation.	[Fan, Zhichao; Ley, Klaus] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, 9420 Athena Circle Dr, La Jolla, CA 92037 USA; [Ley, Klaus] Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr, La Jolla, CA 92093 USA	La Jolla Institute for Immunology; University of California System; University of California San Diego	Ley, K (corresponding author), La Jolla Inst Allergy & Immunol, Div Inflammat Biol, 9420 Athena Circle Dr, La Jolla, CA 92037 USA.; Ley, K (corresponding author), Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr, La Jolla, CA 92093 USA.	klaus@lji.org	Fan, Zhichao/A-9835-2014	Fan, Zhichao/0000-0001-5385-9626				Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Drifte G, 2013, CRIT CARE MED, V41, P820, DOI 10.1097/CCM.0b013e318274647d; Fan ZC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12658; Galluzzi L, 2014, CELL, V159, P1263, DOI 10.1016/j.cell.2014.11.006; Ma YT, 2013, IMMUNITY, V39, P211, DOI 10.1016/j.immuni.2013.07.017; Riffelmacher T, 2017, IMMUNITY, V47, P466, DOI 10.1016/j.immuni.2017.08.005; Riffelmacher T, 2017, FEBS J, V284, P1008, DOI 10.1111/febs.13962; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; von Vietinghoff S, 2008, J IMMUNOL, V181, P5183, DOI 10.4049/jimmunol.181.8.5183	10	2	2	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2017	47	3					393	395		10.1016/j.immuni.2017.08.013	http://dx.doi.org/10.1016/j.immuni.2017.08.013			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4MG	28930652	Bronze			2022-12-18	WOS:000411128200003
J	Sun, MX; Kee, BL				Sun, Mengxi; Kee, Barbara L.			Lnc'ing Id2 to ILC1	IMMUNITY			English	Editorial Material							INNATE LYMPHOID-CELLS; NK CELLS; PROGRAM	The transcriptional repressor Id2 is constitutively expressed in all innate lymphoid cells (ILCs) and is required for their development. In this issue of Immunity, Mowel et al. (2017) demonstrate that Id2 expression is regulated by a cell type-specific cis-regulatory element in group 1 ILCs that is demarcated by a long non-coding RNA.	[Sun, Mengxi; Kee, Barbara L.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Sun, Mengxi; Kee, Barbara L.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Kee, BL (corresponding author), Univ Chicago, Dept Pathol, Chicago, IL 60637 USA.; Kee, BL (corresponding author), Univ Chicago, Comm Immunol, Chicago, IL 60637 USA.	bkee@bsd.uchicago.edu						Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Delas MJ, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170121; Delconte RB, 2016, IMMUNITY, V44, P103, DOI 10.1016/j.immuni.2015.12.007; Li HYS, 2012, BLOOD, V120, P4363, DOI 10.1182/blood-2012-07-441311; Mowel WK, 2017, IMMUNITY, V47, P435, DOI 10.1016/j.immuni.2017.08.012; Seillet C, 2016, CELL REP, V17, P436, DOI 10.1016/j.celrep.2016.09.025; Spits H, 2016, NAT IMMUNOL, V17, P758, DOI 10.1038/ni.3482; Zook EC, 2016, NAT IMMUNOL, V17, P775, DOI 10.1038/ni.3481	9	2	2	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2017	47	3					389	390		10.1016/j.immuni.2017.08.019	http://dx.doi.org/10.1016/j.immuni.2017.08.019			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4MG	28930650	Bronze			2022-12-18	WOS:000411128200001
J	Lazarevic, V; Szabo, S; Glimcher, LH				Lazarevic, Vanja; Szabo, Susanne; Glimcher, Laurie H.			T-bet Runs INTERFERence	IMMUNITY			English	Editorial Material							TRANSCRIPTION FACTORS; 17 CELLS; HELPER; ACTIVATION; INFECTION; TYPE-1	In this issue of Immunity, Iwata et al. (2017) report that the transcription factor T-bet acts as a selective repressor of the type I interferon (IFN) transcriptional program in response to IFN-gamma signaling.	[Lazarevic, Vanja] NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA; [Szabo, Susanne] Primal Therapies Inc, Menlo Pk, CA 94025 USA; [Glimcher, Laurie H.] Dana Farber Canc Inst, Boston, MA 02215 USA; [Glimcher, Laurie H.] Harvard Med Sch, Boston, MA 02215 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Lazarevic, V (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	lazarevicv@mail.nih.gov		Lazarevic, Vanja/0000-0002-5783-7130	Intramural NIH HHS [ZIA BC011431-02] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Havenar-Daughton C, 2006, J IMMUNOL, V176, P3315, DOI 10.4049/jimmunol.176.6.3315; Hegazy AN, 2010, IMMUNITY, V32, P116, DOI 10.1016/j.immuni.2009.12.004; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Iwata S, 2017, IMMUNITY, V46, P983, DOI 10.1016/j.immuni.2017.05.005; Lazarevic V, 2011, NAT IMMUNOL, V12, P96, DOI 10.1038/ni.1969; Nguyen KB, 2002, SCIENCE, V297, P2063, DOI 10.1126/science.1074900; Wang Y, 2014, IMMUNITY, V40, P355, DOI 10.1016/j.immuni.2014.01.002; Weinmann AS, 2014, ADV IMMUNOL, V124, P171, DOI 10.1016/B978-0-12-800147-9.00006-6; Yang YH, 2009, J EXP MED, V206, P1549, DOI 10.1084/jem.20082584	10	2	2	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 20	2017	46	6					968	970		10.1016/j.immuni.2017.05.010	http://dx.doi.org/10.1016/j.immuni.2017.05.010			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY0RM	28636963	Green Accepted, Bronze			2022-12-18	WOS:000403665900006
J	Bouchery, T; Harris, NL				Bouchery, Tiffany; Harris, Nicola L.			Only Two Can Tango: Mast Cells Displace Epithelial Cells to Dance with ILC2s	IMMUNITY			English	Editorial Material							INNATE LYMPHOID-CELLS; INFLAMMATION; IL-33	Mast cells have been implicated in protective immunity to helminth infection, but the precise mechanism remains unclear. In this issue of Immunity, Shimokawa et al., 2017 report that mast cells are a bridge linking dying epithelial cells with effector type 2 innate lymphoid cells.	[Bouchery, Tiffany; Harris, Nicola L.] Ecole Polytech Fed Lausanne, Global Hlth Inst, CH-1015 Lausanne, Switzerland	Ecole Polytechnique Federale de Lausanne	Harris, NL (corresponding author), Ecole Polytech Fed Lausanne, Global Hlth Inst, CH-1015 Lausanne, Switzerland.	nicola.harris@epfl.ch	harris, nicola/E-5342-2019	harris, nicola/0000-0003-2922-0210; bouchery, tiffany/0000-0003-3743-7356				Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Kouzaki H, 2011, J IMMUNOL, V186, P4375, DOI 10.4049/jimmunol.1003020; Lefrancais E, 2014, P NATL ACAD SCI USA, V111, P15502, DOI 10.1073/pnas.1410700111; Mohapatra A, 2016, MUCOSAL IMMUNOL, V9, P275, DOI 10.1038/mi.2015.59; Moretti S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14017; Reber LL, 2015, MUCOSAL IMMUNOL, V8, P444, DOI 10.1038/mi.2014.131; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Zaiss MM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003531; Zhao AP, 2003, J IMMUNOL, V171, P948, DOI 10.4049/jimmunol.171.2.948	9	2	2	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 16	2017	46	5					766	768		10.1016/j.immuni.2017.04.020	http://dx.doi.org/10.1016/j.immuni.2017.04.020			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EU8VJ	28514681	Bronze			2022-12-18	WOS:000401316300010
J	Crowe, JE				Crowe, James E., Jr.			Treating Flu with Skin of Frog	IMMUNITY			English	Editorial Material							CHYTRIDIOMYCOSIS; PEPTIDES	Glands in frog skin secrete substances that possess broad antimicrobial function. Holthausen et al. mined this soup of natural products and discovered a peptide that destroys diverse human influenza strains (Holthausen et al., 2017). This study points the way to the discovery of novel anti-influenza molecules targeting conserved elements on influenza surface proteins.	[Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, Nashville, TN 37232 USA; [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Crowe, JE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA.; Crowe, JE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA.; Crowe, JE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, Nashville, TN 37232 USA.; Crowe, JE (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN 37232 USA.	james.crowe@vanderbilt.edu	Crowe, James/B-5549-2009	Crowe, James/0000-0002-0049-1079				Conlon JM, 2015, PEPTIDES, V67, P29, DOI 10.1016/j.peptides.2015.03.005; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Guimaraes AB, 2016, PROTEIN PEPTIDE LETT, V23, P722, DOI 10.2174/0929866523666160530185137; Holthausen DJ, 2017, IMMUNITY, V46, P587, DOI 10.1016/j.immuni.2017.03.018; Rollins-Smith LA, 2011, INTEGR COMP BIOL, V51, P552, DOI 10.1093/icb/icr095; Rollins-Smith LA, 2009, BBA-BIOMEMBRANES, V1788, P1593, DOI 10.1016/j.bbamem.2009.03.008; Shafee TMA, 2017, CELL MOL LIFE SCI, V74, P663, DOI 10.1007/s00018-016-2344-5; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765	10	2	2	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2017	46	4					517	518		10.1016/j.immuni.2017.04.007	http://dx.doi.org/10.1016/j.immuni.2017.04.007			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES3TD	28423328	Bronze			2022-12-18	WOS:000399451100001
J	Quatrini, L; Ugolini, S				Quatrini, Linda; Ugolini, Sophie			Disarming the Killers: Brain Strikes on NK Cells	IMMUNITY			English	Editorial Material							STROKE		[Quatrini, Linda; Ugolini, Sophie] Aix Marseille Univ, INSERM, CNRS, Ctr Immunol Marseille Luminy, F-13288 Marseille, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Ugolini, S (corresponding author), Aix Marseille Univ, INSERM, CNRS, Ctr Immunol Marseille Luminy, F-13288 Marseille, France.	ugolini@ciml.univ-mrs.fr	Quatrini, Linda/AAA-4580-2019	Quatrini, Linda/0000-0002-6994-2595; Ugolini, Sophie/0000-0003-4041-0103				Chamorro A, 2007, STROKE, V38, P1097, DOI 10.1161/01.STR.0000258346.68966.9d; Clark SE, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005708; Liu Q, 2017, IMMUNITY, V46, P474, DOI 10.1016/j.immuni.2017.02.015; Logan RW, 2011, BRAIN BEHAV IMMUN, V25, P101, DOI 10.1016/j.bbi.2010.08.007; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301	8	2	2	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2017	46	3					340	342		10.1016/j.immuni.2017.03.001	http://dx.doi.org/10.1016/j.immuni.2017.03.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6QR	28329698	Bronze			2022-12-18	WOS:000396818100005
J	Silverstein, NJ; Huh, JR				Silverstein, Noah J.; Huh, Jun R.			Interleukin-17: Why the Worms Squirm	IMMUNITY			English	Editorial Material							INTERFERON-GAMMA		[Silverstein, Noah J.; Huh, Jun R.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Silverstein, Noah J.; Huh, Jun R.] Univ Massachusetts, Sch Med, Dept Med, Program Innate Immun, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Huh, JR (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA.; Huh, JR (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Program Innate Immun, Worcester, MA 01605 USA.	jun.huh@umassmed.edu		Silverstein, Noah/0000-0001-5688-9978				Chen C, 2017, NATURE, V542, P210, DOI 10.1038/nature20817; Choi GB, 2016, SCIENCE, V351, P933, DOI 10.1126/science.aad0314; Filiano AJ, 2016, NATURE, V535, P425, DOI 10.1038/nature18626; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Kang J, 2015, ANNU REV IMMUNOL, V33, P505, DOI 10.1146/annurev-immunol-032414-112025; Kim T. K., 2016, MOL NEUROBIOL; Laurent P, 2015, ELIFE, V4, DOI 10.7554/eLife.04241; Schmidt C, 2015, NAT BIOTECHNOL, V33, P894, DOI 10.1038/nbt0915-894b; Stoop R, 2014, CURR OPIN NEUROBIOL, V29, P187, DOI 10.1016/j.conb.2014.09.012; Zhu PJ, 2011, CELL, V147, P1384, DOI 10.1016/j.cell.2011.11.029	10	2	2	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2017	46	3					347	349		10.1016/j.immuni.2017.03.007	http://dx.doi.org/10.1016/j.immuni.2017.03.007			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6QR	28329701	Bronze			2022-12-18	WOS:000396818100008
J	Openshaw, PJM				Openshaw, Peter J. M.			RSV Takes Control of Neonatal Breg Cells: Two Hands on the Wheel	IMMUNITY			English	Editorial Material							RESPIRATORY SYNCYTIAL VIRUS	The viral attachment protein of RSV has many surprising features, especially its mimicry of fractalkine (CX3CL1). Zhivaki et al. (2017) now show that, in addition to using this homology to attach to ciliated cells, it activates human neonatal regulatory B cells, thereby inhibiting immunological responses.	[Openshaw, Peter J. M.] Imperial Coll London, Natl Heart & Lung Inst, Resp Sci, St Marys Campus, London W2 1PG, England	Imperial College London	Openshaw, PJM (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, Resp Sci, St Marys Campus, London W2 1PG, England.	p.openshaw@imperial.ac.uk	Openshaw, Peter/AAL-9442-2020	Openshaw, Peter/0000-0002-7220-2555	Imperial's Health Protection Research Unit (HPRU) in Respiratory Infection; Imperial Biomedical Research Centre (BRC) at Imperial College Healthcare NHS Trust [IS-BRC-1215-20013]; Wellcome Trust [P57603/4]; Medical Research Council, UK [MR/R502121/1];  [602525]; Medical Research Council [G1000758, MR/R502121/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10150] Funding Source: researchfish; Asthma UK [MRC-AsthmaUKCentre, MRC-Asthma UK Centre] Funding Source: researchfish; MRC [MR/R502121/1] Funding Source: UKRI	Imperial's Health Protection Research Unit (HPRU) in Respiratory Infection; Imperial Biomedical Research Centre (BRC) at Imperial College Healthcare NHS Trust; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The author is a member of the EU FP7 PREPARE consortium (project 602525) and has a National Institute for Health Research (NIHR) Senior Investigator award. His work is also supported by Imperial's Health Protection Research Unit (HPRU) in Respiratory Infection and the Imperial Biomedical Research Centre (BRC) at Imperial College Healthcare NHS Trust (IS-BRC-1215-20013). He is in receipt of research funds from the Wellcome Trust (P57603/4) and Medical Research Council, UK (MR/R502121/1).	Jeong KI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130517; Johnson SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005318; Melero JA, 2017, VACCINE, V35, P461, DOI 10.1016/j.vaccine.2016.09.045; Openshaw P.J., 2017, ANN REV IMM IN PRESS; Rosser EC, 2015, IMMUNITY, V42, P607, DOI 10.1016/j.immuni.2015.04.005; Sparer TE, 1998, J EXP MED, V187, P1921, DOI 10.1084/jem.187.11.1921; Tripp RA, 2001, NAT IMMUNOL, V2, P732, DOI 10.1038/90675; Valarcher JF, 2001, VIROLOGY, V291, P55, DOI 10.1006/viro.2001.1083; Zhivaki D, 2017, IMMUNITY, V46, P301, DOI 10.1016/j.immuni.2017.01.010	9	2	3	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2017	46	2					171	173		10.1016/j.immuni.2017.01.011	http://dx.doi.org/10.1016/j.immuni.2017.01.011			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO0TM	28228275	Bronze, Green Accepted, Green Submitted			2022-12-18	WOS:000396410900005
J	Mahlakoiv, T; Artis, D				Mahlakoiv, Tanel; Artis, David			Allergen Exposure: When Timing Is Everything	IMMUNITY			English	Editorial Material							INNATE LYMPHOID-CELLS; LUNG INFLAMMATION	It is known that young children exposed to allergens are prone to develop asthma later in life. In this issue of Immunity, de Kleer et al. (2016) identify IL-33 as a key player in the developing lung for sensitization to environmental allergens and airway hyperreactivity.	[Mahlakoiv, Tanel; Artis, David] Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Joan & Sanford I Weill Dept Med, Weill Cornell Med,Dept Microbiol & Immunol, New York, NY 10021 USA	Cornell University	Artis, D (corresponding author), Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Joan & Sanford I Weill Dept Med, Weill Cornell Med,Dept Microbiol & Immunol, New York, NY 10021 USA.	dartis@med.cornell.edu		Mahlakoiv, Tanel/0000-0001-9059-0486; Artis, David/0000-0002-1753-4100				de Kleer IM, 2016, IMMUNITY, V45, P1285, DOI 10.1016/j.immuni.2016.10.031; Drake LY, 2016, J IMMUNOL, V196; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Ho J, 2015, CLIN EXP ALLERGY, V45, P394, DOI 10.1111/cea.12462; Hong JY, 2014, J ALLERGY CLIN IMMUN, V134, P429, DOI 10.1016/j.jaci.2014.04.020; Klose CSN, 2016, NAT IMMUNOL, V17, P765, DOI 10.1038/ni.3489; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Martinez-Gonzalez I, 2016, IMMUNITY, V45, P198, DOI 10.1016/j.immuni.2016.06.017; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Schuger L, 1996, DEVELOPMENT, V122, P1759	10	2	4	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 20	2016	45	6					1188	1190		10.1016/j.immuni.2016.12.007	http://dx.doi.org/10.1016/j.immuni.2016.12.007			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EJ0RN	28002727	Bronze			2022-12-18	WOS:000392918100006
J	Migueles, SA; Connors, M				Migueles, Stephen A.; Connors, Mark			Class II-Restricted CD8s: New Lessons Violate Old Paradigms	IMMUNITY			English	Editorial Material							T-CELLS; COMPLEX		[Migueles, Stephen A.; Connors, Mark] NIAID, HIV Specif Immun Sect, Immunoregulat Lab, Div Intramural Res, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Connors, M (corresponding author), NIAID, HIV Specif Immun Sect, Immunoregulat Lab, Div Intramural Res, 9000 Rockville Pike, Bethesda, MD 20892 USA.	mconnors@nih.gov			Intramural NIH HHS [Z99 AI999999, ZIA AI000855-18] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000855] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Hansen SG, 2016, SCIENCE, V351, P714, DOI 10.1126/science.aac9475; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hansen SG, 2013, SCIENCE, V340, P940, DOI 10.1126/science.1237874; Heemskerk MHM, 2001, P NATL ACAD SCI USA, V98, P6806, DOI 10.1073/pnas.111162298; Hirosawa T, 2011, CANCER SCI, V102, P1281, DOI 10.1111/j.1349-7006.2011.01949.x; Matechak EO, 1996, IMMUNITY, V4, P337, DOI 10.1016/S1074-7613(00)80247-2; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Ranasinghe S, 2016, IMMUNITY, V45, P917, DOI 10.1016/j.immuni.2016.09.015; Rist M, 2009, BLOOD, V114, P2244, DOI 10.1182/blood-2009-05-222596	9	2	2	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 18	2016	45	4					712	714		10.1016/j.immuni.2016.10.004	http://dx.doi.org/10.1016/j.immuni.2016.10.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FM	27760334	Green Accepted, Bronze			2022-12-18	WOS:000389473200004
J	Gaiha, GD; Walker, BD				Gaiha, Gaurav D.; Walker, Bruce D.			CD8(+) T Cells and cART: A Dynamic Duo?	IMMUNITY			English	Editorial Material							VIREMIA; INFECTION	A new macaque study by Cartwright et al. (2016) suggests that CD8(+) T cells could play a previously unrecognized role in the suppression of HIV-1 during ongoing antiretroviral therapy.	[Gaiha, Gaurav D.; Walker, Bruce D.] MIT & Harvard, MGH, Ragon Inst, Cambridge, MA 02139 USA; [Walker, Bruce D.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Walker, BD (corresponding author), MIT & Harvard, MGH, Ragon Inst, Cambridge, MA 02139 USA.; Walker, BD (corresponding author), MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA.; Walker, BD (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	bwalker@mgh.harvard.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Cartwright EK, 2016, IMMUNITY, V45, P656, DOI 10.1016/j.immuni.2016.08.018; Chun TW, 2011, J INFECT DIS, V204, P135, DOI 10.1093/infdis/jir208; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Gaufin T, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-42; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Maldarelli F, 2007, PLOS PATHOG, V3, P484, DOI 10.1371/journal.ppat.0030046; Ndhlovu ZM, 2015, IMMUNITY, V43, P591, DOI 10.1016/j.immuni.2015.08.012; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857	9	2	2	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 20	2016	45	3					466	468		10.1016/j.immuni.2016.09.003	http://dx.doi.org/10.1016/j.immuni.2016.09.003			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC9HD	27653598	Bronze			2022-12-18	WOS:000388454300005
J	Hu, GQ; Zhao, KJ				Hu, Gangqing; Zhao, Keji			Looping around Bcl6 in Germinal Center to Sharpen B Cell Immunity	IMMUNITY			English	Editorial Material							PROMOTER INTERACTIONS; ORGANIZATION; DOMAINS; GENOME; GENES	We are beginning to understand the function of 3D genome architecture in the immune system. In this issue, Bunting et al. (2016) reported massive multi-layer genome reorganization from naive B cells to germinal center B cells, centered on a locus control region of Bcl6.	[Hu, Gangqing; Zhao, Keji] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Zhao, KJ (corresponding author), NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA.	zhaok@nhlbi.nih.gov	Hu, Gangqing/ABA-3507-2020; Hu, Gangqing/K-5849-2012	Hu, Gangqing/0000-0001-5453-6888	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006031, ZIAHL006030] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bunting KL, 2016, IMMUNITY, V45, P497, DOI 10.1016/j.immuni.2016.08.012; Chepelev I, 2012, CELL RES, V22, P490, DOI 10.1038/cr.2012.15; Denker A, 2016, GENE DEV, V30, P1357, DOI 10.1101/gad.281964.116; Dixon JR, 2016, MOL CELL, V62, P668, DOI 10.1016/j.molcel.2016.05.018; Joshi O, 2015, CELL STEM CELL, V17, P748, DOI 10.1016/j.stem.2015.11.010; Kieffer-Kwon KR, 2013, CELL, V155, P1507, DOI 10.1016/j.cell.2013.11.039; Lin YC, 2012, NAT IMMUNOL, V13, P1196, DOI 10.1038/ni.2432; Mele M, 2016, MOL CELL, V62, P657, DOI 10.1016/j.molcel.2016.05.011; Ramachandrareddy H, 2010, P NATL ACAD SCI USA, V107, P11930, DOI 10.1073/pnas.1004962107; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115	10	2	2	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 20	2016	45	3					459	461		10.1016/j.immuni.2016.08.020	http://dx.doi.org/10.1016/j.immuni.2016.08.020			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC9HD	27653595	Bronze			2022-12-18	WOS:000388454300002
J	Bogunovic, M				Bogunovic, Milena			ILC3s and the Willow Tree of Voices	IMMUNITY			English	Editorial Material							INNATE LYMPHOID-CELLS	Type 3 innate lymphoid cells (ILC3s) and enteric glia, an essential structural component of gut innervation, are well-known regulators of intestinal homeostasis. Ibiza et al. (2016) uncover a new link between commensal bacteria, enteric glial cells, and ILC3s that is required for intestinal homeostasis and defense.	[Bogunovic, Milena] Penn State Univ, Dept Microbiol & Immunol, Coll Med, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Bogunovic, M (corresponding author), Penn State Univ, Dept Microbiol & Immunol, Coll Med, Hershey, PA 17033 USA.	mbogunovich@hmc.psu.edu						Bush TG, 1998, CELL, V93, P189, DOI 10.1016/S0092-8674(00)81571-8; Gabanyi I, 2016, CELL, V164, P378, DOI 10.1016/j.cell.2015.12.023; Ibiza S, 2016, NATURE, V535, P440, DOI 10.1038/nature18644; Kabouridis PS, 2015, NEURON, V85, P289, DOI 10.1016/j.neuron.2014.12.037; Magri G, 2014, NAT IMMUNOL, V15, P354, DOI 10.1038/ni.2830; Margolis KG, 2016, TRENDS IMMUNOL, V37, P487, DOI 10.1016/j.it.2016.05.003; Riol-Blanco L, 2014, NATURE, V510, P157, DOI 10.1038/nature13199; Schmidt PT, 1999, GUT, V45, P679, DOI 10.1136/gut.45.5.679; van de Pavert SA, 2009, NAT IMMUNOL, V10, P1193, DOI 10.1038/ni.1789; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597	10	2	3	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 16	2016	45	2					238	239		10.1016/j.immuni.2016.08.004	http://dx.doi.org/10.1016/j.immuni.2016.08.004			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DU5QV	27533011	Bronze			2022-12-18	WOS:000382267300007
J	Hildebrand, JM; Murphy, JM				Hildebrand, Joanne M.; Murphy, James M.			The Highway to Hell: A RIP Kinase-Directed Shortcut to Inflammatory Cytokine Production	IMMUNITY			English	Editorial Material							NECROPTOSIS; ACTIVATION; APOPTOSIS; NECROSIS; MLKL	RIPK1 and RIPK3 are well-known signaling traffic cops in innate immunity. In this issue of Immunity, Degterev and colleagues show that when they blow the whistle on bacterial infection, they quickly point a white-gloved hand down the express route to inflammatory cytokine production.	[Hildebrand, Joanne M.; Murphy, James M.] Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia; [Hildebrand, Joanne M.; Murphy, James M.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia	Walter & Eliza Hall Institute; University of Melbourne	Murphy, JM (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia.; Murphy, JM (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia.	jamesm@wehi.edu.au	Murphy, James/B-4863-2017	Murphy, James/0000-0003-0195-3949; Hildebrand, Joanne/0000-0002-1456-2042				Dillon CP, 2014, CELL, V157, P1189, DOI 10.1016/j.cell.2014.04.018; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; McComb S, 2014, P NATL ACAD SCI USA, V111, pE3206, DOI 10.1073/pnas.1407068111; Moujalled DM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.201; Najjar M, 2016, IMMUNITY, V45, P46, DOI 10.1016/j.immuni.2016.06.007; Newton K, 2014, SCIENCE, V343, P1357, DOI 10.1126/science.1249361; Rickard JA, 2014, CELL, V157, P1175, DOI 10.1016/j.cell.2014.04.019; Tanzer MC, 2015, BIOCHEM J, V471, P255, DOI 10.1042/BJ20150678; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Wong WWL, 2014, BLOOD, V123, P2562, DOI 10.1182/blood-2013-06-510743	10	2	2	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 19	2016	45	1					1	3		10.1016/j.immuni.2016.06.029	http://dx.doi.org/10.1016/j.immuni.2016.06.029			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS4KC	27438758	Bronze			2022-12-18	WOS:000380749000001
J	Magri, G; Cerutti, A				Magri, Giuliana; Cerutti, Andrea			A Touch of Youth in Gut Microbiota Development	IMMUNITY			English	Editorial Material							IMMUNOGLOBULIN-A; IGA; RESPONSES; ANTIBODIES; BACTERIA; DISEASE	In a recent issue of Nature, Gordon and colleagues show that, during the first 2 years life, the assembly of the gut microbiota follows predictable architectural patterns that correlate with the development of commensal-specific immunoglobulin A responses.	[Magri, Giuliana; Cerutti, Andrea] Inst Hosp Mar Invest Med, Barcelona Biomed Res Pk, Barcelona 08003, Spain; [Cerutti, Andrea] Catalan Inst Res & Adv Studies, Barcelona Biomed Res Pk, Barcelona 08003, Spain; [Cerutti, Andrea] Icahn Sch Med Mt Sinai, Inst Immunol, Dept Med, Div Clin Immunol, New York, NY 10029 USA	Pompeu Fabra University; ICREA; Pompeu Fabra University; Icahn School of Medicine at Mount Sinai	Cerutti, A (corresponding author), Inst Hosp Mar Invest Med, Barcelona Biomed Res Pk, Barcelona 08003, Spain.; Cerutti, A (corresponding author), Catalan Inst Res & Adv Studies, Barcelona Biomed Res Pk, Barcelona 08003, Spain.; Cerutti, A (corresponding author), Icahn Sch Med Mt Sinai, Inst Immunol, Dept Med, Div Clin Immunol, New York, NY 10029 USA.	andrea.cerutti@mssm.edu	Magri, Giuliana/K-6552-2014	Magri, Giuliana/0000-0002-0163-3542; Cerutti, Andrea/0000-0003-3026-4704	ICREA Funding Source: Custom	ICREA(ICREA)		Bunker JJ, 2015, IMMUNITY, V43, P541, DOI 10.1016/j.immuni.2015.08.007; Gutzeit C, 2014, IMMUNOL REV, V260, P76, DOI 10.1111/imr.12189; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Kau AL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4877; Koch MA, 2016, CELL, V165, P827, DOI 10.1016/j.cell.2016.04.055; Lindner C, 2015, NAT IMMUNOL, V16, P880, DOI 10.1038/ni.3213; Pabst O, 2016, TRENDS IMMUNOL, V37, P287, DOI 10.1016/j.it.2016.03.002; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Planer JD, 2016, NATURE, V534, P263, DOI 10.1038/nature17940	10	2	2	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 19	2016	45	1					12	14		10.1016/j.immuni.2016.07.002	http://dx.doi.org/10.1016/j.immuni.2016.07.002			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS4KC	27438763	Bronze			2022-12-18	WOS:000380749000006
J	Schneider, DS				Schneider, David Samuel			Battling the Bite: Tradeoffs in Immunity to Insect-Borne Pathogens	IMMUNITY			English	Editorial Material								Effective pathogens are successful, by definition, because they can defeat our immune response. Pingen et al. (2016) in this issue of Immunity demonstrate that some mosquito-transmitted viruses depend upon a strong host immune response triggered by the innate immune response to the bite to promote dissemination through the body.	[Schneider, David Samuel] Stanford Microbiol & Immunol, Stanford, CA 94305 USA		Schneider, DS (corresponding author), Stanford Microbiol & Immunol, Stanford, CA 94305 USA.	dschneid@stanford.edu						Ayres JS, 2012, ANNU REV IMMUNOL, V30, P271, DOI 10.1146/annurev-immunol-020711-075030; Collin N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000441; Oliveira F, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3043; Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002; Read AF, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002198; Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024; Vale PF, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001769	7	2	2	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 21	2016	44	6					1251	1252		10.1016/j.immuni.2016.06.008	http://dx.doi.org/10.1016/j.immuni.2016.06.008			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP2SE	27332728	Bronze			2022-12-18	WOS:000378341200005
J	Doria-Rose, NA; Mascola, JR				Doria-Rose, Nicole A.; Mascola, John R.			HIV Immunology Goes Out On a Limb	IMMUNITY			English	Editorial Material							BROADLY NEUTRALIZING ANTIBODIES; HIGH-MANNOSE PATCH; MATURATION; LINEAGE	Vaccines against HIV most likely need to elicit broadly neutralizing antibodies. In this issue of Immunity, Poignard and colleagues describe the co-evolution of a broadly neutralizing antibody and the virus that triggered it, providing a template for HIV vaccine design.	[Doria-Rose, Nicole A.; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Mascola, JR (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jmascola@mail.nih.gov	Mascola, John/AAI-7193-2021					Bhiman JN, 2015, NAT MED, V21, P1332, DOI 10.1038/nm.3963; Bonsignori M, 2016, CELL, V165, P449, DOI 10.1016/j.cell.2016.02.022; Doores KJ, 2015, J VIROL, V89, P1105, DOI 10.1128/JVI.02905-14; Doria-Rose NA, 2016, J VIROL, V90, P76, DOI 10.1128/JVI.01791-15; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Gao F, 2014, CELL, V158, P481, DOI 10.1016/j.cell.2014.06.022; Garces F, 2015, IMMUNITY, V43, P1053, DOI 10.1016/j.immuni.2015.11.007; Landais E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005369; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; MacLeod DT, 2016, IMMUNITY, V44, P1215, DOI 10.1016/j.immuni.2016.04.016	10	2	2	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 17	2016	44	5					1088	1090		10.1016/j.immuni.2016.05.004	http://dx.doi.org/10.1016/j.immuni.2016.05.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM6QW	27192575	Bronze			2022-12-18	WOS:000376478500013
J	Malhotra, D; Jenkins, MK				Malhotra, Deepali; Jenkins, Marc K.			Regulatory T Cells: A Crisis Averted	IMMUNITY			English	Editorial Material							SELF; TOLERANCE; ANTIGEN; THYMUS	Although regulatory T cells protect people from autoimmunity, two recent papers in Immunity (Malchow et al., 2016; Kieback et al., 2016) demonstrate that these cells are also a crisis averted. Without the proper education in the thymus, these cells will turn on their host and cause autoimmunity.	[Malhotra, Deepali; Jenkins, Marc K.] Univ Minnesota, Sch Med, Dept Microbiol & Immunol, Ctr Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Jenkins, MK (corresponding author), Univ Minnesota, Sch Med, Dept Microbiol & Immunol, Ctr Immunol, Minneapolis, MN 55455 USA.	jenki002@umn.edu	Jenkins, Marc K/G-1063-2012	Jenkins, Marc K/0000-0001-8009-7655; Malhotra, Deepali/0000-0002-8215-7639	NCI NIH HHS [P30 CA077598] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Birnbaum ME, 2014, CELL, V157, P1073, DOI 10.1016/j.cell.2014.03.047; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Kieback E, 2016, IMMUNITY, V44, P1114, DOI 10.1016/j.immuni.2016.04.018; Legoux FP, 2015, IMMUNITY, V43, P896, DOI 10.1016/j.immuni.2015.10.011; Malchow S, 2016, IMMUNITY, V44, P1102, DOI 10.1016/j.immuni.2016.02.009; Malhotra D, 2016, NAT IMMUNOL, V17, P187, DOI 10.1038/ni.3327; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Nelson RW, 2015, IMMUNITY, V42, P95, DOI 10.1016/j.immuni.2014.12.022; Stritesky GL, 2013, P NATL ACAD SCI USA, V110, P4679, DOI 10.1073/pnas.1217532110; Yu W, 2015, IMMUNITY, V42, P929, DOI 10.1016/j.immuni.2015.05.001	11	2	2	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 17	2016	44	5					1079	1081		10.1016/j.immuni.2016.04.025	http://dx.doi.org/10.1016/j.immuni.2016.04.025			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM6QW	27192571	Bronze			2022-12-18	WOS:000376478500009
J	Exley, MA				Exley, Mark A.			What Makes MAITs Wait?	IMMUNITY			English	Editorial Material							KILLER T-CELLS; ACTIVATION; ANTIGENS	Mucosal-associated invariant T (MAIT) cells recognize microbial non-peptidic antigens presented by non-classical MHC MR1. In this issue of Immunity, Gherardin et al. (2016) show co-crystal structures of MR1 complexed to T cell receptors (TCRs) from two classes of MAIT-type cells.	[Exley, Mark A.] Univ Manchester, Manchester Collaborat Ctr Inflammat Res, Manchester M13 9NT, Lancs, England; [Exley, Mark A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Gastroenterol, Boston, MA 02115 USA; [Exley, Mark A.] Agenus Inc, Lexington, MA 02421 USA	University of Manchester; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Agenus Inc	Exley, MA (corresponding author), Univ Manchester, Manchester Collaborat Ctr Inflammat Res, Manchester M13 9NT, Lancs, England.	mexley@partners.org		Exley, Mark/0000-0002-5088-1032	NCI NIH HHS [CA170194] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA170194] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brennan PJ, 2013, NAT REV IMMUNOL, V13, P101, DOI 10.1038/nri3369; Chandra S, 2015, ADV IMMUNOL, V127, P145, DOI 10.1016/bs.ai.2015.03.003; Corbett AJ, 2014, NATURE, V509, P361, DOI 10.1038/nature13160; Gapin L, 2014, J IMMUNOL, V192, P4475, DOI 10.4049/jimmunol.1400119; Gherardin NA, 2016, IMMUNITY, V44, P32, DOI 10.1016/j.immuni.2015.12.005; Girardi E, 2012, NAT IMMUNOL, V13, P851, DOI 10.1038/ni.2371; Godfrey DI, 2015, NAT IMMUNOL, V16, P1114, DOI 10.1038/ni.3298; Le Bourhis L, 2013, CURR OPIN IMMUNOL, V25, P174, DOI 10.1016/j.coi.2013.01.005; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Salio M, 2014, ANNU REV IMMUNOL, V32, P323, DOI 10.1146/annurev-immunol-032713-120243	10	2	2	1	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 19	2016	44	1					7	9		10.1016/j.immuni.2015.12.021	http://dx.doi.org/10.1016/j.immuni.2015.12.021			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB2NU	26789915	Bronze			2022-12-18	WOS:000368347000004
J	Forster, R; Worbs, T; Werth, K				Foerster, Reinhold; Worbs, Tim; Werth, Kathrin			A 4-midable Connection: CCR7 Tetramers Link GPCR to Src Kinase Signaling	IMMUNITY			English	Editorial Material							LYMPH-NODES; MIGRATION; GRADIENTS; IMMUNITY; LIGANDS; CELLS	Chemokine receptors are known to signal through heterotrimeric G proteins. In this issue, Hauser et al. (2016) report that inflammatory cues can induce tetramers of the chemokine receptor CCR7 that serve as scaffolds integrating G protein with Src kinase signaling.	[Foerster, Reinhold; Worbs, Tim; Werth, Kathrin] Hannover Med Sch, Inst Immunol, D-30625 Hannover, Germany	Hannover Medical School	Forster, R (corresponding author), Hannover Med Sch, Inst Immunol, D-30625 Hannover, Germany.	foerster.reinhold@mh-hannover.de	Förster, Reinhold/D-6770-2011	Forster, Reinhold/0000-0001-6190-7923; Worbs, Tim/0000-0001-9945-3103				Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Girard JP, 2012, NAT REV IMMUNOL, V12, P762, DOI 10.1038/nri3298; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Hauser MA, 2016, IMMUNITY, V44, P59, DOI 10.1016/j.immuni.2015.12.010; Kiermaier E., 2015, SCIENCE; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; Shulman Z, 2012, NAT IMMUNOL, V13, P67, DOI 10.1038/ni.2173; Ulvmar MH, 2014, NAT IMMUNOL, V15, P623, DOI 10.1038/ni.2889; Zidar DA, 2009, P NATL ACAD SCI USA, V106, P9649, DOI 10.1073/pnas.0904361106	10	2	2	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 19	2016	44	1					9	11		10.1016/j.immuni.2015.12.009	http://dx.doi.org/10.1016/j.immuni.2015.12.009			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB2NU	26789916	Bronze			2022-12-18	WOS:000368347000005
J	Brodin, P				Brodin, Petter			Powerful Populations Respond to Viruses and Vaccines	IMMUNITY			English	Editorial Material								In this issue of Immunity, Andres-Terre et al. (2015) and Nakaya et al. (2015) perform multi- cohort meta-analyses of immune responses to viruses and vaccines. With increased statistical power and more diverse sampling populations, their findings promise to be more generally applicable and suggestive of novel mechanisms for regulating immunity.	[Brodin, Petter] Karolinska Inst, Dept Med Solna, Sci Life Lab, S-17121 Stockholm, Sweden	Karolinska Institutet	Brodin, P (corresponding author), Karolinska Inst, Dept Med Solna, Sci Life Lab, S-17121 Stockholm, Sweden.	petter.brodin@ki.se	Brodin, Petter/C-3317-2011	Brodin, Petter/0000-0002-8103-0046				Andres-Terre M, 2015, IMMUNITY, V43, P1199, DOI 10.1016/j.immuni.2015.11.003; Bhattacharya S, 2014, IMMUNOL RES, V58, P234, DOI 10.1007/s12026-014-8516-1; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Furman D, 2014, P NATL ACAD SCI USA, V111, P869, DOI 10.1073/pnas.1321060111; Hagan T, 2015, VACCINE, V33, P5294, DOI 10.1016/j.vaccine.2015.03.072; Janetzki S, 2009, IMMUNITY, V31, P527, DOI 10.1016/j.immuni.2009.09.007; Khatri P, 2013, J EXP MED, V210, P2205, DOI 10.1084/jem.20122709; Nakaya HI, 2015, IMMUNITY, V43, P1186, DOI 10.1016/j.immuni.2015.11.012; Ravindran R, 2014, SCIENCE, V343, P313, DOI 10.1126/science.1246829; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499	11	2	2	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2015	43	6					1035	1037		10.1016/j.immuni.2015.11.018	http://dx.doi.org/10.1016/j.immuni.2015.11.018			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DS	26682979	Bronze			2022-12-18	WOS:000366846600007
J	Conejo-Garcia, JR; Rutkowski, MR				Conejo-Garcia, Jose R.; Rutkowski, Melanie R.			Small but Mighty: Selected Commensal Bacterial Species Determine the Effectiveness of Anti-cancer Immunotherapies	IMMUNITY			English	Editorial Material							MICROBIOTA; INFLAMMATION	Commensal microorganisms influence malignant progression by altering systemic inflammation. New data from two groups (Vetizou et al., 2015; Sivan et al., 2015) indicate that the abundance of specific commensal bacterial species enhances the anti-cancer activity of immune checkpoint inhibitors.	[Conejo-Garcia, Jose R.] Wistar Inst Anat & Biol, Tumor Microenvironm & Metastasis Program, Philadelphia, PA 19104 USA; [Rutkowski, Melanie R.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA	The Wistar Institute; University of Virginia	Conejo-Garcia, JR (corresponding author), Wistar Inst Anat & Biol, Tumor Microenvironm & Metastasis Program, 3601 Spruce St, Philadelphia, PA 19104 USA.	jrconejo@wistar.org	Conejo-Garcia, Jose R/V-1897-2019	Conejo-Garcia, Jose R/0000-0001-6431-4074; Rutkowski, Melanie/0000-0001-8604-815X	NATIONAL CANCER INSTITUTE [R01CA124515, P30CA010815] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA010815, R01 CA124515] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Rutkowski MR, 2015, CANCER CELL, V27, P27, DOI 10.1016/j.ccell.2014.11.009; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Tuddenham S, 2015, CURR OPIN INFECT DIS, V28, P464, DOI 10.1097/QCO.0000000000000196; Veiga P, 2010, P NATL ACAD SCI USA, V107, P18132, DOI 10.1073/pnas.1011737107; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537	10	2	2	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2015	43	6					1037	1039		10.1016/j.immuni.2015.11.014	http://dx.doi.org/10.1016/j.immuni.2015.11.014			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DS	26682980	Bronze			2022-12-18	WOS:000366846600008
J	Munz, C				Muenz, Christian			Live Long and Prosper for Antigen Cross-Presentation	IMMUNITY			English	Editorial Material							CROSSPRESENTATION; COMPARTMENT	Even though proteolytic antigen fragments are displayed for cross-presentation, rapid proteolysis of endocytosed antigens inhibits this process. In this issue of Immunity, Alloatti et al. (2015) describe how maturing dendritic cells keep phagosomes and lysosomes apart to ensure extended antigen life that leads to prosperous cross-presentation.	[Muenz, Christian] Univ Zurich, Inst Expt Immunol, Viral Immunobiol, CH-8057 Zurich, Switzerland	University of Zurich	Munz, C (corresponding author), Univ Zurich, Inst Expt Immunol, Viral Immunobiol, CH-8057 Zurich, Switzerland.	christian.muenz@uzh.ch	Münz, Christian/W-4881-2017	Munz, Christian/0000-0001-6419-1940				Alloatti A, 2015, IMMUNITY, V43, P1087, DOI 10.1016/j.immuni.2015.11.006; Cebrian I, 2011, CELL, V147, P1355, DOI 10.1016/j.cell.2011.11.021; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Nair-Gupta P, 2014, CELL, V158, P506, DOI 10.1016/j.cell.2014.04.054; Romao S, 2013, J CELL BIOL, V203, P757, DOI 10.1083/jcb.201308173; Samie M, 2015, NAT IMMUNOL, V16, P729, DOI 10.1038/ni.3196; Saveanu L, 2009, SCIENCE, V325, P213, DOI 10.1126/science.1172845; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Manh TPV, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00260; Wang TL, 2002, MOL BIOL CELL, V13, P4317, DOI 10.1091/mbc.E02-05-0280	10	2	2	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2015	43	6					1028	+		10.1016/j.immuni.2015.11.013	http://dx.doi.org/10.1016/j.immuni.2015.11.013			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DS	26682976	Bronze			2022-12-18	WOS:000366846600004
J	Snyder, CM				Snyder, Christopher M.			Front-Line Memory T Cells Think Outside the T-box... Mostly	IMMUNITY			English	Editorial Material							MAINTENANCE; EFFECTOR	Tissue-resident memory T (Trm) cells patrol barrier tissues. In this issue of Immunity, Carbone and colleagues show that downregulation of T-box proteins Eomesodermin and T-bet is critical for their differentiation, but residual levels of T-bet are important for long-term Trm survival and function.	[Snyder, Christopher M.] Thomas Jefferson Univ, Dept Microbiol & Immunol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Jefferson University	Snyder, CM (corresponding author), Thomas Jefferson Univ, Dept Microbiol & Immunol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA.	christopher.snyder@jefferson.edu		Snyder, Christopher/0000-0003-1370-7198				Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Laidlaw BJ, 2014, IMMUNITY, V41, P633, DOI 10.1016/j.immuni.2014.09.007; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Zhang N, 2013, IMMUNITY, V39, P687, DOI 10.1016/j.immuni.2013.08.019	9	2	2	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2015	43	6					1030	1032		10.1016/j.immuni.2015.11.020	http://dx.doi.org/10.1016/j.immuni.2015.11.020			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DS	26682977	Bronze			2022-12-18	WOS:000366846600005
J	Lee, JS; Tato, CM; Joyce-Shaikh, B; Gulen, MF; Cayatte, C; Chen, Y; Blumenschein, WM; Judo, M; Ayanoglu, G; McClanahan, TK; Li, XX; Cua, DJ				Lee, Jacob S.; Tato, Cristina M.; Joyce-Shaikh, Barbara; Gulen, Muhammet F.; Cayatte, Corinne; Chen, Yi; Blumenschein, Wendy M.; Judo, Michael; Ayanoglu, Gulesi; McClanahan, Terrill K.; Li, Xiaoxia; Cua, Daniel J.			Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability (vol 43, pg 727, 2015 )	IMMUNITY			English	Correction												daniel.cua@merck.com						Lee JS, 2015, IMMUNITY, V43, P727, DOI 10.1016/j.immuni.2015.09.003	1	2	2	1	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2015	43	5					1022	1022		10.1016/j.immuni.2015.10.019	http://dx.doi.org/10.1016/j.immuni.2015.10.019			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DM		Bronze			2022-12-18	WOS:000366846000021
J	Sanford, JA; Gallo, RL				Sanford, James A.; Gallo, Richard L.			IL-17A Has Some Nerve!	IMMUNITY			English	Editorial Material							SENSORY NEURONS; CELLS	Sensory neurons are important in controlling cutaneous inflammation, but the role of neurons in host antimicrobial defense was relatively unknown. Kaplan and colleagues now demonstrate that nociceptive fibers within the dermis play a crucial role in antifungal defenses through their influence on dermal dendritic cells and induction of IL-17A.	[Sanford, James A.; Gallo, Richard L.] Univ Calif San Diego, Dept Dermatol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Gallo, RL (corresponding author), Univ Calif San Diego, Dept Dermatol, La Jolla, CA 92093 USA.	rgallo@ucsd.edu	Gallo, Richard L/A-8931-2009	Gallo, Richard L/0000-0002-1401-7861; Sanford, James/0000-0001-7901-5579				Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Gray EE, 2011, J IMMUNOL, V186, P6091, DOI 10.4049/jimmunol.1100427; Kashem SW, 2015, IMMUNITY, V43, P515, DOI 10.1016/j.immuni.2015.08.016; MacLeod AS, 2013, J CLIN INVEST, V123, P4364, DOI 10.1172/JCI70064; McDonald DR, 2012, J ALLERGY CLIN IMMUN, V129, P1429, DOI 10.1016/j.jaci.2012.03.034; Meseguer V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4125; Ostrowski SM, 2011, J INVEST DERMATOL, V131, P1530, DOI 10.1038/jid.2011.60; Radek KA, 2010, CELL HOST MICROBE, V7, P277, DOI 10.1016/j.chom.2010.03.009; Riol-Blanco L, 2014, NATURE, V510, P157, DOI 10.1038/nature13199	10	2	2	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2015	43	3					414	415		10.1016/j.immuni.2015.08.025	http://dx.doi.org/10.1016/j.immuni.2015.08.025			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CR8BE	26377893	Bronze			2022-12-18	WOS:000361575300003
J	Kostrzewski, T; Brady, HJM				Kostrzewski, Tomasz; Brady, Hugh J. M.			ILC Lineage Specification: To Be or Not 11b, That Is the Question	IMMUNITY			English	Editorial Material							TRANSCRIPTION FACTOR BCL11B; CELLS	The transcription factor Bcl11b is important for T cell development and maintaining their phenotype. In this issue of Immunity, Califano et al. (2015) show that Bcl11b has a role in specifying type II innate lymphoid cell (ILC2) identity and blocks their conversion to ILC3s.	[Kostrzewski, Tomasz; Brady, Hugh J. M.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England	Imperial College London	Brady, HJM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England.	h.brady@imperial.ac.uk		Brady, Hugh/0000-0002-3152-067X	Medical Research Council [G0901737] Funding Source: Medline; MRC [G0901737] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Califano D, 2015, IMMUNITY, V43, P354, DOI 10.1016/j.immuni.2015.07.005; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Li P, 2010, SCIENCE, V329, P85, DOI 10.1126/science.1188063; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Walker JA, 2015, J EXP MED, V212, P875, DOI 10.1084/jem.20142224; Yang Q, 2013, IMMUNITY, V38, P694, DOI 10.1016/j.immuni.2012.12.003; Yu Y, 2015, J EXP MED, V212, P865, DOI 10.1084/jem.20142318	10	2	2	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2015	43	2					220	222		10.1016/j.immuni.2015.08.005	http://dx.doi.org/10.1016/j.immuni.2015.08.005			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WW	26287679	Bronze			2022-12-18	WOS:000360101200005
J	Lambrecht, BN; Galli, SJ				Lambrecht, Bart N.; Galli, Stephen J.			SnapShot: Integrated Type 2 Immune Responses	IMMUNITY			English	Editorial Material													Lambrecht, Bart N/K-2484-2014	Lambrecht, Bart N/0000-0003-4376-6834					0	2	2	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2015	43	2					408	408		10.1016/j.immuni.2015.07.019	http://dx.doi.org/10.1016/j.immuni.2015.07.019			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WW	26287685	Green Published, Bronze			2022-12-18	WOS:000360101200021
J	Wagner, JA; Fehniger, TA				Wagner, Julia A.; Fehniger, Todd A.			Memory NK Cells Take Out the (Mitochondrial) Garbage	IMMUNITY			English	Editorial Material							NATURAL-KILLER-CELLS	The molecular mechanisms important to generate innate natural killer cell "memory" are poorly understood. In this issue of Immunity, O'Sullivan et al. (2015) demonstrate that mitophagy plays a critical role in natural killer cell memory formation following viral infection.	[Wagner, Julia A.; Fehniger, Todd A.] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA	Washington University (WUSTL)	Fehniger, TA (corresponding author), Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA.	tfehnige@wustl.edu						Cooper MA, 2009, P NATL ACAD SCI USA, V106, P1915, DOI 10.1073/pnas.0813192106; Min-Oo G, 2013, TRENDS IMMUNOL, V34, P251, DOI 10.1016/j.it.2013.02.005; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; O'Sullivan T.E., 2015, J INNATE IMMUN; O'Sullivan TE, 2015, IMMUNITY, V43, P331, DOI 10.1016/j.immuni.2015.07.012; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Xu XJ, 2014, NAT IMMUNOL, V15, P1152, DOI 10.1038/ni.3025	7	2	4	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2015	43	2					218	220		10.1016/j.immuni.2015.08.009	http://dx.doi.org/10.1016/j.immuni.2015.08.009			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WW	26287678	Bronze			2022-12-18	WOS:000360101200004
J	Nechanitzky, R; Mak, TW				Nechanitzky, Robert; Mak, Tak Wah			Passenger Mutations Identified in the Blink of an Eye	IMMUNITY			English	Editorial Material							MICE	Passenger mutations specific to particular mouse strains can distort experimental outcomes. In this issue of Immunity, Vanden Berghe et al. (2015) demonstrate that passenger mutations are frequent in most genetically engineered congenic mice and persist even after extensive backcrossing.	[Nechanitzky, Robert; Mak, Tak Wah] Univ Hlth Network, Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto	Mak, TW (corresponding author), Univ Hlth Network, Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2M9, Canada.	tmak@uhnresearch.ca		Nechanitzky, Robert/0000-0002-0429-0688				Gertsenstein M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011260; Hall Bradford, 2009, Curr Protoc Cell Biol, VChapter 19, DOI 10.1002/0471143030.cb1912s44; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kenneth NS, 2012, BIOCHEM J, V443, P355, DOI 10.1042/BJ20120249; Ledford H, 2015, NATURE, V522, P20, DOI 10.1038/522020a; Lin CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106916; Lusis AJ, 2007, ARTERIOSCL THROM VAS, V27, P2100, DOI 10.1161/ATVBAHA.107.147918; Vanden Berghe T, 2015, IMMUNITY, V43, P200, DOI 10.1016/j.immuni.2015.06.011; Yalcin B, 2011, NATURE, V477, P326, DOI 10.1038/nature10432	10	2	2	1	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 21	2015	43	1					9	11		10.1016/j.immuni.2015.07.004	http://dx.doi.org/10.1016/j.immuni.2015.07.004			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WV	26200008	Bronze			2022-12-18	WOS:000360101100005
J	Boothby, MR; Raybuck, AL; Cho, SH				Boothby, Mark R.; Raybuck, Ariel L.; Cho, Sung Hoon			Complementing T Cells' Functions: Bringing in Metabolism Matters	IMMUNITY			English	Editorial Material							RESPONSES; SIGNALS; C5A	Components of the complement system act directly on T cells to alter conventional and regulatory T cell subsets. In this issue of Immunity, Kolev, Dimeloe, Le Friec et al. (2015) provide evidence of a mechanism by which the complement stimulates sustained mTORC1 activation and regulates cellular metabolism.	[Boothby, Mark R.; Cho, Sung Hoon] Vanderbilt Univ, Program Immunol, Nashville, TN 37232 USA; [Boothby, Mark R.] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; [Boothby, Mark R.; Raybuck, Ariel L.; Cho, Sung Hoon] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Boothby, MR (corresponding author), Vanderbilt Univ, Program Immunol, Nashville, TN 37232 USA.	mark.boothby@vanderbilt.edu		Raybuck, Ariel/0000-0003-3445-2112				Kolev M, 2015, IMMUNITY, V42, P1033, DOI 10.1016/j.immuni.2015.05.024; Kwan WH, 2013, J EXP MED, V210, P257, DOI 10.1084/jem.20121525; Lajoie S, 2013, IMMUNITY, V39, P1000, DOI 10.1016/j.immuni.2013.11.015; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Pekkarinen PT, 2015, EUR J IMMUNOL, V45, P915, DOI 10.1002/eji.201444948; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; Truscott SM, 2010, INFECT IMMUN, V78, P5295, DOI 10.1128/IAI.00513-10; Yang K, 2013, IMMUNITY, V39, P1043, DOI 10.1016/j.immuni.2013.09.015; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297	10	2	2	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2015	42	6					977	979		10.1016/j.immuni.2015.06.008	http://dx.doi.org/10.1016/j.immuni.2015.06.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK6UC	26084014	Bronze			2022-12-18	WOS:000356362800001
J	Nelson, RW; Beisang, D; Tubo, NJ; Dileepan, T; Wiesner, DL; Nielsen, K; Wuthrich, M; Klein, BS; Kotov, DI; Spanier, JA; Fife, BT; Moon, JJ; Jenkins, MK				Nelson, Ryan W.; Beisang, Daniel; Tubo, Noah J.; Dileepan, Thamotharampillai; Wiesner, Darin L.; Nielsen, Kirsten; Wuethrich, Marcel; Klein, Bruce S.; Kotov, Dmitri I.; Spanier, Justin A.; Fife, Brian T.; Moon, James J.; Jenkins, Marc K.			T Cell Receptor Cross-Reactivity between Similar Foreign and Self Peptides Influences Naive Cell Population Size and Autoimmunity (vol 42, pg 95, 2015)	IMMUNITY			English	Correction												jenki002@umn.edu	Jenkins, Marc K/G-1063-2012; moon, james/F-1031-2014; Fife, Brian/D-2042-2013	Jenkins, Marc K/0000-0001-8009-7655; moon, james/0000-0001-8071-1491; Fife, Brian/0000-0001-9826-5637; DILEEPAN, THAMOTHARAMPILLAI/0000-0002-2810-6996				Nelson RW, 2015, IMMUNITY, V42, P95, DOI 10.1016/j.immuni.2014.12.022	1	2	2	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2015	42	6					1212	1213		10.1016/j.immuni.2015.06.007	http://dx.doi.org/10.1016/j.immuni.2015.06.007			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK6UC		Bronze			2022-12-18	WOS:000356362800023
J	Onder, L; Ludewig, B				Onder, Lucas; Ludewig, Burkhard			Another TLO in the Wall: Education and Control of T Cells in Atherosclerotic Arteries	IMMUNITY			English	Editorial Material							LYMPHOID-TISSUE; CORONARY-ARTERY	Atherosclerosis is a lipid-storage disease of arteries that is exacerbated by chronic inflammatory processes. In this issue of Immunity, Hu et al. (2015) demonstrate that T cell responses in atherosclerotic lesions are controlled in tertiary lymphoid organs in the arterial wall.	[Onder, Lucas; Ludewig, Burkhard] Kantonsspital St Gallen, Inst Immunobiol, CH-9007 St Gallen, Switzerland	Kantonsspital St. Gallen	Ludewig, B (corresponding author), Kantonsspital St Gallen, Inst Immunobiol, CH-9007 St Gallen, Switzerland.	burkhard.ludewig@kssg.ch			British Heart Foundation [PG/12/81/29897] Funding Source: Medline	British Heart Foundation(British Heart Foundation)		Grabner R, 2009, J EXP MED, V206, P233, DOI 10.1084/jem.20080752; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hu DS, 2015, IMMUNITY, V42, P1100, DOI 10.1016/j.immuni.2015.05.015; Junt T, 2008, NAT REV IMMUNOL, V8, P764, DOI 10.1038/nri2414; Lotzer K, 2010, ARTERIOSCL THROM VAS, V30, P395, DOI 10.1161/ATVBAHA.109.191395; Onder L, 2013, J EXP MED, V210, P465, DOI 10.1084/jem.20121462; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; Watanabe M, 2007, J ATHEROSCLER THROMB, V14, P325, DOI 10.5551/jat.E489; Wick G, 1997, FASEB J, V11, P1199, DOI 10.1096/fasebj.11.13.9367355	10	2	2	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2015	42	6					981	983		10.1016/j.immuni.2015.05.022	http://dx.doi.org/10.1016/j.immuni.2015.05.022			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK6UC	26084016	Bronze			2022-12-18	WOS:000356362800003
J	McGovern, N; Schlitzer, A; Gunawan, M; Jardine, L; Shin, A; Poyner, E; Green, K; Dickinson, R; Wang, XN; Low, D; Best, K; Covins, S; Milne, P; Pagan, S; Aljefri, K; Windebank, M; Miranda-Saavedra, D; Larbi, A; Wasan, PS; Kaibo, D; Poidinger, M; Bigley, V; Ginhoux, F; Collin, M; Haniffa, M				McGovern, Naomi; Schlitzer, Andreas; Gunawan, Merry; Jardine, Laura; Shin, Amanda; Poyner, Elizabeth; Green, Kile; Dickinson, Rachel; Wang, Xiao-nong; Low, Donovan; Best, Katie; Covins, Samuel; Milne, Paul; Pagan, Sarah; Aljefri, Khadija; Windebank, Martin; Miranda-Saavedra, Diego; Larbi, Anis; Wasan, Pavandip Singh; Kaibo, Duan; Poidinger, Michael; Bigley, Venetia; Ginhoux, Florent; Collin, Matthew; Haniffa, Muzlifah			Population of Monocyte-Derived Macrophages (vol 41, pg 465, 2014)	IMMUNITY			English	Correction												matthew.collin@newcastle.ac.uk; m.a.haniffa@newcastle.ac.uk	Bigley, Venetia/AAU-9738-2020; Larbi, Anis/ABE-5868-2020	Bigley, Venetia/0000-0002-3017-2474; Green, Kile/0000-0002-4777-5458; Best, Katie/0000-0002-1745-6392				McGovern N, 2014, IMMUNITY, V41, P465, DOI 10.1016/j.immuni.2014.08.006	1	2	2	1	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 17	2015	42	2					391	391		10.1016/j.immuni.2015.01.018	http://dx.doi.org/10.1016/j.immuni.2015.01.018			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB8XT	28843277	Green Published, hybrid			2022-12-18	WOS:000349916400021
J	Sumpter, TL; Falo, LD				Sumpter, Tina L.; Falo, Louis D., Jr.			"Toll''-erance in the Skin	IMMUNITY			English	Editorial Material							STAPHYLOCOCCUS-AUREUS; LIPOPROTEINS	Interactions between potentially pathogenic commensal bacteria and cutaneous immunity are poorly understood. In this issue of Immunity, Skabytska et al. (2014) show that S. aureus-derived TLR2/6 heterodimer ligands can recruit myeloid-derived suppressor cells into the skin, countering rather than promoting inflammation.	[Sumpter, Tina L.; Falo, Louis D., Jr.] Univ Pittsburgh, Sch Med, Dept Dermatol, Pittsburgh, PA 15213 USA; [Falo, Louis D., Jr.] Univ Pittsburgh, Sch Med, Dept Bioengn, Pittsburgh, PA 15213 USA; [Falo, Louis D., Jr.] Univ Pittsburgh, Sch Med, Pittsburgh Clin & Translat Sci Inst, Pittsburgh, PA 15213 USA; [Falo, Louis D., Jr.] Univ Pittsburgh, Sch Med, McGowan Inst Regenerat Med, Pittsburgh, PA 15213 USA; [Falo, Louis D., Jr.] Univ Pittsburgh, Sch Med, Inst Canc, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Falo, LD (corresponding author), Univ Pittsburgh, Sch Med, Dept Dermatol, Pittsburgh, PA 15213 USA.	lof2@pitt.edu	Falo, Louis/ABD-1499-2020					Chalmin F, 2010, J CLIN INVEST, V120, P457, DOI 10.1172/JCI40483; Hashimoto M, 2006, J IMMUNOL, V177, P3162, DOI 10.4049/jimmunol.177.5.3162; Kaesler S, 2014, J ALLERGY CLIN IMMUN, V134, P92, DOI 10.1016/j.jaci.2014.02.017; Kurokawa K, 2012, J BACTERIOL, V194, P3299, DOI 10.1128/JB.00314-12; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Pandey SP, 2014, J IMMUNOL, V193, P3632, DOI 10.4049/jimmunol.1400672; Skabytska Y, 2014, IMMUNITY, V41, P762, DOI 10.1016/j.immuni.2014.10.009; Travers JB, 2010, J ALLERGY CLIN IMMUN, V125, P146, DOI 10.1016/j.jaci.2009.09.052; Vu AT, 2010, J ALLERGY CLIN IMMUN, V126, P985, DOI 10.1016/j.jaci.2010.09.002	9	2	2	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2014	41	5					677	U27		10.1016/j.immuni.2014.11.003	http://dx.doi.org/10.1016/j.immuni.2014.11.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3ID	25517608	Bronze			2022-12-18	WOS:000345504900004
J	Yamamoto, H; Kemper, C				Yamamoto, Hidekazu; Kemper, Claudia			Complement and IL-22: Partnering Up for Border Patrol	IMMUNITY			English	Editorial Material							COMMENSAL BACTERIA; HOST-DEFENSE; CELLS	Intestinal pathobionts that escape into the periphery can cause serious morbidity and death. In this issue of Immunity, Hasegawa et al. (2014) show that the host's protective measures against such events include interleukin-22-driven systemic elimination of pathobionts via complement regulation.	[Yamamoto, Hidekazu; Kemper, Claudia] Kings Coll London, Guys Hosp, MRC Ctr Transplantat, Div Transplant Immunol & Mucosal Biol, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Kemper, C (corresponding author), Kings Coll London, Guys Hosp, MRC Ctr Transplantat, Div Transplant Immunol & Mucosal Biol, London SE1 9RT, England.	claudia.kemper@kcl.ac.uk	Kemper, Claudia/B-1502-2015; Yamamoto, Hide/AAM-7208-2020	Yamamoto, Hide/0000-0003-0831-9174; Kemper, Claudia/0000-0003-4196-1417	Medical Research Council [MR/J006742/1] Funding Source: Medline; Wellcome Trust [102932] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Behnsen J, 2014, IMMUNITY, V40, P262, DOI 10.1016/j.immuni.2014.01.003; Cardone J, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00028; Goto Y, 2014, SCIENCE, V345, P1310, DOI 10.1126/science.1254009; Hasegawa M, 2014, IMMUNITY, V41, P620, DOI 10.1016/j.immuni.2014.09.010; Hasegawa M, 2012, J IMMUNOL, V189, P3085, DOI 10.4049/jimmunol.1200821; Liang SC, 2010, J IMMUNOL, V185, P5531, DOI 10.4049/jimmunol.0904091; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	10	2	3	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2014	41	4					511	513		10.1016/j.immuni.2014.10.002	http://dx.doi.org/10.1016/j.immuni.2014.10.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3HY	25367566	Bronze			2022-12-18	WOS:000345504300004
J	Zitvogel, L; Kroemer, G				Zitvogel, Laurence; Kroemer, Guido			Targeting Foxp1 for Reinstating Anticancer Immunosurveillance	IMMUNITY			English	Editorial Material							T-CELLS; EXHAUSTION; CANCER	Transforming growth factor beta (TGF-beta) is a canonical immunosuppressive cytokine secreted by tumors. In this issue of Immunity, Stephen et al. (2014) reveal that tumor-derived TGF-beta deactivates antitumor CD8(+) T cell responses through T cell upregulation of the FoxP1 transcription factor.	[Zitvogel, Laurence; Kroemer, Guido] Gustave Roussy Canc Campus, Villejuif, France; [Zitvogel, Laurence] INSERM, U1015, Villejuif, France; [Zitvogel, Laurence] Univ Paris 11, Fac Med, Le Kremlin Bicetre, France; [Zitvogel, Laurence] Ctr Clin Invest Biotherapies Canc CICBT 507, Villejuif, France; [Kroemer, Guido] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Kroemer, Guido] Gustave Roussy, Metabol & Cell Biol Platforms, Villejuif, France; [Kroemer, Guido] INSERM, Equipe Labellise Ligue Canc 11, Ctr Rech Cordeliers, U1138, Paris, France; [Kroemer, Guido] Hop Europe Georges Pompidou, AP HP, Pole Biol, Paris, France	UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Zitvogel, L (corresponding author), Gustave Roussy Canc Campus, Villejuif, France.	laurence.zitvogel@gustaveroussy.fr	Kroemer, Guido/AAY-9859-2020; KROEMER, Guido/B-4263-2013	KROEMER, Guido/0000-0002-9334-4405; ZITVOGEL, laurence/0000-0003-1596-0998				Akbar AN, 2011, NAT REV IMMUNOL, V11, P289, DOI 10.1038/nri2959; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Feng XM, 2011, NAT IMMUNOL, V12, P544, DOI 10.1038/ni.2034; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; McKarns SC, 2004, J IMMUNOL, V172, P4275, DOI 10.4049/jimmunol.172.7.4275; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Stephen TL, 2014, IMMUNITY, V41, P427, DOI 10.1016/j.immuni.2014.08.012; Zitvogel L, 2006, NAT REV IMMUNOL, V6, P715, DOI 10.1038/nri1936	10	2	2	2	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2014	41	3					345	347		10.1016/j.immuni.2014.09.001	http://dx.doi.org/10.1016/j.immuni.2014.09.001			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ2ON	25238089	Bronze			2022-12-18	WOS:000342626500003
J	Jameson, SC; Renkema, KR				Jameson, Stephen C.; Renkema, Kristin R.			An Uncommon Tail about the Common gamma-Chain	IMMUNITY			English	Editorial Material							T-CELLS; FAMILY; CYTOKINES	The common gamma-chain (gamma c) is a key component of multiple cytokine receptors. In this issue of Immunity, Hong et al. (2014) demonstrate a unique function of gamma c as a secreted protein capable of inhibiting cytokine responses and promoting autoimmunity.	[Jameson, Stephen C.; Renkema, Kristin R.] Univ Minnesota, Dept Lab Med & Pathol, Ctr Immunol, Minneapolis, MN 55414 USA	University of Minnesota System; University of Minnesota Twin Cities	Jameson, SC (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Ctr Immunol, Minneapolis, MN 55414 USA.	james024@umn.edu	Jameson, Stephen C/D-9892-2013	Jameson, Stephen C/0000-0001-9137-1146	NCI NIH HHS [T32 CA009138] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009138] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Hong CW, 2014, IMMUNITY, V40, P910, DOI 10.1016/j.immuni.2014.04.020; Nishio J, 2001, J RHEUMATOL, V28, P240; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Yamane H, 2012, NAT IMMUNOL, V13, P1037, DOI 10.1038/ni.2431	6	2	2	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2014	40	6					859	860		10.1016/j.immuni.2014.05.008	http://dx.doi.org/10.1016/j.immuni.2014.05.008			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6DT	24950207	Bronze			2022-12-18	WOS:000341440200007
J	Fray, MA; Bunnell, SC				Fray, Michael A.; Bunnell, Stephen C.			p53 Keeps Bystanders at the Gates	IMMUNITY			English	Editorial Material							TUMOR-SUPPRESSOR P53; T-CELLS; SURVIVAL		[Fray, Michael A.; Bunnell, Stephen C.] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Program Immunol, Boston, MA 02111 USA; [Bunnell, Stephen C.] Tufts Univ, Sch Med, Dept Integrat Physiol & Pathobiol, Boston, MA 02111 USA	Tufts University; Tufts University	Bunnell, SC (corresponding author), Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Program Immunol, Boston, MA 02111 USA.	stephen.bunnell@tufts.edu		Fray, Michael/0000-0001-8388-1875; Bunnell, Stephen/0000-0001-6887-0828	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI103022, R01AI076575] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI076575, R01 AI103022] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		den Braber I, 2012, IMMUNITY, V36, P288, DOI 10.1016/j.immuni.2012.02.006; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Guidos CJ, 1996, GENE DEV, V10, P2038, DOI 10.1101/gad.10.16.2038; Haks MC, 1999, IMMUNITY, V11, P91, DOI 10.1016/S1074-7613(00)80084-9; Kawashima H, 2013, J IMMUNOL, V191, P3614, DOI 10.4049/jimmunol.1300509; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Watanabe M, 2014, IMMUNITY, V40, P681, DOI 10.1016/j.immuni.2014.04.006; Xiong J, 2013, IMMUNOLOGY, V138, P382, DOI 10.1111/imm.12050	10	2	2	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2014	40	5					633	635		10.1016/j.immuni.2014.05.001	http://dx.doi.org/10.1016/j.immuni.2014.05.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AH3LW	24837097	Green Accepted, Bronze			2022-12-18	WOS:000336026100001
J	Edelmann, SL; Heissmeyer, V				Edelmann, Stephanie L.; Heissmeyer, Vigo			Tfh Cell Differentiation: Missing Stat3 Uncovers Interferons' Interference	IMMUNITY			English	Editorial Material							HELPER T-CELLS; FOLLICULAR HELPER	Viral infection induces a number of cytokines that shape T cell responses. In this issue of Immunity, Ray et al. (2014) describe how CD4(+) T cells decide on T follicular helper (Tfh) or T helper 1 (Th1) cell skewed gene expression during acute viral infection.	[Edelmann, Stephanie L.; Heissmeyer, Vigo] Univ Munich, Inst Immunol, D-80336 Munich, Germany; [Edelmann, Stephanie L.; Heissmeyer, Vigo] Helmholtz Zentrum Munchen, Res Unit Mol Immune Regulat, Inst Mol Immunol, D-81377 Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Heissmeyer, V (corresponding author), Univ Munich, Inst Immunol, Goethestr 31, D-80336 Munich, Germany.	vigo.heissmeyer@med.uni-muenchen.de		Heissmeyer, Vigo/0000-0002-2263-8545				Choi YS, 2013, J IMMUNOL, V190, P3049, DOI 10.4049/jimmunol.1203032; Hegazy AN, 2010, IMMUNITY, V32, P116, DOI 10.1016/j.immuni.2009.12.004; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Lee SK, 2012, IMMUNITY, V37, P880, DOI 10.1016/j.immuni.2012.10.010; Luthje K, 2012, NAT IMMUNOL, V13, P491, DOI 10.1038/ni.2261; Nakayamada S, 2014, J IMMUNOL, V192, P2156, DOI 10.4049/jimmunol.1300675; Nurieva RI, 2012, J BIOL CHEM, V287, P11234, DOI 10.1074/jbc.M111.324046; Oestreich KJ, 2012, NAT IMMUNOL, V13, P405, DOI 10.1038/ni.2242; Ray JP, 2014, IMMUNITY, V40, P367, DOI 10.1016/j.immuni.2014.02.005; Yamane H, 2012, NAT IMMUNOL, V13, P1037, DOI 10.1038/ni.2431	10	2	3	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2014	40	3					307	309		10.1016/j.immuni.2014.02.008	http://dx.doi.org/10.1016/j.immuni.2014.02.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AD7DQ	24656041	Bronze			2022-12-18	WOS:000333422300002
J	Lambrecht, BN; Hammad, H				Lambrecht, Bart N.; Hammad, Hamida			Innate Immune Cells to the Help	IMMUNITY			English	Editorial Material							LYMPHOID-CELLS; TYPE-2	A study by Halim and Steer (2014) in this issue of Immunity shows that innate lymphoid cells type 2 (ILC2s) are crucial for inducing adaptive T helper 2 immunity by providing interleukin-13. Another study by van Dyken et al. (2014) shows that ILC2s control eosinophilia and alternative activation of macrophages.	[Lambrecht, Bart N.; Hammad, Hamida] Univ Ghent, VIB Inflammat Res Ctr, B-9000 Ghent, Belgium; [Lambrecht, Bart N.; Hammad, Hamida] Univ Hosp Ghent, Dept Resp Med, Ghent, Belgium; [Lambrecht, Bart N.] Erasmus MC, Dept Pulm Med, Rotterdam, Netherlands	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University Hospital; Erasmus University Rotterdam; Erasmus MC	Lambrecht, BN (corresponding author), Univ Ghent, VIB Inflammat Res Ctr, B-9000 Ghent, Belgium.	bart.lambrecht@ugent.be; hamida.hammad@ugent.be	Lambrecht, Bart N/K-2484-2014; Hammad, Hamida/J-9391-2015	Lambrecht, Bart N/0000-0003-4376-6834; Hammad, Hamida/0000-0003-3762-8603				Barlow JL, 2012, J ALLERGY CLIN IMMUN, V129, P191, DOI 10.1016/j.jaci.2011.09.041; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Halim TYF, 2012, IMMUNITY, V37, P463, DOI 10.1016/j.immuni.2012.06.012; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Van Dyken SJ, 2014, IMMUNITY, V40, P414, DOI 10.1016/j.immuni.2014.02.003	7	2	3	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2014	40	3					313	314		10.1016/j.immuni.2014.02.010	http://dx.doi.org/10.1016/j.immuni.2014.02.010			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AD7DQ	24656044	Bronze			2022-12-18	WOS:000333422300005
J	Yamasaki, S				Yamasaki, Sho			Clec12a: Quieting the Dead	IMMUNITY			English	Editorial Material							MICL CLEC12A; IMMUNITY; IDENTIFICATION; ACTIVATION; CRYSTALS; RECEPTOR; CELLS	Immune activation as a result of the recognition of damage-associated molecular patterns needs to be controlled. In this issue of Immunity, Neumann et al. (2014) demonstrates that Clec12a is a receptor for dead cells through the recognition of uric acid crystals and contributes to the dampening of the responses.	Kyushu Univ, Div Mol Immunol, Res Ctr Infect Dis, Med Inst Bioregulat,Higashi Ku, Fukuoka 8128582, Japan	Kyushu University	Yamasaki, S (corresponding author), Kyushu Univ, Div Mol Immunol, Res Ctr Infect Dis, Med Inst Bioregulat,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yamasaki@bioreg.kyushu-u.ac.jp		Yamasaki, Sho/0000-0002-5184-6917				Barabe F, 1998, FASEB J, V12, P209, DOI 10.1096/fasebj.12.2.209; Marshall ASJ, 2006, EUR J IMMUNOL, V36, P2159, DOI 10.1002/eji.200535628; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Neumann K, 2014, IMMUNITY, V40, P389, DOI 10.1016/j.immuni.2013.12.015; Pyz E, 2008, EUR J IMMUNOL, V38, P1157, DOI 10.1002/eji.200738057; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Shi Y, 2010, IMMUNOL REV, V233, P203, DOI 10.1111/j.0105-2896.2009.00851.x; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651	10	2	2	1	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2014	40	3					309	311		10.1016/j.immuni.2014.03.001	http://dx.doi.org/10.1016/j.immuni.2014.03.001			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AD7DQ	24656042	Bronze			2022-12-18	WOS:000333422300003
J	De Libero, G; Mori, L				De Libero, Gennaro; Mori, Lucia			Professional Differences in Antigen Presentation to iNKT Cells	IMMUNITY			English	Editorial Material							ANTIBODY-RESPONSES; ACTIVATION; VIVO; BIAS		[De Libero, Gennaro; Mori, Lucia] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [De Libero, Gennaro; Mori, Lucia] ASTAR, Singapore Immunol Network SIgN, Biopolis, Singapore	University of Basel; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	De Libero, G (corresponding author), Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland.	gennaro_delibero@immunol.a-star.edu.sg	De Libero, Gennaro/P-2694-2017	De Libero, Gennaro/0000-0003-0853-7868				Arora P, 2014, IMMUNITY, V40, P105, DOI 10.1016/j.immuni.2013.12.004; Bai L, 2013, P NATL ACAD SCI USA, V110, P16097, DOI 10.1073/pnas.1303218110; Bai L, 2012, J IMMUNOL, V188, P3053, DOI 10.4049/jimmunol.1102414; Barral P, 2008, P NATL ACAD SCI USA, V105, P8345, DOI 10.1073/pnas.0802968105; Barral P, 2010, NAT IMMUNOL, V11, P303, DOI 10.1038/ni.1853; Carnaud C, 1999, J IMMUNOL, V163, P4647; Im JS, 2009, IMMUNITY, V30, P888, DOI 10.1016/j.immuni.2009.03.022; King IL, 2012, NAT IMMUNOL, V13, P44, DOI 10.1038/ni.2172; Lee WY, 2010, NAT IMMUNOL, V11, P295, DOI 10.1038/ni.1855; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097	10	2	2	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2014	40	1					5	7		10.1016/j.immuni.2013.12.008	http://dx.doi.org/10.1016/j.immuni.2013.12.008			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB0JD	24439262	Bronze			2022-12-18	WOS:000331476900003
J	Cox, AL; Siliciano, RF				Cox, Andrea L.; Siliciano, Robert F.			Making Sense of HIV Innate Sensing	IMMUNITY			English	Editorial Material							GMP-AMP SYNTHASE; SAMHD1; INFECTION; CELLS	Innate sensing of HIV is important in host control and pathogenesis. In this issue of Immunity, Lahaye et al. (2013) demonstrate that HIV capsid-cyclophilin A interactions affect viral cDNA sensing by the DNA sensor cCAS and contribute to differential pathogenesis of HIV-1 and HIV-2.	[Cox, Andrea L.; Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Siliciano, Robert F.] Howard Hughes Med Inst, Baltimore, MD 21201 USA	Johns Hopkins University; Howard Hughes Medical Institute	Cox, AL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	acox@jhmi.edu		Cox, Andrea/0000-0002-9331-2462	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108403] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI108403] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Cooper A, 2013, NATURE, V498, P376, DOI 10.1038/nature12274; Deeks SG, 2013, IMMUNITY, V39, P633, DOI 10.1016/j.immuni.2013.10.001; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahaye X, 2013, IMMUNITY, V39, P1132, DOI 10.1016/j.immuni.2013.11.002; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458	10	2	3	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 12	2013	39	6					998	1000		10.1016/j.immuni.2013.11.014	http://dx.doi.org/10.1016/j.immuni.2013.11.014			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UZ	24332027	Green Accepted, Bronze			2022-12-18	WOS:000330951000006
J	Kawakami, T; Ando, T				Kawakami, Toshiaki; Ando, Tomoaki			Salmonella's Masterful Skill in Mast Cell Suppression	IMMUNITY			English	Editorial Material							PROTEIN; TYPHIMURIUM; INFECTION; SURVIVAL; MODEL; MICE; IGE	Salmonella bacteria often cause food-borne diseases. In this issue of Immunity, Choi et al. ( 2013) demonstrate that the Salmonella Typhimurium-secreted protein tyrosine phosphatase, SptP, suppresses mast cell degranulation, which enables bacterial dissemination.	[Kawakami, Toshiaki] La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA 92037 USA; [Kawakami, Toshiaki; Ando, Tomoaki] RIKEN, Ctr Integrat Med Sci IMS RCAI, Lab Allerg Dis, Yokohama, Kanagawa 2300045, Japan	La Jolla Institute for Immunology; RIKEN	Kawakami, T (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA 92037 USA.	toshi@liai.org	Kawakami, Toshiaki/O-1616-2015		Grants-in-Aid for Scientific Research [25253071] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		BECKERS CJM, 1989, NATURE, V339, P397, DOI 10.1038/339397a0; Chatterjea D, 2005, IMMUNOL LETT, V99, P122, DOI 10.1016/j.imlet.2005.02.015; Choi HW, 2013, IMMUNITY, V39, P1108, DOI 10.1016/j.immuni.2013.11.009; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Kaniga K, 1996, MOL MICROBIOL, V21, P633, DOI 10.1111/j.1365-2958.1996.tb02571.x; Mathur R, 2012, CELL, V151, P590, DOI 10.1016/j.cell.2012.08.042; Okayama Y, 2006, IMMUNOL RES, V34, P97, DOI 10.1385/IR:34:2:97; Piliponsky AM, 2010, AM J PATHOL, V176, P926, DOI 10.2353/ajpath.2010.090342; Zhang J, 1996, J EXP MED, V184, P71, DOI 10.1084/jem.184.1.71	10	2	2	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 12	2013	39	6					996	998		10.1016/j.immuni.2013.11.007	http://dx.doi.org/10.1016/j.immuni.2013.11.007			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UZ	24332026	Bronze			2022-12-18	WOS:000330951000005
J	Huber, M; Lohoff, M				Huber, Magdalena; Lohoff, Michael			IRF4 Provides Rations for Cytotoxic CD8(+) T Cell Soldiers	IMMUNITY			English	Editorial Material							TRANSCRIPTION FACTOR IRF4; DIFFERENTIATION; EFFECTOR		[Huber, Magdalena; Lohoff, Michael] Univ Marburg, Inst Med Microbiol, D-35043 Marburg, Germany; [Huber, Magdalena; Lohoff, Michael] Univ Marburg, Hosp Hyg, D-35043 Marburg, Germany	Philipps University Marburg; Philipps University Marburg	Lohoff, M (corresponding author), Univ Marburg, Inst Med Microbiol, D-35043 Marburg, Germany.	lohoff@med.uni-marburg.de	Huber, Magdalena/ABD-1810-2020	Huber, Magdalena/0000-0002-2963-0693				Biswas PS, 2010, IMMUNOL REV, V233, P79, DOI 10.1111/j.0105-2896.2009.00864.x; Bollig N, 2012, P NATL ACAD SCI USA, V109, P8664, DOI 10.1073/pnas.1205834109; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Huber M, 2013, J CLIN INVEST, V123, P247, DOI 10.1172/JCI63681; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; Murphy TL, 2013, NAT REV IMMUNOL, V13, P499, DOI 10.1038/nri3470; Raczkowski F, 2013, P NATL ACAD SCI USA, V110, P15019, DOI 10.1073/pnas.1309378110; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Yao SY, 2013, IMMUNITY, V39, P833, DOI 10.1016/j.immuni.2013.10.007	10	2	2	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 14	2013	39	5					797	799		10.1016/j.immuni.2013.10.008	http://dx.doi.org/10.1016/j.immuni.2013.10.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UV	24238334	Bronze			2022-12-18	WOS:000330950600001
J	Nicolas, L; Chaudhuri, J				Nicolas, Laura; Chaudhuri, Jayanta			4C-ing the Igh Landscape	IMMUNITY			English	Editorial Material							HEAVY-CHAIN GENE; IMMUNOGLOBULIN LOCI; REGULATORY ELEMENTS; REARRANGEMENTS; RECOMBINATION	The assembly of antigen receptors in developing B lymphocytes is determined by the spatio-temporal organization of the immunoglobulin heavy chain locus (Igh). In this issue of Immunity, Medvedovic et al. (2013) provide a comprehensive dynamic view of the Igh locus architecture.	[Nicolas, Laura; Chaudhuri, Jayanta] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Chaudhuri, J (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, 1275 York Ave, New York, NY 10065 USA.	chaudhuj@mskcc.org			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072194] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI072194] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ebert A, 2011, IMMUNITY, V34, P175, DOI 10.1016/j.immuni.2011.02.005; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Guo CY, 2011, CELL, V147, P332, DOI 10.1016/j.cell.2011.08.049; Guo CG, 2011, NATURE, V477, P424, DOI 10.1038/nature10495; Hewitt SL, 2009, NAT IMMUNOL, V10, P655, DOI 10.1038/ni.1735; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Medvedovic J, 2013, IMMUNITY, V39, P229, DOI 10.1016/j.immuni.2013.08.011; Perlot T, 2008, ADV IMMUNOL, V99, P1, DOI 10.1016/S0065-2776(08)00601-9; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150	10	2	2	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 22	2013	39	2					199	201		10.1016/j.immuni.2013.08.014	http://dx.doi.org/10.1016/j.immuni.2013.08.014			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UE	23973215	Bronze, Green Accepted			2022-12-18	WOS:000330948800001
J	Forster, R; Moschovakis, GL				Foerster, Reinhold; Moschovakis, G. Leandros			Orchestrating the Organizers: Lymphotoxin-beta Receptor Conducts Fibroblastic Reticular Cell Maturation	IMMUNITY			English	Editorial Material							LYMPH-NODE; TISSUES; ORGANOGENESIS	Lymphotoxin-beta receptor (LT beta R) signaling in lymphoid tissue organizer (LTo) cells may assist lymph node (LN) organogenesis. In this issue of Immunity, Chai et al. (2013) demonstrate that LTo-specific LT beta R ablation doesn't affect LN development but impairs LN fibroblastic reticular cell function.	[Foerster, Reinhold; Moschovakis, G. Leandros] Hannover Med Sch, Inst Immunol, D-30625 Hannover, Germany	Hannover Medical School	Forster, R (corresponding author), Hannover Med Sch, Inst Immunol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	foerster.reinhold@mh-hannover.de	Förster, Reinhold/D-6770-2011	Forster, Reinhold/0000-0001-6190-7923				Benezech C, 2012, IMMUNITY, V37, P721, DOI 10.1016/j.immuni.2012.06.010; Benezech C, 2010, J IMMUNOL, V184, P4521, DOI 10.4049/jimmunol.0903113; Chai Q, 2013, IMMUNITY, V38, P1013, DOI 10.1016/j.immuni.2013.03.012; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Koning JJ, 2012, TRENDS IMMUNOL, V33, P264, DOI 10.1016/j.it.2011.10.006; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Ohl L, 2003, SEMIN IMMUNOL, V15, P249, DOI 10.1016/j.smim.2003.08.003; Onder L, 2013, J EXP MED, V210, P465, DOI 10.1084/jem.20121462; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; van de Pavert SA, 2009, NAT IMMUNOL, V10, P1193, DOI 10.1038/ni.1789	10	2	2	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 23	2013	38	5					851	853		10.1016/j.immuni.2013.05.003	http://dx.doi.org/10.1016/j.immuni.2013.05.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RT	23706665	Bronze			2022-12-18	WOS:000330942500004
J	Bertino, SA; Craft, J				Bertino, Sarah A.; Craft, Joe			Roquin Paralogs Add a New Dimension to ICOS Regulation	IMMUNITY			English	Editorial Material							HELPER T-CELLS; AUTOIMMUNITY	Two studies in the current issue of Immunity (Pratama et al., 2013; Vogel et al., 2013) demonstrate that the RNA-binding proteins Roquin-1 and Roquin-2 have redundant function in the posttranscriptional repression of Icos messenger RNA by CD4(+) T cells.	[Bertino, Sarah A.; Craft, Joe] Yale Univ, Sch Med, Dept Immunol, New Haven, CT 06510 USA; [Craft, Joe] Yale Univ, Sch Med, Dept Internal Med Rheumatol, New Haven, CT 06510 USA	Yale University; Yale University	Craft, J (corresponding author), Yale Univ, Sch Med, Dept Immunol, New Haven, CT 06510 USA.	joseph.craft@yale.edu			NIAMS NIH HHS [R37 AR040072, R21 AR063942, R01 AR040072, P30 AR053495, R21 AR062842] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR062842, P30AR053495, R21AR063942, R37AR040072, R01AR040072] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bertossi A, 2011, J EXP MED, V208, P1749, DOI 10.1084/jem.20110578; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Craft JE, 2012, NAT REV RHEUMATOL, V8, P337, DOI 10.1038/nrrheum.2012.58; Glasmacher E, 2010, NAT IMMUNOL, V11, P725, DOI 10.1038/ni.1902; Linterman MA, 2009, IMMUNITY, V30, P228, DOI 10.1016/j.immuni.2008.12.015; Pratama A, 2013, IMMUNITY, V38, P669, DOI 10.1016/j.immuni.2013.01.011; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vogel KU, 2013, IMMUNITY, V38, P655, DOI 10.1016/j.immuni.2012.12.004	9	2	7	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2013	38	4					624	626		10.1016/j.immuni.2013.03.007	http://dx.doi.org/10.1016/j.immuni.2013.03.007			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RP	23601678	Green Accepted, Bronze			2022-12-18	WOS:000330942100003
J	Brendecke, SM; Prinz, M				Brendecke, Stefanie M.; Prinz, Marco			I kappa B-zeta Deficiency Leaves Epithelial Cells High and Dry	IMMUNITY			English	Editorial Material							SJOGRENS-SYNDROME; TRANSCRIPTION	The pathogenic mechanisms driving Sjogren's syndrome (SS) are unclear. In this issue of Immunity, Okuma et al. (2013) demonstrate that tissue-specific dysfunction, namely deficiency of the transcriptional regulator I kappa B-zeta in epithelial cells, rather than hematopoietic cell pathology, is sufficient to elicit SS-like inflammation.	[Brendecke, Stefanie M.; Prinz, Marco] Univ Freiburg, Inst Neuropathol, D-79100 Freiburg, Germany; [Prinz, Marco] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79100 Freiburg, Germany	University of Freiburg; University of Freiburg	Prinz, M (corresponding author), Univ Freiburg, Inst Neuropathol, D-79100 Freiburg, Germany.	marco.prinz@uniklinik-freiburg.de						Groom J, 2002, J CLIN INVEST, V109, P59, DOI 10.1172/JCI200214121; Guo ZL, 2011, IMMUNOL LETT, V135, P34, DOI 10.1016/j.imlet.2010.09.009; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Okuma A, 2013, IMMUNITY, V38, P450, DOI 10.1016/j.immuni.2012.11.016; Peng BL, 2010, P NATL ACAD SCI USA, V107, P15193, DOI 10.1073/pnas.1005533107; Raasch J, 2011, BRAIN, V134, P1184, DOI 10.1093/brain/awq359; Ramos-Casals M, 2012, BMJ-BRIT MED J, V344, DOI [10.1136/bmj.e3821, 10.1024/1661-8157/a001133]; van Loo G, 2006, NAT IMMUNOL, V7, P954, DOI 10.1038/ni1372; Yamazaki S, 2001, J BIOL CHEM, V276, P27657, DOI 10.1074/jbc.M103426200	10	2	2	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2013	38	3					404	406		10.1016/j.immuni.2013.02.016	http://dx.doi.org/10.1016/j.immuni.2013.02.016			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RJ	23521879	Bronze			2022-12-18	WOS:000330941500004
J	Gabrilovich, DI				Gabrilovich, Dmitry I.			Applying Pressure on Macrophages	IMMUNITY			English	Editorial Material							METASTASIS	In this issue of Immunity, Cortez-Retamozo et al. (2013) demonstrate that the increased production of angiotensin II in tumor-bearing mice induces the expansion of macrophage progenitors and the supply of macrophages.	H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33647 USA	H Lee Moffitt Cancer Center & Research Institute	Gabrilovich, DI (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, MRC 2067,12902 Magnolia Dr, Tampa, FL 33647 USA.	dmitry.gabrilovich@moffitt.org	Gabrilovich, Dmitry/ABE-7122-2020					Cortez-Retamozo V, 2013, IMMUNITY, V38, P296, DOI 10.1016/j.immuni.2012.10.015; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Jun JY, 2012, HYPERTENSION, V60, P1316, DOI 10.1161/HYPERTENSIONAHA.112.199547; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Shen XZ, 2008, INT IMMUNOPHARMACOL, V8, P171, DOI 10.1016/j.intimp.2007.08.010; Wilop S, 2009, J CANCER RES CLIN, V135, P1429, DOI 10.1007/s00432-009-0587-3	9	2	2	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2013	38	2					205	206		10.1016/j.immuni.2013.02.004	http://dx.doi.org/10.1016/j.immuni.2013.02.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RC	23438819	Bronze			2022-12-18	WOS:000330940800003
J	Alter, G; Ackerman, ME				Alter, Galit; Ackerman, Margaret E.			What mAbs Tell Us about Shapes: Multiple Roads Lead to Rome	IMMUNITY			English	Editorial Material							HIV-1 VACCINE EFFICACY; ANTIBODIES; REGIONS; INFECTION; LOOP		[Alter, Galit] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Ackerman, Margaret E.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Dartmouth College	Ackerman, ME (corresponding author), Dartmouth Coll, Thayer Sch Engn, 14 Engn Dr, Hanover, NH 03755 USA.	margaret.e.ackerman@dartmouth.edu						Gorny MK, 2012, VIROLOGY, V427, P198, DOI 10.1016/j.virol.2012.02.003; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Karasavvas N, 2012, AIDS RES HUM RETROV, V28, P1444, DOI 10.1089/aid.2012.0103; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Rong R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000594; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801	9	2	2	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 24	2013	38	1					8	9		10.1016/j.immuni.2013.01.003	http://dx.doi.org/10.1016/j.immuni.2013.01.003			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	079TQ	23352219	Bronze			2022-12-18	WOS:000314195500004
J	Neuenhahn, M; Busch, DH				Neuenhahn, Michael; Busch, Dirk H.			Whole-Body Anatomy of Human T Cells	IMMUNITY			English	Editorial Material									[Neuenhahn, Michael; Busch, Dirk H.] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; [Neuenhahn, Michael; Busch, Dirk H.] Helmholtz Ctr Munich Neuherberg, Clin Cooperat Grp Antigen Specif Immunotherapy, D-81675 Munich, Germany; [Neuenhahn, Michael; Busch, Dirk H.] Helmholtz Ctr Munich Neuherberg, Clin Cooperat Grp Immune Monitoring, D-81675 Munich, Germany; [Busch, Dirk H.] Tech Univ Munich, Inst Adv Study, Focus Grp Clin Cell Proc & Purificat, D-81675 Munich, Germany	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Busch, DH (corresponding author), Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany.	dirk.busch@mikrobio.med.tum.de						Buchholz VR, 2011, CURR OPIN IMMUNOL, V23, P549, DOI 10.1016/j.coi.2011.05.002; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; Gowans JL, 1996, IMMUNOL TODAY, V17, P288, DOI 10.1016/0167-5699(96)80547-0; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Masopust D, 2012, J IMMUNOL, V188, P5811, DOI 10.4049/jimmunol.1102695; Mazo IB, 2005, IMMUNITY, V22, P259, DOI 10.1016/j.immuni.2005.01.008; Neuenhahn M, 2009, IMMUNITY, V31, P702, DOI 10.1016/j.immuni.2009.10.002; O'MALLEY C D, 1964, Med Hist, V8, P299; Sathaliyawala T., 2012, IMMUNITY, V38	9	2	2	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN 24	2013	38	1					10	12		10.1016/j.immuni.2013.01.006	http://dx.doi.org/10.1016/j.immuni.2013.01.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	079TQ	23352220	Bronze			2022-12-18	WOS:000314195500005
J	Duffy, D; Perrin, H; Abadie, V; Benhabiles, N; Boissonnas, A; Liard, C; Descours, B; Reboulleau, D; Bonduelle, O; Verrier, B; Van Rooijen, N; Combadiere, C; Combadiere, B				Duffy, Darragh; Perrin, Helene; Abadie, Valerie; Benhabiles, Nora; Boissonnas, Alexandre; Liard, Christelle; Descours, Benjamin; Reboulleau, Damien; Bonduelle, Olivia; Verrier, Bernard; Van Rooijen, Nico; Combadiere, Christophe; Combadiere, Behazine			Neutrophils Transport Antigen from the Dermis to the Bone Marrow, Initiating a Source of Memory CD8(+) T Cells (Vol 37, Pg 917, 2012)	IMMUNITY			English	Correction												behazine.combadiere@upmc.fr	Combadiere, Behazine/G-3881-2013; Boissonnas, Alexandre/A-2801-2016; Combadiere, Behazine/S-8054-2019	Boissonnas, Alexandre/0000-0002-7770-7210; Combadiere, Behazine/0000-0002-2353-4406				Duffy D, 2012, IMMUNITY, V37, P917, DOI 10.1016/j.immuni.2012.07.015	1	2	2	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	DEC 14	2012	37	6					1145	1145		10.1016/j.immuni.2012.11.002	http://dx.doi.org/10.1016/j.immuni.2012.11.002			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057PH		Bronze			2022-12-18	WOS:000312575000020
J	Chorny, A; Cerutti, A				Chorny, Alejo; Cerutti, Andrea			CEACAM1-S: The Virtues of Alternative Splicing in Gut Immunity	IMMUNITY			English	Editorial Material							T-CELLS; GENERATION	Immunoglobulin A (IgA) is the main intestinal antibody. In this issue of Immunity, Chen et al. (2012) show that intestinal T cells enhance protective IgA responses by expressing a short isoform of the CEACAM1 protein.	[Chorny, Alejo; Cerutti, Andrea] Mt Sinai Sch Med, Dept Med, Inst Immunol, New York, NY 10029 USA; [Cerutti, Andrea] IMIM Inst Hosp Mar Invest Med, Barcelona 08003, Spain; [Cerutti, Andrea] ICREA Catalan Inst Res & Adv Studies, Barcelona 08003, Spain	Icahn School of Medicine at Mount Sinai; Institut Hospital del Mar d'Investigacions Mediques (IMIM); ICREA	Cerutti, A (corresponding author), Mt Sinai Sch Med, Dept Med, Inst Immunol, 1425 Madison Ave, New York, NY 10029 USA.	andrea.cerutti@mssm.edu		Cerutti, Andrea/0000-0003-3026-4704; Chorny, Alejo/0000-0001-5874-350X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074378, P01AI061093, U19AI096187, U01AI095613, R01AI057653] Funding Source: NIH RePORTER; NIAID NIH HHS [U19 AI096187, U01 AI095613, R01 AI057653, R01 AI074378, P01 AI061093] Funding Source: Medline; ICREA Funding Source: Custom	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ICREA(ICREA)		Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Chen LF, 2012, IMMUNITY, V37, P930, DOI 10.1016/j.immuni.2012.07.016; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Kawamoto S, 2012, SCIENCE, V336, P485, DOI 10.1126/science.1217718; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; Suzuki K, 2010, IMMUNITY, V33, P71, DOI 10.1016/j.immuni.2010.07.003; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Wei M, 2011, NAT IMMUNOL, V12, P264, DOI 10.1038/ni.1991	9	2	2	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 16	2012	37	5					768	770		10.1016/j.immuni.2012.10.011	http://dx.doi.org/10.1016/j.immuni.2012.10.011			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	042GP	23159224	Green Accepted, Bronze			2022-12-18	WOS:000311460000005
J	Mankan, AK; Hornung, V				Mankan, Arun K.; Hornung, Veit			Retroviral Danger from Within: TLR7 Is in Control	IMMUNITY			English	Editorial Material							ENDOGENOUS RETROVIRUSES; VIRUS; INFECTION; IMMUNITY	In this issue of Immunity, Yu et al. (2012) outline a fascinating model in which TLR7-mediated antibody production acts as a dominant immunosurveillance mechanism against endogenous retroviruses (ERVs), with additional support of TLR3 and TLR9 that function to prevent ERV-mediated malignancy.	[Mankan, Arun K.; Hornung, Veit] Univ Bonn, Inst Clin Chem & Clin Pharmacol, Unit Clin Biochem, Univ Hosp, D-53127 Bonn, Germany	University of Bonn	Hornung, V (corresponding author), Univ Bonn, Inst Clin Chem & Clin Pharmacol, Unit Clin Biochem, Univ Hosp, D-53127 Bonn, Germany.	veit.hornung@uni-bonn.de	Hornung, Veit/C-3565-2012	Hornung, Veit/0000-0002-4150-194X				Browne EP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002293; GREENBERGER JS, 1975, J IMMUNOL, V115, P317; HANNA MG, 1972, CANCER RES, V32, P2226; Kane M, 2011, IMMUNITY, V35, P135, DOI 10.1016/j.immuni.2011.05.011; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; MCCUBREY J, 1982, J EXP MED, V156, P337, DOI 10.1084/jem.156.2.337; Stocking C, 2008, CELL MOL LIFE SCI, V65, P3383, DOI 10.1007/s00018-008-8497-0; Stoye JP, 2012, NAT REV MICROBIOL, V10, P395, DOI 10.1038/nrmicro2783; Young G.R., 2012, NATURE; Yu P, 2012, IMMUNITY, V37, P867, DOI 10.1016/j.immuni.2012.07.018	10	2	2	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 16	2012	37	5					763	766		10.1016/j.immuni.2012.10.009	http://dx.doi.org/10.1016/j.immuni.2012.10.009			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	042GP	23159222	Bronze			2022-12-18	WOS:000311460000003
J	Tikhonova, A; Aifantis, I				Tikhonova, Anastasia; Aifantis, Iannis			The Taming of the NF-kappa B: PP4R1 Navigates while PP4c Dephosphorylates	IMMUNITY			English	Editorial Material							T-CELL LYMPHOMA	The NF-kappa B signaling pathway is important in the regulation of physiological and malignant hematopoiesis. In this issue of Immunity, Brechmann et al. (2012) identify a phosphatase, PP4R1, that inhibits NF-kappa B activation in T cells and T cell lymphoma.	[Tikhonova, Anastasia; Aifantis, Iannis] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Tikhonova, Anastasia; Aifantis, Iannis] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA	Howard Hughes Medical Institute; New York University; New York University	Aifantis, I (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA.	iannis.aifantis@nyumc.org	Tikhonova, Anastasia/F-1186-2015		NATIONAL CANCER INSTITUTE [R01CA133379, R01CA149655, R01CA105129] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA133379, R01 CA149655, R01 CA105129] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brechmann M, 2012, IMMUNITY, V37, P697, DOI 10.1016/j.immuni.2012.07.014; Gamble C, 2012, BRIT J PHARMACOL, V165, P802, DOI 10.1111/j.1476-5381.2011.01608.x; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Kloeker S, 1999, J BIOL CHEM, V274, P5339, DOI 10.1074/jbc.274.9.5339; Lee DH, 2010, NAT STRUCT MOL BIOL, V17, P365, DOI 10.1038/nsmb.1769; Li HY, 2008, NAT IMMUNOL, V9, P533, DOI 10.1038/ni.1600; Lim KH, 2012, IMMUNOL REV, V246, P359, DOI 10.1111/j.1600-065X.2012.01105.x; Sors A, 2006, BLOOD, V107, P2354, DOI 10.1182/blood-2005-06-2536; Wong HK, 2011, BRIT J HAEMATOL, V155, P150, DOI 10.1111/j.1365-2141.2011.08852.x	10	2	2	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT 19	2012	37	4					594	596		10.1016/j.immuni.2012.10.006	http://dx.doi.org/10.1016/j.immuni.2012.10.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	025JQ	23084354	Bronze, Green Accepted			2022-12-18	WOS:000310185400003
J	Walker, LSK				Walker, Lucy S. K.			Maintaining a Competitive Edge: New Rules for Peripheral T Cell Homeostasis	IMMUNITY			English	Editorial Material							SURVIVAL; NAIVE; LYMPHOCYTES; ABSENCE	The contraction of T cell populations after immune responses is poorly understood. In this issue of Immunity, Singh et al. show that "deletor" T cells regulate the frequency of antigen-specific T cells by competing for shared subthreshold ligands.	Univ Birmingham, Sch Med, Ctr Immune Regulat, MRC, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Walker, LSK (corresponding author), Univ Birmingham, Sch Med, Ctr Immune Regulat, MRC, Birmingham B15 2TT, W Midlands, England.	l.s.walker@bham.ac.uk		Walker, Lucy/0000-0001-5986-5015	Medical Research Council [G0802382] Funding Source: Medline; MRC [G0802382] Funding Source: UKRI; Medical Research Council [G9818340B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		BURNET M, 1959, BMJ-BRIT MED J, V2, P645, DOI 10.1136/bmj.2.5153.645; Ebert PJR, 2009, NAT IMMUNOL, V10, P1162, DOI 10.1038/ni.1797; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Singh NJ, 2012, IMMUNITY, V37, P735, DOI 10.1016/j.immuni.2012.08.008; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Witherden D, 2000, J EXP MED, V191, P355, DOI 10.1084/jem.191.2.355	9	2	2	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT 19	2012	37	4					598	600		10.1016/j.immuni.2012.10.005	http://dx.doi.org/10.1016/j.immuni.2012.10.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	025JQ	23084356	Bronze			2022-12-18	WOS:000310185400005
J	Yap, GS; Rivera, A				Yap, George S.; Rivera, Amariliz			IFN-gamma Signals a Changing of the Guards	IMMUNITY			English	Editorial Material							CD8-ALPHA(+) DENDRITIC CELLS; INFLAMMATORY MONOCYTES; TOXOPLASMA-GONDII; INFECTION; INTERLEUKIN-12; RESPONSES	After acute inflammation or infection, tissue-resident macrophages are replaced by inflammatory DCs and effector macrophages that arise from circulating monocytes. In this issue of Immunity, Goldszmid et al. (2012) demonstrate a central role for NK cell-derived IFN-gamma in signaling and facilitating this transition.	[Yap, George S.; Rivera, Amariliz] UMDNJ New Jersey Med Sch, Ctr Immun & Inflammat, Newark, NJ 07101 USA; [Yap, George S.] UMDNJ New Jersey Med Sch, Dept Med, Newark, NJ 07101 USA; [Rivera, Amariliz] UMDNJ New Jersey Med Sch, Dept Pediat, Newark, NJ 07101 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Yap, GS (corresponding author), UMDNJ New Jersey Med Sch, Ctr Immun & Inflammat, Newark, NJ 07101 USA.	yapgs@umdnj.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083405] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI083405] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Goldszmid RS, 2012, IMMUNITY, V36, P1047, DOI 10.1016/j.immuni.2012.03.026; Hohl TM, 2009, CELL HOST MICROBE, V6, P470, DOI 10.1016/j.chom.2009.10.007; Iijima N, 2011, P NATL ACAD SCI USA, V108, P284, DOI 10.1073/pnas.1005201108; Ingersoll MA, 2011, TRENDS IMMUNOL, V32, P470, DOI 10.1016/j.it.2011.05.001; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Mashayekhi M, 2011, IMMUNITY, V35, P249, DOI 10.1016/j.immuni.2011.08.008; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Sousa CRE, 1997, J EXP MED, V186, P1819, DOI 10.1084/jem.186.11.1819	10	2	2	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN 29	2012	36	6					904	906		10.1016/j.immuni.2012.06.007	http://dx.doi.org/10.1016/j.immuni.2012.06.007			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	969ZE	22749350	Green Accepted, Bronze			2022-12-18	WOS:000306097100009
J	Malek, TR; Khan, WN				Malek, Thomas R.; Khan, Wasif N.			IL-2: Fine-tuning the Germinal Center Reaction	IMMUNITY			English	Editorial Material							STAT5		[Malek, Thomas R.; Khan, Wasif N.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Malek, Thomas R.; Khan, Wasif N.] Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA	University of Miami; University of Miami	Malek, TR (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA.	tmalek@imed.miami.edu						Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Saadoun D, 2011, NEW ENGL J MED, V365, P2067, DOI 10.1056/NEJMoa1105143; Vinuesa CG, 2011, IMMUNITY, V35, P671, DOI 10.1016/j.immuni.2011.11.001; Yu AX, 2009, IMMUNITY, V30, P204, DOI 10.1016/j.immuni.2008.11.014	10	2	3	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY 25	2012	36	5					702	704		10.1016/j.immuni.2012.05.005	http://dx.doi.org/10.1016/j.immuni.2012.05.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	954VL	22633457	Bronze			2022-12-18	WOS:000304976000005
J	Ciraci, C; Sutterwala, FS				Ciraci, Ceren; Sutterwala, Fayyaz S.			Inhibitors of Apoptosis Proteins and IL-1 beta: A Tangled Relationship	IMMUNITY			English	Editorial Material							RIPOPTOSOME; DEATH	Inhibitors of apoptosis proteins (IAPs) are important regulators of both cell death and inflammation. In this issue of Immunity, Vince et al. (2012) report that inhibition of IAPs results in the processing and secretion of IL-1 beta through RIP3-mediated caspase-1- and caspase-8-dependent pathways.	[Ciraci, Ceren; Sutterwala, Fayyaz S.] Univ Iowa, Dept Internal Med, Inflammat Program, Carver Coll Med, Iowa City, IA 52242 USA; [Sutterwala, Fayyaz S.] Vet Affairs Med Ctr, Iowa City, IA 52241 USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Sutterwala, FS (corresponding author), Univ Iowa, Dept Internal Med, Inflammat Program, Carver Coll Med, Iowa City, IA 52242 USA.	fayyaz-sutterwala@uiowa.edu	ciraci, ceren/ABA-7687-2020; Sutterwala, Fayyaz/AAH-5859-2021; Cassel, Suzanne/AAI-3947-2021	ciraci, ceren/0000-0003-2162-0930; Cassel, Suzanne/0000-0003-2492-1923				Bertrand MJM, 2009, IMMUNITY, V30, P789, DOI 10.1016/j.immuni.2009.04.011; Broemer M, 2009, TRENDS CELL BIOL, V19, P130, DOI 10.1016/j.tcb.2009.01.004; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Krieg A, 2009, P NATL ACAD SCI USA, V106, P14524, DOI 10.1073/pnas.0907131106; Labbe K, 2011, IMMUNITY, V35, P897, DOI 10.1016/j.immuni.2011.10.016; Lopez J, 2010, CURR OPIN CELL BIOL, V22, P872, DOI 10.1016/j.ceb.2010.08.025; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Mao AP, 2010, J BIOL CHEM, V285, P9470, DOI 10.1074/jbc.M109.071043; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012	11	2	2	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	FEB 24	2012	36	2					155	157		10.1016/j.immuni.2012.02.007	http://dx.doi.org/10.1016/j.immuni.2012.02.007			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899JO	22365658	Bronze			2022-12-18	WOS:000300812400001
J	Bedoui, S; Heath, WR				Bedoui, Sammy; Heath, William R.			A Local Role for CD103(+) Dendritic Cells in Atherosclerosis	IMMUNITY			English	Editorial Material							REGULATORY T-CELLS; SUBSETS; MICE	In this issue of Immunity, Choi et al. (2011) analyzed the cellular composition of aortic vessels in normal and atherosclerotic mice, revealing the presence of conventional CD103(+) DCs with a potentially protective influence on atherosclerosis.	[Bedoui, Sammy; Heath, William R.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia	University of Melbourne	Heath, WR (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	wrheath@unimelb.edu.au		BEDOUI, SAMMY/0000-0002-7443-0543; Heath, William/0000-0001-9670-259X				Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Choi JH, 2011, IMMUNITY, V35, P819, DOI 10.1016/j.immuni.2011.09.014; Choi JH, 2009, J EXP MED, V206, P497, DOI 10.1084/jem.20082129; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Weber C, 2011, J CLIN INVEST, V121, P2898, DOI 10.1172/JCI44925	10	2	2	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 23	2011	35	5					665	667		10.1016/j.immuni.2011.11.005	http://dx.doi.org/10.1016/j.immuni.2011.11.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	852XM	22118522	Bronze			2022-12-18	WOS:000297390800006
J	Cai, YH; Shen, XY; Ding, CL; Qi, CJ; Li, KJ; Li, X; Jala, VR; Zhang, HG; Wang, TA; Zheng, J; Yan, J				Cai, Yihua; Shen, Xiaoyan; Ding, Chuanlin; Qi, Chunjian; Li, Kejia; Li, Xia; Jala, Venkatakrishna R.; Zhang, Huang-ge; Wang, Tian; Zheng, Jie; Yan, Jun			Pivotal Role of Dermal IL-17-Producing gamma delta T Cells in Skin Inflammation (vol 35, pg 596, 2011)	IMMUNITY			English	Correction												jie-zheng2001@126.com; jun.yan@louisville.edu	Jala, Venkatakrishna R/K-7255-2018	Jala, Venkatakrishna R/0000-0002-4206-7305				Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001	1	2	2	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 28	2011	35	4					649	649		10.1016/j.immuni.2011.10.006	http://dx.doi.org/10.1016/j.immuni.2011.10.006			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	843FM		Bronze			2022-12-18	WOS:000296657700023
J	Li, ST; Wang, LY; Berman, M; Kong, YY; Dorf, ME				Li, Shitao; Wang, Lingyan; Berman, Michael; Kong, Young-Yun; Dorf, Martin E.			Mapping a Dynamic Innate Immunity Protein Interaction Network Regulating Type I Interferon Production (vol 35, pg 426, 2011)	IMMUNITY			English	Correction												lishitao@hotmail.com; dorf@hms.harvard.edu						Li ST, 2011, IMMUNITY, V35, P426, DOI 10.1016/j.immuni.2011.06.014	1	2	2	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT 28	2011	35	4					647	648		10.1016/j.immuni.2011.10.002	http://dx.doi.org/10.1016/j.immuni.2011.10.002			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	843FM		Bronze			2022-12-18	WOS:000296657700022
J	Awasthi, A; Kuchroo, VK				Awasthi, Amit; Kuchroo, Vijay K.			Value Added: Neural Progenitor Cells Suppress Inflammation and Autoimmunity	IMMUNITY			English	Editorial Material							DIFFERENTIATION		[Awasthi, Amit; Kuchroo, Vijay K.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kuchroo, VK (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA.	vkuchroo@rics.bwh.harvard.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI073748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS030843, R01NS045937] Funding Source: NIH RePORTER; NIAID NIH HHS [P01 AI073748-05, P01 AI073748-03, P01 AI073748, P01 AI073748-04] Funding Source: Medline; NINDS NIH HHS [R37 NS030843-17, R37 NS030843, R01 NS045937, R01 NS045937-09, R01 NS045937-08, R01 NS045937-07, R37 NS030843-16] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Cao W, 2011, IMMUNITY, V35, P273, DOI 10.1016/j.immuni.2011.06.011; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Einstein O, 2003, MOL CELL NEUROSCI, V24, P1074, DOI 10.1016/j.mcn.2003.08.009; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kuchroo VK, 2002, ANNU REV IMMUNOL, V20, P101, DOI 10.1146/annurev.immunol.20.081701.141316; Liu XB, 2008, J IMMUNOL, V180, P6070, DOI 10.4049/jimmunol.180.9.6070; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001	9	2	3	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 26	2011	35	2					156	157		10.1016/j.immuni.2011.08.005	http://dx.doi.org/10.1016/j.immuni.2011.08.005			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	813SC	21867924	Bronze, Green Accepted			2022-12-18	WOS:000294387900005
J	Gascoigne, NRJ				Gascoigne, Nicholas R. J.			T Cell Receptor Structures: Three for the Price of One	IMMUNITY			English	Editorial Material							MHC; COMPLEX		Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Scripps Research Institute	Gascoigne, NRJ (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gascoigne@scripps.edu			NIAID NIH HHS [R01 AI074074] Funding Source: Medline; NIGMS NIH HHS [R01 GM065230] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065230] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; Huseby E, 2004, EUR J IMMUNOL, V34, P1243, DOI 10.1002/eji.200425000; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; Scott-Browne JP, 2009, NATURE, V458, P1043, DOI 10.1038/nature07812; Sim BC, 1998, IMMUNOL TODAY, V19, P276, DOI 10.1016/S0167-5699(98)01257-2; Van Laethem F, 2007, IMMUNITY, V27, P735, DOI 10.1016/j.immuni.2007.10.007; Yin L, 2011, IMMUNITY, V35, P23, DOI 10.1016/j.immuni.2011.04.017	10	2	2	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 22	2011	35	1					1	3		10.1016/j.immuni.2011.07.001	http://dx.doi.org/10.1016/j.immuni.2011.07.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	797EM	21777791	Bronze			2022-12-18	WOS:000293107300001
J	Liberatore, RA; Bieniasz, PD				Liberatore, Rachel A.; Bieniasz, Paul D.			Sensing Retroviruses	IMMUNITY			English	Editorial Material							PLASMACYTOID DENDRITIC CELLS; I INTERFERONS; AUTOIMMUNITY; IMMUNITY; SENSOR		[Liberatore, Rachel A.; Bieniasz, Paul D.] Rockefeller Univ, Howard Hughes Med Inst, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA	Howard Hughes Medical Institute; Rockefeller University	Bieniasz, PD (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Aaron Diamond AIDS Res Ctr, 455 1st Ave, New York, NY 10016 USA.	pbienias@adarc.org		Liberatore, Rachel/0000-0002-3861-5858	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050111, R37AI064003] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R37 AI064003, R37 AI064003-06, R01 AI050111-10, R01 AI050111] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Browne EP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000298; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Kane M, 2011, IMMUNITY, V35, P135, DOI 10.1016/j.immuni.2011.05.011; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; McCartney SA, 2009, IMMUNOL REV, V227, P87, DOI 10.1111/j.1600-065X.2008.00726.x; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843	10	2	2	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 22	2011	35	1					8	10		10.1016/j.immuni.2011.07.004	http://dx.doi.org/10.1016/j.immuni.2011.07.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	797EM	21777794	Green Accepted, Bronze			2022-12-18	WOS:000293107300004
J	Roth, S; Ruland, J				Roth, Susanne; Ruland, Juergen			Caspase-8: Clipping off RIG-I Signaling	IMMUNITY			English	Editorial Material							RECOGNITION; ACTIVATION; RECEPTORS; NEMO	Activation of the RIG-I signaling molecule is essential for antiviral immunity but mechanisms downmodulating the response are ill defined. In this issue of Immunity, Rajput et al. (2011) describe caspase-8-mediated RIP1 cleavage as a key step for restricting RIG-I signaling.	[Roth, Susanne; Ruland, Juergen] Tech Univ Munich, Klinikum Rechts Isar, Inst Mol Immunol, D-81675 Munich, Germany; [Ruland, Juergen] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Lab Signaling Immune Syst, D-85764 Neuherberg, Germany	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Ruland, J (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Inst Mol Immunol, D-81675 Munich, Germany.	jruland@lrz.tum.de	Ruland, Jürgen/Q-6680-2018	Ruland, Jürgen/0000-0002-8381-3597				Ben Moshe T, 2007, HEPATOLOGY, V45, P1014, DOI 10.1002/hep.21495; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Kovalenko A, 2009, J EXP MED, V206, P2161, DOI 10.1084/jem.20090616; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Meylan E, 2005, TRENDS BIOCHEM SCI, V30, P151, DOI 10.1016/j.tibs.2005.01.003; Rajput A, 2011, IMMUNITY, V34, P340, DOI 10.1016/j.immuni.2010.12.018; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x	9	2	2	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 25	2011	34	3					283	285		10.1016/j.immuni.2011.03.011	http://dx.doi.org/10.1016/j.immuni.2011.03.011			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	743JL	21435580	Bronze			2022-12-18	WOS:000289014500002
J	Vaishnava, S; Hooper, LV				Vaishnava, Shipra; Hooper, Lora V.			Eat Your Carrots! T Cells Are RARing to Go	IMMUNITY			English	Editorial Material							RETINOIC ACID; DIFFERENTIATION	In this issue of Immunity, Hall et al. (2011) show that vitamin A and its metabolites play a central role in regulating adaptive immunity by promoting the development of both inflammatory and regulatory T cell responses.	[Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Vaishnava, Shipra; Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hooper, LV (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	lora.hooper@utsouthwestern.edu						Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nolting J, 2009, J EXP MED, V206, P2131, DOI 10.1084/jem.20090639; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Wang CW, 2010, J IMMUNOL, V184, P5519, DOI 10.4049/jimmunol.0903942	9	2	2	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 25	2011	34	3					290	292		10.1016/j.immuni.2011.03.007	http://dx.doi.org/10.1016/j.immuni.2011.03.007			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	743JL	21435583	Bronze			2022-12-18	WOS:000289014500005
J	Tangye, SG				Tangye, Stuart G.			Plasmacytoid DCs Induce Gutsy Plasma Cells	IMMUNITY			English	Editorial Material							DENDRITIC CELLS; B-CELLS; GENERATION	Immunoglobulin (Ig) A is critical for protective immune responses at mucosal surfaces. In this issue of Immunity, Tezuka et al. (2011) identify an important relay between stromal cells and plasmacytoid dendritic cells that regulates IgA production by murine B cells.	[Tangye, Stuart G.] Garvan Inst Med Res, Program Immunol, Darlinghurst, NSW 2010, Australia; [Tangye, Stuart G.] Univ NSW, St Vincents Clin Sch, Darlinghurst, NSW 2010, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney	Tangye, SG (corresponding author), Garvan Inst Med Res, Program Immunol, Darlinghurst, NSW 2010, Australia.	s.tangye@garvan.org.au	Tangye, Stuart G/H-4023-2014	Tangye, Stuart G/0000-0002-5360-5180				CERUTTI A, 2010, ANN REV IMM IN PRESS; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Massacand JC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002588; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Sato A, 2003, J IMMUNOL, V171, P3684, DOI 10.4049/jimmunol.171.7.3684; Suzuki K, 2010, IMMUNITY, V33, P71, DOI 10.1016/j.immuni.2010.07.003; Tangye SG, 2006, SEMIN IMMUNOL, V18, P305, DOI 10.1016/j.smim.2006.04.004; Tezuka H, 2007, NATURE, V448, P929, DOI 10.1038/nature06033; Tezuka H, 2011, IMMUNITY, V34, P247, DOI 10.1016/j.immuni.2011.02.002; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622	10	2	3	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	FEB 25	2011	34	2					144	146		10.1016/j.immuni.2011.02.009	http://dx.doi.org/10.1016/j.immuni.2011.02.009			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	729YD	21349426	Bronze			2022-12-18	WOS:000287989500004
J	Zhu, MZ; Fu, YX				Zhu, Mingzhao; Fu, Yang-Xin			Deflating the Lymph Node	IMMUNITY			English	Editorial Material							IFN-GAMMA; LYMPHANGIOGENESIS; VASCULATURE; CELLS; VEGF	Although the lymph node lymphatic vessel growth and development is positively regulated by B cells and macrophages, Kataru et al. (2011), in this issue of Immunity, show negative regulation of lymphatic vessels by interferon-gamma from T cells.	[Zhu, Mingzhao] Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100101, Peoples R China; [Fu, Yang-Xin] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Fu, Yang-Xin] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Chicago; University of Chicago	Zhu, MZ (corresponding author), Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100101, Peoples R China.	zhumz@ibp.ac.cn; yxfu@bsd.uchicago.edu	Zhu, Mingzhao/L-8662-2019	fu, yang-xin/0000-0001-8441-6617; Zhu, Mingzhao/0000-0003-2001-2669	NCI NIH HHS [R01 CA141975, R01 CA134563-03, R01 CA141975-02, R01 CA134563-02, R01 CA134563] Funding Source: Medline; NIAID NIH HHS [R21 AI090392, R21 AI090392-02] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA141975, R01CA134563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090392] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Angeli V, 2006, IMMUNITY, V24, P203, DOI 10.1016/j.immuni.2006.01.003; Chyou S, 2008, J IMMUNOL, V181, P3887, DOI 10.4049/jimmunol.181.6.3887; Halin C, 2007, BLOOD, V110, P3158, DOI 10.1182/blood-2007-01-066811; Kataru RP, 2011, IMMUNITY, V34, P96, DOI 10.1016/j.immuni.2010.12.016; Kataru RP, 2009, BLOOD, V113, P5650, DOI 10.1182/blood-2008-09-176776; Kim KE, 2009, AM J PATHOL, V175, P1733, DOI 10.2353/ajpath.2009.090133; Liao S, 2006, J IMMUNOL, V177, P3369, DOI 10.4049/jimmunol.177.5.3369; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Ruegg C, 1998, NAT MED, V4, P408, DOI 10.1038/nm0498-408; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222	10	2	2	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 28	2011	34	1					8	10		10.1016/j.immuni.2011.01.005	http://dx.doi.org/10.1016/j.immuni.2011.01.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	721EO	21272783	Green Accepted, Bronze			2022-12-18	WOS:000287336600004
J	Egen, JG; Ouyang, W				Egen, Jackson G.; Ouyang, Wenjun			Even Neurons Are Excited by Th17 Cells	IMMUNITY			English	Editorial Material									[Egen, Jackson G.; Ouyang, Wenjun] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA	Roche Holding; Genentech	Egen, JG (corresponding author), Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA.	egen.jackson@gene.com; ouyang@gene.com	Ouyang, Wenjun/ABA-8763-2020	Egen, Jackson/0000-0003-2053-0837; Ouyang, Wenjun/0000-0002-1811-5864				Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Kang ZZ, 2010, IMMUNITY, V32, P414, DOI 10.1016/j.immuni.2010.03.004; Kawakami N, 2010, SEMIN IMMUNOPATHOL, V32, P275, DOI 10.1007/s00281-010-0216-x; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Siffrin V, 2010, IMMUNITY, V33, P424, DOI 10.1016/j.immuni.2010.08.018; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001	10	2	4	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 24	2010	33	3					298	300		10.1016/j.immuni.2010.09.004	http://dx.doi.org/10.1016/j.immuni.2010.09.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	662HP	20870172	Bronze			2022-12-18	WOS:000282798500005
J	Levy, DE				Levy, David E.			NF-kappa B-ISGF3 Transcription Factor Cooperation: Coincidence Detector or Memory Chip?	IMMUNITY			English	Editorial Material								Induction of gene expression involves deployment of transcription factors. In this issue of Immunity, Farlik et al. (2010) provide a view in which cooperation between transcription factors NF-kappa B and ISGF3 divides the task of transcription by recruiting and activating distinct components of the transcriptional machinery.	NYU, Sch Med, New York, NY 10016 USA	New York University	Levy, DE (corresponding author), NYU, Sch Med, 550 1st Ave MSB550, New York, NY 10016 USA.	david.levy@nyumc.org	Levy, David/GPS-4945-2022; Levy, David/AAG-6202-2019	Levy, David/0000-0002-7320-7788				Adelman K, 2009, P NATL ACAD SCI USA, V106, P18207, DOI 10.1073/pnas.0910177106; Brickner JH, 2009, CURR OPIN CELL BIOL, V21, P127, DOI 10.1016/j.ceb.2009.01.007; Farlik M, 2010, IMMUNITY, V33, P25, DOI 10.1016/j.immuni.2010.07.001; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Kundu S, 2007, GENE DEV, V21, P997, DOI 10.1101/gad.1506607; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020	8	2	2	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 23	2010	33	1					1	2		10.1016/j.immuni.2010.07.011	http://dx.doi.org/10.1016/j.immuni.2010.07.011			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	632JD	20643331	Bronze			2022-12-18	WOS:000280418100001
J	Di Santo, JP				Di Santo, James P.			An IL-1 beta-Dependent Switch in Innate Mucosal Immunity?	IMMUNITY			English	Editorial Material							NATURAL-KILLER-CELLS; DIFFERENTIATION; PRECURSORS	The mechanisms that guide the development of mucosal-associated innate lymphoid cells (ILCs) producing IL-17, IL-22, and IFN-gamma are the subject of intense interest. In this issue of Immunity, Hughes et al. (2010) identify a new role for IL-1 beta in regulating an IL-22-producing ILC.	[Di Santo, James P.] Inst Pasteur, Innate Immun Unit, F-75724 Paris, France; [Di Santo, James P.] INSERM, U668, F-75724 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Di Santo, JP (corresponding author), Inst Pasteur, Innate Immun Unit, F-75724 Paris, France.	james.di-santo@pasteur.fr	Di Santo, James P/M-4298-2014	Di Santo, James P/0000-0002-7146-1862				Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Crellin NK, 2010, J EXP MED, V207, P281, DOI 10.1084/jem.20091509; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Freud AG, 2006, J EXP MED, V203, P1033, DOI 10.1084/jem.20052507; Hughes T, 2010, IMMUNITY, V32, P803, DOI 10.1016/j.immuni.2010.06.007; Hughes T, 2009, BLOOD, V113, P4008, DOI 10.1182/blood-2008-12-192443; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Satoh-Takayama N, 2010, J EXP MED, V207, P273, DOI 10.1084/jem.20092029	10	2	2	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN 25	2010	32	6					734	736		10.1016/j.immuni.2010.06.012	http://dx.doi.org/10.1016/j.immuni.2010.06.012			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	618OQ	20620939	Bronze			2022-12-18	WOS:000279365800004
J	Pham, D; Kaplan, MH				Pham, Duy; Kaplan, Mark H.			Antisocial Networking in T Helper Cells	IMMUNITY			English	Editorial Material							INTERFERON-GAMMA; TYPE-1 CELLS; BET; TH1	T helper cell differentiation is controlled by a network of transcription factors. In this issue of Immunity, Yagi et al. (2010) describe the opposing effects of transcription factors Runx3 and GATA3 in the network promoting T helper 1 cell development.	[Pham, Duy; Kaplan, Mark H.] Indiana Univ, Sch Med, Dept Pediat, Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Pham, Duy; Kaplan, Mark H.] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Wells Ctr Pediat Res, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Kaplan, MH (corresponding author), Indiana Univ, Sch Med, Dept Pediat, Wells Ctr Pediat Res, 1044 W Walnut St, Indianapolis, IN 46202 USA.							Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Kohu K, 2009, J IMMUNOL, V183, P7817, DOI 10.4049/jimmunol.0802527; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Naoe Y, 2007, J EXP MED, V204, P1749, DOI 10.1084/jem.20062456; Schulz EG, 2009, IMMUNITY, V30, P673, DOI 10.1016/j.immuni.2009.03.013; Thieu VT, 2008, IMMUNITY, V29, P679, DOI 10.1016/j.immuni.2008.08.017; Usui T, 2003, IMMUNITY, V18, P415, DOI 10.1016/S1074-7613(03)00057-8; Yagi R, 2010, IMMUNITY, V32, P507, DOI 10.1016/j.immuni.2010.04.004; Yang Y, 2008, J IMMUNOL, V181, P8700, DOI 10.4049/jimmunol.181.12.8700; Yu Q, 2008, J IMMUNOL, V181, P3346, DOI 10.4049/jimmunol.181.5.3346	10	2	2	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 23	2010	32	4					500	501		10.1016/j.immuni.2010.04.006	http://dx.doi.org/10.1016/j.immuni.2010.04.006			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	589RW	20412760	Bronze			2022-12-18	WOS:000277171900007
J	Constantin, G; Laudanna, C				Constantin, Gabriela; Laudanna, Carlo			A Deadly Migration	IMMUNITY			English	Editorial Material							RECEPTOR; ARREST; ROLES; CD95		[Constantin, Gabriela; Laudanna, Carlo] Univ Verona, Div Gen Pathol, Dept Pathol, I-37134 Verona, Italy	University of Verona	Laudanna, C (corresponding author), Univ Verona, Div Gen Pathol, Dept Pathol, Str Grazie 8, I-37134 Verona, Italy.	carlo.laudanna@univr.it		Constantin, Gabriela/0000-0001-8978-3539				Bolomini-Vittori M, 2009, NAT IMMUNOL, V10, P185, DOI 10.1038/ni.1691; Bouillet P, 2009, NAT REV IMMUNOL, V9, P514, DOI 10.1038/nri2570; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; Laudanna C, 2006, THROMB HAEMOSTASIS, V95, P5, DOI 10.1160/TH05-07-0482; Letellier E, 2010, IMMUNITY, V32, P240, DOI 10.1016/j.immuni.2010.01.011; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001	10	2	2	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 26	2010	32	2					147	149		10.1016/j.immuni.2010.02.003	http://dx.doi.org/10.1016/j.immuni.2010.02.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	566BX	20189478	Bronze			2022-12-18	WOS:000275346000004
J	Chen, QZ; Yang, W; Gupta, S; Biswas, P; Smith, P; Bhagat, G; Pernis, AB				Chen, Qinzhong; Yang, Wen; Gupta, Sanjay; Biswas, Partha; Smith, Paula; Bhagat, Govind; Pernis, Alessandra B.			Does Def6 Deficiency Cause Autoimmunity? Response	IMMUNITY			English	Letter							TRANSCRIPTION FACTOR; PROTEIN		[Chen, Qinzhong; Yang, Wen; Gupta, Sanjay; Biswas, Partha; Pernis, Alessandra B.] Columbia Univ, Dept Med, New York, NY 10032 USA; [Bhagat, Govind] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Smith, Paula] Howard Univ, Washington, DC 20059 USA	Columbia University; Columbia University; Howard University	Pernis, AB (corresponding author), Columbia Univ, Dept Med, New York, NY 10032 USA.	abp1@columbia.edu	Bhagat, Govind/AAE-9493-2021	Bhagat, Govind/0000-0001-6250-048X				Becart S, 2008, IMMUNITY, V29, P704, DOI 10.1016/j.immuni.2008.08.015; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Chen QZ, 2008, IMMUNITY, V29, P899, DOI 10.1016/j.immuni.2008.10.011; Huber M, 2008, P NATL ACAD SCI USA, V105, P20846, DOI 10.1073/pnas.0809077106; Jorgensen TN, 2004, CURR OPIN IMMUNOL, V16, P787, DOI 10.1016/j.coi.2004.09.013; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706	6	2	2	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2009	31	1					2	3		10.1016/j.immuni.2009.06.012	http://dx.doi.org/10.1016/j.immuni.2009.06.012			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	473PN		Bronze			2022-12-18	WOS:000268219900002
J	Stein, JV				Stein, Jens V.			How to be Naive	IMMUNITY			English	Editorial Material							T-CELLS; MIGRATION; TRANSCRIPTION	The transcription factor KLF2 directs expression of receptors involved in trafficking of naive T cells. In this issue of Immunity, Weinreich et al. (2009) demonstrate that KLF2 additionally represses IL-4 production, which otherwise induces CXCR3 expression.	Univ Bern, Theodor Kocher Inst, CH-3012 Bern, Switzerland	University of Bern	Stein, JV (corresponding author), Univ Bern, Theodor Kocher Inst, Freiestr 1, CH-3012 Bern, Switzerland.	jstein@tki.unibe.ch		Stein, Jens V/0000-0002-8199-9586				Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Guarda G, 2007, NAT IMMUNOL, V8, P743, DOI 10.1038/ni1469; Junt T, 2008, NAT REV IMMUNOL, V8, P764, DOI 10.1038/nri2414; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Sebzda E, 2008, NAT IMMUNOL, V9, P292, DOI 10.1038/ni1565; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Weinreich MA, 2009, IMMUNITY, V31, P122, DOI 10.1016/j.immuni.2009.05.011	10	2	2	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 17	2009	31	1					9	11		10.1016/j.immuni.2009.06.010	http://dx.doi.org/10.1016/j.immuni.2009.06.010			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	473PN	19604488	Bronze			2022-12-18	WOS:000268219900006
J	Hill, JA; Hall, JA; Sun, CM; Cai, Q; Ghyselinck, N; Chambon, P; Belkaid, Y; Mathis, D; Benoist, C				Hill, Jonathan A.; Hall, Jason A.; Sun, Cheng-Ming; Cai, Qj; Ghyselinck, Norbert; Chambon, Pierre; Belkaid, Yasmine; Mathis, Diane; Benoist, Christophe			Retinoic Acid Can Directly Promote TGF-beta-Mediated Foxp3(+) Treg Cell Conversion of Naive T Cells Response to Letter from Mucida et al.	IMMUNITY			English	Letter							INDUCTION; INHIBITION; EXPRESSION; RECEPTOR; PATHWAY		[Hill, Jonathan A.; Mathis, Diane; Benoist, Christophe] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Joslin Diabet Ctr,Sect Immunol & Immunog, Boston, MA 02215 USA; [Hall, Jason A.; Sun, Cheng-Ming; Belkaid, Yasmine] NIAID, NIH, Parasit Dis Lab, Mucosal Immun Unit, Bethesda, MD 20892 USA; [Hall, Jason A.] Univ Penn, Immunol Grad Grp, Philadelphia, PA 19104 USA; [Cai, Qj; Ghyselinck, Norbert; Chambon, Pierre] Univ Strasbourg 1, Inst Natl Sante & Rech Med, Ctr Natl Rech Sci, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Joslin Diabetes Center, Inc.; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Pennsylvania; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Benoist, C (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Joslin Diabet Ctr,Sect Immunol & Immunog, Boston, MA 02215 USA.	cbdm@joslin.harvard.edu	GHYSELINCK, Norbert/I-6999-2015; Cai, Qi/E-4357-2014	GHYSELINCK, Norbert/0000-0003-4042-6818; Cai, Qi/0000-0002-2598-542X				Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Hill JA, 2008, IMMUNITY, V29, P758, DOI 10.1016/j.immuni.2008.09.018; Maynard CL, 2009, J EXP MED, V206, P343, DOI 10.1084/jem.20080950; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Mucida D, 2009, IMMUNITY, V30, P471, DOI 10.1016/j.immuni.2009.03.008; Takaki H, 2008, J BIOL CHEM, V283, P14955, DOI 10.1074/jbc.M801123200; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277	8	2	2	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2009	30	4					472	473		10.1016/j.immuni.2009.03.012	http://dx.doi.org/10.1016/j.immuni.2009.03.012			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	435BT		Bronze			2022-12-18	WOS:000265319000002
J	Van Parijs, L; Peterson, DA; Abbas, AK				Van Parijs, Luk; Peterson, Daniel A.; Abbas, Abul K.			The Fas/Fas Ligand Pathway and Bcl-2 Regulate T Cell Responses to Model Self and Foreign Antigens (Retraction of vol. 8, pg. 265, 1998)	IMMUNITY			English	Correction												abul.abbas@ucsf.edu						PARIJS LV, 1998, IMMUNITY, V8, P254	1	2	3	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR 17	2009	30	4					611	611		10.1016/j.immuni.2009.04.001	http://dx.doi.org/10.1016/j.immuni.2009.04.001			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	435BT		Bronze			2022-12-18	WOS:000265319000018
J	Ward, SG				Ward, Stephen G.			Millipede-like Lymphocyte Crawling: Feeling the Way with Filopodia	IMMUNITY			English	Editorial Material							LFA-1	In this issue of Immunity, Shulman et al. (2009) describe shear-facilitated chemokine-induced adhesive filopodia on crawling T lymphocytes that scan the endothelial surface for potential sites of transendothelial migration. These filopodia facilitate a novel millipede-like mode of lymphocyte locomotion over endothelial cells prior to extravasation.	Univ Bath, Inflammatory Cell Biol Lab, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England	University of Bath	Ward, SG (corresponding author), Univ Bath, Inflammatory Cell Biol Lab, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England.	s.g.ward@bath.ac.uk	Ward, Stephen/AAE-4341-2020	Ward, Stephen G./0000-0002-6795-6002				Bolomini-Vittori M, 2009, NAT IMMUNOL, V10, P185, DOI 10.1038/ni.1691; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Carman CV, 2004, J CELL BIOL, V167, P377, DOI 10.1083/jcb.200404129; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Pasvolsky R, 2007, J EXP MED, V204, P1571, DOI 10.1084/jem.20070058; Shulman Z, 2009, IMMUNITY, V30, P384, DOI 10.1016/j.immuni.2008.12.020; Stanley P, 2008, EMBO J, V27, P62, DOI 10.1038/sj.emboj.7601959; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499	8	2	10	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2009	30	3					315	317		10.1016/j.immuni.2009.03.002	http://dx.doi.org/10.1016/j.immuni.2009.03.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	422CU	19303383	Bronze			2022-12-18	WOS:000264405500002
J	Tough, DF				Tough, David F.			Turnabout Is Fair Play: T Cell Stimulation by Dendritic Cell-Expressed CD40L	IMMUNITY			English	Editorial Material							CD8 MEMORY; HELP		GlaxoSmithKline, Immunoinflammat Ctr Excellence Drug Discovery, Stevenage SG1 2NY, Herts, England	GlaxoSmithKline	Tough, DF (corresponding author), GlaxoSmithKline, Immunoinflammat Ctr Excellence Drug Discovery, Gunnels Wood Rd, Stevenage SG1 2NY, Herts, England.	david.f.tough@gsk.com						Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Carreno BM, 2009, IMMUNOL CELL BIOL, V87, P167, DOI 10.1038/icb.2008.80; Johnson S, 2009, IMMUNITY, V30, P218, DOI 10.1016/j.immuni.2008.11.015; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Lee BO, 2003, J EXP MED, V198, P1759, DOI 10.1084/jem.20031440; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Sun JC, 2004, J IMMUNOL, V172, P3385, DOI 10.4049/jimmunol.172.6.3385	9	2	2	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2009	30	2					171	173		10.1016/j.immuni.2009.01.002	http://dx.doi.org/10.1016/j.immuni.2009.01.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	412FT	19239898	Bronze			2022-12-18	WOS:000263710500002
J	Elliott, T				Elliott, Tim			More Images that Yet Fresh Images Beget	IMMUNITY			English	Editorial Material							TAPASIN	In this issue of Immunity, Dong et al. (2009) describe the protein crystal structure heterodimer of tapasin and ERp57, which helps visualize the function of these proteins in loading of peptide antigens onto MHC class I molecules as part of the peptide loading complex within the endoplasmic reticulum.	Univ Southampton, Sch Med, Canc Sci Div, Southampton SO16 6YD, Hants, England	University of Southampton	Elliott, T (corresponding author), Univ Southampton, Sch Med, Canc Sci Div, Southampton SO16 6YD, Hants, England.	t.j.elliott@soton.ac.uk		Elliott, Tim/0000-0003-1097-0222	Cancer Research UK [10601] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Howarth M, 2004, P NATL ACAD SCI USA, V101, P11737, DOI 10.1073/pnas.0306294101; Lewis JW, 1998, CURR BIOL, V8, P717, DOI 10.1016/S0960-9822(98)70280-5; Sieker F, 2008, MOL IMMUNOL, V45, P3714, DOI 10.1016/j.molimm.2008.06.009; Williams AP, 2002, IMMUNITY, V16, P509, DOI 10.1016/S1074-7613(02)00304-7	6	2	2	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN 16	2009	30	1					1	2		10.1016/j.immuni.2008.12.011	http://dx.doi.org/10.1016/j.immuni.2008.12.011			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398ZJ	19144309	Bronze			2022-12-18	WOS:000262769900001
J	Tang, QZ; Walker, LSK; Bluestone, JA				Tang, Qizhi; Walker, Lucy S. K.; Bluestone, Jeffrey A.			Response: Regulating Treg Cells at Sites of Inflammation	IMMUNITY			English	Letter							INTERLEUKIN-2; AUTOIMMUNITY		[Bluestone, Jeffrey A.] Univ Calif San Francisco, UCSF Diabet Ctr, San Francisco, CA 94143 USA; [Tang, Qizhi] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Walker, Lucy S. K.] Univ Birmingham, Sch Med, Med Res Council Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Birmingham	Bluestone, JA (corresponding author), Univ Calif San Francisco, UCSF Diabet Ctr, 513 Parnassus Ave,Box 0540, San Francisco, CA 94143 USA.	jbluest@diabetes.ucsf.edu		Tang, Qizhi/0000-0001-7313-3574				Clough LE, 2008, J IMMUNOL, V180, P5393, DOI 10.4049/jimmunol.180.8.5393; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958	4	2	2	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2008	29	4					512	512		10.1016/j.immuni.2008.09.011	http://dx.doi.org/10.1016/j.immuni.2008.09.011			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364DP		Bronze			2022-12-18	WOS:000260316700002
J	Belz, GT				Belz, Gabrielle T.			DC migration: Hard-wired for T cell activation	IMMUNITY			English	Editorial Material							CD8-ALPHA(+) DENDRITIC CELLS; ANTIGEN PRESENTATION; ENTRY	Dendritic cells (DCs) play a central role in responding to pathogens. In this issue of Immunity, Aoshi et al. (2008) highlight the fact that the migratory route DCs take to drive T cell activation is independent of the architecture of lymphoid tissues.	Walter & Eliza Hall Inst Med Res, Div Immunol, Melbourne, Vic 3050, Australia	Walter & Eliza Hall Institute	Belz, GT (corresponding author), Walter & Eliza Hall Inst Med Res, Div Immunol, Melbourne, Vic 3050, Australia.	belz@wehi.edu.au	Belz, Gabrielle T/C-9350-2013	Belz, Gabrielle T/0000-0002-9660-9587				Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Aoshi T, 2008, IMMUNITY, V29, P476, DOI 10.1016/j.immuni.2008.06.013; Belz GT, 2005, J IMMUNOL, V175, P196, DOI 10.4049/jimmunol.175.1.196; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; Khanna KM, 2007, SCIENCE, V318, P116, DOI 10.1126/science.1146291; Neuenhahn M, 2006, IMMUNITY, V25, P619, DOI 10.1016/j.immuni.2006.07.017; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254	9	2	2	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2008	29	3					388	390		10.1016/j.immuni.2008.08.003	http://dx.doi.org/10.1016/j.immuni.2008.08.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	355KX	18799148	Bronze			2022-12-18	WOS:000259708900009
J	Kondo, M				Kondo, Motonari			Multitalented E2A: A new role in lymphoid-lineage priming	IMMUNITY			English	Editorial Material							BONE-MARROW; STEM-CELLS; COMMITMENT; MARKS	How do hematopoietic stem cells choose to be lymphocytes? In this issue of Immunity, Dias et al. (2008) uncover the requirement for E2A during lymphoid-lineage priming in the multipotent progenitor population.	Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	Duke University	Kondo, M (corresponding author), Duke Univ, Med Ctr, Dept Immunol, 101 Jones Bldg,DUMC Box 3010,Res Dr, Durham, NC 27710 USA.	motonari.kondo@duke.edu						Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Dias S, 2008, IMMUNITY, V29, P217, DOI 10.1016/j.immuni.2008.05.015; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Murre C, 2005, NAT IMMUNOL, V6, P1079, DOI 10.1038/ni1260; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; Ueda Y, 2005, J EXP MED, V201, P1771, DOI 10.1084/jem.20041419; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314	8	2	2	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	AUG 15	2008	29	2					169	170		10.1016/j.immuni.2008.07.004	http://dx.doi.org/10.1016/j.immuni.2008.07.004			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339XO	18701077	Bronze			2022-12-18	WOS:000258610800002
J	Desiderio, S				Desiderio, Stephen			Along came a spider: AID escapes a microRNA web	IMMUNITY			English	Editorial Material							LYMPHOMA		Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Johns Hopkins University	Desiderio, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	sdesider@jhmi.edu						Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Kluiver J, 2007, ONCOGENE, V26, P3769, DOI 10.1038/sj.onc.1210147; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Tam W, 2002, J VIROL, V76, P4275, DOI 10.1128/JVI.76.9.4275-4286.2002; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009	11	2	2	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2008	28	5					596	598		10.1016/j.immuni.2008.04.012	http://dx.doi.org/10.1016/j.immuni.2008.04.012			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	302XS	18482561	Bronze			2022-12-18	WOS:000256003900002
J	Takabayshi, K; Corr, M; Hayashi, T; Redecke, V; Beck, L; Guiney, D; Sheppard, D; Raz, E				Takabayshi, Kenji; Corr, Maripat; Hayashi, Tomoko; Redecke, Vanessa; Beck, Lucinda; Guiney, Donald; Sheppard, Dean; Raz, Eyal			Induction of a homeostatic circuit in lung tissue by microbial compounds (Retraction of vol 24, pg 475, 2006)	IMMUNITY			English	Correction												eraz@ucsd.edu			NIAID NIH HHS [P01 AI040682] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Takabayshi K, 2006, IMMUNITY, V24, P475, DOI 10.1016/j.immuni.2006.02.008	1	2	2	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY	2008	28	5					724	724		10.1016/j.immuni.2008.04.011	http://dx.doi.org/10.1016/j.immuni.2008.04.011			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	302XS	18504811	Bronze			2022-12-18	WOS:000256003900019
J	Kolls, JK				Kolls, Jay K.			Balancing mucosal immunity: Caught between CYLD and Charybdis	IMMUNITY			English	Editorial Material							NF-KAPPA-B; DEUBIQUITINATING ENZYME	The molecular mechanism of acute lung injury caused by Streptococcus pneumoniae is unclear. In this issue of Immunity, Lim et al. (2007) demonstrate that CYLD, a deubiquinating enzyme, represses the expression of plasminogen activator inhibitor-1, which is critical in preventing tissue damage.	Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kolls, JK (corresponding author), Childrens Hosp Pittsburgh, Suite 3765,3705 5th Ave, Pittsburgh, PA 15213 USA.	jay.kolls@chp.edu	Kolls, Jay/AAH-1829-2019	Kolls, Jay/0000-0001-5151-6304				Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Lim JH, 2007, IMMUNITY, V27, P349, DOI 10.1016/j.immuni.2007.07.011; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Mizgerd JP, 2006, PLOS MED, V3, P155, DOI 10.1371/journal.pmed.0030076; Quinton LJ, 2007, J IMMUNOL, V178, P1896, DOI 10.4049/jimmunol.178.3.1896; Reiley WW, 2006, NAT IMMUNOL, V7, P411, DOI 10.1038/ni1315; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Zhang J, 2006, J CLIN INVEST, V116, P3042, DOI 10.1172/JCI28746	10	2	4	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2007	27	2					187	189		10.1016/j.immuni.2007.08.004	http://dx.doi.org/10.1016/j.immuni.2007.08.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	204PK	17723213	Bronze			2022-12-18	WOS:000249056300006
J	Iwasaki, H; Akashi, K				Iwasaki, Hiromi; Akashi, Koichi			Thymus exclusivity: All the right conditions for T cells	IMMUNITY			English	Editorial Material							MOUSE BONE-MARROW; PROGENITORS; EXPRESSION; SPECIFICATION; COMMITMENT; LINEAGE; PU.1		Kyushu Univ Hosp, Ctr Cellular & Mol Med, Fukuoka 8128582, Japan; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA	Kyushu University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Iwasaki, H (corresponding author), Kyushu Univ Hosp, Ctr Cellular & Mol Med, Fukuoka 8128582, Japan.							Anderson MK, 2002, IMMUNITY, V16, P285, DOI 10.1016/S1074-7613(02)00277-7; Dejbakhsh-Jones S, 2001, P NATL ACAD SCI USA, V98, P7455, DOI 10.1073/pnas.131559798; Franco CB, 2006, P NATL ACAD SCI USA, V103, P11993, DOI 10.1073/pnas.0601188103; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Mori S, 2001, BLOOD, V98, P696, DOI 10.1182/blood.V98.3.696; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Traver D, 2004, ADV IMMUNOL, V83, P1	10	2	2	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2006	25	5					697	700		10.1016/j.immuni.2006.10.005	http://dx.doi.org/10.1016/j.immuni.2006.10.005			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	105WN	17098201	Bronze			2022-12-18	WOS:000242063100004
J	Zuniga-Pflucker, JC; Ciofani, M				Zuniga-Pflucker, JC; Ciofani, M			Pre-T cell receptor's clashing signals: "Should I stay or should I go"	IMMUNITY			English	Editorial Material							DEVELOPING THYMOCYTES; PROLIFERATION; SURVIVAL; SELECTION; PROTEIN	In this issue of immunity, Kersh and colleagues (Xi et al., 2006) investigate the regulatory network that permits two otherwise clashing cellular processes-proliferation and gene rearrangement-to occur at temporally distinct periods following the formation of the pre-T cell receptor (pre-TCR) complex.	Univ Toronto, Sunnybrook Res Inst, Dept Immunol, Toronto, ON M4N 3M5, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Zuniga-Pflucker, JC (corresponding author), Univ Toronto, Sunnybrook Res Inst, Dept Immunol, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.		Zuniga-Pflucker, Juan C/H-1295-2012	Ciofani, Maria/0000-0001-6472-5260; Zuniga-Pflucker, Juan Carlos/0000-0003-2538-3178				Aifantis I, 2006, IMMUNOL REV, V209, P159, DOI 10.1111/j.0105-2896.2006.00343.x; Engel I, 2004, EMBO J, V23, P202, DOI 10.1038/sj.emboj.7600017; Konrad MAP, 2005, EUR J IMMUNOL, V35, P3030, DOI 10.1002/eji.200526345; Michie AM, 2002, SEMIN IMMUNOL, V14, P311, DOI 10.1016/S1044-5323(02)00064-7; Rivera RR, 2000, IMMUNITY, V12, P17, DOI 10.1016/S1074-7613(00)80155-7; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; vonBoehmer H, 1997, ANNU REV IMMUNOL, V15, P433, DOI 10.1146/annurev.immunol.15.1.433; Xi HK, 2004, J IMMUNOL, V173, P340, DOI 10.4049/jimmunol.173.1.340; Xi HK, 2004, J IMMUNOL, V172, P964, DOI 10.4049/jimmunol.172.2.964; Xi HK, 2006, IMMUNITY, V24, P813, DOI 10.1016/j.immuni.2006.03.023	10	2	2	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2006	24	6					669	670		10.1016/j.immuni.2006.06.006	http://dx.doi.org/10.1016/j.immuni.2006.06.006			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057JN	16782022	Bronze			2022-12-18	WOS:000238592200004
J	Dong, C; Sanjabi, S; Eynon, E				Dong, C; Sanjabi, S; Eynon, E			Gene regulation and function: It's rocking science (vol 23, pg 557, 2005)	IMMUNITY			English	Correction									MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; Yale Univ, Immunobiol Sect, New Haven, CT USA	University of Texas System; UTMD Anderson Cancer Center; Yale University	Dong, C (corresponding author), MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	cdong@mdanderson.org						Dong C, 2005, IMMUNITY, V23, P557, DOI 10.1016/j.immuni.2005.11.005	1	2	2	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2006	24	1					119	119		10.1016/j.immuni.2005.12.009	http://dx.doi.org/10.1016/j.immuni.2005.12.009			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	005UT		Bronze			2022-12-18	WOS:000234850200015
J	Lee, PT				Lee, PT			New leaf	IMMUNITY			English	Editorial Material																			0	2	2	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2005	23	5					459	459		10.1016/j.immuni.2005.10.006	http://dx.doi.org/10.1016/j.immuni.2005.10.006			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	989GK		Bronze			2022-12-18	WOS:000233660700001
J	Rogers, NC; Slack, EC; Edwards, AD; Nolte, MA; Schulz, O; Schweighoffer, E; Williams, DL; Gordon, S; Tybulewicz, VL; Brown, GD; Sousa, CRE				Rogers, NC; Slack, EC; Edwards, AD; Nolte, MA; Schulz, O; Schweighoffer, E; Williams, DL; Gordon, S; Tybulewicz, VL; Brown, GD; Sousa, CRE			Syk-dependent cytokine induction by dectin-1 reveals a novel pattern recognition pathway for C type lectins (vol 22, pg , 2005)	IMMUNITY			English	Correction									London Res Inst, Canc Res UK, Immunobiol Lab, London WC2A 3PX, England; Natl Inst Med Res, London NW7 1AA, England; E Tennessee State Univ, James H Quillen Coll Med, Dept Surg, Johnson City, TN 37614 USA; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Cancer Research UK; MRC National Institute for Medical Research; East Tennessee State University; University of Oxford	Sousa, CRE (corresponding author), London Res Inst, Canc Res UK, Immunobiol Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	caetano@cancer.org.uk	Nolte, Martijn A./AAC-8092-2022; Edwards, Alexander D/F-7440-2010; Edwards, Alexander Daniel/AAX-8524-2021	Nolte, Martijn A./0000-0002-5447-0839; Edwards, Alexander D/0000-0003-2369-989X; Edwards, Alexander Daniel/0000-0003-2369-989X; Rogers, Neil/0000-0001-8977-7585; Schulz, Oliver/0000-0002-1493-3341				Bergman MP, 2004, J EXP MED, V200, P979, DOI 10.1084/jem.20041061; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; ROGERS NC, 2005, IMMUNITY, V22	7	2	3	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2005	22	6					773	774		10.1016/j.immuni.2005.06.005	http://dx.doi.org/10.1016/j.immuni.2005.06.005			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	940XX		Bronze			2022-12-18	WOS:000230180300015
J	Zhang, XW; Schwartz, JCD; Guo, XL; Bhatia, S; Cao, EH; Lorenz, M; Cammer, M; Chen, LP; Zhang, ZY; Edidin, MA; Nathenson, SG; Almo, SC				Zhang, XW; Schwartz, JCD; Guo, XL; Bhatia, S; Cao, EH; Lorenz, M; Cammer, M; Chen, LP; Zhang, ZY; Edidin, MA; Nathenson, SG; Almo, SC			Structural and functional analysis of the costimulatory receptor programmed death-1 (vol 20, pg 337, 2004)	IMMUNITY			English	Correction																		Zhang XW, 2004, IMMUNITY, V20, P337, DOI 10.1016/S1074-7613(04)00051-2	1	2	3	1	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2004	20	5					651	651		10.1016/S1074-7613(04)00114-1	http://dx.doi.org/10.1016/S1074-7613(04)00114-1			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	823RX		Bronze			2022-12-18	WOS:000221631900014
J	Iwakoshi, NN; Lee, AH; Glimcher, LH				Iwakoshi, NN; Lee, AH; Glimcher, LH			It's a good year for blimp-1 (and plasma cells)	IMMUNITY			English	Editorial Material							TRANSCRIPTION FACTOR XBP-1; UNFOLDED PROTEIN RESPONSE; DIFFERENTIATION; EXPRESSION		Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Iwakoshi, NN (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.							Calame KL, 2001, NAT IMMUNOL, V2, P1103, DOI 10.1038/ni1201-1103; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; McHeyzer-Williams LJ, 2000, J EXP MED, V191, P1149, DOI 10.1084/jem.191.7.1149; Morse L, 1997, IMMUNITY, V6, P47, DOI 10.1016/S1074-7613(00)80241-1; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	9	2	2	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2003	19	4					466	468		10.1016/S1074-7613(03)00274-7	http://dx.doi.org/10.1016/S1074-7613(03)00274-7			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	734JK	14563311	Bronze			2022-12-18	WOS:000186051900003
J	Topham, DJ; Crispe, IN				Topham, DJ; Crispe, IN			Contrasting urban and rural lifestyles of memory CD8(+) T cells	IMMUNITY			English	Article							ANTIGEN; LOCALIZATION; PROTECTION; INFECTIONS; APOPTOSIS; CYTOKINES; LUNG	Memory CD8(+) T cells in lymphoid tissue exhibit an unexpectedly high apoptosis rate, while memory cells located in several nonlymphoid tissues do not. This may be because the lymphoid CD8(+) memory T cell repertoire is being continuously updated, while the tissue repertoire is more stable.	Univ Rochester, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA	University of Rochester	Topham, DJ (corresponding author), Univ Rochester, David H Smith Ctr Vaccine Biol & Immunol, 601 Elmwood Ave, Rochester, NY 14642 USA.							Bachmann MF, 1997, P NATL ACAD SCI USA, V94, P640, DOI 10.1073/pnas.94.2.640; Chen HD, 2001, NAT IMMUNOL, V2, P1067, DOI 10.1038/ni727; Hogan RJ, 2001, J EXP MED, V193, P981, DOI 10.1084/jem.193.8.981; Kedl RM, 2000, J EXP MED, V192, P1105, DOI 10.1084/jem.192.8.1105; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Marshall DR, 2001, P NATL ACAD SCI USA, V98, P6313, DOI 10.1073/pnas.101132698; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Selin LK, 1999, IMMUNITY, V11, P733, DOI 10.1016/S1074-7613(00)80147-8; Topham DJ, 2001, J IMMUNOL, V167, P6983, DOI 10.4049/jimmunol.167.12.6983; Wang XTZ, 2003, IMMUNITY, V18, P631, DOI 10.1016/S1074-7613(03)00116-X; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6; Zheng LX, 1998, J IMMUNOL, V160, P763	15	2	2	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2003	18	5					584	586		10.1016/S1074-7613(03)00118-3	http://dx.doi.org/10.1016/S1074-7613(03)00118-3			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	680DZ	12753734	Bronze			2022-12-18	WOS:000182962200002
J	Krensky, AM; Pober, JS				Krensky, AM; Pober, JS			Immunologic frontiers of transplantation	IMMUNITY			English	Editorial Material									Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Stanford Univ, Dept Pediat, Stanford, CA 94305 USA	Yale University; Stanford University	Krensky, AM (corresponding author), Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.								0	2	2	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2001	14	4					345	346		10.1016/S1074-7613(01)00114-5	http://dx.doi.org/10.1016/S1074-7613(01)00114-5			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	424TB		Bronze			2022-12-18	WOS:000168246700001
J	Sandrin, MS; Apostolopoulos, J; McKenzie, FC				Sandrin, MS; Apostolopoulos, J; McKenzie, FC			Ly6d-L, a cell surface ligand for mouse Ly6d (vol 12, pg 223, 2000)	IMMUNITY			English	Correction							MOLECULAR-CLONING; EXPRESSION; RECEPTOR; PROTEIN; RNA		Austin& Repatriat Med Ctr, Austin Res Inst, Mol Immuogenet & Transplantat Lab, Heidelberg, Vic 3084, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health	Sandrin, MS (corresponding author), Austin& Repatriat Med Ctr, Austin Res Inst, Mol Immuogenet & Transplantat Lab, Kronheimer Bldg, Heidelberg, Vic 3084, Australia.							Apostolopoulos J, 2000, IMMUNITY, V12, P223, DOI 10.1016/S1074-7613(00)80175-2; ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P8573, DOI 10.1073/pnas.84.23.8573; Huelseweh B, 1998, BIOCHEM J, V332, P483, DOI 10.1042/bj3320483; KLMELMAN D, 1989, CELL, V17, P687; Knee R, 1997, P NATL ACAD SCI USA, V94, P4943, DOI 10.1073/pnas.94.10.4943; LAZAR MA, 1989, MOL CELL BIOL, V9, P1128, DOI 10.1128/MCB.9.3.1128; Li AW, 1996, BIOCHEM BIOPH RES CO, V223, P19, DOI 10.1006/bbrc.1996.0839; MIYAJIMA N, 1989, CELL, V57, P31, DOI 10.1016/0092-8674(89)90169-4; REAUME AG, 1992, DEV BIOL, V154, P377, DOI 10.1016/0012-1606(92)90076-S; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365	10	2	2	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2000	13	6												2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	387VJ					2022-12-18	WOS:000166142300010
J	Maltbaek, JH; Cambier, S; Snyder, JM; Stetson, DB				Maltbaek, Joanna H.; Cambier, Stephanie; Snyder, Jessica M.; Stetson, Daniel B.			ABCC1 transporter exports the immunostimulatory cyclic dinucleotide cGAMP	IMMUNITY			English	Article							GMP-AMP SYNTHASE; INTERFERON RESPONSE; IN-VITRO; RESISTANCE; GENE; ACTIVATION; PUMP; MACROPHAGES; RECOGNITION; CELLS	The DNA sensor cyclic GMP-AMP synthase (cGAS) is important for antiviral and anti-tumor immunity. cGAS generates cyclic GMP-AMP (cGAMP), a diffusible cyclic dinucleotide that activates the antiviral response through the adaptor protein stimulator of interferon genes (STING). cGAMP cannot passively cross cell mem-branes, but recent advances have established a role for extracellular cGAMP as an "immunotransmitter"that can be imported into cells. However, the mechanism by which cGAMP exits cells remains unknown. Here, we identifed ABCC1 as a direct, ATP-dependent cGAMP exporter in mouse and human cells. We show that ABCC1 overexpression enhanced cGAMP export and limited STING signaling and that loss of ABCC1 reduced cGAMP export and potentiated STING signaling. We demonstrate that ABCC1 deficiency exacer-bated cGAS-dependent autoimmunity in the Trex1-/- mouse model of Aicardi-Goutieres syndrome. Thus, ABCC1-mediated cGAMP export is a key regulatory mechanism that limits cell-intrinsic activation of STING and ameliorates STING-dependent autoimmune disease.	[Maltbaek, Joanna H.; Cambier, Stephanie; Stetson, Daniel B.] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98109 USA; [Maltbaek, Joanna H.; Cambier, Stephanie; Stetson, Daniel B.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98109 USA; [Snyder, Jessica M.] Univ Washington, Sch Med, Dept Comparat Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Stetson, DB (corresponding author), Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98109 USA.; Stetson, DB (corresponding author), Univ Washington, Sch Med, Dept Med, Seattle, WA 98109 USA.	stetson@uw.edu			NIH [T32-GM007270-44A1, R21-AI159037]; Howard Hughes Medical Institute Faculty Scholar Award [55108572]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Faculty Scholar Award	We thank N. Mausolf and S. Miller for expert mouse colony management, B. Johnson (University of Washington Histology and Imaging Core) for histology preparation, and all the members of the Stetson lab for helpful discussions. This work was supported by NIH T32-GM007270-44A1 (J.H.M.) , NIH R21-AI159037 (D.B.S.) , and Howard Hughes Medical Institute Faculty Scholar Award 55108572 (D.B.S.) .	COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Cordova AF, 2021, ACS CENTRAL SCI, V7, P1073, DOI 10.1021/acscentsci.1c00440; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crowl JT, 2017, ANNU REV IMMUNOL, V35, P313, DOI 10.1146/annurev-immunol-051116-052331; Dean M, 2005, ANNU REV GENOM HUM G, V6, P123, DOI 10.1146/annurev.genom.6.080604.162122; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gallman AE, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abg1101; Gao DX, 2015, P NATL ACAD SCI USA, V112, pE5699, DOI 10.1073/pnas.1516465112; Gao M, 2000, J BIOL CHEM, V275, P13098, DOI 10.1074/jbc.275.17.13098; Gentili M, 2015, SCIENCE, V349, P1232, DOI 10.1126/science.aab3628; GEY GO, 1952, CANCER RES, V12, P264; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Gray EE, 2016, IMMUNITY, V45, P255, DOI 10.1016/j.immuni.2016.06.015; Gray EE, 2015, J IMMUNOL, V195, P1939, DOI 10.4049/jimmunol.1500969; Gui X, 2019, NATURE, V567, P262, DOI 10.1038/s41586-019-1006-9; Guo YP, 2003, J BIOL CHEM, V278, P29509, DOI 10.1074/jbc.M304059200; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Holleufer A, 2021, NATURE, V597, P114, DOI 10.1038/s41586-021-03800-z; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jedlitschky G, 2000, J BIOL CHEM, V275, P30069, DOI 10.1074/jbc.M005463200; Johnson ZL, 2017, CELL, V168, P1075, DOI 10.1016/j.cell.2017.01.041; Kato K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06922-7; Keppler D, 1999, ADV ENZYME REGUL, V39, P237, DOI 10.1016/S0065-2571(98)00015-6; Kranzusch PJ, 2015, MOL CELL, V59, P891, DOI 10.1016/j.molcel.2015.07.022; Lahey LJ, 2020, MOL CELL, V80, P578, DOI 10.1016/j.molcel.2020.10.021; LEIER I, 1994, J BIOL CHEM, V269, P27807; Li LY, 2014, NAT CHEM BIOL, V10, P1043, DOI [10.1038/NChemBio.1661, 10.1038/nchembio.1661]; Li T, 2018, J EXP MED, V215, P1287, DOI 10.1084/jem.20180139; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Lorico A, 1997, CANCER RES, V57, P5238; Lowey B, 2020, CELL, V182, P38, DOI 10.1016/j.cell.2020.05.019; Luteijn RD, 2019, NATURE, V573, P434, DOI 10.1038/s41586-019-1553-0; Maelfait J, 2020, J MOL BIOL, V432, P552, DOI 10.1016/j.jmb.2019.11.016; Marcus A, 2018, IMMUNITY, V49, P754, DOI 10.1016/j.immuni.2018.09.016; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; Morehouse BR, 2020, NATURE, V586, P429, DOI 10.1038/s41586-020-2719-5; Nelson JW, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aam8812; Orozco S, 2014, CELL DEATH DIFFER, V21, P1511, DOI 10.1038/cdd.2014.76; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Prechtl S, 2000, J IMMUNOL, V164, P754, DOI 10.4049/jimmunol.164.2.754; Reid G, 2003, MOL PHARMACOL, V63, P1094, DOI 10.1124/mol.63.5.1094; Ritchie C, 2022, ANNU REV BIOCHEM, V91, P599, DOI 10.1146/annurev-biochem-040320-101629; Ritchie C, 2019, MOL CELL, V75, P372, DOI 10.1016/j.molcel.2019.05.006; Robey RW, 2018, NAT REV CANCER, V18, P452, DOI 10.1038/s41568-018-0005-8; SAFA AR, 1988, P NATL ACAD SCI USA, V85, P7187, DOI 10.1073/pnas.85.19.7187; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Slavik KM, 2021, NATURE, V597, P109, DOI 10.1038/s41586-021-03743-5; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun YL, 2012, CHIN J CANCER, V31, P51, DOI 10.5732/cjc.011.10466; Valmori D, 1998, J IMMUNOL, V160, P1750; Vasiliou Vasilis, 2009, Human Genomics, V3, P281; Volkman HE, 2019, ELIFE, V8, DOI 10.7554/eLife.47491; Weidner LD, 2015, J PHARMACOL EXP THER, V354, P384, DOI 10.1124/jpet.115.225482; Whiteley AT, 2019, NATURE, V567, P194, DOI 10.1038/s41586-019-0953-5; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Zhou C, 2020, IMMUNITY, V52, P767, DOI 10.1016/j.immuni.2020.03.016; Zhou Y, 2020, IMMUNITY, V52, P357, DOI 10.1016/j.immuni.2020.01.014	64	1	1	9	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 11	2022	55	10					1799	+		10.1016/j.immuni.2022.08.006	http://dx.doi.org/10.1016/j.immuni.2022.08.006			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6P0WA	36070769				2022-12-18	WOS:000890655400001
J	Pedersen, TK; Brown, EM; Plichta, DR; Johansen, J; Twardus, SW; Delorey, TM; Lau, H; Vlamakis, H; Moon, JJ; Xavier, RJ; Graham, DB				Pedersen, Thomas K.; Brown, Eric M.; Plichta, Damian R.; Johansen, Joachim; Twardus, Shaina W.; Delorey, Toni M.; Lau, Helena; Vlamakis, Hera; Moon, James J.; Xavier, Ramnik J.; Graham, Daniel B.			The CD4(+) T cell response to a commensal-derived epitope transitions from a tolerant to an inflammatory state in Crohn's disease	IMMUNITY			English	Article							BOWEL-DISEASE; T(H)17 CELLS; SINGLE-CELL; MICROBIOTA; PREDICTION; INDUCTION; INTERLEUKIN-17; SPECIFICITY; ASSOCIATION; EXPRESSION	Reciprocal interactions between host T helper cells and gut microbiota enforce local immunological tolerance and modulate extra-intestinal immunity. However, our understanding of antigen-specific tolerance to the microbiome is limited. Here, we developed a systematic approach to predict HLA class-II-specific epitopes using the humanized bacteria-originated T cell antigen (hBOTA) algorithm. We identified a diverse set of microbiome epitopes spanning all major taxa that are compatible with presentation by multiple HLA-II alleles. In particular, we uncovered an immunodominant epitope from the TonB-dependent receptor SusC that was universally recognized and ubiquitous among Bacteroidales. In healthy human subjects, SusC-reactive T cell responses were characterized by IL-10-dominant cytokine profiles, whereas in patients with active Crohn's disease, responses were associated with elevated IL-17A. Our results highlight the potential of targeted antigen discovery within the microbiome to reveal principles of tolerance and functional transitions during inflammation.	[Pedersen, Thomas K.; Brown, Eric M.; Plichta, Damian R.; Johansen, Joachim; Xavier, Ramnik J.; Graham, Daniel B.] Broad Inst MIT & Harvard, Infect Dis & Microbiome Program, Cambridge, MA 02142 USA; [Pedersen, Thomas K.] Tech Univ Denmark, Dept Biotechnol & Biomed, Sect Prot Sci & Biotherapeut, Dis Syst Immunol, DK-2800 Kongens Lyngby, Denmark; [Brown, Eric M.; Xavier, Ramnik J.; Graham, Daniel B.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Dept Mol Biol, Boston, MA 02114 USA; [Johansen, Joachim] Univ Copenhagen, Novo Nord Fdn Ctr Prot Res, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark; [Twardus, Shaina W.; Lau, Helena; Xavier, Ramnik J.; Graham, Daniel B.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Dept Med, Boston, MA 02114 USA; [Delorey, Toni M.; Xavier, Ramnik J.] Broad Inst MIT & Harvard, Klarman Cell Observ, Cambridge, MA 02142 USA; [Moon, James J.] Harvard Med Sch, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA; [Moon, James J.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Div Pulm & Crit Care Med, Boston, MA 02114 USA; [Xavier, Ramnik J.; Graham, Daniel B.] MIT, Ctr Microbiome Informat & Therapeut, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Technical University of Denmark; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Copenhagen; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT)	Xavier, RJ; Graham, DB (corresponding author), Broad Inst MIT & Harvard, Infect Dis & Microbiome Program, Cambridge, MA 02142 USA.; Xavier, RJ; Graham, DB (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Dept Mol Biol, Boston, MA 02114 USA.; Xavier, RJ; Graham, DB (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Dept Med, Boston, MA 02114 USA.; Xavier, RJ (corresponding author), Broad Inst MIT & Harvard, Klarman Cell Observ, Cambridge, MA 02142 USA.; Xavier, RJ; Graham, DB (corresponding author), MIT, Ctr Microbiome Informat & Therapeut, Cambridge, MA 02139 USA.	xavier@molbio.mgh.harvard.edu; dgraham@broadinstitute.org			Helmsley Foundation; Center for Microbiome Informatics and Therapeutics (CMIT) at MIT grant [6938971]; National Institutes of Health (NIH) [U19 AI110495, DK127171, HL157717, P30 DK043351]	Helmsley Foundation; Center for Microbiome Informatics and Therapeutics (CMIT) at MIT grant; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We greatly appreciate all the study participants without whom this research would not be possible. We thank all the involved clinical staff, including Sara M. Gregory and Cara McConaughey, for establishment and coordination of the patient cohort. We are grateful to Elizabeth Heppenheimer for editorial assistance with the manuscript and figures. We thank Spencer Vaughan and Olivia Venezia for assistance with tetramer production, and Natan Pirete and Patricia Rogers for support with cell sorting. We thank members of the Xavier laboratories for helpful feedback. We thank Kawther Abu Elneel, Yanhua Zhao, Daphney Chin, and Luke Besse for their help in coordinating this project. The graphical abstract was created with BioRender.com. This work was supported by grants from the Helmsley Foundation, the Center for Microbiome Informatics and Therapeutics (CMIT) at MIT grant #6938971 to D.B.G., and the National Institutes of Health (NIH) U19 AI110495, DK127171, HL157717, and P30 DK043351 to R.J.X.	Abelin JG, 2019, IMMUNITY, V51, P766, DOI 10.1016/j.immuni.2019.08.012; Ansaldo E, 2019, SCIENCE, V364, P1179, DOI 10.1126/science.aaw7479; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Armstrong H, 2019, MICROBIOME, V7, DOI 10.1186/s40168-018-0604-3; Belkaid Y, 2017, IMMUNITY, V46, P562, DOI 10.1016/j.immuni.2017.04.008; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Blanvillain S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000224; Bolam DN, 2012, CURR OPIN STRUC BIOL, V22, P563, DOI 10.1016/j.sbi.2012.06.006; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonomo ME, 2018, CLIN INFECT DIS, V67, P1129, DOI 10.1093/cid/ciy323; Borcherding Nicholas, 2020, F1000Res, V9, P47, DOI 10.12688/f1000research.22139.1; Brucklacher-Waldert V, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00488; Calderon-Gomez E, 2016, GASTROENTEROLOGY, V151, P489, DOI 10.1053/j.gastro.2016.05.050; Chai JN, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal5068; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Conway JR, 2017, BIOINFORMATICS, V33, P2938, DOI 10.1093/bioinformatics/btx364; de Lange KM, 2017, NAT GENET, V49, P256, DOI 10.1038/ng.3760; Doytchinova IA, 2018, BMC IMMUNOL, V19, DOI 10.1186/s12865-018-0248-x; Duck LW, 2007, INFLAMM BOWEL DIS, V13, P1191, DOI 10.1002/ibd.20237; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Elhenawy W, 2014, MBIO, V5, DOI 10.1128/mBio.00909-14; Emond B, 2019, CURR MED RES OPIN, V35, P1751, DOI 10.1080/03007995.2019.1620713; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Gonzalez-Galarza FF, 2020, NUCLEIC ACIDS RES, V48, pD783, DOI 10.1093/nar/gkz1029; Graham DB, 2018, NAT MED, V24, P1762, DOI 10.1038/s41591-018-0203-7; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Hall AO, 2018, NAT IMMUNOL, V19, P648, DOI 10.1038/s41590-018-0141-z; Hamilton NE, 2018, J STAT SOFTW, V87, P1, DOI 10.18637/jss.v087.c03; Hand TW, 2012, SCIENCE, V337, P1553, DOI 10.1126/science.1220961; Hao YH, 2021, CELL, V184, P3573, DOI 10.1016/j.cell.2021.04.048; Hegazy AN, 2017, GASTROENTEROLOGY, V153, P1320, DOI 10.1053/j.gastro.2017.07.047; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; Huang HL, 2017, NATURE, V547, P173, DOI 10.1038/nature22969; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Huerta-Cepas J, 2017, MOL BIOL EVOL, V34, P2115, DOI 10.1093/molbev/msx148; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jensen KK, 2018, IMMUNOLOGY, V154, P394, DOI 10.1111/imm.12889; Jones EJ, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00057; Kaparakis-Liaskos M, 2015, NAT REV IMMUNOL, V15, P375, DOI 10.1038/nri3837; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Knoop KA, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aao1314; Kullberg MC, 2003, P NATL ACAD SCI USA, V100, P15830, DOI 10.1073/pnas.2534546100; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Li B, 2020, NAT METHODS, V17, P793, DOI 10.1038/s41592-020-0905-x; Li DH, 2015, BIOINFORMATICS, V31, P1674, DOI 10.1093/bioinformatics/btv033; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Lloyd-Price J, 2019, NATURE, V569, P655, DOI 10.1038/s41586-019-1237-9; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Maxwell JR, 2015, IMMUNITY, V43, P739, DOI 10.1016/j.immuni.2015.08.019; Maynard CL, 2009, IMMUNITY, V31, P389, DOI 10.1016/j.immuni.2009.08.012; Moon JJ, 2011, P NATL ACAD SCI USA, V108, P14602, DOI 10.1073/pnas.1109806108; Morgan NN, 2021, J IMMUNOL, V206, P345, DOI 10.4049/jimmunol.2000918; Mucida D, 2013, NAT IMMUNOL, V14, P281, DOI 10.1038/ni.2523; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Reis BS, 2013, NAT IMMUNOL, V14, P271, DOI 10.1038/ni.2518; RStudio Team, 2021, RSTUDIO INT DEV ENV; Russler-Germain EV, 2017, MUCOSAL IMMUNOL, V10, P1375, DOI 10.1038/mi.2017.65; Schauer K, 2008, TRENDS BIOCHEM SCI, V33, P330, DOI 10.1016/j.tibs.2008.04.012; Schrodinger LLC, 2021, PYMOL MOL GRAPH SYST; Shen Y, 2012, CELL HOST MICROBE, V12, P509, DOI 10.1016/j.chom.2012.08.004; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sujino T, 2016, SCIENCE, V352, P1581, DOI 10.1126/science.aaf3892; Szabo PA, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aas9673; Targan SR, 2005, GASTROENTEROLOGY, V128, P2020, DOI 10.1053/j.gastro.2005.03.046; Targan SR, 2012, GASTROENTEROLOGY, V143, pE26, DOI 10.1053/j.gastro.2012.07.084; Tian L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19940-1; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Uchida AM, 2020, CELL MOL GASTROENTER, V10, P507, DOI 10.1016/j.jcmgh.2020.04.013; Vita R, 2019, NUCLEIC ACIDS RES, V47, pD339, DOI 10.1093/nar/gky1006; Wegorzewska MM, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau9079; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zegarra-Ruiz DF, 2021, NATURE, V594, P413, DOI 10.1038/s41586-021-03531-1; Zhao Q, 2018, IMMUNOLOGY, V154, P28, DOI 10.1111/imm.12896; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	90	1	1	5	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 11	2022	55	10					1909	+		10.1016/j.immuni.2022.08.016	http://dx.doi.org/10.1016/j.immuni.2022.08.016			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	5Q7NB	36115338				2022-12-18	WOS:000874012400003
J	Ricardo-Gonzalez, RR; Kotas, ME; O'Leary, CE; Singh, K; Damsky, W; Liao, C; Arouge, E; Tenvooren, I; Marquez, DM; Schroeder, AW; Cohen, JN; Fassett, MS; Lee, J; Daniel, SG; Bittinger, K; Diaz, RE; Fraser, JS; Ali, N; Ansel, KM; Spitzer, MH; Liang, HE; Locksley, RM				Ricardo-Gonzalez, Roberto R.; Kotas, Maya E.; O'Leary, Claire E.; Singh, Katelyn; Damsky, William; Liao, Chang; Arouge, Elizabeth; Tenvooren, Iliana; Marquez, Diana M.; Schroeder, Andrew W.; Cohen, Jarish N.; Fassett, Marlys S.; Lee, Jinwoo; Daniel, Scott G.; Bittinger, Kyle; Diaz, Roberto Efrain; Fraser, James S.; Ali, Niwa; Ansel, K. Mark; Spitzer, Matthew H.; Liang, Hong-Erh; Locksley, Richard M.			Article Innate type 2 immunity controls hair follicle commensalism by Demodex mites	IMMUNITY			English	Article							LYMPHOID-CELLS; SKIN; IDENTIFICATION; FOLLICULORUM; INFESTATION; TRAFFICKING; RECEPTOR; ABSENCE; DENSITY	Demodex mites are commensal parasites of hair follicles (HFs). Normally asymptomatic, inflammatory outgrowth of mites can accompany malnutrition, immune dysfunction, and aging, but mechanisms restricting Demodex outgrowth are not defined. Here, we show that control of mite HF colonization in mice required group 2 innate lymphoid cells (ILC2s), interleukin-13 (IL-13), and its receptor, IL-4Ra-IL-13Ra1. HF-associ-ated ILC2s elaborated IL-13 that attenuated HFs and epithelial proliferation at anagen onset; in their absence, Demodex colonization led to increased epithelial proliferation and replacement of gene programs for repair by aberrant inflammation, leading to the loss of barrier function and HF exhaustion. Humans with rhinophym-atous acne rosacea, an inflammatory condition associated with Demodex, had increased HF inflammation with decreased type 2 cytokines, consistent with the inverse relationship seen in mice. Our studies uncover a key role for skin ILC2s and IL-13, which comprise an immune checkpoint that sustains cutaneous integrity and restricts pathologic infestation by colonizing HF mites.	[Ricardo-Gonzalez, Roberto R.; Arouge, Elizabeth; Fassett, Marlys S.; Ali, Niwa] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Ricardo-Gonzalez, Roberto R.; Fassett, Marlys S.; Ansel, K. Mark; Locksley, Richard M.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Kotas, Maya E.; O'Leary, Claire E.; Liao, Chang; Schroeder, Andrew W.; Lee, Jinwoo; Liang, Hong-Erh; Locksley, Richard M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Singh, Katelyn; Damsky, William] Yale Sch Med, Dept Dermatol, New Haven, CT USA; [Damsky, William] Yale Sch Med, Dept Pathol, New Haven, CT USA; [Tenvooren, Iliana; Marquez, Diana M.; Spitzer, Matthew H.] Univ Calif San Francisco, Dept Otolaryngol & Microbiol & Immunol, San Francisco, CA USA; [Cohen, Jarish N.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Daniel, Scott G.; Bittinger, Kyle] Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA USA; [Diaz, Roberto Efrain; Fraser, James S.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA USA; [Diaz, Roberto Efrain] Univ Calif San Francisco, Tetrad Grad Program, San Francisco, CA USA; [Spitzer, Matthew H.] Parker Inst Canc Immunotherapy, San Francisco, CA USA; [Ricardo-Gonzalez, Roberto R.; Spitzer, Matthew H.] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Yale University; Yale University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Ricardo-Gonzalez, RR (corresponding author), Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA.; Ricardo-Gonzalez, RR; Locksley, RM (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.; Locksley, RM (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Ricardo-Gonzalez, RR (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.; Locksley, RM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	roberto.ricardo-gonzalez@ucsf.edu; richard.locksley@ucsf.edu			National Institutes of Health [AR007175, AR075880, HL140868, DK121476, AI159229, AR074556, AI026918, HL107202]; Dermatology Foundation; A.P. Giannini Foundation; Robert Wood Johnson Foundation; Howard Hughes Medical Institute; University of California Tobacco-Related Disease Research Program [T29IP0554]; Sandler Asthma Basic Research Center at the University of California San Francisco; NSF GRFP [1650113]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dermatology Foundation; A.P. Giannini Foundation; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); University of California Tobacco-Related Disease Research Program(University of California System); Sandler Asthma Basic Research Center at the University of California San Francisco; NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD))	We thank M. Ji and M. Conseco for technical expertise and mouse colony maintenance, Z. Wang for cell sorting, J. Bolen and X.Y. Jiang and the UCSF Biomarkers and Histology Core for assistance with histology. We thank members of the Locksley laboratory and M.D. Rosenblum, A.L. DeFranco, J. von Moltke, and C. Schneider for comments on the manuscript. Figure diagrams were created with BioRender. This work was supported by the National Institutes of Health (AR007175 to R.R.R.-G. and M.S.F., AR075880 to R.R.R.-G., HL140868 to M.E.K., DK121476 to C.E.O., AI159229 to W.D., AR074556 to M.S.F., and AI026918 and HL107202 to R.M.L.) , Dermatology Foundation (R.R.R.-G. and M.S.F.) ,A.P. Giannini Foundation (R.R.R.-G. and M.E.K.) , Robert Wood Johnson Foundation (R.R.R.-G.) , Howard Hughes Medical Institute (R.M.L.) , University of California Tobacco-Related Disease Research Program (T29IP0554 to J.S.F.) , and the Sandler Asthma Basic Research Center at the University of California San Francisco. R.E.D. was supported by NSF GRFP (#1650113) . R.E.D. is a Howard Hughes Medical Institute Gilliam Fellow (#GT11377) . R.R.R.-G. and M.H.S. are Chan Zuckerberg Investigators.	Ali N, 2017, CELL, V169, P1119, DOI 10.1016/j.cell.2017.05.002; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Bando JK, 2015, NAT IMMUNOL, V16, P153, DOI 10.1038/ni.3057; Bando JK, 2013, J LEUKOCYTE BIOL, V94, P877, DOI 10.1189/jlb.0213084; Barbe J, 2021, INT J DERMATOL, V60, P1520, DOI 10.1111/ijd.15584; Behbehani GK, 2014, CYTOM PART A, V85A, P1011, DOI 10.1002/cyto.a.22573; Bielecki P, 2021, NATURE, V592, P128, DOI 10.1038/s41586-021-03188-w; Bokulich NA, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0470-z; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Bruggner RV, 2014, P NATL ACAD SCI USA, V111, pE2770, DOI 10.1073/pnas.1408792111; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/nmeth.3869, 10.1038/NMETH.3869]; Campbell L, 2019, J EXP MED, V216, P2714, DOI 10.1084/jem.20180610; Carpino N, 2004, MOL CELL BIOL, V24, P2584, DOI 10.1128/MCB.24.6.2584-2592.2004; Chen YE, 2018, NATURE, V553, P427, DOI 10.1038/nature25177; Cheng LE, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016352; Chovatiya RJ, 2016, AM J TRANSPLANT, V16, P712, DOI 10.1111/ajt.13462; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; FORTON F, 1993, BRIT J DERMATOL, V128, P650, DOI 10.1111/j.1365-2133.1993.tb00261.x; Gause WC, 2020, NAT REV IMMUNOL, V20, P603, DOI 10.1038/s41577-020-0301-x; Ge YJ, 2020, P NATL ACAD SCI USA, V117, P5339, DOI 10.1073/pnas.1901720117; Georgala S, 2001, J EUR ACAD DERMATOL, V15, P441, DOI 10.1046/j.1468-3083.2001.00331.x; Gieseck RL, 2018, NAT REV IMMUNOL, V18, P62, DOI 10.1038/nri.2017.90; Gonzales KAU, 2021, SCIENCE, V374, P1097, DOI 10.1126/science.abh2444; Gur-Cohen S, 2019, SCIENCE, V366, P1218, DOI 10.1126/science.aay4509; Harrison OJ, 2019, SCIENCE, V363, P43, DOI 10.1126/science.aat6280; Heibel HD, 2021, J DERMATOL TREAT, V32, P114, DOI 10.1080/09546634.2019.1624683; Hoshino K, 1999, J EXP MED, V190, P1541, DOI 10.1084/jem.190.10.1541; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; Hu L, 2019, PARASITOL RES, V118, P3223, DOI 10.1007/s00436-019-06461-0; Huang YF, 2018, SCIENCE, V359, P114, DOI 10.1126/science.aam5809; Joost S, 2020, CELL STEM CELL, V26, P441, DOI 10.1016/j.stem.2020.01.012; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kleppe M, 2017, CELL STEM CELL, V21, P489, DOI 10.1016/j.stem.2017.08.011; Kobayashi T, 2019, CELL, V176, P982, DOI 10.1016/j.cell.2018.12.031; Lacey N, 2011, DERMATOLOGY, V222, P128, DOI 10.1159/000323009; Lay K, 2018, ELIFE, V7, DOI 10.7554/eLife.41661; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Mathur AN, 2019, IMMUNITY, V50, P655, DOI 10.1016/j.immuni.2019.02.013; Mayer JU, 2021, NAT IMMUNOL, V22, P1538, DOI 10.1038/s41590-021-01067-0; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Medzhitov R, 2021, SCIENCE, V374, P1070, DOI 10.1126/science.abi5200; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Nagao K, 2012, NAT IMMUNOL, V13, P744, DOI 10.1038/ni.2353; Naik S, 2018, CELL, V175, P908, DOI 10.1016/j.cell.2018.08.071; Nashat MA, 2018, J AM ASSOC LAB ANIM, V57, P483, DOI [10.30802/AALAS-JAALAS-18-000003, 10.30802/aalas-jaalas-18-000003]; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Palopoli MF, 2015, P NATL ACAD SCI USA, V112, P15958, DOI 10.1073/pnas.1512609112; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Quint T, 2020, J CLIN MED, V9, DOI 10.3390/jcm9041241; Rather PA, 2014, INDIAN J DERMATOL, V59, P60, DOI [10.4103/0019-5154.123498, 10.4103/0019-5154.143579]; Reynolds G, 2021, SCIENCE, V371, P364, DOI 10.1126/science.aba6500; Ricardo-Gonzalez RR, 2020, J EXP MED, V217, DOI 10.1084/jem.20191172; Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4; Rosshart SP, 2019, SCIENCE, V365, P461, DOI 10.1126/science.aaw4361; Sakamoto K, 2021, IMMUNITY, V54, P2321, DOI 10.1016/j.immuni.2021.09.001; Sanman LE, 2021, DEV CELL, V56, P356, DOI 10.1016/j.devcel.2020.12.020; Sastre N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165765; Schneider C, 2019, IMMUNITY, V50, P1425, DOI 10.1016/j.immuni.2019.04.019; Schneider C, 2018, CELL, V174, P271, DOI 10.1016/j.cell.2018.05.014; Simpson EL, 2016, NEW ENGL J MED, V375, P2335, DOI 10.1056/NEJMoa1610020; Smith G, 2022, MOL BIOL EVOL, V39, DOI 10.1093/molbev/msac125; Smith PC, 2016, COMPARATIVE MED, V66, P278; Spitzer MH, 2017, CELL, V168, P487, DOI 10.1016/j.cell.2016.12.022; Spitzer MH, 2015, SCIENCE, V349, DOI 10.1126/science.1259425; Thoemmes MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106265; Van Dyken SJ, 2017, CELL, V169, P497, DOI 10.1016/j.cell.2017.03.044; Van Dyken SJ, 2016, NAT IMMUNOL, V17, P1381, DOI 10.1038/ni.3582; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Wang Alice, 2021, JID Innov, V1, P100021, DOI 10.1016/j.xjidi.2021.100021; Yang H, 2017, CELL, V169, P483, DOI 10.1016/j.cell.2017.03.038; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhao YE, 2010, ARCH DERMATOL, V146, P896, DOI 10.1001/archdermatol.2010.196; Zhao YE, 2012, J ZHEJIANG UNIV-SC B, V13, P763, DOI 10.1631/jzus.B1200155; Zunder ER, 2015, CELL STEM CELL, V16, P323, DOI 10.1016/j.stem.2015.01.015	78	1	1	2	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 11	2022	55	10					1891	+		10.1016/j.immuni.2022.08.001	http://dx.doi.org/10.1016/j.immuni.2022.08.001			31	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	5Q7NB	36044899	hybrid			2022-12-18	WOS:000874012400002
J	Saggau, C; Martini, GR; Rosati, E; Meise, S; Messner, B; Kamps, AK; Bekel, N; Gigla, J; Rose, R; Voss, M; Geisen, UM; Reid, HM; Sumbul, M; Tran, F; Berner, DK; Khodamoradi, Y; Vehreschild, MJGT; Cornely, O; Koehler, P; Krumbholz, A; Fickenscher, H; Kreuzer, O; Schreiber, C; Franke, A; Schreiber, S; Hoyer, B; Scheffold, A; Bacher, P				Saggau, Carina; Martini, Gabriela Rios; Rosati, Elisa; Meise, Silja; Messner, Berith; Kamps, Ann-Kristin; Bekel, Nicole; Gigla, Johannes; Rose, Ruben; Voss, Mathias; Geisen, Ulf M.; Reid, Hayley M.; Sumbul, Melike; Tran, Florian; Berner, Dennis K.; Khodamoradi, Yascha; Vehreschild, Maria J. G. T.; Cornely, Oliver; Koehler, Philipp; Krumbholz, Andi; Fickenscher, Helmut; Kreuzer, Oliver; Schreiber, Claudia; Franke, Andre; Schreiber, Stefan; Hoyer, Bimba; Scheffold, Alexander; Bacher, Petra			The pre-exposure SARS-CoV-2-specific T cell repertoire determines the quality of the immune response to vaccination	IMMUNITY			English	Article							NAIVE; DIVERSITY; FREQUENCY; SPECIFICITY; AGE	SARS-CoV-2 infection and vaccination generates enormous host-response heterogeneity and an age -dependent loss of immune-response quality. How the pre-exposure T cell repertoire contributes to this heterogeneity is poorly understood. We combined analysis of SARS-CoV-2-specific CD4+ T cells pre-and post-vaccination with longitudinal T cell receptor tracking. We identified strong pre-exposure T cell variability that correlated with subsequent immune-response quality and age. High-quality responses, defined by strong expansion of high-avidity spike-specific T cells, high interleukin-21 production, and specific immuno-globulin G, depended on an intact naive repertoire and exclusion of pre-existing memory T cells. In the elderly, T cell expansion from both compartments was severely compromised. Our results reveal that an intrinsic defect of the CD4+ T cell repertoire causes the age-dependent decline of immune-response quality against SARS-CoV-2 and highlight the need for alternative strategies to induce high-quality T cell responses against newly arising pathogens in the elderly.	[Saggau, Carina; Martini, Gabriela Rios; Rosati, Elisa; Meise, Silja; Messner, Berith; Kamps, Ann-Kristin; Bekel, Nicole; Scheffold, Alexander; Bacher, Petra] Christian Albrecht Univ Kiel, Inst Immunol, Arnold Heller Str 3, D-24105 Kiel, Schleswig Holst, Germany; [Martini, Gabriela Rios; Rosati, Elisa; Messner, Berith; Kamps, Ann-Kristin; Bekel, Nicole; Gigla, Johannes; Tran, Florian; Franke, Andre; Schreiber, Stefan; Bacher, Petra] Christian Albrecht Univ Kiel, Inst Clin Mol Biol, Rosalind Franklin Str 12, D-24105 Kiel, Schleswig Holst, Germany; [Rose, Ruben; Voss, Mathias; Krumbholz, Andi] Christian Albrecht Univ Kiel, Inst Infect Med, Kiel, Germany; [Rose, Ruben; Voss, Mathias; Krumbholz, Andi] Univ Med Ctr Schleswig Holstein Campus Kiel, Kiel, Germany; [Geisen, Ulf M.; Berner, Dennis K.; Hoyer, Bimba] Univ Med Ctr Schleswig Holstein Campus Kiel, Med Dept 1, Dept Rheumatol, Kiel, Schleswig Holst, Germany; [Geisen, Ulf M.; Berner, Dennis K.; Hoyer, Bimba] Univ Med Ctr Schleswig Holstein Campus Kiel, Clin Immunol, Kiel, Schleswig Holst, Germany; [Sumbul, Melike] Univ Med Ctr Schleswig Holstein Campus Kiel, Dept Dermatol, Kiel, Schleswig Holst, Germany; [Tran, Florian; Schreiber, Claudia; Schreiber, Stefan] Univ Med Ctr Schleswig Holstein Campus Kiel, Dept Internal Med1, Kiel, Schleswig Holst, Germany; [Khodamoradi, Yascha; Vehreschild, Maria J. G. T.] Univ Hosp Frankfurt, Dept Internal Med, Infect Dis, Frankfurt, Germany; [Khodamoradi, Yascha; Vehreschild, Maria J. G. T.] Goethe Univ Frankfurt, Ctr Mol Med Cologne CMMC, Frankfurt, Germany; [Cornely, Oliver; Koehler, Philipp] Univ Cologne, Fac Med, Cologne, Germany; [Cornely, Oliver; Koehler, Philipp] Univ Hosp Cologne, Ctr Integrated Oncol Aachen Bonn Cologne Duesseldo, Dept Internal Med 1, Cologne, Germany; [Cornely, Oliver; Koehler, Philipp] Univ Hosp Cologne, Translat Res, Cologne Excellence Cluster Cellular Stress Respons, Cologne, Germany	University of Kiel; University of Kiel; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; University of Cologne; University of Cologne; University of Cologne	Bacher, P (corresponding author), Christian Albrecht Univ Kiel, Inst Immunol, Arnold Heller Str 3, D-24105 Kiel, Schleswig Holst, Germany.; Bacher, P (corresponding author), Christian Albrecht Univ Kiel, Inst Clin Mol Biol, Rosalind Franklin Str 12, D-24105 Kiel, Schleswig Holst, Germany.	p.bacher@ikmb.uni-kiel.de	Vehreschild, Maria/HGB-6948-2022; Bacher, Petra/AAF-1565-2021; Scheffold, Alexander/S-2090-2016	Bacher, Petra/0000-0003-4264-6451; Scheffold, Alexander/0000-0002-0626-343X; Rose, Ruben/0000-0003-0657-2993; Khodamoradi, Yascha/0000-0001-5972-0967	German Research Foundation (DFG) [390884018]; RU5042 -miTarget; DFG [433038070]; Land Schleswig-Holstein [DIO002/CoVispecT]	German Research Foundation (DFG)(German Research Foundation (DFG)); RU5042 -miTarget; DFG(German Research Foundation (DFG)); Land Schleswig-Holstein	We thank Ulf Klein for critical reading of the manuscript; Anastasia Minervina and Mikhail Pogorelyy for their support with the TCRdist analysis and visualization; the flow cytometry facility, Cyto Kiel, and the Competence Centre for Genomic Analysis (CCGA) for support with cell sorting and TCR sequencing; and Monika Br_uggemann, Patience Eschenhagen, Vanessa M_arz, and Ina Martens for help with recruitment of study participants or technical assistance. This research was supported by the German Research Foundation (DFG) under Germany's Excellence Strategy -EXC 2167-390884018 Precision Medicine in Chronic Inflammation (to A.F., S.S., B.H., A.S., P.B.); RU5042 -miTarget to A.F., P.B.; DFG grant no. 433038070 (to P.B., A.F., and A.S.); and a COVID-19 research grant from the Land Schleswig-Holstein, DIO002/CoVispecT (to P.B., A.S.).	Allen JC, 2020, VACCINE, V38, P8264, DOI 10.1016/j.vaccine.2020.11.002; Anderson EJ, 2020, NEW ENGL J MED, V383, P2427, DOI 10.1056/NEJMoa2028436; Bacher P, 2020, IMMUNITY, V53, P1258, DOI 10.1016/j.immuni.2020.11.016; Bacher P, 2019, CELL, V176, P1340, DOI 10.1016/j.cell.2019.01.041; Bacher P, 2016, CELL, V167, P1067, DOI 10.1016/j.cell.2016.09.050; Bacher P, 2013, CYTOM PART A, V83A, P692, DOI [10.1002/cyto.a.22317, 10.1002/cyto.22317]; Bacher P, 2013, J IMMUNOL, V190, P3967, DOI 10.4049/jimmunol.1202221; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Bartolo L., 2021, BIORXIV, DOI [10.1101/2021.11, DOI 10.1101/2021.11]; Bastian M., 2009, P INT AAAI C WEB SOC, V3, P361, DOI 10.13140/2.1.1341.1520; Birnbaum ME, 2014, CELL, V157, P1073, DOI 10.1016/j.cell.2014.03.047; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Braun J, 2020, NATURE, V587, P270, DOI 10.1038/s41586-020-2598-9; Campion SL, 2014, J EXP MED, V211, P1273, DOI 10.1084/jem.20130555; Cicin-Sain L, 2010, J IMMUNOL, V184, P6739, DOI 10.4049/jimmunol.0904193; Collier DA, 2021, NATURE, V596, P417, DOI 10.1038/s41586-021-03739-1; Cornberg M, 2006, J CLIN INVEST, V116, P1443, DOI 10.1172/JCI27804; Csardi G., 2006, INTERJOURNAL COMPLEX, V1695, P5; Dash P, 2017, NATURE, V547, P89, DOI 10.1038/nature22383; Dowell AC, 2022, NAT IMMUNOL, V23, P40, DOI 10.1038/s41590-021-01089-8; Dykema AG, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI146922; Rosati E, 2021, bioRxiv, DOI 10.1101/2021.11.19.469229; Geisen UM, 2021, RMD OPEN, V7, DOI 10.1136/rmdopen-2021-002008; Geisen UM, 2021, ANN RHEUM DIS, V80, P1306, DOI 10.1136/annrheumdis-2021-220272; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Guerrera G, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl5344; Gustafson CE, 2020, J ALLERGY CLIN IMMUN, V145, P1309, DOI 10.1016/j.jaci.2020.03.017; Hill DL, 2021, ELIFE, V10, DOI [10.7554/eLife.70554, 10.7554/eLife.70554.sa1, 10.7554/eLife.70554.sa2]; Juthani PV, 2021, LANCET INFECT DIS, V21, P1485, DOI 10.1016/S1473-3099(21)00558-2; Kundu Rhia, 2022, Nat Commun, V13, P80, DOI 10.1038/s41467-021-27674-x; Kwok WW, 2012, J IMMUNOL, V188, P2537, DOI 10.4049/jimmunol.1102190; Lanzer KG, 2014, IMMUN AGEING, V11, DOI 10.1186/1742-4933-11-9; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Li JX, 2021, NAT MED, V27, P1062, DOI 10.1038/s41591-021-01330-9; Lipsitch M, 2020, NAT REV IMMUNOL, V20, P709, DOI 10.1038/s41577-020-00460-4; Loyal L, 2021, SCIENCE, V374, P171, DOI 10.1126/science.abh1823; Mallajosyula V, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abg5669; Mateus J, 2021, SCIENCE, V374, P420, DOI 10.1126/science.abj9853; Mateus J, 2020, SCIENCE, V370, P89, DOI 10.1126/science.abd3871; Meyer-Arndt L, 2022, J IMMUNOL, V208, P1001, DOI 10.4049/jimmunol.2100990; Meyer-Olson D, 2004, J EXP MED, V200, P307, DOI 10.1084/jem.20040638; Mittelbrunn M, 2021, NAT IMMUNOL, V22, P687, DOI 10.1038/s41590-021-00927-z; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moss P, 2022, NAT IMMUNOL, V23, P186, DOI 10.1038/s41590-021-01122-w; Mudd PA, 2022, CELL, V185, P603, DOI 10.1016/j.cell.2021.12.026; Nelde A, 2021, NAT IMMUNOL, V22, P74, DOI 10.1038/s41590-020-00808-x; Neumann F, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9070700; Nienen M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00593; Ogbe A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21856-3; Oksanen J, 2008, VEGAN COMMUNITY ECOL; Pan YG, 2021, IMMUNITY, V54, P1245, DOI 10.1016/j.immuni.2021.04.023; Renyi A., 1961, P 4 BERKELEY S MATH, V1; Romero-Olmedo AJ, 2022, LANCET INFECT DIS, V22, P588, DOI 10.1016/S1473-3099(22)00219-5; Romero-Olmedo AJ, 2022, NAT MICROBIOL, V7, P195, DOI 10.1038/s41564-021-01046-z; Rose R, 2022, ALLERGY, V77, P3130, DOI 10.1111/all.15395; Rose R, 2022, BMC MED, V20, DOI 10.1186/s12916-021-02231-x; Saletti G, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78506-9; Schattgen SA, 2022, NAT BIOTECHNOL, V40, P54, DOI 10.1038/s41587-021-00989-2; Sewell AK, 2012, NAT REV IMMUNOL, V12, P668, DOI 10.1038/nri3279; Shugay M, 2014, NAT METHODS, V11, P653, DOI [10.1038/nmeth.2960, 10.1038/NMETH.2960]; Stervbo U, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75972-z; Stromer A, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9010058; Stromer A, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8101572; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Su LF, 2013, IMMUNITY, V38, P373, DOI 10.1016/j.immuni.2012.10.021; Swadling L, 2022, NATURE, V601, DOI 10.1038/s41586-021-04186-8; Tan CCS, 2021, INFECT GENET EVOL, V95, DOI 10.1016/j.meegid.2021.105075; Wang GC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003647; Wang SY, 2022, LANCET MICROBE, V3, pE4, DOI 10.1016/S2666-5247(21)00306-2; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Woodland DL, 2006, TRENDS IMMUNOL, V27, P303, DOI 10.1016/j.it.2006.05.002; Yager EJ, 2008, J EXP MED, V205, P711, DOI 10.1084/jem.20071140; Yek C, 2022, MMWR-MORBID MORTAL W, V71, P19, DOI [10.15585/mmwr.mm7101a4, 10.1101/2021.07.08.21259776v1]; Zeileis A., 2014, INEQ MEASURING INEQU	75	1	1	3	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 11	2022	55	10					1924	+		10.1016/j.immuni.2022.08.003	http://dx.doi.org/10.1016/j.immuni.2022.08.003			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	5Q7NB	35985324	Bronze, Green Published			2022-12-18	WOS:000874012400004
J	Delfini, M; Stakenborg, N; Viola, MF; Boeckxstaens, G				Delfini, Marcello; Stakenborg, Nathalie; Viola, Maria Francesca; Boeckxstaens, Guy			Macrophages in the gut: Masters in multitasking	IMMUNITY			English	Review							ENTERIC NERVOUS-SYSTEM; DENDRITIC CELLS; POSTOPERATIVE ILEUS; EPITHELIAL-CELLS; INTESTINAL INFLAMMATION; MUSCULARIS MACROPHAGES; LINKS INFLAMMATION; FETAL MONOCYTES; SALMONELLA; IMMUNE	The gastrointestinal tract has the important task of absorbing nutrients, a complex process that requires an intact barrier allowing the passage of nutrients but that simultaneously protects the host against invading microorganisms. To maintain and regulate intestinal homeostasis, the gut is equipped with one of the largest populations of macrophages in the body. Here, we will discuss our current understanding of intestinal macrophage heterogeneity and describe their main functions in the different anatomical niches of the gut during steady state. In addition, their role in inflammatory conditions such as infection, inflammatory bowel disease, and postoperative ileus are discussed, highlighting the roles of macrophages in immune defense. To conclude, we describe the interaction between macrophages and the enteric nervous system during development and adulthood and highlight their contribution to neurodegeneration in the context of aging and diabetes.	[Delfini, Marcello; Stakenborg, Nathalie; Viola, Maria Francesca; Boeckxstaens, Guy] Univ Leuven, KU Leuven, Translat Res Ctr GI Disorders TARGID, Dept Chron Dis Metab & Ageing, Leuven, Belgium	KU Leuven	Boeckxstaens, G (corresponding author), Univ Leuven, KU Leuven, Translat Res Ctr GI Disorders TARGID, Dept Chron Dis Metab & Ageing, Leuven, Belgium.	guy.boeckxstaens@kuleuven.be		Viola, Maria/0000-0003-0660-9506	European Research Council (ERC) [ERC-833816-NEUMACS]; FWO [12V3619N]; FWO PhD fellowship [11C2219N]	European Research Council (ERC)(European Research Council (ERC)European Commission); FWO(FWO); FWO PhD fellowship(FWO)	This work was supported by the European Research Council (ERC) Advanced Grant (ERC-833816-NEUMACS) to G.B. N.S. is supported by an FWO post- doctoral research fellowship (12V3619N) . M.F.V. is supported by an FWO PhD fellowship (11C2219N) .	Aegerter H, 2020, NAT IMMUNOL, V21, P145, DOI 10.1038/s41590-019-0568-x; Ahrends T, 2021, CELL, V184, P5715, DOI 10.1016/j.cell.2021.10.004; Alphonse N, 2022, CELL, V185, P2354, DOI 10.1016/j.cell.2022.04.028; Anup R, 1999, SURGERY, V125, P560, DOI 10.1016/S0039-6060(99)70209-6; Asano K., 2015, NAT COMMUN, V6, P7802; Asano K, 2018, J BIOCHEM, V164, P77, DOI 10.1093/jb/mvy050; Ashida H, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00219; Askenase MH, 2015, IMMUNITY, V42, P1130, DOI 10.1016/j.immuni.2015.05.011; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; BARKHORDAR RA, 1989, ORAL SURG ORAL MED O, V68, P770, DOI 10.1016/0030-4220(89)90170-9; Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Becker L, 2018, GUT, V67, P827, DOI 10.1136/gutjnl-2016-312940; BERNARD CE, 2014, MOTIL, V26, P1275, DOI DOI 10.1111/NMO.12389; Bernardo D, 2018, MUCOSAL IMMUNOL, V11, P1114, DOI 10.1038/s41385-018-0030-7; Bertocchi A, 2021, CANCER CELL, V39, P708, DOI 10.1016/j.ccell.2021.03.004; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Bleriot C, 2020, IMMUNITY, V52, P957, DOI 10.1016/j.immuni.2020.05.014; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Boyapati RK, 2016, MUCOSAL IMMUNOL, V9, P567, DOI 10.1038/mi.2016.14; Bujko A, 2018, J EXP MED, V215, P441, DOI 10.1084/jem.20170057; Bulgin R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000683; Cahill TJ, 2021, DEVELOPMENT, V148, DOI 10.1242/dev.194563; Chakravortty D, 2002, J EXP MED, V195, P1155, DOI 10.1084/jem.20011547; Chandramowlishwaran P, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.614331; Chandrasekharan B, 2007, NEUROGASTROENT MOTIL, V19, P951, DOI 10.1111/j.1365-2982.2007.01023.x; Chang SY, 2013, IMMUNITY, V38, P153, DOI 10.1016/j.immuni.2012.09.018; Cheminay U, 2004, INFECT IMMUN, V72, P468, DOI 10.1128/IAI.72.1.468-477.2004; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Chikina AS, 2020, CELL, V183, P411, DOI 10.1016/j.cell.2020.08.048; Choi KM, 2010, GASTROENTEROLOGY, V138, P2399, DOI 10.1053/j.gastro.2010.02.014; Choi KM, 2008, GASTROENTEROLOGY, V135, P2055, DOI 10.1053/j.gastro.2008.09.003; Cipriani G, 2018, GASTROENTEROLOGY, V154, P2122, DOI 10.1053/j.gastro.2018.02.027; Cipriani G, 2016, CELL MOL GASTROENTER, V2, P120, DOI 10.1016/j.jcmgh.2016.01.003; Collins SM, 2009, GASTROENTEROLOGY, V136, P2003, DOI 10.1053/j.gastro.2009.01.075; Cosin-Roger J, 2016, MUCOSAL IMMUNOL, V9, P986, DOI 10.1038/mi.2015.123; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Cummings L.A., 2009, ECOSAL PLUS, V3; Cummings RJ, 2016, NATURE, V539, P565, DOI 10.1038/nature20138; Da Silva C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01254; De Backer O, 2009, GUT, V58, P347, DOI 10.1136/gut.2008.155481; de Jong MF, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.84, 10.1038/NMICROBIOL.2016.84]; de Lange KM, 2017, NAT GENET, V49, P256, DOI 10.1038/ng.3760; De Maeyer RPH, 2021, IMMUNOL LETT, V230, P1, DOI 10.1016/j.imlet.2020.12.003; De Schepper S, 2019, CELL, V176, P676, DOI 10.1016/j.cell.2019.01.010; De Schepper S, 2018, CELL, V175, P400, DOI 10.1016/j.cell.2018.07.048; Dige A, 2016, SCAND J GASTROENTERO, V51, P692, DOI 10.3109/00365521.2015.1134649; Domanska D, 2022, J EXP MED, V219, DOI 10.1084/jem.20211846; Dora D, 2021, CELL MOL GASTROENTER, V12, P1617, DOI 10.1016/j.jcmgh.2021.07.003; dos Reis RS, 2010, GUT PATHOG, V2, DOI 10.1186/1757-4749-2-8; Drokhlyansky E, 2020, CELL, V182, P1606, DOI 10.1016/j.cell.2020.08.003; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Huynh D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056951; Fantuzzi G, 1999, J CLIN IMMUNOL, V19, P1, DOI 10.1023/A:1020506300324; Farro G, 2016, NEUROGASTROENT MOTIL, V28, P934, DOI 10.1111/nmo.12796; Farro G, 2017, GUT, V66, P2098, DOI 10.1136/gutjnl-2016-313144; Fernandez-Prada CM, 2000, INFECT IMMUN, V68, P3608, DOI 10.1128/IAI.68.6.3608-3619.2000; Ferrante M, 2006, GASTROENTEROLOGY, V130, P1595, DOI 10.1053/j.gastro.2006.02.025; Feuerstein R, 2020, ELIFE, V9, DOI 10.7554/eLife.55602; Francesca V.M., 2022, NEUROIMMUNE CROSSTAL, DOI [10.1101/2022, DOI 10.1101/2022.05.12.491517]; Gabanyi I, 2016, CELL, V164, P378, DOI 10.1016/j.cell.2015.12.023; GARDINER KR, 1995, GUT, V36, P897, DOI 10.1136/gut.36.6.897; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Graham DB, 2020, NATURE, V578, P527, DOI 10.1038/s41586-020-2025-2; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Griffin AJ, 2011, MUCOSAL IMMUNOL, V4, P371, DOI 10.1038/mi.2011.2; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Gross-Vered M, 2020, ELIFE, V9, DOI 10.7554/eLife.49998; Grover M, 2017, NEUROGASTROENT MOTIL, V29, DOI 10.1111/nmo.13018; Guilliams M, 2021, NAT IMMUNOL, V22, P118, DOI 10.1038/s41590-020-00849-2; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hausmann M, 2002, GASTROENTEROLOGY, V122, P1987, DOI 10.1053/gast.2002.33662; Hersh D, 1999, P NATL ACAD SCI USA, V96, P2396, DOI 10.1073/pnas.96.5.2396; Hiemstra IH, 2014, IMMUNOLOGY, V142, P269, DOI 10.1111/imm.12251; Hilbi H, 1998, J BIOL CHEM, V273, P32895, DOI 10.1074/jbc.273.49.32895; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Honda M, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-27614-9; Honda M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15068-4; Jasso GJ, 2022, PLOS BIOL, V20, DOI 10.1371/journal.pbio.3001532; Jeong JH, 2017, SCI REP-UK, V7, DOI 10.1038/srep39848; Jones GR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02764; Jones RM, 2008, CELL HOST MICROBE, V3, P233, DOI 10.1016/j.chom.2008.02.016; Kalff JC, 1998, ANN SURG, V228, P652, DOI 10.1097/00000658-199811000-00004; Kamada N, 2008, J CLIN INVEST, V118, P2269, DOI [10.1172/JCI34610, 10.1172/JC134610]; Kang B, 2020, MUCOSAL IMMUNOL, V13, P216, DOI 10.1038/s41385-019-0228-3; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Khan I, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.716299; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kikuchi K, 2018, J IMMUNOL, V201, P635, DOI 10.4049/jimmunol.1800040; Kim M, 2018, IMMUNITY, V49, P151, DOI 10.1016/j.immuni.2018.05.009; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Kuroda N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45012-6; Kurtz J, 2003, NATURE, V425, P37, DOI 10.1038/425037a; Leoni G, 2013, J CLIN INVEST, V123, P443, DOI 10.1172/JCI65831; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Locati M, 2020, ANNU REV PATHOL-MECH, V15, P123, DOI 10.1146/annurev-pathmechdis-012418-012718; Lomax AE, 2005, NEUROGASTROENT MOTIL, V17, P4, DOI 10.1111/j.1365-2982.2004.00607.x; Lundberg U, 1999, J BACTERIOL, V181, P3433, DOI 10.1128/JB.181.11.3433-3437.1999; Luo JL, 2018, IMMUNITY, V49, P107, DOI 10.1016/j.immuni.2018.04.021; Malvin NP, 2012, MUCOSAL IMMUNOL, V5, P194, DOI 10.1038/mi.2011.65; Marathe C.S., 2000, GASTROINTESTINAL DIS; Martin JC, 2019, CELL, V178, P1493, DOI 10.1016/j.cell.2019.08.008; Martinez-Guryn K, 2019, CELL HOST MICROBE, V26, P314, DOI 10.1016/j.chom.2019.08.011; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; Matheis F, 2020, CELL, V180, P64, DOI 10.1016/j.cell.2019.12.002; Matsudaira T, 2022, IMMUNOL LETT, V245, P51, DOI 10.1016/j.imlet.2022.04.001; Matsumoto S, 2010, J IMMUNOL, V184, P1543, DOI 10.4049/jimmunol.0801217; Mattock E, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00064; Mazzini E, 2014, IMMUNITY, V40, P248, DOI 10.1016/j.immuni.2013.12.012; Moore B.A., 2011, GASTROENTEROLOGY, V141, pe1281; Moore BA, 2011, GASTROENTEROLOGY, V141, P1283, DOI 10.1053/j.gastro.2011.06.035; Morita N, 2019, NATURE, V566, P110, DOI 10.1038/s41586-019-0884-1; MOUNIER J, 1992, INFECT IMMUN, V60, P237, DOI 10.1128/IAI.60.1.237-248.1992; Muller PA, 2014, CELL, V158, P300, DOI 10.1016/j.cell.2014.04.050; Munro DAD, 2019, ELIFE, V8, DOI 10.7554/eLife.43271; Na YR, 2019, NAT REV GASTRO HEPAT, V16, P531, DOI 10.1038/s41575-019-0172-4; Nakanishi Y, 2018, MUCOSAL IMMUNOL, V11, P871, DOI 10.1038/mi.2017.104; Nayar S, 2021, NATURE, V593, P275, DOI 10.1038/s41586-021-03484-5; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Newton HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000898; Niess JH, 2010, J IMMUNOL, V184, P2026, DOI 10.4049/jimmunol.0901936; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Rojo OP, 2007, INFLAMM BOWEL DIS, V13, P269, DOI 10.1002/ibd.20019; Pasztoi M, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23095181; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Perez F, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.581445; Petrey AC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00101; Quiros M, 2017, J CLIN INVEST, V127, P3516, DOI 10.1172/JCI90229; Rieder F, 2017, GASTROENTEROLOGY, V152, P340, DOI 10.1053/j.gastro.2016.09.047; Riehl TE, 2020, AM J PHYSIOL-GASTR L, V319, pG63, DOI 10.1152/ajpgi.00242.2019; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Santos RL, 2009, TRENDS MICROBIOL, V17, P498, DOI 10.1016/j.tim.2009.08.008; Sauter KA, 2014, J LEUKOCYTE BIOL, V96, P265, DOI 10.1189/jlb.2A0114-006R; Scheibe K, 2019, GASTROENTEROLOGY, V156, P1082, DOI 10.1053/j.gastro.2018.11.029; Scheibe K, 2017, GUT, V66, P823, DOI 10.1136/gutjnl-2015-310374; Schett G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05800-6; Schneider R, 2021, EMBO MOL MED, V13, DOI 10.15252/emmm.202012724; Schridde A, 2017, MUCOSAL IMMUNOL, V10, P1387, DOI 10.1038/mi.2016.142; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Sehgal A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03638-6; Seno H, 2009, P NATL ACAD SCI USA, V106, P256, DOI 10.1073/pnas.0803343106; Seo DH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00840-2; Serrano C, 2019, J IMMUNOL, V202, P1239, DOI 10.4049/jimmunol.1801060; Shaw TN, 2018, J EXP MED, V215, P1507, DOI 10.1084/jem.20180019; Smillie CS, 2019, CELL, V178, P714, DOI 10.1016/j.cell.2019.06.029; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Spadoni I, 2015, SCIENCE, V350, P830, DOI 10.1126/science.aad0135; Spear ET, 2019, AM J PHYSIOL-GASTR L, V317, pG853, DOI 10.1152/ajpgi.00206.2019; Sperandio B, 2008, J EXP MED, V205, P1121, DOI 10.1084/jem.20071698; Stakenborg N, 2017, HANDB EXP PHARMACOL, V239, P39, DOI 10.1007/164_2016_108; Stakenborg N, 2021, INT IMMUNOL, V33, P337, DOI 10.1093/intimm/dxab014; Stavely R, 2020, CURR DRUG TARGETS, V21, P1428, DOI 10.2174/1389450121666200516173242; Stein K, 2016, J LEUKOCYTE BIOL, V99, P231, DOI 10.1189/jlb.3HI0515-189R; Stoffels B, 2014, GASTROENTEROLOGY, V146, P176, DOI 10.1053/j.gastro.2013.09.030; Stzepourginski I, 2017, P NATL ACAD SCI USA, V114, pE506, DOI 10.1073/pnas.1620059114; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; Taniguchi K, 2015, NATURE, V519, P57, DOI 10.1038/nature14228; Thevaranjan N, 2017, CELL HOST MICROBE, V21, P455, DOI 10.1016/j.chom.2017.03.002; Turler A, 2006, ANN SURG, V244, P220, DOI 10.1097/01.sla.0000229963.37544.59; Ueda Y, 2010, INT IMMUNOL, V22, P953, DOI 10.1093/intimm/dxq449; van der Velden AWM, 2000, INFECT IMMUN, V68, P5702, DOI 10.1128/IAI.68.10.5702-5709.2000; Van Nhieu GT, 2003, NAT CELL BIOL, V5, P720, DOI 10.1038/ncb1021; Vazquez-Torres A, 2000, SCIENCE, V287, P1655, DOI 10.1126/science.287.5458.1655; Viola MF, 2021, GUT, V70, P1383, DOI 10.1136/gutjnl-2020-323121; Vos ACW, 2012, INFLAMM BOWEL DIS, V18, P401, DOI 10.1002/ibd.21818; Vos ACW, 2011, GASTROENTEROLOGY, V140, P221, DOI 10.1053/j.gastro.2010.10.008; Waddell A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-89119-1; Wagner C, 2018, CELL IMMUNOL, V330, P159, DOI 10.1016/j.cellimm.2018.01.012; Wang PL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16355-w; Wang ZY, 2019, CELL BIOSCI, V9, DOI 10.1186/s13578-019-0271-5; Weber B, 2011, EUR J IMMUNOL, V41, P773, DOI 10.1002/eji.201040965; Wehner S, 2007, GUT, V56, P176, DOI 10.1136/gut.2005.089615; West NR, 2017, NAT MED, V23, P579, DOI 10.1038/nm.4307; Yan XC, 2022, COMMUN BIOL, V5, DOI 10.1038/s42003-022-03252-9; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Yuan Q, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108724; Zhuang XN, 2017, CELL MOL IMMUNOL, V14, P237, DOI 10.1038/cmi.2016.52	180	1	1	27	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 13	2022	55	9					1530	1548		10.1016/j.immuni.2022.08.005	http://dx.doi.org/10.1016/j.immuni.2022.08.005			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	4W2PR	36103851				2022-12-18	WOS:000860009600001
J	Yang, C; Jin, JS; Yang, YQ; Sun, HX; Wu, LL; Shen, MY; Hong, XC; Li, WW; Lu, L; Cao, DQ; Wang, XR; Sun, J; Ye, YQ; Su, B; Deng, LF				Yang, Chao; Jin, Jingsi; Yang, Yuanqin; Sun, Hongxiang; Wu, Lingling; Shen, Mingyi; Hong, Xiaochuan; Li, Wenwen; Lu, Lu; Cao, Dongqing; Wang, Xinran; Sun, Jing; Ye, Youqiong; Su, Bing; Deng, Liufu			Androgen receptor-mediated CD8(+) T cell stemness programs drive sex differences in antitumor immunity (vol 55, 1268.e1, 2022)	IMMUNITY			English	Correction												dengliufu@sjtu.edu.cn	Wu, Ling/GZN-2235-2022					Yang C, 2022, IMMUNITY, V55, P1268, DOI 10.1016/j.immuni.2022.05.012	1	1	1	5	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 13	2022	55	9					1747	1747		10.1016/j.immuni.2022.07.016	http://dx.doi.org/10.1016/j.immuni.2022.07.016			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	4X1ZN	36103859	Bronze			2022-12-18	WOS:000860648000003
J	Zaman, R; Epelman, S				Zaman, Rysa; Epelman, Slava			Resident cardiac macrophages Heterogeneity and function in health and disease	IMMUNITY			English	Review							HEART-FAILURE; HEMATOPOIETIC STEM; STEADY-STATE; MONOCYTES; REVEALS; MICROGLIA; MYOCARDIUM; MECHANISMS; CONDUCTION; CONTRIBUTE	Understanding tissue macrophage biology has become challenging in recent years due the ever-increasing complexity in macrophage-subset identification and functional characterization. This is particularly important within the myocardium, as we have come to understand that macrophages play multifaceted roles in cardiac health and disease, and heart disease remains the leading cause of death worldwide. Here, we review recent progress in the field, focusing on resident cardiac macrophage heterogeneity, origins, and functions at steady state and after injury. We stratify resident cardiac macrophage functions by the ability of macrophages to either directly influence cardiac physiology or indirectly influence cardiac physiology through orchestrating multi-cellular communication with cardiomyocytes and stromal and immune populations.	[Zaman, Rysa; Epelman, Slava] Univ Hlth Network, Toronto Gen Hosp Res Inst, Toronto, ON, Canada; [Zaman, Rysa; Epelman, Slava] Ted Rogers Ctr Heart Res, Translat Biol & Engn Program, Toronto, ON, Canada; [Zaman, Rysa; Epelman, Slava] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Epelman, Slava] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Epelman, Slava] Toronto Gen Hosp, Peter Munk Cardiac Ctr, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; Peter Munk Cardiac Centre; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Epelman, S (corresponding author), Univ Hlth Network, Toronto Gen Hosp Res Inst, Toronto, ON, Canada.; Epelman, S (corresponding author), Ted Rogers Ctr Heart Res, Translat Biol & Engn Program, Toronto, ON, Canada.; Epelman, S (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.; Epelman, S (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.; Epelman, S (corresponding author), Toronto Gen Hosp, Peter Munk Cardiac Ctr, Toronto, ON, Canada.	slava.epelman@uhn.ca	Zaman, Rysa/B-2467-2018	Zaman, Rysa/0000-0002-0007-4128				Almamlouk R, 2022, CLIN MICROBIOL INFEC, V28, P1066, DOI 10.1016/j.cmi.2022.03.021; Anzai A, 2019, J EXP MED, V216, P369, DOI 10.1084/jem.20180722; Asp M, 2019, CELL, V179, P1647, DOI 10.1016/j.cell.2019.11.025; Aurora AB, 2014, J CLIN INVEST, V124, P1382, DOI 10.1172/JCI72181; Bajpai G, 2019, CIRC RES, V124, P263, DOI 10.1161/CIRCRESAHA.118.314028; Bajpai G, 2018, NAT MED, V24, P1234, DOI 10.1038/s41591-018-0059-x; Bendall JK, 2002, CIRCULATION, V105, P293, DOI 10.1161/hc0302.103712; Bizou M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-95723-y; Brakenhielm E, 2019, NAT REV CARDIOL, V16, P56, DOI 10.1038/s41569-018-0087-8; Brestoff JR, 2021, CELL METAB, V33, P270, DOI 10.1016/j.cmet.2020.11.008; Cahill TJ, 2021, DEVELOPMENT, V148, DOI 10.1242/dev.194563; Calcagno DM, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aaz1974; Chaffin M, 2022, NATURE, V608, P174, DOI 10.1038/s41586-022-04817-8; Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; Clemente-Casares X, 2017, IMMUNITY, V47, P974, DOI 10.1016/j.immuni.2017.10.011; Colliva A, 2020, J PHYSIOL-LONDON, V598, P2923, DOI 10.1113/JP276758; Cui YL, 2019, CELL REP, V26, P1934, DOI 10.1016/j.celrep.2019.01.079; DeBerge M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01428; Deniset JF, 2019, IMMUNITY, V51, P131, DOI 10.1016/j.immuni.2019.06.010; Dick SA, 2022, SCI IMMUNOL, V7, DOI 10.1126/sciimmunol.abf7777; Dick SA, 2019, NAT IMMUNOL, V20, P29, DOI [10.1038/s41590-018-0272-2, 10.1038/s41590-019-0363-8]; Dick SA, 2016, CIRC RES, V119, P159, DOI 10.1161/CIRCRESAHA.116.308030; Dongaonkar RM, 2010, CARDIOVASC RES, V87, P331, DOI 10.1093/cvr/cvq145; Dutta P, 2015, CELL STEM CELL, V16, P477, DOI 10.1016/j.stem.2015.04.008; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Farbehi N, 2019, ELIFE, V8, DOI 10.7554/eLife.43882; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Fujiu K, 2017, NAT MED, V23, P611, DOI 10.1038/nm.4326; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Glinton KE, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI140685; Grune Jana, 2022, Nat Cardiovasc Res, V1, P649, DOI 10.1038/s44161-022-00094-w; Guilliams M, 2020, IMMUNITY, V52, P434, DOI 10.1016/j.immuni.2020.02.015; Gula G, 2021, HISTOCHEM CELL BIOL, V155, P117, DOI 10.1007/s00418-020-01934-1; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Heidt T, 2014, CIRC RES, V115, P284, DOI 10.1161/CIRCRESAHA.115.303567; Henri O, 2016, CIRCULATION, V133, P1484, DOI 10.1161/CIRCULATIONAHA.115.020143; Hilgendorf I, 2014, CIRC RES, V114, P1611, DOI 10.1161/CIRCRESAHA.114.303204; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Hoyer FF, 2019, IMMUNITY, V51, P899, DOI 10.1016/j.immuni.2019.10.010; Hua XM, 2020, CIRCULATION, V142, P384, DOI 10.1161/CIRCULATIONAHA.119.043545; Hulsmans M, 2017, CELL, V169, P510, DOI 10.1016/j.cell.2017.03.050; Inamdar AA, 2016, J CLIN MED, V5, DOI 10.3390/jcm5070062; de Giusti CJ, 2015, J MOL CELL CARDIOL, V85, P58, DOI 10.1016/j.yjmcc.2015.05.010; Jin HW, 2022, CIRC RES, V130, P1682, DOI 10.1161/CIRCRESAHA.122.320567; Jin KY, 2022, SMALL METHODS, V6, DOI 10.1002/smtd.202100752; Jumah H., 2022, CARDIOVASC PATHOL, V60, P107447, DOI [10.1016/j.carpath.2022.107447, DOI 10.1016/J.CARPATH.2022.107447]; Kim JS, 2021, IMMUNITY, V54, P176, DOI 10.1016/j.immuni.2020.11.007; King KR, 2017, NAT MED, V23, P1481, DOI 10.1038/nm.4428; Kirchhoff S, 2000, CIRC RES, V87, P399; Koenig Andrew L, 2022, Nat Cardiovasc Res, V1, P263, DOI 10.1038/s44161-022-00028-6; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Kubin T, 2011, CELL STEM CELL, V9, P420, DOI 10.1016/j.stem.2011.08.013; Kuhl U, 2005, CIRCULATION, V111, P887, DOI 10.1161/01.CIR.0000155616.07901.35; Lavine KJ, 2014, P NATL ACAD SCI USA, V111, P16029, DOI 10.1073/pnas.1406508111; Leid J, 2016, CIRC RES, V118, P1498, DOI 10.1161/CIRCRESAHA.115.308270; Leuschner F, 2015, EUR HEART J, V36, P1478, DOI 10.1093/eurheartj/ehu225; Liao XD, 2022, JCI INSIGHT, V7, DOI 10.1172/jci.insight.156236; Liao XD, 2018, P NATL ACAD SCI USA, V115, pE4661, DOI 10.1073/pnas.1720065115; Lim HY, 2018, IMMUNITY, V49, P326, DOI [10.1016/j.immuni.2018.12.009, 10.1016/j.immuni.2018.06.008]; Lindner D, 2020, JAMA CARDIOL, V5, P1281, DOI 10.1001/jamacardio.2020.3551; Litvinukova M, 2020, NATURE, V588, P466, DOI 10.1038/s41586-020-2797-4; Mamas MA, 2017, EUR J HEART FAIL, V19, P1095, DOI 10.1002/ejhf.822; Martini E, 2019, CIRCULATION, V140, P2089, DOI 10.1161/CIRCULATIONAHA.119.041694; Molawi K, 2014, J EXP MED, V211, P2151, DOI 10.1084/jem.20140639; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Ni SH, 2022, CARDIOVASC RES, V118, P1303, DOI 10.1093/cvr/cvab193; Nicolas-Avila JA, 2020, CELL, V183, P94, DOI 10.1016/j.cell.2020.08.031; Nishiga M, 2020, NAT REV CARDIOL, V17, P543, DOI 10.1038/s41569-020-0413-9; Panizzi P, 2010, J AM COLL CARDIOL, V55, P1629, DOI 10.1016/j.jacc.2009.08.089; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Pinto AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036814; Popescu DM, 2019, NATURE, V574, P365, DOI 10.1038/s41586-019-1652-y; Reichart D, 2022, SCIENCE, V377, P619, DOI 10.1126/science.abo1984; Revelo X, 2021, CIRC RES, V129, P1086, DOI 10.1161/CIRCRESAHA.121.319737; Rizzo G., 2020, BIORXIV, DOI [10.1101/2020.04.14.040451, DOI 10.1101/2020.04.14.040451]; Sadek HA, 2014, STEM CELL REP, V3, P690, DOI [10.1016/j.stemcr.2014.09.019, 10.1016/j.stemcr.2014.06.009]; Sager HB, 2016, CIRC RES, V119, P853, DOI 10.1161/CIRCRESAHA.116.309001; Sajti E, 2020, NAT IMMUNOL, V21, P221, DOI 10.1038/s41590-019-0582-z; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Shemer A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07548-5; Shimizu I, 2016, J MOL CELL CARDIOL, V97, P245, DOI 10.1016/j.yjmcc.2016.06.001; Simon-Chica A, 2022, CARDIOVASC RES, V118, P798, DOI 10.1093/cvr/cvab126; Stotland A, 2016, J MOL CELL CARDIOL, V90, P53, DOI 10.1016/j.yjmcc.2015.11.032; Sugita J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22178-0; Talman V, 2016, CELL TISSUE RES, V365, P563, DOI 10.1007/s00441-016-2431-9; Tauber AI, 2003, NAT REV MOL CELL BIO, V4, P897, DOI 10.1038/nrm1244; Tucker NR, 2020, CIRCULATION, V142, P466, DOI 10.1161/CIRCULATIONAHA.119.045401; van Amerongen MJ, 2007, AM J PATHOL, V170, P818, DOI 10.2353/ajpath.2007.060547; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; VANFURTH R, 1984, J EXP MED, V160, P1273, DOI 10.1084/jem.160.5.1273; Vieira JM, 2018, J CLIN INVEST, V128, P3402, DOI 10.1172/JCI97192; Wang ZN, 2019, P NATL ACAD SCI USA, V116, P18455, DOI 10.1073/pnas.1905824116; Weckbach LT, 2021, CIRC-CARDIOVASC IMAG, V14, DOI 10.1161/CIRCIMAGING.120.011713; Wong A, 2022, NAT REV CARDIOL, V19, P395, DOI 10.1038/s41569-022-00701-0; Wong NR, 2021, IMMUNITY, V54, P2072, DOI 10.1016/j.immuni.2021.07.003; Wu L, 2014, J EXP MED, V211, P1441, DOI 10.1084/jem.20132126; Xie Y, 2022, NAT MED, V28, P583, DOI 10.1038/s41591-022-01689-3; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Yoshida M, 2004, CELL MOL BIOL, V50, P639; Zaman R, 2021, IMMUNITY, V54, P2057, DOI 10.1016/j.immuni.2021.07.006; Zaman R, 2021, CURR OPIN IMMUNOL, V68, P54, DOI 10.1016/j.coi.2020.09.005; Zhang HW, 2020, CIRC RES, V127, P610, DOI 10.1161/CIRCRESAHA.119.316428	105	1	1	7	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 13	2022	55	9					1549	1563		10.1016/j.immuni.2022.08.009	http://dx.doi.org/10.1016/j.immuni.2022.08.009			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	4W2PR	36103852				2022-12-18	WOS:000860009600002
J	Bi, QQ; Wang, C; Cheng, G; Chen, NT; Wei, B; Liu, XL; Li, L; Lu, C; He, J; Weng, YC; Yin, CY; Lin, YF; Wan, S; Zhao, L; Xu, JX; Wang, Y; Gu, Y; Shen, XZ; Shi, P				Bi, Qianqian; Wang, Chao; Cheng, Guo; Chen, Ningting; Wei, Bo; Liu, Xiaoli; Li, Li; Lu, Cheng; He, Jian; Weng, Yuancheng; Yin, Chunyou; Lin, Yunfan; Wan, Shu; Zhao, Li; Xu, Jiaxi; Wang, Yi; Gu, Yan; Shen, Xiao Z.; Shi, Peng			Article Microglia-derived PDGFB promotes neuronal potassium currents to suppress basal sympathetic tonicity and limit hypertension	IMMUNITY			English	Article							CENTRAL-NERVOUS-SYSTEM; A-TYPE CURRENTS; PERIVASCULAR MACROPHAGES; PARAVENTRICULAR NUCLEUS; COGNITIVE DYSFUNCTION; ANGIOTENSIN-II; DIETARY SALT; EXPRESSION; GROWTH; K+	Although many studies have addressed the regulatory circuits affecting neuronal activities, local non -synap-tic mechanisms that determine neuronal excitability remain unclear. Here, we found that microglia prevented overactivation of pre-sympathetic neurons in the hypothalamic paraventricular nucleus (PVN) at steady state. Microglia constitutively released platelet-derived growth factor (PDGF) B, which signaled via PDGFR alpha on neuronal cells and promoted their expression of Kv4.3, a key subunit that conducts potassium currents. Abla-tion of microglia, conditional deletion of microglial PDGFB, or suppression of neuronal PDGFRa expression in the PVN elevated the excitability of pre-sympathetic neurons and sympathetic outflow, resulting in a pro-found autonomic dysfunction. Disruption of the PDGFB(MG)-Kv4.3(Neuron )pathway predisposed mice to develop hypertension, whereas central supplementation of exogenous PDGFB suppressed pressor response when mice were under hypertensive insult. Our results point to a non-immune action of resident microglia in main-taining the balance of sympathetic outflow, which is important in preventing cardiovascular diseases.	[Bi, Qianqian; Cheng, Guo; Chen, Ningting; Wei, Bo; Lu, Cheng; Shen, Xiao Z.; Shi, Peng] Zhejiang Univ Sch Med, Affiliated Hosp 2, Dept Cardiol, Hangzhou 310058, Zhejiang, Peoples R China; [Bi, Qianqian; Cheng, Guo; Chen, Ningting; Wei, Bo; Lu, Cheng; Shi, Peng] Zhejiang Univ Sch Med, Inst Translat Med, Hangzhou 310058, Zhejiang, Peoples R China; [Wang, Chao; Gu, Yan] Zhejiang Univ Sch Med, Affiliated Hosp 2, Ctr Stem Cell & Regenerat Med, Dept Neurol, Hangzhou 310058, Zhejiang, Peoples R China; [Wang, Chao; Gu, Yan] Zhejiang Univ, MOE Frontier Sci Ctr Brain Sci & Brain Machine Int, NHC, CAMS Key Lab Med Neurobiol, Hangzhou 310058, Zhejiang, Peoples R China; [Liu, Xiaoli] Zhejiang Univ Sch Med, Affiliated Zhejiang Hosp, Depatment Neurol, Hangzhou 310058, Zhejiang, Peoples R China; [Li, Li] Zhejiang Univ Sch Med, Affiliated Zhejiang Hosp, Depatment Pharm, Hangzhou 310013, Zhejiang, Peoples R China; [He, Jian; Weng, Yuancheng; Yin, Chunyou; Shen, Xiao Z.] Zhejiang Univ Sch Med, Depatment Physiol, Hangzhou 310058, Zhejiang, Peoples R China; [Lin, Yunfan] Zhejiang Univ, Univ Edinburgh Inst, Zhejiang Univ Sch Med, Haining 314400, Zhejiang, Peoples R China; [Wan, Shu] Zhejiang Univ Sch Med, Affiliated Zhejiang Hosp, Brain Ctr, Hangzhou 310058, Zhejiang, Peoples R China; [Zhao, Li] Zhejiang Univ, Coll Biomed Engn & Instrument Sci, Key Lab Biomed Engn, Minist Educ, Hangzhou 310058, Zhejiang, Peoples R China; [Xu, Jiaxi] Xian Jiaotong Univ Hlth Sci Ctr, Depatment Physiol & Pathophysiol, Xian 710061, Shanxi, Peoples R China; [Wang, Yi] Zhejiang Univ Sch Med, Depatment Pharmacol, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Shen, XZ; Shi, P (corresponding author), Zhejiang Univ Sch Med, Affiliated Hosp 2, Dept Cardiol, Hangzhou 310058, Zhejiang, Peoples R China.; Shi, P (corresponding author), Zhejiang Univ Sch Med, Inst Translat Med, Hangzhou 310058, Zhejiang, Peoples R China.; Gu, Y (corresponding author), Zhejiang Univ Sch Med, Affiliated Hosp 2, Ctr Stem Cell & Regenerat Med, Dept Neurol, Hangzhou 310058, Zhejiang, Peoples R China.; Gu, Y (corresponding author), Zhejiang Univ, MOE Frontier Sci Ctr Brain Sci & Brain Machine Int, NHC, CAMS Key Lab Med Neurobiol, Hangzhou 310058, Zhejiang, Peoples R China.; Shen, XZ (corresponding author), Zhejiang Univ Sch Med, Depatment Physiol, Hangzhou 310058, Zhejiang, Peoples R China.	guyan2015@zju.edu.cn; shenx@zju.edu.cn; ship@zju.edu.cn	Liu, Xiaoli/HGE-7614-2022; Weng, Yuancheng/GXV-6183-2022	Lin, Yunfan/0000-0002-6560-5209	Core Facility, Zhejiang University School of Medicine; National Natural Science Foundation of China [31771266, 82170441, 82188102, 31970898, 32170894, 32071021]; Natural Science Foundation of Zhejiang Province [LZ19C110001]; MOE Frontier Science Center for Brain Science & Brain -Machine Integration, Zhejiang University; Medical Health Science and Technology Key Project of Zhejiang Provincial Health Commission [WKJ-ZJ-2014]; Key Research and Development Project of Zhejiang Provincial Department of Science and Technology [2021C03105]	Core Facility, Zhejiang University School of Medicine; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); MOE Frontier Science Center for Brain Science & Brain -Machine Integration, Zhejiang University; Medical Health Science and Technology Key Project of Zhejiang Provincial Health Commission; Key Research and Development Project of Zhejiang Provincial Department of Science and Technology	We acknowledge the technical support by the Core Facility, Zhejiang University School of Medicine. This work was supported by the National Natural Science Foundation of China (31771266, 82170441, and 82188102 to P.S.; 31970898 and 32170894 to X.Z.S.; and 32071021 to Y.G.) ; Natural Science Foundation of Zhejiang Province (LZ19C110001 to P.S.) ; MOE Frontier Science Center for Brain Science & Brain -Machine Integration, Zhejiang University to L.Z., P.S., and X.L.; Medical Health Science and Technology Key Project of Zhejiang Provincial Health Commission (WKJ-ZJ-2014 to S.W.) ; and Key Research and Development Project of Zhejiang Provincial Department of Science and Technology (2021C03105 to S.W.) .	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Asai H, 2015, NAT NEUROSCI, V18, P1584, DOI 10.1038/nn.4132; Azizi M, 2008, NEW ENGL J MED, V358, P95, DOI 10.1056/NEJMc072330; Azizi M, 2018, LANCET, V391, P2335, DOI 10.1016/S0140-6736(18)31082-1; BAINS JS, 1995, AM J PHYSIOL-REG I, V268, pR625, DOI 10.1152/ajpregu.1995.268.3.R625; Balzano M, 2017, J FOOD COMPOS ANAL, V59, P88, DOI 10.1016/j.jfca.2017.01.013; Bisht K, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25590-8; BROWN D, 1988, TRENDS NEUROSCI, V11, P294, DOI 10.1016/0166-2236(88)90089-6; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bushnell B., 2014, BBMAP FAST ACCURATE; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Calvillo L, 2019, NAT REV CARDIOL, V16, P476, DOI 10.1038/s41569-019-0178-1; Cao YH, 2013, TRENDS MOL MED, V19, P460, DOI 10.1016/j.molmed.2013.05.002; Chen TT, 2021, GENOM PROTEOM BIOINF, V19, P578, DOI 10.1016/j.gpb.2021.08.001; Chittajallu R, 2005, J NEUROSCI, V25, P8601, DOI 10.1523/JNEUROSCI.2122-05.2005; Cipolla MJ, 2018, J CEREBR BLOOD F MET, V38, P2129, DOI 10.1177/0271678X18800589; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358; Csaszar E, 2022, J EXP MED, V219, DOI 10.1084/jem.20211071; Cserep C, 2020, SCIENCE, V367, P528, DOI 10.1126/science.aax6752; Dampney RA, 2018, AM J PHYSIOL-HEART C, V315, pH1200, DOI 10.1152/ajpheart.00216.2018; DiBona GF, 2013, HYPERTENSION, V61, P556, DOI 10.1161/HYPERTENSIONAHA.111.00633; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Escalante CP, 2016, CURR HYPERTENS REV, V12, P112, DOI 10.2174/1573402112666160302101319; Escalante CP, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/816897; Faraco G, 2016, J CLIN INVEST, V126, P4674, DOI 10.1172/JCI86950; Favuzzi E, 2021, CELL, V184, P4048, DOI 10.1016/j.cell.2021.06.018; Gao L, 2010, AM J PHYSIOL-HEART C, V298, pH945, DOI 10.1152/ajpheart.00145.2009; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Gouwens NW, 2020, CELL, V183, P935, DOI 10.1016/j.cell.2020.09.057; Grassi G, 2015, CIRC RES, V116, P976, DOI 10.1161/CIRCRESAHA.116.303604; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Hagemeyer N, 2017, ACTA NEUROPATHOL, V134, P441, DOI 10.1007/s00401-017-1747-1; Hammond TR, 2019, IMMUNITY, V50, P253, DOI 10.1016/j.immuni.2018.11.004; Harley SBR, 2021, J NEUROSCI, V41, P4172, DOI 10.1523/JNEUROSCI.2539-20.2021; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Hefendehl JK, 2014, AGING CELL, V13, P60, DOI 10.1111/acel.12149; Heldin CH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-97; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Iadecola C, 2019, CIRC RES, V124, P1025, DOI 10.1161/CIRCRESAHA.118.313260; Isbrandt D, 2000, GENOMICS, V64, P144, DOI 10.1006/geno.2000.6117; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kim DM, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a029231; Kim ER, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17578-7; Kim JS, 2021, IMMUNITY, V54, P176, DOI 10.1016/j.immuni.2020.11.007; Klawonn AM, 2021, IMMUNITY, V54, P225, DOI 10.1016/j.immuni.2020.12.016; Koizumi T, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1467-7; Kopec W, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13227-w; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Li QY, 2019, NEURON, V101, P207, DOI 10.1016/j.neuron.2018.12.006; Li Y, 2012, DEV CELL, V23, P1189, DOI 10.1016/j.devcel.2012.10.027; Li Y, 2017, STROKE, V48, P2557, DOI 10.1161/STROKEAHA.117.017370; Liu XL, 2020, NEUROTOX RES, V38, P27, DOI 10.1007/s12640-020-00182-4; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; LOVICK TA, 1988, BRAIN RES, V454, P123, DOI 10.1016/0006-8993(88)90810-4; Luther JA, 2000, J PHYSIOL-LONDON, V523, P193, DOI 10.1111/j.1469-7793.2000.t01-1-00193.x; Luther JA, 2002, J NEUROENDOCRINOL, V14, P929, DOI 10.1046/j.1365-2826.2002.00867.x; MacDonald TJ, 2001, NAT GENET, V29, P143, DOI 10.1038/ng731; Maitland ML, 2009, CLIN CANCER RES, V15, P6250, DOI 10.1158/1078-0432.CCR-09-0058; Mann SJ, 2018, CLIN AUTON RES, V28, P363, DOI 10.1007/s10286-018-0541-z; Marsh SE, 2022, NAT NEUROSCI, V25, P306, DOI 10.1038/s41593-022-01022-8; McClellan M, 2019, CIRCULATION, V139, pE44, DOI 10.1161/CIR.0000000000000652; McKinnon RD, 2005, J NEUROSCI, V25, P3499, DOI 10.1523/JNEUROSCI.5049-04.2005; Merlini M, 2021, NAT NEUROSCI, V24, P19, DOI 10.1038/s41593-020-00756-7; Morohashi Y, 2002, J BIOL CHEM, V277, P14965, DOI 10.1074/jbc.M200897200; Nadal MS, 2003, NEURON, V37, P449, DOI 10.1016/S0896-6273(02)01185-6; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Norris AJ, 2010, J NEUROSCI, V30, P5092, DOI 10.1523/JNEUROSCI.5890-09.2010; Osborn JW, 2007, CURR HYPERTENS REP, V9, P228, DOI 10.1007/s11906-007-0041-3; Park L, 2017, CIRC RES, V121, P258, DOI 10.1161/CIRCRESAHA.117.311054; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; Pires PW, 2013, AM J PHYSIOL-HEART C, V304, pH1598, DOI 10.1152/ajpheart.00490.2012; Poulter NR, 2015, LANCET, V386, P801, DOI 10.1016/S0140-6736(14)61468-9; Pyner S, 2014, EXP PHYSIOL, V99, P332, DOI 10.1113/expphysiol.2013.072678; Salter MW, 2017, NAT MED, V23, P1018, DOI 10.1038/nm.4397; Sanford M, 2010, BIODRUGS, V24, P279, DOI 10.2165/11205480-000000000-00000; Scala F, 2021, NATURE, V598, P144, DOI 10.1038/s41586-020-2907-3; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Serodio P, 1998, J NEUROPHYSIOL, V79, P1081, DOI 10.1152/jn.1998.79.2.1081; Shen XZ, 2015, HYPERTENSION, V66, P309, DOI 10.1161/HYPERTENSIONAHA.115.05333; Shi P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092937; Shi P, 2010, HYPERTENSION, V56, P297, DOI 10.1161/HYPERTENSIONAHA.110.150409; Sladek CD, 2015, COMPR PHYSIOL, V5, P1281, DOI 10.1002/cphy.c140028; Soliven B, 2003, AM J PHYSIOL-CELL PH, V284, pC85, DOI 10.1152/ajpcell.00145.2002; Song WJ, 1998, J NEUROSCI, V18, P3124; Sonner PM, 2011, J PHYSIOL-LONDON, V589, P667, DOI 10.1113/jphysiol.2010.198556; Sonner PA, 2007, J PHYSIOL-LONDON, V582, P1219, DOI 10.1113/jphysiol.2007.134379; Sonner PM, 2008, J PHYSIOL-LONDON, V586, P1605, DOI 10.1113/jphysiol.2007.147413; Stern JE, 2001, J PHYSIOL-LONDON, V537, P161, DOI 10.1111/j.1469-7793.2001.0161k.x; Stevens B, 2018, DEV NEUROBIOL, V78, P559, DOI 10.1002/dneu.22594; Stocker SD, 2017, HYPERTENSION, V70, P474, DOI 10.1161/HYPERTENSIONAHA.117.08936; Thomas P, 2015, PEDIATR NEPHROL, V30, P549, DOI 10.1007/s00467-014-2789-4; Ungvari Z, 2021, NAT REV NEPHROL, V17, P639, DOI 10.1038/s41581-021-00430-6; Van Hove H, 2019, NAT NEUROSCI, V22, P1021, DOI 10.1038/s41593-019-0393-4; Wang C, 2020, SCIENCE, V367, P688, DOI 10.1126/science.aaz2288; Wang ML, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1131-7; Werneburg S, 2020, IMMUNITY, V52, P167, DOI 10.1016/j.immuni.2019.12.004; Whelton PK, 2018, J AM COLL CARDIOL, V71, P2275, DOI 10.1016/j.jacc.2018.03.016; Wilton DK, 2019, ANNU REV NEUROSCI, V42, P107, DOI 10.1146/annurev-neuro-070918-050306; Wu YE, 2017, NEURON, V96, P313, DOI 10.1016/j.neuron.2017.09.026; Xiao L, 2015, CIRC RES, V117, P547, DOI 10.1161/CIRCRESAHA.115.306010; Xiao ZY, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1553-7; Xu JX, 2019, HYPERTENSION, V73, P1266, DOI 10.1161/HYPERTENSIONAHA.119.12832; Xue YB, 2022, NUCLEIC ACIDS RES, V50, pD27, DOI 10.1093/nar/gkab951; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu Y, 2010, HYPERTENSION, V55, P652, DOI 10.1161/HYPERTENSIONAHA.109.142836; Zhang XX, 2019, NUCLEIC ACIDS RES, V47, pD721, DOI 10.1093/nar/gky900; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhao TTV, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau6426; Zhou JJ, 2019, NEUROSCI BULL, V35, P124, DOI 10.1007/s12264-018-0316-5	118	1	1	25	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 9	2022	55	8					1466	+		10.1016/j.immuni.2022.06.018	http://dx.doi.org/10.1016/j.immuni.2022.06.018			27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	4W7VU	35863346				2022-12-18	WOS:000860366700002
J	Gong, Z; Li, Q; Shi, JY; Wei, J; Li, PS; Chang, CH; Shultz, LD; Ren, GW				Gong, Zheng; Li, Qing; Shi, Jiayuan; Wei, Jian; Li, Peishan; Chang, Chih-Hao; Shultz, Leonard D.; Ren, Guangwen			Lung fibroblasts facilitate pre-metastatic niche formation by remodeling the local immune microenvironment	IMMUNITY			English	Article							DENDRITIC CELL SUBSETS; GENE-EXPRESSION; KAPPA-B; CANCER; COX-2; INFLAMMATION; TRISTETRAPROLIN; MACROPHAGES; INHIBITORS; IMPACT	Primary tumors are drivers of pre-metastatic niche formation, but the coordination by the secondary organ toward metastatic dissemination is underappreciated. Here, by single-cell RNA sequencing and immunoflu-orescence, we identified a population of cyclooxygenase 2 (COX-2)-expressing adventitial fibroblasts that remodeled the lung immune microenvironment. At steady state, fibroblasts in the lungs produced prosta-glandin E2 (PGE2), which drove dysfunctional dendritic cells (DCs) and suppressive monocytes. This lung -intrinsic stromal program was propagated by tumor-associated inflammation, particularly the pro -inflamma-tory cytokine interleukin-1b, supporting a pre-metastatic niche. Genetic ablation of Ptgs2 (encoding COX-2) in fibroblasts was sufficient to reverse the immune-suppressive phenotypes of lung-resident myeloid cells, resulting in heightened immune activation and diminished lung metastasis in multiple breast cancer models. Moreover, the anti-metastatic activity of DC-based therapy and PD-1 blockade was improved by fibroblast -specific Ptgs2 deletion or dual inhibition of PGE2 receptors EP2 and EP4. Collectively, lung-resident fibro-blasts reshape the local immune landscape to facilitate breast cancer metastasis.	[Gong, Zheng; Li, Qing; Shi, Jiayuan; Wei, Jian; Li, Peishan; Chang, Chih-Hao; Shultz, Leonard D.; Ren, Guangwen] Jackson Lab, Bar Harbor, ME 04609 USA; [Chang, Chih-Hao; Ren, Guangwen] Tufts Univ Sch Med, Boston, MA 02111 USA; [Chang, Chih-Hao; Ren, Guangwen] Univ Maine, Grad Sch Biomed Sci & Engn, Orono, ME 04469 USA	Jackson Laboratory; Tufts University; University of Maine System; University of Maine Orono	Ren, GW (corresponding author), Jackson Lab, Bar Harbor, ME 04609 USA.; Ren, GW (corresponding author), Tufts Univ Sch Med, Boston, MA 02111 USA.; Ren, GW (corresponding author), Univ Maine, Grad Sch Biomed Sci & Engn, Orono, ME 04469 USA.	gary.ren@jax.org			NIH [R00-CA188093, R37-CA237307, R01-CA251433, P30-CA034196, R24-OD026440]; Brooks Scholar Award Program at The Jackson Laboratory; Jackson Laboratory Scientific Service	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brooks Scholar Award Program at The Jackson Laboratory; Jackson Laboratory Scientific Service	We thank Dr. Scott I. Abrams (Roswell Park Comprehensive Cancer Center) for providing the AT3 cell line and Dr. Robert A. Weinberg (MIT) for providing the lentiviral vector expressing the mouse G-CSF. This work was supported by NIH grants (R00-CA188093, R37-CA237307, R01-CA251433, and P30-CA034196 to G.R., and R24-OD026440 to L.D.S.) . Z.G. is supported by the Brooks Scholar Award Program at The Jackson Laboratory. We appreciate Dr. Iiro Taneli Helenius for his critical editing of the manuscript, Drs. Edison T. Liu, Karolina Palucka, Nadia A. Rosenthal, and David V. Serreze for their insightful advice during the project, and also thank the assistance from The Jackson Laboratory Scientific Service.	Altorki NK, 2019, NAT REV CANCER, V19, P9, DOI 10.1038/s41568-018-0081-9; Baharom F, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00499; Buechler MB, 2021, NATURE, V593, P575, DOI 10.1038/s41586-021-03549-5; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Coombes RC, 2021, JAMA ONCOL, V7, P1291, DOI 10.1001/jamaoncol.2021.2193; Dahlgren MW, 2019, TRENDS IMMUNOL, V40, P877, DOI 10.1016/j.it.2019.08.002; Davidson S, 2021, NAT REV IMMUNOL, V21, P704, DOI 10.1038/s41577-021-00540-z; Desai O, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00043; Desch AN, 2013, IMMUNOL RES, V55, P178, DOI 10.1007/s12026-012-8359-6; Diebold SS, 2001, GENE THER, V8, P487, DOI 10.1038/sj.gt.3301433; Doni A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00712; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gao Y, 2019, DEV CELL, V49, P375, DOI 10.1016/j.devcel.2019.04.012; Gong Z, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.759188; Goswami S, 2022, NAT REV IMMUNOL, DOI 10.1038/s41577-022-00737-w; Habermann AC, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba1972; Hamy AS, 2019, J CLIN ONCOL, V37, P624, DOI 10.1200/JCO.18.00636; Hawk E, 2018, JNCI-J NATL CANCER I, V110, P927, DOI 10.1093/jnci/djy049; Headley MB, 2016, NATURE, V531, P513, DOI 10.1038/nature16985; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Holland CH, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-1949-z; Iams WT, 2020, NAT REV CLIN ONCOL, V17, P300, DOI 10.1038/s41571-019-0316-z; Ishikawa TO, 2006, MOL IMAGING BIOL, V8, P171, DOI 10.1007/s11307-006-0034-7; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; King EM, 2009, J PHARMACOL EXP THER, V330, P575, DOI 10.1124/jpet.109.151423; Kitamura T, 2015, NAT REV IMMUNOL, V15, P73, DOI 10.1038/nri3789; Kolahian S, 2016, AM J RESP CELL MOL, V55, P309, DOI 10.1165/rcmb.2016-0121TR; Koliaraki V, 2020, NAT IMMUNOL, V21, P974, DOI 10.1038/s41590-020-0741-2; Krausgruber T, 2020, NATURE, V583, P296, DOI 10.1038/s41586-020-2424-4; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Le Naour A, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-01418-1; Li PS, 2020, NAT IMMUNOL, V21, P1444, DOI 10.1038/s41590-020-0783-5; Li PS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18125-0; Liu Y, 2016, CANCER CELL, V30, P668, DOI 10.1016/j.ccell.2016.09.011; Lopez-Soto A, 2017, CANCER CELL, V32, P135, DOI 10.1016/j.ccell.2017.06.009; Lu WQ, 2021, EMBO MOL MED, V13, DOI 10.15252/emmm.202012798; Lutz MB, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01388; Mackay CR, 2001, NAT IMMUNOL, V2, P95, DOI 10.1038/84298; Massague J, 2016, NATURE, V529, P298, DOI 10.1038/nature17038; Mazhar D, 2006, BRIT J CANCER, V94, P346, DOI 10.1038/sj.bjc.6602942; Misharin AV, 2013, AM J RESP CELL MOL, V49, P503, DOI 10.1165/rcmb.2013-0086MA; Mittal M, 2016, P NATL ACAD SCI USA, V113, pE8151, DOI 10.1073/pnas.1614935113; Miura A, 2021, BIOCHEM BIOPH RES CO, V534, P186, DOI 10.1016/j.bbrc.2020.11.114; Mizgerd JP, 2012, AM J RESP CRIT CARE, V186, P824, DOI 10.1164/rccm.201206-1063PP; Nakanishi M, 2013, SEMIN IMMUNOPATHOL, V35, P123, DOI 10.1007/s00281-012-0342-8; Neyt K, 2013, IMMUNOL REV, V255, P57, DOI 10.1111/imr.12100; Palucka K, 2013, IMMUNITY, V39, P38, DOI 10.1016/j.immuni.2013.07.004; Pannunzio A, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11040101; Pathria P, 2019, TRENDS IMMUNOL, V40, P310, DOI 10.1016/j.it.2019.02.003; Peinado H, 2017, NAT REV CANCER, V17, P302, DOI 10.1038/nrc.2017.6; Peng SH, 2022, CLIN CANCER RES, V28, P552, DOI 10.1158/1078-0432.CCR-21-0299; Perruche S, 2008, NAT MED, V14, P528, DOI 10.1038/nm1749; Pulaski B A, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2002s39; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Reader J, 2011, CANCER METAST REV, V30, P449, DOI 10.1007/s10555-011-9303-2; Regulski M, 2016, DRUG DISCOV TODAY, V21, P598, DOI 10.1016/j.drudis.2015.12.003; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roth RB, 2006, NEUROGENETICS, V7, P67, DOI 10.1007/s10048-006-0032-6; Sajiki Yamato, 2020, Immunohorizons, V4, P837, DOI 10.4049/immunohorizons.2000089; Saleh R, 2020, SEMIN CANCER BIOL, V65, P13, DOI 10.1016/j.semcancer.2019.07.017; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Samarelli AV, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.692551; Sanduja S, 2012, FRONT BIOSCI-LANDMRK, V17, P174, DOI 10.2741/3920; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Siiskonen H, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00043; Spiegel A, 2016, CANCER DISCOV, V6, P630, DOI 10.1158/2159-8290.CD-15-1157; Stenmark KR, 2011, COMPR PHYSIOL, V1, P141, DOI 10.1002/cphy.c090017; Stewart TJ, 2007, J IMMUNOL, V179, P2851, DOI 10.4049/jimmunol.179.5.2851; Strasser-Weippl K, 2018, JNCI-J NATL CANCER I, V110, P1003, DOI 10.1093/jnci/djy017; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Taniguchi K, 2018, NAT REV IMMUNOL, V18, P309, DOI 10.1038/nri.2017.142; Tokumasu M, 2022, INT IMMUNOL, V34, P293, DOI 10.1093/intimm/dxac004; Travaglini KJ, 2020, NATURE, V587, DOI 10.1038/s41586-020-2922-4; Ushakumary MG, 2021, STEM CELL TRANSL MED, V10, P1021, DOI 10.1002/sctm.20-0526; Vermaelen K, 2005, AM J RESP CRIT CARE, V172, P530, DOI 10.1164/rccm.200410-1384SO; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Vignesh KS, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102197; Wang LM, 2016, EUR J IMMUNOL, V46, P2454, DOI 10.1002/eji.201546274; Wang Y, 2021, ONCOIMMUNOLOGY, V10, DOI 10.1080/2162402X.2021.1896643; Wculek SK, 2020, NAT REV IMMUNOL, V20, P7, DOI 10.1038/s41577-019-0210-z; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Xie T, 2018, CELL REP, V22, P3625, DOI 10.1016/j.celrep.2018.03.010; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zepp JA, 2017, CELL, V170, P1134, DOI 10.1016/j.cell.2017.07.034; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	87	1	1	25	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 9	2022	55	8					1483	+		10.1016/j.immuni.2022.07.001	http://dx.doi.org/10.1016/j.immuni.2022.07.001			28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	4W7VU	35908547				2022-12-18	WOS:000860366700003
J	Burnett, CE; Okholm, TLH; Tenvooren, I; Marquez, DM; Tamaki, S; Sandoval, PM; Willmore, A; Hendrickson, CM; Kangelaris, KN; Langelier, CR; Krummel, MF; Woodruff, PG; Calfee, CS; Erle, DJ; Ansel, KM; Spitzer, MH				Burnett, Cassandra E.; Okholm, Trine Line Hauge; Tenvooren, Iliana; Marquez, Diana M.; Tamaki, Stanley; Sandoval, Priscila Munoz; Willmore, Andrew; Hendrickson, Carolyn M.; Kangelaris, Kirsten N.; Langelier, Charles R.; Krummel, Matthew F.; Woodruff, Prescott G.; Calfee, Carolyn S.; Erle, David J.; Ansel, K. Mark; Spitzer, Matthew H.		UCSF COMET Consortium	Mass cytometry reveals a conserved immune trajectory of recovery in hospitalized COVID-19 patients	IMMUNITY			English	Article								While studies have elucidated many pathophysiological elements of COVID-19, little is known about immunological changes during COVID-19 resolution. We analyzed immune cells and phosphorylated signaling states at single-cell resolution from longitudinal blood samples of patients hospitalized with COVID-19, pneumonia and/or sepsis, and healthy individuals by mass cytometry. COVID-19 patients showed distinct immune compositions and an early, coordinated, and elevated immune cell signaling profile associated with early hospital discharge. Intra-patient longitudinal analysis revealed changes in myeloid and T cell frequencies and a reduction in immune cell signaling across cell types that accompanied disease resolution and discharge. These changes, together with increases in regulatory T cells and reduced signaling in basophils, also accompanied recovery from respiratory failure and were associated with better outcomes at time of admission. Therefore, although patients have heterogeneous immunological baselines and highly variable disease courses, a core immunological trajectory exists that defines recovery from severe SARS-CoV-2 infection.	[Burnett, Cassandra E.; Okholm, Trine Line Hauge; Tenvooren, Iliana; Marquez, Diana M.; Spitzer, Matthew H.] Univ Calif San Francisco, Dept Otolaryngol Head & Neck Canc, San Francisco, CA 94143 USA; [Burnett, Cassandra E.; Okholm, Trine Line Hauge; Tenvooren, Iliana; Marquez, Diana M.; Sandoval, Priscila Munoz; Ansel, K. Mark; Spitzer, Matthew H.] Univ Calif San Francisco, Dept Immunol & Immunol, San Francisco, CA 94143 USA; [Burnett, Cassandra E.; Okholm, Trine Line Hauge; Tenvooren, Iliana; Marquez, Diana M.; Sandoval, Priscila Munoz; Ansel, K. Mark; Spitzer, Matthew H.] Univ Calif San Francisco, Sandler Asthma Basic Res Ctr, San Francisco, CA 94143 USA; [Burnett, Cassandra E.; Okholm, Trine Line Hauge; Tenvooren, Iliana; Marquez, Diana M.; Spitzer, Matthew H.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA; [Burnett, Cassandra E.; Okholm, Trine Line Hauge; Tenvooren, Iliana; Marquez, Diana M.; Spitzer, Matthew H.] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [Burnett, Cassandra E.; Okholm, Trine Line Hauge; Tenvooren, Iliana; Marquez, Diana M.; Spitzer, Matthew H.] Parker Inst Canc Immunotherapy, San Francisco, CA 94129 USA; [Tamaki, Stanley; Krummel, Matthew F.; Erle, David J.] Univ Calif San Francisco, UCSF CoLabs, San Francisco, CA 94143 USA; [Willmore, Andrew; Hendrickson, Carolyn M.; Woodruff, Prescott G.; Calfee, Carolyn S.] Univ Calif San Francisco, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA 94110 USA; [Willmore, Andrew; Calfee, Carolyn S.; Erle, David J.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Kangelaris, Kirsten N.] Univ Calif San Francisco, Div Hosp Med, Dept Med, San Francisco, CA 94143 USA; [Langelier, Charles R.] Univ Calif San Francisco, Div Infect Dis, San Francisco, CA 94143 USA; [Krummel, Matthew F.; Spitzer, Matthew H.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94115 USA; [Krummel, Matthew F.; Erle, David J.; Ansel, K. Mark] Univ Calif San Francisco, ImmunoX Initiat, San Francisco, CA 94143 USA; [Erle, David J.] Univ Calif San Francisco, Lung Biol Ctr, Dept Med, San Francisco, CA 94143 USA; [Erle, David J.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Spitzer, MH (corresponding author), Univ Calif San Francisco, Dept Otolaryngol Head & Neck Canc, San Francisco, CA 94143 USA.; Spitzer, MH (corresponding author), Univ Calif San Francisco, Dept Immunol & Immunol, San Francisco, CA 94143 USA.; Spitzer, MH (corresponding author), Univ Calif San Francisco, Sandler Asthma Basic Res Ctr, San Francisco, CA 94143 USA.; Spitzer, MH (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA.; Spitzer, MH (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.; Spitzer, MH (corresponding author), Parker Inst Canc Immunotherapy, San Francisco, CA 94129 USA.; Spitzer, MH (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94115 USA.	matthew.spitzer@ucsf.edu			Carlsberg Foundation; COVID-19 Fast Grants; NCI [1F31CA260938-01]; NSF GRFP; UCSF Discovery Fellowship; NIH NIAID Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC) Network [3U19AI077439-13S1, 3U19AI077439-13S2]; Howard Hughes Medical Institute James H. Gilliam Fellowship; NHLBI [R35 HL140026]; NIAID; NHLBI K23; DOD; Chan Zuckerberg Foundation [2019-202665]; Genentech [TSK-020586]; NIH [P30DK063720, S10OD018040, S10OD021822]	Carlsberg Foundation(Carlsberg Foundation); COVID-19 Fast Grants; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); UCSF Discovery Fellowship; NIH NIAID Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC) Network; Howard Hughes Medical Institute James H. Gilliam Fellowship; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI K23(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DOD(United States Department of Defense); Chan Zuckerberg Foundation; Genentech(Roche HoldingGenentech); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from The Carlsberg Foundation (T.L.H.O.) ; COVID-19 Fast Grants (M.H.S.) ; NCI 1F31CA260938-01 (C.E.B.) ; NSF GRFP (C.E.B.) ; UCSF Discovery Fellowship (C.E.B.) ; NIH NIAID Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC) Network (3U19AI077439-13S1 and 3U19AI077439-13S2) ; Howard Hughes Medical Institute James H. Gilliam Fellowship (P.M.S.) ; NHLBI R35 HL140026 (C.S.C.) ; funding from NHLBI and NIAID to C.R.L.; NHLBI K23 and a DOD grants to C.M.H.; grant 2019-202665 from the Chan Zuckerberg Foundation and TSK-020586 from Genen-tech; and NIH Grants P30DK063720, S10OD018040, S10OD018040, and S10OD021822 to the UCSF Flow Cytometry CoLab. M.H.S. is an investigator of the Chan Zuckerberg Biohub and the Parker Institute for Cancer Immunotherapy.	Allen BM, 2020, NAT MED, V26, P1125, DOI 10.1038/s41591-020-0892-6; Angus DC, 2020, JAMA-J AM MED ASSOC, V324, P1317, DOI 10.1001/jama.2020.17022; Asano T, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl4348; Bange EM, 2021, NAT MED, V27, P1280, DOI 10.1038/s41591-021-01386-7; Bruggner R., 2021, CYTOFCORE CYTOFCORE; CDC, 2021, MON US E CIG SAL STA; Chang SE, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25509-3; Chen H, 2021, CHEST, V159, P1793, DOI 10.1016/j.chest.2020.11.050; Combes AJ, 2021, NATURE, V591, P124, DOI 10.1038/s41586-021-03234-7; Garibaldi BT, 2013, AM J RESP CELL MOL, V48, P35, DOI 10.1165/rcmb.2012-0198OC; Gherardini P.F, 2021, PREMESSA R PACKAGE P; Han GJ, 2018, NAT PROTOC, V13, P2121, DOI 10.1038/s41596-018-0016-7; Horby PW, 2021, LANCET, V397, P1637, DOI 10.1016/S0140-6736(21)00676-0; Lee K, 2009, GLOB INST, P1; Logue JK, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.0830; Lucas C, 2021, NAT MED, V27, P1178, DOI 10.1038/s41591-021-01355-0; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Mann ER, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd6197; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; Mock JR, 2014, MUCOSAL IMMUNOL, V7, P1440, DOI 10.1038/mi.2014.33; Moore JB, 2020, SCIENCE, V368, P473, DOI 10.1126/science.abb8925; Null N, 2021, SCI IMMUNOL, V6, peabf3733; R Core Team, 2020, R LANG ENV STAT COMP; RECOVERY Collaborative Group, 2021, NEW ENGL J MED, V384, P693; Rosas IO, 2021, NEW ENGL J MED, V384, P1503, DOI 10.1056/NEJMoa2028700; RStudio Team, 2016, RSTUDIO INT DEV ENV; Shankar-Hari M, 2021, JAMA-J AM MED ASSOC, V326, P499, DOI 10.1001/jama.2021.11330; Sinha P, 2021, AM J RESP CRIT CARE, V204, P1274, DOI 10.1164/rccm.202105-1302OC; Sinha P, 2020, JAMA INTERN MED, V180, P1152, DOI 10.1001/jamainternmed.2020.3313; Soresina A, 2020, PEDIAT ALLERG IMM-UK, V31, P565, DOI 10.1111/pai.13263; Tsai A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76187-y; Van Gassen S, 2021, CYTONORM NORMALISATI; Wagner C, 2021, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD014963; Wang EY, 2021, NATURE, V595, P283, DOI [10.1038/s41586-021-03631-y, 10.1101/2020.12.10.20247205]; Wilson JG, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.140289; World Health Organization, 2021, WHO R D BLUEPR NOV C; Yang L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00243-2; Zhang Q, 2020, SCIENCE, V370, DOI 10.1126/science.abd4570; Zhang WJ, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2019-000285; Zunder ER, 2015, NAT PROTOC, V10, P316, DOI 10.1038/nprot.2015.020	40	1	1	3	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 12	2022	55	7					1284	+		10.1016/j.immuni.2022.06.004	http://dx.doi.org/10.1016/j.immuni.2022.06.004			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3D3AD	35779527	Bronze, Green Published			2022-12-18	WOS:000829177900004
J	Gregoire, C; Spinelli, L; Villazala-Merino, S; Gil, L; Holgado, MP; Moussa, M; Dong, C; Zarubica, A; Fallet, M; Navarro, JM; Malissen, B; Milpied, P; Gaya, M				Gregoire, Claude; Spinelli, Lionel; Villazala-Merino, Sergio; Gil, Laurine; Holgado, Maria Pia; Moussa, Myriam; Dong, Chuang; Zarubica, Ana; Fallet, Mathieu; Navarro, Jean-Marc; Malissen, Bernard; Milpied, Pierre; Gaya, Mauro			Viral infection engenders bona fide and bystander subsets of lung-resident memory B cells through a permissive mechanism	IMMUNITY			English	Article							ACTIVATION; MICE; RESPONSES; SELECTION; SHAPES	Lung-resident memory B cells (MBCs) provide localized protection against reinfection in respiratory airways. Currently, the biology of these cells remains largely unexplored. Here, we combined influenza and SARS-CoV-2 infection with fluorescent-reporter mice to identify MBCs regardless of antigen specificity. We found that two main transcriptionally distinct subsets of MBCs colonized the lung peribronchial niche after infec-tion. These subsets arose from different progenitors and were both class switched, somatically mutated, and intrinsically biased in their differentiation fate toward plasma cells. Combined analysis of antigen spec-ificity and B cell receptor repertoire segregated these subsets into ???bona fide???virus-specific MBCs and ???bystander???MBCs with no apparent specificity for eliciting viruses generated through an alternative permis-sive process. Thus, diverse transcriptional programs in MBCs are not linked to specific effector fates but rather to divergent strategies of the immune system to simultaneously provide rapid protection from reinfec-tion while diversifying the initial B cell repertoire.	[Gregoire, Claude; Spinelli, Lionel; Villazala-Merino, Sergio; Gil, Laurine; Holgado, Maria Pia; Moussa, Myriam; Dong, Chuang; Fallet, Mathieu; Navarro, Jean-Marc; Malissen, Bernard; Milpied, Pierre; Gaya, Mauro] Aix Marseille Univ, Ctr Immunol Marseille Luminy CIML, CNRS, INSERM, Marseille, France; [Zarubica, Ana; Malissen, Bernard] Aix Marseille Univ, Ctr Immunophenom CIPHE, CNRS, INSERM, Marseille, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Milpied, P; Gaya, M (corresponding author), Aix Marseille Univ, Ctr Immunol Marseille Luminy CIML, CNRS, INSERM, Marseille, France.	milpied@ciml.univ-mrs.fr; gaya@ciml.univ-mrs.fr	Milpied, Pierre J/Q-1380-2015; Malissen, Bernard/AAK-4659-2020	Milpied, Pierre J/0000-0003-1873-5358; Malissen, Bernard/0000-0003-1340-9342	ATIP-AVENIR young group leader program (INSERM); Marie Curie reintegration fellowship (EU); Fondation pour la Recherche Medicale (FRM) fellowship; COVIDHUMICE project [FRM-ANR Flash Covid-COVI-0066]; Centre d'Immunologie de Marseille Luminy from Aix Marseille University; CNRS; INSERM;  [ANR-17CE15-0009-01];  [ANR-10-INBS-04-01]	ATIP-AVENIR young group leader program (INSERM); Marie Curie reintegration fellowship (EU); Fondation pour la Recherche Medicale (FRM) fellowship; COVIDHUMICE project; Centre d'Immunologie de Marseille Luminy from Aix Marseille University; CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ; 	We thank the flow cytometry, imaging, bioinformatics, and genomics platforms for their technical support and the biological resource unit for the breeding of animals (CIML). We thank C.A. Reynaud and J.C. Weill for the Aicda-CreERT2 mice. We thank S. Mancini for the mMT mice. We thank M. Wilson for the IL-4-GFP mice. We thank J. Marvel for the CXCR3-/-bone marrows. We thank T. Mak, D. Wakeham, and J. Haight for the Fcmr-/-bone marrows. We thank R. Le Goffic for the influenza X31. We thank D. Kitamura, M. Cogne ', and E. Pinaud for the 40LB cells. We thank the NIH Tetramer Core Facility for the CD1d tetramers. We thank L. Alexopoulou for the autoantigens. We thank N. Mossadegh-Keller for the assistance with the in vivo experiments. We thank A. Sansoni, P. Hoest, L. Gelard, Q. Bardin, and M. Malissen for performing the studies with SARS-CoV-2 in the CIPHE biosafety level 3. We thank C. Lutz and The Jackson Laboratory for the K18-hACE2 mice. We thank S. van der Werf for the BetaCoV/France/IDF0372/2020 strain and B. La Scola for the advice on SARS-CoV-2 handling. We thank F. Batista and P. Golstein for the critical reading of the manuscript. We thank Centre de Calcul Intensif d'Aix-Marseille for granting access to its computing resources. This work was supported by the ATIP-AVENIR young group leader program (INSERM) and the Marie Curie reintegration fellowship (EU) to M.G.; the Fondation pour la Recherche Me ' dicale (FRM) fellowship to S.V.-M.; ANR-17CE15-0009-01 (MoDEx-GC) to P.M.; the COVIDHUMICE project (FRM-ANR Flash Covid-COVI-0066) to B.M.; ANR-10-INBS-04-01 France Bio Imaging; and the Centre d'Immunologie de Marseille Luminy, which receives its core funding from Aix Marseille University, CNRS, and INSERM.	Adachi Y, 2015, J EXP MED, V212, P1709, DOI 10.1084/jem.20142284; Aguado E, 2002, SCIENCE, V296, P2036, DOI 10.1126/science.1069057; Akkaya M, 2020, NAT REV IMMUNOL, V20, P229, DOI 10.1038/s41577-019-0244-2; Allie SR, 2019, NAT IMMUNOL, V20, P97, DOI 10.1038/s41590-018-0260-6; Anderson SM, 2007, J EXP MED, V204, P2103, DOI 10.1084/jem.20062571; Attaf N, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00216; Denton AE, 2019, J EXP MED, V216, P621, DOI 10.1084/jem.20181216; DeWitt WS, 2018, MOL BIOL EVOL, V35, P1253, DOI 10.1093/molbev/msy020; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Duan LH, 2021, IMMUNITY, V54, P2256, DOI 10.1016/j.immuni.2021.08.028; Finak G, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-546; Genton C, 2006, J IMMUNOL, V177, P2285, DOI 10.4049/jimmunol.177.4.2285; Horns F, 2020, CELL REP, V30, P905, DOI 10.1016/j.celrep.2019.12.063; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; KIKUTANI H, 1986, CELL, V47, P657, DOI 10.1016/0092-8674(86)90508-8; Koike T, 2019, ELIFE, V8, DOI 10.7554/eLife.44245; Kometani K, 2013, IMMUNITY, V39, P136, DOI 10.1016/j.immuni.2013.06.011; Kuraoka M, 2016, IMMUNITY, V44, P542, DOI 10.1016/j.immuni.2016.02.010; Kurosaki T, 2015, NAT REV IMMUNOL, V15, P149, DOI 10.1038/nri3802; Lang KS, 2013, P NATL ACAD SCI USA, V110, P2593, DOI 10.1073/pnas.1222264110; Le Gallou S, 2018, J EXP MED, V215, P2035, DOI 10.1084/jem.20180977; Lutz J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9575; MacLean AJ, 2022, IMMUNITY, V55, P718, DOI 10.1016/j.immuni.2022.03.003; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; McCray PB, 2007, J VIROL, V81, P813, DOI 10.1128/JVI.02012-06; McHeyzer-Williams LJ, 2015, NAT IMMUNOL, V16, P296, DOI 10.1038/ni.3095; Mesin L, 2020, CELL, V180, P92, DOI 10.1016/j.cell.2019.11.032; Mimitou EP, 2019, NAT METHODS, V16, P409, DOI 10.1038/s41592-019-0392-0; Nakagawa R, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2016425118; Nojima T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1475; O'Flanagan CH, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1830-0; Oh JE, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abj5129; Onodera T, 2012, P NATL ACAD SCI USA, V109, P2485, DOI 10.1073/pnas.1115369109; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Perona-Wright G, 2010, NAT IMMUNOL, V11, P520, DOI 10.1038/ni.1866; Reboldi A, 2016, SCIENCE, V352, DOI 10.1126/science.aaf4822; Riedel R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16464-6; Stoeckius M, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1603-1; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Szabo PA, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aas9673; Tan HX, 2022, SCI IMMUNOL, V7, DOI 10.1126/sciimmunol.abf5314; Viant C, 2021, J EXP MED, V218, DOI 10.1084/jem.20202489; Viant C, 2020, CELL, V183, P1298, DOI 10.1016/j.cell.2020.09.063; Wan ZR, 2019, IMMUNOL REV, V288, P28, DOI 10.1111/imr.12747; Weisel F, 2017, ANNU REV IMMUNOL, V35, P255, DOI 10.1146/annurev-immunol-041015-055531; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004; Wong R, 2020, IMMUNITY, V53, P1078, DOI 10.1016/j.immuni.2020.09.001; Yewdell WT, 2021, CELL REP, V37, DOI 10.1016/j.celrep.2021.109961; Zaretsky I, 2017, J EXP MED, V214, P3435, DOI 10.1084/jem.20171129; Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914	50	1	1	5	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 12	2022	55	7					1216	+		10.1016/j.immuni.2022.06.002	http://dx.doi.org/10.1016/j.immuni.2022.06.002			28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3G7UF	35768001	Green Published			2022-12-18	WOS:000831554100012
J	Hume, DA; Offermanns, S; Bonnavion, R				Hume, David A.; Offermanns, Stefan; Bonnavion, Remy			Contamination of isolated mouse Kupffer cells with liver sinusoidal endothelial cells	IMMUNITY			English	Letter									[Hume, David A.] Univ Queensland, Mater Res Inst, Brisbane, Qld, Australia; [Offermanns, Stefan; Bonnavion, Remy] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany	Mater Research; University of Queensland; Max Planck Society	Hume, DA (corresponding author), Univ Queensland, Mater Res Inst, Brisbane, Qld, Australia.	david.hume@uq.edu.au						Bleriot C, 2021, IMMUNITY, V54, P2101, DOI 10.1016/j.immuni.2021.08.006; De Simone G, 2021, IMMUNITY, V54, P2089, DOI 10.1016/j.immuni.2021.05.005; Guilliams M, 2022, CELL, V185, P379, DOI 10.1016/j.cell.2021.12.018; Hama H, 2015, NAT NEUROSCI, V18, P1518, DOI 10.1038/nn.4107; Kolodziejczyk AA, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1102-2; Le Mercier A, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2021596118; Liang Y, 2022, DEV CELL, V57, P398, DOI 10.1016/j.devcel.2022.01.004; Lynch RW, 2018, J LEUKOCYTE BIOL, V104, P579, DOI 10.1002/JLB.1TA0517-169R; Summers KM, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000859; Terkelsen MK, 2020, HEPATOLOGY, V72, P2119, DOI 10.1002/hep.31215	10	1	1	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 12	2022	55	7					1139	1140		10.1016/j.immuni.2022.06.010	http://dx.doi.org/10.1016/j.immuni.2022.06.010			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3G7UF	35830818				2022-12-18	WOS:000831554100001
J	Alameh, MG; Tombacz, I; Bettini, E; Lederer, K; Ndeupen, S; Sittplangkoon, C; Wilmore, JR; Gaudette, BT; Soliman, OY; Pine, M; Hicks, P; Manzoni, TB; Knox, JJ; Johnson, JL; Laczko, D; Muramatsu, H; Davis, B; Meng, WZ; Rosenfeld, AM; Strohmeier, S; Lin, PJC; Mui, BL; Tam, YK; Kariko, K; Jacquet, A; Krammer, F; Bates, P; Cancro, MP; Weissman, D; Prak, ETL; Allman, D; Igyarto, BZ; Locci, M; Pardi, N				Alameh, Mohamad-Gabriel; Tombacz, Istvan; Bettini, Emily; Lederer, Katlyn; Ndeupen, Sonia; Sittplangkoon, Chutamath; Wilmore, Joel R.; Gaudette, Brian T.; Soliman, Ousamah Y.; Pine, Matthew; Hicks, Philip; Manzoni, Tomaz B.; Knox, James J.; Johnson, John L.; Laczko, Dorottya; Muramatsu, Hiromi; Davis, Benjamin; Meng, Wenzhao; Rosenfeld, Aaron M.; Strohmeier, Shirin; Lin, Paulo J. C.; Mui, Barbara L.; Tam, Ying K.; Kariko, Katalin; Jacquet, Alain; Krammer, Florian; Bates, Paul; Cancro, Michael P.; Weissman, Drew; Prak, Eline T. Luning; Allman, David; Igyarto, Botond Z.; Locci, Michela; Pardi, Norbert			Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses (vol 54, pg 2877, 2021)	IMMUNITY			English	Correction									[Alameh, Mohamad-Gabriel; Tombacz, Istvan; Soliman, Ousamah Y.; Pine, Matthew; Laczko, Dorottya; Muramatsu, Hiromi; Davis, Benjamin; Pardi, Norbert] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Bettini, Emily; Lederer, Katlyn; Hicks, Philip; Manzoni, Tomaz B.; Bates, Paul; Locci, Michela] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Ndeupen, Sonia] Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; [Sittplangkoon, Chutamath] Chulalongkorn Univ, Ctr Excellence Vaccine Res & Dev, Fac Med, Bangkok, Thailand; [Wilmore, Joel R.; Gaudette, Brian T.; Knox, James J.; Johnson, John L.; Meng, Wenzhao; Rosenfeld, Aaron M.; Cancro, Michael P.; Prak, Eline T. Luning; Allman, David] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Hicks, Philip] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; [Strohmeier, Shirin] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Lin, Paulo J. C.; Mui, Barbara L.; Tam, Ying K.] Acuitas Therapeut, Vancouver, BC, Canada; [Kariko, Katalin] BioNTech RNA Pharmaceut, Mainz, Germany	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Jefferson University; Chulalongkorn University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Icahn School of Medicine at Mount Sinai; BioNTech SE	Pardi, N (corresponding author), Univ Penn, Dept Med, Philadelphia, PA 19104 USA.; Locci, M (corresponding author), Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	michela.locci@pennmedicine.upenn.edu; pnorbert@pennmedicine.upenn.edu	Jacquet, Alain/GQI-0546-2022; Krammer, Florian/H-3237-2019	Jacquet, Alain/0000-0002-0980-9741; Krammer, Florian/0000-0003-4121-776X; Bettini, Emily/0000-0003-0424-2472; Alameh, Mohamad-Gabriel/0000-0002-5672-6930	National Institute of Allergy and Infectious Diseases (NIAID) [R01AI146101, R01AI153064]; NIAID [R01AI153064, R01AI123738, R01AI139123, R01AI154932]; NIH/NIAID [UM1-AI-144371, 1U19AI135902, U19AI142596, R01-AI124429, HHS-NIH-NIAID-BAA2018]; SRA from BioNTech; NIAID Collaborative Influenza Vaccine Innovation Centers (CIVIC) [75N93019C00051];  [P01 AI106697];  [P30 CA016520];  [<LF>P30-AI 0450080]	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); SRA from BioNTech; NIAID Collaborative Influenza Vaccine Innovation Centers (CIVIC); ; ; 	N.P. was supported by the National Institute of Allergy and Infectious Diseases (NIAID, R01AI146101 and R01AI153064). M.L. was supported by NIAID (R01AI123738 and R01AI153064). D.W. is supported by NIH/NIAID (UM1-AI-144371, 1U19AI135902, U19AI142596, R01-AI124429, HHS-NIH-NIAID-BAA2018) and an SRA from BioNTech. E.L.P., W.M., J.K.K., and A.M.R. were supported by P01 AI106697. F.K. was supported by the NIAID Collaborative Influenza Vaccine Innovation Centers (CIVIC) contract 75N93019C00051. D.A. was supported by NIAID (R01AI139123 and R01AI154932). We thank the NIH Tetramer Core Facility for producing the I-A(d) Influenza A HA PE-conjugated tetramer (HNTNGVTAACSHE) used in this study and the Human Immunology Core facility for assistance with immunoglobulin gene rearrangement sequencing (with infrastructure support from P30 CA016520 and P30-AI 0450080). We thank Dr. Florin Tuluc and Jennifer Murray of the Children's Hospital of Philadelphia (CHOP) Flow Cytometry core facility for technical assistance. PR8 HA probes for initial LLPC and MBC studies were provided by Scott E. Hensley (University of Pennsylvania). Mouse-adapted A/Puerto Rico/8/1934 influenza virus for challenge studies was provided by Michael J. Hogan and Laurence C. Eisenlohr (CHOP). We thank Michael J. Hogan for the critical reading of the manuscript. The graphical abstract was created with BioRender.	Alameh MG, 2021, IMMUNITY, V54, P2877, DOI 10.1016/j.immuni.2021.11.001	1	1	1	7	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 14	2022	55	6					1136	1138		10.1016/j.immuni.2022.05.007	http://dx.doi.org/10.1016/j.immuni.2022.05.007			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3F2TY	35704995	Bronze, Green Published			2022-12-18	WOS:000830524400008
J	Smith, KN				Smith, Kellie N.			Big fish in small ponds: Narrow repertoires of stem-like tissue-resident T cells yield great power in anti-tumor immunity	IMMUNITY			English	Editorial Material							PD-1 BLOCKADE	Metastatic ovarian cancer is a significant clinical challenge due in part to its poor response to immuno-therapy. In a recent issue of Cancer Cell, Anandon et al. (2022) identify a population of stem-like tissue-resi-dent memory T cells that are responsible for the bulk of anti-tumor T cell immunity, with insights into improving therapeutic response.	[Smith, Kellie N.] Johns Hopkins Sch Med, Bloomberg Kimmel Inst Canc Immunotherapy, Baltimore, MD 21205 USA; [Smith, Kellie N.] Johns Hopkins Sch Med, Sydney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Smith, KN (corresponding author), Johns Hopkins Sch Med, Bloomberg Kimmel Inst Canc Immunotherapy, Baltimore, MD 21205 USA.; Smith, KN (corresponding author), Johns Hopkins Sch Med, Sydney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA.	kellie@jhmi.edu						Anadon CM, 2022, CANCER CELL, V40, P545, DOI 10.1016/j.ccell.2022.03.008; [Anonymous], 2022, CANCER; Caushi JX, 2021, NATURE, V596, P126, DOI 10.1038/s41586-021-03752-4; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Muroyama Y, 2021, CSH PERSPECT BIOL, V13, DOI 10.1101/cshperspect.a037929; Oliveira G, 2021, NATURE, V596, P119, DOI 10.1038/s41586-021-03704-y; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Shaw LA, 2016, NAT IMMUNOL, V17, P834, DOI 10.1038/ni.3461; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Yarchoan M, 2017, NEW ENGL J MED, V377, P2500, DOI 10.1056/NEJMc1713444	10	1	1	2	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 14	2022	55	6					979	981		10.1016/j.immuni.2022.05.017	http://dx.doi.org/10.1016/j.immuni.2022.05.017			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	2U6UT	35705001				2022-12-18	WOS:000823293900008
J	Ampie, L; McGavern, DB				Ampie, Leonel; McGavern, Dorian B.			Immunological defense of CNS barriers against infections	IMMUNITY			English	Review							CENTRAL-NERVOUS-SYSTEM; MEMORY T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; B-CELLS; CHOROID-PLEXUS; GAMMA-INTERFERON; IMMUNE SURVEILLANCE; VIRUS-INFECTION; VESICULAR STOMATITIS; GLUCOSE-TRANSPORTER	Neuroanatomical barriers with physical, chemical, and immunological properties play an essential role in preventing the spread of peripheral infections into the CNS. A failure to contain pathogens within these barriers can result in very serious CNS diseases. CNS barriers are inhabited by an elaborate conglomerate of innate and adaptive immune cells that are highly responsive to environmental challenges. The CNS and its barriers can also be protected by memory T and B cells elicited by prior infection or vaccination. Here, we discuss the different CNS barriers from a developmental, anatomical, and immunological standpoint and summarize our current understanding of how memory cells protect the CNS compartment. We then discuss a contemporary challenge to CNS-barrier system (SARS-CoV-2 infection) and highlight approaches to promote immunological protection of the CNS via vaccination.	[Ampie, Leonel; McGavern, Dorian B.] Natl Inst Neurol Disorders & Stroke, Natl Inst Hlth, Viral Immunol & Intravital Imaging Sect, Bethesda, MD 20824 USA; [Ampie, Leonel] Natl Inst Neurol Disorders & Stroke, Natl Inst Hlth, Dept Neurol Surg, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	McGavern, DB (corresponding author), Natl Inst Neurol Disorders & Stroke, Natl Inst Hlth, Viral Immunol & Intravital Imaging Sect, Bethesda, MD 20824 USA.	mcgavernd@mail.nih.gov	McGavern, Dorian/HCH-3601-2022	McGavern, Dorian/0000-0001-9568-545X	National Institute of Neurological Disorders & Stroke (NINDS), National Institutes of Health (NIH)	National Institute of Neurological Disorders & Stroke (NINDS), National Institutes of Health (NIH)	This work was supported by the intramural program at the National Institute of Neurological Disorders & Stroke (NINDS), National Institutes of Health (NIH). We thank Alan Hoofring and Ethan Tyler in the NIH Medical Arts Design Section for their help with the illustrations shown in Figures 1, 2, 3, and 4.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Ahn JH, 2019, NATURE, V572, P62, DOI 10.1038/s41586-019-1419-5; Akkaya M, 2020, NAT REV IMMUNOL, V20, P229, DOI 10.1038/s41577-019-0244-2; Al-Dalahmah O, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-01024-2; Anandasabapathy N, 2011, J EXP MED, V208, P1695, DOI 10.1084/jem.20102657; Andreone BJ, 2015, ANNU REV NEUROSCI, V38, P25, DOI 10.1146/annurev-neuro-071714-033835; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Atkinson JR, 2019, J VIROL, V93, DOI 10.1128/JVI.00875-18; Barkalow FJ, 1996, BLOOD, V88, P4585, DOI 10.1182/blood.V88.12.4585.bloodjournal88124585; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; Baruch K, 2014, SCIENCE, V346, P89, DOI 10.1126/science.1252945; Baruch K, 2013, P NATL ACAD SCI USA, V110, P2264, DOI 10.1073/pnas.1211270110; BAUER H, 1995, DEV BRAIN RES, V86, P317, DOI 10.1016/0165-3806(95)00044-E; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Binder GK, 2001, SCIENCE, V293, P303, DOI 10.1126/science.1059742; Boldrini M, 2021, JAMA PSYCHIAT, V78, P682, DOI 10.1001/jamapsychiatry.2021.0500; Brann DH, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc5801; Brioschi S, 2021, SCIENCE, V373, P408, DOI 10.1126/science.abf9277; Brizic I, 2018, EUR J IMMUNOL, V48, P950, DOI 10.1002/eji.201847526; Buckley MW, 2022, IMMUNOL REV, V306, P58, DOI 10.1111/imr.13066; Burdeinick-Kerr R, 2009, J VIROL, V83, P3429, DOI 10.1128/JVI.02381-08; CANTIN EM, 1995, J VIROL, V69, P4898, DOI 10.1128/JVI.69.8.4898-4905.1995; Carrithers MD, 2000, BRAIN, V123, P1092, DOI 10.1093/brain/123.6.1092; Carrithers MD, 2002, J NEUROIMMUNOL, V129, P51, DOI 10.1016/S0165-5728(02)00172-8; Carson MJ, 2006, IMMUNOL REV, V213, P48, DOI 10.1111/j.1600-065X.2006.00441.x; Cepok S, 2001, BRAIN, V124, P2169, DOI 10.1093/brain/124.11.2169; Chow BW, 2015, TRENDS NEUROSCI, V38, P598, DOI 10.1016/j.tins.2015.08.003; Clarkson BD, 2017, SCI REP-UK, V7, DOI 10.1038/srep42856; Coles JA, 2017, PROG NEUROBIOL, V156, P107, DOI 10.1016/j.pneurobio.2017.05.002; Cornish TE, 2001, VET PATHOL, V38, P396, DOI 10.1354/vp.38-4-396; Cugurra A, 2021, SCIENCE, V373, P409, DOI 10.1126/science.abf7844; Cui J, 2021, TRENDS NEUROSCI, V44, P864, DOI 10.1016/j.tins.2021.07.002; Cupovic J, 2016, IMMUNITY, V44, P622, DOI 10.1016/j.immuni.2015.12.022; Da Mesquita S, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe4601; Da Mesquita S, 2018, NATURE, V560, P185, DOI 10.1038/s41586-018-0368-8; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Dani Neil, 2021, Cell, V184, P3056, DOI 10.1016/j.cell.2021.04.003; Daniels BP, 2014, MBIO, V5, DOI 10.1128/mBio.01476-14; Dasgupta K, 2019, GENESIS, V57, DOI 10.1002/dvg.23288; De Kleer I, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00423; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Detje CN, 2009, J IMMUNOL, V182, P2297, DOI 10.4049/jimmunol.0800596; DiSano KD, 2017, BRAIN BEHAV IMMUN, V60, P71, DOI 10.1016/j.bbi.2016.09.022; Douaud G, 2022, NATURE, V604, P697, DOI [10.1038/s41586-022-04569-5, 10.1101/2021.06.11.21258690]; Echchannaoui H, 2002, J INFECT DIS, V186, P798, DOI 10.1086/342845; Eggers EL, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92724; Eide PK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25666-4; Farber DL, 2014, NAT REV IMMUNOL, V14, P24, DOI 10.1038/nri3567; Filiano AJ, 2015, BRAIN RES, V1617, P18, DOI 10.1016/j.brainres.2014.07.050; Fitzpatrick Z, 2020, NATURE, V587, P472, DOI 10.1038/s41586-020-2886-4; FUNGLEUNG WP, 1991, J EXP MED, V174, P1425, DOI 10.1084/jem.174.6.1425; Gandhi RT, 2020, NEW ENGL J MED, V383, P1757, DOI 10.1056/NEJMcp2009249; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; GLEDHILL AW, 1967, NATURE, V214, P178, DOI 10.1038/214178c0; Glowacka I, 2011, J VIROL, V85, P4122, DOI 10.1128/JVI.02232-10; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Gourley TS, 2004, SEMIN IMMUNOL, V16, P323, DOI 10.1016/j.smim.2004.08.013; Gu J, 2005, J EXP MED, V202, P415, DOI 10.1084/jem.20050828; Guidotti LG, 2001, ANNU REV IMMUNOL, V19, P65, DOI 10.1146/annurev.immunol.19.1.65; Haddad-Tovolli R, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00224; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Helms J, 2020, NEW ENGL J MED, V382, P2268, DOI 10.1056/NEJMc2008597; Herisson F, 2018, NAT NEUROSCI, V21, P1209, DOI 10.1038/s41593-018-0213-2; Herz J, 2017, IMMUNITY, V46, P943, DOI 10.1016/j.immuni.2017.06.007; Herz J, 2015, J EXP MED, V212, P1153, DOI 10.1084/jem.20142047; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hogan RJ, 2001, J EXP MED, V193, P981, DOI 10.1084/jem.193.8.981; Holmes EC, 2021, CELL, V184, P4848, DOI 10.1016/j.cell.2021.08.017; Howland SW, 2013, EMBO MOL MED, V5, P984, DOI 10.1002/emmm.201202273; Hsu M, 2022, NAT IMMUNOL, V23, P581, DOI 10.1038/s41590-022-01158-6; Hsu M, 2021, FRONT CELL NEUROSCI, V15, DOI 10.3389/fncel.2021.683676; Hsu M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08163-0; Imayoshi I, 2008, DEVELOPMENT, V135, P2531, DOI 10.1242/dev.021535; Ivanovs A, 2011, J EXP MED, V208, P2417, DOI 10.1084/jem.20111688; Jacobs JL, 2022, CLIN INFECT DIS, V74, P1525, DOI 10.1093/cid/ciab686; Jain RW, 2022, NAT REV IMMUNOL, V22, P513, DOI 10.1038/s41577-021-00652-6; Javed K, 2021, NEUROANATOMY CHOROID; JOLY E, 1992, NEURON, V8, P1185, DOI 10.1016/0896-6273(92)90138-4; Kacem K, 1998, GLIA, V23, P1; Kang SS, 2008, FRONT BIOSCI-LANDMRK, V13, P4529, DOI 10.2741/3021; Kang SS, 2011, J EXP MED, V208, P747, DOI 10.1084/jem.20101295; KIDA S, 1993, NEUROPATH APPL NEURO, V19, P480, DOI 10.1111/j.1365-2990.1993.tb00476.x; Kim JV, 2009, NATURE, V457, P191, DOI 10.1038/nature07591; Kipnis J, 2016, SCIENCE, V353, P766, DOI 10.1126/science.aag2638; Kivisakk P, 2002, CLIN EXP IMMUNOL, V129, P510, DOI 10.1046/j.1365-2249.2002.01947.x; KLAVINSKIS LS, 1989, J VIROL, V63, P4311, DOI 10.1128/JVI.63.10.4311-4316.1989; Klein M, 2008, J INFECT DIS, V198, P1028, DOI 10.1086/591626; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Kooij G, 2014, ACTA NEUROPATHOL, V127, P699, DOI 10.1007/s00401-014-1244-8; Korin B, 2017, NAT NEUROSCI, V20, P1300, DOI 10.1038/nn.4610; Kyriakidis NC, 2021, NPJ VACCINES, V6, DOI 10.1038/s41541-021-00292-w; Landrith TA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00335; Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; LIANG SH, 1994, J IMMUNOL, V152, P1653; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Liu T, 2001, J VIROL, V75, P11178, DOI 10.1128/JVI.75.22.11178-11184.2001; Louveau A, 2018, NAT NEUROSCI, V21, P1380, DOI 10.1038/s41593-018-0227-9; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; LUNDH B, 1987, NEUROPATH APPL NEURO, V13, P111, DOI 10.1111/j.1365-2990.1987.tb00175.x; Lv P, 2021, EXP THER MED, V21, DOI 10.3892/etm.2021.9793; Masopust D, 2019, ANNU REV IMMUNOL, V37, P521, DOI 10.1146/annurev-immunol-042617-053214; Mastorakos P, 2021, NAT NEUROSCI, V24, P245, DOI 10.1038/s41593-020-00773-6; Mastorakos P, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav0492; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; Matschke J, 2020, LANCET NEUROL, V19, P919, DOI 10.1016/S1474-4422(20)30308-2; MEDAWAR PB, 1948, BRIT J EXP PATHOL, V29, P58; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Meinhardt J, 2021, NAT NEUROSCI, V24, P168, DOI 10.1038/s41593-020-00758-5; Metcalf TU, 2013, J VIROL, V87, P2420, DOI 10.1128/JVI.01769-12; Mockus TE, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007365; Moriguchi T, 2020, INT J INFECT DIS, V94, P55, DOI 10.1016/j.ijid.2020.03.062; Moseman EA, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abb1817; Mrdjen D, 2018, IMMUNITY, V48, P380, DOI 10.1016/j.immuni.2018.01.011; Nagyoszi P, 2010, NEUROCHEM INT, V57, P556, DOI 10.1016/j.neuint.2010.07.002; Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240; Nayak Debasis, 2012, Intravital, V1, P95, DOI 10.4161/intv.22823; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Neuwelt EA, 2011, NAT REV NEUROSCI, V12, P169, DOI 10.1038/nrn2995; Novi G, 2020, NEUROL-NEUROIMMUNOL, V7, DOI 10.1212/NXI.0000000000000797; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Odoardi F, 2012, NATURE, V488, P675, DOI 10.1038/nature11337; ORAHILLY R, 1986, J NEUROPATH EXP NEUR, V45, P588, DOI 10.1097/00005072-198609000-00008; Patterson CE, 2002, J VIROL, V76, P4497, DOI 10.1128/JVI.76.9.4497-4506.2002; Pavlov VA, 2012, NAT REV ENDOCRINOL, V8, P743, DOI 10.1038/nrendo.2012.189; Perl DP, 2021, NEW ENGL J MED, V384, P481, DOI 10.1056/NEJMc2033369; Phares TW, 2014, J VIROL, V88, P8853, DOI 10.1128/JVI.00861-14; Prager O, 2017, EXP THER MED, V13, P799, DOI 10.3892/etm.2017.4082; Prasad S, 2019, VIRAL IMMUNOL, V32, P48, DOI 10.1089/vim.2018.0084; Prasad S, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0860-3; Radjavi A, 2014, MOL PSYCHIATR, V19, P531, DOI 10.1038/mp.2013.79; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Reichard RR, 2020, ACTA NEUROPATHOL, V140, P1, DOI 10.1007/s00401-020-02166-2; Riggle BA, 2020, J CLIN INVEST, V130, P1128, DOI 10.1172/JCI133474; RISAU W, 1986, DEV BIOL, V117, P537, DOI 10.1016/0012-1606(86)90321-0; Ritzel RM, 2016, J IMMUNOL, V196, P3318, DOI 10.4049/jimmunol.1502021; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Rua R, 2019, NAT IMMUNOL, V20, P407, DOI 10.1038/s41590-019-0344-y; Rua R, 2018, TRENDS MOL MED, V24, P542, DOI 10.1016/j.molmed.2018.04.003; Rustenhoven J, 2021, CELL, V184, P1000, DOI 10.1016/j.cell.2020.12.040; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Salkeni MA, 2009, J NEUROIMMUNE PHARM, V4, P276, DOI 10.1007/s11481-008-9138-y; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sasso E, 2020, SEMIN IMMUNOL, V50, DOI 10.1016/j.smim.2020.101430; Schafflick D, 2021, NAT NEUROSCI, V24, P1225, DOI 10.1038/s41593-021-00880-y; Scholler AS, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00351; Schuchardt F, 2015, EUR RADIOL, V25, P2371, DOI 10.1007/s00330-014-3587-x; Schwabenland M, 2021, IMMUNITY, V54, P1594, DOI 10.1016/j.immuni.2021.06.002; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; Seydel KB, 2015, NEW ENGL J MED, V372, P1126, DOI 10.1056/NEJMoa1400116; Shedlock DJ, 2011, VACCINE, V29, P6755, DOI 10.1016/j.vaccine.2010.12.064; Spudich S, 2022, SCIENCE, V375, P267, DOI 10.1126/science.abm2052; Steinbach K, 2016, J EXP MED, V213, P1571, DOI 10.1084/jem.20151916; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; SVENNINGSSON A, 1993, ANN NEUROL, V34, P155, DOI 10.1002/ana.410340210; Swanson P. A., 2015, BLOOD BRAIN BARRIER, P23; Swanson PA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006022; Swanson PA, 2015, CURR OPIN VIROL, V11, P44, DOI 10.1016/j.coviro.2014.12.009; Tietz S, 2015, J CELL BIOL, V209, P493, DOI 10.1083/jcb.201412147; Tishon A, 2006, VIROLOGY, V347, P234, DOI 10.1016/j.virol.2006.01.050; Phan TG, 2017, CURR OPIN IMMUNOL, V45, P132, DOI 10.1016/j.coi.2017.03.005; Urban SL, 2020, NAT IMMUNOL, V21, P938, DOI 10.1038/s41590-020-0711-8; Utz SG, 2020, CELL, V181, P557, DOI 10.1016/j.cell.2020.03.021; V'kovski P, 2021, NAT REV MICROBIOL, V19, P155, DOI 10.1038/s41579-020-00468-6; van Riel D, 2015, J PATHOL, V235, P277, DOI 10.1002/path.4461; Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283; Vivatbutsiri P, 2008, J ANAT, V212, P603, DOI 10.1111/j.1469-7580.2008.00893.x; VOETMANN E, 1949, Ugeskr Laeger, V111, P1051; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Wang Y, 2021, IMMUNITY, V54, P2784, DOI 10.1016/j.immuni.2021.09.016; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Weisel F, 2017, ANNU REV IMMUNOL, V35, P255, DOI 10.1146/annurev-immunol-041015-055531; Williams K, 2001, GLIA, V36, P156, DOI 10.1002/glia.1105; Wolburg H, 2005, ACTA NEUROPATHOL, V109, P181, DOI 10.1007/s00401-004-0928-x; Woo MS, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa205; Woolf SH, 2021, JAMA-J AM MED ASSOC, V325, P123, DOI 10.1001/jama.2020.24865; Yang AC, 2021, NATURE, V595, P565, DOI 10.1038/s41586-021-03710-0; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Yu YJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002230; Zhang XM, 2017, NAT REV IMMUNOL, V17, P495, DOI 10.1038/nri.2017.54; Ziegler CGK, 2020, CELL, V181, P1016, DOI 10.1016/j.cell.2020.04.035	189	1	1	7	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 10	2022	55	5					781	799		10.1016/j.immuni.2022.04.012	http://dx.doi.org/10.1016/j.immuni.2022.04.012			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1P7FS	35545028	Green Published, Bronze			2022-12-18	WOS:000802171100004
J	Sette, A; Saphire, EO				Sette, Alessandro; Saphire, Erica Ollmann			Inducing broad-based immunity against viruses with pandemic potential	IMMUNITY			English	Review							CD8(+) T-CELL; INFLUENZA-A VIRUS; NEUTRALIZING ANTIBODIES; PROTECTIVE ROLE; MONOCLONAL-ANTIBODIES; HEMAGGLUTININ STEM; RESPONSES; BINDING; SARS-COV-2; EPITOPES	The brutal toll of another viral pandemic can be blunted by investing now in research that uncovers mecha-nisms of broad-based immunity so we may have vaccines and therapeutics at the ready. We do not know exactly what pathogen may trigger the next wave or next pandemic. We do know, however, that the human immune system must respond and must be bolstered with effective vaccines and other therapeutics to preserve lives and livelihoods. These countermeasures must focus on features conserved among families of pathogens in order to be responsive against something yet to emerge. Here, we focus on immunological ap-proaches to mitigate the impact of the next emerging virus pandemic by developing vaccines that elicit both broadly protective antibodies and T cells. Identifying human immune mechanisms of broad protection against virus families with pandemic potential will be our best defense for humanity in the future.	[Sette, Alessandro; Saphire, Erica Ollmann] La Jolla Inst Immunol, Ctr Infect Dis & Vaccine Res, La Jolla, CA 92037 USA	La Jolla Institute for Immunology	Sette, A; Saphire, EO (corresponding author), La Jolla Inst Immunol, Ctr Infect Dis & Vaccine Res, La Jolla, CA 92037 USA.	sette@lji.org; erica@lji.org	Sette, Alessandro/AFO-8916-2022		National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [U19AI142790, P01AI165072, 75N93021C00016, 75N93019C00065]; Bill and Melinda Gates Foundation [INV-006133]	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This project has been funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under grants U19AI142790 and P01AI165072 and contracts 75N93021C00016 and75N93019C00065, as well as The Bill and Melinda Gates Foundation grant INV-006133.	Acharya P., PREPRINT, DOI [10.1101/2020.06.30, DOI 10.1101/2020.06.30]; Alexander J, 2010, HUM IMMUNOL, V71, P468, DOI 10.1016/j.humimm.2010.02.014; Alexander J, 2010, VACCINE, V28, P664, DOI 10.1016/j.vaccine.2009.10.103; Alter G, 2021, NATURE, V596, P268, DOI 10.1038/s41586-021-03681-2; Angeletti D, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028852; Antunes RD, 2021, J INFECT DIS, V224, P70, DOI 10.1093/infdis/jiab176; Apostolidis SA, 2021, NAT MED, V27, P1990, DOI 10.1038/s41591-021-01507-2; Assarsson E, 2008, J VIROL, V82, P12241, DOI 10.1128/JVI.01563-08; Bacher P, 2020, IMMUNITY, V53, P1258, DOI 10.1016/j.immuni.2020.11.016; Bahnan W, 2022, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.808932; BALACHANDRAN N, 1982, INFECT IMMUN, V37, P1132, DOI 10.1128/IAI.37.3.1132-1137.1982; Botten J, 2010, J VIROL, V84, P9947, DOI 10.1128/JVI.00672-10; Cagigi A, 2018, J INFECT DIS, V218, pS537, DOI 10.1093/infdis/jiy450; Caillat C, 2021, ELIFE, V10, DOI 10.7554/eLife.65005; Callendret B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192312; Calvert AE, 2022, VIROLOGY, V565, P13, DOI 10.1016/j.virol.2021.09.007; Chen TH, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.692700; Corbeil S, 1996, VACCINE, V14, P521, DOI 10.1016/0264-410X(95)00222-M; Cottrell CA, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008753; Cross RW, 2020, J CLIN INVEST, V130, P539, DOI 10.1172/JCI131958; Crowe JE, 2017, CELL HOST MICROBE, V22, P193, DOI 10.1016/j.chom.2017.07.013; Dang HV, 2021, NAT STRUCT MOL BIOL, V28, P426, DOI 10.1038/s41594-021-00584-8; Dangi T, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109664; Darricarrere N, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abe5449; de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109; Dejnirattisai W, 2022, CELL, V185, P467, DOI 10.1016/j.cell.2021.12.046; Dowell AC, 2022, NAT IMMUNOL, V23, P40, DOI 10.1038/s41590-021-01089-8; Duan HY, 2018, IMMUNITY, V49, P301, DOI 10.1016/j.immuni.2018.07.005; Dubrovskaya V, 2019, IMMUNITY, V51, P915, DOI 10.1016/j.immuni.2019.10.008; Dufloo J, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28307-7; Ellebedy AH, 2014, P NATL ACAD SCI USA, V111, P13133, DOI 10.1073/pnas.1414070111; Fedechkin SO, 2020, J VIROL, V94, DOI 10.1128/JVI.01879-19; Ferretti AP, 2020, IMMUNITY, V53, P1095, DOI 10.1016/j.immuni.2020.10.006; Flyak AI, 2018, NAT MICROBIOL, V3, P670, DOI 10.1038/s41564-018-0157-z; Forthal DN, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0019-2014; Gao Y, 2022, NAT MED, V28, P472, DOI 10.1038/s41591-022-01700-x; Geers D, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abj1750; Gianfrani C, 2000, HUM IMMUNOL, V61, P438, DOI 10.1016/S0198-8859(00)00105-1; Gong X, 2016, CELL, V165, P1467, DOI 10.1016/j.cell.2016.05.022; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Grifoni A, 2020, J VIROL, V94, DOI 10.1128/JVI.00089-20; Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]; Grunst MW, 2022, CELL REP MED, V3, DOI 10.1016/j.xcrm.2022.100540; Guthmiller JJ, 2022, NATURE, V602, P314, DOI 10.1038/s41586-021-04356-8; Habel JR, 2020, P NATL ACAD SCI USA, V117, P24384, DOI 10.1073/pnas.2015486117; Hashiguchi T, 2015, CELL, V160, P904, DOI 10.1016/j.cell.2015.01.041; Hastie KM, 2021, SCIENCE, V374, P472, DOI 10.1126/science.abh2315; Hastie KM, 2019, CELL, V178, P1004, DOI 10.1016/j.cell.2019.07.020; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hsieh CL, 2021, CELL REP, V37, DOI 10.1016/j.celrep.2021.109929; Impagliazzo A, 2015, SCIENCE, V349, P1301, DOI 10.1126/science.aac7263; Jendroszek A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92280-2; Jennewein MF, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109353; Jin J, 2018, CELL HOST MICROBE, V24, P417, DOI 10.1016/j.chom.2018.07.018; Jun SR, 2015, FEMS MICROBIOL REV, V39, P764, DOI 10.1093/femsre/fuv031; Kalimuddin S, 2021, MED-CAMBRIDGE, V2, P682, DOI 10.1016/j.medj.2021.04.003; Keeton R, 2022, NATURE, V603, P488, DOI 10.1038/s41586-022-04460-3; Keeton R, 2021, CELL HOST MICROBE, V29, P1611, DOI 10.1016/j.chom.2021.10.003; Keller MD, 2020, BLOOD, V136, P2905, DOI 10.1182/blood.2020008488; Kim AS, 2021, CELL, V184, P4414, DOI 10.1016/j.cell.2021.07.006; King LB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09732-7; Kotturi Maya F, 2010, Immunome Res, V6, P4, DOI 10.1186/1745-7580-6-4; Kotturi MF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000695; Kundu Rhia, 2022, Nat Commun, V13, P80, DOI 10.1038/s41467-021-27674-x; LaBranche CC, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007431; Le Bert N, 2021, J EXP MED, V218, DOI 10.1084/jem.20202617; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Lee CCD, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009407; Lehrer AT, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.703986; Li WW, 2022, CELL REP, V38, DOI [10.1016/j.celrep.2021.110210, 10.1101/2021.08.02.454546]; Lin QS, 2018, J VIROL, V92, DOI 10.1128/JVI.00547-18; Lin WS, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.795741; Lineburg KE, 2021, IMMUNITY, V54, P1055, DOI 10.1016/j.immuni.2021.04.006; Liu JY, 2022, NATURE, V603, P493, DOI 10.1038/s41586-022-04465-y; Loyal L, 2021, SCIENCE, V374, P171, DOI 10.1126/science.abh1823; Madelon N., 2021, PREPRINT; Mallajosyula VVA, 2014, P NATL ACAD SCI USA, V111, pE2514, DOI 10.1073/pnas.1402766111; Matassov D, 2018, J VIROL, V92, DOI 10.1128/JVI.01190-17; Mateus J, 2021, SCIENCE, V374, P420, DOI 10.1126/science.abj9853; Mateus J, 2020, SCIENCE, V370, P89, DOI 10.1126/science.abd3871; Melo-Gonzalez F, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.747830; Milligan JC, 2022, CELL, V185, P995, DOI 10.1016/j.cell.2022.02.023; Milligan JC, 2019, J INFECT DIS, V219, P415, DOI 10.1093/infdis/jiy532; Moderbacher CR, 2020, CELL, V183, P996, DOI 10.1016/j.cell.2020.09.038; Neerukonda SN, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248348; Nelde A, 2021, NAT IMMUNOL, V22, P74, DOI 10.1038/s41590-020-00808-x; Ng KW, 2021, SEMIN IMMUNOL, V55, DOI 10.1016/j.smim.2021.101507; Ngono AE, 2016, EBIOMEDICINE, V13, P284, DOI 10.1016/j.ebiom.2016.10.006; Nguyen DN, 2019, ACS CENTRAL SCI, V5, P237, DOI 10.1021/acscentsci.8b00588; Oda M, 2000, MOL IMMUNOL, V37, P1111, DOI 10.1016/S0161-5890(01)00028-1; Peng YC, 2022, NAT IMMUNOL, V23, P50, DOI 10.1038/s41590-021-01084-z; Perspective De Marco L., 2021, PRESERVED T CELL REA, DOI [10.1101/ 2021.12.30.474453, DOI 10.1101/2021.12.30.474453]; Pinto D, 2021, SCIENCE, V373, P1109, DOI 10.1126/science.abj3321; Pinto D, 2019, CELL HOST MICROBE, V26, P623, DOI 10.1016/j.chom.2019.09.016; Prakash S, 2021, J IMMUNOL, V206, P2566, DOI 10.4049/jimmunol.2001438; Redd A.D., 2021, CD8 T CELL RESPONSES, V8, DOI 10.1093/ofid/ofab143; Regla-Nava JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05458-0; Remmel JL, 2021, VIROLOGY, V559, P57, DOI 10.1016/j.virol.2021.03.013; Roozendaal R, 2020, NPJ VACCINES, V5, DOI 10.1038/s41541-020-00261-9; Sabatino JJ, 2022, JCI INSIGHT, V7, DOI 10.1172/jci.insight.156978; Sagar M, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI143380; Sauer MM, 2021, NAT STRUCT MOL BIOL, V28, P478, DOI [10.1038/s41594-021-00596-4, 10.1101/2020.12.29.424482]; Saunders KO, 2017, CELL REP, V18, P2175, DOI 10.1016/j.celrep.2017.02.003; Schouest B, 2021, J VIROL, V95, DOI 10.1128/JVI.00132-21; Schulien I, 2021, NAT MED, V27, P78, DOI 10.1038/s41591-020-01143-2; Sekine T, 2020, CELL, V183, P158, DOI 10.1016/j.cell.2020.08.017; Sette A, 2020, NAT REV IMMUNOL, V20, P457, DOI 10.1038/s41577-020-0389-z; Shomuradova AS, 2020, IMMUNITY, V53, P1245, DOI 10.1016/j.immuni.2020.11.004; Sidney J, 2020, SEMIN IMMUNOL, V50, DOI 10.1016/j.smim.2020.101418; Soresina A, 2020, PEDIAT ALLERG IMM-UK, V31, P565, DOI 10.1111/pai.13263; Swadling L, 2022, NATURE, V601, DOI 10.1038/s41586-021-04186-8; Tan AT, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108728; Tarke A, 2022, CELL, V185, P847, DOI 10.1016/j.cell.2022.01.015; Tarke A, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100355; Terajima M, 2011, J VIROL, V85, P13463, DOI 10.1128/JVI.05193-11; Thulin NK, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6030036; Tsai WY, 2018, J VIROL, V92, DOI [10.1128/JVI.00556-18, 10.1128/jvi.00556-18]; Tsai WY, 2013, J VIROL, V87, P12562, DOI 10.1128/JVI.00871-13; Tyagi A, 2020, J STRUCT BIOL-X, V4, DOI 10.1016/j.yjsbx.2020.100028; van Erp EA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00548; VanBlargan LA, 2016, MICROBIOL MOL BIOL R, V80, DOI 10.1128/MMBR.00024-15; Vanderheijden N, 2022, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.790415; Walls Alexandra C, 2021, Cell, V184, P5432, DOI [10.1101/2021.03.15.435528, 10.1016/j.cell.2021.09.015]; Wang CY, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21968-w; Wang PF, 2021, NATURE, V593, P130, DOI 10.1038/s41586-021-03398-2; Weiskopf D, 2016, J INFECT DIS, V214, P1117, DOI 10.1093/infdis/jiw309; Weiskopf D, 2015, J VIROL, V89, P120, DOI 10.1128/JVI.02129-14; Weiskopf D, 2014, J VIROL, V88, P11383, DOI 10.1128/JVI.01108-14; Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110; Wen JS, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107566; Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36; West BR, 2018, MBIO, V9, DOI [10.1128/mBio.01674-18, 10.1128/mbio.01674-18]; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; Williams WB, 2021, CELL, V184, P2955, DOI 10.1016/j.cell.2021.04.042; Williamson LE, 2021, CELL, V184, P4430, DOI 10.1016/j.cell.2021.07.033; Wu NC, 2020, CSH PERSPECT MED, V10, DOI 10.1101/cshperspect.a038778; Yamayoshi S, 2021, ECLINICALMEDICINE, V32, DOI 10.1016/j.eclinm.2021.100734; Yang F, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.606569; Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709; Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974; Yin V, 2021, ACS CENTRAL SCI, V7, P1863, DOI 10.1021/acscentsci.1c00804; Zellweger RM, 2015, J VIROL, V89, P6494, DOI 10.1128/JVI.00036-15; Zhou PP, 2022, SCI TRANSL MED, V14, DOI 10.1126/scitranslmed.abi9215	146	1	1	3	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 10	2022	55	5					738	748		10.1016/j.immuni.2022.04.010	http://dx.doi.org/10.1016/j.immuni.2022.04.010			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1P7FS	35545026				2022-12-18	WOS:000802171100002
J	Azzoni, R; Marsland, BJ				Azzoni, Rossana; Marsland, Benjamin J.			The lung-brain axis: A new frontier in host-microbe interactions	IMMUNITY			English	Editorial Material								The gut microbiome is well-known to shape local and distal immune responses, both in health and disease. In a recent issue of Nature, Hosang et al. demonstrate how the lung microbiome regulates the magnitude of autoimmune inflammation in the brain.	[Azzoni, Rossana; Marsland, Benjamin J.] Monash Univ, Dept Immunol & Pathol, Melbourne, Vic, Australia	Monash University	Azzoni, R; Marsland, BJ (corresponding author), Monash Univ, Dept Immunol & Pathol, Melbourne, Vic, Australia.	rossana.azzoni@monash.edu; benjamin.marsland@monash.edu						Abdel-Haq R, 2019, J EXP MED, V216, P41, DOI 10.1084/jem.20180794; Baecher-Allan C, 2018, NEURON, V97, P742, DOI 10.1016/j.neuron.2018.01.021; Berer K, 2017, P NATL ACAD SCI USA, V114, P10719, DOI 10.1073/pnas.1711233114; Goldmann T, 2016, CURR OPIN NEUROBIOL, V36, P38, DOI 10.1016/j.conb.2015.09.003; Hosang L, 2022, NATURE, V603, P138, DOI 10.1038/s41586-022-04427-4; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Odoardi F, 2012, NATURE, V488, P675, DOI 10.1038/nature11337; Pattaroni C, 2018, CELL HOST MICROBE, V24, P857, DOI 10.1016/j.chom.2018.10.019; Sencio V, 2021, MUCOSAL IMMUNOL, V14, P296, DOI 10.1038/s41385-020-00361-8	9	1	1	11	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 12	2022	55	4					589	591		10.1016/j.immuni.2022.03.015	http://dx.doi.org/10.1016/j.immuni.2022.03.015			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0W2LH	35417673				2022-12-18	WOS:000788864600006
J	Ozga, AJ; Chow, MT; Lopes, ME; Servis, RL; Di Pilato, M; Dehio, P; Lian, J; Mempel, TR; Luster, AD				Ozga, Aleksandra J.; Chow, Melvyn T.; Lopes, Mateus E.; Servis, Rachel L.; Di Pilato, Mauro; Dehio, Philippe; Lian, Jeffrey; Mempel, Thorsten R.; Luster, Andrew D.			CXCL10 chemokine regulates heterogeneity of the CD8(+) T cell response and viral set point during chronic infection	IMMUNITY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; RECEPTOR CXCR3; PERSISTENCE; INTERNALIZATION; EXHAUSTION; SIGNATURE; SURVIVAL; SUBSETS; LIMITS; IP-10	CD8(+) T cells responding to chronic infection adapt an altered differentiation program that provides some restraint on pathogen replication yet limits immunopathology. This adaptation is imprinted in stem-like cells and propagated to their progeny. Understanding the molecular control of CD8(+) T cell differentiation in chronic infection has important therapeutic implications. Here, we find that the chemokine receptor CXCR3 is highly expressed on viral-specific stem-like CD8(+) T cells and that one of its ligands, CXCL10, regulates the persistence and heterogeneity of responding CD8(+) T cells in spleens of mice chronically infected with lymphocytic choriomeningitis virus. CXCL10 is produced by inflammatory monocytes and fibroblasts of the splenic red pulp, where it grants stem-like cells access to signals promoting differentiation and limits their exposure to pro-survival niches in the white pulp. Consequently, functional CD8(+) T cell responses are greater in Cxcl10(-/)(-) mice and are associated with a lower viral set point.	[Ozga, Aleksandra J.; Chow, Melvyn T.; Lopes, Mateus E.; Servis, Rachel L.; Di Pilato, Mauro; Dehio, Philippe; Lian, Jeffrey; Mempel, Thorsten R.; Luster, Andrew D.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Div Rheumatol Allergy & Immunol, Boston, MA 02129 USA; [Lopes, Mateus E.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, Ctr Gastrointestinal Biol, BR-31270901 Belo Horizonte, MG, Brazil; [Di Pilato, Mauro] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77054 USA; [Dehio, Philippe] Univ Basel, Dept Biomed, CH-4031 Basel, Switzerland	Harvard University; Harvard Medical School; Massachusetts General Hospital; Universidade Federal de Minas Gerais; University of Texas System; UTMD Anderson Cancer Center; University of Basel	Luster, AD (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Div Rheumatol Allergy & Immunol, Boston, MA 02129 USA.	aluster@mgh.harvard.edu	; Eustaquio de Moura Lopes, Mateus/T-3145-2017	Di Pilato, Mauro/0000-0003-3902-7406; Eustaquio de Moura Lopes, Mateus/0000-0001-8730-7336; Lian, Jeffrey/0000-0001-9470-7864	National Institutes of Health [R01 AI163223]; Cancer Research Institute; Swiss National Science Foundation Early Postdoctoral Mobility Award [P3BEP3_165406]; American Association Cancer Research Basic Science Fellowship Program [18-40-01-OZGA]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; Swiss National Science Foundation Early Postdoctoral Mobility Award; American Association Cancer Research Basic Science Fellowship Program	We thank J. Wherry and his lab members (M. Kurachi, S. Ngiow, and R. Staupe) for LCMV Arm and Cl13 viral stocks and valuable advice; A. Sharpe and her lab members (K. Pauken, and M. LaFleur) for sharing P14 mice; J. Farber for Cxcl9-/-mice and C. Gerard for the Cxcr3-/-mice; and J. de la Torre for sharing pCITE-GP plasmid and protocols. We also thank W. Hudson for critical comments on the manuscript. This work was supported by grants from the National Institutes of Health (R01 CA204028) and the Cancer Research Institute to A.D.L., the Swiss National Science Foundation Early Postdoctoral Mobility Award (P3BEP3_165406) and the American Association Cancer Research Basic Science Fellowship Program (18-40-01-OZGA) to A.J.O, and the National Institutes of Health (R01 AI163223) to T.R.M.	AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Argilaguet J, 2019, GENOME RES, V29, P907, DOI 10.1101/gr.241372.118; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Blank CU, 2019, NAT REV IMMUNOL, V19, P665, DOI 10.1038/s41577-019-0221-9; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Chow MT, 2019, IMMUNITY, V50, P1498, DOI 10.1016/j.immuni.2019.04.010; Dangi Tanushree, 2020, Curr Protoc Immunol, V130, pe99, DOI 10.1002/cpim.99; Di Pilato M, 2021, CELL, V184, P4512, DOI 10.1016/j.cell.2021.07.015; Duckworth BC, 2021, NAT IMMUNOL, V22, P434, DOI 10.1038/s41590-021-00878-5; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Groom JR, 2012, IMMUNITY, V37, P1091, DOI 10.1016/j.immuni.2012.08.016; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Hancock WW, 2000, J EXP MED, V192, P1515, DOI 10.1084/jem.192.10.1515; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Hickman HD, 2015, IMMUNITY, V42, P524, DOI 10.1016/j.immuni.2015.02.009; Hu JK, 2011, P NATL ACAD SCI USA, V108, pE118, DOI 10.1073/pnas.1101881108; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Huang Z, 2019, J EXP MED, V216, P1791, DOI 10.1084/jem.20190173; Hudson WH, 2019, IMMUNITY, V51, P1043, DOI 10.1016/j.immuni.2019.11.002; Im SJ, 2020, P NATL ACAD SCI USA, V117, P4292, DOI 10.1073/pnas.1917298117; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Jansen CS, 2019, NATURE, V576, P465, DOI 10.1038/s41586-019-1836-5; Khan IA, 2000, IMMUNITY, V12, P483, DOI 10.1016/S1074-7613(00)80200-9; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Kurachi M, 2011, J EXP MED, V208, P1605, DOI 10.1084/jem.20102101; LaFleur MW, 2019, NAT IMMUNOL, V20, P1335, DOI 10.1038/s41590-019-0480-4; Man K, 2017, IMMUNITY, V47, P1129, DOI 10.1016/j.immuni.2017.11.021; McCausland MM, 2008, J VIROL METHODS, V147, P167, DOI 10.1016/j.jviromet.2007.08.025; Meiser A, 2008, J IMMUNOL, V180, P6713, DOI 10.4049/jimmunol.180.10.6713; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Norris BA, 2013, IMMUNITY, V38, P309, DOI 10.1016/j.immuni.2012.10.022; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Park MK, 2002, J IMMUNOL, V169, P1433, DOI 10.4049/jimmunol.169.3.1433; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Rutishauser RL, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.136648; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Sauty A, 2001, J IMMUNOL, V167, P7084, DOI 10.4049/jimmunol.167.12.7084; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Utzschneider DT, 2020, NAT IMMUNOL, V21, P1256, DOI 10.1038/s41590-020-0760-z; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zander R, 2019, IMMUNITY, V51, P1028, DOI 10.1016/j.immuni.2019.10.009	53	1	1	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 11	2022	55	1					82	+		10.1016/j.immuni.2021.11.002	http://dx.doi.org/10.1016/j.immuni.2021.11.002			25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YI0BU	34847356				2022-12-18	WOS:000743523600010
J	Sivapalan, L; Anagnostou, V				Sivapalan, Lavanya; Anagnostou, Valsamo			Genetic variation in antigen presentation and cancer immunotherapy	IMMUNITY			English	Editorial Material							CHECKPOINT BLOCKADE	Human leukocyte antigen (HLA) molecules are critical mediators of anti-tumor immune responses. In this issue of Immunity, Chhibber et al. (2021) challenge previous associations between germline HLA zygosity and immunotherapy outcomes, demonstrating that germline HLA genotypes and diversity alone are not independent biomarkers of anti-PD1 clinical efficacy.	[Sivapalan, Lavanya; Anagnostou, Valsamo] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Sch Med, Baltimore, MD 21287 USA; [Anagnostou, Valsamo] Johns Hopkins Univ, Bloomberg Kimmel Inst Canc Immunotherapy, Sch Med, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Anagnostou, V (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Sch Med, Baltimore, MD 21287 USA.; Anagnostou, V (corresponding author), Johns Hopkins Univ, Bloomberg Kimmel Inst Canc Immunotherapy, Sch Med, Baltimore, MD 21287 USA.	vanagno1@jhmi.edu			U.S. National Institutes of Health [CA121113]; Bloomberg-Kimmel Institute for Cancer Immunotherapy	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bloomberg-Kimmel Institute for Cancer Immunotherapy	This work was supported in part by the U.S. National Institutes of Health grant CA121113 (V.A.) and the Bloomberg-Kimmel Institute for Cancer Immunotherapy (V.A.).	Anagnostou V, 2020, NAT CANCER, V1, P99, DOI 10.1038/s43018-019-0008-8; Carrot-Zhang J, 2021, CANCER DISCOV, V11, P591, DOI 10.1158/2159-8290.CD-20-1165; Chhibber A., 2021, IMMUNITY, V55, P56; Chowell D, 2019, NAT MED, V25, P1715, DOI 10.1038/s41591-019-0639-4; Chowell D, 2018, SCIENCE, V359, P582, DOI 10.1126/science.aao4572; Litchfield K, 2021, CELL, V184, P596, DOI 10.1016/j.cell.2021.01.002; Marty R, 2017, CELL, V171, P1272, DOI 10.1016/j.cell.2017.09.050; McGranahan N, 2017, CELL, V170, P825, DOI 10.1016/j.cell.2017.08.012; Montesion Meagan, 2021, Cancer Discov, V11, P282, DOI 10.1158/2159-8290.CD-20-0672; Rosenthal R, 2019, NATURE, V567, P479, DOI 10.1038/s41586-019-1032-7	10	1	1	2	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 11	2022	55	1					3	+		10.1016/j.immuni.2021.12.010	http://dx.doi.org/10.1016/j.immuni.2021.12.010			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YI0BU	35021056				2022-12-18	WOS:000743523600002
J	Clatworthy, MR				Clatworthy, Menna R.			The meninges-a cradle and school for nurturing and educating developing B cells	IMMUNITY			English	Editorial Material									[Clatworthy, Menna R.] Univ Cambridge, Dept Med, Cambridge Inst Therapeut Immunol & Infect Dis, Mol Immun Unit, Cambridge, England; [Clatworthy, Menna R.] Wellcome Sanger Inst, Cellular Genet, Hinxton, England	University of Cambridge; Wellcome Trust Sanger Institute	Clatworthy, MR (corresponding author), Univ Cambridge, Dept Med, Cambridge Inst Therapeut Immunol & Infect Dis, Mol Immun Unit, Cambridge, England.; Clatworthy, MR (corresponding author), Wellcome Sanger Inst, Cellular Genet, Hinxton, England.	mrc38@cam.ac.uk						Brioschi S, 2021, SCIENCE, V373, P408, DOI 10.1126/science.abf9277; Cai RY, 2019, NAT NEUROSCI, V22, P317, DOI 10.1038/s41593-018-0301-3; Fitzpatrick Z, 2020, NATURE, V587, P472, DOI 10.1038/s41586-020-2886-4; Herisson F, 2018, NAT NEUROSCI, V21, P1209, DOI 10.1038/s41593-018-0213-2; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Korin B, 2017, NAT NEUROSCI, V20, P1300, DOI 10.1038/nn.4610; Mundt S, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau8380; Schafflick D, 2021, NAT NEUROSCI, V24, P1225, DOI 10.1038/s41593-021-00880-y; Wang Y, 2021, IMMUNITY, V54, P2784, DOI 10.1016/j.immuni.2021.09.016	9	1	1	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2021	54	12					2688	2690		10.1016/j.immuni.2021.11.010	http://dx.doi.org/10.1016/j.immuni.2021.11.010		DEC 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XQ6GW	34910935				2022-12-18	WOS:000731645300005
J	Hoffman, D; Tevet, Y; Trzebanski, S; Rosenberg, G; Vainman, L; Solomon, A; Hen-Avivi, S; Ben-Moshe, NB; Avraham, R				Hoffman, Dotan; Tevet, Yaara; Trzebanski, Sebastien; Rosenberg, Gili; Vainman, Leia; Solomon, Aryeh; Hen-Avivi, Shelly; Ben-Moshe, Noa Bossel; Avraham, Roi			A non-classical monocyte-derived macrophage subset provides a splenic replication niche for intracellular Salmonella	IMMUNITY			English	Article							PATHOGENICITY ISLAND 2; III SECRETION SYSTEM; RED PULP MACROPHAGES; CELL RNA-SEQ; MARGINAL ZONE; INFECTION; HETEROGENEITY; NECROPTOSIS; EXPRESSION; EPITHELIUM	Interactions between intracellular bacteria and mononuclear phagocytes give rise to diverse cellular phenotypes that may determine the outcome of infection. Recent advances in single-cell RNA sequencing (scRNA-seq) have identified multiple subsets within the mononuclear population, but implications to their function during infection are limited. Here, we surveyed the mononuclear niche of intracellular Salmonella Typhimurium (S.Tm) during early systemic infection in mice. We described eclipse-like growth kinetics in the spleen, with a first phase of bacterial control mediated by tissue-resident red-pulp macrophages. A second phase involved extensive bacterial replication within a macrophage population characterized by CD9 expression. We demonstrated that CD9(+) macrophages induced pathways for detoxificating oxidized lipids, that may be utilized by intracellular S.Tm. We established that CD9(+) macrophages originated from non-classical monocytes (NCM), and NCM-depleted mice were more resistant to S.Tm infection. Our study defines macrophage subset-specific host-pathogen interactions that determine early infection dynamics and infection outcome of the entire organism.	[Hoffman, Dotan; Tevet, Yaara; Rosenberg, Gili; Vainman, Leia; Solomon, Aryeh; Hen-Avivi, Shelly; Ben-Moshe, Noa Bossel; Avraham, Roi] Weizmann Inst Sci, Dept Biol Regulat, IL-7610001 Rehovot, Israel; [Trzebanski, Sebastien] Weizmann Inst Sci, Dept Immunol, IL-7610001 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Avraham, R (corresponding author), Weizmann Inst Sci, Dept Biol Regulat, IL-7610001 Rehovot, Israel.	roi.avraham@weizmann.ac.il		Avraham, Roi/0000-0002-9098-3885; Hoffman, Dotan/0000-0002-7126-2943	European Research Council (ERC) [756653]; Israel Science Foundation [1890/17]; Sagol Weiz-mann-MIT Bridge Program; Pasteur-Weizmann Delegation; Merle S. Cahn Foundation; Estate of Zvia Zeroni; Estate of Leah Arbel	European Research Council (ERC)(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation); Sagol Weiz-mann-MIT Bridge Program; Pasteur-Weizmann Delegation; Merle S. Cahn Foundation; Estate of Zvia Zeroni; Estate of Leah Arbel	We thank Steffen Jung and Lynn Hedrick for their valuable advice. We thank Florent Ginhoux, Masato Tanaka, and Kenji Kohno for providing mice strains. This work was supported by the European Research Council (ERC grant No. 756653) , the Israel Science Foundation (grant No. 1890/17) , Sagol Weiz-mann-MIT Bridge Program, Pasteur-Weizmann Delegation, the Merle S. Cahn Foundation, the Estate of Zvia Zeroni, and the Estate of Leah Arbel. R.A. is the Incumbent of Philip Harris and Gerald Ronson career development chair.	Agac D, 2018, BRAIN BEHAV IMMUN, V74, P176, DOI 10.1016/j.bbi.2018.09.004; Baran Y, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1812-2; Batista-Gonzalez A, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02993; Bleriot C, 2015, IMMUNITY, V42, P145, DOI 10.1016/j.immuni.2014.12.020; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Bruhl H, 2007, ARTHRITIS RHEUM, V56, P2975, DOI 10.1002/art.22854; CARTER PB, 1974, J EXP MED, V139, P1189, DOI 10.1084/jem.139.5.1189; Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; da Silva HB, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00480; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; De Jesus M, 2008, MED MYCOL, V46, P153, DOI 10.1080/13693780701747182; Dick SA, 2019, NAT IMMUNOL, V20, P29, DOI [10.1038/s41590-018-0272-2, 10.1038/s41590-019-0363-8]; Eisele NA, 2013, CELL HOST MICROBE, V14, P171, DOI 10.1016/j.chom.2013.07.010; Ercoli G, 2018, NAT MICROBIOL, V3, P600, DOI 10.1038/s41564-018-0147-1; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Frost AJ, 1997, VET PATHOL, V34, P369, DOI 10.1177/030098589703400501; Geddes K, 2007, PLOS PATHOG, V3, P2017, DOI 10.1371/journal.ppat.0030196; Giladi A, 2020, NAT IMMUNOL, V21, P525, DOI 10.1038/s41590-020-0661-1; Ginhoux F, 2017, TRENDS IMMUNOL, V38, P693, DOI 10.1016/j.it.2017.05.009; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Goldberg MF, 2018, IMMUNITY, V49, P1090, DOI 10.1016/j.immuni.2018.10.009; Guilliams M, 2018, IMMUNITY, V49, P595, DOI 10.1016/j.immuni.2018.10.005; Hashimshony T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0938-8; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Helaine S, 2014, SCIENCE, V343, P204, DOI 10.1126/science.1244705; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; Huang L, 2018, J EXP MED, V215, P1135, DOI 10.1084/jem.20172020; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Keren-Shaul H, 2019, NAT PROTOC, V14, P1841, DOI 10.1038/s41596-019-0164-4; Kirby AC, 2009, AM J PATHOL, V175, P1107, DOI 10.2353/ajpath.2009.090258; Kolter J, 2019, IMMUNITY, V50, P1482, DOI 10.1016/j.immuni.2019.05.009; Liu ZY, 2019, CELL, V178, P1509, DOI 10.1016/j.cell.2019.08.009; Mack M, 2001, J IMMUNOL, V166, P4697, DOI 10.4049/jimmunol.166.7.4697; McLaughlin PA, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007847; Menezes S, 2016, IMMUNITY, V45, P1205, DOI 10.1016/j.immuni.2016.12.001; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Mills E, 2017, CURR OPIN MICROBIOL, V36, P69, DOI 10.1016/j.mib.2017.01.005; Miyake Y, 2007, J CLIN INVEST, V117, P2268, DOI 10.1172/JCI31990; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Narasimhan PB, 2019, ANNU REV IMMUNOL, V37, P439, DOI 10.1146/annurev-immunol-042617-053119; Olingy CE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00477-1; Pham THM, 2020, CELL HOST MICROBE, V27, P54, DOI 10.1016/j.chom.2019.11.011; Price JV, 2014, IMMUNITY, V41, P685, DOI 10.1016/j.immuni.2014.10.015; Ramachandran P, 2019, NATURE, V575, P512, DOI 10.1038/s41586-019-1631-3; Robinson N, 2012, NAT IMMUNOL, V13, P954, DOI 10.1038/ni.2397; Salcedo SP, 2001, CELL MICROBIOL, V3, P587, DOI 10.1046/j.1462-5822.2001.00137.x; Saliba AE, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.206; Schleier L, 2020, GUT, V69, P252, DOI 10.1136/gutjnl-2018-316772; Schyns J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11843-0; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; TAKEUCHI A, 1967, AM J PATHOL, V50, P109; Tam JW, 2014, INFECT IMMUN, V82, P2606, DOI 10.1128/IAI.01590-13; Thomas GD, 2016, IMMUNITY, V45, P975, DOI 10.1016/j.immuni.2016.10.011; Trzebanski S, 2020, IMMUNOL LETT, V227, P66, DOI 10.1016/j.imlet.2020.07.007; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; Venables W.N., 2002, MODERN APPL STAT S, V4, DOI [10.1007/978-0-387-21706-2, DOI 10.1007/978-0-387-21706-2]; Vrieling F, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007724; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	63	1	1	3	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2021	54	12					2712	+		10.1016/j.immuni.2021.10.015	http://dx.doi.org/10.1016/j.immuni.2021.10.015		DEC 2021	19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XQ6GW	34788598	Green Published, hybrid			2022-12-18	WOS:000731645300011
J	Rao, M; Bogunovic, M				Rao, Meenakshi; Bogunovic, Milena			Enteric glia worm their way into gut immunity	IMMUNITY			English	Editorial Material									[Rao, Meenakshi] Boston Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; [Rao, Meenakshi] Harvard Med Sch, Boston, MA 02115 USA; [Bogunovic, Milena] UMass Chan Med Sch, Dept Pathol, Worcester, MA 01655 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Bogunovic, M (corresponding author), UMass Chan Med Sch, Dept Pathol, Worcester, MA 01655 USA.	milena.bogunovic@umassmed.edu						Chow AK, 2021, CELL MOL GASTROENTER, V12, P1215, DOI 10.1016/j.jcmgh.2021.06.008; Grubisic V, 2017, J PHYSIOL-LONDON, V595, P3409, DOI 10.1113/JP273492; Ibiza S, 2016, NATURE, V535, P440, DOI 10.1038/nature18644; Kinchen J, 2018, CELL, V175, P372, DOI 10.1016/j.cell.2018.08.067; Kirby L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11638-3; Kovler ML, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abg3459; Lucas TA, 2021, GLIA, V69, P1799, DOI 10.1002/glia.23993; Progatzky F, 2021, NATURE, V599, P125, DOI 10.1038/s41586-021-04006-z; Rao M, 2017, GASTROENTEROLOGY, V153, P1068, DOI 10.1053/j.gastro.2017.07.002; Yuan R, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.595892	10	1	1	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2021	54	12					2698	2700		10.1016/j.immuni.2021.11.014	http://dx.doi.org/10.1016/j.immuni.2021.11.014		DEC 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XQ6GW	34910939				2022-12-18	WOS:000731645300009
J	Faust, TE; Schafer, DP				Faust, Travis E.; Schafer, Dorothy P.			IL-6 boosts synaptogenesis STAT!	IMMUNITY			English	Editorial Material							FETAL-BRAIN DEVELOPMENT; SCHIZOPHRENIA; INTERLEUKIN-6	Maternal infection during pregnancy increases the offspring's risk of developing neurodevelopmental disorders. While IL-6 is involved, the mechanism by which IL-6 and other cytokines affect developing neural circuits is unknown. In this issue of Immunity, Mirabella et al. (2021) show that the pro-inflammatory cytokine IL-6 specifically increases synaptogenesis in immature excitatory neurons through downstream neuronal STAT3-dependent transcriptional regulation of Rgs4.	[Faust, Travis E.; Schafer, Dorothy P.] Univ Massachusetts, Dept Neurobiol, Brudnick Neuropsychiat Res Inst, Med Sch, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Schafer, DP (corresponding author), Univ Massachusetts, Dept Neurobiol, Brudnick Neuropsychiat Res Inst, Med Sch, Worcester, MA 01605 USA.	dorothydori.schafer@umassmed.edu		Faust, Travis/0000-0002-4567-8435	NIMH [R01MH113743]; NINDS [R01NS117533]; NIA [RF1AG068281]; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation	This work was supported by NIMH R01MH113743 (D.P.S.) , NINDS R01NS117533 (D.P.S.) , NIA RF1AG068281 (D.P.S.) , and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (D.P.S.) . The figure illustration was created with BioRender.com .	Choi GB, 2016, SCIENCE, V351, P933, DOI 10.1126/science.aad0314; Dahlgren J, 2006, PEDIATR RES, V60, P147, DOI 10.1203/01.pdr.0000230026.74139.18; Levitt P, 2006, BIOL PSYCHIAT, V60, P534, DOI 10.1016/j.biopsych.2006.04.028; Lur G, 2015, CELL REP, V12, P326, DOI 10.1016/j.celrep.2015.06.029; Mirabella F, 2021, IMMUNITY, V54, P2611, DOI 10.1016/j.immuni.2021.10.006; Ozaki K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78294-2; Patterson PH, 2009, BEHAV BRAIN RES, V204, P313, DOI 10.1016/j.bbr.2008.12.016; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Werneburg S, 2017, CURR OPIN NEUROBIOL, V47, P138, DOI 10.1016/j.conb.2017.10.002; Wu WL, 2017, BRAIN BEHAV IMMUN, V62, P11, DOI 10.1016/j.bbi.2016.11.007	10	1	1	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 9	2021	54	11					2444	2446		10.1016/j.immuni.2021.10.010	http://dx.doi.org/10.1016/j.immuni.2021.10.010		NOV 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WX1LS	34758335	Bronze			2022-12-18	WOS:000718366000004
J	Lagree, K; Underhill, DM				Lagree, Katherine; Underhill, David M.			Candida-induced asthma steps up to the plate-lets	IMMUNITY			English	Editorial Material							DAMAGE	Fungal proteases are well-known allergens. In this issue of Immunity, Wu et al. (2021) observe that allergic airway responses to Candida albicans are mediated by the peptide toxin candidalysin rather than proteases. Candidalysin promotes these responses by stimulating platelets to release the Wnt antagonist Dickkopf-1.	[Lagree, Katherine; Underhill, David M.] Cedars Sinai Med Ctr, Dept Biomed Sci, Res Div Immunol, Los Angeles, CA 90048 USA; [Lagree, Katherine; Underhill, David M.] Cedars Sinai Med Ctr, F Widjaja Fdn, Inflammatory Bowel & Immunobiol Res Inst, Los Angeles, CA 90048 USA; [Lagree, Katherine; Underhill, David M.] Cedars Sinai Med Ctr, Dept Med, Karsh Div Gastroenterol & Hepatol, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Underhill, DM (corresponding author), Cedars Sinai Med Ctr, Dept Biomed Sci, Res Div Immunol, Los Angeles, CA 90048 USA.; Underhill, DM (corresponding author), Cedars Sinai Med Ctr, F Widjaja Fdn, Inflammatory Bowel & Immunobiol Res Inst, Los Angeles, CA 90048 USA.; Underhill, DM (corresponding author), Cedars Sinai Med Ctr, Dept Med, Karsh Div Gastroenterol & Hepatol, Los Angeles, CA 90048 USA.	david.underhill@csmc.edu						Balenga NA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7763; Cayrol C, 2018, NAT IMMUNOL, V19, P375, DOI 10.1038/s41590-018-0067-5; Chae WJ, 2016, IMMUNITY, V44, P246, DOI 10.1016/j.immuni.2016.01.008; Landers CT, 2019, J BIOL CHEM, V294, P8834, DOI 10.1074/jbc.RA118.006724; Naglik JR, 2019, CURR OPIN MICROBIOL, V52, P100, DOI 10.1016/j.mib.2019.06.002; Valero A, 2017, ALLERGY, V72, P1306, DOI 10.1111/all.13141; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wiesner DL, 2020, CELL HOST MICROBE, V27, P614, DOI 10.1016/j.chom.2020.02.006; Woolnough KF, 2017, CLIN EXP ALLERGY, V47, P48, DOI 10.1111/cea.12848; Wu YF, 2021, IMMUNITY, V54, P2595, DOI 10.1016/j.immuni.2021.08.009	10	1	1	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 9	2021	54	11					2442	2444		10.1016/j.immuni.2021.10.014	http://dx.doi.org/10.1016/j.immuni.2021.10.014		NOV 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WX1LS	34758334	Bronze			2022-12-18	WOS:000718366000003
J	Andrews, LP; Vignali, KM; Szymczak-Workman, AL; Burton, AR; Brunazzi, EA; Ngiow, SF; Harusato, A; Sharpe, AH; Wherry, EJ; Taniuchi, I; Workman, CJ; Vignali, DAA				Andrews, Lawrence P.; Vignali, Kate M.; Szymczak-Workman, Andrea L.; Burton, Amanda R.; Brunazzi, Erin A.; Ngiow, Shin Foong; Harusato, Akihito; Sharpe, Arlene H.; Wherry, E. John; Taniuchi, Ichiro; Workman, Creg J.; Vignali, Dario A. A.			A Cre-driven allele-conditioning line to interrogate CD4(+) conventional T cells	IMMUNITY			English	Article							EXPRESSION; CD8; DISRUPTION; THYMOCYTES; THYMUS; HELPER; LEADS	CD4(+) T cells share common developmental pathways with CD8(+) T cells, and upon maturation, CD4(+) T conventional T (Tconv) cells lack phenotypic markers that distinguish these cells from FoxP3(+) T regulatory cells. We developed a tamoxifen-inducible ThPOKCreERT2.hCD2 line with Frt sites inserted on either side of the CreERT2-hCD2 cassette, and a Foxp3(Ametrine-FlpO) strain, expressing Ametrine and FlpO in Foxp3(+) cells. Breeding these mice resulted in a CD4conv(iCreERT2-hCD2) line that allows for the specific manipulation of a gene in CD4(+) Tconv cells. As FlpO removes the CreERT2-hCD2 cassette, CD4(+) Treg cells are spared from Cre activity, which we refer to as allele conditioning. Comparison with an E8I(iCreERT2.GFP) mouse that enables inducible targeting of CD8(+) T cells, and deletion of two inhibitory receptors, PD-1 and LAG-3, in a melanoma model, support the fidelity of these lines. These engineered mouse strains present a resource for the temporal manipulation of genes in CD4(+) T cells and CD4(+) Tconv cells.	[Andrews, Lawrence P.; Vignali, Kate M.; Szymczak-Workman, Andrea L.; Brunazzi, Erin A.; Workman, Creg J.; Vignali, Dario A. A.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA; [Andrews, Lawrence P.; Vignali, Kate M.; Brunazzi, Erin A.; Workman, Creg J.; Vignali, Dario A. A.] UPMC Hillman Canc Ctr, Tumor Microenvironm Ctr, Pittsburgh, PA 15232 USA; [Burton, Amanda R.] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Ngiow, Shin Foong; Wherry, E. John] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Ngiow, Shin Foong; Wherry, E. John] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Harusato, Akihito; Taniuchi, Ichiro] RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Sharpe, Arlene H.] Harvard Med Sch, Blavatnik Inst, Dept Immunol, Boston, MA 02115 USA; [Vignali, Dario A. A.] UPMC Hillman Canc Ctr, Canc Immunol & Immunotherapy Program, Pittsburgh, PA 15232 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; St Jude Children's Research Hospital; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; RIKEN; Harvard University; Harvard Medical School	Vignali, DAA (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA.; Vignali, DAA (corresponding author), UPMC Hillman Canc Ctr, Tumor Microenvironm Ctr, Pittsburgh, PA 15232 USA.; Vignali, DAA (corresponding author), UPMC Hillman Canc Ctr, Canc Immunol & Immunotherapy Program, Pittsburgh, PA 15232 USA.	dvignali@pitt.edu	; Taniuchi, Ichiro/N-6399-2015	Andrews, Lawrence/0000-0002-4923-142X; Harusato, Akihito/0000-0001-9204-1819; Taniuchi, Ichiro/0000-0002-9853-9068	NIH [P01 AI108545, S10 OD011925-01, <LF>R01 CA203689<LF>R01 DK089125<LF>R01 AI129893<LF>R01 AI144422<LF>P01 AI56299<LF>AI105343<LF>AI155577<LF>AI149680]; Parker Institute for Cancer Immunotherapy; Cancer Immunology program at UPenn; Australia NHMRC C.J. Martin Fellowship [GNT1111469]; Mark Foundation Momentum Fellowship	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker Institute for Cancer Immunotherapy; Cancer Immunology program at UPenn; Australia NHMRC C.J. Martin Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Mark Foundation Momentum Fellowship	The authors would like to thank the Vignali lab (Vignali-lab.com; Twitter: @Vignali_Lab) for discussions and critically reading the manuscript. We thank A. MacIntyre, D. Falkner, N. Sheng, and H. Gunzelman from the Immunology Flow Core for cell sorting and the staff of the Division of Laboratory Animal Services for the animal husbandry. This study was supported by the NIH (P01 AI108545 to D.A.A.V., A.H.S., and E.J.W.; R01 CA203689, R01 DK089125, R01 AI129893, and R01 AI144422 to D.A.A.V.; P01 AI56299 to A.H.S.; AI105343, AI155577, and AI149680 to E.J.W.). E.J.W. is also supported by the Parker Institute for Cancer Immunotherapy, which supports the Cancer Immunology program at UPenn. S.F.N. is supported by an Australia NHMRC C.J. Martin Fellowship (GNT1111469) and the Mark Foundation Momentum Fellowship. This work benefitted from SPECIAL BD LSRFORTESSATM used the UPSOM Unified Flow Core funded by NIH S10 OD011925-01.	Becher B, 2018, IMMUNITY, V48, P835, DOI 10.1016/j.immuni.2018.05.002; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Cai D, 2013, NAT METHODS, V10, P540, DOI [10.1038/NMETH.2450, 10.1038/nmeth.2450]; Carow B, 2016, J IMMUNOL, V197, P2261, DOI 10.4049/jimmunol.1600827; Ellmeier W, 1997, IMMUNITY, V7, P537, DOI 10.1016/S1074-7613(00)80375-1; Ellmeier W, 1998, IMMUNITY, V9, P485, DOI 10.1016/S1074-7613(00)80632-9; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Han XM, 2021, CELL STEM CELL, V28, P1160, DOI 10.1016/j.stem.2021.01.007; Hernandez-Hoyos G, 2000, IMMUNITY, V12, P313, DOI 10.1016/S1074-7613(00)80184-3; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Hostert A, 1997, IMMUNITY, V7, P525, DOI 10.1016/S1074-7613(00)80374-X; Kakugawa K, 2017, CELL REP, V19, P1176, DOI 10.1016/j.celrep.2017.04.038; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Mucida D, 2013, NAT IMMUNOL, V14, P281, DOI 10.1038/ni.2523; Plummer NW, 2015, DEVELOPMENT, V142, P4385, DOI 10.1242/dev.129981; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Reis BS, 2013, NAT IMMUNOL, V14, P271, DOI 10.1038/ni.2518; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Seo W, 2017, SCI REP-UK, V7, DOI 10.1038/srep41351; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Szymczak AL, 2005, EXPERT OPIN BIOL TH, V5, P627, DOI 10.1517/14712598.5.5.627; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Takahama Y, 1998, EUR J IMMUNOL, V28, P2159, DOI 10.1002/(SICI)1521-4141(199807)28:07<2159::AID-IMMU2159>3.0.CO;2-B; Tan CL, 2021, J EXP MED, V218, DOI 10.1084/jem.20182232; Taniuchi I, 2018, ANNU REV IMMUNOL, V36, P579, DOI 10.1146/annurev-immunol-042617-053411; Wang L, 2008, IMMUNITY, V29, P876, DOI 10.1016/j.immuni.2008.09.019; Wu D, 2020, IMMUNOLOGY, V159, P231, DOI 10.1111/imm.13153; Zhang QX, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aah4569; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	35	1	1	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 12	2021	54	10					2209	+		10.1016/j.immuni.2021.08.029	http://dx.doi.org/10.1016/j.immuni.2021.08.029		OCT 2021	15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WG2VB	34551314	Bronze			2022-12-18	WOS:000706854100010
J	Collin, M; Bigley, V				Collin, Matthew; Bigley, Venetia			Many Langerhans make light work of skin immunity	IMMUNITY			English	Editorial Material							DENDRITIC CELLS; DISTINCT	The concept of functional specialization is fundamental to the immune system but has not been previously observed in human Langerhans cells. In this issue of Immunity, Liu et al. use single-cell approaches to define two distinct epidermal subsets converging on a common activation and migration pathway.	[Collin, Matthew; Bigley, Venetia] Newcastle Univ, Translat & Clin Res Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Collin, Matthew; Bigley, Venetia] Newcastle Tyne Hosp NHS Fdn Trust, Northern Ctr Canc, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England	Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Bigley, V (corresponding author), Newcastle Univ, Translat & Clin Res Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; Bigley, V (corresponding author), Newcastle Tyne Hosp NHS Fdn Trust, Northern Ctr Canc, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England.	venetia.bigley@ncl.ac.uk			Wellcome Trust, UK [101155/Z/13/Z, 219562/Z/19/Z]	Wellcome Trust, UK(Wellcome Trust)	This work was supported by grants from the Wellcome Trust, UK; 101155/Z/13/Z to V.B. and 219562/Z/19/Z to M.C.	Bertram KM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10697-w; Bigley V, 2015, J LEUKOCYTE BIOL, V97, P627, DOI 10.1189/jlb.1HI0714-351R; Byrd AL, 2018, NAT REV MICROBIOL, V16, P143, DOI 10.1038/nrmicro.2017.157; Capucha T, 2015, IMMUNITY, V43, P369, DOI 10.1016/j.immuni.2015.06.017; Cheng JB, 2018, CELL REP, V25, P871, DOI 10.1016/j.celrep.2018.09.006; Kaplan DH, 2017, NAT IMMUNOL, V18, P1068, DOI 10.1038/ni.3815; Liu XC, 2021, IMMUNITY, V54, P2305, DOI 10.1016/j.immuni.2021.08.012; Milne P, 2015, BLOOD, V125, P470, DOI 10.1182/blood-2014-08-593582; Reynolds G, 2021, SCIENCE, V371, P364, DOI 10.1126/science.aba6500; Wollenberg A, 1996, J INVEST DERMATOL, V106, P446, DOI 10.1111/1523-1747.ep12343596	10	1	1	4	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 12	2021	54	10					2188	2190		10.1016/j.immuni.2021.09.006	http://dx.doi.org/10.1016/j.immuni.2021.09.006		OCT 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WG2VB	34644554	Bronze			2022-12-18	WOS:000706854100007
J	Meng, X; Zeng, WW				Meng, Xia; Zeng, Wenwen			Fat mesenchyme closes the neural-ILC2 circuit	IMMUNITY			English	Editorial Material								The immune milieu and neuronal activity each impact adipose metabolic health, yet their interplay remains largely undefined. In a recent issue of Nature, Cardoso et al. uncover a sympathetic neuro-mesenchymal-ILC2s circuit from brain-to-fat controlling obesity and glucose metabolism.	[Meng, Xia; Zeng, Wenwen] Tsinghua Univ, Sch Med, Inst Immunol, Beijing 100084, Peoples R China; [Meng, Xia; Zeng, Wenwen] Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing 100084, Peoples R China; [Meng, Xia; Zeng, Wenwen] Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Meng, Xia; Zeng, Wenwen] Beijing Key Lab Immunol Res Chron Dis, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University	Zeng, WW (corresponding author), Tsinghua Univ, Sch Med, Inst Immunol, Beijing 100084, Peoples R China.; Zeng, WW (corresponding author), Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing 100084, Peoples R China.; Zeng, WW (corresponding author), Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China.; Zeng, WW (corresponding author), Beijing Key Lab Immunol Res Chron Dis, Beijing 100084, Peoples R China.	wenwenzeng@tsinghua.edu.cn	Zeng, Wenwen/D-7276-2017	Zeng, Wenwen/0000-0001-8544-3318	National Key R&D Program of China [2017YFA0505800]; National Natural Science Foundation of China [31822018, 31770936, 91742106]; Center for Life Sciences; Institute for Immunology at Tsinghua University	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Center for Life Sciences; Institute for Immunology at Tsinghua University	W.Z. is supported by the National Key R&D Program of China (2017YFA0505800), the National Natural Science Foundation of China (31822018, 31770936, 91742106), the Center for Life Sciences, and the Institute for Immunology at Tsinghua University.	Cardoso F, 2021, NATURE, V597, P410, DOI 10.1038/s41586-021-03830-7; Chi JY, 2018, CELL METAB, V27, P226, DOI 10.1016/j.cmet.2017.12.011; Henriques F, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107998; Jiang HC, 2017, CELL METAB, V26, P686, DOI 10.1016/j.cmet.2017.08.016; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Moriyama S, 2018, SCIENCE, V359, P1056, DOI 10.1126/science.aan4829; Nguyen NLT, 2014, AM J PHYSIOL-REG I, V306, pR375, DOI 10.1152/ajpregu.00552.2013; Petkevicius K, 2021, MOL METAB, V48, DOI 10.1016/j.molmet.2021.101220; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Zhang X, 2020, NATURE, V581, P204, DOI 10.1038/s41586-020-2235-7	10	1	1	3	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 12	2021	54	10					2191	2193		10.1016/j.immuni.2021.09.012	http://dx.doi.org/10.1016/j.immuni.2021.09.012		OCT 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WG2VB	34644555	Bronze			2022-12-18	WOS:000706854100008
J	Piper, CJM; Mauri, C				Piper, Christopher J. M.; Mauri, Claudia			25-hydroxycholesterol: Gatekeeper of intestinal IgA	IMMUNITY			English	Editorial Material								High levels of cholesterol and diets high in fat are associated with immune dysfunction and inflammatory disease. In this issue of Immunity, Trindade et al. (2021) report how the cholesterol metabolite 25-hydroxycholesterol restrains IgA plasma cell differentiation from germinal-center B cells in the Peyer's patches through regulation of the sterol-sensing transcription factor SREBP2, independently of EBI2-mediated migration.	[Piper, Christopher J. M.; Mauri, Claudia] UCL, Div Infect & Immun & Transplantat, Ctr Rheumatol, London WC1E 6JF, England	University of London; University College London	Mauri, C (corresponding author), UCL, Div Infect & Immun & Transplantat, Ctr Rheumatol, London WC1E 6JF, England.	c.mauri@ucl.ac.uk	Mauri, Chiara/GXN-0766-2022	Mauri, Claudia/0000-0001-9761-2625				Bauman DR, 2009, P NATL ACAD SCI USA, V106, P16764, DOI 10.1073/pnas.0909142106; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Chiba K, 2005, PHARMACOL THERAPEUT, V108, P308, DOI 10.1016/j.pharmthera.2005.05.002; Choi C, 2020, METABOLITES, V10, DOI 10.3390/metabo10100384; Cui GL, 2011, J CLIN INVEST, V121, P658, DOI 10.1172/JCI42974; Cyster JG, 2014, NAT REV IMMUNOL, V14, P731, DOI 10.1038/nri3755; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; Kolodziejczyk AA, 2019, NAT REV MICROBIOL, V17, P742, DOI 10.1038/s41579-019-0256-8; Martinez-Medina M, 2014, GUT, V63, P116, DOI 10.1136/gutjnl-2012-304119; Trindade BC, 2021, IMMUNITY, V54, P2273, DOI 10.1016/j.immuni.2021.09.004	10	1	1	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 12	2021	54	10					2182	2185		10.1016/j.immuni.2021.09.017	http://dx.doi.org/10.1016/j.immuni.2021.09.017		OCT 2021	5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WG2VB	34644552	Bronze			2022-12-18	WOS:000706854100005
J	Hossain, DMS; Panda, AK; Manna, A; Mohanty, S; Bhattacharjee, P; Bhattacharyya, S; Saha, T; Chakraborty, S; Kar, RK; Das, T; Chatterjee, S; Sa, G				Hossain, Dewan Md Sakib; Panda, Abir K.; Manna, Argha; Mohanty, Suchismita; Bhattacharjee, Pushpak; Bhattacharyya, Sankar; Saha, Taniya; Chakraborty, Sreeparna; Kar, Rajiv K.; Das, Tanya; Chatterjee, Subhrangsu; Sa, Gaurisankar			RETRACTION: FoxP3 Acts as a Cotranscription Factor with STAT3 in Tumor-Induced Regulatory T Cells (Retraction of Vol 39, Pg 1057, 2013)	IMMUNITY			English	Retraction												gauri@jcbose.ac.in	Bhattacharyya, Sankar/GZH-3091-2022	Bhattacharyya, Sankar/0000-0002-3235-4220				Hossain DMS, 2013, IMMUNITY, V39, P1057, DOI 10.1016/j.immuni.2013.11.005	1	1	1	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 14	2021	54	9					2167	2167		10.1016/j.immuni.2021.08.008	http://dx.doi.org/10.1016/j.immuni.2021.08.008		SEP 2021	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UQ0VB		Bronze			2022-12-18	WOS:000695789800022
J	Spreckels, JE; Zhernakova, A				Spreckels, Johanne E.; Zhernakova, Alexandra			Milk and bugs educate infant immune systems	IMMUNITY			English	Editorial Material							GUT MICROBIOME	Immune-system maturation starts early in life, but studies investigating immune-system education in human infants remain scarce. In a recent issue of Cell, Henrick et al. study early gut microbiota and immune-system development in two infant cohorts. The authors describe that Bifidobacteria can use milk sugars to produce immunoregulatory compounds that induce immune tolerance and reduce intestinal inflammation.	[Spreckels, Johanne E.; Zhernakova, Alexandra] Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands	University of Groningen	Zhernakova, A (corresponding author), Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.	a.zhernakova@umcg.nl	Zhernakova, Alexandra/ABA-9372-2020	Spreckels, Johanne Elisabeth/0000-0002-8711-1736	European Research Council (ERC) [715772]; Dutch Research Council (NWO-VIDI) [016.178.056]	European Research Council (ERC)(European Research Council (ERC)European Commission); Dutch Research Council (NWO-VIDI)	We thank Katherine McIntyre for critically revising the manuscript. A.Z. is supported by the European Research Council (ERC starting grant 715772) and the Dutch Research Council (NWO-VIDI grant 016.178.056).	Al Nabhani Z, 2020, MUCOSAL IMMUNOL, V13, P183, DOI 10.1038/s41385-020-0257-y; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.05.012, 10.1016/j.chom.2015.04.004]; Ehrlich AM, 2020, BMC MICROBIOL, V20, DOI 10.1186/s12866-020-02023-y; Henrick BM, 2021, CELL, V184, P3884, DOI 10.1016/j.cell.2021.05.030; Lefebvre G, 2020, FRONT NUTR, V7, DOI 10.3389/fnut.2020.574459; Nguyen M, 2021, FRONT PEDIATR, V9, DOI 10.3389/fped.2021.618009; Sundblad V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00379; Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007; Wu BB, 2016, WORLD J PEDIATR, V12, P177, DOI 10.1007/s12519-015-0025-3; Yassour M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad0917	10	1	1	3	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 10	2021	54	8					1633	1635		10.1016/j.immuni.2021.07.013	http://dx.doi.org/10.1016/j.immuni.2021.07.013		AUG 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TZ6OI	34380062	Bronze, Green Published			2022-12-18	WOS:000684589700005
J	Wells, AI; Coyne, CB				Wells, Alexandra I.; Coyne, Carolyn B.			Uterine NK cell education: Learning the ropes in pregnancy	IMMUNITY			English	Editorial Material							CD94/NKG2A; RECEPTOR; MHC	The impact of inhibitory receptor NKG2A-mediated education on uterine NK (uNK) cell responsiveness to vascular remodeling on pregnancy outcomes has remained unclear. In this issue of Immunity, Shreeve et al. show that loss of NKG2A(+) uNK cells results in deficient vascularization and restricted fetal growth.	[Wells, Alexandra I.; Coyne, Carolyn B.] Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Duke University	Coyne, CB (corresponding author), Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	carolyn.coyne@duke.edu		Wells, Alexandra/0000-0001-8178-0376	NIH [T32-AI060525, F31-AI149866, AI081759, AI150151, AI145828, AI145296]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	A.I.W. is supported by NIH T32-AI060525 and NIH F31-AI149866, and C.B.C. is supported by NIH AI081759, AI150151, AI145828, and AI145296.	Apps R, 2009, IMMUNOLOGY, V127, P26, DOI 10.1111/j.1365-2567.2008.03019.x; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Hiby SE, 2004, J EXP MED, V200, P957, DOI 10.1084/jem.20041214; Horowitz A, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aag1672; Koopman LA, 2003, J EXP MED, V198, P1201, DOI 10.1084/jem.20030305; Kopcow HD, 2005, P NATL ACAD SCI USA, V102, P15563, DOI 10.1073/pnas.0507835102; Sharkey AM, 2015, J IMMUNOL, V195, P3026, DOI 10.4049/jimmunol.1501229; Shreeve N, 2021, IMMUNITY, V54, P1231, DOI 10.1016/j.immuni.2021.03.021; Trowsdale J, 2001, IMMUNITY, V15, P363, DOI 10.1016/S1074-7613(01)00197-2; Vance RE, 1998, J EXP MED, V188, P1841, DOI 10.1084/jem.188.10.1841	10	1	2	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 8	2021	54	6					1102	1104		10.1016/j.immuni.2021.05.009	http://dx.doi.org/10.1016/j.immuni.2021.05.009		JUN 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SP7ZL	34107267	Bronze			2022-12-18	WOS:000659882900003
J	Magnaye, KM; Lynch, SV				Magnaye, Kevin M.; Lynch, Susan V.			Fungus fuels mucosal wounds in Crohn's disease	IMMUNITY			English	Editorial Material								Intestinal microbiome perturbation characterizes Crohn's disease (CD), though specific contributors to pathophysiology remain elusive. In a recent issue of Science, Jain et al. showthat Debaryomyces hansenii impairs intestinal healing in mice via effects on type I interferon signaling and chemokine CCL5 expression in macrophages and that it is also prevalent in the inflamed mucosa of CD patients.	[Magnaye, Kevin M.; Lynch, Susan V.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Lynch, SV (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	susan.lynch@ucsf.edu			Crohn's and Colitis Foundation of American; Rainin Foundation	Crohn's and Colitis Foundation of American; Rainin Foundation	S.V.L.'s inflammatory bowel disease research program is funded by generous gifts from the Crohn's and Colitis Foundation of American and by the Rainin Foundation.	Alphonse N, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.624094; Arijs I, 2011, AM J GASTROENTEROL, V106, P748, DOI 10.1038/ajg.2011.27; Chassaing B, 2011, GASTROENTEROLOGY, V140, P1720, DOI 10.1053/j.gastro.2011.01.054; Jaeger N, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22164-6; Jain U, 2021, SCIENCE, V371, P1154, DOI 10.1126/science.abd0919; Murira A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00609; Oliveira SB, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2083; Singh SB, 2017, DIGEST DIS SCI, V62, P1486, DOI 10.1007/s10620-017-4589-8; Torres J, 2020, J CROHNS COLITIS, V14, P4, DOI 10.1093/ecco-jcc/jjz180; Wang MH, 2017, GASTROENTEROL CLIN N, V46, P449, DOI 10.1016/j.gtc.2017.05.002	10	1	1	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 11	2021	54	5					856	858		10.1016/j.immuni.2021.04.013	http://dx.doi.org/10.1016/j.immuni.2021.04.013		MAY 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SE4BY	33979584	Bronze			2022-12-18	WOS:000652019500005
J	Kohne, M; Beyer, M				Koehne, Maren; Beyer, Marc			ATAC-ing human tissue Treg cells	IMMUNITY			English	Editorial Material							REGULATORY T-CELLS; LANDSCAPE	What defines regulatory T (Treg) cells in healthy human tissues? In this issue of Immunity, Delacher et al. describe a human follicular helper T cell-like tissue-repair Treg cell signature governed by BATF based on chromatin accessibility data and link this on a transcriptome and protein level to important functional features like CCR8 expression.	[Koehne, Maren; Beyer, Marc] German Ctr Neurodegenerat Dis DZNE, Mol Immunol Neurodegenerat, D-53127 Bonn, Germany; [Beyer, Marc] German Ctr Neurodegenerat Dis DZNE, PRECISE Platform Single Cell Genom & Epigen, D-53127 Bonn, Germany; [Beyer, Marc] Univ Bonn, D-53127 Bonn, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn	Kohne, M; Beyer, M (corresponding author), German Ctr Neurodegenerat Dis DZNE, Mol Immunol Neurodegenerat, D-53127 Bonn, Germany.; Beyer, M (corresponding author), German Ctr Neurodegenerat Dis DZNE, PRECISE Platform Single Cell Genom & Epigen, D-53127 Bonn, Germany.; Beyer, M (corresponding author), Univ Bonn, D-53127 Bonn, Germany.	maren.koehne@dzne.de; marc.beyer@dzne.de						Coghill JM, 2013, BLOOD, V122, P825, DOI 10.1182/blood-2012-06-435735; De Simone M, 2016, IMMUNITY, V45, P1135, DOI 10.1016/j.immuni.2016.10.021; Delacher M, 2021, IMMUNITY, V54, P702, DOI 10.1016/j.immuni.2021.03.007; Delacher M, 2020, IMMUNITY, V52, P295, DOI 10.1016/j.immuni.2019.12.002; Delacher M, 2017, NAT IMMUNOL, V18, P1160, DOI 10.1038/ni.3799; Hayatsu N, 2017, IMMUNITY, V47, P268, DOI 10.1016/j.immuni.2017.07.008; James KR, 2020, NAT IMMUNOL, V21, P343, DOI 10.1038/s41590-020-0602-z; Miragaia RJ, 2019, IMMUNITY, V50, P493, DOI 10.1016/j.immuni.2019.01.001; Plitas G, 2016, IMMUNITY, V45, P1122, DOI 10.1016/j.immuni.2016.10.032; Satpathy AT, 2019, NAT BIOTECHNOL, V37, P925, DOI 10.1038/s41587-019-0206-z	10	1	1	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 13	2021	54	4					605	607		10.1016/j.immuni.2021.03.014	http://dx.doi.org/10.1016/j.immuni.2021.03.014		APR 2021	4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RN1GO	33852825	Bronze			2022-12-18	WOS:000640102800002
J	Qian, LJ; Guo, TN				Qian, Liujia; Guo, Tiannan			Immunometabolism the CyTOF way	IMMUNITY			English	Editorial Material							MASS CYTOMETRY; SINGLE	In this issue of Immunity, Levine et al. report a CyTOF-based approach for the analyses of CD8(+) T cells metabolic changes at the single-cell level. This approach identified a transition state early in T cell activation that is characterized by high glycolytic and oxidative activity, providing new insight into the metabolic changes that underlie the transition to effector and memory T cell fates.	[Qian, Liujia; Guo, Tiannan] Westlake Univ, Sch Life Sci, Key Lab Struct Biol Zhejiang Prov, Hangzhou 310024, Peoples R China; [Qian, Liujia; Guo, Tiannan] Ctr Infect Dis Res, Westlake Lab Life Sci & Biomed, Hangzhou 310024, Peoples R China; [Qian, Liujia; Guo, Tiannan] Westlake Inst Adv Study, Inst Basic Med Sci, Hangzhou 310024, Peoples R China	Westlake University; Westlake University	Guo, TN (corresponding author), Westlake Univ, Sch Life Sci, Key Lab Struct Biol Zhejiang Prov, Hangzhou 310024, Peoples R China.; Guo, TN (corresponding author), Ctr Infect Dis Res, Westlake Lab Life Sci & Biomed, Hangzhou 310024, Peoples R China.; Guo, TN (corresponding author), Westlake Inst Adv Study, Inst Basic Med Sci, Hangzhou 310024, Peoples R China.	guotiannan@westlake.edu.cn	liu, qian/HDM-2936-2022; Qian, Liu/GYU-5886-2022		National Key R&D Program of China [2020YFE0202200]; National Natural Science Foundation of China [81972492]; Zhejiang Provincial Natural Science Foundation for Distinguished Young Scholars [LR19C050001]; Hangzhou Agriculture and Society Advancement Program [20190101A04]; Westlake Education Foundation	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation for Distinguished Young Scholars; Hangzhou Agriculture and Society Advancement Program; Westlake Education Foundation	We thank Dr O.L. Kon for editing. Our research is supported by grants from the National Key R&D Program of China (no. 2020YFE0202200), the National Natural Science Foundation of China (81972492), Zhejiang Provincial Natural Science Foundation for Distinguished Young Scholars (LR19C050001), Hangzhou Agriculture and Society Advancement Program (20190101A04), and Westlake Education Foundation.	Ahl PJ, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-1027-9; Artyomov MN, 2020, CELL METAB, V32, P710, DOI 10.1016/j.cmet.2020.09.013; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Cong YZ, 2021, CHEM SCI, V12, P1001, DOI 10.1039/d0sc03636f; Fessenden M, 2016, NATURE, V540, P153, DOI 10.1038/540153a; Hartmann FJ, 2021, NAT BIOTECHNOL, V39, DOI 10.1038/s41587-020-0651-8; Levine LS, 2021, IMMUNITY, V54, P829, DOI 10.1016/j.immuni.2021.02.018; Spitzer MH, 2016, CELL, V165, P780, DOI 10.1016/j.cell.2016.04.019	9	1	1	3	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 13	2021	54	4					610	613		10.1016/j.immuni.2021.03.019	http://dx.doi.org/10.1016/j.immuni.2021.03.019		APR 2021	5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RN1GO	33852827	Bronze			2022-12-18	WOS:000640102800004
J	Wu, JJ; Yan, N				Wu, Jianjun; Yan, Nan			A "KU'' new sensor for cytosolic DNA in T cells	IMMUNITY			English	Editorial Material								Adaptive immune cells are usually not equipped with pattern recognition receptors. In this issue of Immunity, Wang et al. revealed an "innate-like'' cytosolic DNA-sensing mechanism by the KU complex in aged CD4(+) T cells, which exacerbates aging-related autoimmunity.	[Wu, Jianjun; Yan, Nan] Univ Texas Southwestern Med Sch, Dept Immunol, Dallas, TX 75390 USA; [Yan, Nan] Univ Texas Southwestern Med Sch, Dept Microbiol, Dallas, TX 75390 USA		Yan, N (corresponding author), Univ Texas Southwestern Med Sch, Dept Immunol, Dallas, TX 75390 USA.; Yan, N (corresponding author), Univ Texas Southwestern Med Sch, Dept Microbiol, Dallas, TX 75390 USA.	nan.yan@utsouthwestern.edu		Wu, Jianjun/0000-0003-4518-8361				Burleigh K, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aba4219; Ferguson BJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00047; Peters NE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003649; Scutts SR, 2018, CELL REP, V25, P1953, DOI 10.1016/j.celrep.2018.10.034; Vance RE, 2016, IMMUNITY, V45, P227, DOI 10.1016/j.immuni.2016.08.006; Wang Y, 2021, IMMUNITY, V54, P632, DOI 10.1016/j.immuni.2021.02.003; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048; Zhang X, 2011, J IMMUNOL, V186, P4541, DOI 10.4049/jimmunol.1003389	8	1	1	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 13	2021	54	4					603	605		10.1016/j.immuni.2021.03.017	http://dx.doi.org/10.1016/j.immuni.2021.03.017		APR 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RN1GO	33852824	Bronze			2022-12-18	WOS:000640102800001
J	Christgen, S; Kanneganti, TD				Christgen, Shelbi; Kanneganti, Thirumala-Devi			Sepsis take-out: Inhibiting bacterial deliveries	IMMUNITY			English	Editorial Material							HEPARIN	Sepsis remains a deadly disease with limited treatment options. In this issue of Immunity, Tang et al. propose that heparin provides protection during gram-negative sepsis by dampening harmful CASP11-dependent signaling through inhibition of HMGB1- and heparanase-mediated cytosolic delivery of LPS.	[Christgen, Shelbi; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, MS 351,262 Danny Thomas Pl, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA.; Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, MS 351,262 Danny Thomas Pl, Memphis, TN 38105 USA.	thirumala-devi.kanneganti@stjude.org	Kanneganti, Thirumala-Devi/Y-2503-2019	Kanneganti, Thirumala-Devi/0000-0002-6395-6443				Deng MH, 2018, IMMUNITY, V49, P740, DOI 10.1016/j.immuni.2018.08.016; Karki R, 2021, CELL, V184, P149, DOI 10.1016/j.cell.2020.11.025; Li L, 2015, CYTOKINE, V72, P36, DOI 10.1016/j.cyto.2014.12.010; Li X, 2017, BRIT J HAEMATOL, V179, P389, DOI 10.1111/bjh.14885; Man SM, 2017, IMMUNOL REV, V277, P61, DOI 10.1111/imr.12534; Man SM, 2016, CELL, V167, P382, DOI 10.1016/j.cell.2016.09.012; Stowe I, 2015, IMMUNOL REV, V265, P75, DOI 10.1111/imr.12292; Tang YT, 2021, IMMUNITY, V54, P454, DOI 10.1016/j.immuni.2021.01.007; van der Poll T, 2017, NAT REV IMMUNOL, V17, P407, DOI 10.1038/nri.2017.36; Yang XY, 2019, IMMUNITY, V51, P983, DOI 10.1016/j.immuni.2019.11.005	10	1	1	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 9	2021	54	3					399	401		10.1016/j.immuni.2021.02.010	http://dx.doi.org/10.1016/j.immuni.2021.02.010		MAR 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RU	33691128	Green Accepted, Bronze			2022-12-18	WOS:000627409300006
J	Shoukry, NH; Turcotte, S				Shoukry, Naglaa H.; Turcotte, Simon			Cancer immunotherapy: Macs in the middle	IMMUNITY			English	Editorial Material							LIVER	Response to immune checkpoint blockade cancer immunotherapy is variable, but the mechanisms that underlie this variability remain unclear. In a recent issue of Nature Medicine, Yu et al. demonstrate that liver metastases limit immunotherapy efficacy by promoting macrophage-mediated elimination of tumor-specific CD8(+) T cells. Liver-directed radiotherapy in preclinical models could partially overcome this effect.	[Shoukry, Naglaa H.; Turcotte, Simon] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada; [Shoukry, Naglaa H.; Turcotte, Simon] Inst Canc Montreal, Montreal, PQ, Canada; [Shoukry, Naglaa H.] Univ Montreal, Fac Med, Dept Med, Montreal, PQ, Canada; [Turcotte, Simon] Ctr Hosp Univ Montreal, Serv Chirurg Hepatobiliaire & Pancreat & Transpla, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Shoukry, NH (corresponding author), Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada.; Shoukry, NH (corresponding author), Inst Canc Montreal, Montreal, PQ, Canada.; Shoukry, NH (corresponding author), Univ Montreal, Fac Med, Dept Med, Montreal, PQ, Canada.	naglaa.shoukry@umontreal.ca						Cassetta L, 2018, NAT REV DRUG DISCOV, V17, P887, DOI 10.1038/nrd.2018.169; Crispe IN, 2000, IMMUNOL REV, V174, P47, DOI 10.1034/j.1600-0528.2002.017412.x; Kubes P, 2018, ANNU REV IMMUNOL, V36, P247, DOI 10.1146/annurev-immunol-051116-052415; Lee JC, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aba0759; MacParland SA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06318-7; Ramachandran P, 2019, NATURE, V575, P512, DOI 10.1038/s41586-019-1631-3; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; ROSENBERG SA, 1986, SCIENCE, V233, P1318, DOI 10.1126/science.3489291; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Yu JL, 2021, NAT MED, V27, P152, DOI 10.1038/s41591-020-1131-x	10	1	1	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 9	2021	54	3					409	411		10.1016/j.immuni.2021.02.012	http://dx.doi.org/10.1016/j.immuni.2021.02.012		MAR 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RU	33691132	Bronze			2022-12-18	WOS:000627409300010
J	Stephen-Victor, E; Cui, Y; Wang, ZW; Benamar, M; Charbonnier, LM; Chatila, TA				Stephen-Victor, Emmanuel; Cui, Ye; Wang, Ziwei; Benamar, Mehdi; Charbonnier, Louis-Marie; Chatila, Talal A.			Essential functions of regulatory T cell TGF-beta 1 revealed by differential gene-targeting approaches	IMMUNITY			English	Letter									[Stephen-Victor, Emmanuel; Cui, Ye; Wang, Ziwei; Benamar, Mehdi; Charbonnier, Louis-Marie; Chatila, Talal A.] Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Stephen-Victor, Emmanuel; Cui, Ye; Benamar, Mehdi; Charbonnier, Louis-Marie; Chatila, Talal A.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Chatila, TA (corresponding author), Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA.; Chatila, TA (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.	talal.chatila@childrens.harvard.edu	Stephen Victor, Emmanuel/HDN-0252-2022	Stephen Victor, Emmanuel/0000-0001-5049-7017; Benamar, Mehdi/0000-0003-1532-8642	NIH NIAID [5R01AI1269151, 5R01AI085090]	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH NIAID grants 5R01AI1269151 and 5R01AI085090 (T.A.C.).	[Anonymous], TITLE ERROR, DOI 10.1016/j.bbi.2019.12.019; Azhar M, 2009, GENESIS, V47, P423, DOI 10.1002/dvg.20516; Turner JA, 2020, IMMUNITY, V53, P1202, DOI [10.1016/j.immuni.2020.10.002, 10.1016/j.immuni.2020.11.011]	3	1	1	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 9	2021	54	3					397	398		10.1016/j.immuni.2021.02.005	http://dx.doi.org/10.1016/j.immuni.2021.02.005		MAR 2021	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RU	33691127	Bronze, Green Accepted			2022-12-18	WOS:000627409300005
J	Jardine, L; Haniffa, M				Jardine, Laura; Haniffa, Muzlifah			Human lung macrophages: roll up for the MISTRG tour	IMMUNITY			English	Editorial Material							CELLS; LIFE	The human lung harbors diverse macrophages that provide barrier immunity and maintain homeostasis, but their precursors are unclear. In this issue of Immunity, Evren et al. use a humanized mouse model to discern that classical monocytes give rise to alveolar and interstitial macrophages, whereas non-classical monocytes contribute to pulmonary intravascular macrophages.	[Jardine, Laura; Haniffa, Muzlifah] Newcastle Univ, Biosci Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Jardine, Laura] Newcastle Upon Tyne Hosp NHS Fdn Trust, Freeman Hosp, Dept Haematol, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; [Haniffa, Muzlifah] Newcastle Upon Tyne Hosp NHS Fdn Trust, Dept Dermatol, Newcastle Upon Tyne NE2 4LP, Tyne & Wear, England; [Haniffa, Muzlifah] Newcastle Upon Tyne Hosp NHS Fdn Trust, NIHR Newcastle Biomed Res Ctr, Newcastle Upon Tyne NE2 4LP, Tyne & Wear, England; [Haniffa, Muzlifah] Wellcome Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England	Newcastle University - UK; Newcastle Freeman Hospital; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Wellcome Trust Sanger Institute	Jardine, L; Haniffa, M (corresponding author), Newcastle Univ, Biosci Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; Jardine, L (corresponding author), Newcastle Upon Tyne Hosp NHS Fdn Trust, Freeman Hosp, Dept Haematol, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England.; Haniffa, M (corresponding author), Newcastle Upon Tyne Hosp NHS Fdn Trust, Dept Dermatol, Newcastle Upon Tyne NE2 4LP, Tyne & Wear, England.; Haniffa, M (corresponding author), Newcastle Upon Tyne Hosp NHS Fdn Trust, NIHR Newcastle Biomed Res Ctr, Newcastle Upon Tyne NE2 4LP, Tyne & Wear, England.; Haniffa, M (corresponding author), Wellcome Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England.	laura.jardine@ncl.ac.uk; m.a.haniffa@ncl.ac.uk						Byrneee AJ, 2020, J EXP MED, V217, DOI 10.1084/jem.20191236; Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964; Desch AN, 2016, AM J RESP CRIT CARE, V193, P614, DOI 10.1164/rccm.201507-1376OC; Evren E, 2021, IMMUNITY, V54, P259, DOI 10.1016/j.immuni.2020.12.003; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Guilliams M, 2020, IMMUNITY, V52, P434, DOI 10.1016/j.immuni.2020.02.015; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Jardine L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09913-4; Patel AA, 2017, J EXP MED, V214, P1913, DOI 10.1084/jem.20170355; Rongvaux A, 2014, NAT BIOTECHNOL, V32, P364, DOI 10.1038/nbt.2858	10	1	1	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 9	2021	54	2					194	196		10.1016/j.immuni.2021.01.006	http://dx.doi.org/10.1016/j.immuni.2021.01.006		FEB 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RE	33567257	Bronze			2022-12-18	WOS:000627407700002
J	Jongsma, MLM; de Waard, AA; Raaben, M; Zhang, T; Cabukusta, B; Platzer, R; Blomen, VA; Xagara, A; Verkerk, T; Bliss, S; Kong, XR; Gerke, C; Janssen, L; Stickel, E; Holst, S; Plomp, R; Mulder, A; Ferrone, S; Claas, FHJ; Heemskerk, MHM; Griffioen, M; Halenius, A; Overkleeft, H; Huppa, JB; Wuhrer, M; Brummelkamp, TR; Neefjes, J; Spaapen, RM				Jongsma, Marlieke L. M.; de Waard, Antonius A.; Raaben, Matthijs; Zhang, Tao; Cabukusta, Birol; Platzer, Rene; Blomen, Vincent A.; Xagara, Anastasia; Verkerk, Tamara; Bliss, Sophie; Kong, Xiangrui; Gerke, Carolin; Janssen, Lennert; Stickel, Elmer; Holst, Stephanie; Plomp, Rosina; Mulder, Arend; Ferrone, Soldano; Claas, Frans H. J.; Heemskerk, Mirjam H. M.; Griffioen, Marieke; Halenius, Anne; Overkleeft, Hermen; Huppa, Johannes B.; Wuhrer, Manfred; Brummelkamp, Thijn R.; Neefjes, Jacques; Spaapen, Robbert M.			The SPPL3-defined glycosphingolipid repertoire orchestrates HLA class I-mediated immune responses (vol 54, 132.e1, 2021)	IMMUNITY			English	Correction												r.spaapen@sanquin.nl	Neefjes, Jacques J.C./H-8780-2017; Heemskerk, Mirjam H.M./ABI-2336-2020; Wuhrer, Manfred/ABE-9168-2020; Huppa, Johannes Bernhard/AAY-9471-2021	Neefjes, Jacques J.C./0000-0001-6763-2211; Heemskerk, Mirjam H.M./0000-0001-6320-9133; Wuhrer, Manfred/0000-0002-0814-4995; Huppa, Johannes Bernhard/0000-0003-2634-8198				Jongsma MLM, 2021, IMMUNITY, V54, P132, DOI 10.1016/j.immuni.2020.11.003	1	1	1	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 9	2021	54	2					387	387		10.1016/j.immuni.2021.01.016	http://dx.doi.org/10.1016/j.immuni.2021.01.016		FEB 2021	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RE	33567263	Bronze, Green Submitted, Green Published			2022-12-18	WOS:000627407700019
J	Matteoli, M; Pozzi, D				Matteoli, Michela; Pozzi, Davide			Feeling depressed? Keep calm, and watch microglia	IMMUNITY			English	Editorial Material							INFLAMMATION; INTERLEUKIN-6; AVERSION	The immune system actively regulates brain activity through the engagement of immune cells and immunomodulatory molecules. In this issue of Immunity, Klawonn et al. show that the activation of microglia in the striatum triggers an IL-6-mediated autocrine loop and the release of prostaglandins, which in turn induce a negative affective state via the stimulation of medium spiny neurons.	[Matteoli, Michela; Pozzi, Davide] Humanitas Clin & Res Ctr IRCCS, Milan, Italy; [Matteoli, Michela] CNR Inst Neurosci, Milan, Italy; [Pozzi, Davide] Humanitas Univ, Dept Biomed Sci, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); Humanitas University	Matteoli, M; Pozzi, D (corresponding author), Humanitas Clin & Res Ctr IRCCS, Milan, Italy.; Matteoli, M (corresponding author), CNR Inst Neurosci, Milan, Italy.; Pozzi, D (corresponding author), Humanitas Univ, Dept Biomed Sci, Milan, Italy.	michela.matteoli@hunimed.eu; davide.pozzi@humanitasresearch.it	Pozzi, Davide/A-7021-2016; Matteoli, Michela/K-4526-2018	Pozzi, Davide/0000-0001-6436-0556; Matteoli, Michela/0000-0002-3569-7843	PRIN (Ministero dell'Istruzione, dell'Universita e della Ricerca) [2017A9MK4R]; Regione Lombardia "NeOn'' POR-FESR 2014-2020 [239047]; Ministry of Health (Ministero della Salute) [RF-201602361571]; FISM [2019/R-Single/032]; CARIPLO Foundation [20191973]; Telethon Foundation [GGP19226A]; Fondazione Pisa [107/16]	PRIN (Ministero dell'Istruzione, dell'Universita e della Ricerca); Regione Lombardia "NeOn'' POR-FESR 2014-2020; Ministry of Health (Ministero della Salute); FISM(Fondazione Italiana Sclerosi Multipla (FISM)); CARIPLO Foundation(Fondazione Cariplo); Telethon Foundation(Fondazione Telethon); Fondazione Pisa	Work in our lab is supported by PRIN (Ministero dell'Istruzione, dell'Universita e della Ricerca, 2017A9MK4R); Regione Lombardia "NeOn'' POR-FESR 2014-2020, ID 239047, Fondazione Pisa 107/16; Ministry of Health (Ministero della Salute RF-201602361571); FISM (2019/R-Single/032) to M.M.; and CARIPLO Foundation 20191973 and Telethon Foundation GGP19226A to D.	Beurel E, 2020, NEURON, V107, P234, DOI 10.1016/j.neuron.2020.06.002; Campbell IL, 2014, J NEUROSCI, V34, P2503, DOI 10.1523/JNEUROSCI.2830-13.2014; Choi KW, 2021, J PSYCHIATR RES, V133, P73, DOI 10.1016/j.jpsychires.2020.12.011; Eisenberger NI, 2010, BRAIN BEHAV IMMUN, V24, P558, DOI 10.1016/j.bbi.2009.12.009; Fritz M, 2016, J CLIN INVEST, V126, P695, DOI 10.1172/JCI83844; Klawonn AM, 2021, IMMUNITY, V54, P225, DOI 10.1016/j.immuni.2020.12.016; Nerurkar L, 2019, LANCET PSYCHIAT, V6, P164, DOI 10.1016/S2215-0366(18)30255-4; Salter MW, 2017, NAT MED, V23, P1018, DOI 10.1038/nm.4397; Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4; Sbolli M, 2020, EUR J HEART FAIL, V22, P2007, DOI 10.1002/ejhf.1865; Verharen JPH, 2020, CURR OPIN NEUROBIOL, V64, P46, DOI 10.1016/j.conb.2020.02.002	11	1	1	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 9	2021	54	2					191	193		10.1016/j.immuni.2021.01.010	http://dx.doi.org/10.1016/j.immuni.2021.01.010		FEB 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RE	33567256	Bronze			2022-12-18	WOS:000627407700001
J	Camell, CD				Camell, Christina D.			Taa Cells and Granzyme K: Old Players with New Tricks	IMMUNITY			English	Editorial Material								Inflammaging is associated with chronic diseases, but tissue-specific changes in the immune system remain unknown. In this issue of Immunity, Mogilenko et al. use single-cell RNA sequencing, flow cytometry, and mass cytometry to describe age-related differences, including the accumulation of age-associated T cells that contribute to inflammaging.	[Camell, Christina D.] Univ Minnesota, Inst Biol Aging & Metab, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Camell, CD (corresponding author), Univ Minnesota, Inst Biol Aging & Metab, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	ccamell@umn.edu			National Institute of Health (NIH) (National Institute on Aging) [RO1 AG063543-02S1, R00 AG058800]; Medical Discovery Team on the Biology of Aging; Fesler-Lampert Chair in Aging Studies	National Institute of Health (NIH) (National Institute on Aging); Medical Discovery Team on the Biology of Aging; Fesler-Lampert Chair in Aging Studies	This work was supported by National Institute of Health (NIH) grants RO1 AG063543-02S1 (National Institute on Aging) and R00 AG058800 (National Institute on Aging), the Medical Discovery Team on the Biology of Aging, and the Fesler-Lampert Chair in Aging Studies. The figure was created with BioRender.com.	Bordon Y, 2019, NAT REV IMMUNOL, V19, P476, DOI 10.1038/s41577-019-0193-9; Bovenschen N, 2010, IMMUNOL REV, V235, P117, DOI 10.1111/j.0105-2896.2010.00889.x; Camell CD, 2017, NATURE, V550, P119, DOI 10.1038/nature24022; Fagnoni FF, 1996, IMMUNOLOGY, V88, P501, DOI 10.1046/j.1365-2567.1996.d01-689.x; Franceschi C, 2018, SEMIN IMMUNOL, V40, P1, DOI 10.1016/j.smim.2018.10.008; Kale A, 2020, IMMUN AGEING, V17, DOI 10.1186/s12979-020-00187-9; Lages CS, 2010, AGING CELL, V9, P785, DOI 10.1111/j.1474-9726.2010.00611.x; Mogilenko DA, 2021, IMMUNITY, V54, P99, DOI 10.1016/j.immuni.2020.11.005; Schaum N, 2020, NATURE, V583, P596, DOI 10.1038/s41586-020-2499-y	9	1	1	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 12	2021	54	1					6	8		10.1016/j.immuni.2020.12.008	http://dx.doi.org/10.1016/j.immuni.2020.12.008		JAN 2021	4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PS3GL	33440137	Bronze			2022-12-18	WOS:000607814000003
J	Nielsen, JR; Lazear, HM				Nielsen, Joshua R.; Lazear, Helen M.			Antiviral Effector RTP4 Bats against Flaviviruses	IMMUNITY			English	Editorial Material								Bats harbor diverse viruses and manifest distinct antiviral immune responses. Recently in Cell Host & Microbe, Boys et al. demonstrated that bat receptor transporter protein 4 (RTP4) is an innate antiviral effector that inhibits flavivirus replication, revealing an evolutionary arms race between flaviviruses and their hosts.	[Nielsen, Joshua R.; Lazear, Helen M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Lazear, HM (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.	helen.lazear@med.unc.edu						[Anonymous], 2019, VIRUSES BASEL, DOI [DOI 10.1146/annurev-virology-110615-042203, DOI 10.3390/V11030215]; Best SM, 2017, J VIROL, V91, DOI [10.1128/JVI.01970-16, 10.1128/jvi.01970-16]; Blitvich BJ, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060154; Boys I. N., 2020, CELL HOST MICROBE, V28, P712; Daugherty MD, 2012, ANNU REV GENET, V46, P677, DOI 10.1146/annurev-genet-110711-155522; Hayman DTS, 2016, ANNU REV VIROL, V3, P77, DOI 10.1146/annurev-virology-110615-042203; Letko M, 2020, NAT REV MICROBIOL, V18, P461, DOI 10.1038/s41579-020-0394-z; Pierson TC, 2020, NAT MICROBIOL, V5, P796, DOI 10.1038/s41564-020-0714-0; Van Valen L, 1973, EVOL THEORY, V1, P1	9	1	1	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2020	53	6					1133	1135		10.1016/j.immuni.2020.11.019	http://dx.doi.org/10.1016/j.immuni.2020.11.019			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9JT	33326764	Green Published, Bronze			2022-12-18	WOS:000599363300005
J	Baumgarth, N				Baumgarth, Nicole			Memory Lapses-Winning the Slow Race	IMMUNITY			English	Editorial Material								Pre-existing humoral immunity can impact immune responses to heterologous infections. In this issue of Immunity, Wong et al. reveal that memory B cells, while failing to re-enter the germinal center, create an affinity-restricted, diversified B cell repertoire for rapid plasma blast responses. Their findings have important implications to vaccine design.	[Baumgarth, Nicole] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Ctr Immunol & Infect Dis, Cty Rd 98 & Hutchison Dr, Davis, CA 95616 USA	University of California System; University of California Davis	Baumgarth, N (corresponding author), Univ Calif Davis, Dept Pathol Microbiol & Immunol, Ctr Immunol & Infect Dis, Cty Rd 98 & Hutchison Dr, Davis, CA 95616 USA.	nbaumgarth@ucdavis.edu						Baumgarth N, 2013, IMMUNOL REV, V255, P82, DOI 10.1111/imr.12094; Chen H, 2020, NATURE, V582, P421, DOI 10.1038/s41586-020-2262-4; DESTGROTH SF, 1966, J EXP MED, V124, P331, DOI 10.1084/jem.124.3.331; Ngono AE, 2018, ANNU REV IMMUNOL, V36, P279, DOI 10.1146/annurev-immunol-042617-053142; Shlomchik MJ, 2019, IMMUNOL REV, V288, P49, DOI 10.1111/imr.12744; Wong R, 2020, IMMUNITY, V53, P1078, DOI 10.1016/j.immuni.2020.09.001; Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914	7	1	1	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2020	53	5					902	904		10.1016/j.immuni.2020.10.017	http://dx.doi.org/10.1016/j.immuni.2020.10.017			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9ED	33207214	Bronze			2022-12-18	WOS:000599348200004
J	Cheadle, CE; Glencross, DA; Hawrylowicz, CM				Cheadle, Charlotte E.; Glencross, Drew A.; Hawrylowicz, Catherine M.			Allergens TRP a swITCH to Initiate Type 2 Immunity	IMMUNITY			English	Editorial Material							DERMAL DENDRITIC CELLS	Allergens induce type-2 immunity, but unresolved questions remain about initiation of this response. In this issue, Perner et al. propose that cutaneous activation of TRPV1(+) sensory neurons by protease allergens stimulates release of substance P to induce migration of Th2-skewing CD301b(+) DC to draining lymph nodes.	[Cheadle, Charlotte E.; Glencross, Drew A.; Hawrylowicz, Catherine M.] Kings Coll London, Sch Immunol & Microbial Sci, Asthma UK Ctr Allerg Mech Asthma, London SE1 9RT, England	University of London; King's College London	Hawrylowicz, CM (corresponding author), Kings Coll London, Sch Immunol & Microbial Sci, Asthma UK Ctr Allerg Mech Asthma, London SE1 9RT, England.	catherine.hawrylowicz@kcl.ac.uk	; Hawrylowicz, Catherine/Q-8483-2017	Cheadle, Charlotte/0000-0002-0293-1840; Hawrylowicz, Catherine/0000-0002-2337-7463	Newton Fund -Thailand partnership [527372388]; Asthma UK PhD studentship	Newton Fund -Thailand partnership; Asthma UK PhD studentship	C.E.C. is supported by an Institutional Links grant, ID 527372388, under the Newton Fund -Thailand partnership. D.A.G. is supported by an Asthma UK PhD studentship.	Belvisi MG, 2017, EUR RESPIR J, V50, DOI [10.1183/13993003.01357-2016, 10.1183/13993003.00579-2017]; Cohen JA, 2019, CELL, V178, P919, DOI 10.1016/j.cell.2019.06.022; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Kashem SW, 2015, IMMUNITY, V43, P515, DOI 10.1016/j.immuni.2015.08.016; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Perner C, 2020, IMMUNITY, V53, P1063, DOI 10.1016/j.immuni.2020.10.001; Reed CE, 2004, J ALLERGY CLIN IMMUN, V114, P997, DOI 10.1016/j.jaci.2004.07.060; Serhan N, 2019, NAT IMMUNOL, V20, P1435, DOI 10.1038/s41590-019-0493-z; Sokol CL, 2018, IMMUNITY, V49, P449, DOI 10.1016/j.immuni.2018.07.012	9	1	1	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2020	53	5					900	902		10.1016/j.immuni.2020.10.019	http://dx.doi.org/10.1016/j.immuni.2020.10.019			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9ED	33207213	Bronze			2022-12-18	WOS:000599348200003
J	Smith, P; Benezech, C				Smith, Peter; Benezech, Cecile			Creeping Fat in Crohn's Disease: Innocuous or innocuum?	IMMUNITY			English	Editorial Material								In Crohn's disease, the characteristic expansion of mesenteric tissue on sites of intestinal inflammation is known as creeping fat. In a recent issue of Cell, Ha et al. report that translocation of gut bacteria to the mesenteries is associated with the formation of creeping fat.	[Smith, Peter; Benezech, Cecile] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh EH16 4TJ, Midlothian, Scotland	University of Edinburgh	Benezech, C (corresponding author), Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh EH16 4TJ, Midlothian, Scotland.	cbenezec@ed.ac.uk			British Heart Foundation-University of Edinburgh PhD studentship [RE/18/5/3426]	British Heart Foundation-University of Edinburgh PhD studentship	P.S. is supported by a British Heart Foundation (RE/18/5/3426)-University of Edinburgh PhD studentship.	Anhe FF, 2020, NAT METAB, V2, P233, DOI 10.1038/s42255-020-0178-9; Benezech C, 2015, NAT IMMUNOL, V16, P819, DOI 10.1038/ni.3215; Chang J, 2017, GASTROENTEROLOGY, V153, P723, DOI 10.1053/j.gastro.2017.05.056; Crohn B.B., 1932, J AM MED ASS; Ha CWY, 2020, CELL, V183, P666, DOI 10.1016/j.cell.2020.09.009; Jackson-Jones LH, 2020, IMMUNITY, V52, P700, DOI 10.1016/j.immuni.2020.03.011; Massier L, 2020, GUT, V69, P1796, DOI 10.1136/gutjnl-2019-320118; Pastorelli L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00280; Randolph GJ, 2016, AM J PATHOL, V186, P3066, DOI 10.1016/j.ajpath.2016.07.026	9	1	1	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2020	53	5					905	907		10.1016/j.immuni.2020.10.018	http://dx.doi.org/10.1016/j.immuni.2020.10.018			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9ED	33207215	Bronze			2022-12-18	WOS:000599348200005
J	Effern, M; Holzel, M				Effern, Maike; Hoelzel, Michael			Not Sweet: Glucocorticoids from Intratumoral Myeloid Cells Disable T Cells	IMMUNITY			English	Editorial Material							ACTIVATION	In this issue, Acharya et al. demonstrate that glucocorticoids produced by macrophages and monocytes in the tumor microenvironment induce a dysfunctional CD8(+) T cell phenotype. Blocking myeloid glucocortico-genesis enhances tumor immune surveillance and responsiveness to immune checkpoint therapy.	[Effern, Maike; Hoelzel, Michael] Univ Bonn, Fac Med, Univ Hosp Bonn, Inst Expt Oncol IEO, D-53127 Bonn, Germany	University of Bonn	Holzel, M (corresponding author), Univ Bonn, Fac Med, Univ Hosp Bonn, Inst Expt Oncol IEO, D-53127 Bonn, Germany.	michael.hoelzel@ukbonn.de			Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [EXC2151-390873048]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	M.E. and M.H. were supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy-EXC2151-390873048.	Acharya N, 2020, IMMUNITY, V53, P658, DOI 10.1016/j.immuni.2020.08.005; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; Kurtulus S, 2019, IMMUNITY, V50, P181, DOI 10.1016/j.immuni.2018.11.014; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; San Phan T, 2019, GENES IMMUN, V20, P627, DOI 10.1038/s41435-019-0058-z; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Singer M, 2016, CELL, V166, P1500, DOI 10.1016/j.cell.2016.08.052; Xing KL, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0103-2; Yu BF, 2017, NAT IMMUNOL, V18, P573, DOI 10.1038/ni.3706	10	1	1	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2020	53	3					476	478		10.1016/j.immuni.2020.08.007	http://dx.doi.org/10.1016/j.immuni.2020.08.007			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NO9KZ	32937147	Bronze			2022-12-18	WOS:000569806100003
J	He, XY; Ng, D; Egeblad, M				He, Xue-Yan; Ng, David; Egeblad, Mikala			Gut Feelings Block the Flow: Microbiota Links Stress to Vascular Disease	IMMUNITY			English	Editorial Material								Stress is linked to negative outcomes in cardiovascular diseases but exactly why is unclear. In this issue of Immunity, Xu et al. report that stress elicits glucocorticoid-induced gut permeability, in turn triggering the expansion of a population of neutrophils that can stimulate vaso-occlusive episodes.	[He, Xue-Yan; Ng, David; Egeblad, Mikala] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Egeblad, M (corresponding author), Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA.	egeblad@cshl.edu	Egeblad, Mikala/GNP-0620-2022; He, Xue-Yan/AAK-8453-2021	He, Xue-Yan/0000-0001-5423-5997; Ng, David/0000-0001-8584-7558; Egeblad, Mikala/0000-0002-3371-1445				Adrover JM, 2019, IMMUNITY, V50, P390, DOI 10.1016/j.immuni.2019.01.002; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; Hedblom GA, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01991; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Nielsen MM, 2017, NAT REV IMMUNOL, V17, P733, DOI 10.1038/nri.2017.101; Porter L S, 2000, J Health Psychol, V5, P53, DOI 10.1177/135910530000500109; Tsigos C., 2016, STRESS ENDOCRINE PHY; Xu CL, 2020, IMMUNITY, V53, P417, DOI 10.1016/j.immuni.2020.06.025; Zhang DC, 2016, BLOOD, V127, P801, DOI 10.1182/blood-2015-09-618538; Zhang DC, 2015, NATURE, V525, P528, DOI 10.1038/nature15367	10	1	1	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2020	53	2					238	240		10.1016/j.immuni.2020.07.013	http://dx.doi.org/10.1016/j.immuni.2020.07.013			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NC4NX	32814021	Bronze			2022-12-18	WOS:000561190600003
J	Yang, TLB; Kim, BS				Yang, Ting-Lin B.; Kim, Brian S.			Scratching Beyond the Surface of Itchy Wounds	IMMUNITY			English	Editorial Material							RECEPTOR; NEURONS	In this issue of Immunity, Xu et al. reveal that dermal dendritic cells produce interleukin-31, which acts on neurons to promote wound itch. Their findings link itch associated with deeper wounds-wounds that extend beyond the epithelium-to the cells and cytokines that mediate wound healing.	[Yang, Ting-Lin B.; Kim, Brian S.] Washington Univ, Sch Med, Ctr Study Itch, St Louis, MO 63110 USA; [Yang, Ting-Lin B.; Kim, Brian S.] Washington Univ, Sch Med, Dept Med, Div Dermatol, St Louis, MO 63110 USA; [Kim, Brian S.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Kim, Brian S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Kim, BS (corresponding author), Washington Univ, Sch Med, Ctr Study Itch, St Louis, MO 63110 USA.; Kim, BS (corresponding author), Washington Univ, Sch Med, Dept Med, Div Dermatol, St Louis, MO 63110 USA.; Kim, BS (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.; Kim, BS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	briankim@wustl.edu	Kim, Brian/GZK-6649-2022	Kim, Brian/0000-0002-8100-7161				Cevikbas F, 2014, J ALLERGY CLIN IMMUN, V133, P448, DOI 10.1016/j.jaci.2013.10.048; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; Liu BY, 2016, P NATL ACAD SCI USA, V113, pE7572, DOI 10.1073/pnas.1606608113; Oetjen LK, 2017, CELL, V171, P217, DOI 10.1016/j.cell.2017.08.006; Ruzicka T, 2017, NEW ENGL J MED, V376, P826, DOI 10.1056/NEJMoa1606490; Stander S, 2020, NEW ENGL J MED, V382, P706, DOI 10.1056/NEJMoa1908316; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Wang F, 2020, IMMUNITY, V52, P753, DOI 10.1016/j.immuni.2020.04.008; Wilson SR, 2013, CELL, V155, P285, DOI 10.1016/j.cell.2013.08.057; Xu J., 2020, IMMUNITY, V52, P371	10	1	1	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2020	53	2					235	237		10.1016/j.immuni.2020.07.016	http://dx.doi.org/10.1016/j.immuni.2020.07.016			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NC4NX	32814020	Bronze			2022-12-18	WOS:000561190600002
J	Bohnert, V; Ritchie, C; Li, LY				Bohnert, Volker; Ritchie, Christopher; Li, Lingyin			IFN-Independent STING Signaling: Friend or Foe?	IMMUNITY			English	Editorial Material								In this issue, Wu et al. demonstrate the importance of the neglected interferon (IFN)-independent STING signaling axis in mice. They find that although this axis is important for antiviral HSV-1 resistance, it has a pro-cancer role by promoting T cell death.	[Bohnert, Volker; Ritchie, Christopher; Li, Lingyin] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Bohnert, Volker; Ritchie, Christopher; Li, Lingyin] Stanford Univ, Inst Chem Engn & Med Human Hlth ChEM H, Stanford, CA 94305 USA	Stanford University; Stanford University	Li, LY (corresponding author), Stanford Univ, Dept Biochem, Stanford, CA 94305 USA.; Li, LY (corresponding author), Stanford Univ, Inst Chem Engn & Med Human Hlth ChEM H, Stanford, CA 94305 USA.	lingyinl@stanford.edu		Ritchie, Christopher/0000-0001-9432-8602				Carozza JA, 2020, NAT CANCER, V1, P184, DOI 10.1038/s43018-020-0028-4; Cordova A.F., 2020, BIORXIV, DOI [10.1101/2020.04.15.043299, DOI 10.1101/2020.04.15.043299]; Du MJ, 2018, SCIENCE, V361, P704, DOI 10.1126/science.aat1022; Ergun SL, 2019, CELL, V178, P290, DOI 10.1016/j.cell.2019.05.036; Konno H, 2013, CELL, V155, P688, DOI 10.1016/j.cell.2013.09.049; Kranzusch PJ, 2015, MOL CELL, V59, P891, DOI 10.1016/j.molcel.2015.07.022; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Wu JJ, 2020, IMMUNITY, V53, P115, DOI 10.1016/j.immuni.2020.06.009; Yamashiro L.H., 2019, BIORXIV, DOI [10.1101/2019.12.12.874792, DOI 10.1101/2019.12.12.874792]	10	1	1	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 14	2020	53	1					8	10		10.1016/j.immuni.2020.06.021	http://dx.doi.org/10.1016/j.immuni.2020.06.021			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MN8UK	32668231	Bronze			2022-12-18	WOS:000551116800003
J	Vergani, S; Yuan, J				Vergani, Stefano; Yuan, Joan			B-1 Cells Carry the Memory of Neonatal Immune Imprinting	IMMUNITY			English	Editorial Material							SELECTION	Group A Streptococcus is a common pathogen that elicits a protective humoral response against the cell wall component GlcNAc. In this issue of Immunity, New et al. demonstrate the ability of long-lived B-1 cells to be programmed by microbial colonization and early life immunization to uniquely incorporate GlcNAc reactivity in mice, establishing their critical role in mediating neonatal immune imprinting.	[Vergani, Stefano; Yuan, Joan] Lund Univ, Dev Immunol Unit, Dept Mol Hematol, Dept Lab Med,Lund Stem Cell Ctr, S-22242 Lund, Sweden	Lund University	Yuan, J (corresponding author), Lund Univ, Dev Immunol Unit, Dept Mol Hematol, Dept Lab Med,Lund Stem Cell Ctr, S-22242 Lund, Sweden.	joan.yuan@med.lu.se	; Yuan, Joan/A-8185-2013	Vergani, Stefano/0000-0003-0524-5093; Yuan, Joan/0000-0001-9129-8356				Al Nabhani Z, 2020, MUCOSAL IMMUNOL, V13, P183, DOI 10.1038/s41385-020-0257-y; [Anonymous], TITLE ERROR, DOI 10.1016/j.bbi.2019.12.019; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Bunker JJ, 2015, IMMUNITY, V43, P541, DOI 10.1016/j.immuni.2015.08.007; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; Kearney JF, 2015, ANNU REV IMMUNOL, V33, P475, DOI 10.1146/annurev-immunol-032713-120140; Kreuk LSM, 2019, ELIFE, V8, DOI 10.7554/eLife.47015; Vanhee S, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aax4453; Xu XJ, 2020, P NATL ACAD SCI USA, V117, P3718, DOI 10.1073/pnas.1915247117; Yang Y, 2015, ELIFE, V4, DOI 10.7554/eLife.09083	10	1	1	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 14	2020	53	1					11	13		10.1016/j.immuni.2020.06.018	http://dx.doi.org/10.1016/j.immuni.2020.06.018			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MN8UK	32668222	Bronze			2022-12-18	WOS:000551116800004
J	Andrews, SF; Moir, S				Andrews, Sarah F.; Moir, Susan			T-bet(+) Memory B Cells Stay in Place	IMMUNITY			English	Editorial Material							BET; DIFFERENTIATION	Memory B cells (MBCs) expressing the transcription factor T-bet have been described in normal and dysregulated immune responses. In this issue of Immunity, Johnson et al. report that T-bet(+) MBCs, formed in response to a primary influenza infection, contribute to protective antibody titers and persist mainly in the spleen with restricted trafficking between tissues.	[Andrews, Sarah F.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Moir, Susan] NIAID, Lab Immunoregulat, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Moir, S (corresponding author), NIAID, Lab Immunoregulat, NIH, Bethesda, MD 20892 USA.	smoir@niaid.nih.gov			intramural research program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health	intramural research program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the intramural research program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.	Andrews SF, 2019, IMMUNITY, V51, P398, DOI 10.1016/j.immuni.2019.06.024; Austin JW, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aax0904; Barnett BE, 2016, J IMMUNOL, V197, P1017, DOI 10.4049/jimmunol.1500368; Jenks SA, 2018, IMMUNITY, V49, P725, DOI 10.1016/j.immuni.2018.08.015; Johrens K, 2005, HAEMATOLOGICA, V90, P1070; Johnson JL, 2020, IMMUNITY, V52, P842, DOI 10.1016/j.immuni.2020.03.020; Lau D, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aai8153; Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899; Piovesan D, 2017, CELL REP, V19, P461, DOI 10.1016/j.celrep.2017.03.060; Stone SL, 2019, IMMUNITY, V50, P1172, DOI 10.1016/j.immuni.2019.04.004	10	1	1	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2020	52	5					726	728		10.1016/j.immuni.2020.04.013	http://dx.doi.org/10.1016/j.immuni.2020.04.013			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR0EZ	32433944	Bronze			2022-12-18	WOS:000535371100004
J	Sixt, M; Lammermann, T				Sixt, Michael; Laemmermann, Tim			T Cells: Bridge-and-Channel Commute to the White Pulp	IMMUNITY			English	Editorial Material							MIGRATION	In contrast to lymph nodes, the lymphoid regions of the spleen-the white pulp-are located deep within the organ, yielding the trafficking paths of T cells in the white pulp largely invisible. In an intravital microscopy tour de force reported in this issue of Immunity, Chauveau et al. show that T cells perform unidirectional, perivascular migration through the enigmatic marginal zone bridging channels.	[Sixt, Michael] Inst Sci & Technol Austria IST Austria, Klosterneuburg, Austria; [Laemmermann, Tim] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany	Institute of Science & Technology - Austria; Max Planck Society	Sixt, M (corresponding author), Inst Sci & Technol Austria IST Austria, Klosterneuburg, Austria.; Lammermann, T (corresponding author), Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany.	sixt@ist.ac.at; laemmermann@ie-freiburg.mpg.de	Lämmermann, Tim/AAD-7453-2022	Sixt, Michael/0000-0002-6620-9179				Arnon TI, 2013, NATURE, V493, P684, DOI 10.1038/nature11738; Bajenoff M, 2008, J IMMUNOL, V181, P3947, DOI 10.4049/jimmunol.181.6.3947; BRELINSKA R, 1984, CELL TISSUE RES, V236, P661, DOI 10.1007/BF00217236; Chauveau A, 2020, IMMUNITY, V52, P794, DOI 10.1016/j.immuni.2020.03.010; Cyster JG., 2017, SCI IMMUNOL, V2; Herz J, 2012, MICROSC MICROANAL, V18, P730, DOI 10.1017/S1431927612000281; Lewis SM, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau6085; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; MITCHELL J, 1973, IMMUNOLOGY, V24, P93; Tadayon S, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aat0297	10	1	1	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2020	52	5					721	723		10.1016/j.immuni.2020.04.020	http://dx.doi.org/10.1016/j.immuni.2020.04.020			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR0EZ	32433942	Bronze			2022-12-18	WOS:000535371100002
J	Charbonneau, ME; O'Riordan, MXD				Charbonneau, Marie-Eve; O'Riordan, Mary X. D.			Reducing Stress PERKs up Anti-tumor Immunity	IMMUNITY			English	Editorial Material								Myeloid-derived suppressor cells (MDSCs) can promote tumor progression. In this issue of Immunity, Mohamed et al. show that the unfolded protein response sensor, PERK, enhances MDSC-mediated immunosuppression through the NRF2 transcription factor, preventing oxidative damage, mitochondrial DNA release, and DNA sensor-STING-dependent type I interferon production.	[Charbonneau, Marie-Eve; O'Riordan, Mary X. D.] Univ Michigan, Med Sch, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	O'Riordan, MXD (corresponding author), Univ Michigan, Med Sch, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	oriordan@umich.edu		O'Riordan, Mary/0000-0001-6014-4637	NIAID NIH HHS [R21 AI101777] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cubillos-Ruiz JR, 2017, CELL, V168, P692, DOI 10.1016/j.cell.2016.12.004; Cubillos-Ruiz JR, 2015, CELL, V161, P1527, DOI 10.1016/j.cell.2015.05.025; Dysthe M, 2020, ADV EXP MED BIOL, V1224, P117, DOI 10.1007/978-3-030-35723-8_8; Hetz C, 2018, MOL CELL, V69, P169, DOI 10.1016/j.molcel.2017.06.017; Mohamed E, 2020, IMMUNITY, V52, P668, DOI 10.1016/j.immuni.2020.03.004; Musella M, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1314424; Thevenot PT, 2014, IMMUNITY, V41, P389, DOI 10.1016/j.immuni.2014.08.015; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; Wu SJ, 2019, CANCER MED-US, V8, P2252, DOI 10.1002/cam4.2101	9	1	1	3	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 14	2020	52	4					575	577		10.1016/j.immuni.2020.03.012	http://dx.doi.org/10.1016/j.immuni.2020.03.012			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LE5TM	32294402	Bronze, Green Accepted			2022-12-18	WOS:000526782600002
J	Kokkinou, E; Mjosberg, J				Kokkinou, Efthymia; Mjosberg, Jenny			Tummy Time for ILC2	IMMUNITY			English	Editorial Material							CELLS	Little is known about host-microbiota interactions regulating anti-microbial immunity in the stomach. In this issue, Satoh-Takayama et al. describe an additional immune mechanism involving innate lymphoid cells type 2 (ILC2), which controls infection with Helicobacter pylori, a bacterium associated with inflammation and cancer.	[Kokkinou, Efthymia; Mjosberg, Jenny] Karolinska Inst, Dept Med, Ctr Infect Med, Stockholm, Sweden	Karolinska Institutet	Mjosberg, J (corresponding author), Karolinska Inst, Dept Med, Ctr Infect Med, Stockholm, Sweden.	jenny.mjosberg@ki.se						Beura LK, 2016, NATURE, V532, P512, DOI 10.1038/nature17655; Engstrand L, 2020, DIGEST DIS SCI, V65, P865, DOI 10.1007/s10620-020-06101-z; Huang YF, 2018, SCIENCE, V359, P114, DOI 10.1126/science.aam5809; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Kramer B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006373; Lehours P, 2019, HELICOBACTER, V24, DOI 10.1111/hel.12644; Li R, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/4927964; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Satoh-Takayama N, 2020, IMMUNITY, V52, P635, DOI 10.1016/j.immuni.2020.03.002	10	1	1	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 14	2020	52	4					573	575		10.1016/j.immuni.2020.03.008	http://dx.doi.org/10.1016/j.immuni.2020.03.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LE5TM	32294401	Bronze			2022-12-18	WOS:000526782600001
J	Blander, JM				Blander, J. Magarian			MerTK Blockade Fuels Anti-tumor Immunity	IMMUNITY			English	Editorial Material								Phagocytosis of apoptotic cells via the receptor MerTK is important for immune tolerance. In this issue of Immunity, Zhou et al. report that blockade of MerTK-mediated phagocytosis mobilizes anti-tumor immunity through a mechanism that involves the transport of tumor-derived cGAMP into macrophages via the ATP activated channel P2X7R.	[Blander, J. Magarian] Cornell Univ, Weill Cornell Med,Sandra & Edward Meyer Canc Ctr, Weill Cornell Grad Sch Med Sci,Joan & Sanford I W, Dept Microbiol & Immunol,Jill Roberts Inst Res In, New York, NY 10021 USA	Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Blander, JM (corresponding author), Cornell Univ, Weill Cornell Med,Sandra & Edward Meyer Canc Ctr, Weill Cornell Grad Sch Med Sci,Joan & Sanford I W, Dept Microbiol & Immunol,Jill Roberts Inst Res In, New York, NY 10021 USA.	jmblander@med.cornell.edu						Ablasser A, 2019, SCIENCE, V363, P1055, DOI 10.1126/science.aat8657; Feng MY, 2019, NAT REV CANCER, V19, P568, DOI 10.1038/s41568-019-0183-z; Labi V, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.20; O'Donnell JS, 2019, NAT REV CLIN ONCOL, V16, P151, DOI 10.1038/s41571-018-0142-8; Pitt JM, 2017, ADV EXP MED BIOL, V1036, P65, DOI 10.1007/978-3-319-67577-0_5; Roberts EW, 2016, CANCER CELL, V30, P324, DOI 10.1016/j.ccell.2016.06.003; Sachet M, 2017, APOPTOSIS, V22, P1189, DOI 10.1007/s10495-017-1413-z; Snyder AG, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw2004; Strauss L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aay1863	9	1	1	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 18	2020	52	2					212	214		10.1016/j.immuni.2020.01.015	http://dx.doi.org/10.1016/j.immuni.2020.01.015			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN8FZ	32075723	Bronze			2022-12-18	WOS:000515082000004
J	Chi, X; Bensinger, SJ				Chi, Xun; Bensinger, Steven J.			(Sterol)ized Immunity: Could PI3K/AKT3 Be the Answer?	IMMUNITY			English	Editorial Material							CHOLESTEROL-SYNTHESIS; 25-HYDROXYCHOLESTEROL	Type I interferons (IFNs) can reprogram the cholesterol biosynthetic pathway to facilitate innate immune responses. In this issue of Immunity, Xiao et al. (2020) reveal that type I IFN signaling and 7-dehydrocholesterol (7-DHC) accumulation form a positive feedback loop to amplify innate immune responses to control viral infections by activating AKT3.	[Chi, Xun; Bensinger, Steven J.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Bensinger, Steven J.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Bensinger, SJ (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.; Bensinger, SJ (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	sbensinger@mednet.ucla.edu						Blanc M, 2013, IMMUNITY, V38, P106, DOI 10.1016/j.immuni.2012.11.004; Blanc M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000598; Dang EV, 2017, CELL, V171, P1057, DOI 10.1016/j.cell.2017.09.029; Gong Y, 2006, CELL METAB, V3, P15, DOI 10.1016/j.cmet.2005.11.014; Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005; Reboldi A, 2014, SCIENCE, V345, P679, DOI 10.1126/science.1254790; Soccio RE, 2004, ARTERIOSCL THROM VAS, V24, P1150, DOI 10.1161/01.ATV.0000131264.66417.d5; Xiao J, 2020, IMMUNITY, V52, P109, DOI 10.1016/j.immuni.2019.11.015; York AG, 2015, CELL, V163, P1716, DOI 10.1016/j.cell.2015.11.045	9	1	1	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 14	2020	52	1					4	6		10.1016/j.immuni.2019.12.017	http://dx.doi.org/10.1016/j.immuni.2019.12.017			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KC7WX	31951549	Bronze			2022-12-18	WOS:000507384600002
J	Crotty, S; Blish, C; Cadwell, K; Chi, HB; Goldrath, A; Green, D; Kaech, SM; Krummel, M; Pepper, M; Rothlin, CV; Wherry, EJ				Crotty, Shane; Blish, Catherine; Cadwell, Ken; Chi, Hongbo; Goldrath, Ananda; Green, Douglas; Kaech, Susan M.; Krummel, Matthew; Pepper, Marion; Rothlin, Carla V.; Wherry, E. John		Once-A-Year Pledge Supporters	Reinvigorating NIH Grant Peer Review	IMMUNITY			English	Letter									[Crotty, Shane] La Jolla Inst Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA; [Crotty, Shane] Univ Calif San Diego, Dept Med, Div Infect Dis & Global Publ Hlth, La Jolla, CA 92037 USA; [Blish, Catherine] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Cadwell, Ken] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA; [Cadwell, Ken] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Chi, Hongbo; Green, Douglas] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Goldrath, Ananda] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Kaech, Susan M.] Salk Inst Biol Studies, NOMIS Ctr Immunobiol & Microbial Pathogenesis, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Krummel, Matthew] Univ Calif San Francisco, Dept Pathol, ImmunoX Initiat, San Francisco, CA 94143 USA; [Krummel, Matthew] Univ Calif San Francisco, Parker Inst Canc Immunotherapy, San Francisco, CA 94143 USA; [Pepper, Marion] Univ Washington, Dept Immunol, Seattle, WA 98109 USA; [Rothlin, Carla V.] Yale Univ, Dept Immunobiol, New Haven, CT USA; [Wherry, E. John] Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Wherry, E. John] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Wherry, E. John] Univ Penn, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA	La Jolla Institute for Immunology; University of California System; University of California San Diego; Stanford University; New York University; New York University; St Jude Children's Research Hospital; University of California System; University of California San Diego; Salk Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; Yale University; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Crotty, S (corresponding author), La Jolla Inst Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA.; Crotty, S (corresponding author), Univ Calif San Diego, Dept Med, Div Infect Dis & Global Publ Hlth, La Jolla, CA 92037 USA.	shane@lji.org	Chi, Hongbo/M-9397-2018; Wherry, John/ABI-1280-2020	Chi, Hongbo/0000-0002-9997-2496; Blish, Catherine/0000-0001-6946-7627; Cadwell, Ken/0000-0002-5860-0661				Standage Tom, 2005, FUTURE TECHNOLOGY	1	1	1	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 14	2020	52	1					1	3		10.1016/j.immuni.2019.12.016	http://dx.doi.org/10.1016/j.immuni.2019.12.016			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KC7WX	31940266	Bronze			2022-12-18	WOS:000507384600001
J	Xin, W; Chan, JR				Xin, Wendy; Chan, Jonah R.			That Wasn't a Complement-Too Much C3 in Demyelinating Disease	IMMUNITY			English	Editorial Material								Multiple sclerosis is a chronic inflammatory disease characterized by demyelination in the central nervous system. In this issue of Immunity, Werneberg et al. report a striking loss of synapses driven by excessive microglial pruning early in demyelinating disease, which can be rescued by inhibiting the complement component C3.	[Xin, Wendy; Chan, Jonah R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Xin, Wendy; Chan, Jonah R.] Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Xin, W (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA.; Xin, W (corresponding author), Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94158 USA.	wen.xin@ucsf.edu		Xin, Wendy/0000-0002-1425-834X	National Institutes of Health/National Institute of Neurological Disorders and Stroke [R01NS097428, R01NS095889]; Rachleff Family Endowment	National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Rachleff Family Endowment	This commentary was supported by the National Institutes of Health/National Institute of Neurological Disorders and Stroke (R01NS097428 and R01NS095889) and the Rachleff Family Endowment.	Dutta R, 2011, ANN NEUROL, V69, P445, DOI 10.1002/ana.22337; Janova H, 2018, J CLIN INVEST, V128, P734, DOI 10.1172/JCI97032; Jurgens T, 2016, BRAIN, V139, P39, DOI 10.1093/brain/awv353; KIM YU, 1995, J EXP MED, V181, P151, DOI 10.1084/jem.181.1.151; Reich DS, 2018, NEW ENGL J MED, V378, P169, DOI 10.1056/NEJMra1401483; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Turnberg D, 2003, MOL IMMUNOL, V40, P145, DOI 10.1016/S0161-5890(03)00110-X; Werneburg S, 2020, IMMUNITY, V52, P167, DOI 10.1016/j.immuni.2019.12.004	9	1	1	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 14	2020	52	1					11	13		10.1016/j.immuni.2019.12.014	http://dx.doi.org/10.1016/j.immuni.2019.12.014			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KC7WX	31951547	Green Accepted, Bronze			2022-12-18	WOS:000507384600005
J	Sansom, DM; Walker, LSK				Sansom, David M.; Walker, Lucy S. K.			Dimers Aren't Forever: CD80 Breaks up with PD-L1	IMMUNITY			English	Editorial Material							CELL; COMPLEX	Targeting the CTLA-4 and PD-1 "checkpoints" is an effective treatment for a number of cancers. In this issue of Immunity, Hui et al. reveal that interaction between a CTLA-4 ligand, CD80, and its counterpart in the PD-1 pathway, PD-L1, affects both PD-1 and CTLA-4 function, raising new questions about the biological effects of using checkpoint inhibitors alone and in combination.	[Sansom, David M.; Walker, Lucy S. K.] UCL, Royal Free Hosp, Inst Immun & Transplantat, London NW3 2PF, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Sansom, DM; Walker, LSK (corresponding author), UCL, Royal Free Hosp, Inst Immun & Transplantat, London NW3 2PF, England.	d.sansom@ucl.ac.uk; lucy.walker@ucl.ac.uk		Sansom, David/0000-0001-6506-3115	Medical Research Council [MR/N001435/1] Funding Source: Medline; MRC [MR/N001435/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Chaudhri A, 2018, CANCER IMMUNOL RES, V6, P921, DOI 10.1158/2326-6066.CIR-17-0316; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Lin DYW, 2008, P NATL ACAD SCI USA, V105, P3011, DOI 10.1073/pnas.0712278105; Ovcinnikovs V, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw0902; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; Sugiura D, 2019, SCIENCE, V364, P558, DOI 10.1126/science.aav7062; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Zhao YF, 2019, WORLD ENVIRONMENTAL AND WATER RESOURCES CONGRESS 2019: HYDRAULICS, WATERWAYS, AND WATER DISTRIBUTION SYSTEMS ANALYSIS, P1	10	1	2	2	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 17	2019	51	6					972	974		10.1016/j.immuni.2019.11.011	http://dx.doi.org/10.1016/j.immuni.2019.11.011			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JW6ME	31951541	Bronze, Green Submitted			2022-12-18	WOS:000503162900003
J	Bruckner, K				Bruckner, Katja			Renal Function: Guardian of Immune Homeostasis	IMMUNITY			English	Editorial Material							RECEPTOR	Microbial cell components from the intestinal microbiota spread systemically in a healthy host, posing the threat of inappropriate immune activation. In this issue of Immunity, Troha et al. identify a key role for renal function in the clearance of circulating Lys-type peptidoglycan, revealing a mechanism that keeps these inflammatory triggers in check to maintain systemic immune homeostasis.	[Bruckner, Katja] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Bruckner, Katja] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Bruckner, Katja] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bruckner, K (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.; Bruckner, K (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.; Bruckner, K (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	katja.brueckner@ucsf.edu			National Institutes of Health [1R01GM112083, 1R01GM131094]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112083] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	K.B. is supported by National Institutes of Health grants 1R01GM112083 and 1R01GM131094.	Arefin B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136593; Buchon N, 2014, NAT REV IMMUNOL, V14, P796, DOI 10.1038/nri3763; Chiu YC, 2009, J IMMUNOL, V183, P2785, DOI 10.4049/jimmunol.0802826; Denholm B, 2009, CURR OPIN GENET DEV, V19, P526, DOI 10.1016/j.gde.2009.08.006; Irazoki O, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00500; Kieser KJ, 2017, NAT REV IMMUNOL, V17, P376, DOI 10.1038/nri.2017.25; Knight R, 2017, ANNU REV GENOM HUM G, V18, P65, DOI 10.1146/annurev-genom-083115-022438; Kurts C, 2013, NAT REV IMMUNOL, V13, P738, DOI 10.1038/nri3523; Su H, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00405; Troha K, 2019, IMMUNITY, V51, P625, DOI 10.1016/j.immuni.2019.08.020	10	1	1	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 15	2019	51	4					596	598		10.1016/j.immuni.2019.09.017	http://dx.doi.org/10.1016/j.immuni.2019.09.017			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JD7DP	31618649	Green Accepted, Bronze, Green Published			2022-12-18	WOS:000490141700004
J	Relman, DA				Relman, David A.			Maternal IgA: Matchmaking in Early Childhood	IMMUNITY			English	Editorial Material							HUMAN-MILK; RESPONSES	In a recent issue of Nature Medicine, Gopalakrishna et al. show that altered patterns of IgA binding to gut bacteria in premature infants are associated with necrotizing enterocolitis, underscoring the critical role of host mucosal immunity in shaping the microbiota.	[Relman, David A.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Relman, David A.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Relman, David A.] Vet Affairs Palo Alto Hlth Care Syst, Infect Dis Sect, Palo Alto, CA 94304 USA; [Relman, David A.] Chan Zuckerberg Biohub Microbiome Initiat, San Francisco, CA 94158 USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Relman, DA (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.; Relman, DA (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.; Relman, DA (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Infect Dis Sect, Palo Alto, CA 94304 USA.; Relman, DA (corresponding author), Chan Zuckerberg Biohub Microbiome Initiat, San Francisco, CA 94158 USA.	relman@stanford.edu		Relman, David A./0000-0001-8331-1354				Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002; Bunker JJ, 2015, IMMUNITY, V43, P541, DOI 10.1016/j.immuni.2015.08.007; Charbonneau MR, 2016, NATURE, V535, P48, DOI 10.1038/nature18845; Demers-Mathieu V, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050631; Gopalakrishna KP, 2019, NAT MED, V25, P1110, DOI 10.1038/s41591-019-0480-9; Grootjans J, 2019, SCIENCE, V363, P993, DOI 10.1126/science.aat7186; Koch MA, 2016, CELL, V165, P827, DOI 10.1016/j.cell.2016.04.055; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Meinzen-Derr J, 2009, J PERINATOL, V29, P57, DOI 10.1038/jp.2008.117; Planer JD, 2016, NATURE, V534, P263, DOI 10.1038/nature17940	10	1	1	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 20	2019	51	2					211	213		10.1016/j.immuni.2019.07.010	http://dx.doi.org/10.1016/j.immuni.2019.07.010			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS3XX	31433968	Bronze			2022-12-18	WOS:000482088500006
J	Chong, SZ; Angeli, V				Chong, Shu Zhen; Angeli, Veronique			Cavity Macrophages Get to the Heart of the Issue	IMMUNITY			English	Editorial Material								In this issue of Immunity, Deniset et al. (2019) reveal a reparative function for GATA6(+) pericardial cavity macrophages following cardiac injury. Their findings call for reconsideration of surgical procedures that involve the removal of the pericardium.	[Chong, Shu Zhen] ASTAR, Singapore Immunol Network, Singapore 138648, Singapore; [Angeli, Veronique] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Immunol Programme,Life Sci Inst, Singapore 117597, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore	Angeli, V (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Immunol Programme,Life Sci Inst, Singapore 117597, Singapore.	micva@nus.edu.sg		Chong, Shu Zhen/0000-0002-2682-912X	National Medical Research Council; National Research Foundation, Prime Minister's Office, Singapore under its Campus for Research Excellence and Technological Enterprise (CREATE) program; SIgN, A*STAR, Singapore; NMRC Young Investigator research grant [OFYIRG17may036]	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation, Prime Minister's Office, Singapore under its Campus for Research Excellence and Technological Enterprise (CREATE) program(National Research Foundation, Singapore); SIgN, A*STAR, Singapore; NMRC Young Investigator research grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from National Medical Research Council and the National Research Foundation, Prime Minister's Office, Singapore under its Campus for Research Excellence and Technological Enterprise (CREATE) program to V.A. and by SIgN, A*STAR, Singapore and a NMRC Young Investigator research grant (OFYIRG17may036) to S.Z.C.	Bain CC, 2018, CELL IMMUNOL, V330, P126, DOI 10.1016/j.cellimm.2018.01.003; Bain CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11852; Boyd WD, 2012, EXPERT REV CARDIOVAS, V10, P1109, DOI [10.1586/ERC.12.87, 10.1586/erc.12.87]; Buechler MB, 2019, IMMUNITY, V51, P119, DOI 10.1016/j.immuni.2019.05.010; Camara A, 2019, IMMUNITY, V50, P1467, DOI 10.1016/j.immuni.2019.05.008; Deniset JF, 2019, IMMUNITY, V51, P131, DOI 10.1016/j.immuni.2019.06.010; Dick SA, 2019, NAT IMMUNOL, V20, P29, DOI [10.1038/s41590-018-0272-2, 10.1038/s41590-019-0363-8]; Gautier EL, 2014, J EXP MED, V211, P1525, DOI 10.1084/jem.20140570; Mondor I, 2019, IMMUNITY, V50, P1453, DOI 10.1016/j.immuni.2019.04.002; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Rosas M, 2014, SCIENCE, V344, P645, DOI 10.1126/science.1251414; Wang J, 2016, CELL, V165, P668, DOI 10.1016/j.cell.2016.03.009; Zhang N, 2019, J EXP MED, V216, P1291, DOI 10.1084/jem.20182024	13	1	1	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 16	2019	51	1					7	9		10.1016/j.immuni.2019.06.020	http://dx.doi.org/10.1016/j.immuni.2019.06.020			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	II9ZW	31315037	Bronze			2022-12-18	WOS:000475561000004
J	Wang, LF; Wu, H				Wang, Longfei; Wu, Hao			Keeping the Death Protein in Check	IMMUNITY			English	Editorial Material							GASDERMIN-D; PYROPTOSIS; GSDMD; PORE; CASPASE-11	Gasdermin D is an executioner of inflammatory cell death. In this issue, Liu et al. report the crystal structures of full- length human and mouse gasdermin D, which contributes to our understanding of gasdermin D auto-inhibition and activation and will inform the future development of therapeutics targeting gasdermin D.	[Wang, Longfei; Wu, Hao] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Wang, Longfei; Wu, Hao] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Wu, H (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Wu, H (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.	hao.wu@childrens.harvard.edu			National Institutes of Health [1R01 AI139914]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI139914] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by National Institutes of Health (1R01 AI139914 to H.W.).	Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; Chen X, 2016, CELL RES, V26, P1007, DOI 10.1038/cr.2016.100; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Liu Z., 2019, IMMUNITY, V51; Ruan JB, 2018, NATURE, V557, P62, DOI 10.1038/s41586-018-0058-6; Sborgi L, 2016, EMBO J, V35, P1766, DOI 10.15252/embj.201694696; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514	10	1	1	3	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 16	2019	51	1					1	2		10.1016/j.immuni.2019.06.011	http://dx.doi.org/10.1016/j.immuni.2019.06.011			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	II9ZW	31315028	Bronze			2022-12-18	WOS:000475561000001
J	Makris, S; Acton, SE				Makris, Spyridon; Acton, Sophie E.			The Stromal Niche Guarding the Gatekeepers	IMMUNITY			English	Editorial Material							MACROPHAGES	In this issue of Immunity, Mondor et al. (2019) and Camara et al. (2019) show that lymphatic endothelial cells are essential components of the niche that forms and maintains the subcapsular sinusoidal macrophage network in homeostasis and throughout an immune challenge.	[Makris, Spyridon; Acton, Sophie E.] UCL, Mol Cell Biol Lab, MRC, Stromal Immunol Grp, Gower St, London WC1E 6BT, England	University of London; University College London	Acton, SE (corresponding author), UCL, Mol Cell Biol Lab, MRC, Stromal Immunol Grp, Gower St, London WC1E 6BT, England.	s.acton@ucl.ac.uk		Makris, Spyridon/0000-0001-9243-2369				Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Bellomo A, 2018, CELL IMMUNOL, V330, P168, DOI 10.1016/j.cellimm.2018.01.010; Camara A, 2019, IMMUNITY, V50, P1467, DOI 10.1016/j.immuni.2019.05.008; Detmar M, 2002, J EXP MED, V196, P713, DOI 10.1084/jem.20021346; Gaya M, 2015, SCIENCE, V347, P667, DOI 10.1126/science.aaa1300; Glass CK, 2016, NAT IMMUNOL, V17, P26, DOI 10.1038/ni.3306; Mondor I, 2019, IMMUNITY, V50, P1453, DOI 10.1016/j.immuni.2019.04.002; Perdiguero EG, 2016, NAT IMMUNOL, V17, P2, DOI 10.1038/ni.3341; T'Jonck W, 2018, CELL IMMUNOL, V330, P43, DOI 10.1016/j.cellimm.2018.02.005; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017	10	1	1	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 18	2019	50	6					1344	1346		10.1016/j.immuni.2019.05.019	http://dx.doi.org/10.1016/j.immuni.2019.05.019			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7PZ	31216457	Bronze			2022-12-18	WOS:000471876100005
J	Moussion, C; Mellman, I				Moussion, Christine; Mellman, Ira			The Dendritic Cell Strikes Back (vol 49, pg 997, 2018)	IMMUNITY			English	Correction												mellman.ira@gene.com	Mellman, Ira/ABG-5896-2020					Moussion C, 2018, IMMUNITY, V49, P997, DOI 10.1016/j.immuni.2018.12.007	1	1	1	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 19	2019	50	2					533	533		10.1016/j.immuni.2019.01.022	http://dx.doi.org/10.1016/j.immuni.2019.01.022			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL8QC	30784580	Bronze			2022-12-18	WOS:000459006700024
J	Holley, CL; Coll, RC; Schroder, K				Holley, Caroline L.; Coll, Rebecca C.; Schroder, Kate			NLRC3 Restrains Responses to a T	IMMUNITY			English	Editorial Material							MEMBER; FAMILY	The NOD-like receptor protein NLRC3 attenuates myeloid cell inflammatory responses. In this issue of Immunity, Uchimura et al. (2018) reveal additional T-cell-intrinsic functions for NLRC3 in restricting T cell metabolism, T helper 1 and T helper 17 cell responses, and antiviral and autoimmune responses.	[Holley, Caroline L.; Coll, Rebecca C.; Schroder, Kate] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Holley, Caroline L.; Coll, Rebecca C.; Schroder, Kate] Univ Queensland, IMB Ctr Inflammat & Dis Res, St Lucia, Qld, Australia	University of Queensland; University of Queensland	Schroder, K (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia.; Schroder, K (corresponding author), Univ Queensland, IMB Ctr Inflammat & Dis Res, St Lucia, Qld, Australia.	k.schroder@imb.uq.edu.au	Coll, Rebecca/J-2124-2014; Schroder, Kate/C-6132-2008; Holley, Caroline/AHC-6503-2022; Holley, Caroline/C-7992-2017	Coll, Rebecca/0000-0002-7359-6023; Schroder, Kate/0000-0001-9261-3805; Holley, Caroline/0000-0002-2231-0136				Conti BJ, 2005, J BIOL CHEM, V280, P18375, DOI 10.1074/jbc.M413169200; Damsker JM, 2010, ANN NY ACAD SCI, V1183, P211, DOI 10.1111/j.1749-6632.2009.05133.x; Galvan-Pena S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00420; Hu SF, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007266; Kors L, 2018, BBA-MOL BASIS DIS, V1864, P1883, DOI 10.1016/j.bbadis.2018.03.003; Palmer CS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00001; Schneider M, 2012, NAT IMMUNOL, V13, P823, DOI 10.1038/ni.2378; Uchimura T, 2018, IMMUNITY, V49, P1049, DOI 10.1016/j.immuni.2018.10.008; Zhang L, 2014, IMMUNITY, V40, P329, DOI 10.1016/j.immuni.2014.01.010	9	1	1	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2018	49	6					989	991		10.1016/j.immuni.2018.12.003	http://dx.doi.org/10.1016/j.immuni.2018.12.003			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HE6VX	30566886	Bronze			2022-12-18	WOS:000453556500002
J	Oh, DY; Fong, L				Oh, David Y.; Fong, Lawrence			Immunity in the Time of Metastases	IMMUNITY			English	Editorial Material								Multiplexed interrogation of tumor genomic and immune features in serial patient metastases reported in a recent issue of Cell (Angelova et al., 2018) reveals a pivotal role for immune editing in shaping clonal evolution of metastases.	[Oh, David Y.; Fong, Lawrence] Univ Calif San Francisco, Dept Med, Div Hematol Oncol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Fong, L (corresponding author), Univ Calif San Francisco, Dept Med, Div Hematol Oncol, San Francisco, CA 94143 USA.	lawrence.fong@ucsf.edu						Angelova M, 2018, CELL, V175, P751, DOI 10.1016/j.cell.2018.09.018; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Pages F, 2018, LANCET, V391, P2128, DOI 10.1016/S0140-6736(18)30789-X	5	1	1	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2018	49	6					1002	1003		10.1016/j.immuni.2018.12.008	http://dx.doi.org/10.1016/j.immuni.2018.12.008			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HE6VX	30566878	Bronze			2022-12-18	WOS:000453556500007
J	Sallis, BF; Fiebiger, E				Sallis, Benjamin F.; Fiebiger, Edda			A Shocking Type of Communication	IMMUNITY			English	Editorial Material							CROSS-PRESENTATION; DENDRITIC CELLS; MAST-CELLS	In allergic patients, small amounts of allergen activate mast cells and trigger an immune cascade that can result in anaphylactic shock. In a recent issue of Science, Choi et al. (2018) show that dendritic cells sample the lumen of blood vessels and use microvesicles to trigger mast cell degranulation and anaphylaxis.	[Sallis, Benjamin F.] Boston Childrens Hosp, Div Gastroenterol Hepatol & Nutr, Dept Pediat, Boston, MA USA; [Fiebiger, Edda] Harvard Med Sch, Dept Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Fiebiger, E (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.	edda.fiebiger@childrens.harvard.edu		Sallis, Benjamin Fidelius/0000-0001-7572-7210				Baravalle G, 2014, J IMMUNOL, V192, P3280, DOI 10.4049/jimmunol.1301751; Cheng LE, 2013, IMMUNITY, V38, P166, DOI 10.1016/j.immuni.2012.09.022; Choi HW, 2018, SCIENCE, V362, P656, DOI 10.1126/science.aao0666; Kubo M, 2018, CURR OPIN IMMUNOL, V54, P74, DOI 10.1016/j.coi.2018.06.006; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Oettgen HC, 2015, CURR OPIN IMMUNOL, V36, P109, DOI 10.1016/j.coi.2015.07.007; Platzer B, 2015, CELL REP, V10, P1487, DOI 10.1016/j.celrep.2015.02.015; Renz H, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2017.98; Shin JS, 2015, CELL MOL LIFE SCI, V72, P2349, DOI 10.1007/s00018-015-1870-x; Zehner M, 2013, MOL IMMUNOL, V55, P146, DOI 10.1016/j.molimm.2012.10.010	10	1	1	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2018	49	6					999	1001		10.1016/j.immuni.2018.12.004	http://dx.doi.org/10.1016/j.immuni.2018.12.004			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HE6VX	30566890	Bronze			2022-12-18	WOS:000453556500006
J	Carreras, A; Backhed, F				Carreras, Alba; Backhed, Fredrik			23, 22 Calling the Microbiota to Control Atherosclerosis	IMMUNITY			English	Editorial Material								While the commensal microbiota is considered an important regulator of immunity and metabolism, the mechanisms controlling the interplay between diet, cytokine signaling, and the microbiota in atherosclerosis remains unknown. In this issue of Immunity, Fatkhullina et al. (2018) demonstrate that interlukin-23-22 axis regulates diet-induced atherosclerosis by repressing pro-atherogenic microbiota.	[Carreras, Alba; Backhed, Fredrik] Univ Gothenburg, Inst Med, Wallenberg Lab, Dept Mol & Clin Med, Gothenburg, Sweden; [Carreras, Alba; Backhed, Fredrik] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Backhed, Fredrik] Univ Copenhagen, Sect Metab Receptol & Enteroendocrinol, Novo Nordisk Fdn Ctr Basic Metab Res, Fac Hlth Sci, Copenhagen, Denmark	University of Gothenburg; Sahlgrenska University Hospital; Novo Nordisk Foundation; University of Copenhagen	Backhed, F (corresponding author), Univ Gothenburg, Inst Med, Wallenberg Lab, Dept Mol & Clin Med, Gothenburg, Sweden.; Backhed, F (corresponding author), Sahlgrens Univ Hosp, Gothenburg, Sweden.; Backhed, F (corresponding author), Univ Copenhagen, Sect Metab Receptol & Enteroendocrinol, Novo Nordisk Fdn Ctr Basic Metab Res, Fac Hlth Sci, Copenhagen, Denmark.	fredrik@wlab.gu.se	Backhed, Fredrik/ABE-6613-2020	Backhed, Fredrik/0000-0002-4871-8818	Swedish Heart Lung Foundation; Knut and Alice Wallenberg Foundation; Leducq Foundation; ERC Consolidator Grant (European Research Council) [615362 - METABASE]	Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Leducq Foundation(Leducq Foundation); ERC Consolidator Grant (European Research Council)(European Research Council (ERC))	The authors are grateful to Kimberly Krautkramer for critically commenting on the text. Work in the Backhed laboratory is in part supported by Swedish Heart Lung Foundation, Knut and Alice Wallenberg Foundation, and the Transatlantic Networks of Excellence Award from the Leducq Foundation. F.B. is Torsten Soderberg Professor in Medicine and recipient of an ERC Consolidator Grant (European Research Council, Consolidator grant 615362 - METABASE).	David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Fatkhullina AR, 2018, IMMUNITY, V49, P943, DOI 10.1016/j.immuni.2018.09.011; Jonsson AL, 2018, ARTERIOSCL THROM VAS, V38, P2318, DOI 10.1161/ATVBAHA.118.311233; Jonsson AL, 2017, NAT REV CARDIOL, V14, P79, DOI 10.1038/nrcardio.2016.183; Matsui Y, 2003, ARTERIOSCL THROM VAS, V23, P1029, DOI 10.1161/01.ATV.0000074878.29805.D0; Qi JQ, 2018, J CELL MOL MED, V22, P185, DOI 10.1111/jcmm.13307; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wiekowski MT, 2001, J IMMUNOL, V166, P7563, DOI 10.4049/jimmunol.166.12.7563; Zenewicz LA, 2013, J IMMUNOL, V190, P5306, DOI 10.4049/jimmunol.1300016; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	10	1	1	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2018	49	5					788	790		10.1016/j.immuni.2018.11.006	http://dx.doi.org/10.1016/j.immuni.2018.11.006			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HB1AY	30462992	Bronze			2022-12-18	WOS:000450752200003
J	Girard, M; Watts, TH				Girard, Melanie; Watts, Tania H.			Fc-Engineered Anti-4-1BB Antibodies Pack a One-Two Punch	IMMUNITY			English	Editorial Material							CANCER-IMMUNOTHERAPY; 4-1BB	A key issue in immuno-oncology is how to optimize and combine antibody therapies for improved efficacy. In this issue of Immunity, Buchan et al. (2018) reveal the importance of antibody Fc region, Fc receptor availability, and sequence of administration for optimal cancer therapy with antibodies targeting the co-stimulatory receptor 4-1BB.	[Girard, Melanie; Watts, Tania H.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada	University of Toronto	Watts, TH (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada.	tania.watts@utoronto.ca						Buchan SL, 2018, IMMUNITY, V49, P958, DOI 10.1016/j.immuni.2018.09.014; Chester C, 2018, BLOOD, V131, P49, DOI 10.1182/blood-2017-06-741041; Furness AJS, 2014, TRENDS IMMUNOL, V35, P290, DOI 10.1016/j.it.2014.05.002; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Quezada SA, 2019, CLIN CANCER RES, V25, P1130, DOI 10.1158/1078-0432.CCR-18-2509; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Segal NH, 2018, CLIN CANCER RES, V24, P1816, DOI 10.1158/1078-0432.CCR-17-1922; Segal NH, 2017, CLIN CANCER RES, V23, P1929, DOI 10.1158/1078-0432.CCR-16-1272; Snell LM, 2011, IMMUNOL REV, V244, P197, DOI 10.1111/j.1600-065X.2011.01063.x; White AL, 2015, CANCER CELL, V27, P138, DOI 10.1016/j.ccell.2014.11.001	10	1	1	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2018	49	5					791	793		10.1016/j.immuni.2018.11.001	http://dx.doi.org/10.1016/j.immuni.2018.11.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HB1AY	30462993	Bronze			2022-12-18	WOS:000450752200004
J	Hughes, LD; Ghosh, S; Rothlin, CV				Hughes, Lindsey D.; Ghosh, Sourav; Rothlin, Carla V.			Cenabis Bene: Treg Cells Invite Macrophages to Dine	IMMUNITY			English	Editorial Material							REGULATORY T-CELLS; MECHANISMS	Resolution of the immune response requires a coordinated effort to dampen inflammatory mediators and remove dying cells and debris. In this issue of Immunity, Proto et al. (2018) describe a circuit by which regulatory T cells enhance macrophage consumption of apoptotic cells during resolution.	[Hughes, Lindsey D.; Rothlin, Carla V.] Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06510 USA; [Ghosh, Sourav] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Ghosh, Sourav; Rothlin, Carla V.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	Rothlin, CV (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06510 USA.; Ghosh, S (corresponding author), Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA.; Ghosh, S; Rothlin, CV (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA.	sourav.ghosh@yale.edu; carla.rothlin@yale.edu		Ghosh, Sourav/0000-0001-5990-8708				Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Hall AB, 2006, IMMUNITY, V24, P305, DOI 10.1016/j.immuni.2006.02.005; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Mahajan NP, 2003, J BIOL CHEM, V278, P42596, DOI 10.1074/jbc.M305817200; Proto JD, 2018, IMMUNITY, V49, P666, DOI 10.1016/j.immuni.2018.07.015; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; Wynn TA, 2015, NAT REV IMMUNOL, V15, P271, DOI 10.1038/nri3831	9	1	1	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2018	49	4					579	582		10.1016/j.immuni.2018.10.002	http://dx.doi.org/10.1016/j.immuni.2018.10.002			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX0FW	30332622	Bronze			2022-12-18	WOS:000447386700002
J	van Gent, M; Gack, MU				van Gent, Michiel; Gack, Michaela U.			Viral Anti-CRISPR Tactics: No Success without Sacrifice	IMMUNITY			English	Editorial Material							BACTERIAL IMMUNE-SYSTEM; BACTERIOPHAGE	Co-evolution with their bacterial hosts has led to viral countermeasures against CRISPR-mediated immunity. In a recent issue of Cell, Landsberger et al. (2018) and Borges et al. (2018) report that cooperation among bacteriophages and multiple infection events are necessary to overcome CRISPR immune responses.	[van Gent, Michiel; Gack, Michaela U.] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA	University of Chicago	Gack, MU (corresponding author), Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA.	mgack@uchicago.edu						Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Bondy-Denomy J, 2015, NATURE, V526, P136, DOI 10.1038/nature15254; Borges AL, 2018, CELL, V174, P917, DOI 10.1016/j.cell.2018.06.013; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Hille F, 2018, CELL, V172, P1239, DOI 10.1016/j.cell.2017.11.032; Koonin EV, 2017, ANNU REV MICROBIOL, V71, P233, DOI 10.1146/annurev-micro-090816-093830; Landsberger M, 2018, CELL, V174, P908, DOI 10.1016/j.cell.2018.05.058; Pawluk A, 2018, NAT REV MICROBIOL, V16, P12, DOI 10.1038/nrmicro.2017.120; van Houte S, 2016, NATURE, V532, P385, DOI 10.1038/nature17436	10	1	1	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2018	49	3					391	393		10.1016/j.immuni.2018.08.023	http://dx.doi.org/10.1016/j.immuni.2018.08.023			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GU0AK	30231980	Bronze			2022-12-18	WOS:000444909600007
J	Ueno, H				Ueno, Hideki			Location, Location, Location	IMMUNITY			English	Editorial Material							CELLS; CXCR3	The B7 receptor PD-1 is highly expressed by T follicular helper (Tfh) cells and represents one of the major markers for Tfh cells localized within the germinal centers (GCs). In this issue of Immunity, Shi et al. (2018) shows that PD-1 is involved in the tissue positioning of Tfh cells in lymphoid organs.	[Ueno, Hideki] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, 1468 Madison Ave,Box 1124,Annenberg Bldg, New York, NY 10029 USA; [Ueno, Hideki] Icahn Sch Med Mt Sinai, Dept Microbiol, 1468 Madison Ave,Box 1124,Annenberg Bldg, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Ueno, H (corresponding author), Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, 1468 Madison Ave,Box 1124,Annenberg Bldg, New York, NY 10029 USA.; Ueno, H (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, 1468 Madison Ave,Box 1124,Annenberg Bldg, New York, NY 10029 USA.	hideki.ueno@mssm.edu	Ueno, Hideki/L-1237-2016	Ueno, Hideki/0000-0001-7747-0738				Groom JR, 2012, IMMUNITY, V37, P1091, DOI 10.1016/j.immuni.2012.08.016; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Rabin RL, 2003, J IMMUNOL, V171, P2812, DOI 10.4049/jimmunol.171.6.2812; Sharpe AH, 2018, NAT REV IMMUNOL, V18, P153, DOI 10.1038/nri.2017.108; Shi J., 2018, IMMUNITY, V49; Ueno H, 2015, NAT IMMUNOL, V16, P142, DOI 10.1038/ni.3054; Velu V, 2016, J IMMUNOL, V197, P1832, DOI 10.4049/jimmunol.1600143; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058	8	1	1	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2018	49	2					197	+		10.1016/j.immuni.2018.08.006	http://dx.doi.org/10.1016/j.immuni.2018.08.006			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR1YX	30134195	Bronze			2022-12-18	WOS:000442354500002
J	Descamps, H; Thaiss, CA				Descamps, Helene; Thaiss, Christoph A.			Intestinal Tolerance, with a Little Help from Our Microbial Friends	IMMUNITY			English	Editorial Material							CELLS; IMMUNITY; COLITIS	The intestinal immune system performs a tightrope walk between anti-pathogen immunity and tolerance to innocuous luminal antigens. In this issue of Immunity, Kim et al. (2018) demonstrate that the microbiota is driving tolerance to food antigens and dampening inflammatory responses through CX(3)CR1(+) mononuclear phagocytes.	[Descamps, Helene; Thaiss, Christoph A.] Univ Penn, Microbiol Dept, Perelman Sch Med, Philadelphia, PA 19104 USA; [Descamps, Helene; Thaiss, Christoph A.] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Thaiss, CA (corresponding author), Univ Penn, Microbiol Dept, Perelman Sch Med, Philadelphia, PA 19104 USA.; Thaiss, CA (corresponding author), Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA.	thaiss@pennmedicine.upenn.edu		Descamps, Helene/0000-0001-5591-5839				Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Aychek T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7525; Kayama H, 2012, P NATL ACAD SCI USA, V109, P5010, DOI 10.1073/pnas.1114931109; Kim M, 2018, IMMUNITY, V49, P151, DOI 10.1016/j.immuni.2018.05.009; Leonardi I, 2018, SCIENCE, V359, P232, DOI 10.1126/science.aao1503; Mazzini E, 2014, IMMUNITY, V40, P248, DOI 10.1016/j.immuni.2013.12.012; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Thaiss CA, 2016, NATURE, V535, P65, DOI 10.1038/nature18847; Zigmond E, 2014, IMMUNITY, V40, P720, DOI 10.1016/j.immuni.2014.03.012	10	1	1	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2018	49	1					4	6		10.1016/j.immuni.2018.06.015	http://dx.doi.org/10.1016/j.immuni.2018.06.015			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GN3YN	30021145	Bronze			2022-12-18	WOS:000438949100002
J	Castillo, PAC; Hand, TW				Castillo, Patricia A. C.; Hand, Timothy W.			A Little Fiber Goes a Long Way	IMMUNITY			English	Editorial Material							GUT MICROBIOTA	In this issue of Immunity, Trompette et al. (2018) show that dietary fiber and short chain fatty acids reduce influenza A virus-associated immunopathology by enhancing CD8(+) T cell effector function and by promoting the differentiation of alternatively activated macrophages.	[Castillo, Patricia A. C.; Hand, Timothy W.] Univ Pittsburgh, Dept Pediat & Immunol, Childrens Hosp Pittsburgh UPMC, Richard King Mellon Fdn Inst Pediat Res, Pittsburgh, PA 15224 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hand, TW (corresponding author), Univ Pittsburgh, Dept Pediat & Immunol, Childrens Hosp Pittsburgh UPMC, Richard King Mellon Fdn Inst Pediat Res, Pittsburgh, PA 15224 USA.	timothy.hand@chp.edu						Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Ghorbani P, 2015, EUR RESPIR J, V46, P1033, DOI 10.1183/09031936.00143614; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Trompette A, 2018, IMMUNITY, V48, P992, DOI 10.1016/j.immuni.2018.04.022; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774	12	1	1	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2018	48	5					844	846		10.1016/j.immuni.2018.05.001	http://dx.doi.org/10.1016/j.immuni.2018.05.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG1ZI	29768170	Bronze			2022-12-18	WOS:000432488600005
J	Mikami, Y; Kanno, Y				Mikami, Yohei; Kanno, Yuka			GoldiRunx and Remembering Cytotoxic Memory	IMMUNITY			English	Editorial Material							T-CELL DIFFERENTIATION; EFFECTOR; PROTEINS	The molecular basis for T cell memory differentiation remains elusive. Wang et al. (2018) identify Runx3 as an initiating transcription factor that specifies regulatory regions required for cytotoxic T cell (CTL) memory differentiation early after TCR signaling and constrains the ability of T-bet to drive terminal effector generation.	[Mikami, Yohei; Kanno, Yuka] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Kanno, Y (corresponding author), NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA.	kannoy@mail.nih.gov	Kanno, Yuka/B-5802-2013; MIKAMI, YOHEI/GRJ-8133-2022	Kanno, Yuka/0000-0001-5668-9319; MIKAMI, YOHEI/0000-0001-5104-4415				Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chang JT, 2014, NAT IMMUNOL, V15, P1104, DOI 10.1038/ni.3031; Collins A, 2009, NAT REV IMMUNOL, V9, P106, DOI 10.1038/nri2489; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Milner JJ, 2017, NATURE, V552, P253, DOI 10.1038/nature24993; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Wang DP, 2018, IMMUNITY, V48, P659, DOI 10.1016/j.immuni.2018.03.028; Zeng CM, 1997, P NATL ACAD SCI USA, V94, P6746, DOI 10.1073/pnas.94.13.6746	10	1	1	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2018	48	4					614	615		10.1016/j.immuni.2018.03.032	http://dx.doi.org/10.1016/j.immuni.2018.03.032			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD0OA	29669241	Bronze			2022-12-18	WOS:000430198900005
J	Moretta, L; Vivier, E				Moretta, Lorenzo; Vivier, Eric			Alessandro Moretta (1953-2018) Obituary	IMMUNITY			English	Biographical-Item									[Moretta, Lorenzo] Pediat Hosp Bambino Gesu, Rome, Italy; [Vivier, Eric] Innate Pharma, Innate Pharma Res Labs, Marseille, France; [Vivier, Eric] Aix Marseille Univ, Ctr Immunol Marseille Luminy, INSERM, CNRS, Marseille, France; [Vivier, Eric] Hop La Timone, AP HP, Serv Immunol, Marseille Immunopole, Marseille, France	IRCCS Bambino Gesu; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Moretta, L (corresponding author), Pediat Hosp Bambino Gesu, Rome, Italy.; Vivier, E (corresponding author), Innate Pharma, Innate Pharma Res Labs, Marseille, France.; Vivier, E (corresponding author), Aix Marseille Univ, Ctr Immunol Marseille Luminy, INSERM, CNRS, Marseille, France.; Vivier, E (corresponding author), Hop La Timone, AP HP, Serv Immunol, Marseille Immunopole, Marseille, France.	lorenzo.moretta@opbg.net; vivier@ciml.univ-mrs.fr	Moretta, Lorenzo/AAA-7239-2020; Vivier, Eric/F-8939-2010	Moretta, Lorenzo/0000-0003-4658-1747; Vivier, Eric/0000-0001-7022-8287				MORETTA A, PUBLICATION LIST	1	1	1	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2018	48	4					601	602		10.1016/j.immuni.2018.03.021	http://dx.doi.org/10.1016/j.immuni.2018.03.021			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD0OA		Bronze			2022-12-18	WOS:000430198900001
J	Izcue, A; Pabst, O				Izcue, Ana; Pabst, Oliver			Mdr1 Saves T Cells from Bile	IMMUNITY			English	Editorial Material							INFLAMMATORY-BOWEL-DISEASE; P-GLYCOPROTEIN; IMMUNE-SYSTEM; GUT MICROBIOTA	The gut contents shape intestinal immune homeostasis, a phenomenon best documented for microbiota-immune interactions. In this issue of Immunity, Cao et al. (2017) show that bile acids trigger T cell-mediated inflammation at their site of active absorption in the ileum, unless cells are protected by the membrane transporter Mdr1.	[Izcue, Ana; Pabst, Oliver] RWTH Univ, Inst Mol Med, Aachen, Germany	RWTH Aachen University	Pabst, O (corresponding author), RWTH Univ, Inst Mol Med, Aachen, Germany.	opabst@ukaachen.de		Izcue, Ana/0000-0002-7974-7451	Deutsche Forschungsgemeinschaft [DFG PA921/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank Vuk Cerovic, Frank Schaap, and Thomas Clavel for their thoughts on this text. This work was supported by a Deutsche Forschungsgemeinschaft grant, DFG PA921/4-1, to O.P.	Borst P, 2013, J CLIN INVEST, V123, P4131, DOI 10.1172/JCI70430; Brestoff JR, 2013, NAT IMMUNOL, V14, P676, DOI 10.1038/ni.2640; Cao W, 2017, IMMUNITY, V47, P1182, DOI 10.1016/j.immuni.2017.11.012; Cario E, 2017, WORLD J GASTROENTERO, V23, P1513, DOI 10.3748/wjg.v23.i9.1513; Clavel T, 2017, IMMUNOL REV, V279, P8, DOI 10.1111/imr.12578; Langmann T, 2004, GASTROENTEROLOGY, V127, P26, DOI 10.1053/j.gastro.2004.04.019; Panwala CM, 1998, J IMMUNOL, V161, P5733; Postler TS, 2017, CELL METAB, V26, P110, DOI 10.1016/j.cmet.2017.05.008; Ramesh R, 2014, J EXP MED, V211, P89, DOI 10.1084/jem.20130301; Schubert K, 2017, IMMUNOL REV, V279, P23, DOI 10.1111/imr.12579	10	1	1	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2017	47	6					1016	1018		10.1016/j.immuni.2017.11.027	http://dx.doi.org/10.1016/j.immuni.2017.11.027			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FQ6PM	29262344	Bronze			2022-12-18	WOS:000418486500006
J	Libby, P; Vromman, A				Libby, Peter; Vromman, Amelie			Swell, or Not Too Swell: Cytokines Regulate Arterial Aneurysm Formation (vol 47, pg 814, 2017)	IMMUNITY			English	Correction												plibby@bwh.harvard.edu	Libby, Peter/AAY-6404-2021	Libby, Peter/0000-0002-1502-502X				Libby P, 2017, IMMUNITY, V47, P814, DOI 10.1016/j.immuni.2017.11.011	1	1	1	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2017	47	6					1210	1210		10.1016/j.immuni.2017.11.019	http://dx.doi.org/10.1016/j.immuni.2017.11.019			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FQ6PM	29262352	Bronze			2022-12-18	WOS:000418486500022
J	Estes, ML; McAllister, AK				Estes, Myka L.; McAllister, A. Kimberley			Brain, Immunity, Gut: "BIG" Links between Pregnancy and Autism	IMMUNITY			English	Editorial Material								Although dysregulation of brain, immune, and gut physiology during pregnancy have each been implicated in neuropsychiatric disorders, whether and how these presumably distinct systems are linked to cause disease is unclear. Kim et al. (2017) and Shin Yim et al. (2017) identify a pathway to explain how these aspects of our physiology are deeply and inextricably connected.	[Estes, Myka L.; McAllister, A. Kimberley] Univ Calif Davis, Ctr Neurosci, One Shields Ave, Davis, CA 95616 USA	University of California System; University of California Davis	McAllister, AK (corresponding author), Univ Calif Davis, Ctr Neurosci, One Shields Ave, Davis, CA 95616 USA.	kmcallister@ucdavis.edu		McAllister, A. Kimberley/0000-0001-9177-9889	Stanley and Jacqueline Schilling Neuroscience Postdoctoral Research Fellowship; ARCS (Achievement Rewards for College Scientists) Foundation; University of California Office of the President; National Institute of Neurological Disorders and Stroke [R01-NS060125-05]; National Institute of Mental Health [P50-MH106438-01]; Simons Foundation [321998]; University of California Davis Research Investments in Science and Engineering Program; Dennis Weatherstone Predoctoral Fellowship from Autism Speaks [7825]	Stanley and Jacqueline Schilling Neuroscience Postdoctoral Research Fellowship; ARCS (Achievement Rewards for College Scientists) Foundation; University of California Office of the President(University of California System); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation; University of California Davis Research Investments in Science and Engineering Program; Dennis Weatherstone Predoctoral Fellowship from Autism Speaks	A.K.M. and M.L.E. are listed as inventors on a patent application (U.S. Patent Application 61/989,791) entitled "Methods for Diagnosing and Treating Neuroimmune-Based Psychiatric Disorders.'' M.L.E. has been supported by a Stanley and Jacqueline Schilling Neuroscience Postdoctoral Research Fellowship, a Dennis Weatherstone Predoctoral Fellowship from Autism Speaks (no. 7825), the Letty and James Callinan and Cathy and Andrew Moley Fellowship from the ARCS (Achievement Rewards for College Scientists) Foundation, and a Dissertation Year Fellowship from the University of California Office of the President. A.K.M. is supported by grants from the National Institute of Neurological Disorders and Stroke (R01-NS060125-05), the National Institute of Mental Health (P50-MH106438-01), the Simons Foundation (SFARI no. 321998), and the University of California Davis Research Investments in Science and Engineering Program.	Choi GB, 2016, SCIENCE, V351, P933, DOI 10.1126/science.aad0314; Ericsson AC, 2014, COMPARATIVE MED, V64, P90; Estes ML, 2016, SCIENCE, V353, P772, DOI 10.1126/science.aag3194; Kim S, 2017, NATURE, V549, P528, DOI 10.1038/nature23910; Lombardelli Letizia, 2016, Clin Mol Allergy, V14, P1, DOI 10.1186/s12948-016-0039-y; Okada H, 2010, CLIN EXP IMMUNOL, V160, P1, DOI 10.1111/j.1365-2249.2010.04139.x; Silverstein NJ, 2017, IMMUNITY, V46, P347, DOI 10.1016/j.immuni.2017.03.007; Stoner R, 2014, NEW ENGL J MED, V370, P1209, DOI 10.1056/NEJMoa1307491; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279; Yim YS, 2017, NATURE, V549, P482, DOI 10.1038/nature23909	10	1	2	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 21	2017	47	5					816	819		10.1016/j.immuni.2017.10.019	http://dx.doi.org/10.1016/j.immuni.2017.10.019			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Immunology	FO0YZ	29166585	Bronze			2022-12-18	WOS:000416483700007
J	Milam, AAV; Allen, PM				Milam, Ashley A. Viehmann; Allen, Paul M.			The TCR Takes Some Immune Responsibility	IMMUNITY			English	Editorial Material							MAJOR HISTOCOMPATIBILITY COMPLEX; CELL	In this issue of Immunity, Van Braeckel-Budimmir et al. (2017) reveal that the pathogenic response of mice to a Plasmodium berghei infection is dominated by a V beta 8.1 T cell response. Mice lacking Vb8.1 T cells fail to mount a pathogenic response, thus showing that the TCR locus can be an Immune response (Ir) gene.	[Milam, Ashley A. Viehmann; Allen, Paul M.] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Allen, PM (corresponding author), Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA.	pallen@wustl.edu		Allen, Paul/0000-0003-3796-6047	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024157, R21AI126150] Funding Source: NIH RePORTER; NIAID NIH HHS [R21 AI126150, R01 AI024157] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BABBITT BP, 1985, NATURE, V317, P359, DOI 10.1038/317359a0; Dash P, 2017, NATURE, V547, P89, DOI 10.1038/nature22383; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Glanville J, 2017, NATURE, V547, P94, DOI 10.1038/nature22976; Katz D. H., 1976, ROLE PRODUCTS HISTOC; LEVINE BERNARD B., 1963, JOUR EXPTL MED, V118, P953, DOI 10.1084/jem.118.6.953; MCDEVITT HO, 1965, J EXP MED, V122, P517, DOI 10.1084/jem.122.3.517; McDevitt HO, 2000, ANNU REV IMMUNOL, V18, P1, DOI 10.1146/annurev.immunol.18.1.1; Van Braeckel-Budimir N, 2017, IMMUNITY, V47, P835, DOI 10.1016/j.immuni.2017.10.013; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003	10	1	1	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 21	2017	47	5					803	804		10.1016/j.immuni.2017.10.018	http://dx.doi.org/10.1016/j.immuni.2017.10.018			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FO0YZ	29166579	Bronze, Green Accepted			2022-12-18	WOS:000416483700001
J	Julg, B; Barouch, DH				Julg, Boris; Barouch, Dan H.			HIV-1 Latency by Transition	IMMUNITY			English	Editorial Material							CD4(+) T-CELLS; RHESUS-MONKEYS; RESERVOIR; INFECTION	The latent HIV-1 reservoir represents the major barrier for the development of an HIV-1 cure. In this issue of Immunity, Shan et al. (2017) highlight that effector-to-memory transitioning (EMT) CD4(+) T cells are particularly permissive for the establishment of latent HIV-1 infection.	[Julg, Boris; Barouch, Dan H.] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02115 USA; [Julg, Boris; Barouch, Dan H.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02139 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Barouch, DH (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02115 USA.; Barouch, DH (corresponding author), Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02139 USA.	dbarouch@bidmc.harvard.edu	Barouch, Dan/Y-3918-2019; Juelg, Boris/ABA-1955-2020	Juelg, Boris/0000-0002-4687-9626	NIAID NIH HHS [K08 AI106408] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Borducchi EN, 2016, NATURE, V540, P284, DOI 10.1038/nature20583; BUKRINSKY MI, 1992, P NATL ACAD SCI USA, V89, P6580, DOI 10.1073/pnas.89.14.6580; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Lusic M, 2017, NAT REV MICROBIOL, V15, P69, DOI 10.1038/nrmicro.2016.162; Shan L, 2017, IMMUNITY, V47, P766, DOI 10.1016/j.immuni.2017.09.014; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Whitney JB, 2014, NATURE, V512, P74, DOI 10.1038/nature13594	10	1	1	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2017	47	4					611	612		10.1016/j.immuni.2017.09.019	http://dx.doi.org/10.1016/j.immuni.2017.09.019			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FJ9JE	29045893	Bronze			2022-12-18	WOS:000413091600005
J	Pronovost, GN; Hsiao, EY				Pronovost, Geoffrey N.; Hsiao, Elaine Y.			Microbes REV up Host Metabolism around the Clock	IMMUNITY			English	Editorial Material							CIRCADIAN CLOCK; HOMEOSTASIS	There is increasing evidence that the microbiome regulates host metabolism, but specific mechanisms underlying these interactions remain poorly understood. In a recent paper in Science, Wang et al. (2017) reveal that the gut microbiota regulates the expression of circadian-clock genes to impact host lipid metabolism and body composition.	[Pronovost, Geoffrey N.; Hsiao, Elaine Y.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Pronovost, GN (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA.	geoffpro@ucla.edu			NIAID NIH HHS [T32 AI007323] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007323] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Buxton OM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003200; Everett LJ, 2014, TRENDS ENDOCRIN MET, V25, P586, DOI 10.1016/j.tem.2014.06.011; Leone V, 2015, CELL HOST MICROBE, V17, P681, DOI 10.1016/j.chom.2015.03.006; Mukherji A, 2013, CELL, V153, P812, DOI 10.1016/j.cell.2013.04.020; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang YH, 2017, SCIENCE, V357, P913, DOI 10.1126/science.aan0677; Yu XF, 2014, ELIFE, V3, DOI 10.7554/eLife.04406	10	1	3	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2017	47	4					618	620		10.1016/j.immuni.2017.10.004	http://dx.doi.org/10.1016/j.immuni.2017.10.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FJ9JE	29045896	Bronze			2022-12-18	WOS:000413091600008
J	Shin, S; Cherry, S				Shin, Sunny; Cherry, Sara			A RHIM with a View: FLYing with Functional Amyloids	IMMUNITY			English	Editorial Material							CELL-DEATH; NECROPTOSIS; FORMS	Recognition of bacterial peptidoglycan by the Drosophila IMD pathway triggers NF-kappa B activation and an associated immune response. In this issue of Immunity, Kleino et al. (2017) show that proteins in the IMD pathway form functional amyloids via a cryptic motif resembling the RHIM motif found in mammalian RIPK proteins. Amyloid formation can be negatively regulated, suggesting that it presents a regulatory point in multiple biological processes.	[Shin, Sunny; Cherry, Sara] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Cherry, S (corresponding author), Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA.	cherrys@pennmedicine.upenn.edu		cherry, sara/0000-0003-3956-6610				Buchon N, 2014, NAT REV IMMUNOL, V14, P796, DOI 10.1038/nri3763; Cai X., 2017, COLD SPRING HARB PER, V9; Daniels BP, 2017, CELL, V169, P301, DOI 10.1016/j.cell.2017.03.011; Daskalov A, 2016, P NATL ACAD SCI USA, V113, P2720, DOI 10.1073/pnas.1522361113; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Kleino A, 2017, IMMUNITY, V47, P635, DOI 10.1016/j.immuni.2017.09.011; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Liu SZ, 2017, P NATL ACAD SCI USA, V114, pE7450, DOI 10.1073/pnas.1707531114; Najjar M, 2016, IMMUNITY, V45, P46, DOI 10.1016/j.immuni.2016.06.007; Wu H, 2016, CELL, V165, P1055, DOI 10.1016/j.cell.2016.05.004	10	1	1	3	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2017	47	4					604	606		10.1016/j.immuni.2017.10.001	http://dx.doi.org/10.1016/j.immuni.2017.10.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FJ9JE	29045890	Bronze			2022-12-18	WOS:000413091600002
J	Wang, HG; Hogquist, KA				Wang, Haiguang; Hogquist, Kristin A.			Wait, Wait. OK Now Go In: iNKT Cells Resolve Liver Inflammation	IMMUNITY			English	Editorial Material							NKT CELLS; IMMUNITY	Resolution of inflammation is pivotal to restoring tissue homeostasis, yet there is limited understanding of how this process is regulated. In this issue of Immunity, Liew et al. (2017) reveal a critical role for invariant natural killer T (iNKT) cells in switching inflammation to tissue repair in an interlukin-4-dependent process.	[Wang, Haiguang; Hogquist, Kristin A.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Wang, Haiguang; Hogquist, Kristin A.] Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Hogquist, KA (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.; Hogquist, KA (corresponding author), Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA.	hogqu001@umn.edu						Bai L, 2012, J IMMUNOL, V188, P3053, DOI 10.4049/jimmunol.1102414; Dal-Secco D, 2015, J EXP MED, V212, P447, DOI 10.1084/jem.20141539; Du J, 2017, BLOOD, V129, P3121, DOI 10.1182/blood-2016-11-752444; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Holzapfel KL, 2014, J IMMUNOL, V192, P5490, DOI 10.4049/jimmunol.1400722; Hong S, 2001, NAT MED, V7, P1052, DOI 10.1038/nm0901-1052; Lee WY, 2010, NAT IMMUNOL, V11, P295, DOI 10.1038/ni.1855; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Liew PX, 2017, IMMUNITY, V47, P752, DOI 10.1016/j.immuni.2017.09.016; Trobonjaca Z, 2001, J IMMUNOL, V167, P1413, DOI 10.4049/jimmunol.167.3.1413	10	1	1	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2017	47	4					609	610		10.1016/j.immuni.2017.10.002	http://dx.doi.org/10.1016/j.immuni.2017.10.002			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FJ9JE	29045892	Bronze			2022-12-18	WOS:000413091600004
J	Bolz, M; Ernst, JD				Bolz, Miriam; Ernst, Joel D.			Fishing for Answers in Human Mycobacterial Infections	IMMUNITY			English	Editorial Material							TUBERCULOSIS; MACROPHAGES; LEPRAE	Two recent studies (Cambier et al., 2017; Madigan et al., 2017) reveal in vivo functions for specific phenolic glycolipids (PGLs) in the mycobacteria that cause tuberculosis or leprosy. M. tuberculosis (and M. marinum) PGL promotes bacterial spread to growth-permissive macrophages, while M. leprae PGL-1 induces macrophages to cause nerve demyelination characteristic of human leprosy.	[Bolz, Miriam; Ernst, Joel D.] NYU, Div Infect Dis & Immunol, Dept Med, Sch Med, New York, NY 10016 USA; [Ernst, Joel D.] NYU, Dept Microbiol, Sch Med, New York, NY 10016 USA; [Ernst, Joel D.] NYU, Dept Pathol, Sch Med, New York, NY 10016 USA	New York University; New York University; New York University	Ernst, JD (corresponding author), NYU, Div Infect Dis & Immunol, Dept Med, Sch Med, New York, NY 10016 USA.; Ernst, JD (corresponding author), NYU, Dept Microbiol, Sch Med, New York, NY 10016 USA.; Ernst, JD (corresponding author), NYU, Dept Pathol, Sch Med, New York, NY 10016 USA.	joel.ernst@med.nyu.edu		Ernst, Joel/0000-0001-9951-6207	NIAID NIH HHS [R01 AI051242, U19 AI111211, R01 AI124471] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051242, R01AI124471, U19AI111211] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Athman JJ, 2015, J IMMUNOL, V195, P1044, DOI 10.4049/jimmunol.1402894; Cambier CJ, 2017, IMMUNITY, V47, P552, DOI 10.1016/j.immuni.2017.08.003; Cambier CJ, 2014, NATURE, V505, P218, DOI 10.1038/nature12799; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; HUNTER SW, 1981, J BACTERIOL, V147, P728, DOI 10.1128/JB.147.3.728-735.1981; Madigan CA, 2017, CELL, V170, P973, DOI 10.1016/j.cell.2017.07.030; Prados-Rosales R, 2011, J CLIN INVEST, V121, P1471, DOI 10.1172/JCI44261; Rich EA, 1997, TUBERCLE LUNG DIS, V78, P247, DOI 10.1016/S0962-8479(97)90005-8; Srivastava S, 2016, CELL HOST MICROBE, V19, P44, DOI 10.1016/j.chom.2015.12.003; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509	10	1	1	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2017	47	3					395	397		10.1016/j.immuni.2017.09.005	http://dx.doi.org/10.1016/j.immuni.2017.09.005			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4MG	28930653	Bronze, Green Accepted			2022-12-18	WOS:000411128200004
J	Fasolino, M; Vahedi, G				Fasolino, Maria; Vahedi, Golnaz			GR Extinguishes Inflamed Chromatin, and NF-kappa B Evacuates	IMMUNITY			English	Editorial Material							GLUCOCORTICOID-RECEPTOR; BINDING; GENES	In this issue of Immunity, Oh et al. (2017) provide insight into the molecular effects of glucocorticoid receptor (GR) activation at a clinically relevant time point, after an inflammatory stimulus. They report that GR activation causes a global reduction in NF-kappa B binding, as well as time-dependent transcriptional effects.	[Fasolino, Maria; Vahedi, Golnaz] Univ Penn, Perelman Sch Med, Epigenet Inst, Dept Genet,Inst Immunol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Vahedi, G (corresponding author), Univ Penn, Perelman Sch Med, Epigenet Inst, Dept Genet,Inst Immunol, Philadelphia, PA 19104 USA.	vahedi@mail.med.upenn.edu						Clark AR, 2007, MOL CELL ENDOCRINOL, V275, P79, DOI 10.1016/j.mce.2007.04.013; Coutinho AE, 2011, MOL CELL ENDOCRINOL, V335, P2, DOI 10.1016/j.mce.2010.04.005; Hubner S, 2015, BIOL CHEM, V396, P1223, DOI 10.1515/hsz-2015-0106; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Oh KS, 2017, IMMUNITY, V47, P298, DOI 10.1016/j.immuni.2017.07.012; Rao NAS, 2011, GENOME RES, V21, P1404, DOI 10.1101/gr.118042.110; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Reichardt HM, 2001, EMBO J, V20, P7168, DOI 10.1093/emboj/20.24.7168; Smale ST, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016261; Uhlenhaut NH, 2013, MOL CELL, V49, P158, DOI 10.1016/j.molcel.2012.10.013	11	1	1	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 15	2017	47	2					214	216		10.1016/j.immuni.2017.07.025	http://dx.doi.org/10.1016/j.immuni.2017.07.025			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FD8QD	28813652	Bronze			2022-12-18	WOS:000407788300006
J	Deenick, EK; Tangye, SG				Deenick, Elissa K.; Tangye, Stuart G.			The TORC that Gets the GC Cycling	IMMUNITY			English	Editorial Material							GERMINAL CENTER; KINASE; MYC	The signaling pathways regulating positive selection in germinal centers (GCs) are incompletely understood. Ersching et al. (2017) identify a critical but temporal role for the action of the kinase mechanistic target of rapamycin complex (mTORC1), which promotes key changes in GC B cells and thereby facilitates affinity maturation.	[Deenick, Elissa K.; Tangye, Stuart G.] Garvan Inst Med Res, Immunol Res Program, Darlinghurst, NSW, Australia; [Deenick, Elissa K.; Tangye, Stuart G.] Univ New South Wales, St Vincents Clin Sch, Darlinghurst, NSW, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney	Deenick, EK (corresponding author), Garvan Inst Med Res, Immunol Res Program, Darlinghurst, NSW, Australia.; Deenick, EK (corresponding author), Univ New South Wales, St Vincents Clin Sch, Darlinghurst, NSW, Australia.	e.deenick@garvan.org.au	Tangye, Stuart G/H-4023-2014; Deenick, Elissa/AAY-8998-2020	Tangye, Stuart G/0000-0002-5360-5180; Deenick, Elissa/0000-0002-9271-0004				Boothby M, 2017, IMMUNITY, V46, P743, DOI 10.1016/j.immuni.2017.04.009; Calado DP, 2012, NAT IMMUNOL, V13, P1092, DOI 10.1038/ni.2418; Chou C, 2016, IMMUNITY, V45, P570, DOI 10.1016/j.immuni.2016.07.023; Dominguez-Sola D, 2015, IMMUNITY, V43, P1064, DOI 10.1016/j.immuni.2015.10.015; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Ersching J, 2017, IMMUNITY, V46, P1045, DOI 10.1016/j.immuni.2017.06.005; Lucas CL, 2016, NAT REV IMMUNOL, V16, P702, DOI 10.1038/nri.2016.93; Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001; Sander S, 2015, IMMUNITY, V43, P1075, DOI 10.1016/j.immuni.2015.10.021; Zeng H, 2016, IMMUNITY, V45, P540, DOI 10.1016/j.immuni.2016.08.017	10	1	1	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 20	2017	46	6					974	976		10.1016/j.immuni.2017.06.003	http://dx.doi.org/10.1016/j.immuni.2017.06.003			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY0RM	28636966	Bronze			2022-12-18	WOS:000403665900009
J	Bhiman, JN; Moore, PL				Bhiman, Jinal N.; Moore, Penny L.			Size Doesn't Matter: Shorter Antibody Loops Can Infiltrate HIV's Env Apex Defenses	IMMUNITY			English	Editorial Material							BROADLY NEUTRALIZING ANTIBODIES; INDUCTION; LINEAGE	An HIV vaccine that elicits broadly neutralizing antibodies, which often have unusual structural features, has not yet been developed. In Immunity this month, Cale et al., 2017 describe how a new mode of binding allows a conventional antibody to infiltrate HIV's armor.	[Bhiman, Jinal N.; Moore, Penny L.] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr HIV & STIs, ZA-2131 Johannesburg, South Africa; [Bhiman, Jinal N.; Moore, Penny L.] Univ Witwatersrand, Fac Hlth Sci, ZA-2050 Johannesburg, South Africa; [Moore, Penny L.] Univ KwaZulu Natal, CAPRISA, ZA-4013 Durban, South Africa	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Kwazulu Natal	Moore, PL (corresponding author), Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr HIV & STIs, ZA-2131 Johannesburg, South Africa.; Moore, PL (corresponding author), Univ Witwatersrand, Fac Hlth Sci, ZA-2050 Johannesburg, South Africa.; Moore, PL (corresponding author), Univ KwaZulu Natal, CAPRISA, ZA-4013 Durban, South Africa.	pennym@nicd.ac.za	Bhiman, Jinal/ABA-6029-2021	Bhiman, Jinal/0000-0001-6354-4003				Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Cale EM, 2017, IMMUNITY, V46, P777, DOI 10.1016/j.immuni.2017.04.011; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; MacLeod DT, 2016, IMMUNITY, V44, P1215, DOI 10.1016/j.immuni.2016.04.016; McCoy LE, 2017, IMMUNOL REV, V275, P11, DOI 10.1111/imr.12484; Moore PL, 2017, IMMUNOL REV, V275, P217, DOI 10.1111/imr.12501; Rusert P, 2016, NAT MED, V22, P1260, DOI 10.1038/nm.4187; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wibmer CK, 2015, CURR OPIN HIV AIDS, V10, P135, DOI 10.1097/COH.0000000000000153	10	1	1	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 16	2017	46	5					762	764		10.1016/j.immuni.2017.04.012	http://dx.doi.org/10.1016/j.immuni.2017.04.012			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EU8VJ	28514679	Bronze			2022-12-18	WOS:000401316300008
J	Barber, GN				Barber, Glen N.			The Birds, the Bees, and Innate Immunity	IMMUNITY			English	Editorial Material							INFECTION; MUTATIONS; RECEPTORS; GENE	The cytoplasm is usually a DNA-free zone, but during fertilization, sperm DNA enters oocyte cytoplasm and could potentially trigger a response. Abe et al. (2017) identify NLRP14 as a germ-cell-specific negative regulator of DNA sensing that may be of particular importance during fertilization.	[Barber, Glen N.] Univ Miami, Dept Cell Biol, Miller Sch Med, 511 Papanicolaou Bldg,1550 NW 10th Ave, Miami, FL 33136 USA	University of Miami	Barber, GN (corresponding author), Univ Miami, Dept Cell Biol, Miller Sch Med, 511 Papanicolaou Bldg,1550 NW 10th Ave, Miami, FL 33136 USA.	gbarber@med.miami.edu						Abe T, 2017, IMMUNITY, V46, P621, DOI 10.1016/j.immuni.2017.03.020; Barber GN, 2015, NAT REV IMMUNOL, V15, P760, DOI 10.1038/nri3921; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ, 2014, NEW ENGL J MED, V371, P568, DOI 10.1056/NEJMe1407246; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Westerveld GH, 2006, HUM REPROD, V21, P3178, DOI 10.1093/humrep/del293	8	1	1	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2017	46	4					521	522		10.1016/j.immuni.2017.04.002	http://dx.doi.org/10.1016/j.immuni.2017.04.002			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES3TD	28423330	Bronze			2022-12-18	WOS:000399451100003
J	del Fresno, C; Hidalgo, A				del Fresno, Carlos; Hidalgo, Andres			Neutrophils acROSs the Enemy Lines	IMMUNITY			English	Editorial Material							RECEPTOR DECTIN-1; RECOGNITION; ACTIVATION		[del Fresno, Carlos] Fdn Ctr Nacl Invest Cardiovasc CNIC Carlos III, Dept Myocardial Pathophysiol, Madrid 28029, Spain; [Hidalgo, Andres] Fdn Ctr Nacl Invest Cardiovasc CNIC Carlos III, Dept Cell & Dev Biol, Madrid 28029, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Centro Nacional de Investigaciones Cardiovasculares (CNIC)	del Fresno, C (corresponding author), Fdn Ctr Nacl Invest Cardiovasc CNIC Carlos III, Dept Myocardial Pathophysiol, Madrid 28029, Spain.; Hidalgo, A (corresponding author), Fdn Ctr Nacl Invest Cardiovasc CNIC Carlos III, Dept Cell & Dev Biol, Madrid 28029, Spain.	carlos.delfresno@cnic.es; ahidalgo@cnic.es	Del Fresno Sánchez, CArlos/AAY-1525-2021; Del Fresno, Carlos/ABD-7766-2020; Hidalgo, Andrés/L-5643-2014	Del Fresno, Carlos/0000-0003-1771-7254; Hidalgo, Andrés/0000-0001-5513-555X				Nicolas-Avila JA, 2017, IMMUNITY, V46, P15, DOI 10.1016/j.immuni.2016.12.012; Branzk N, 2014, NAT IMMUNOL, V15, P1017, DOI 10.1038/ni.2987; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Lowman DW, 2014, J BIOL CHEM, V289, P3432, DOI 10.1074/jbc.M113.529131; Rosas M, 2008, J IMMUNOL, V181, P3549, DOI 10.4049/jimmunol.181.5.3549; Schorey JS, 2008, CURR DRUG TARGETS, V9, P123, DOI 10.2174/138945008783502430; Ueyama T, 2011, J BIOL CHEM, V286, P40693, DOI 10.1074/jbc.M111.237289; Warnatsch A, 2017, IMMUNITY, V46, P421, DOI 10.1016/j.immuni.2017.02.013	10	1	1	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2017	46	3					335	337		10.1016/j.immuni.2017.03.003	http://dx.doi.org/10.1016/j.immuni.2017.03.003			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6QR	28329696	Green Submitted, Bronze			2022-12-18	WOS:000396818100003
J	Heidegger, S; Haas, T; Poeck, H				Heidegger, Simon; Haas, Tobias; Poeck, Hendrik			Cutting Edge in IFN Regulation: Inflammatory Caspases Cleave cGAS	IMMUNITY			English	Editorial Material							DNA		[Heidegger, Simon; Haas, Tobias; Poeck, Hendrik] Tech Univ Munich, Med Klin 3, Klinikum Rechts Isar, D-81675 Munich, Germany	Technical University of Munich	Poeck, H (corresponding author), Tech Univ Munich, Med Klin 3, Klinikum Rechts Isar, D-81675 Munich, Germany.	hendrik.poeck@tum.de	Heidegger, Simon/ABF-7070-2021	Heidegger, Simon/0000-0001-6394-5130				Corrales L, 2016, J IMMUNOL, V196, P3191, DOI 10.4049/jimmunol.1502538; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Liu YL, 2016, J VIROL, V90, P9406, DOI 10.1128/JVI.00748-16; Rajput A, 2011, IMMUNITY, V34, P340, DOI 10.1016/j.immuni.2010.12.018; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037; Wang YT, 2017, IMMUNITY, V46, P393, DOI 10.1016/j.immuni.2017.02.011; White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036	9	1	1	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2017	46	3					333	335		10.1016/j.immuni.2017.03.004	http://dx.doi.org/10.1016/j.immuni.2017.03.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6QR	28329695	Bronze			2022-12-18	WOS:000396818100002
J	Narni-Mancinelli, E; Vivier, E				Narni-Mancinelli, Emilie; Vivier, Eric			Killer ILCs in the Fat	IMMUNITY			English	Editorial Material							INNATE LYMPHOID-CELLS; INSULIN-RESISTANCE; OBESITY; LINK	Innate lymphoid cells (ILCs) residing in adipose tissue participate in the pathogenesis of obesity, but their contribution toward adipose tissue homeostasis in the lean state is unclear. Boulenouar et al. (2017) now report that heterogenous type 1 ILCs in adipose tissues regulate macrophage homeostasis through cytotoxicity.	[Narni-Mancinelli, Emilie; Vivier, Eric] Aix Marseille Univ, Ctr Immunol Marseille Luminy, INSERM, CNRS, F-13009 Marseille, France; [Vivier, Eric] Hop La Timone, AP HM, F-13009 Marseille, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Narni-Mancinelli, E (corresponding author), Aix Marseille Univ, Ctr Immunol Marseille Luminy, INSERM, CNRS, F-13009 Marseille, France.	narni@ciml.univ-mrs.fr	Vivier, Eric/F-8939-2010; Narni-Mancinelli, Emilie/X-1888-2018	Vivier, Eric/0000-0001-7022-8287; Narni-Mancinelli, Emilie/0000-0002-7001-1026				Boulenouar S, 2017, IMMUNITY, V46, P273, DOI 10.1016/j.immuni.2017.01.008; Deauvieau F, 2016, CURR TOP MICROBIOL, V395, P173, DOI 10.1007/82_2015_473; Lee BC, 2016, CELL METAB, V23, P685, DOI 10.1016/j.cmet.2016.03.002; Lynch LA, 2009, OBESITY, V17, P601, DOI 10.1038/oby.2008.565; Menasche G, 2005, IMMUNOL REV, V203, P165, DOI 10.1111/j.0105-2896.2005.00224.x; O'Sullivan TE, 2016, IMMUNITY, V45, P428, DOI 10.1016/j.immuni.2016.06.016; Vely F, 2016, NAT IMMUNOL, V17, P1291, DOI 10.1038/ni.3553; Wensveen FM, 2015, NAT IMMUNOL, V16, P376, DOI 10.1038/ni.3120; Yang D, 2016, OBES REV, V17, P485, DOI 10.1111/obr.12397	9	1	1	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2017	46	2					169	171		10.1016/j.immuni.2017.02.004	http://dx.doi.org/10.1016/j.immuni.2017.02.004			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO0TM	28228274	Green Published, Bronze			2022-12-18	WOS:000396410900004
J	Le, HT; Min, B				Le, Hongnga T.; Min, Booki			Precision Targeting: Mast Cells Wipe Out Infected Bladder Epithelia	IMMUNITY			English	Editorial Material							UROPATHOGENIC ESCHERICHIA-COLI; URINARY-TRACT-INFECTIONS; HOST DEFENSES	Exfoliating infected bladder epithelium is a powerful host defense mechanism that reduces bacterial burden. In this issue of Immunity, Choi et al. (2016) present a function of mast cells that orchestrates the infected epithelial cell exfoliation via cytolytic granules.	[Le, Hongnga T.; Min, Booki] Cleveland Clin Fdn, Lerner Res Inst, Dept Immunol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Min, B (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Immunol, Cleveland, OH 44195 USA.	minb@ccf.org						Abraham SN, 2015, NAT REV IMMUNOL, V15, P655, DOI 10.1038/nri3887; Brumbaugh AR, 2012, EXPERT REV VACCINES, V11, P663, DOI [10.1586/erv.12.36, 10.1586/ERV.12.36]; Chan CY, 2013, IMMUNITY, V38, P349, DOI 10.1016/j.immuni.2012.10.019; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; Hamilton MJ, 2014, INFLAMM BOWEL DIS, V20, P2364, DOI 10.1097/MIB.0000000000000142; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829; Sivick KE, 2010, INFECT IMMUN, V78, P568, DOI 10.1128/IAI.01000-09	9	1	1	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 20	2016	45	6					1179	1181		10.1016/j.immuni.2016.12.002	http://dx.doi.org/10.1016/j.immuni.2016.12.002			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EJ0RN	28002723	Bronze			2022-12-18	WOS:000392918100002
J	Franckaert, D; Liston, A				Franckaert, Dean; Liston, Adrian			Expression Diversity Adds Richness to T Cell Populations	IMMUNITY			English	Editorial Material								Variation in protein expression is a feature of all cell populations. Using T cell subsets as a proof-of-concept, Lu et al. (2016) develop a framework for dissecting out the contributors to this cell-to-cell expression variation from high-parameter flow cytometry studies.	[Franckaert, Dean; Liston, Adrian] VIB, Translat Immunol Lab, B-3000 Leuven, Belgium; [Franckaert, Dean; Liston, Adrian] Univ Leuven, KU Leuven, Dept Microbiol & Immunol, B-3000 Leuven, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven	Liston, A (corresponding author), VIB, Translat Immunol Lab, B-3000 Leuven, Belgium.; Liston, A (corresponding author), Univ Leuven, KU Leuven, Dept Microbiol & Immunol, B-3000 Leuven, Belgium.	adrian.liston@vib.be						Antebi YE, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001616; Davis MM, 2007, ANNU REV IMMUNOL, V25, P681, DOI 10.1146/annurev.immunol.24.021605.090600; Dowling MR, 2009, TRENDS IMMUNOL, V30, P295, DOI 10.1016/j.it.2009.04.006; Lu Y, 2016, IMMUNITY, V45, P1162, DOI 10.1016/j.immuni.2016.10.025; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Ye CJ, 2014, SCIENCE, V345, P1311, DOI 10.1126/science.1254665	7	1	1	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 15	2016	45	5					960	962		10.1016/j.immuni.2016.10.019	http://dx.doi.org/10.1016/j.immuni.2016.10.019			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FP	27851924	Bronze			2022-12-18	WOS:000389473500008
J	Mack, MR; Kim, BS				Mack, Madison R.; Kim, Brian S.			Superficial Immunity: Antimicrobial Responses Are More Than Skin Deep	IMMUNITY			English	Editorial Material							INTERFERON-ALPHA; BETA	The skin barrier is essential for host defense, but how the skin provides protection when the barrier is breached is not well understood. In this issue of Immunity, Gallo and colleagues report that keratinocytes integrate signals from antimicrobial peptides via MAVS signaling to amplify their antiviral immune response.	[Mack, Madison R.; Kim, Brian S.] Washington Univ, Sch Med, Dept Med, Div Dermatol, 660 S Euclid Ave,Box 8123, St Louis, MO 63110 USA; [Mack, Madison R.; Kim, Brian S.] Washington Univ, Sch Med, Ctr Study Itch, St Louis, MO 63110 USA; [Mack, Madison R.; Kim, Brian S.] Washington Univ, Sch Med, Div Biol & Biomed Sci, St Louis, MO 63110 USA; [Kim, Brian S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Kim, Brian S.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Kim, BS (corresponding author), Washington Univ, Sch Med, Dept Med, Div Dermatol, 660 S Euclid Ave,Box 8123, St Louis, MO 63110 USA.; Kim, BS (corresponding author), Washington Univ, Sch Med, Ctr Study Itch, St Louis, MO 63110 USA.; Kim, BS (corresponding author), Washington Univ, Sch Med, Div Biol & Biomed Sci, St Louis, MO 63110 USA.; Kim, BS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Kim, BS (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.	briankim@wustl.edu	Kim, Brian/GZK-6649-2022	Kim, Brian/0000-0002-8100-7161				Chen ZH, 2007, J VIROL, V81, P964, DOI 10.1128/JVI.02076-06; Fujisawa H, 1997, J INTERF CYTOK RES, V17, P721, DOI 10.1089/jir.1997.17.721; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; Ng CT, 2015, CELL HOST MICROBE, V17, P653, DOI 10.1016/j.chom.2015.04.005; Wolk K, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006245; Zhang LJ, 2016, IMMUNITY, V45, P119, DOI 10.1016/j.immuni.2016.06.021	8	1	2	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 19	2016	45	1					6	8		10.1016/j.immuni.2016.07.001	http://dx.doi.org/10.1016/j.immuni.2016.07.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS4KC	27438760	Bronze			2022-12-18	WOS:000380749000003
J	Lewis, CA; Vander Heiden, MG				Lewis, Caroline A.; Vander Heiden, Matthew G.			InterFeriNg with Acet gamma lation: Stress-Levels of Acetate Improve Memory T Cell Function	IMMUNITY			English	Editorial Material								Catabolic stress can lead to changes in circulating acetate levels. In this issue of Immunity, Balmer et al. (2016) report that serum acetate increases in response to acute infection and describe amechanism by which this results in acetylation of the glycolytic enzyme GAPDH and improves the recall function of memory CD8(+) T cells.	[Lewis, Caroline A.; Vander Heiden, Matthew G.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Lewis, CA; Vander Heiden, MG (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lewisca@mit.edu; mvh@mit.edu						Balmer ML, 2016, IMMUNITY, V44, P1312, DOI 10.1016/j.immuni.2016.03.016; BEISEL WR, 1975, ANNU REV MED, V26, P9, DOI 10.1146/annurev.me.26.020175.000301; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Comerford SA, 2014, CELL, V159, P1591, DOI 10.1016/j.cell.2014.11.020; KNOWLES SE, 1974, BIOCHEM J, V142, P401, DOI 10.1042/bj1420401; Li TT, 2014, J BIOL CHEM, V289, P3775, DOI 10.1074/jbc.M113.531640; Loftus RM, 2016, J BIOL CHEM, V291, P1, DOI 10.1074/jbc.R115.693903; Mashimo T, 2014, CELL, V159, P1603, DOI 10.1016/j.cell.2014.11.025; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Schug ZT, 2015, CANCER CELL, V27, P57, DOI 10.1016/j.ccell.2014.12.002	10	1	1	2	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 21	2016	44	6					1243	1245		10.1016/j.immuni.2016.06.004	http://dx.doi.org/10.1016/j.immuni.2016.06.004			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP2SE	27332725	Bronze			2022-12-18	WOS:000378341200002
J	Walker, CM; Lemon, SM				Walker, Christopher M.; Lemon, Stanley M.			Getting the Skinny on CD4(+) T Cell Survival in Fatty Livers	IMMUNITY			English	Editorial Material							HEPATOCELLULAR-CARCINOMA; IMMUNOTHERAPY	Non-alcoholic fatty liver disease is associated with hepatocellular carcinoma. In the March 10 issue of Nature, Greten and colleagues report that this metabolic disruption affects tumor surveillance by depleting CD4+ T helper cells through lipotoxic mechanisms associated with NAFLD.	[Walker, Christopher M.] Ohio State Univ, Nationwide Childrens Hosp, Ctr Vaccines & Immun, Columbus, OH 43205 USA; [Walker, Christopher M.] Ohio State Univ, Dept Pediat, Coll Med, Columbus, OH 43205 USA; [Lemon, Stanley M.] Univ N Carolina, Dept Med, Div Infect Dis, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27517 USA; [Lemon, Stanley M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27517 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Walker, CM (corresponding author), Ohio State Univ, Nationwide Childrens Hosp, Ctr Vaccines & Immun, Columbus, OH 43205 USA.; Walker, CM (corresponding author), Ohio State Univ, Dept Pediat, Coll Med, Columbus, OH 43205 USA.	christopher.walker@nationwidechildrens.org			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047367] Funding Source: NIH RePORTER; NIAID NIH HHS [R37 AI047367] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Angulo P, 2015, SEMIN LIVER DIS, V35, P132, DOI 10.1055/s-0035-1550065; Gelband H., 2015, CANC DIS CONTROL PRI, V3, P147; Goossens N, 2014, HEPATOLOGY, V59, P2403, DOI 10.1002/hep.26905; Knolle PA, 2016, CURR OPIN IMMUNOL, V40, P36, DOI 10.1016/j.coi.2016.02.009; Ma C, 2016, NATURE, V531, P253, DOI 10.1038/nature16969; Machado M. V., 2016, GASTROENTEROLOGY; Prieto J, 2015, NAT REV GASTRO HEPAT, V12, P681, DOI 10.1038/nrgastro.2015.173; Schmidt N, 2012, DIGEST DIS, V30, P483, DOI 10.1159/000341697; Wang DQH, 2013, COMPR PHYSIOL, V3, P1493, DOI 10.1002/cphy.c130001; Zoller H., 2016, METABOLISM, P00025	10	1	1	1	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 19	2016	44	4					725	727		10.1016/j.immuni.2016.04.001	http://dx.doi.org/10.1016/j.immuni.2016.04.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ8EC	27096315	Green Accepted, Bronze			2022-12-18	WOS:000374444300006
J	Di Paolo, NC; Shafiani, S; Day, T; Papayannopoulou, T; Russell, DW; Iwakura, Y; Sherman, D; Urdahl, K; Shayakhmetov, DM				Di Paolo, Nelson C.; Shafiani, Shahin; Day, Tracey; Papayannopoulou, Thalia; Russell, David W.; Iwakura, Yoichiro; Sherman, David; Urdahl, Kevin; Shayakhmetov, Dmitry M.			Interdependence between Interleukin-1 and Tumor Necrosis Factor Regulates TNF-Dependent Control of Mycobacterium tuberculosis Infection (vol 43, pg 1125, 2015)	IMMUNITY			English	Correction												ncdipaolo@emory.edu; dmitryshay@emory.edu	Iwakura, Yoichiro/E-5457-2011	Iwakura, Yoichiro/0000-0002-9934-5775; Urdahl, Kevin/0000-0003-0088-1066				Di Paolo NC, 2015, IMMUNITY, V43, P1125, DOI 10.1016/j.immuni.2015.11.016	1	1	1	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 16	2016	44	2					438	438		10.1016/j.immuni.2016.01.005	http://dx.doi.org/10.1016/j.immuni.2016.01.005			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE0DC		Bronze			2022-12-18	WOS:000370294000024
J	Heaton, NS; Moshkina, N; Fenouil, R; Gardner, TJ; Aguirre, S; Shah, PS; Zhao, N; Manganaro, L; Hultquist, JF; Noel, J; Sachs, D; Hamilton, J; Leon, PE; Chawdury, A; Tripathi, S; Melegari, C; Campisi, L; Hai, R; Metreveli, G; Gamarnik, AV; Garcia-Sastre, A; Greenbaum, B; Simon, V; Fernandez-Sesma, A; Krogan, NJ; Mulder, LCF; van Bakel, H; Tortorella, D; Taunton, J; Palese, P; Marazzi, I				Heaton, Nicholas S.; Moshkina, Natasha; Fenouil, Romain; Gardner, Thomas J.; Aguirre, Sebastian; Shah, Priya S.; Zhao, Nan; Manganaro, Lara; Hultquist, Judd F.; Noel, Justine; Sachs, David; Hamilton, Jennifer; Leon, Paul E.; Chawdury, Amit; Tripathi, Shashank; Melegari, Camilla; Campisi, Laura; Hai, Rong; Metreveli, Giorgi; Gamarnik, Andrea V.; Garcia-Sastre, Adolfo; Greenbaum, Benjamin; Simon, Viviana; Fernandez-Sesma, Ana; Krogan, Nevan J.; Mulder, Lubbertus C. F.; van Bakel, Harm; Tortorella, Domenico; Taunton, Jack; Palese, Peter; Marazzi, Ivan			Targeting Viral Proteostasis Limits Influenza Virus, HIV, and Dengue Virus Infection (vol 44, pg 46, 2016)	IMMUNITY			English	Correction												ivan.marazzi@mssm.edu	simon, viviana/A-9131-2008; Manganaro, Lara/AAL-8632-2020; Campisi, Laura/AAL-2064-2021	simon, viviana/0000-0002-6416-5096; Manganaro, Lara/0000-0003-2743-2658; Campisi, Laura/0000-0003-4173-4521; Garcia-Sastre, Adolfo/0000-0002-6551-1827; Tortorella, Domenico/0000-0003-0961-3535; Palese, Peter/0000-0002-0337-5823; marazzi, ivan/0000-0003-3376-0922; Fernandez-Sesma, Ana/0000-0002-3405-6702; Aguirre, Sebastian/0000-0001-6079-5544				Heaton NS, 2016, IMMUNITY, V44, P46, DOI 10.1016/j.immuni.2015.12.017	1	1	2	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 16	2016	44	2					438	438		10.1016/j.immuni.2016.01.016	http://dx.doi.org/10.1016/j.immuni.2016.01.016			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE0DC		Green Published, Bronze			2022-12-18	WOS:000370294000023
J	Koning, JJ; Mebius, RE				Koning, Jasper J.; Mebius, Reina E.			Fungi Take Control of Lymphocyte Recirculation	IMMUNITY			English	Editorial Material							CELLS; NODES	Factors regulating leukocyte migration to neonatal lymph nodes are not sufficiently identified. In this issue of Immunity, Zhang et al. (2016) reveal that fungi drive emigration of gut DCs to lymph nodes, where these DCs instruct endothelial cell receptivity to leukocytes.	[Koning, Jasper J.; Mebius, Reina E.] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, NL-1081 HZ Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Mebius, RE (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, NL-1081 HZ Amsterdam, Netherlands.	r.mebius@vumc.nl		Mebius, Reina/0000-0003-0451-7464				BAUER H, 1963, AM J PATHOL, V42, P471; Girard JP, 2012, NAT REV IMMUNOL, V12, P762, DOI 10.1038/nri3298; Mebius RE, 1996, P NATL ACAD SCI USA, V93, P11019, DOI 10.1073/pnas.93.20.11019; Molenaar R, 2011, J IMMUNOL, V186, P1934, DOI 10.4049/jimmunol.1001672; Moussion C., 2011, NATURE, V479, P542; Netea MG, 2015, NAT REV IMMUNOL, V15, P630, DOI 10.1038/nri3897; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; Wendland M, 2011, IMMUNITY, V35, P945, DOI 10.1016/j.immuni.2011.10.017; Zhang ZD, 2016, IMMUNITY, V44, P330, DOI 10.1016/j.immuni.2016.01.004	9	1	1	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 16	2016	44	2					211	213		10.1016/j.immuni.2016.01.017	http://dx.doi.org/10.1016/j.immuni.2016.01.017			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE0DC	26885851	Bronze			2022-12-18	WOS:000370294000003
J	Netea, MG; Joosten, LAB				Netea, Mihai G.; Joosten, Leo A. B.			TLRs of Our Fathers	IMMUNITY			English	Editorial Material							INNATE IMMUNITY GENES; NEANDERTHAL; INTROGRESSION; SELECTION; GENOME; HUMANS	Two new studies published in The American Journal of Human Genetics (Dannemann et al., 2016; Deschamps et al., 2016) show that introgression of innate immune genes from Neandertals and Denisovans contributed to the modern genome of European and Asian, but not African, populations, and this might partly explain differences in susceptibility to immune-mediated diseases.	[Netea, Mihai G.; Joosten, Leo A. B.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 GA Nijmegen, Netherlands; [Netea, Mihai G.; Joosten, Leo A. B.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis RCI, NL-6525 GA Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Netea, MG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 GA Nijmegen, Netherlands.; Netea, MG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis RCI, NL-6525 GA Nijmegen, Netherlands.	mihai.netea@radboudumc.nl	Joosten, Leo AB/H-3138-2015; Netea, Mihai/N-5155-2014	Joosten, Leo AB/0000-0001-6166-9830; 				Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; Dannemann M, 2016, AM J HUM GENET, V98, P22, DOI 10.1016/j.ajhg.2015.11.015; Deschamps M, 2016, AM J HUM GENET, V98, P5, DOI 10.1016/j.ajhg.2015.11.014; Ferrer-Admetlla A, 2008, J IMMUNOL, V181, P1315, DOI 10.4049/jimmunol.181.2.1315; Fumagalli M, 2014, CURR OPIN IMMUNOL, V30, P9, DOI 10.1016/j.coi.2014.05.001; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Grossman SR, 2013, CELL, V152, P703, DOI 10.1016/j.cell.2013.01.035; Oosting M, 2014, P NATL ACAD SCI USA, V111, pE4478, DOI 10.1073/pnas.1410293111; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961	9	1	1	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 16	2016	44	2					218	220		10.1016/j.immuni.2016.02.003	http://dx.doi.org/10.1016/j.immuni.2016.02.003			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE0DC	26885854	Bronze			2022-12-18	WOS:000370294000006
J	Germain, RN; Fowlkes, BJ; Samelson, LE; Leonard, WJ				Germain, Ronald N.; Fowlkes, B. J.; Samelson, Lawrence E.; Leonard, Warren J.			William E. Paul, MD (1936-2015)	IMMUNITY			English	Biographical-Item									[Germain, Ronald N.] NIAID, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Fowlkes, B. J.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Samelson, Lawrence E.] NCI, Lab Cellular & Mol Biol, NIH, Bethesda, MD 20892 USA; [Leonard, Warren J.] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Leonard, Warren J.] NHLBI, Ctr Immunol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Germain, RN (corresponding author), NIAID, Lab Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	rgermain@nih.gov	Germain, Ronald N./Z-1945-2019; Germain, Ronald/ABE-7090-2020; Leonard, Warren/AAA-1397-2022					PAUL WE, PUBLICATION LIST	1	1	1	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 20	2015	43	4					617	619		10.1016/j.immuni.2015.10.006	http://dx.doi.org/10.1016/j.immuni.2015.10.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CU4ED	26788561	Bronze			2022-12-18	WOS:000363478700001
J	Barchet, W; Zillinger, T				Barchet, Winfried; Zillinger, Thomas			Exonuclease TREX1 also Has a Sweet Tooth	IMMUNITY			English	Editorial Material							AICARDI-GOUTIERES SYNDROME; DNA; DISEASE	TREX1 regulates innate immune responses by counteracting DNA accumulation in the cytosol. In this issue of Immunity, Hasan et al. (2015) show that TREX1 also safeguards the cell against free glycan build-up in the endoplasmic reticulum, thereby preventing glycan-induced inflammation.	[Barchet, Winfried; Zillinger, Thomas] Univ Bonn, Inst Clin Chem & Clin Pharmacol, Univ Hosp, D-53127 Bonn, Germany; [Barchet, Winfried] Univ Bonn, German Ctr Infect Res DZIF, Univ Hosp, D-53127 Bonn, Germany	University of Bonn; German Center for Infection Research; University of Bonn	Barchet, W (corresponding author), Univ Bonn, Inst Clin Chem & Clin Pharmacol, Univ Hosp, D-53127 Bonn, Germany.	winfried.barchet@ukb.uni-bonn.de	Zillinger, Thomas/AAD-7320-2020	Zillinger, Thomas/0000-0002-0866-4835; Barchet, Winfried/0000-0002-6745-6606				Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Gray EE, 2015, J IMMUNOL, V195, P1939, DOI 10.4049/jimmunol.1500969; Grieves JL, 2015, P NATL ACAD SCI USA, V112, P5117, DOI 10.1073/pnas.1423804112; Hasan M, 2015, IMMUNITY, V43, P463, DOI 10.1016/j.immuni.2015.07.022; Hasan M, 2013, NAT IMMUNOL, V14, P61, DOI 10.1038/ni.2475; Junt T, 2015, NAT REV IMMUNOL, V15, P529, DOI 10.1038/nri3875; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Rabinovich GA, 2012, ANN NY ACAD SCI, V1253, P1, DOI 10.1111/j.1749-6632.2012.06492.x; Richards A, 2007, NAT GENET, V39, P1068, DOI 10.1038/ng2082; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032	10	1	1	1	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2015	43	3					411	413		10.1016/j.immuni.2015.08.026	http://dx.doi.org/10.1016/j.immuni.2015.08.026			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CR8BE	26377892	Bronze			2022-12-18	WOS:000361575300002
J	Lee, V; Savage, PA				Lee, Victoria; Savage, Peter A.			Close Encounters of the Tertiary Kind	IMMUNITY			English	Editorial Material							CANCER; ANTIBODIES	Elucidating the function of tumor-infiltrating regulatory T (Treg) cells has been difficult. In this issue of Immunity, Joshi et al. (2015) demonstrate that Treg cells associated with murine lung cancers are found within tertiary lymphoid structures and actively restrain effector T cells at the tumor site.	[Lee, Victoria; Savage, Peter A.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago	Savage, PA (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	psavage@bsd.uchicago.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110507] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI110507] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		deLeeuw RJ, 2012, CLIN CANCER RES, V18, P3022, DOI 10.1158/1078-0432.CCR-11-3216; Dieu-Nosjean MC, 2014, TRENDS IMMUNOL, V35, P571, DOI 10.1016/j.it.2014.09.006; Furness AJS, 2014, TRENDS IMMUNOL, V35, P290, DOI 10.1016/j.it.2014.05.002; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Joshi NS, 2015, IMMUNITY, V43, P579, DOI 10.1016/j.immuni.2015.08.006; McFadden DG, 2014, CELL, V156, P1298, DOI 10.1016/j.cell.2014.02.031; Page DB, 2014, ANNU REV MED, V65, P185, DOI 10.1146/annurev-med-092012-112807; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Westcott PMK, 2015, NATURE, V517, P489, DOI 10.1038/nature13898	9	1	1	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2015	43	3					418	420		10.1016/j.immuni.2015.08.022	http://dx.doi.org/10.1016/j.immuni.2015.08.022			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CR8BE	26377895	Bronze			2022-12-18	WOS:000361575300005
J	Schoggins, JW				Schoggins, John W.			A Sense of Self: RIG-I's Tolerance to Host RNA	IMMUNITY			English	Editorial Material							STRANDED-RNA; RECOGNITION; ACTIVATION; MDA5	The innate immune sensor RIG-I recognizes viral RNA while avoiding unwanted activation by self RNA. In this issue of Immunity, Schuberth-Wagner et al. (2015) show that a histidine residue in the RNA binding pocket of RIG-I sterically excludes the cap1 structure of self RNA, thereby preventing downstream activation.	Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Schoggins, JW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA.	john.schoggins@utsouthwestern.edu						Anchisi S, 2015, MBIO, V6, DOI 10.1128/mBio.02349-14; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Kolakofsky D, 2012, RNA, V18, P2118, DOI 10.1261/rna.035949.112; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schuberth-Wagner C, 2015, IMMUNITY, V43, P41, DOI 10.1016/j.immuni.2015.06.015; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048; Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979	10	1	1	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 21	2015	43	1					1	2		10.1016/j.immuni.2015.06.022	http://dx.doi.org/10.1016/j.immuni.2015.06.022			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WV	26200004	Bronze			2022-12-18	WOS:000360101100001
J	Ichiyama, K; Chen, TT; Wang, XH; Yan, XW; Kim, BS; Tanaka, S; Ndiaye-Lobry, D; Deng, YH; Zou, YL; Zheng, P; Tian, Q; Aifantis, I; Wei, L; Dong, C				Ichiyama, Kenji; Chen, Tingting; Wang, Xiaohu; Yan, Xiaowei; Kim, Byung-Seok; Tanaka, Shinya; Ndiaye-Lobry, Delphine; Deng, Yuhua; Zou, Yanli; Zheng, Pan; Tian, Qiang; Aifantis, Iannis; Wei, Lai; Dong, Chen			The Methylcytosine Dioxygenase Tet2 Promotes DNA Demethylation and Activation of Cytokine Gene Expression in T Cells (vol 42, pg 613, 2015)	IMMUNITY			English	Correction												weil9@mail.sysu.edu.cn; chendong@tsinghua.edu.cn	Tanaka, Shinya/AAO-8771-2021; Zheng, Pan/E-8691-2011; dong, chen/B-3181-2009; Tanaka, Shinya/D-3586-2011	Tanaka, Shinya/0000-0001-6470-3301; Zheng, Pan/0000-0003-2598-3544; dong, chen/0000-0002-0084-9130; Ichiyama, Kenji/0000-0002-3340-9799				Ichiyama K, 2015, IMMUNITY, V42, P613, DOI 10.1016/j.immuni.2015.03.005	1	1	1	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2015	42	6					1214	1214		10.1016/j.immuni.2015.06.005	http://dx.doi.org/10.1016/j.immuni.2015.06.005			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK6UC		Bronze			2022-12-18	WOS:000356362800024
J	Kitz, A; Hafler, DA				Kitz, Alexandra; Hafler, David A.			Thymic Selection: To Thine Own Self Be True	IMMUNITY			English	Editorial Material							T-CELL RECOGNITION; TOLERANCE; ANTIGEN	It has been shown that self-reactive T cells can be detected in the periphery. In this issue of Immunity, Yu et al. (2015) show that clonal deletion prunes the T cell repertoire but does not eliminate self-reactive T cell clones.	[Kitz, Alexandra; Hafler, David A.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA; [Kitz, Alexandra; Hafler, David A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Yale University; Yale University	Hafler, DA (corresponding author), Yale Univ, Sch Med, Dept Neurol, 333 Cedar St, New Haven, CT 06520 USA.	david.hafler@yale.edu						Birnbaum ME, 2014, CELL, V157, P1073, DOI 10.1016/j.cell.2014.03.047; Burnet SFM., 1959, CLONAL SELECTION THE, DOI 10.5962/bhl.title.8281; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; OTA K, 1990, NATURE, V346, P183, DOI 10.1038/346183a0; Su LF, 2013, IMMUNITY, V38, P373, DOI 10.1016/j.immuni.2012.10.021; VIDOVIC D, 1988, NATURE, V336, P222, DOI 10.1038/336222a0; Wooldridge L, 2012, J BIOL CHEM, V287, P1168, DOI 10.1074/jbc.M111.289488; Yu W, 2015, IMMUNITY, V42, P929, DOI 10.1016/j.immuni.2015.05.001	10	1	1	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2015	42	5					788	789		10.1016/j.immuni.2015.05.007	http://dx.doi.org/10.1016/j.immuni.2015.05.007			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI5VH	25992854	Bronze			2022-12-18	WOS:000354827400005
J	Beura, LK; Masopust, D				Beura, Lalit K.; Masopust, David			Infected Cells Call Their Killers to the Scene of the Crime	IMMUNITY			English	Editorial Material							T-CELLS; RESPONSES; CHEMOKINES; GUIDANCE		[Beura, Lalit K.; Masopust, David] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Beura, Lalit K.; Masopust, David] Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Masopust, D (corresponding author), Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA.	masopust@umn.edu	masopust, david/B-5027-2008; Beura, Lalit/W-6281-2019					Ariotti S, 2012, P NATL ACAD SCI USA, V109, P19739, DOI 10.1073/pnas.1208927109; Friedman RS, 2006, NAT IMMUNOL, V7, P1101, DOI 10.1038/ni1384; Harris TH, 2012, NATURE, V486, P545, DOI 10.1038/nature11098; Hickman HD, 2013, CELL HOST MICROBE, V13, P155, DOI 10.1016/j.chom.2013.01.004; Kastenmuller W, 2013, IMMUNITY, V38, P502, DOI 10.1016/j.immuni.2012.11.012; Mueller SN, 2013, IMMUNOL CELL BIOL, V91, P290, DOI 10.1038/icb.2012.75; Sung JH, 2012, CELL, V150, P1249, DOI 10.1016/j.cell.2012.08.015; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831	9	1	1	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2015	42	3					399	401		10.1016/j.immuni.2015.03.001	http://dx.doi.org/10.1016/j.immuni.2015.03.001			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CD7VE	25786170	Bronze			2022-12-18	WOS:000351301900004
J	Nagao, K; Udey, MC				Nagao, Keisuke; Udey, Mark C.			Mushrooming Insights into Skin Dendritic Cell Physiology	IMMUNITY			English	Editorial Material							CHRONIC MUCOCUTANEOUS CANDIDIASIS; IMMUNITY; RESIDENT	Mechanisms responsible for protective immunity against epicutaneous Candida infections are incompletely characterized. In this issue of Immunity, Kashem et al. demonstrate that different Candida life forms engage selected skin dendritic cell subsets in distinct compartments, resulting in qualitatively different immune responses.	[Nagao, Keisuke; Udey, Mark C.] NCI, Dermatol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Nagao, K (corresponding author), NCI, Dermatol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	keisuke.nagao@nih.gov; udeym@mail.nih.gov	Nagao, Keisuke/P-3837-2018; Nagao, Keisuke/J-5116-2013	Nagao, Keisuke/0000-0002-7005-3138; Nagao, Keisuke/0000-0002-7005-3138	NATIONAL CANCER INSTITUTE [ZIABC011561] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Heath WR, 2013, NAT IMMUNOL, V14, P978, DOI 10.1038/ni.2680; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Kashem SW, 2015, IMMUNITY, V42, P356, DOI 10.1016/j.immuni.2015.01.008; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Marakalala MJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003315; Maubon D, 2014, INTENS CARE MED, V40, P1241, DOI 10.1007/s00134-014-3404-7; Ouchi T, 2011, J EXP MED, V208, P2607, DOI 10.1084/jem.20111718; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Sampaio EP, 2013, J ALLERGY CLIN IMMUN, V131, P1624, DOI 10.1016/j.jaci.2013.01.052	10	1	1	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 17	2015	42	2					210	213		10.1016/j.immuni.2015.01.025	http://dx.doi.org/10.1016/j.immuni.2015.01.025			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB8XT	25692697	Bronze			2022-12-18	WOS:000349916400005
B	Paul, WE	Paul, WE			Paul, William E.	Paul, WE		Tracing an Immune Response	IMMUNITY			English	Article; Book Chapter																			0	1	1	0	0	JOHNS HOPKINS UNIV PRESS	BALTIMORE	2715 N CHARLES ST, BALTIMORE, MD 21218-4319 USA			978-1-4214-1802-5; 978-1-4214-1801-8				2015							14	19						6	Immunology	Book Citation Index – Science (BKCI-S)	Immunology	BD7YP					2022-12-18	WOS:000363697400003
J	Basler, CF				Basler, Christopher F.			New Hope in the Search for Ebola Virus Treatments	IMMUNITY			English	Editorial Material							ANTIBODY; PROTECTION	Because of its lethality, the Ebola virus often appears to be an invincible adversary. In Nature, Qiu et al. (2014) recently described the complete protection of nonhuman primates from deadly Ebola virus disease, even when treatment was begun as late as 5 days after infection.	Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Basler, CF (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.	chris.basler@mssm.edu	Basler, Christopher/AAG-8346-2019	Basler, Christopher/0000-0003-4195-425X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109945, R01AI059536, U19AI109664] Funding Source: NIH RePORTER; NIAID NIH HHS [R01AI05953, U19 AI109664, U19AI109945, U19 AI109945, U19AI109664, R01 AI059536] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bente D, 2009, DIS MODEL MECH, V2, P12, DOI 10.1242/dmm.000471; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; Dias JM, 2011, NAT STRUCT MOL BIOL, V18, P1424, DOI 10.1038/nsmb.2150; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Martinez O, 2011, J INFECT DIS, V204, pS825, DOI 10.1093/infdis/jir295; Pettitt J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006608; Qiu X., 2014, NATURE, V2014, P29; Qiu XG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006605; Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027; Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664	10	1	2	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2014	41	4					515	517		10.1016/j.immuni.2014.10.001	http://dx.doi.org/10.1016/j.immuni.2014.10.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3HY	25367568	Bronze			2022-12-18	WOS:000345504300006
J	Huang, SCC; Pearce, EJ				Huang, Stanley Ching-Cheng; Pearce, Edward J.			For Macrophages, Ndufs Is Enough	IMMUNITY			English	Editorial Material							COMPLEX-I; INFLAMMATION	Proinflammatory macrophage activation is coupled to a metabolic switch toward glycolysis. In Cell Metabolism, Jin et al. (2014) show that this process is negatively regulated by mitochondrial electron transport chain complex I through both cell intrinsic and extrinsic pathways.	[Huang, Stanley Ching-Cheng; Pearce, Edward J.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Pearce, EJ (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	edwardpearce@path.wustl.edu	Huang, Stanley Ching-Cheng/AAE-7866-2019	Huang, Stanley Ching-Cheng/0000-0002-6557-3737				Chen YQ, 2007, J CELL SCI, V120, P4155, DOI 10.1242/jcs.011163; Colegio OR, 2014, NATURE; Erridge C, 2009, ARTERIOSCL THROM VAS, V29, P1944, DOI 10.1161/ATVBAHA.109.194050; Jin ZX, 2014, CELL METAB, V20, P483, DOI 10.1016/j.cmet.2014.07.011; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Leong DW, 2012, J BIOL CHEM, V287, P20652, DOI 10.1074/jbc.M111.327601; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Papa S, 2012, FEBS LETT, V586, P568, DOI 10.1016/j.febslet.2011.09.019; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022	10	1	2	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2014	41	3					351	353		10.1016/j.immuni.2014.09.004	http://dx.doi.org/10.1016/j.immuni.2014.09.004			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ2ON	25238092	Bronze			2022-12-18	WOS:000342626500006
J	Anderson, G; Baik, S				Anderson, Graham; Baik, Song			The Primordial Thymus: Everything You Need Under One Roof	IMMUNITY			English	Editorial Material							T-CELL DEVELOPMENT; EPITHELIAL-CELLS; SELECTION	Lymphocytes normally develop within anatomically distinct tissues. In Cell Reports, Swann et al. (2014) reconstruct the primordial thymus and suggest that it was a site of combined T and B lymphopoiesis before evolving into an organ specialized for T cell production.	[Anderson, Graham; Baik, Song] Univ Birmingham, Ctr Immune Regulat, Sch Immun & Infect, MRC, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Anderson, G (corresponding author), Univ Birmingham, Ctr Immune Regulat, Sch Immun & Infect, MRC, Birmingham B15 2TT, W Midlands, England.	g.anderson@bham.ac.uk		anderson, graham/0000-0002-2917-4085	Medical Research Council [G1000213] Funding Source: Medline; MRC [G1000213] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; Anderson G, 2012, TRENDS IMMUNOL, V33, P256, DOI 10.1016/j.it.2012.03.005; Bajoghli B, 2011, NATURE, V470, P90, DOI 10.1038/nature09655; Calderon L, 2012, CELL, V149, P159, DOI 10.1016/j.cell.2012.01.049; COOPER MD, 1966, J EXP MED, V123, P75, DOI 10.1084/jem.123.1.75; Perera J, 2013, P NATL ACAD SCI USA, V110, P17011, DOI 10.1073/pnas.1313001110; Shah DK, 2014, J IMMUNOL, V192, P4017, DOI 10.4049/jimmunol.1302259; Swann J.B., 2014, CELL REPORTS, V8; Zamisch M, 2005, J IMMUNOL, V174, P60, DOI 10.4049/jimmunol.174.1.60; Zhang SL, 2014, CURR TOP MICROBIOL, V373, P87, DOI 10.1007/82_2013_324	10	1	1	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2014	41	2					178	180		10.1016/j.immuni.2014.07.012	http://dx.doi.org/10.1016/j.immuni.2014.07.012			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6JA	25148021	Bronze, Green Published			2022-12-18	WOS:000341455300006
J	Locati, M				Locati, Massimo			Macrophages Have a Grip on the Gut	IMMUNITY			English	Editorial Material							POSTOPERATIVE ILEUS; MICE	We host a world inside, and every day, new evidence reveals how relevant our microbiota is for daily living. In the most recent issue of Cell, Muller and colleagues demonstrate that microbiota commensals also influence colon peristalsis via a direct effect of muscolaris externae macrophages (Muller et al., 2014).	[Locati, Massimo] Univ Milan, Dept Med Biotechnol & Translat Med, I-20122 Milan, Italy; [Locati, Massimo] Humanitas Clin & Res Ctr, Milan, Italy	University of Milan	Locati, M (corresponding author), Univ Milan, Dept Med Biotechnol & Translat Med, I-20122 Milan, Italy.	massimo.locati@humanitasresearch.it	Locati, Massimo/ABF-6807-2021; Locati, Massimo/H-8404-2015	Locati, Massimo/0000-0003-3077-590X				Boeckxstaens GE, 2009, GUT, V58, P1300, DOI 10.1136/gut.2008.169250; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Chalazonitis A, 2008, J COMP NEUROL, V509, P474, DOI 10.1002/cne.21770; De Jonge WJ, 2003, GASTROENTEROLOGY, V125, P1137, DOI 10.1016/S0016-5085(03)01197-1; Kalff JC, 1999, SURGERY, V126, P498, DOI 10.1016/S0039-6060(99)70091-7; Mikkelsen HB, 2010, J CELL MOL MED, V14, P818, DOI 10.1111/j.1582-4934.2010.01025.x; Mikkelsen HB, 1999, CELL TISSUE RES, V295, P485, DOI 10.1007/s004410051254; Muller P.A., 2014, CELL, V158; Wehner S, 2007, GUT, V56, P176, DOI 10.1136/gut.2005.089615; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034	10	1	1	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2014	41	1					11	13		10.1016/j.immuni.2014.07.002	http://dx.doi.org/10.1016/j.immuni.2014.07.002			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6FC	25035949	Bronze			2022-12-18	WOS:000341444200006
J	Sorbara, MT; Ellison, LK; Ramjeet, M; Travassos, LH; Jones, NL; Girardin, SE; Philpott, DJ				Sorbara, Matthew T.; Ellison, Lisa K.; Ramjeet, Mahendrasingh; Travassos, Leonardo H.; Jones, Nicola L.; Girardin, Stephen E.; Philpott, Dana J.			The Protein ATG16L1 Suppresses Inflammatory Cytokines Induced by the Intracellular Sensors Nod1 and Nod2 in an Autophagy-Independent Manner(vol 39, pg 858, 2013)	IMMUNITY			English	Correction												dana.philpott@utoronto.ca						Sorbara MT, 2013, IMMUNITY, V39, P858, DOI 10.1016/j.immuni.2013.10.013	1	1	1	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2014	40	2					303	303		10.1016/j.immuni.2014.01.001	http://dx.doi.org/10.1016/j.immuni.2014.01.001			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB2QQ		Bronze			2022-12-18	WOS:000331637600016
J	Hardy, RR; Roederer, M				Hardy, Richard R.; Roederer, Mario			Leonard Herzenberg (1931-2013): The Life of FACS Obituary	IMMUNITY			English	Biographical-Item									[Hardy, Richard R.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Roederer, Mario] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	Fox Chase Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Roederer, M (corresponding author), NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA.	roederer@nih.gov	Roederer, Mario/G-1887-2011					HERZENBERG L, PUBLICATION LIST	1	1	1	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 12	2013	39	6					989	991		10.1016/j.immuni.2013.11.008	http://dx.doi.org/10.1016/j.immuni.2013.11.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UZ	24479158	Bronze			2022-12-18	WOS:000330951000002
J	Ward, PA				Ward, Peter A.			The Bipolar Role of miR-466l in Inflammation	IMMUNITY			English	Editorial Material							EXTRACELLULAR HISTONES; MEDIATORS; SEPSIS; DEATH		Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Ward, PA (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	pward@umich.edu						Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Korns D, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00057; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Li YS, 2013, IMMUNITY, V39, P885, DOI 10.1016/j.immuni.2013.10.011; Lomas-Niera JL, 2005, SHOCK, V24, P33, DOI 10.1097/01.shk.0000191411.48719.ab; Recchiuti A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00298; Serhan CN, 2009, J THROMB HAEMOST, V7, P44, DOI 10.1111/j.1538-7836.2009.03396.x; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Xu J, 2011, J IMMUNOL, V187, P2626, DOI 10.4049/jimmunol.1003930; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053	10	1	1	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 14	2013	39	5					801	802		10.1016/j.immuni.2013.10.014	http://dx.doi.org/10.1016/j.immuni.2013.10.014			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UV	24238336	Bronze			2022-12-18	WOS:000330950600003
J	Bowie, AG				Bowie, Andrew G.			Removing the TREX1 Safety Net: Oxidized DNA Overcomes Immune Silencing by Exonuclease TREX1	IMMUNITY			English	Editorial Material							AUTOIMMUNITY		Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland	Trinity College Dublin	Bowie, AG (corresponding author), Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland.	agbowie@tcd.ie		Bowie, Andrew/0000-0001-5316-4373				Chamilos G, 2012, BLOOD, V120, P3699, DOI 10.1182/blood-2012-01-401364; Gehrke N, 2013, IMMUNITY, V39, P482, DOI 10.1016/j.immuni.2013.08.004; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; LUNEC J, 1994, FEBS LETT, V348, P131, DOI 10.1016/0014-5793(94)00583-4; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Xiao TS, 2013, MOL CELL, V51, P135, DOI 10.1016/j.molcel.2013.07.004; Zelenay S, 2013, TRENDS IMMUNOL, V34, P329, DOI 10.1016/j.it.2013.03.005	9	1	1	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2013	39	3					423	425		10.1016/j.immuni.2013.08.023	http://dx.doi.org/10.1016/j.immuni.2013.08.023			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UM	24054323	Green Submitted, Bronze			2022-12-18	WOS:000330949600004
J	Miller, E; Bhardwaj, N				Miller, Elizabeth; Bhardwaj, Nina			A Bloody Mess: Dendritic Cells Use Hemophagocytosis to Regulate Viral Inflammation	IMMUNITY			English	Editorial Material							IN-VIVO; INFECTION; BLOCKADE; MICE		[Miller, Elizabeth] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Med, Div Infect Dis, New York, NY 10029 USA; [Bhardwaj, Nina] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Div Hematol & Oncol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Bhardwaj, N (corresponding author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, Div Hematol & Oncol, New York, NY 10029 USA.	nina.bhardwaj@mssm.edu		Bhardwaj, Nina/0000-0003-1865-4187	NIAID NIH HHS [R37 AI044628] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI044628] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Frleta D, 2012, J CLIN INVEST, V122, P4685, DOI 10.1172/JCI64439; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Krebs P, 2011, BLOOD, V117, P6582, DOI 10.1182/blood-2011-01-329607; Naicker DD, 2009, J INFECT DIS, V200, P448, DOI 10.1086/600072; Ohyagi H, 2013, IMMUNITY, V39, P584, DOI 10.1016/j.immuni.2013.06.019; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662	10	1	1	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2013	39	3					429	431		10.1016/j.immuni.2013.08.024	http://dx.doi.org/10.1016/j.immuni.2013.08.024			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UM	24054326	Green Accepted, Bronze			2022-12-18	WOS:000330949600007
J	Libby, P; Lichtman, AH; Hansson, GK				Libby, Peter; Lichtman, Andrew H.; Hansson, Goeran K.			Immune Effector Mechanisms Implicated in Atherosclerosis: From Mice to Humans (vol 38, pg 1092, 2013)	IMMUNITY			English	Correction												plibby@rics.bwh.harvard.edu	Libby, Peter/AAY-6404-2021	Libby, Peter/0000-0002-1502-502X				Libby P, 2013, IMMUNITY, V38, P1092, DOI 10.1016/j.immuni.2013.06.009	1	1	1	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 22	2013	39	2					413	413		10.1016/j.immuni.2013.07.015	http://dx.doi.org/10.1016/j.immuni.2013.07.015			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UE		Bronze			2022-12-18	WOS:000330948800021
J	Marshall, HD; Kaech, SM				Marshall, Heather D.; Kaech, Susan M.			Generating CD8 T Cell Heterogeneity: Attack of the Clones	IMMUNITY			English	Editorial Material							EFFECTOR; DIFFERENTIATION; DIVISION	Pathogen-induced inflammation modulates CD8 T cell effector and memory differentiation. In this issue of Immunity, Plumlee et al. (2013) demonstrate that clonally distinct CD8 T cells have the ability to generate numerous types of effector cell fates based on extrinsic pathogen-induced environmental cues.	[Marshall, Heather D.; Kaech, Susan M.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Kaech, Susan M.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University	Kaech, SM (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	susan.kaech@yale.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066232, R01AI074699] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI066232, R01 AI074699] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; Joshi NS, 2011, J IMMUNOL, V187, P4068, DOI 10.4049/jimmunol.1002145; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; King CG, 2012, IMMUNITY, V37, P709, DOI 10.1016/j.immuni.2012.06.021; Lemaitre F, 2013, J IMMUNOL, V191, P1578, DOI 10.4049/jimmunol.1300424; Plumlee CR, 2013, IMMUNITY, V39, P347, DOI 10.1016/j.immuni.2013.07.014; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657	10	1	2	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 22	2013	39	2					203	205		10.1016/j.immuni.2013.08.008	http://dx.doi.org/10.1016/j.immuni.2013.08.008			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UE	23973217	Green Accepted, Bronze			2022-12-18	WOS:000330948800003
J	Murre, C				Murre, Cornelis			Boosting Lymphocyte Production	IMMUNITY			English	Editorial Material							PROMOTE		Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Murre, C (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	murre@biomail.ucsd.edu						Alvarez JD, 2000, GENE DEV, V14, P521; Dias S, 2008, IMMUNITY, V29, P217, DOI 10.1016/j.immuni.2008.05.015; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Mercer EM, 2011, SEMIN IMMUNOL, V23, P317, DOI 10.1016/j.smim.2011.08.004; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Satoh Y, 2013, IMMUNITY, V38, P1105, DOI 10.1016/j.immuni.2013.05.014; Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Semerad CL, 2009, P NATL ACAD SCI USA, V106, P1930, DOI 10.1073/pnas.0808866106; Will B, 2013, NAT IMMUNOL, V14, P437, DOI 10.1038/ni.2572; Yang Q, 2008, J IMMUNOL, V181, P5885, DOI 10.4049/jimmunol.181.9.5885	11	1	1	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 27	2013	38	6					1081	1083		10.1016/j.immuni.2013.06.002	http://dx.doi.org/10.1016/j.immuni.2013.06.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TR	23809155	Bronze			2022-12-18	WOS:000330947500001
J	Angosto, D; Lopez-Castejon, G; Mulero, V; Pelegrin, P				Angosto, Diego; Lopez-Castejon, Gloria; Mulero, Victoriano; Pelegrin, Pablo			Cell Swelling and the NLRP3 Inflammasome Response	IMMUNITY			English	Letter							ZEBRAFISH; FISH		[Angosto, Diego; Mulero, Victoriano] Univ Murcia, Fac Biol, Dept Cell Biol & Histol, E-30100 Murcia, Spain; [Lopez-Castejon, Gloria] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Pelegrin, Pablo] Univ Hosp Virgen Arrixaca Fdn Formac & Invest San, Murcia Biomed Res Inst IMIB, Ctr Invest Biomed Red Area Temat Enfermedades Hep, Inflammat & Expt Surg Unit, Murcia 30120, Spain	University of Murcia; University of Manchester; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Mulero, V (corresponding author), Univ Murcia, Fac Biol, Dept Cell Biol & Histol, E-30100 Murcia, Spain.	vmulero@um.es; pablo.pelegrin@ffis.es	Lopez-Castejon, Gloria/F-6985-2015; Angosto, Diego/AAG-1096-2021; Pelegrin, Pablo/M-2007-2014	Lopez-Castejon, Gloria/0000-0002-8585-3381; Pelegrin, Pablo/0000-0002-9688-1804; Angosto, Diego/0000-0001-5990-4678				Angosto D, 2012, INNATE IMMUN-LONDON, V18, P815, DOI 10.1177/1753425912441956; Compan V, 2012, IMMUNITY, V37, P487, DOI 10.1016/j.immuni.2012.06.013; Juliana C, 2010, J BIOL CHEM, V285, P9792, DOI 10.1074/jbc.M109.082305; Laing KJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-42; Vojtech LN, 2012, INFECT IMMUN, V80, P2878, DOI 10.1128/IAI.00543-12	5	1	1	1	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2013	38	3					400	401		10.1016/j.immuni.2013.02.019	http://dx.doi.org/10.1016/j.immuni.2013.02.019			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RJ	23521877	Bronze			2022-12-18	WOS:000330941500002
J	Goonetilleke, N; McMichael, AJ				Goonetilleke, Nilu; McMichael, Andrew J.			HIV-1 Vaccines: Let's Get Physical	IMMUNITY			English	Editorial Material							RESPONSES; EPITOPE; ESCAPE	Ferguson et al. (2013) use applied physics to quantitate the fitness of HIV-1 Gag based on sequence variability across the protein. This enables a new approach to vaccine design that focuses CD8(+) T cell responses on fitness-constrained parts of Gag.	[Goonetilleke, Nilu; McMichael, Andrew J.] John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England	University of Oxford	McMichael, AJ (corresponding author), John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England.	andrew.mcmichael@ndm.ox.ac.uk			NIAID NIH HHS [UM1 AI100645] Funding Source: Medline; MRC [MR/K012037/1] Funding Source: UKRI; Medical Research Council [MR/K012037/1] Funding Source: researchfish	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Crawford H, 2007, J VIROL, V81, P8346, DOI 10.1128/JVI.00465-07; Ferguson AL, 2013, IMMUNITY, V38, P606, DOI 10.1016/j.immuni.2012.11.022; Goepfert PA, 2008, J EXP MED, V205, P1009, DOI 10.1084/jem.20072457; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; Liu MKP, 2013, J CLIN INVEST, V123, P380, DOI 10.1172/JCI65330; Mostowy R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002525; Mothe B, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-208; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157	10	1	1	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2013	38	3					410	413		10.1016/j.immuni.2013.02.017	http://dx.doi.org/10.1016/j.immuni.2013.02.017			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RJ	23521882	Green Published, Bronze			2022-12-18	WOS:000330941500007
J	Nolz, JC; Harty, JT				Nolz, Jeffrey C.; Harty, John T.			One Bug or Another: Promiscuous T Cells Form Lifelong Memory	IMMUNITY			English	Editorial Material								As humans age, their T cell repertoire becomes dominated by cells exhibiting "memory" characteristics. In this issue of Immunity, Su et al. (2013) demonstrate that a large percentage of virus-specific CD4(+) T cells also exhibit a memory phenotype in unexposed adults.	[Nolz, Jeffrey C.; Harty, John T.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Harty, John T.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Harty, John T.] Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Harty, JT (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.	john-harty@uiowa.edu		Harty, John/0000-0001-7266-2802				Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Clute SC, 2005, J CLIN INVEST, V115, P3602, DOI 10.1172/JCI25078; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Jenkins MK, 2001, ANNU REV IMMUNOL, V19, P23, DOI 10.1146/annurev.immunol.19.1.23; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Sewell AK, 2012, NAT REV IMMUNOL, V12, P668, DOI 10.1038/nri3279; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Su LF, 2013, IMMUNITY, V38, P373, DOI 10.1016/j.immuni.2012.10.021	9	1	1	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 21	2013	38	2					207	208		10.1016/j.immuni.2013.02.002	http://dx.doi.org/10.1016/j.immuni.2013.02.002			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RC	23438820	Bronze			2022-12-18	WOS:000330940800004
J	de Zoete, MR; Flavell, RA				de Zoete, Marcel R.; Flavell, Richard A.			NLRP1 Joins the Dark Side?	IMMUNITY			English	Editorial Material							INFLAMMASOME; ACTIVATION; DISEASE; NALP1	NLRP1 has long remained an elusive member of the NOD-like-receptor family of innate immune sensors. In this issue of Immunity, Masters et al. (2012) describe its role in immune responses to stress and infection.	[de Zoete, Marcel R.; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Flavell, Richard A.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	richard.flavell@yale.edu	de Zoete, Marcel R/O-3012-2014; de Zoete, Marcel/ABA-7918-2021	de Zoete, Marcel/0000-0002-6561-5810				Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masters SL, 2012, IMMUNITY, V37, P1009, DOI 10.1016/j.immuni.2012.08.027; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759	10	1	1	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	DEC 14	2012	37	6					950	952		10.1016/j.immuni.2012.11.008	http://dx.doi.org/10.1016/j.immuni.2012.11.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057PH	23244714	Bronze			2022-12-18	WOS:000312575000002
J	Vladimer, GI; Weng, D; Paquette, SWM; Vanaja, SK; Rathinam, VAK; Aune, MH; Conlon, JE; Burbage, JJ; Proulx, MK; Liu, Q; Reed, G; Mecsas, JC; Iwakura, Y; Bertin, J; Goguen, JD; Fitzgerald, KA; Lien, E				Vladimer, Gregory I.; Weng, Dan; Paquette, Sara W. Montminy; Vanaja, Sivapriya Kailasan; Rathinam, Vijay A. K.; Aune, Marie Hjelmseth; Conlon, Joseph E.; Burbage, Joseph J.; Proulx, Megan K.; Liu, Qin; Reed, George; Mecsas, Joan C.; Iwakura, Yoichiro; Bertin, John; Goguen, Jon D.; Fitzgerald, Katherine A.; Lien, Egil			The NLRP12 Inflammasome Recognizes Yersinia pestis (vol 37, pg 96, 2012)	IMMUNITY			English	Correction												egil.lien@umassmed.edu	Vladimer, Gregory/X-4547-2018; Fitzgerald, Katherine/ABE-6317-2020; Iwakura, Yoichiro/E-5457-2011	Vladimer, Gregory/0000-0003-4205-7585; Iwakura, Yoichiro/0000-0002-9934-5775				Vladimer GI, 2012, IMMUNITY, V37, P96, DOI 10.1016/j.immuni.2012.07.006	1	1	1	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP 21	2012	37	3					588	588		10.1016/j.immuni.2012.09.001	http://dx.doi.org/10.1016/j.immuni.2012.09.001			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	011XG		Green Submitted, Bronze, Green Accepted			2022-12-18	WOS:000309199000021
J	Hochreiter-Hufford, AE; Ravichandran, KS				Hochreiter-Hufford, Amelia E.; Ravichandran, Kodi S.			Oxygenated Lipids: A Mode to WiPE Out Inflammation?	IMMUNITY			English	Editorial Material							APOPTOTIC CELLS; AUTOIMMUNITY; CLEARANCE		[Hochreiter-Hufford, Amelia E.; Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Carter Immunol Ctr, Charlottesville, VA 22908 USA; [Hochreiter-Hufford, Amelia E.; Ravichandran, Kodi S.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Ravichandran, KS (corresponding author), Univ Virginia, Dept Microbiol Immunol & Canc Biol, Carter Immunol Ctr, Charlottesville, VA 22908 USA.	kr4h@virginia.edu		Ravichandran, Kodi/0000-0001-9049-1410				Dobrian AD, 2011, PROG LIPID RES, V50, P115, DOI 10.1016/j.plipres.2010.10.005; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Godson C, 2000, J IMMUNOL, V164, P1663, DOI 10.4049/jimmunol.164.4.1663; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Kadl A, 2010, CIRC RES, V107, P737, DOI 10.1161/CIRCRESAHA.109.215715; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Uderhardt S, 2012, IMMUNITY, V36, P834, DOI 10.1016/j.immuni.2012.03.010	10	1	1	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY 25	2012	36	5					699	701		10.1016/j.immuni.2012.05.006	http://dx.doi.org/10.1016/j.immuni.2012.05.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	954VL	22633456	Bronze			2022-12-18	WOS:000304976000004
J	Lacy-Hulbert, A; Stuart, LM				Lacy-Hulbert, Adam; Stuart, Lynda M.			Penetration Resistance: PKR's Other Talent	IMMUNITY			English	Editorial Material									[Lacy-Hulbert, Adam; Stuart, Lynda M.] Harvard Univ, Sch Med, CCIB Massachusetts Gen Hosp, Boston, MA 02144 USA; [Stuart, Lynda M.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Stuart, LM (corresponding author), Harvard Univ, Sch Med, CCIB Massachusetts Gen Hosp, Boston, MA 02144 USA.	lstuart@partners.org		Lacy-Hulbert, Adam/0000-0003-2162-0156	NIAID NIH HHS [R01 AI079198] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079198] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aktories K, 2011, FEBS J, V278, P4526, DOI 10.1111/j.1742-4658.2011.08113.x; Boyer L, 2011, IMMUNITY, V35, P536, DOI 10.1016/j.immuni.2011.08.015; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Hardham AR, 2007, CURR OPIN PLANT BIOL, V10, P342, DOI 10.1016/j.pbi.2007.05.001; Irving AT, 2012, IMMUNITY, V36, P795, DOI 10.1016/j.immuni.2012.02.020; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kostrikis LG, 1998, NAT MED, V4, P350, DOI 10.1038/nm0398-350; Melo JA, 2012, CELL, V149, P452, DOI 10.1016/j.cell.2012.02.050; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343	9	1	2	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY 25	2012	36	5					695	696		10.1016/j.immuni.2012.05.010	http://dx.doi.org/10.1016/j.immuni.2012.05.010			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	954VL	22633454	Bronze			2022-12-18	WOS:000304976000002
J	Blecher-Gonen, R; Amit, I				Blecher-Gonen, Ronnie; Amit, Ido			M(odu)LLating the Innate Response	IMMUNITY			English	Editorial Material							CHROMATIN	The integration of chromatin modifiers into specific regulatory networks is not fully understood. In this issue of Immunity, Austenaa et al. (2012) demonstrate a specific role for the for histone methyltransferase MLL4 (Wbp7) in controlling the expression of critical molecules in the Toll-like receptor pathway.	[Blecher-Gonen, Ronnie; Amit, Ido] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Amit, I (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	ido.amit@weizmann.ac.il		Blecher, Ronnie/0000-0003-2847-1149				Akashi-Takamura S, 2008, CURR OPIN IMMUNOL, V20, P420, DOI 10.1016/j.coi.2008.07.001; Amit I, 2011, NAT REV IMMUNOL, V11, P873, DOI 10.1038/nri3109; Austenaa L, 2012, IMMUNITY, V36, P572, DOI 10.1016/j.immuni.2012.02.016; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Watanabe R, 2000, EMBO J, V19, P4402, DOI 10.1093/emboj/19.16.4402; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	10	1	1	1	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR 20	2012	36	4					551	552		10.1016/j.immuni.2012.04.002	http://dx.doi.org/10.1016/j.immuni.2012.04.002			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	931ML	22520848	Bronze			2022-12-18	WOS:000303223900005
J	Khanna, KM; Lefrancois, L				Khanna, Kamal M.; Lefrancois, Leo			B Cells, Not Just for Antibody Anymore	IMMUNITY			English	Editorial Material							CYTOMEGALOVIRUS; INTERFERON; VIRUS; INFECTION; DETENTE	B cell antibody production is thought to be crucial for protection against virus infection. In this issue of Immunity, Moseman et al. (2012) illustrate an antibody-independent role for B cells in macrophage activation that prevents virus dissemination after subcutaneous infection.	[Khanna, Kamal M.; Lefrancois, Leo] UCONN Hlth Ctr, Ctr Integrated Immunol & Vaccine Res, Dept Immunol, Farmington, CT 06030 USA	University of Connecticut	Lefrancois, L (corresponding author), UCONN Hlth Ctr, Ctr Integrated Immunol & Vaccine Res, Dept Immunol, Farmington, CT 06030 USA.	llefranc@neuron.uchc.edu			NIAID NIH HHS [R01 AI076457, R01 AI076457-05, R01 AI041576-15, R01 AI041576] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041576, R01AI076457] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Benedict CA, 2001, IMMUNITY, V15, P617, DOI 10.1016/S1074-7613(01)00222-9; Ciavarra RP, 2005, VIROLOGY, V342, P177, DOI 10.1016/j.virol.2005.07.031; Delale T, 2005, J IMMUNOL, V175, P6723, DOI 10.4049/jimmunol.175.10.6723; Edelson BT, 2011, IMMUNITY, V35, P236, DOI 10.1016/j.immuni.2011.06.012; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Honke N, 2012, NAT IMMUNOL, V13, P51, DOI 10.1038/ni.2169; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Mebius RE, 2004, CRIT REV IMMUNOL, V24, P449, DOI 10.1615/CritRevImmunol.v24.i6.40; Moseman EA, 2012, IMMUNITY, V36, P415, DOI 10.1016/j.immuni.2012.01.013; Schneider K, 2008, CELL HOST MICROBE, V3, P67, DOI 10.1016/j.chom.2007.12.008	10	1	2	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAR 23	2012	36	3					315	317		10.1016/j.immuni.2012.02.011	http://dx.doi.org/10.1016/j.immuni.2012.02.011			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	915ST	22444627	Green Accepted, Bronze			2022-12-18	WOS:000302048400003
J	Haines, CJ; Cua, DJ				Haines, Christopher J.; Cua, Daniel J.			Orphan Cytokine Reveals IL-17 Family Secret	IMMUNITY			English	Editorial Material							RECEPTORS	The biology of interleukin-17C (IL-17C) has remained largely a mystery for more than a decade. Chang et al. (2011), in this issue of Immunity, and two other reports (Song et al., 2011; Ramirez-Carrozzi et al., 2011) demonstrate that IL-17C has broad functions in a variety of tissues.	[Haines, Christopher J.; Cua, Daniel J.] Merck Res Labs, Palo Alto, CA 94304 USA	Merck & Company	Cua, DJ (corresponding author), Merck Res Labs, 901 Calif Ave, Palo Alto, CA 94304 USA.	daniel.cua@merck.com						Chang SH, 2011, IMMUNITY, V35, P611, DOI 10.1016/j.immuni.2011.09.010; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Johansen C, 2009, BRIT J DERMATOL, V160, P319, DOI 10.1111/j.1365-2133.2008.08902.x; Li HZ, 2000, P NATL ACAD SCI USA, V97, P773, DOI 10.1073/pnas.97.2.773; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; RAMIREZCARROZZI V, 2011, NAT IMMUNOL; SONG X, 2011, NAT IMMUNOL; Wu Q, 2007, MICROBES INFECT, V9, P78, DOI 10.1016/j.micinf.2006.10.012; Yamaguchi Y, 2007, J IMMUNOL, V179, P7128, DOI 10.4049/jimmunol.179.10.7128; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	11	1	1	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT 28	2011	35	4					498	500		10.1016/j.immuni.2011.10.008	http://dx.doi.org/10.1016/j.immuni.2011.10.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	843FM	22035844	Bronze			2022-12-18	WOS:000296657700009
J	Froelich, C; Metkar, S				Froelich, Christopher; Metkar, Sunil			Intracellular Trafficking of Perforin: To Thwart a Killer	IMMUNITY			English	Editorial Material							C2 DOMAIN; MEMBRANE-BINDING; MECHANISM	How do killer cells restrain perforin, the most potent toxin known to biologists, at its point of synthesis in the endoplasmic reticulum, where conditions are ideal for its activation? In this issue of Immunity, Brennan et al. (2011) study its trafficking, offering insights into protective mechanisms.	[Froelich, Christopher; Metkar, Sunil] NorthShore Univ, HealthSyst Res Inst, Evanston, IL 60201 USA	NorthShore University Health System	Froelich, C (corresponding author), NorthShore Univ, HealthSyst Res Inst, Evanston, IL 60201 USA.	cfroelich@uchicago.edu			NIAID NIH HHS [R01 AI044941, R01 AI044941-10] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044941] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brennan AJ, 2011, IMMUNITY, V34, P879, DOI 10.1016/j.immuni.2011.04.007; Hughson FM, 2010, CURR OPIN CELL BIOL, V22, P454, DOI 10.1016/j.ceb.2010.03.011; Law RHP, 2010, NATURE, V468, P447, DOI 10.1038/nature09518; Makedonas G, 2009, J IMMUNOL, V182, P5560, DOI 10.4049/jimmunol.0803945; Moreno RU, 2009, BLOOD, V113, P338, DOI 10.1182/blood-2008-08-172924; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; Uellner R, 1997, EMBO J, V16, P7287, DOI 10.1093/emboj/16.24.7287; Voskoboinik I, 2005, J BIOL CHEM, V280, P8426, DOI 10.1074/jbc.M413303200; Yang ST, 2010, BIOPHYS J, V99, P2525, DOI 10.1016/j.bpj.2010.08.029	9	1	1	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN 24	2011	34	6					823	825		10.1016/j.immuni.2011.06.008	http://dx.doi.org/10.1016/j.immuni.2011.06.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	787AT	21703535	Bronze, Green Accepted			2022-12-18	WOS:000292349700002
J	Bandukwala, HS; Wu, YQ; Feuerer, M; Chen, YH; Barboza, B; Ghosh, S; Stroud, JC; Benoist, C; Mathis, D; Rao, A; Chen, L				Bandukwala, Hozefa S.; Wu, Yongqing; Feuerer, Markus; Chen, Yongheng; Barboza, Bianca; Ghosh, Srimoyee; Stroud, James C.; Benoist, Christophe; Mathis, Diane; Rao, Anjana; Chen, Lin			Structure of a Domain-Swapped FOXP3 Dimer on DNA and Its Function in Regulatory T Cells (vol 34, pg 479, 2011)	IMMUNITY			English	Correction												arao@idi.harvard.edu; linchen@usc.edu						Bandukwala HS, 2011, IMMUNITY, V34, P479, DOI 10.1016/j.immuni.2011.02.017	1	1	1	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR 22	2011	34	4					627	627		10.1016/j.immuni.2011.04.011	http://dx.doi.org/10.1016/j.immuni.2011.04.011			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	761AQ		Bronze			2022-12-18	WOS:000290367300020
J	Sugiyama, T; Nagasawa, T				Sugiyama, Tatsuki; Nagasawa, Takashi			Emergency Evacuation! Hematopoietic Niches Induce Cell Exit in Infection	IMMUNITY			English	Editorial Material							BONE-MARROW; STEM-CELLS	The roles of hematopoietic stem and/or progenitor cell niches during infection remain unclear. In this issue of Immunity, Shi et al. (2011) reveal that these niches upregulate MCP1 chemokine expression, inducing emigration of bone marrow monocytes into the circulation via the endothelium.	[Sugiyama, Tatsuki; Nagasawa, Takashi] Kyoto Univ, Inst Frontier Med Sci, Dept Immunobiol & Hematol, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University	Nagasawa, T (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Immunobiol & Hematol, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	tnagasa@frontier.kyoto-u.ac.jp		Sugiyama, Tatsuki/0000-0002-9349-0824; Nagasawa, Takashi/0000-0002-1085-0960	Grants-in-Aid for Scientific Research [22390096] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Ara T, 2003, IMMUNITY, V19, P257, DOI 10.1016/S1074-7613(03)00201-2; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shi C, 2011, IMMUNITY, V34, P590, DOI 10.1016/j.immuni.2011.02.016; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; WEISS L, 1976, ANAT RECORD, V186, P161, DOI 10.1002/ar.1091860204	10	1	2	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR 22	2011	34	4					463	465		10.1016/j.immuni.2011.04.009	http://dx.doi.org/10.1016/j.immuni.2011.04.009			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	761AQ	21511181	Bronze			2022-12-18	WOS:000290367300006
J	Fugmann, SD				Fugmann, Sebastian D.			RAG-2 Unleashed: Lymphocytes Beware	IMMUNITY			English	Editorial Material							DNA-REPAIR	The programmed degradation of the RAG-2 enzyme upon entry to S phase restricts V(D)J recombination to the G0-G1 phase of the cell cycle. In this issue of Immunity, Zhang et al. (2011) show that this is critical to prevent lymphoma formation.	NIA, Lab Mol Biol & Immunol, NIH, Biomed Res Ctr, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Fugmann, SD (corresponding author), NIA, Lab Mol Biol & Immunol, NIH, Biomed Res Ctr, 251 Bayview Blvd,Suite 100,Room 6C218, Baltimore, MD 21224 USA.	fugmanns@grc.nia.nih.gov			NATIONAL INSTITUTE ON AGING [ZIAAG000388] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA AG000388-04] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; Desiderio S, 2010, SEMIN IMMUNOL, V22, P362, DOI 10.1016/j.smim.2010.09.001; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; Raghavan SC, 2004, NATURE, V428, P88, DOI 10.1038/nature02355; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Zhang L, 2011, IMMUNITY, V34, P163, DOI 10.1016/j.immuni.2011.02.003	8	1	1	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	FEB 25	2011	34	2					137	139		10.1016/j.immuni.2011.02.007	http://dx.doi.org/10.1016/j.immuni.2011.02.007			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	729YD	21349423	Bronze, Green Accepted			2022-12-18	WOS:000287989500001
J	Kerdiles, YM				Kerdiles, Yann M.			Foxo Transcription Factors Control Regulatory T Cell Development and Function (vol 33, pg 890, 2010)	IMMUNITY			English	Correction													kerdiles, yann/U-2190-2018; Ramaraj, Dr. in Engg., and Dr. in Law., R. Ravi/U-7781-2018	kerdiles, yann/0000-0002-8605-1073; Ramaraj, Dr. in Engg., and Dr. in Law., R. Ravi/0000-0002-6288-808X				Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002	1	1	1	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 28	2011	34	1					135	135		10.1016/j.immuni.2011.01.008	http://dx.doi.org/10.1016/j.immuni.2011.01.008			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	721EO		Bronze			2022-12-18	WOS:000287336600016
J	Paz, S; Hiscott, J				Paz, Suzanne; Hiscott, John			CuRTAiling Interferon Regulatory Factor Signaling with the E3 Ligase RAUL	IMMUNITY			English	Editorial Material							MEDIATED DEGRADATION; UBIQUITIN; RECOGNITION; IRF7	Interferon regulatory factor 3 (IRF3) and IRF7 modulate the transcription of type I interferon. In this issue of Immunity, Yu and Hayward (2010) identify RAUL, the bona fide ubiquitin ligase that regulates turnover of IRF3 and IRF7.	[Paz, Suzanne; Hiscott, John] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Hiscott, John] Vaccine & Gene Therapy Inst Florida, Port St Lucie, FL 34987 USA	Lady Davis Institute; McGill University; Vaccine & Gene Therapy Institute of Florida	Hiscott, J (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada.	john.hiscott@mcgill.ca		Paz, Suzanne/0000-0002-0465-7144				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Higgs R, 2008, BIOCHEM SOC T, V36, P453, DOI 10.1042/BST0360453; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Ribet D, 2010, CELL, V143, P694, DOI 10.1016/j.cell.2010.11.019; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Viswanathan K, 2010, CURR OPIN MICROBIOL, V13, P517, DOI 10.1016/j.mib.2010.05.012; Yu YX, 2010, IMMUNITY, V33, P863, DOI 10.1016/j.immuni.2010.11.027; Yu YX, 2005, IMMUNITY, V22, P59, DOI 10.1016/j.immuni.2004.11.011	10	1	1	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	DEC 22	2010	33	6					833	835		10.1016/j.immuni.2010.12.006	http://dx.doi.org/10.1016/j.immuni.2010.12.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	707NS	21168773	Bronze			2022-12-18	WOS:000286293900002
J	Pear, WS				Pear, Warren S.			Hooked on Hes: A T-ALL of Addiction	IMMUNITY			English	Editorial Material								Hes1 is a direct Notch1 target; however, its precise function is unclear. In this issue of Immunity, Wendorff et al. (2010) report that Hes1 regulates the number of T cell progenitors and has important functions in both the induction and maintenance of T cell leukemia.	[Pear, Warren S.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Pear, Warren S.] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Pear, WS (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	wpear@mail.med.upenn.edu						Aster JC, 2011, J PATHOL, V223, P262, DOI 10.1002/path.2789; Espinosa L, 2010, CANCER CELL, V18, P268, DOI 10.1016/j.ccr.2010.08.006; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kaneta M, 2000, J IMMUNOL, V164, P256, DOI 10.4049/jimmunol.164.1.256; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; Nakahara F, 2010, BLOOD, V115, P2872, DOI 10.1182/blood-2009-05-222836; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Sang LY, 2008, SCIENCE, V321, P1095, DOI 10.1126/science.1155998; Tomita K, 1999, GENE DEV, V13, P1203, DOI 10.1101/gad.13.9.1203; Wendorff AA, 2010, IMMUNITY, V33, P671, DOI 10.1016/j.immuni.2010.11.014	10	1	1	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 24	2010	33	5					645	647		10.1016/j.immuni.2010.11.018	http://dx.doi.org/10.1016/j.immuni.2010.11.018			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	704VB	21094458	Bronze			2022-12-18	WOS:000286082600001
J	Deshane, J; Chaplin, DD				Deshane, Jessy; Chaplin, David D.			Follicular Dendritic Cell Makes Environmental Sense	IMMUNITY			English	Editorial Material							SIGNALS; DANGER	Follicular dendritic cells (FDCs) are key organizers of B cell follicles and germinal centers. In this issue of Immunity, Suzuki et al. (2010) and Garin et al. (2010) identify the roles of Toll-like receptors in the responses of FDCs, providing a unique link between innate and adaptive immunity.	[Deshane, Jessy; Chaplin, David D.] Univ Alabama, Dept Microbiol, Birmingham, AL 35233 USA	University of Alabama System; University of Alabama Birmingham	Chaplin, DD (corresponding author), Univ Alabama, Dept Microbiol, Birmingham, AL 35233 USA.	dchaplin@uab.edu		Chaplin, David/0000-0002-1354-3069	NHLBI NIH HHS [F32 HL095341-01A1, P01 HL073907, P01 HL073907-040003, F32 HL095341] Funding Source: Medline; NIAID NIH HHS [T32 AI007051] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL095341, P01HL073907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007051] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Garin A, 2010, IMMUNITY, V33, P84, DOI 10.1016/j.immuni.2010.07.005; Hreggvidsdottir HS, 2009, J LEUKOCYTE BIOL, V86, P655, DOI 10.1189/jlb.0908548; Hwang IY, 2009, J EXP MED, V206, P2641, DOI 10.1084/jem.20091982; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; Meyer-Bahlburg A, 2007, J EXP MED, V204, P3095, DOI 10.1084/jem.20071250; Suzuki K, 2010, IMMUNITY, V33, P71, DOI 10.1016/j.immuni.2010.07.003; van der Heijden IM, 2000, ARTHRITIS RHEUM-US, V43, P593, DOI 10.1002/1529-0131(200003)43:3<593::AID-ANR16>3.0.CO;2-1; van Nierop K, 2002, SEMIN IMMUNOL, V14, P251, DOI 10.1016/S1044-5323(02)00057-X	11	1	1	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 23	2010	33	1					2	4		10.1016/j.immuni.2010.07.008	http://dx.doi.org/10.1016/j.immuni.2010.07.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	632JD	20643332	Green Accepted, Bronze			2022-12-18	WOS:000280418100002
J	Villunger, A				Villunger, Andreas			Only the Strong Survive	IMMUNITY			English	Editorial Material							T-CELLS; BH3-ONLY PROTEINS; DEATH; NOXA; BIM	Whether apoptosis is relevant for interclonal competition of T cells after antigen encounter has remained uncertain. In this issue of Immunity, Wensveen et al. (2010) establish a critical role for the proapoptotic BH3-only protein Noxa in this selection process.	Innsbruck Med Univ, Bioctr, Div Dev Immunol, Innsbruck, Austria	Medical University of Innsbruck	Villunger, A (corresponding author), Innsbruck Med Univ, Bioctr, Div Dev Immunol, Innsbruck, Austria.	andreas.villunger@i-med.ac.at	Tieber, Claus/J-7557-2015	Tieber, Claus/0000-0001-7471-9817				Alves NL, 2006, IMMUNITY, V24, P703, DOI 10.1016/j.immuni.2006.03.018; Bauer A, 2006, P NATL ACAD SCI USA, V103, P10979, DOI 10.1073/pnas.0603625103; Fischer SF, 2007, BLOOD, V110, P3978, DOI 10.1182/blood-2007-05-091306; Huntington ND, 2007, NAT IMMUNOL, V8, P856, DOI 10.1038/ni1487; Malherbe L, 2004, IMMUNITY, V21, P669, DOI 10.1016/j.immuni.2004.09.008; Ploner C, 2008, ONCOGENE, V27, pS84, DOI 10.1038/onc.2009.46; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Yamashita M, 2008, J EXP MED, V205, P1109, DOI 10.1084/jem.20072000; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657	9	1	1	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN 25	2010	32	6					729	731		10.1016/j.immuni.2010.06.010	http://dx.doi.org/10.1016/j.immuni.2010.06.010			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	618OQ	20620937	Bronze			2022-12-18	WOS:000279365800002
J	Govern, CC; Chakraborty, AK				Govern, Christopher C.; Chakraborty, Arup K.			For T Cell Receptors, Some Breakups Might Not Last Forever	IMMUNITY			English	Editorial Material							ACTIVATION; TCR; AFFINITIES; KINETICS; LIGANDS; BINDING; CD8		[Govern, Christopher C.; Chakraborty, Arup K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT & Harvard, Ragon Inst, Massachusetts Gen Hosp, Boston, MA 02129 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Chakraborty, AK (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	arupc@mit.edu						Aleksic M, 2010, IMMUNITY, V32, P163, DOI 10.1016/j.immuni.2009.11.013; Gao GF, 2002, TRENDS IMMUNOL, V23, P408, DOI 10.1016/S1471-4906(02)02282-2; Holler PD, 2003, IMMUNITY, V18, P255, DOI 10.1016/S1074-7613(03)00019-0; Kalergis AM, 2001, NAT IMMUNOL, V2, P229, DOI 10.1038/85286; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Stone JD, 2009, IMMUNOLOGY, V126, P165, DOI 10.1111/j.1365-2567.2008.03015.x; Tian S, 2007, J IMMUNOL, V179, P2952, DOI 10.4049/jimmunol.179.5.2952	9	1	1	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 26	2010	32	2					141	142		10.1016/j.immuni.2010.02.005	http://dx.doi.org/10.1016/j.immuni.2010.02.005			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	566BX	20189475	Green Published, Bronze			2022-12-18	WOS:000275346000001
J	Sasaki, Y; Kurosaki, T				Sasaki, Yoshiteru; Kurosaki, Tomohiro			Immobile BCRs: The Safety on the Signal Trigger	IMMUNITY			English	Editorial Material							CELL ANTIGEN RECEPTOR; COMPLEXES		[Kurosaki, Tomohiro] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Lymphocyte Differentiat, Osaka 5650982, Japan; [Sasaki, Yoshiteru] Riken Ctr Dev Biol, Lab Stem Cell Biol, Kobe, Hyogo 6500047, Japan; [Kurosaki, Tomohiro] Riken Ctr Allergy & Immunol, Lab Lymphocyte Differentiat, Yokohama, Kanagawa 2300045, Japan	Osaka University; RIKEN; RIKEN	Kurosaki, T (corresponding author), Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Lymphocyte Differentiat, Osaka 5650982, Japan.	kurosaki@ifrec.osaka-u.ac.jp	Kurosaki, Tomohiro/D-1306-2009	Kurosaki, Tomohiro/0000-0002-6352-304X				Delgado P, 2009, NAT IMMUNOL, V10, P880, DOI 10.1038/ni.1749; Fuentes-Panana EM, 2005, J IMMUNOL, V174, P1245, DOI 10.4049/jimmunol.174.3.1245; Hao SL, 2005, MOL BIOL CELL, V16, P2275, DOI 10.1091/mbc.e04-10-0881; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Tolar P, 2005, NAT IMMUNOL, V6, P1168, DOI 10.1038/ni1262; Treanor B, 2010, IMMUNITY, V32, P187, DOI 10.1016/j.immuni.2009.12.005; Zhang Y, 1998, EMBO J, V17, P7304, DOI 10.1093/emboj/17.24.7304	10	1	1	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 26	2010	32	2					143	144		10.1016/j.immuni.2010.02.007	http://dx.doi.org/10.1016/j.immuni.2010.02.007			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	566BX	20189476	Bronze			2022-12-18	WOS:000275346000002
J	Marcus, E				Marcus, Emilie			Taming Supplemental Material	IMMUNITY			English	Editorial Material												emarcus@cell.com							0	1	1	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 20	2009	31	5					691	691		10.1016/j.immuni.2009.10.005	http://dx.doi.org/10.1016/j.immuni.2009.10.005			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	523TQ	19932065	Bronze			2022-12-18	WOS:000272097900001
J	Bunnell, SC				Bunnell, Stephen C.			A View to a Kill: How Ligand Quality Controls Lethal Hits	IMMUNITY			English	Editorial Material							IMMUNOLOGICAL SYNAPSE; CELL	In this issue of Immunity, Beal et al. (2009) and Jenkins et al. (2009) demonstrate that relatively weak stimuli support synapse formation and microtubule polarization, but fail to trigger efficient killing because of their inability to recruit lytic granules to the synaptic cleft.	Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA	Tufts University	Bunnell, SC (corresponding author), Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA.	stephen.bunnell@tufts.edu		Bunnell, Stephen/0000-0001-6887-0828				Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Beal AM, 2008, J IMMUNOL, V181, P4815, DOI 10.4049/jimmunol.181.7.4815; Beal AM, 2009, IMMUNITY, V31, P632, DOI 10.1016/j.immuni.2009.09.004; Combs J, 2006, P NATL ACAD SCI USA, V103, P14883, DOI 10.1073/pnas.0600914103; Jenkins MR, 2009, IMMUNITY, V31, P621, DOI 10.1016/j.immuni.2009.08.024; Lioudyno MI, 2008, P NATL ACAD SCI USA, V105, P2011, DOI 10.1073/pnas.0706122105; Lyubchenko TA, 2001, IMMUNITY, V15, P847, DOI 10.1016/S1074-7613(01)00233-3; Quann EJ, 2009, NAT IMMUNOL, V10, P627, DOI 10.1038/ni.1734; Stinchcombe JC, 2007, ANNU REV CELL DEV BI, V23, P495, DOI 10.1146/annurev.cellbio.23.090506.123521	9	1	1	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT 16	2009	31	4					531	533		10.1016/j.immuni.2009.09.011	http://dx.doi.org/10.1016/j.immuni.2009.09.011			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	514OI	19833082	Bronze			2022-12-18	WOS:000271403900003
J	Harkiolaki, M; Holmes, SL; Svendsen, P; Gregersen, JW; Jensen, LT; McMahon, R; Friese, MA; van Boxel, G; Etzensperger, R; Tzartos, JS; Kranc, K; Sainsbury, S; Harlos, K; Mellins, ED; Palace, J; Esiri, MM; van der Merwe, PA; Jones, EY; Fugger, L				Harkiolaki, Maria; Holmes, Samantha L.; Svendsen, Pia; Gregersen, Jon W.; Jensen, Lise T.; McMahon, Roisin; Friese, Manuel A.; van Boxel, Gijs; Etzensperger, Ruth; Tzartos, John S.; Kranc, Kamil; Sainsbury, Sarah; Harlos, Karl; Mellins, Elizabeth D.; Palace, Jackie; Esiri, Margaret M.; van der Merwe, P. Anton; Jones, E. Yvonne; Fugger, Lars			T Cell-Mediated Autoimmune Disease Due to Low-Affinity Crossreactivity to Common Microbial Peptides (vol 30, pg 348, 2009)	IMMUNITY			English	Correction												yvonne@strubi.ox.ac.uk	van der Merwe, P. Anton/F-8539-2011					Harkiolaki M, 2009, IMMUNITY, V30, P348, DOI 10.1016/j.immuni.2009.01.009	1	1	1	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2009	30	4					610	610		10.1016/j.immuni.2009.03.009	http://dx.doi.org/10.1016/j.immuni.2009.03.009			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	435BT		Bronze			2022-12-18	WOS:000265319000017
J	Kee, BL; Dias, S				Kee, Barbara L.; Dias, Sheila			A s-myly Route toward Lymphoid Differentiation	IMMUNITY			English	Editorial Material							MULTIPOTENT PROGENITORS; STEM-CELLS; HEMATOPOIESIS	In this issue of Immunity, Ng et al. (2009) show that lymphoid-lineage priming occurs in hematopoietic stem cells and is dependent on the Ikaros transcription factor, as is repression of self-renewal genes during lymphoid differentiation.	[Kee, Barbara L.; Dias, Sheila] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Kee, Barbara L.; Dias, Sheila] Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA; [Kee, Barbara L.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Kee, Barbara L.] Univ Chicago, Comm Dev Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago	Kee, BL (corresponding author), Univ Chicago, Dept Pathol, Chicago, IL 60637 USA.	bkee@bsd.uchicago.edu						Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Chi AW, 2009, CURR OPIN IMMUNOL, V21, P121, DOI 10.1016/j.coi.2009.01.012; Crispino JD, 2005, SEMIN CELL DEV BIOL, V16, P137, DOI 10.1016/j.semcdb.2004.11.002; Dias S, 2008, IMMUNITY, V29, P217, DOI 10.1016/j.immuni.2008.05.015; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Ng SYM, 2009, IMMUNITY, V30, P493, DOI 10.1016/j.immuni.2009.01.014; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Wagers AJ, 2002, GENE THER, V9, P606, DOI 10.1038/sj.gt.3301717; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314	9	1	1	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR 17	2009	30	4					474	476		10.1016/j.immuni.2009.03.006	http://dx.doi.org/10.1016/j.immuni.2009.03.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	435BT	19371711	Bronze			2022-12-18	WOS:000265319000003
J	Kortum, RL; Samelson, LE				Kortum, Robert L.; Samelson, Lawrence E.			Priming the Pump: Adhesion Enhances T Cell Antigen Receptor-Induced Signaling	IMMUNITY			English	Editorial Material							PROTEIN-KINASE; ACTIVATION; THRESHOLD	In this issue of Immunity, Conche et al. (2009) define an antigen-independent signaling pathway that is dependent on cyclic adenosine monophosphate and extracellular signal-regulated kinase and T cells for subsequent T cell antigen receptor signaling.	[Kortum, Robert L.; Samelson, Lawrence E.] NCI, Cellular & Mol Biol Lab, Ctr Canc Res, Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Samelson, LE (corresponding author), NCI, Cellular & Mol Biol Lab, Ctr Canc Res, Natl Inst Hlth, Bethesda, MD 20892 USA.	samelson@helix.nih.gov			NATIONAL CANCER INSTITUTE [ZIABC010304, Z01BC010304] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 BC010304-04] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Asirvatham AL, 2004, J IMMUNOL, V173, P4806, DOI 10.4049/jimmunol.173.8.4806; Conche C, 2009, IMMUNITY, V30, P33, DOI 10.1016/j.immuni.2008.10.020; Doucey MA, 2003, J BIOL CHEM, V278, P26983, DOI 10.1074/jbc.M302709200; Lovatt M, 2006, MOL CELL BIOL, V26, P8655, DOI 10.1128/MCB.00168-06; Nika K, 2004, BIOCHEM J, V378, P335, DOI 10.1042/BJ20031244; Randriamampita C, 2003, EUR J IMMUNOL, V33, P1215, DOI 10.1002/eji.200323844; Revy P, 2001, NAT IMMUNOL, V2, P925, DOI 10.1038/ni713; Ruppelt A, 2007, J IMMUNOL, V179, P5159, DOI 10.4049/jimmunol.179.8.5159; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Tasken K, 2006, BIOCHEM SOC T, V34, P476, DOI 10.1042/BST0340476	10	1	1	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2009	30	1					3	5		10.1016/j.immuni.2008.12.007	http://dx.doi.org/10.1016/j.immuni.2008.12.007			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398ZJ	19144310	Green Accepted, Bronze			2022-12-18	WOS:000262769900002
J	Mempel, TR; Marangoni, F				Mempel, Thorsten R.; Marangoni, Francesco			CD44 Keeps Tumor Killers Polarized	IMMUNITY			English	Editorial Material							T-CELL EXTRAVASATION	In this issue of Immunity, Mrass et al. (2008) report that CD44 critically contributes to the stabilization of polarity in migrating cytotoxic T lymphocytes by anchoring cytoskeletal proteins to the cell membrane at their uropods.	[Mempel, Thorsten R.; Marangoni, Francesco] Harvard Univ, Massachusetts Gen Hosp, Sch Med,Ctr Immunol & Inflammatory Dis, Div Rheumatol Allergy & Immunol, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Mempel, TR (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med,Ctr Immunol & Inflammatory Dis, Div Rheumatol Allergy & Immunol, Charlestown, MA 02129 USA.	tmempel@mgh.harvard.edu	Marangoni, Francesco/I-9087-2012	Marangoni, Francesco/0000-0002-2490-849X				ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; Foger N, 2001, J CELL SCI, V114, P1169; LESLEY J, 1994, J EXP MED, V180, P383, DOI 10.1084/jem.180.1.383; Mrass P, 2008, IMMUNITY, V29, P971, DOI 10.1016/j.immuni.2008.10.015; Nandi A, 2004, IMMUNITY, V20, P455, DOI 10.1016/S1074-7613(04)00077-9; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Schmits R, 1997, BLOOD, V90, P2217, DOI 10.1182/blood.V90.6.2217.2217_2217_2233; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885	10	1	2	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	DEC 19	2008	29	6					843	845		10.1016/j.immuni.2008.12.004	http://dx.doi.org/10.1016/j.immuni.2008.12.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	388IB	19100697	Bronze			2022-12-18	WOS:000262012400004
J	Bolland, S				Bolland, Silvia			An Innate Path to Human B Cell Tolerance	IMMUNITY			English	Editorial Material							TOLL-LIKE RECEPTORS	Self-reactive B cells are eliminated during development by antibody-affinity selection and receptor-editing mechanisms. Work by Isnardi et al. (2008) in this issue of immunity suggests that removal of autoreactivity from the immature B cell pool also requires innate immunity pathways.	NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Bolland, S (corresponding author), NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA.	sbolland@niaid.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000912] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA AI000912-08] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Grimaldi C, 2007, ADV EXP MED BIOL, V596, P181; Herve M, 2007, J EXP MED, V204, P1583, DOI 10.1084/jem.20062287; Isnardi I, 2008, IMMUNITY, V29, P746, DOI 10.1016/j.immuni.2008.09.015; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Marshak-Rothstein A, 2007, ANNU REV IMMUNOL, V25, P419, DOI 10.1146/annurev.immunol.22.012703.104514; Ng YS, 2004, J EXP MED, V200, P927, DOI 10.1084/jem.20040920; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Wardemann H, 2007, ADV IMMUNOL, V95, P83, DOI 10.1016/S0065-2776(07)95003-8; Zhang SY, 2007, IMMUNOL REV, V220, P225, DOI 10.1111/j.1600-065X.2007.00564.x	9	1	1	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 14	2008	29	5					667	669		10.1016/j.immuni.2008.10.001	http://dx.doi.org/10.1016/j.immuni.2008.10.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	374IC	19006689	Green Accepted, Bronze			2022-12-18	WOS:000261036000003
J	Chtanova, T; Schaeffer, M; Han, SJ; van Dooren, GG; Nollmann, M; Herzmark, P; Chan, SW; Satija, H; Camfield, K; Aaron, H; Striepen, B; Robey, EA				Chtanova, Tatyana; Schaeffer, Marie; Han, Seong-Ji; van Dooren, Giel G.; Nollmann, Marcelo; Herzmark, Paul; Chan, Shiao Wei; Satija, Harshita; Camfield, Kristin; Aaron, Holly; Striepen, Boris; Robey, Ellen A.			Dynamics of Neutrophil Migration in Lymph Nodes during Infection (vol 29, pg 487, 2008)	IMMUNITY			English	Correction												erobey@berkeley.edu		Chtanova, Tatyana/0000-0003-3419-4483; Schaeffer, Marie/0000-0002-2063-5324; Striepen, Boris/0000-0002-7426-432X				Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012	1	1	1	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2008	29	4					661	661		10.1016/j.immuni.2008.09.007	http://dx.doi.org/10.1016/j.immuni.2008.09.007			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364DP		Bronze			2022-12-18	WOS:000260316700019
J	Dunay, IR; DaMatta, RA; Fux, B; Presti, R; Greco, S; Colonna, M; Sibley, LD				Dunay, Ildiko R.; DaMatta, Renato A.; Fux, Blima; Presti, Rachel; Greco, Suellen; Colonna, Marco; Sibley, L. David			Gr1(+) Inflammatory Monocytes Are Required for Mucosal Resistance to the Pathogen Toxoplasma gondii (vol 29, pg 306, 2008)	IMMUNITY			English	Correction												sibley@wustl.edu	Sibley, L. David/C-4616-2008; Fux, Blima/AAO-2941-2020; DaMatta, Renato/G-8367-2015	DaMatta, Renato/0000-0002-0108-9268; Fux, Blima/0000-0002-5038-3551; Colonna, Marco/0000-0001-5222-4987				Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019	1	1	1	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2008	29	4					660	660		10.1016/j.immuni.2008.09.004	http://dx.doi.org/10.1016/j.immuni.2008.09.004			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364DP		Bronze			2022-12-18	WOS:000260316700018
J	Bonneville, M				Bonneville, Marc			gamma delta T cell selection: Is anyone useless?	IMMUNITY			English	Editorial Material							POSITIVE SELECTION		INSERM, U892, F-44035 Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Bonneville, M (corresponding author), INSERM, U892, F-44035 Nantes, France.	bonnevil@nantes.inserm.fr						Chien YH, 2006, CELL MOL LIFE SCI, V63, P2089, DOI 10.1007/s00018-006-6020-z; He YW, 2002, J LEUKOCYTE BIOL, V72, P440; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Lewis JM, 2006, NAT IMMUNOL, V7, P843, DOI 10.1038/ni1363; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; Schweighoer E, 1996, J EXP MED, V183, P2033, DOI 10.1084/jem.183.5.2033; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Xiong N, 2004, IMMUNITY, V21, P121, DOI 10.1016/j.immuni.2004.06.008	9	1	1	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 18	2008	29	1					3	5		10.1016/j.immuni.2008.06.007	http://dx.doi.org/10.1016/j.immuni.2008.06.007			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	329YB	18631449	Bronze			2022-12-18	WOS:000257905400002
J	Broussard, C; Fleischacker, C; Horai, R; Chetana, M; Venegas, AM; Sharp, LL; Hedrick, SM; Fowlkes, BJ; Schwartzberg, PL				Broussard, Christine; Fleischacker, Christine; Horai, Relko; Chetana, Madeva; Venegas, Ana M.; Sharp, Leslie L.; Hedrick, Stephen M.; Fowlkes, B. J.; Schwartzberg, Pamela L.			Altered development of CD8(+) T cell lineages in mice deficient for the Tec kinases Itk and Rlk (vol 25, pg 93, 2006)	IMMUNITY			English	Correction												pams@nhgri.nih.gov	Hedrick, Stephen M/E-9171-2010	Broussard, Christine/0000-0001-6202-8154				Broussard C, 2006, IMMUNITY, V25, P93, DOI 10.1016/j.immuni.2006.05.011	1	1	1	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2006	25	5					849	849		10.1016/j.immuni.2006.10.009	http://dx.doi.org/10.1016/j.immuni.2006.10.009			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	105WN		Bronze			2022-12-18	WOS:000242063100016
J	Angeli, V; Ginhoux, F; Llodra, J; Quemeneur, L; Frenette, PS; Skobe, M; Jessberger, R; Merad, M; Randolph, GJ				Angeli, Veronique; Ginhoux, Florent; Llodra, Jaime; Quemeneur, Laurence; Frenette, Paul S.; Skobe, Mihaela; Jessberger, Rolf; Merad, Miriam; Randolph, Gwendalyn J.			B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization (vol 24, pg 203, 2006)	IMMUNITY			English	Correction												veronique.angeli@mssm.edu	Frenette, Paul S/J-8272-2012	Frenette, Paul S/0000-0003-0862-9922				Angeli V, 2006, IMMUNITY, V24, P203, DOI 10.1016/j.immuni.2006.01.003	1	1	1	1	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2006	25	4					689	689		10.1016/j.immuni.2006.10.002	http://dx.doi.org/10.1016/j.immuni.2006.10.002			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097WZ		Bronze			2022-12-18	WOS:000241481500020
J	Johnston, JB; Barrett, JW; Nazarian, SH; Goodwin, M; Ricciuto, D; Wang, G; McFadden, G				Johnston, James B.; Barrett, John W.; Nazarian, Steven H.; Goodwin, Megan; Ricciuto, Dan; Wang, Gen; McFadden, Grant			A poxvirus-encoded pyrin domain protein interacts with ASC-1 to inhibit host inflammatory and apoptotic responses to infection (vol 23, pg 587, 2005)	IMMUNITY			English	Correction												grantmcf@ufl.edu	barrett, john/ABD-8414-2020	McFadden, Grant/0000-0002-2556-3526				Johnston JB, 2005, IMMUNITY, V23, P587, DOI 10.1016/j.immuni.2005.10.003	1	1	1	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2006	25	4					687	687		10.1016/j.immuni.2006.10.003	http://dx.doi.org/10.1016/j.immuni.2006.10.003			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097WZ		Bronze			2022-12-18	WOS:000241481500019
J	Hogquist, KA				Hogquist, Kristin A.			Tec kinases in T cell development: A clue behind the mask?	IMMUNITY			English	Editorial Material							SELECTION; PROMOTER; CD1D	In this issue of Immunity, studies from Atherly et al. (2006) and Broussard et al. (2006) show that mice deficient in Tec kinases support development of a population of CD8(+) T cells with "innate-immune" properties. The similarity of these cells to NKT and MHC-class-Ib-restricted T cells suggests a common developmental pathway.	Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Hogquist, KA (corresponding author), Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA.			Hogquist, Kristin/0000-0001-9963-5687				ATHERLY LO, 2006, IMMUNITY; BENDELAC A, 1994, SCIENCE, V263, P1774, DOI 10.1126/science.7907820; Broussard C, 2006, IMMUNITY, V25, P93, DOI 10.1016/j.immuni.2006.05.011; Forestier C, 2003, J IMMUNOL, V171, P4096, DOI 10.4049/jimmunol.171.8.4096; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Schaeffer EM, 2000, J EXP MED, V192, P987, DOI 10.1084/jem.192.7.987; Surh CD, 2005, SEMIN IMMUNOL, V17, P183, DOI 10.1016/j.smim.2005.02.007; Urdahl KB, 2002, NAT IMMUNOL, V3, P772, DOI 10.1038/ni814; Xu HL, 2003, J IMMUNOL, V171, P4105, DOI 10.4049/jimmunol.171.8.4105; Yamagata T, 2004, NAT IMMUNOL, V5, P597, DOI 10.1038/ni1070	10	1	1	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2006	25	1					9	11		10.1016/j.immuni.2006.07.006	http://dx.doi.org/10.1016/j.immuni.2006.07.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	072ZX	16860750	Bronze			2022-12-18	WOS:000239713000003
J	Prabhakaran, K; Sheridan, BS; Kinchington, PR; Khanna, KM; Decman, V; Lathrop, K; Hendricks, RL				Prabhakaran, Kartik; Sheridan, Brian S.; Kinchington, Paul R.; Khanna, Kamal M.; Decman, Vilma; Lathrop, Kira; Hendricks, Robert L.			Sensory neurons regulate the effector functions of CD8(+) T cells in controlling HSV-1 latency ex vivo (Retraction of vol 23, pg 515, 2005)	IMMUNITY			English	Correction									Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Grad Program Immunol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hendricks, RL (corresponding author), Univ Pittsburgh, Sch Med, Dept Ophthalmol, 203 Lothrop St, Pittsburgh, PA 15213 USA.	hendricksrr@upmc.edu						Prabhakaran K, 2005, IMMUNITY, V23, P515, DOI 10.1016/j.immuni.2005.09.017	1	1	1	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY	2006	24	5					657	657		10.1016/j.immuni.2006.05.009	http://dx.doi.org/10.1016/j.immuni.2006.05.009			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	048TT		Bronze			2022-12-18	WOS:000237970100021
J	Singh, H; Sciammas, R				Singh, H; Sciammas, R			Shedding B cell identity	IMMUNITY			English	Editorial Material								In this issue of Immunity, Delogu et al. (2006) and Nera et al. (2006) find that the downregulation of Pax-5 during antigen-dependent-terminal differentiation results in a substantial loss of B cell identity and the transition to a plasma cell state.	Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	Howard Hughes Medical Institute; University of Chicago	Singh, H (corresponding author), Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, 929 E 57th St,CIS W522, Chicago, IL 60637 USA.				Medical Research Council [G9900989B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Nera KP, 2006, IMMUNITY, V24, P283, DOI 10.1016/j.immuni.2006.02.003; Niu HF, 1998, GENE DEV, V12, P1953, DOI 10.1101/gad.12.13.1953; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102	5	1	1	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	2006	24	3					239	240		10.1016/j.immuni.2006.03.005	http://dx.doi.org/10.1016/j.immuni.2006.03.005			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	028QY	16546090	Bronze			2022-12-18	WOS:000236504500002
J	Davisson, M; Rockwood, S				Davisson, M; Rockwood, S			The benefits of strain donation	IMMUNITY			English	Letter									Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Rockwood, S (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	steve.rockwood@jax.org							0	1	1	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2006	24	1					3	3		10.1016/j.immuni.2005.12.006	http://dx.doi.org/10.1016/j.immuni.2005.12.006			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	005UT	16413915	Bronze			2022-12-18	WOS:000234850200002
J	Murre, C				Murre, C			Marking emerging beta- and gamma delta-selected T cells	IMMUNITY			English	Editorial Material							ALPHA-BETA/GAMMA-DELTA; PRE-TCR; RECEPTOR; REARRANGEMENT		Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Murre, C (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.							Bain G, 1999, J EXP MED, V189, P289, DOI 10.1084/jem.189.2.289; Engel I, 2004, EMBO J, V23, P202, DOI 10.1038/sj.emboj.7600017; Gravestein LA, 1996, J EXP MED, V184, P675, DOI 10.1084/jem.184.2.675; Haks MC, 2005, IMMUNITY, V22, P595, DOI 10.1016/j.immuni.2005.04.003; Hayes SM, 2005, IMMUNITY, V22, P583, DOI 10.1016/j.immuni.2005.03.014; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; Munitic I, 2004, BLOOD, V104, P4165, DOI 10.1182/blood-2004-06-2484; Saint-Ruf C, 2000, NATURE, V406, P524, DOI 10.1038/35020093; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; von Boehmer H, 1998, IMMUNOL REV, V165, P111; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8	13	1	1	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2006	24	1					11	13		10.1016/j.immuni.2005.12.004	http://dx.doi.org/10.1016/j.immuni.2005.12.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	005UT	16413917	Bronze			2022-12-18	WOS:000234850200004
J	Dong, C; Sanjabi, S; Eynon, E				Dong, C; Sanjabi, S; Eynon, E			Gene regulation and function: It's rocking science	IMMUNITY			English	Editorial Material								A symposium entitled "Gene regulation and function in health and diseases" took place in September in celebration of Richard Flavell's 60(th) birthday and his contribution to science.	MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; Yale Univ, Immunol Sect, New Haven, CT USA	University of Texas System; UTMD Anderson Cancer Center; Yale University	Dong, C (corresponding author), MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	cdong@mdanderson.org	dong, chen/B-3181-2009	dong, chen/0000-0002-0084-9130				BUSSLINGER M, 1983, CELL, V34, P197, DOI 10.1016/0092-8674(83)90150-2; FLAVELL RA, 1974, J MOL BIOL, V89, P255, DOI 10.1016/0022-2836(74)90517-8; JEFFREYS AJ, 1977, CELL, V12, P1097, DOI 10.1016/0092-8674(77)90172-6	3	1	1	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2005	23	6					557	560		10.1016/j.immuni.2005.11.005	http://dx.doi.org/10.1016/j.immuni.2005.11.005			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998KH	16392168	Bronze			2022-12-18	WOS:000234316900003
J	Bennasser, Y; Le, SY; Benkirane, M; Jeang, KT				Bennasser, Y; Le, SY; Benkirane, M; Jeang, KT			Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing (vol 22, pg 607, 2005)	IMMUNITY			English	Correction									NIAID, Mol Virol Sect, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; Ctr Canc Res, Lab Expt & Computat Biol, NCI, Ft Detrick, MD 21702 USA; CNRS, Inst Genet Humaine, UPR1142, Mol Virol Lab, Montpellier, France	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Jeang, KT (corresponding author), NIAID, Mol Virol Sect, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA.	kj7e@nih.gov	Jeang, Kuan-Teh/A-2424-2008					Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010	1	1	1	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2005	22	6					773	773		10.1016/j.immuni.2005.05.004	http://dx.doi.org/10.1016/j.immuni.2005.05.004			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	940XX		Bronze			2022-12-18	WOS:000230180300014
J	Denzin, LK; Sant'Angelo, DB				Denzin, LK; Sant'Angelo, DB			Dipping into the cytosol to broaden the MHC class II peptide repertoire	IMMUNITY			English	Editorial Material							ANTIGEN; PROTEINS; DEGRADATION; AUTOPHAGY	A new study by Zhou et al. (2005) in this issue of Immunity explores how cytoplasmic autoantigens gain access to the MHC class II antigen-processing pathway. Their experiments show that hsc70 and Lamp-2a mediate antigen transport into endosomal compartments for presentation by MHC class II.	Cornell Univ, Weill Grad Sch Med Sci, Sloan Kettering Inst, Program Immunol, New York, NY 10021 USA	Cornell University; Memorial Sloan Kettering Cancer Center	Denzin, LK (corresponding author), Cornell Univ, Weill Grad Sch Med Sci, Sloan Kettering Inst, Program Immunol, New York, NY 10021 USA.							CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Lich JD, 2000, J EXP MED, V191, P1513, DOI 10.1084/jem.191.9.1513; Majeski AE, 2004, INT J BIOCHEM CELL B, V36, P2435, DOI 10.1016/j.biocel.2004.02.013; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Tewari MK, 2005, NAT IMMUNOL, V6, P287, DOI 10.1038/ni1171; Wang RF, 1999, SCIENCE, V284, P1351, DOI 10.1126/science.284.5418.1351; Zhou DL, 2005, IMMUNITY, V22, P571, DOI 10.1016/j.immuni.2005.03.009	9	1	1	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2005	22	5					536	537		10.1016/j.immuni.2005.05.003	http://dx.doi.org/10.1016/j.immuni.2005.05.003			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	930WG	15894271	Bronze			2022-12-18	WOS:000229447200003
J	Ashwell, JD				Ashwell, JD			Antigen-driven T cell expansion: Affinity rules	IMMUNITY			English	Editorial Material								TCR affinity and ligand off-rate have both been found to influence the degree of T cell activation by peptide MHC. A report in this issue of Immunity (Malherbe et al., 2004) finds that ligand off -rate does not correlate with antigen-specific peripheral T cell expansion. Moreover, the data point to the surprising notion that there exist TCR affinity thresholds and, once attained, T cells with higher affinity receptors have no competitive advantage.	NCI, Lab Immune Cell Biol, Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ashwell, JD (corresponding author), NCI, Lab Immune Cell Biol, Natl Inst Hlth, Bethesda, MD 20892 USA.							Germain RN, 1999, ANNU REV IMMUNOL, V17, P467, DOI 10.1146/annurev.immunol.17.1.467; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; Malherbe L, 2004, IMMUNITY, V21, P669, DOI 10.1016/j.immuni.2004.09.008; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5	6	1	2	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2004	21	5					603	604		10.1016/j.immuni.2004.11.001	http://dx.doi.org/10.1016/j.immuni.2004.11.001			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	874QN	15539146	Bronze			2022-12-18	WOS:000225365000001
J	Dustin, M				Dustin, M			A supercode for inflammation	IMMUNITY			English	Editorial Material							FIRM ADHESION; INTEGRIN; CD44; HYALURONATE; PATHWAY; VLA-4; FLOW	Siegelman and colleagues demonstrate unexpected synergism of CD44 and VLA-4 during lymphocyte extravasation. This is the first time that molecules mediating rolling and firm adhesion have been shown to associate biochemically leading to direct functional cooperation.	NYU, Sch Med, Skirball Inst Mol Med, Dept Pathol,Program Mol Pathogenesis, New York, NY 10016 USA	New York University	Dustin, M (corresponding author), NYU, Sch Med, Skirball Inst Mol Med, Dept Pathol,Program Mol Pathogenesis, 540 1st Ave, New York, NY 10016 USA.		Dustin, Michael/AAM-4611-2020	Dustin, Michael/0000-0003-4983-6389				ALON R, 1995, J CELL BIOL, V128, P1243, DOI 10.1083/jcb.128.6.1243; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; DeGrendele HC, 1996, J EXP MED, V183, P1119, DOI 10.1084/jem.183.3.1119; Gilcrease MZ, 1996, HUM PATHOL, V27, P1355, DOI 10.1016/S0046-8177(96)90350-0; JALKANEN S, 1987, J CELL BIOL, V105, P983, DOI 10.1083/jcb.105.2.983; Kunkel EJ, 1996, J EXP MED, V183, P57, DOI 10.1084/jem.183.1.57; Nandi A, 2004, IMMUNITY, V20, P455, DOI 10.1016/S1074-7613(04)00077-9; Salas A, 2002, J BIOL CHEM, V277, P50255, DOI 10.1074/jbc.M209822200; Siegelman MH, 2000, J CLIN INVEST, V105, P683, DOI 10.1172/JCI8692; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9	10	1	2	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2004	20	4					361	362		10.1016/S1074-7613(04)00083-4	http://dx.doi.org/10.1016/S1074-7613(04)00083-4			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EK	15084264	Bronze			2022-12-18	WOS:000221442800001
J	Kelly, TA				Kelly, TA			A third mode of integrin antagonism	IMMUNITY			English	Article							SMALL-MOLECULE		Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA	Boehringer Ingelheim	Kelly, TA (corresponding author), Boehringer Ingelheim Pharmaceut Inc, 900 Ridgebury Rd,POB 368, Ridgefield, CT 06877 USA.							Gadek TR, 2002, SCIENCE, V295, P1086, DOI 10.1126/science.295.5557.1086; Giblin PA, 2001, ANNU REP MED CHEM, V36, P181, DOI 10.1016/S0065-7743(01)36058-X; Gottlieb AB, 2002, ARCH DERMATOL, V138, P591, DOI 10.1001/archderm.138.5.591; Hamm CW, 2003, ANNU REV MED, V54, P425, DOI 10.1146/annurev.med.54.101601.152136; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Shimaoka M, 2001, P NATL ACAD SCI USA, V98, P6009, DOI 10.1073/pnas.101130498; Shimaoka M, 2003, IMMUNITY, V19, P391, DOI 10.1016/S1074-7613(03)00238-3; Woska JR, 2001, J LEUKOCYTE BIOL, V70, P329	8	1	1	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2003	19	3					307	308		10.1016/S1074-7613(03)00241-3	http://dx.doi.org/10.1016/S1074-7613(03)00241-3			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	724RD	14499105	Bronze			2022-12-18	WOS:000185499800001
J	Jabri, B; Selby, JM; Negulescu, H; Lee, L; Roberts, AI; Beavis, A; Lopez-Botet, M; Ebert, EC; Winchester, RJ				Jabri, B; Selby, JM; Negulescu, H; Lee, L; Roberts, AI; Beavis, A; Lopez-Botet, M; Ebert, EC; Winchester, RJ			TCR specificity dictates CD94/NKG2A expression by human CTL (vol 17, pg 487, 2002)	IMMUNITY			English	Correction																		Jabri B, 2002, IMMUNITY, V17, P487, DOI 10.1016/S1074-7613(02)00427-2	1	1	1	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2002	17	6					835	835		10.1016/S1074-7613(02)00484-3	http://dx.doi.org/10.1016/S1074-7613(02)00484-3			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	628GU		Bronze			2022-12-18	WOS:000179985500014
J	Naragrajan, UM; Louis-Plence, P; DeSandro, A; Nilsen, R; Bushey, A; Boss, JM				Naragrajan, UM; Louis-Plence, P; DeSandro, A; Nilsen, R; Bushey, A; Boss, JM			RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency (vol 10, pg 153, 1999)	IMMUNITY			English	Correction													Louis-Plence, Pascale/H-1553-2015	Louis-Plence, Pascale/0000-0001-7701-5241				Naragrajan UM, 1999, IMMUNITY, V10	1	1	1	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	1999	10	3												1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	181RJ					2022-12-18	WOS:000079455700012
J	Boniface, JJ; Rabinowitz, JD; Wulfing, C; Hampl, J; Reich, Z; Altman, JD; Kantor, RM; Beeson, C; McConnell, HM; Davis, MM				Boniface, JJ; Rabinowitz, JD; Wulfing, C; Hampl, J; Reich, Z; Altman, JD; Kantor, RM; Beeson, C; McConnell, HM; Davis, MM			Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands (vol 9, pg 459, 1998)	IMMUNITY			English	Correction																		Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9	1	1	1	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	1998	9	6					U7	U7						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	153MJ					2022-12-18	WOS:000077836600014
J	Vales-Gomez, M; Reyburn, HT; Mandelboim, M; Strominger, JL				Vales-Gomez, M; Reyburn, HT; Mandelboim, M; Strominger, JL			Kinetics of HLA-C ligands with natural killer cells inhibitory receptors (vol 9, pg 337, 1998)	IMMUNITY			English	Correction													Reyburn, Hugh T/B-4338-2009; Valés-Gómez, Mar/F-5351-2012; Vales-Gomez, Mar/ABG-7808-2020	Reyburn, Hugh T/0000-0003-2855-1595; Valés-Gómez, Mar/0000-0001-7424-3206; Vales-Gomez, Mar/0000-0001-7424-3206				Vales-Gomez M, 1998, IMMUNITY, V9, P337, DOI 10.1016/S1074-7613(00)80616-0	1	1	1	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	1998	9	6					U9	U9						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	153MJ					2022-12-18	WOS:000077836600015
J	OShea, JJ				OShea, JJ			Jaks, STATs, cytokine signal transduction, and immunoregulation: Are we there yet? (vol 7, pg 1, 1997)	IMMUNITY			English	Correction, Addition																		Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; OShea JJ, 1997, IMMUNITY, V7, P1, DOI 10.1016/S1074-7613(00)80505-1	2	1	1	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	SEP	1997	7	3					U9	U9						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XY830					2022-12-18	WOS:A1997XY83000013
J	Chappert, P; Huetz, F; Espinasse, MA; Chatonnet, F; Pannetier, L; Da Silva, L; Goetz, C; Megret, J; Sokal, A; Crickx, E; Nemazanyy, I; Jung, V; Guerrera, C; Storck, S; Mahevas, M; Cosma, A; Revy, P; Fest, T; Reynaud, CA; Weill, JC				Chappert, Pascal; Huetz, Francois; Espinasse, Marie-Alix; Chatonnet, Fabrice; Pannetier, Louise; Da Silva, Lucie; Goetz, Clara; Megret, Jerome; Sokal, Aurelien; Crickx, Etienne; Nemazanyy, Ivan; Jung, Vincent; Guerrera, Chiara; Storck, Sebastien; Mahevas, Matthieu; Cosma, Antonio; Revy, Patrick; Fest, Thierry; Reynaud, Claude-Agnes; Weill, Jean-Claude			Human anti-smallpox long-lived memory B cells are defined by dynamic interactions in the splenic niche and long-lasting germinal center imprinting	IMMUNITY			English	Article							FOLLICULAR DENDRITIC CELLS; T-CELLS; HUMAN SPLEEN; EXPRESSION; TELOMERASE; IMMUNITY; DIFFERENTIATION; POPULATIONS; ANTIBODIES; SPECIFICITIES	Memory B cells (MBCs) can persist for a lifetime, but the mechanisms that allow their long-term survival remain poorly understood. Here, we isolated and analyzed human splenic smallpox/vaccinia protein B5 -spe-cific MBCs in individuals who were vaccinated more than 40 years ago. Only a handful of clones persisted over such an extended period, and they displayed limited intra-clonal diversity with signs of extensive affin-ity-based selection. These long-lived MBCs appeared enriched in a CD21hiCD20hi IgG+ splenic B cell subset displaying a marginal-zone-like NOTCH/MYC-driven signature, but they did not harbor a unique longevity -associated transcriptional or metabolic profile. Finally, the telomeres of B5-specific, long-lived MBCs were longer than those in patient-paired naive B cells in all the samples analyzed. Overall, these results imply that separate mechanisms such as early telomere elongation, affinity selection during the contraction phase, and access to a specific niche contribute to ensuring the functional longevity of MBCs.	[Chappert, Pascal; Huetz, Francois; Espinasse, Marie-Alix; Pannetier, Louise; Da Silva, Lucie; Goetz, Clara; Sokal, Aurelien; Crickx, Etienne; Storck, Sebastien; Mahevas, Matthieu; Reynaud, Claude-Agnes; Weill, Jean-Claude] Univ Paris Cite, Inst Necker Enfants Malad INEM, INSERM, U1151,CNRS UMR 8253, Paris, France; [Chappert, Pascal] Inovarion, Paris, France; [Chappert, Pascal; Mahevas, Matthieu] Univ Paris Est Creteil UPEC, Equipe 2, Inst Mondor Rech Biomed IMRB, INSERM,U955, Creteil, France; [Huetz, Francois] Univ Paris Cite, Inst Pasteur, Unite Anticorps Therapie & Pathol, UMR 1222,INSERM, Paris, France; [Chatonnet, Fabrice; Fest, Thierry] Univ Rennes 1, INSERM, Etab Francais Sang Bretagne, UMR S1236, Rennes, France; [Chatonnet, Fabrice; Fest, Thierry] Ctr Hosp Univ, Pole Biol, Lab Hematol, Rennes, France; [Megret, Jerome; Nemazanyy, Ivan; Jung, Vincent; Guerrera, Chiara] INSERM, Struct Federat Rech Necker, US24, CNRS,UAR3633, Paris, France; [Crickx, Etienne; Mahevas, Matthieu] Univ Paris Est Creteil UPEC, Ctr Hosp Univ Henri Mondor, AP HP, Serv Med Interne, Creteil, France; [Cosma, Antonio] Luxembourg Inst Hlth, Natl Cytometry Platform, Translat Med Operat Hub, Esch Sur Alzette, Luxembourg; [Revy, Patrick] Univ Paris Cite, Imagine Inst, Labellise Ligue Natl Canc, INSERM UMR 1163,Lab Genome Dynam Immune Syst, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CHU Rennes; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Luxembourg Institute of Health; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Chappert, P; Reynaud, CA; Weill, JC (corresponding author), Univ Paris Cite, Inst Necker Enfants Malad INEM, INSERM, U1151,CNRS UMR 8253, Paris, France.; Chappert, P (corresponding author), Inovarion, Paris, France.; Chappert, P (corresponding author), Univ Paris Est Creteil UPEC, Equipe 2, Inst Mondor Rech Biomed IMRB, INSERM,U955, Creteil, France.	pascal.chappert@inserm.fr; claude-agnes.reynaud@inserm.fr; jean-claude.weill@inserm.fr		chappert, pascal/0000-0002-9799-4608; Reynaud, Claude-Agnes/0000-0002-4519-4473	Fondation Princesse Grace; Merieux grant; ERC Advanced Grants; Fondation EDF	Fondation Princesse Grace; Merieux grant; ERC Advanced Grants; Fondation EDF(Electricite de France (EDF))	We thank Sandra Weller for her invaluable advices; Garnett Kelsoe for the MS40Llo human cell culture system; Alexander van Oudernaarden and Judith Vivier (Hubrecht Institute, Netherlands) for initial advice regarding scRNA-seq analysis; MetaToul (Metabolomics & Fluxomics Facitilies, Toulouse, France) and its staff members (Maud Heuillet, Floriant Bellvert, and Edern Cahoreau) for carrying out the metabolomic analysis; Nicolas Goudin and Beatrice Durel (SFR Necker, Paris, France) for help regarding image acquisition and analysis; Laetitia Kermasson (Imagine Institute, Paris, France) for help regarding the set-up of Telo-FISH assays; Christophe Quetard (SARTORIUS, France) for advice on the use of the OCTET Red instrument; Jerry W. Shay and Woodring E. Wright for the kind gift of the Muntjac cells; and Raymond-Max Aubert for his support. We also gratefully thank all coordinators involved with spleen collections at the Agence de la Biomedecine.The following reagent was obtained through BEI Resources, NIAID, NIH: Vaccinia Virus B5R Protein (NR-746).This work was funded by the Fondation Princesse Grace, by a Merieux grant and by ERC Advanced Grants (Memo-B and B-response). M.A.E was supported by a grant from the Fondation EDF. MetaToul is part of the national infrastructure MetaboHUB-ANR-11-INBS-0010. P.R. is a scientist from Centre National de la Recherche Scientifique (CNRS).	Nellore A, 2021, bioRxiv, DOI 10.1101/643973; Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Akondy RS, 2017, NATURE, V552, P362, DOI 10.1038/nature24633; Albagli-Curiel O, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-85; Aldaz-Carroll L, 2005, J VIROL, V79, P6260, DOI 10.1128/JVI.79.10.6260-6271.2005; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Amanna IJ, 2006, J IMMUNOL METHODS, V317, P175, DOI 10.1016/j.jim.2006.09.005; Andrews SF, 2019, IMMUNITY, V51, P398, DOI 10.1016/j.immuni.2019.06.024; Bauer T, 2006, VACCINE, V24, P572, DOI 10.1016/j.vaccine.2005.08.058; Benyelles M, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201810201; Blackburn EH, 2015, SCIENCE, V350, P1193, DOI 10.1126/science.aab3389; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chen Yunshun, 2016, F1000Res, V5, P1438, DOI 10.12688/f1000research.8987.2; Crickx E, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abc3961; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Cyster JG, 2019, CELL, V177, P524, DOI 10.1016/j.cell.2019.03.016; Davis CW, 2019, CELL, V177, P1566, DOI 10.1016/j.cell.2019.04.036; Descatoire M, 2014, J EXP MED, V211, P986, DOI 10.1084/jem.20132203; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ettinger R, 2007, J IMMUNOL, V178, P2872, DOI 10.4049/jimmunol.178.5.2872; Fali T, 2019, J IMMUNOL, V202, P1962, DOI 10.4049/jimmunol.1801475; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Fenner Frank, 1988, SMALLPOX ITS ERADICA; Foglierini M, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007731; Gaebler C, 2021, NATURE, V591, P639, DOI [10.1038/s41586-021-03207-w, 10.1101/2020.11.03.367391]; Gaudette BT, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI151975; Gilchuk I, 2016, CELL, V167, P684, DOI 10.1016/j.cell.2016.09.049; Glass DR, 2020, IMMUNITY, V53, P217, DOI 10.1016/j.immuni.2020.06.013; Goel RR, 2021, SCIENCE, V374, P1214, DOI 10.1126/science.abm0829; Gorfu G, 2009, CURR MOL MED, V9, P836, DOI 10.2174/156652409789105525; Grun D, 2014, NAT METHODS, V11, P637, DOI [10.1038/NMETH.2930, 10.1038/nmeth.2930]; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Gupta NT, 2015, BIOINFORMATICS, V31, P3356, DOI 10.1093/bioinformatics/btv359; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Hart GT, 2011, P NATL ACAD SCI USA, V108, P716, DOI 10.1073/pnas.1013168108; Hashimshony T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0938-8; Heesters BA, 2014, NAT REV IMMUNOL, V14, P495, DOI 10.1038/nri3689; Heesters BA, 2013, IMMUNITY, V38, P1164, DOI 10.1016/j.immuni.2013.02.023; Hoehn K.B., 2020, BIORXIV, DOI [10.1101/2020.05.30.124446, DOI 10.1101/2020.05.30.124446]; Horns F, 2019, P NATL ACAD SCI USA, V116, P1261, DOI 10.1073/pnas.1814213116; Hu BT, 1997, J IMMUNOL, V159, P1068; Jenks SA, 2018, IMMUNITY, V49, P725, DOI 10.1016/j.immuni.2018.08.015; Johnson JL, 2020, IMMUNITY, V52, P842, DOI 10.1016/j.immuni.2020.03.020; Jones DD, 2015, J IMMUNOL, V195, P4753, DOI 10.4049/jimmunol.1501365; Kibler A, 2021, J EXP MED, V218, DOI 10.1084/jem.20201952; Kim W, 2022, NATURE, V604, P141, DOI 10.1038/s41586-022-04527-1; King HW, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abe6291; Kneitz C, 1999, LEUKEMIA, V13, P98, DOI 10.1038/sj.leu.2401235; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lantto J, 2011, J VIROL, V85, P1820, DOI 10.1128/JVI.02127-10; Lau D, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aai8153; Lechner M, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21359-1; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; Luo XM, 2009, BLOOD, V113, P1422, DOI 10.1182/blood-2008-09-177139; Magri G, 2014, NAT IMMUNOL, V15, P354, DOI 10.1038/ni.2830; Mamani-Matsuda M, 2008, BLOOD, V111, P4653, DOI 10.1182/blood-2007-11-123844; Martens UM, 2002, BRIT J HAEMATOL, V119, P810, DOI 10.1046/j.1365-2141.2002.03910.x; Matsuda K, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau2710; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; Muller-Winkler J, 2021, J EXP MED, V218, DOI 10.1084/jem.20191393; Muraro MJ, 2016, CELL SYST, V3, P385, DOI 10.1016/j.cels.2016.09.002; Nguyen DC, 2021, IMMUNOL REV, V303, P138, DOI 10.1111/imr.13013; Nojima T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1475; Norrback KF, 2001, EUR J HAEMATOL, V67, P309, DOI 10.1034/j.1600-0609.2001.00588.x; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Olivo-Marin JC, 2002, PATTERN RECOGN, V35, P1989, DOI 10.1016/S0031-3203(01)00127-3; Pape KA, 2018, IMMUNITY, V48, P1135, DOI 10.1016/j.immuni.2018.04.019; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Puga I, 2012, NAT IMMUNOL, V13, P170, DOI 10.1038/ni.2194; Rossiello F, 2022, NAT CELL BIOL, V24, P135, DOI 10.1038/s41556-022-00842-x; Rufer N, 1999, J EXP MED, V190, P157, DOI 10.1084/jem.190.2.157; Ryan RJH, 2017, CELL REP, V21, P784, DOI 10.1016/j.celrep.2017.09.066; Sanz I, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02458; Sintes J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01602-4; Sokal A, 2021, IMMUNITY, V54, P2893, DOI 10.1016/j.immuni.2021.09.011; Sokal A, 2021, CELL, V184, P1201, DOI 10.1016/j.cell.2021.01.050; Son NH, 2003, MECH AGEING DEV, V124, P427, DOI 10.1016/S0047-6374(03)00018-6; Steiniger B, 2005, IMMUNOLOGY, V116, P429, DOI 10.1111/j.1365-2567.2005.02242.x; Steiniger BS, 2015, IMMUNOLOGY, V145, P334, DOI 10.1111/imm.12469; Steiniger BS, 2014, IMMUNOLOGY, V143, P462, DOI 10.1111/imm.12325; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sundling C, 2021, IMMUNITY, V54, P988, DOI 10.1016/j.immuni.2021.03.013; Tangye SG, 1998, J EXP MED, V188, P1691, DOI 10.1084/jem.188.9.1691; Taub DD, 2008, AM J MED, V121, P1058, DOI 10.1016/j.amjmed.2008.08.019; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; TREPEL F, 1974, KLIN WOCHENSCHR, V52, P511, DOI 10.1007/BF01468720; van de Sande B, 2020, NAT PROTOC, V15, P2247, DOI 10.1038/s41596-020-0336-2; van den Brink SC, 2017, NAT METHODS, V14, P935, DOI 10.1038/nmeth.4437; van Velthoven CTJ, 2019, CELL STEM CELL, V24, P213, DOI 10.1016/j.stem.2019.01.001; Viant C, 2021, J EXP MED, V218, DOI 10.1084/jem.20202489; Viant C, 2020, CELL, V183, P1298, DOI 10.1016/j.cell.2020.09.063; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Wang ZJ, 2021, NATURE, V595, P426, DOI 10.1038/s41586-021-03696-9; Watanabe A, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.122551; Waters LR, 2018, ISCIENCE, V5, P99, DOI 10.1016/j.isci.2018.07.005; Wec AZ, 2020, P NATL ACAD SCI USA, V117, P6675, DOI 10.1073/pnas.1921388117; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004; Weisel NM, 2022, NAT IMMUNOL, V23, P135, DOI 10.1038/s41590-021-01078-x; Weisel NM, 2020, BLOOD, V136, P2774, DOI 10.1182/blood.2019002782; Weng NP, 1997, P NATL ACAD SCI USA, V94, P10827, DOI 10.1073/pnas.94.20.10827; Wong R, 2020, IMMUNITY, V53, P1078, DOI 10.1016/j.immuni.2020.09.001; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231; Zhao Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06089-1; Zinkernagel RM, 2018, IMMUNOL REV, V283, P238, DOI 10.1111/imr.12648	109	0	0	2	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 11	2022	55	10					1872	+		10.1016/j.immuni.2022.08.019	http://dx.doi.org/10.1016/j.immuni.2022.08.019			29	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	5Q7NB	36130603				2022-12-18	WOS:000874012400001
J	Kobayashi, T; Moro, K				Kobayashi, Tetsuro; Moro, Kazuyo			A hairy situation for ILC2s	IMMUNITY			English	Editorial Material							IMMUNITY; SKIN	The overall contribution of type 2 immunity to cutaneous barrier integrity is poorly understood. In this issue of Immunity, Ricardo-Gonzalez et al. demonstrate the mechanisms by which type 2 cytokines and group 2 innate lymphoid cells (ILC2s) regulate Demodex mite colonization and maintain skin homeostasis.	[Kobayashi, Tetsuro; Moro, Kazuyo] RIKEN Ctr Integrat Med Sci IMS, Lab Innate Immune Syst, 1-7-22 Suehiro Cho,Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Moro, Kazuyo] Osaka Univ, Grad Sch Med, Dept Microbiol & Immunol, Lab Innate Immune Syst, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Moro, Kazuyo] Osaka Univ, Immunol Frontier Res Ctr IFReC, Lab Innate Immune Syst, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan; [Moro, Kazuyo] Osaka Univ, Grad Sch Frontier Biosci, Lab Innate Immune Syst, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan; [Moro, Kazuyo] Osaka Univ, Inst Open & Transdisciplinary Res Initiat, Life Om Res Div, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan	RIKEN; Osaka University; Osaka University; Osaka University; Osaka University	Moro, K (corresponding author), RIKEN Ctr Integrat Med Sci IMS, Lab Innate Immune Syst, 1-7-22 Suehiro Cho,Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan.; Moro, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Microbiol & Immunol, Lab Innate Immune Syst, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.; Moro, K (corresponding author), Osaka Univ, Immunol Frontier Res Ctr IFReC, Lab Innate Immune Syst, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.; Moro, K (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Lab Innate Immune Syst, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.; Moro, K (corresponding author), Osaka Univ, Inst Open & Transdisciplinary Res Initiat, Life Om Res Div, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kazuyo.moro@riken.jp						Ali N, 2017, CELL, V169, P1119, DOI 10.1016/j.cell.2017.05.002; Kobayashi T, 2019, IMMUNITY, V50, P552, DOI 10.1016/j.immuni.2019.02.023; Kobayashi T, 2019, CELL, V176, P982, DOI 10.1016/j.cell.2018.12.031; Niehues Hanna, 2022, JID Innov, V2, P100066, DOI 10.1016/j.xjidi.2021.100066; Obata-Ninomiya K, 2013, J EXP MED, V210, P2583, DOI 10.1084/jem.20130761; Paichitrojjana Anon, 2022, Dermatol Reports, V14, P9339, DOI 10.4081/dr.2022.9339; Ricardo-Gonzalez RR, 2022, IMMUNITY, V55, P1891, DOI 10.1016/j.immuni.2022.08.001; Sakamoto K, 2021, IMMUNITY, V54, P2321, DOI 10.1016/j.immuni.2021.09.001; Wada T, 2010, J CLIN INVEST, V120, P2867, DOI 10.1172/JCI42680; Zhang CL, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2100749118	10	0	0	2	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 11	2022	55	10					1756	1758		10.1016/j.immuni.2022.09.009	http://dx.doi.org/10.1016/j.immuni.2022.09.009			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6P0UM	36223723				2022-12-18	WOS:000890651400001
J	Li, J; Ruffell, B				Li, Jie; Ruffell, Brian			Cytokines drive prostate cancer lineage plasticity	IMMUNITY			English	Editorial Material							NEUROENDOCRINE PHENOTYPE; RECEPTOR	Lineage plasticity is a critical mechanism of therapeutic resistance in cancer. In a recent issue of Science, Chan and colleagues demonstrate that early lineage plasticity in prostate cancer is driven by JAK-STAT in-flammatory cytokine signaling.	[Li, Jie; Ruffell, Brian] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA; [Li, Jie] Univ S Florida, Canc Biol PhD Program, Tampa, FL 33620 USA; [Ruffell, Brian] H Lee Moffitt Canc Ctr & Res Inst, Dept Breast Oncol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute	Ruffell, B (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA.; Ruffell, B (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Breast Oncol, Tampa, FL 33612 USA.	brian.ruffell@moffitt.org			Department of Defense Breast Cancer Research Program; NIH/NCI; Cancer Research Institute Lloyd J. Old STAR Program;  [W81XWH-20-1-0012];  [W81XWH-22-2-0406];  [R01C A230610]	Department of Defense Breast Cancer Research Program(United States Department of Defense); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research Institute Lloyd J. Old STAR Program; ; ; 	ACKNOWLEDGMENTS B.R. is supported by the Department of Defense Breast Cancer Research Program (W81XWH-20-1-0012, W81XWH-22-2-0406) , the NIH/NCI (R01C A230610) , and the Cancer Research Institute Lloyd J. Old STAR Program.	Chan JM, 2022, SCIENCE, V377, P1180, DOI 10.1126/science.abn0478; Davies AH, 2018, NAT REV UROL, V15, P271, DOI 10.1038/nrurol.2018.22; El-Kenawi A, 2021, CANCER RES, V81, P5477, DOI 10.1158/0008-5472.CAN-20-4028; Escamilla J, 2015, CANCER RES, V75, P950, DOI 10.1158/0008-5472.CAN-14-0992; Ku SY, 2017, SCIENCE, V355, P78, DOI 10.1126/science.aah4199; Lee GT, 2011, PROSTATE, V71, P1525, DOI 10.1002/pros.21369; Lu TJ, 2012, MOL ENDOCRINOL, V26, P1707, DOI 10.1210/me.2012-1079; Rubin MA, 2020, MOL CELL, V80, P562, DOI 10.1016/j.molcel.2020.10.033; Sun LJ, 2021, CANCER CELL, V39, P1361, DOI 10.1016/j.ccell.2021.08.005; Wang ML, 2022, CANCER CELL, V40, P1044, DOI 10.1016/j.ccell.2022.08.010	10	0	0	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 11	2022	55	10					1761	1763		10.1016/j.immuni.2022.09.011	http://dx.doi.org/10.1016/j.immuni.2022.09.011			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6N8RH	36223725				2022-12-18	WOS:000889817400001
J	Liu, SP; Lorgulecu, JB; Li, SQ; Borji, M; Barrera-Lopez, IA; Shanmugam, V; Lyu, H; Morriss, JW; Garcia, ZN; Murray, E; Reardon, DA; Yoon, CH; Braun, DA; Livak, KJ; Wu, CJ; Chen, F				Liu, Sophia; Lorgulecu, J. Bryan; Li, Shuqian; Borji, Mehdi; Barrera-Lopez, Irving A.; Shanmugam, Vignesh; Lyu, Haoxiang; Morriss, Julia W.; Garcia, Zoe N.; Murray, Evan; Reardon, David A.; Yoon, Charles H.; Braun, David A.; Livak, Kenneth J.; Wu, Catherine J.; Chen, Fei			Spatial maps of T cell receptors and transcriptomes reveal distinct immune niches and interactions in the adaptive immune response	IMMUNITY			English	Article								T cells mediate antigen-specific immune responses to disease through the specificity and diversity of their clonotypic T cell receptors (TCRs). Determining the spatial distributions of T cell clonotypes in tissues is essential to understanding T cell behavior, but spatial sequencing methods remain unable to profile the TCR repertoire. Here, we developed Slide-TCR-seq, a 10-mm-resolution method, to sequence whole tran-scriptomes and TCRs within intact tissues. We confirmed the ability of Slide-TCR-seq to map the character-istic locations of T cells and their receptors in mouse spleen. In human lymphoid germinal centers, we iden-tified spatially distinct TCR repertoires. Profiling T cells in renal cell carcinoma and melanoma specimens revealed heterogeneous immune responses: T cell states and infiltration differed intra-and inter-clonally, and adjacent tumor and immune cells exhibited distinct gene expression. Altogether, our method yields in-sights into the spatial relationships between clonality, neighboring cell types, and gene expression that drive T cell responses.	[Liu, Sophia] Harvard Univ, Biophys Program, Boston, MA 02115 USA; [Liu, Sophia] MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Liu, Sophia; Lorgulecu, J. Bryan; Li, Shuqian; Borji, Mehdi; Barrera-Lopez, Irving A.; Shanmugam, Vignesh; Morriss, Julia W.; Garcia, Zoe N.; Murray, Evan; Braun, David A.; Wu, Catherine J.; Chen, Fei] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Lorgulecu, J. Bryan; Li, Shuqian; Borji, Mehdi; Lyu, Haoxiang; Reardon, David A.; Braun, David A.; Livak, Kenneth J.; Wu, Catherine J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Lorgulecu, J. Bryan; Shanmugam, Vignesh] Brigham & Womens Hosp, Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA; [Li, Shuqian; Lyu, Haoxiang; Livak, Kenneth J.] Dana Farber Canc Inst, Translat Lab, Boston, MA 02215 USA; [Garcia, Zoe N.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Reardon, David A.; Braun, David A.; Wu, Catherine J.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Yoon, Charles H.] Harvard Med Sch, Brigham & Womens Hosp, Dept Surg Oncol, Boston, MA 02115 USA; [Braun, David A.] Yale Sch Med, Yale Ctr Cellular & Mol Oncol, New Haven, CT 06511 USA; [Wu, Catherine J.] Dana Farber Canc Inst, Div Stem Cell Transplantat & Cellular Therapies, Boston, MA 02215 USA; [Chen, Fei] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Yale University; Harvard University; Dana-Farber Cancer Institute; Harvard University	Wu, CJ; Chen, F (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Wu, CJ (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.; Wu, CJ (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA.; Wu, CJ (corresponding author), Dana Farber Canc Inst, Div Stem Cell Transplantat & Cellular Therapies, Boston, MA 02215 USA.; Chen, F (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	cwu@partners.org; chenf@broadinstitute.org	Chen, Fei/HGE-5690-2022	Chen, Fei/0000-0003-2308-3649; Liu, Sophia/0000-0003-3614-9731; Iorgulescu, J. Bryan/0000-0003-1405-3667; Morriss, Julia/0000-0002-7337-8712; Barrera, Irving/0000-0001-6099-4316	DFCI Glioblastoma Tiger Team; NIH [1DP5OD024583, U19AI082630]; Dana-Farber/Harvard Cancer Center Kidney Cancer SPORE [NCI P50CA101942]; NIH Molecular Biophysics Training Grant [NIH/NIGMS T32GM008313]; National Science Foundation Graduate Research Fellowship; NIH/NCI [U24CA224331, K12CA090354, R01CA155010]; Conquer Cancer Foundation/Sontag Foundation; NCI Research Specialist Award [R50CA251956]; DF/HCC Kidney Cancer SPORE Career Enhancement Program [NCI P50CA101942-15]; DOD Academy of Kidney Cancer Investigators [KC190128]; Parker Institute for Cancer Immunotherapy; NHGRI [R01HG010647]; Burroughs Wellcome Fund CASI award; Merkin Institute	DFCI Glioblastoma Tiger Team; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana-Farber/Harvard Cancer Center Kidney Cancer SPORE; NIH Molecular Biophysics Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Conquer Cancer Foundation/Sontag Foundation; NCI Research Specialist Award; DF/HCC Kidney Cancer SPORE Career Enhancement Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD Academy of Kidney Cancer Investigators; Parker Institute for Cancer Immunotherapy; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Burroughs Wellcome Fund CASI award(Burroughs Wellcome Fund); Merkin Institute	We thank Jamie L. Marshall and Wandi Zhang for expert technical assistance; Sabina Signoretti and Toni Choueiri for RCC biobanking; and Aziz Al?Khafaji, Hans T. Bergal, Ravi Uppaluri, Hattie Chung, Haiqi Chen, Zack Chiang, Dylan M. Cable, Lucas Pomerance, and Giacomo Oliveira for helpful feedback. This work was supported in part by the DFCI Glioblastoma Tiger Team, the NIH U19AI082630, and the Dana-Farber/Harvard Cancer Center Kidney Cancer SPORE (NCI P50CA101942) . S. Liu is supported by the NIH Molecular Biophysics Training Grant (NIH/NIGMS T32GM008313) and the National Science Foundation Graduate Research Fellowship. J.B.I. gratefully acknowl- edges support from the NIH/NCI (K12CA090354) and the Conquer Cancer Foundation/Sontag Foundation. S. Li is supported by the NCI Research Specialist Award (R50CA251956) . D.A.B. acknowledges support from the DF/HCC Kidney Cancer SPORE Career Enhancement Program (NCI P50CA101942-15) and the DOD Academy of Kidney Cancer Investigators (KC190128) . C.J.W. acknowledges support from NIH/NCI R01CA155010 and NIH/NCI U24CA224331 and is supported in part by the Parker Institute for Cancer Immunotherapy. F.C. acknowledges support from the NIH Early In- dependence Award (1DP5OD024583) , the NHGRI (R01HG010647) , the Burroughs Wellcome Fund CASI award, and the Merkin Institute.	Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Bendall ML, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006453; Bi K, 2021, CANCER CELL, V39, P649, DOI 10.1016/j.ccell.2021.02.015; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Bost P, 2020, CELL, V181, P1475, DOI 10.1016/j.cell.2020.05.006; Braun DA, 2021, CANCER CELL, V39, P632, DOI 10.1016/j.ccell.2021.02.013; Cable DM, 2022, NAT METHODS, V19, P1076, DOI 10.1038/s41592-022-01575-3; Cable DM, 2022, NAT BIOTECHNOL, V40, P517, DOI 10.1038/s41587-021-00830-w; Chow MT, 2019, IMMUNITY, V50, P1498, DOI 10.1016/j.immuni.2019.04.010; Dobosy JR, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-80; Fisher R. A., 1992, STAT METHODS RES WOR, P66, DOI [DOI 10.1007/978-1-4612-4380-9_6, 10.1007/978-1-4612-4380-9_6]; Gohil SH, 2021, NAT REV CLIN ONCOL, V18, P244, DOI 10.1038/s41571-020-00449-x; Golumbeanu M, 2018, CELL REP, V23, P942, DOI 10.1016/j.celrep.2018.03.102; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Hwang S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57218-9; James Melville, 2020, Arxiv, DOI arXiv:1802.03426; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Joshi K, 2019, NAT MED, V25, P1549, DOI 10.1038/s41591-019-0592-2; Kimmel JC, 2019, GENOME RES, V29, P2088, DOI 10.1101/gr.253880.119; Kleshchevnikov V, 2022, NAT BIOTECHNOL, V40, P661, DOI 10.1038/s41587-021-01139-4; Krishna C, 2021, CANCER CELL, V39, P662, DOI 10.1016/j.ccell.2021.03.007; Kuang FM, 2021, CELL CHEM BIOL, V28, P765, DOI 10.1016/j.chembiol.2021.01.006; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Li SQ, 2019, NAT PROTOC, V14, P2571, DOI 10.1038/s41596-019-0195-x; Lu S, 2019, JAMA ONCOL, V5, P1195, DOI 10.1001/jamaoncol.2019.1549; Merkenschlager J, 2021, NATURE, V591, P458, DOI 10.1038/s41586-021-03187-x; Meylan M, 2022, IMMUNITY, V55, P527, DOI 10.1016/j.immuni.2022.02.001; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Oakes T, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01267; Oliveira G, 2022, NATURE, V605, P532, DOI 10.1038/s41586-022-04682-5; Oliveira G, 2021, NATURE, V596, P119, DOI 10.1038/s41586-021-03704-y; Pace L, 2018, SCIENCE, V359, P177, DOI 10.1126/science.aah6499; Park JE, 2020, SCIENCE, V367, P868, DOI 10.1126/science.aay3224; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Sautes-Fridman C, 2019, NAT REV CANCER, V19, P307, DOI 10.1038/s41568-019-0144-6; Seabold S., 2010, STATSMODELS ECONOMET, DOI [10.25080/MAJORA-92BF1922-011, DOI 10.25080/MAJORA-92BF1922-011]; Shulman Z, 2013, SCIENCE, V341, P673, DOI 10.1126/science.1241680; Spranger S, 2017, CANCER CELL, V31, P711, DOI 10.1016/j.ccell.2017.04.003; Stickels RR, 2021, NAT BIOTECHNOL, V39, P313, DOI 10.1038/s41587-020-0739-1; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/NMETH.4380, 10.1038/nmeth.4380]; Strbo N, 2003, IMMUNITY, V18, P381, DOI 10.1016/S1074-7613(03)00056-6; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Suan D, 2015, IMMUNITY, V42, P704, DOI 10.1016/j.immuni.2015.03.002; Thome JJC, 2014, CELL, V159, P814, DOI 10.1016/j.cell.2014.10.026; Tirosh I, 2016, NATURE, V539, P309, DOI 10.1038/nature20123; Travaglini KJ, 2020, NATURE, V587, DOI 10.1038/s41586-020-2922-4; Tu AA, 2019, NAT IMMUNOL, V20, P1692, DOI 10.1038/s41590-019-0544-5; Wang WM, 2019, NATURE, V569, P270, DOI 10.1038/s41586-019-1170-y; Wu SZ, 2021, GENOME MED, V13, DOI 10.1186/s13073-021-00885-z; Wu TD, 2020, NATURE, V579, P274, DOI 10.1038/s41586-020-2056-8; Yost KE, 2019, NAT MED, V25, P1251, DOI 10.1038/s41591-019-0522-3; Young MD, 2018, SCIENCE, V361, P594, DOI 10.1126/science.aat1699; Yu CR, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/359674; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zemmour D, 2018, NAT IMMUNOL, V19, P291, DOI 10.1038/s41590-018-0051-0	57	0	0	6	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 11	2022	55	10					1940	+		10.1016/j.immuni.2022.09.002	http://dx.doi.org/10.1016/j.immuni.2022.09.002			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	5Q7NB	36223726				2022-12-18	WOS:000874012400005
J	Rollenske, T; Macpherson, AJ				Rollenske, Tim; Macpherson, Andrew J.			"'ELO, world!"-Early-life origins of B cells	IMMUNITY			English	Editorial Material							REPERTOIRE; GUT; B-1	Immune cells generated in early life play pivotal roles for immune homeostasis in adulthood. Vergani et al. identify a population of early-life-origin IgA B cells that are maintained throughout life to achieve homeostasisin the adult gut.	[Rollenske, Tim; Macpherson, Andrew J.] Univ Bern, Bern Univ Hosp, Dept Visceral Surg & Med, Inselspital, Bern, Switzerland	University of Bern; University Hospital of Bern	Macpherson, AJ (corresponding author), Univ Bern, Bern Univ Hosp, Dept Visceral Surg & Med, Inselspital, Bern, Switzerland.	andrew.macpherson@dbmr.unibe.ch			European Research Council (ERC) [742195]; Swiss National Science Foundation (SNF) [CRSII5_205965]	European Research Council (ERC)(European Research Council (ERC)European Commission); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	Support is acknowledged from the European Research Council (ERC) Ad (HHMM-Neonates 742195) and the Swiss National Science Foundation (SNF) (CRSII5_205965) .	Graf R, 2019, SCIENCE, V363, P748, DOI 10.1126/science.aau8475; HAYAKAWA K, 1986, EUR J IMMUNOL, V16, P1313, DOI 10.1002/eji.1830161021; Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75; Lam KP, 1999, J EXP MED, V190, P471, DOI 10.1084/jem.190.4.471; Lindner C, 2015, NAT IMMUNOL, V16, P880, DOI 10.1038/ni.3213; MACLENNAN ICM, 1982, IMMUNOL TODAY, V3, P305, DOI 10.1016/0167-5699(82)90032-9; Martin F, 2000, IMMUNOL REV, V175, P70, DOI 10.1111/j.1600-065X.2000.imr017515.x; New JS, 2020, IMMUNITY, V53, P172, DOI 10.1016/j.immuni.2020.06.006; Vergani S., 2022, IMMUNITY, V55, DOI [10.1016/j.im- muni.2022.08.018, DOI 10.1016/J.IM-MUNI.2022.08.018]; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	10	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 11	2022	55	10					1753	1755		10.1016/j.immuni.2022.09.012	http://dx.doi.org/10.1016/j.immuni.2022.09.012			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6P5UO	36223722				2022-12-18	WOS:000890995600001
J	Tas, JMJ; Koo, JH; Lin, YC; Xie, ZF; Steichen, JM; Jackson, AM; Hauser, BM; Wang, XS; Cottrell, CA; Torres, JL; Warner, JE; Kirsch, KH; Weldon, SR; Groschel, B; Nogal, B; Ozorowski, G; Bangaru, S; Phelps, N; Adachi, Y; Eskandarzadeh, S; Kubitz, M; Burton, DR; Lingwood, D; Schmidt, AG; Nair, U; Ward, AB; Schief, WR; Batista, FD				Tas, Jeroen M. J.; Koo, Ja-Hyun; Lin, Ying-Cing; Xie, Zhenfei; Steichen, Jon M.; Jackson, Abigail M.; Hauser, Blake M.; Wang, Xuesong; Cottrell, Christopher A.; Torres, Jonathan L.; Warner, John E.; Kirsch, Kathrin H.; Weldon, Stephanie R.; Groschel, Bettina; Nogal, Bartek; Ozorowski, Gabriel; Bangaru, Sandhya; Phelps, Nicole; Adachi, Yumiko; Eskandarzadeh, Saman; Kubitz, Michael; Burton, Dennis R.; Lingwood, Daniel; Schmidt, Aaron G.; Nair, Usha; Ward, Andrew B.; Schief, William R.; Batista, Facundo D.			Antibodies from primary humoral responses modulate the recruitment of naive B cells during secondary responses	IMMUNITY			English	Article							NEUTRALIZING ANTIBODIES; GERMINAL-CENTERS; MEMORY; HIV; ANTIGEN; EPITOPES; DIFFERENTIATION; DYNAMICS; COVERAGE; DESIGN	Vaccines generate high-affinity antibodies by recruiting antigen-specific B cells to germinal centers (GCs), but the mechanisms governing the recruitment to GCs on secondary challenges remain unclear. Here, using preclinical SARS-CoV and HIV mouse models, we demonstrated that the antibodies elicited during primary humoral responses shaped the naive B cell recruitment to GCs during secondary exposures. The antibodies from primary responses could either enhance or, conversely, restrict the GC participation of naive B cells: broad-binding, low-affinity, and low-titer antibodies enhanced recruitment, whereas, by contrast, the high ti-ters of high-affinity, mono-epitope-specific antibodies attenuated cognate naive B cell recruitment. Thus, the directionality and intensity of that effect was determined by antibody concentration, affinity, and epitope specificity. Circulating antibodies can, therefore, be important determinants of antigen immunogenicity. Future vaccines may need to overcome-or could, alternatively, leverage-the effects of circulating primary antibodies on subsequent naive B cell recruitment.	[Tas, Jeroen M. J.; Koo, Ja-Hyun; Lin, Ying-Cing; Xie, Zhenfei; Hauser, Blake M.; Wang, Xuesong; Warner, John E.; Kirsch, Kathrin H.; Weldon, Stephanie R.; Burton, Dennis R.; Lingwood, Daniel; Schmidt, Aaron G.; Nair, Usha; Schief, William R.; Batista, Facundo D.] MIT, Ragon Inst MGH, Cambridge, MA 02139 USA; [Steichen, Jon M.; Cottrell, Christopher A.; Groschel, Bettina; Nogal, Bartek; Phelps, Nicole; Adachi, Yumiko; Eskandarzadeh, Saman; Kubitz, Michael; Burton, Dennis R.; Schief, William R.] Scripps Res Inst, Dept Immunol & Microbiol, San Diego, CA 92037 USA; [Steichen, Jon M.; Jackson, Abigail M.; Cottrell, Christopher A.; Torres, Jonathan L.; Groschel, Bettina; Bangaru, Sandhya; Phelps, Nicole; Adachi, Yumiko; Eskandarzadeh, Saman; Kubitz, Michael; Burton, Dennis R.; Ward, Andrew B.; Schief, William R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, San Diego, CA 92037 USA; [Steichen, Jon M.; Cottrell, Christopher A.; Torres, Jonathan L.; Groschel, Bettina; Nogal, Bartek; Bangaru, Sandhya; Phelps, Nicole; Adachi, Yumiko; Eskandarzadeh, Saman; Kubitz, Michael; Burton, Dennis R.; Ward, Andrew B.; Schief, William R.] Scripps Res Inst, Ctr HIV AIDS Vaccine Dev, San Diego, CA 92037 USA; [Torres, Jonathan L.; Nogal, Bartek; Ozorowski, Gabriel; Bangaru, Sandhya; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, San Diego, CA 92037 USA; [Batista, Facundo D.] Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA; [Batista, Facundo D.] Harvard Med Sch, Dept Microbiol, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Batista, FD (corresponding author), MIT, Ragon Inst MGH, Cambridge, MA 02139 USA.; Batista, FD (corresponding author), Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA.; Batista, FD (corresponding author), Harvard Med Sch, Dept Microbiol, Boston, MA 02115 USA.	fbatista1@mgh.harvard.edu		Hauser, Blake/0000-0002-0100-1684	IAVI Neutralizing Antibody Center through the Collaboration for AIDS Vaccine Discovery grants - Bill and Melinda Gates Foundation [OPP1084519, OPP1147787, INV-034657, OPP1196345/INV-008813, OPP1115782/INV-002916, OPP1170236/INV-004923, INV009585]; Collaboration for AIDS Vaccine Discovery (CAVD); National Institute of Allergy and Infectious Diseases (NIAID) [UM1 Al100663, UM1 AI144462, R01 AI153098, F30 AI160908]; National Research Foundation of Korea's Basic Science Research Program [NRF-2021R1A6A3A14044219]; Ragon Institute of MGH, MIT and Harvard	IAVI Neutralizing Antibody Center through the Collaboration for AIDS Vaccine Discovery grants - Bill and Melinda Gates Foundation; Collaboration for AIDS Vaccine Discovery (CAVD); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Research Foundation of Korea's Basic Science Research Program(National Research Foundation of Korea); Ragon Institute of MGH, MIT and Harvard	We thank all Batista Lab members for assistance with the experiments and Sven Kratochvil for critical reading of the manuscript. We would like to thank several members of The Scripps Research Institute as well, in particular: Leigh M. Sewall for assistance with electron microscopy and Thomas F. Rogers, Na-than Beutler, and Elijah Garcia for providing serum IgGs for human polyclonal studies. We also thank Mimi Guebre-Xabier, Gale Smith, Nita Patel, and Alyse Portnoff from Novavax, Inc. for the provision of materials. This work was sup-ported by the IAVI Neutralizing Antibody Center through the Collaboration for AIDS Vaccine Discovery grants OPP1084519, OPP1147787, INV-034657 (to W.R.S.) , OPP1196345/INV-008813 (to A.B.W. and W.R.S.) , OPP1115782/INV-002916 (to A.B.W.) , OPP1170236/INV-004923 (to A.B.W., D.R.B., and W.R.S.) , and INV009585 (to F.D.B.) funded by the Bill and Melinda Gates Foun-dation and the Collaboration for AIDS Vaccine Discovery (CAVD) ; the National Institute of Allergy and Infectious Diseases (NIAID) UM1 Al100663 (Scripps Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery) (to F.D.B., D.R.B., A.B.W., and W.R.S.) , UM1 AI144462 (Scripps Consortium for HIV/AIDS Vaccine Development) (to W.R.S., A.B.W., D.R.B., and F.D.B.) , R01 AI153098 (to D.L.) , and F30 AI160908 (to B.M.H.) ; by the National Research Foundation of Korea?s Basic Science Research Program NRF-2021R1A6A3A14044219 (to J.H.K.) ; and by the Ragon Institute of MGH, MIT and Harvard (to W.R.S., D.R.B., and F.D.B.) . Graphical abstract was designed by Christina Corbaci.	Abbott RK, 2018, IMMUNITY, V48, P133, DOI 10.1016/j.immuni.2017.11.023; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; BACHMANN MF, 1993, SCIENCE, V262, P1448, DOI 10.1126/science.8248784; Bangaru S, 2022, SCI ADV, V8, DOI 10.1126/sciadv.abn2911; Barnes CO, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03632-y; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Bergstrom JJE, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00238; Bianchi M, 2018, IMMUNITY, V49, P288, DOI 10.1016/j.immuni.2018.07.009; Briney B, 2019, NATURE, V566, P393, DOI 10.1038/s41586-019-0879-y; Brouwer PJM, 2020, SCIENCE, V369, P643, DOI 10.1126/science.abc5902; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; Cirelli KM, 2019, CELL, V177, P1153, DOI 10.1016/j.cell.2019.04.012; Cottrell CA, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008753; Cyster JG, 2019, CELL, V177, P524, DOI 10.1016/j.cell.2019.03.016; DAVENPORT FM, 1953, J EXP MED, V98, P641, DOI 10.1084/jem.98.6.641; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Haynes BF, 2017, IMMUNOL REV, V275, P5, DOI 10.1111/imr.12517; Ju B, 2020, NATURE, V584, P115, DOI 10.1038/s41586-020-2380-z; Kato Y, 2020, IMMUNITY, V53, P548, DOI 10.1016/j.immuni.2020.08.001; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Kringelum JV, 2013, MOL IMMUNOL, V53, P24, DOI 10.1016/j.molimm.2012.06.001; Kurosaki T, 2015, NAT REV IMMUNOL, V15, P149, DOI 10.1038/nri3802; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Laserson U, 2014, P NATL ACAD SCI USA, V111, P4928, DOI 10.1073/pnas.1323862111; Lee JH, 2017, IMMUNITY, V46, P690, DOI 10.1016/j.immuni.2017.03.017; Lin YC, 2018, EMBO J, V37, DOI 10.15252/embj.201899243; MASON DY, 1992, INT IMMUNOL, V4, P163, DOI 10.1093/intimm/4.2.163; McHeyzer-Williams LJ, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028878; McHeyzer-Williams LJ, 2015, NAT IMMUNOL, V16, P296, DOI 10.1038/ni.3095; McNamara HA, 2020, CELL HOST MICROBE, V28, P572, DOI 10.1016/j.chom.2020.07.001; Mesin L, 2020, CELL, V180, P92, DOI 10.1016/j.cell.2019.11.032; Meyer-Hermann M, 2019, CELL REP, V29, P1066, DOI 10.1016/j.celrep.2019.09.058; Moyer TJ, 2020, NAT MED, V26, P430, DOI 10.1038/s41591-020-0753-3; Ota T, 2013, J IMMUNOL, V191, P3179, DOI 10.4049/jimmunol.1301283; Pape KA, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029116; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pulendran B, 2021, NAT REV DRUG DISCOV, V20, P454, DOI 10.1038/s41573-021-00163-y; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Shlomchik MJ, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029405; Smith T, 1909, J EXP MED, V11, P241, DOI 10.1084/jem.11.2.241; Stamatatos L, 2017, IMMUNOL REV, V275, P203, DOI 10.1111/imr.12483; Steichen JM, 2019, SCIENCE, V366, P1216, DOI 10.1126/science.aax4380; Steichen JM, 2016, IMMUNITY, V45, P483, DOI 10.1016/j.immuni.2016.08.016; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tam HH, 2016, P NATL ACAD SCI USA, V113, pE6639, DOI 10.1073/pnas.1606050113; Tas JMJ, 2016, SCIENCE, V351, P1048, DOI 10.1126/science.aad3439; ter Meulen J, 2006, PLOS MED, V3, P1071, DOI 10.1371/journal.pmed.0030237; Victora GD, 2022, ANNU REV IMMUNOL, V40, P413, DOI 10.1146/annurev-immunol-120419-022408; Vijayan K, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109489; von Boehmer L, 2016, NAT PROTOC, V11, P1908, DOI 10.1038/nprot.2016.102; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang XS, 2021, EMBO J, V40, DOI 10.15252/embj.2020105926; Wang Zijun, 2021, bioRxiv, DOI [10.1038/s41586-021-03324-6, 10.1101/2021.01.15.426911]; Weisel F, 2017, ANNU REV IMMUNOL, V35, P255, DOI 10.1146/annurev-immunol-041015-055531; Wong R, 2020, IMMUNITY, V53, P1078, DOI 10.1016/j.immuni.2020.09.001; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yeh CH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03382-x; Yuan M, 2021, SCIENCE, V373, P818, DOI 10.1126/science.abh1139; Yuan M, 2020, SCIENCE, V368, P630, DOI 10.1126/science.abb7269; Zabel F, 2014, J IMMUNOL, V192, P5499, DOI 10.4049/jimmunol.1400065; Zhang A, 2019, J IMMUNOL, V202, P335, DOI 10.4049/jimmunol.1801149; Zhang Y, 2013, J EXP MED, V210, P457, DOI 10.1084/jem.20120150	68	0	0	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 11	2022	55	10					1856	+		10.1016/j.immuni.2022.07.020	http://dx.doi.org/10.1016/j.immuni.2022.07.020			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6P0UI	35987201	hybrid, Green Published			2022-12-18	WOS:000890651000001
J	Thornton, EE; Arnon, TI				Thornton, Emily E.; Arnon, Tal I.			It takes a village to skew a lymph node	IMMUNITY			English	Editorial Material							T-CELLS	Unconventional T cells (UTCs) play important roles in protecting barrier tissues. In this issue of Immunity, Ataide and colleagues show an additional function for these cells: populating downstream lymph nodes and skewing their cytokine profiles. This process allows tissues to adjust the function of draining lymph nodes through imprinting UTC cytokine production, subsequently influencing the immune responses that are triggered.	[Thornton, Emily E.] Univ Oxford, MRC Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England; [Arnon, Tal I.] Univ Oxford, Nuffield Dept Med, Oxford, England; [Arnon, Tal I.] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England	University of Oxford; University of Oxford; University of Oxford	Arnon, TI (corresponding author), Univ Oxford, Nuffield Dept Med, Oxford, England.; Arnon, TI (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, Oxford, England.	tal.arnon@kennedy.ox.ac.uk						Constantinides MG, 2021, SCIENCE, V374, P1338, DOI 10.1126/science.abf0095; DiSpirito JR, 2015, SEMIN IMMUNOL, V27, P315, DOI 10.1016/j.smim.2015.10.005; Fan X, 2016, CELL, V164, P1198, DOI 10.1016/j.cell.2016.02.048; Gray E.E., 2013, DEFICIENCY IL 17 COM; Gray EE, 2013, NAT IMMUNOL, V14, P584, DOI 10.1038/ni.2585; Gutierrez-Arcelus M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08604-4; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Muller PA, 2020, NATURE, V583, P441, DOI 10.1038/s41586-020-2474-7; Qi H, 2014, ANNU REV CELL DEV BI, V30, P141, DOI 10.1146/annurev-cellbio-100913-013254; Ramirez-Valle F, 2015, P NATL ACAD SCI USA, V112, P8046, DOI 10.1073/pnas.1508990112	10	0	0	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 11	2022	55	10					1751	1753		10.1016/j.immuni.2022.09.008	http://dx.doi.org/10.1016/j.immuni.2022.09.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6P0PP	36223721				2022-12-18	WOS:000890638400001
J	Vazquez-Lombardi, R; Jung, JS; Schlatter, FS; Mei, A; Mantuano, NR; Bieberich, F; Hong, KL; Kucharczyk, J; Kapetanovic, E; Aznauryan, E; Weber, CR; Zippelius, A; Laubli, H; Reddy, ST				Vazquez-Lombardi, Rodrigo; Jung, Johanna S.; Schlatter, Fabrice S.; Mei, Anna; Mantuano, Natalia Rodrigues; Bieberich, Florian; Hong, Kai-Lin; Kucharczyk, Jakub; Kapetanovic, Edo; Aznauryan, Erik; Weber, Cedric R.; Zippelius, Alfred; Laubli, Heinz; Reddy, Sai T.			High-throughput T cell receptor engineering by functional screening identifies candidates with enhanced potency and specificity	IMMUNITY			English	Article							CANCER REGRESSION; MELANOMA PATIENTS; GENE-THERAPY; AFFINITY; VACCINATION; EXPRESSION; REACTIVITY; RESPONSES; SELECTION; TOXICITY	A major challenge in adoptive T cell immunotherapy is the discovery of natural T cell receptors (TCRs) with high activity and specificity to tumor antigens. Engineering synthetic TCRs for increased tumor antigen recognition is complicated by the risk of introducing cross-reactivity and by the poor correlation that can exist between binding affinity and activity of TCRs in response to antigen (peptide-MHC). Here, we developed TCR-Engine, a method combining genome editing, computational design, and deep sequencing to engineer the functional activity and specificity of TCRs on the surface of a human T cell line at high throughput. We applied TCR-Engine to successfully engineer synthetic TCRs for increased potency and specificity to a clinically relevant tumor-associated antigen (MAGE-A3) and validated their translational potential through multiple in vitro and in vivo assessments of safety and efficacy. Thus, TCR-Engine represents a valuable tech-nology for engineering of safe and potent synthetic TCRs for immunotherapy applications.	[Vazquez-Lombardi, Rodrigo; Jung, Johanna S.; Schlatter, Fabrice S.; Mei, Anna; Bieberich, Florian; Hong, Kai-Lin; Kucharczyk, Jakub; Kapetanovic, Edo; Aznauryan, Erik; Weber, Cedric R.; Reddy, Sai T.] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Mattenstr 26, CH-4058 Basel, Switzerland; [Vazquez-Lombardi, Rodrigo] Engimmune Therapeut AG, Hegenheimermattweg 167A, CH-4123 Allschwil, Switzerland; [Mantuano, Natalia Rodrigues; Zippelius, Alfred; Laubli, Heinz] Univ Spital Basel, Dept Biomed, Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel	Vazquez-Lombardi, R; Reddy, ST (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Mattenstr 26, CH-4058 Basel, Switzerland.; Vazquez-Lombardi, R (corresponding author), Engimmune Therapeut AG, Hegenheimermattweg 167A, CH-4123 Allschwil, Switzerland.	rodrigo.vl@engimmune.com; sai.reddy@ethz.ch		Bieberich, Florian/0000-0002-6678-5985	Personalized Health and Related Technologies Postdoctoral Fellowship; NCCR Molecular Systems Engineering; Helmut Horten Stiftung	Personalized Health and Related Technologies Postdoctoral Fellowship; NCCR Molecular Systems Engineering; Helmut Horten Stiftung	We thank Dr. Joseph Taft for his advice on the plasmid nicking mutagenesis method, Darya Palianina for her assistance with ELISpot assays, and Me?lanieBuchi for her assistance with mouse experiments. We thank the ETH Zurich D-BSSE Single-Cell Unit for their assistance with FACS. This study is supported by funding from the Personalized Health and Related Technologies Postdoctoral Fellowship (to R.V.-L.) , NCCR Molecular Systems Engineering (to S.T.R.) , and Helmut Horten Stiftung (to S.T.R.) .	Borbulevych OY, 2011, J IMMUNOL, V187, P2453, DOI 10.4049/jimmunol.1101268; Border EC, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2018.1532759; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Cameron BJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006034; Chapuis AG, 2019, NAT MED, V25, P1064, DOI 10.1038/s41591-019-0472-9; Chervin AS, 2008, J IMMUNOL METHODS, V339, P175, DOI 10.1016/j.jim.2008.09.016; Connerotte T, 2008, CANCER RES, V68, P3931, DOI 10.1158/0008-5472.CAN-07-5898; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Froning K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16231-7; Gee MH, 2018, CELL, V172, P549, DOI 10.1016/j.cell.2017.11.043; Hebeisen M, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00582; Hebeisen M, 2013, J CLIN INVEST, V123, P1044, DOI 10.1172/JCI65325; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Holler PD, 2003, NAT IMMUNOL, V4, P55, DOI 10.1038/ni863; Jespersen H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00786-z; Johnson LA, 2006, J IMMUNOL, V177, P6548, DOI 10.4049/jimmunol.177.9.6548; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Karanikas V, 2003, J IMMUNOL, V171, P4898, DOI 10.4049/jimmunol.171.9.4898; Karapetyan AR, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02501; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Kessels HWHC, 2000, P NATL ACAD SCI USA, V97, P14578, DOI 10.1073/pnas.97.26.14578; Kieke MC, 1999, P NATL ACAD SCI USA, V96, P5651, DOI 10.1073/pnas.96.10.5651; Li Y, 2005, NAT BIOTECHNOL, V23, P349, DOI 10.1038/nbt1070; Linette GP, 2013, BLOOD, V122, P863, DOI 10.1182/blood-2013-03-490565; Luft T, 2001, J IMMUNOL, V167, P2529, DOI 10.4049/jimmunol.167.5.2529; Malecek K, 2013, J IMMUNOL METHODS, V392, P1, DOI 10.1016/j.jim.2013.02.018; Mason DM, 2018, NUCLEIC ACIDS RES, V46, P7436, DOI 10.1093/nar/gky550; Duong MN, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0773-z; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Morgan RA, 2013, J IMMUNOTHER, V36, P133, DOI 10.1097/CJI.0b013e3182829903; Parkhurst MR, 2011, MOL THER, V19, P620, DOI 10.1038/mt.2010.272; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Presotto D, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01564; Prommersberger S., 2020, CURR PROTOC IMMUNOL, V128, P93; Rapoport AP, 2015, NAT MED, V21, P914, DOI 10.1038/nm.3910; Rius C, 2018, J IMMUNOL, V200, P2263, DOI 10.4049/jimmunol.1700242; Robbins PF, 2015, CLIN CANCER RES, V21, P1019, DOI 10.1158/1078-0432.CCR-14-2708; Roth TL, 2018, NATURE, V559, P405, DOI 10.1038/s41586-018-0326-5; Sanderson JP, 2020, ONCOIMMUNOLOGY, V9, DOI 10.1080/2162402X.2019.1682381; Sather BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5530; Schmitt TM, 2017, NAT BIOTECHNOL, V35, P1188, DOI 10.1038/nbt.4004; Schober K, 2019, NAT BIOMED ENG, V3, P974, DOI 10.1038/s41551-019-0409-0; Sibener LV, 2018, CELL, V174, P672, DOI 10.1016/j.cell.2018.06.017; Spindler MJ, 2020, NAT BIOTECHNOL, V38, P609, DOI 10.1038/s41587-020-0438-y; Stadtmauer EA, 2020, SCIENCE, V367, P1001, DOI 10.1126/science.aba7365; Stronen E, 2016, SCIENCE, V352, P1337, DOI 10.1126/science.aaf2288; Tan MP, 2015, CLIN EXP IMMUNOL, V180, P255, DOI 10.1111/cei.12570; Thomas S, 2011, BLOOD, V118, P319, DOI 10.1182/blood-2010-12-326736; Uttenthal BJ, 2012, J GENE MED, V14, P386, DOI 10.1002/jgm.2637; Vazquez-Lombardi R, 2018, NAT PROTOC, V13, P99, DOI 10.1038/nprot.2017.126; Wagih O, 2017, BIOINFORMATICS, V33, P3645, DOI 10.1093/bioinformatics/btx469; Wagner EK, 2019, J BIOL CHEM, V294, P5790, DOI 10.1074/jbc.RA118.007187; Wrenbeck EE, 2016, NAT METHODS, V13, P928, DOI 10.1038/nmeth.4029; Zhao X, 2022, SCIENCE, V376, P155, DOI 10.1126/science.abl5282	54	0	0	3	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 11	2022	55	10					1953	+		10.1016/j.immuni.2022.09.004	http://dx.doi.org/10.1016/j.immuni.2022.09.004			25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	5Q7NB	36174557	hybrid, Green Published			2022-12-18	WOS:000874012400006
J	Garris, CS; Arlauckas, SP; Kohler, RH; Trefny, MP; Garren, S; Piot, C; Engblom, C; Pfirschke, C; Siwicki, M; Gungabeesoon, J; Freeman, GJ; Warren, SE; Ong, S; Browning, E; Twitty, CG; Pierce, RH; Le, MH; Algazi, AP; Daud, AI; Pai, SI; Zippelius, A; Weissleder, R; Pittet, MJ				Garris, Christopher S.; Arlauckas, Sean P.; Kohler, Rainer H.; Trefny, Marcel P.; Garren, Seth; Piot, Cecile; Engblom, Camilla; Pfirschke, Christina; Siwicki, Marie; Gungabeesoon, Jeremy; Freeman, Gordon J.; Warren, Sarah E.; Ong, SuFey; Browning, Erica; Twitty, Christopher G.; Pierce, Robert H.; Le, Mai H.; Algazi, Alain P.; Daud, Adil I.; Pai, Sara I.; Zippelius, Alfred; Weissleder, Ralph; Pittet, Mikael J.			Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-gamma and IL-12 (vol 49, 1148.e1, 2018)	IMMUNITY			English	Correction												mpittet@mgh.harvard.edu						Garris CS, 2018, IMMUNITY, V49, P1148, DOI 10.1016/j.immuni.2018.09.024	1	0	0	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 13	2022	55	9					1749	1749		10.1016/j.immuni.2022.07.021	http://dx.doi.org/10.1016/j.immuni.2022.07.021			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	4X1ZN	36103861	Bronze, Green Published			2022-12-18	WOS:000860648000005
J	Leon, B				Leon, Beatriz			Fooling TLR4 to promote fungal virulence	IMMUNITY			English	Editorial Material							ENDOTOXIN; ASTHMA	The invasive fungal pathogen Cryptococcus neoformans promotes type 2 immunity to escape host defenses by unknown mechanisms. In a recent issue of Nature, Dang and colleagues identify a secreted fungal protein that triggers TLR4 signaling and supports a type 2 permissive environment and C. neoformans growth.	[Leon, Beatriz] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Leon, B (corresponding author), Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA.	bleon@uab.edu						Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Bryant CE, 2010, NAT REV MICROBIOL, V8, P8, DOI 10.1038/nrmicro2266; Dang EV, 2022, NATURE, V608, P161, DOI 10.1038/s41586-022-05005-4; Gehring U, 2002, AM J RESP CRIT CARE, V166, P939, DOI 10.1164/rccm.200203-256OC; Kaur K, 2021, CELL REP, V37, DOI 10.1016/j.celrep.2021.110178; Millien VO, 2013, SCIENCE, V341, P792, DOI 10.1126/science.1240342; Muller U, 2012, MUCOSAL IMMUNOL, V5, P299, DOI 10.1038/mi.2012.9; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548	9	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 13	2022	55	9					1591	1593		10.1016/j.immuni.2022.08.015	http://dx.doi.org/10.1016/j.immuni.2022.08.015			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	4W2PR	36103858				2022-12-18	WOS:000860009600006
J	Ryu, S; Sidorov, S; Ravussin, E; Artyomov, M; Iwasaki, A; Wang, A; Dixit, VD				Ryu, Seungjin; Sidorov, Sviatoslav; Ravussin, Eric; Artyomov, Maxim; Iwasaki, Akiko; Wang, Andrew; Dixit, Vishwa Deep			The matricellular protein SPARC induces inflammatory interferon-response in macrophages during aging	IMMUNITY			English	Article							RANDOMIZED CONTROLLED-TRIAL; STIMULATED GENE-EXPRESSION; ADIPOSE-TISSUE; INSULIN-RESISTANCE; CARDIAC INFLAMMATION; CALORIC RESTRICTION; DIETARY RESTRICTION; OBESITY; METABOLISM; REVEALS	The risk of chronic diseases caused by aging is reduced by caloric restriction (CR)-induced immunometa-bolic adaptation. Here, we found that the matricellular protein, secreted protein acidic and rich in cysteine (SPARC), was inhibited by 2 years of 14% sustained CR in humans and elevated by obesity. SPARC con-verted anti-inflammatory macrophages into a pro-inflammatory phenotype with induction of interferon -stim-ulated gene (ISG) expression via the transcription factors IRF3/7. Mechanistically, SPARC-induced ISGs were dependent on toll-like receptor-4 (TLR4)-mediated TBK1, IRF3, IFN-b, and STAT1 signaling without engaging the Myd88 pathway. Metabolically, SPARC dampened mitochondrial respiration, and inhibition of glycolysis abrogated ISG induction by SPARC in macrophages. Furthermore, the N-terminal acidic domain of SPARC was required for ISG induction, while adipocyte-specific deletion of SPARC reduced inflammation and extended health span during aging. Collectively, SPARC, a CR-mimetic adipokine, is an immunometa-bolic checkpoint of inflammation and interferon response that may be targeted to delay age-related metabolic and functional decline.	[Ryu, Seungjin; Dixit, Vishwa Deep] Yale Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Ryu, Seungjin; Sidorov, Sviatoslav; Dixit, Vishwa Deep] Yale Sch Med, Dept Comparat Med, New Haven, CT 06520 USA; [Sidorov, Sviatoslav; Iwasaki, Akiko; Wang, Andrew; Dixit, Vishwa Deep] Yale Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Ravussin, Eric] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Artyomov, Maxim] Washington Sch Med, Sect Immunol, St Louis, MO 63110 USA; [Wang, Andrew] Yale Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Dixit, Vishwa Deep] Yale Sch Med, Yale Ctr Res Aging, New Haven, CT 06520 USA; [Ryu, Seungjin] Hallym Univ, Coll Med, Dept Pharmacol, Chunchon 24252, South Korea	Yale University; Yale University; Yale University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Washington University (WUSTL); Yale University; Yale University; Hallym University	Dixit, VD (corresponding author), Yale Sch Med, Dept Pathol, New Haven, CT 06520 USA.; Dixit, VD (corresponding author), Yale Sch Med, Dept Comparat Med, New Haven, CT 06520 USA.; Dixit, VD (corresponding author), Yale Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.; Dixit, VD (corresponding author), Yale Sch Med, Yale Ctr Res Aging, New Haven, CT 06520 USA.	vishwa.dixit@yale.edu		Ryu, Seungjin/0000-0001-6353-8789; Sidorov, Sviatoslav/0000-0002-1730-265X	AFAR; NIH [AG031797, AG045712, P01AG051459, AR070811]; Glenn Foundation for Medical Research; Cure Alzheimer's Fund (CAF); ging Biology Foundation grant; National Institute on Aging [U01AG022132, U01AG020478, U01AG020487, U01AG020480]	AFAR; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Medical Research; Cure Alzheimer's Fund (CAF); ging Biology Foundation grant; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank all investigators and staff involved in coordinating and executing the CALERIE-II clinical trial. We thank Dr. Gerald Shadel for helpful discussion and protocols to quantify mtDNA. S.R. is a recipient of AFAR postdoctoral fellowship. This research was supported in part by NIH grants AG031797, AG045712, P01AG051459, AR070811, the Glenn Foundation for Medical Research, and Cure Alzheimer's Fund (CAF) to V.D.D. and an Aging Biology Foundation grant to M.A.; CALERIE study was funded by the National Institute on Aging grants U01AG022132, U01AG020478, U01AG020487, and U01AG020480.	Adler MI, 2013, EXP GERONTOL, V48, P539, DOI 10.1016/j.exger.2013.03.007; Bai JL, 2017, P NATL ACAD SCI USA, V114, P12196, DOI 10.1073/pnas.1708744114; Bapat SP, 2015, NATURE, V528, P137, DOI 10.1038/nature16151; Benayoun BA, 2019, GENOME RES, V29, P697, DOI 10.1101/gr.240093.118; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; Camell CD, 2017, NATURE, V550, P119, DOI 10.1038/nature24022; Chan CC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16571-4; Corrigan JK, 2020, ELIFE, V9, DOI 10.7554/eLife.53560; de Cabo R, 2014, CELL, V157, P1515, DOI 10.1016/j.cell.2014.05.031; de Sena Brandine Guilherme, 2019, F1000Res, V8, P1874, DOI 10.12688/f1000research.21142.1; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eguchi K, 2017, J CLIN INVEST, V127, P14, DOI 10.1172/JCI88877; Eming SA, 2017, SCIENCE, V356, P1026, DOI 10.1126/science.aam7928; Fernandez-Verdejo R, 2019, NAT METHODS, V16, P797, DOI 10.1038/s41592-019-0513-9; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4; Fritsch SD, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00630; Gao H, 2020, CELL METAB, V32, P1, DOI 10.1016/j.cmet.2020.06.007; Gardner EM, 2011, ANNU REV NUTR, V31, P353, DOI 10.1146/annurev-nutr-081810-160812; Goldberg EL, 2015, IMMUNOL REV, V265, P63, DOI 10.1111/imr.12295; Hu JW, 2020, J CANCER, V11, P2981, DOI 10.7150/jca.39651; Huang WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042507; Ingram DK, 2006, AGING CELL, V5, P97, DOI 10.1111/j.1474-9726.2006.00202.x; Jiang H, 2016, J IMMUNOL, V197, P2880, DOI 10.4049/jimmunol.1600474; Jun JI, 2020, NAT COMMUN, V11, DOI [10.1038/s41467-020-15075, 10.1038/s41467-020-15075-5]; Jun JI, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8386; Khorooshi R, 2010, J IMMUNOL, V185, P1258, DOI 10.4049/jimmunol.0901753; Kirkwood TBL, 2000, J ANAT, V197, P587, DOI 10.1046/j.1469-7580.2000.19740587.x; Kos K, 2010, NAT REV ENDOCRINOL, V6, P225, DOI 10.1038/nrendo.2010.18; Kos K, 2009, DIABETES, V58, P1780, DOI 10.2337/db09-0211; Kraus WE, 2019, LANCET DIABETES ENDO, V7, P673, DOI 10.1016/S2213-8587(19)30151-2; Kuk JL, 2009, AGEING RES REV, V8, P339, DOI 10.1016/j.arr.2009.06.001; Kumari M, 2016, J CLIN INVEST, V126, P2839, DOI 10.1172/JCI86080; Kzhyshkowska J, 2006, J IMMUNOL, V176, P5825, DOI 10.4049/jimmunol.176.10.5825; Latz E, 2018, SEMIN IMMUNOL, V40, P61, DOI 10.1016/j.smim.2018.09.001; Lee YJ, 2014, OBES SURG, V24, P604, DOI 10.1007/s11695-013-1111-z; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li XX, 2019, PROTEIN SCI, V28, P1819, DOI 10.1002/pro.3696; Liao CY, 2010, AGING CELL, V9, P92, DOI 10.1111/j.1474-9726.2009.00533.x; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; McDonald LT, 2018, AM J PHYSIOL-HEART C, V315, pH92, DOI 10.1152/ajpheart.00719.2017; McDonough A, 2017, J NEUROSCI, V37, P8292, DOI 10.1523/JNEUROSCI.0725-17.2017; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Meydani SN, 2016, AGING-US, V8, P1416, DOI 10.18632/aging.100994; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; Mlcochova P, 2020, CELL REP, V30, P3972, DOI 10.1016/j.celrep.2020.03.008; Ng YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077575; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Okabe Y, 2016, NAT IMMUNOL, V17, P9, DOI 10.1038/ni.3320; Ramkhelawon B, 2014, NAT MED, V20, P377, DOI 10.1038/nm.3467; Rankin LC, 2018, CELL, V173, P554, DOI 10.1016/j.cell.2018.03.013; Ravussin E, 2015, J GERONTOL A-BIOL, V70, P1097, DOI 10.1093/gerona/glv057; Raynor J, 2012, CURR OPIN IMMUNOL, V24, P482, DOI 10.1016/j.coi.2012.04.005; REED MJ, 1993, J HISTOCHEM CYTOCHEM, V41, P1467, DOI 10.1177/41.10.8245406; Ridiandries A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103217; Rienks M, 2016, J MOL CELL CARDIOL, V91, P172, DOI 10.1016/j.yjmcc.2016.01.008; Rivera LB, 2011, J CELL BIOL, V193, P1305, DOI 10.1083/jcb.201011143; Rochon J, 2011, J GERONTOL A-BIOL, V66, P97, DOI 10.1093/gerona/glq168; Ruan BH, 2010, J IMMUNOL, V185, P4213, DOI 10.4049/jimmunol.1000863; Sayed Nazish, 2021, Nat Aging, V1, P598, DOI 10.1038/s43587-021-00082-y; Sergushichev A., 2016, ALGORITHM FAST PRERA, DOI [10.1101/060012, DOI 10.1101/060012]; Sheikh F, 2014, J LEUKOCYTE BIOL, V96, P591, DOI 10.1189/jlb.2A0414-191R; Shen Y, 2014, ACTA HISTOCHEM, V116, P158, DOI 10.1016/j.acthis.2013.06.004; Shin M, 2013, PROSTATE, V73, P1159, DOI 10.1002/pros.22664; Spadaro O, 2022, SCIENCE, V375, P671, DOI 10.1126/science.abg7292; Speakman JR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00034; Suganami T, 2010, J LEUKOCYTE BIOL, V88, P33, DOI 10.1189/jlb.0210072; Sun LL, 2015, CELL HOST MICROBE, V17, P85, DOI 10.1016/j.chom.2014.11.004; Takahashi M, 2001, OBES RES, V9, P388, DOI 10.1038/oby.2001.50; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x; Toba H, 2015, AM J PHYSIOL-CELL PH, V308, pC972, DOI 10.1152/ajpcell.00402.2014; van Beek AA, 2019, TRENDS IMMUNOL, V40, P113, DOI 10.1016/j.it.2018.12.007; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Wang FL, 2018, EBIOMEDICINE, V30, P303, DOI 10.1016/j.ebiom.2018.02.009; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; Xu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081615; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Youm YH, 2013, CELL METAB, V18, P519, DOI 10.1016/j.cmet.2013.09.010; Yousefzadeh MJ, 2021, NATURE, V594, P100, DOI 10.1038/s41586-021-03547-7; Zhang LJ, 2016, IMMUNITY, V45, P119, DOI 10.1016/j.immuni.2016.06.021; Zhong ZY, 2018, NATURE, V560, P198, DOI 10.1038/s41586-018-0372-z	84	0	0	14	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 13	2022	55	9					1609	+		10.1016/j.immuni.2022.07.007	http://dx.doi.org/10.1016/j.immuni.2022.07.007			26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	4W2PR	35963236				2022-12-18	WOS:000860009600007
J	Sather, DN				Sather, D. Noah			Freshly remodeled and ready to fight malaria	IMMUNITY			English	Editorial Material							VACCINE	Poor biochemical characteristics have severely hampered the development of the promising malaria trans-mission-blocking vaccine candidate Pfs48/45. In this issue of Immunity, McLeod et al. applied structure -guided vaccine design to transform this protein into a stable, high-producing antigen that elicits exceptional blocking antibodies, renewing its promise as a tool to fight malaria.	[Sather, D. Noah] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Sather, D. Noah] Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA 98101 USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital	Sather, DN (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.; Sather, DN (corresponding author), Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA 98101 USA.	noah.sather@seattlechildrens.org						Graham BS, 2019, ANNU REV MED, V70, P91, DOI 10.1146/annurev-med-121217-094234; Kundu P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06742-9; McLeod Brandon, 2022, Immunity, V55, P1680, DOI 10.1016/j.immuni.2022.07.015; Sauerwein RW, 2022, AM J TROP MED HYG, V107, P22, DOI 10.4269/ajtmh.21-1320; Stone WJR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02646-2; Takashima E, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.805482; Theisen M, 2017, EXPERT REV VACCINES, V16, P329, DOI 10.1080/14760584.2017.1276833; van Dijk MR, 2001, CELL, V104, P153, DOI 10.1016/S0092-8674(01)00199-4; Vogel G, 2021, SCIENCE, V374, P245, DOI 10.1126/science.acx9344; WHO, 2020, WORLD MALARIA REPORT	10	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 13	2022	55	9					1588	1590		10.1016/j.immuni.2022.08.013	http://dx.doi.org/10.1016/j.immuni.2022.08.013			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	4W2PR	36103857				2022-12-18	WOS:000860009600005
J	Segrist, E; Cherry, S				Segrist, Elisha; Cherry, Sara			Gutcha: The microbiota drives tumor-induced mortality	IMMUNITY			English	Editorial Material								Tumors can cause wasting and mortality, but the connection between these outcomes is unclear. In this issue of Immunity, Chen and colleagues find the outcomes are separable as the tumor-altered gut microbiota activates renal immunity and alters metabolism, leading to mortality independently of wasting.	[Segrist, Elisha] NIAID, Metaorganism Immun Sect, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Cherry, Sara] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Pennsylvania	Cherry, S (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	cherrys@pennmedicine.upenn.edu		cherry, sara/0000-0003-3956-6610				Chen Y., 2022, IMMUNITY, V55; Ding GM, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109553; Kwon Y, 2015, DEV CELL, V33, P36, DOI 10.1016/j.devcel.2015.02.012; Shin HS, 2006, J PAIN SYMPTOM MANAG, V31, P493, DOI 10.1016/j.jpainsymman.2005.11.014; Song W, 2019, DEV CELL, V48, P277, DOI 10.1016/j.devcel.2018.12.003; Suzuki T, 2020, EXPERT OPIN DRUG DIS, V15, P627, DOI 10.1080/17460441.2020.1724954; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; Zugasti O, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70455-7	8	0	0	3	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 13	2022	55	9					1581	1583		10.1016/j.immuni.2022.08.011	http://dx.doi.org/10.1016/j.immuni.2022.08.011			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	4W2PR	36103854				2022-12-18	WOS:000860009600003
J	Wang, ZQ; Lu, Z; Lin, SL; Xia, J; Zhong, ZW; Xie, ZJ; Xing, Y; Qie, JB; Jiao, MX; Li, YF; Wen, HY; Zhao, PY; Zhang, D; Zhou, PH; Qian, JW; Luo, FF; Wang, LM; Yu, HX; Liu, J; Gu, J; Liu, RH; Chu, YW				Wang, Zhiqiang; Lu, Zhou; Lin, Shengli; Xia, Jie; Zhong, Ziwen; Xie, Zhangjuan; Xing, Yun; Qie, Jingbo; Jiao, Mengxia; Li, Yifan; Wen, Haoyu; Zhao, Pengyuan; Zhang, Dan; Zhou, Pinghong; Qian, Jiawen; Luo, Feifei; Wang, Luman; Yu, Hongxiu; Liu, Jie; Gu, Jie; Liu, Ronghua; Chu, Yiwei			Leucine-tRNA-synthase-2-expressing B cells contribute to colorectal cancer immunoevasion (vol 55, 1067.e1, 2022)	IMMUNITY			English	Correction												ronghualiu@fudan.edu.cn; yiweichu@fudan.edu.cn	Li, Yifan/HGA-6843-2022	Li, Yifan/0000-0002-3249-1778				Wang ZQ, 2022, IMMUNITY, V55, P1067, DOI 10.1016/j.immuni.2022.04.017	1	0	0	8	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 13	2022	55	9					1748	1748		10.1016/j.immuni.2022.07.017	http://dx.doi.org/10.1016/j.immuni.2022.07.017			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	4X1ZN	36103860	Bronze			2022-12-18	WOS:000860648000004
J	Zhai, LK; Krawczyk, CM				Zhai, Lukai; Krawczyk, Connie M.			Skip the buffet, for SPARC's sake	IMMUNITY			English	Editorial Material							CALORIC RESTRICTION; CALERIE	Caloric restriction (CR) reduces inflammation and the incidence of chronic diseases, thereby extending healthspan and lifespan. In this issue of Immunity, Ryu et al. (2022) propose that reduction of SPARC, a ma-tricellular protein, during CR offers beneficial effects by reducing SPARC-driven inflammatory phenotypes in macrophages.	[Zhai, Lukai; Krawczyk, Connie M.] Van Andel Inst, Dept Metab & Nutr Programming, Grand Rapids, MI 49503 USA	Van Andel Institute	Krawczyk, CM (corresponding author), Van Andel Inst, Dept Metab & Nutr Programming, Grand Rapids, MI 49503 USA.	connie.krawczyk@vai.org						Dorling JL, 2021, NUTR REV, V79, P98, DOI 10.1093/nutrit/nuaa085; Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2; Hu JW, 2020, J CANCER, V11, P2981, DOI 10.7150/jca.39651; Kos K, 2010, NAT REV ENDOCRINOL, V6, P225, DOI 10.1038/nrendo.2010.18; McGovern KE, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83952-0; Rochon J, 2011, J GERONTOL A-BIOL, V66, P97, DOI 10.1093/gerona/glq168; Ryu S., 2022, MATRICELLULAR PROTEI; Spadaro O, 2022, SCIENCE, V375, P671, DOI 10.1126/science.abg7292; Tai IT, 2008, DRUG RESIST UPDATE, V11, P231, DOI 10.1016/j.drup.2008.08.005; Thomas D, 2017, METABOLISM, V72, P120, DOI 10.1016/j.metabol.2017.04.005	10	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 13	2022	55	9					1583	1585		10.1016/j.immuni.2022.08.012	http://dx.doi.org/10.1016/j.immuni.2022.08.012			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	4W2PR	36103855				2022-12-18	WOS:000860009600004
J	Hohman, LS; Osborne, LC				Hohman, Leah S.; Osborne, Lisa C.			Eo, what are we doing here?	IMMUNITY			English	Editorial Material								A plethora of studies have established the importance of eosinophils in protective immunity against infec-tions and in allergy. In this issue of Immunity, Ignacio et al. (2022) define a vital for eosinophils in coordinating a microbiota-epithelial-immune axis that maintains intestinal homeostasis.	[Hohman, Leah S.; Osborne, Lisa C.] Univ British Columbia, Life Sci Inst, Dept Microbiol & Immunol, Vancouver, BC, Canada	University of British Columbia	Hohman, LS; Osborne, LC (corresponding author), Univ British Columbia, Life Sci Inst, Dept Microbiol & Immunol, Vancouver, BC, Canada.	lhohman@mail.ubc.ca; lisa.osborne@ubc.ca						Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Ensari Arzu, 2018, Gastroenterol Hepatol Bed Bench, V11, P181; Ignacio A, 2022, IMMUNITY, V55, P1250, DOI 10.1016/j.immuni.2022.05.014; Johnston LK, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00051; Lee EH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28371-4; Melo RCN, 2008, J LEUKOCYTE BIOL, V83, P229, DOI 10.1189/jlb.0707503; Mishra A, 1999, J CLIN INVEST, V103, P1719, DOI 10.1172/JCI6560; Weller PF, 2017, NAT REV IMMUNOL, V17, P746, DOI 10.1038/nri.2017.95	8	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 12	2022	55	7					1148	1150		10.1016/j.immuni.2022.06.015	http://dx.doi.org/10.1016/j.immuni.2022.06.015			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3G7UF	35830822				2022-12-18	WOS:000831554100005
J	Iannacone, M; Bleriot, C; Andreata, F; Ficht, X; Laura, C; Garcia-Manteiga, JM; Uderhardt, S; Ginhoux, F				Iannacone, Matteo; Bleriot, Camille; Andreata, Francesco; Ficht, Xenia; Laura, Chiara; Garcia-Manteiga, Jose M.; Uderhardt, Stefan; Ginhoux, Florent			Response to contamination of isolated mouse Kupffer cells with liver sinusoidal endothelial cells	IMMUNITY			English	Letter									[Iannacone, Matteo; Andreata, Francesco; Ficht, Xenia; Laura, Chiara; Garcia-Manteiga, Jose M.] IRCCS San Raffaele Sci Inst, Div Immunol Transplantat & Infect Dis, Milan, Italy; [Iannacone, Matteo; Andreata, Francesco; Ficht, Xenia; Laura, Chiara; Garcia-Manteiga, Jose M.] IRCCS San Raffaele Sci Inst, Expt Imaging Ctr, Milan, Italy; [Iannacone, Matteo; Andreata, Francesco; Ficht, Xenia; Laura, Chiara; Garcia-Manteiga, Jose M.] Univ Vita Salute San Raffaele, Milan, Italy; [Bleriot, Camille; Ginhoux, Florent] Inst Gustave Roussy, INSERM, U1015, F-94800 Villejuif, France; [Uderhardt, Stefan] Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Internal Med Rheumatol & Immunol 3, D-91054 Erlangen, Germany; [Uderhardt, Stefan] Univ Klinikum Erlangen, D-91054 Erlangen, Germany; [Uderhardt, Stefan] Friedrich Alexander Univ Erlangen Nurnberg FAU, Deutsch Zentrum Immuntherapie DZI, D-91054 Erlangen, Germany; [Ginhoux, Florent] ASTAR, Singapore Immunol Network SIgN, Singapore 138648, Singapore; [Ginhoux, Florent] SingHealth Duke NUS Acad Med Ctr, Translat Immunol Inst, Singapore 169856, Singapore; [Ginhoux, Florent] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai 200025, Peoples R China	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Chinese Academy of Sciences; Shanghai Jiao Tong University	Iannacone, M (corresponding author), IRCCS San Raffaele Sci Inst, Div Immunol Transplantat & Infect Dis, Milan, Italy.; Iannacone, M (corresponding author), IRCCS San Raffaele Sci Inst, Expt Imaging Ctr, Milan, Italy.; Iannacone, M (corresponding author), Univ Vita Salute San Raffaele, Milan, Italy.; Ginhoux, F (corresponding author), Inst Gustave Roussy, INSERM, U1015, F-94800 Villejuif, France.; Ginhoux, F (corresponding author), ASTAR, Singapore Immunol Network SIgN, Singapore 138648, Singapore.; Ginhoux, F (corresponding author), SingHealth Duke NUS Acad Med Ctr, Translat Immunol Inst, Singapore 169856, Singapore.; Ginhoux, F (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai 200025, Peoples R China.	iannacone.matteo@hsr.it; florent_ginhoux@immunol.a-star.edu.sg		BLERIOT, Camille/0000-0002-4298-2888				Bleriot C, 2021, IMMUNITY, V54, P2101, DOI 10.1016/j.immuni.2021.08.006; Culemann S, 2019, NATURE, V572, P670, DOI 10.1038/s41586-019-1471-1; De Simone G, 2021, IMMUNITY, V54, P2089, DOI 10.1016/j.immuni.2021.05.005; Guilliams M, 2022, CELL, V185, P379, DOI 10.1016/j.cell.2021.12.018; Hume DA, 2008, J IMMUNOL, V181, P5829, DOI 10.4049/jimmunol.181.9.5829; Hume DA, 2022, IMMUNITY, V55, P1139, DOI 10.1016/j.immuni.2022.06.010; MacParland SA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06318-7; Ramachandran P, 2019, NATURE, V575, P512, DOI 10.1038/s41586-019-1631-3; Su Q, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.103233; Su XB, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4342-x	10	0	0	5	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 12	2022	55	7					1141	1142		10.1016/j.immuni.2022.06.012	http://dx.doi.org/10.1016/j.immuni.2022.06.012			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3G7UF	35830819				2022-12-18	WOS:000831554100002
J	Juban, G; Chazaud, B				Juban, Gaetan; Chazaud, Benedicte			DCs unchained: Whetting dendritic-cell appetite boosts wound healing	IMMUNITY			English	Editorial Material							CROSS-PRESENTATION; EFFEROCYTOSIS	Apoptotic-cell uptake (efferocytosis) by dendritic cells (DCs) has been mainly linked to their antigen presen-tation property. In a recent issue of Nature, Maschalidi et al. identified a break to efferocytosis in DCs, the inhibition of which improves skin debris cleansing after a wound, accelerating healing.	[Juban, Gaetan; Chazaud, Benedicte] Univ Claude Bernard Lyon 1, Unite Physiopathol & Genet Neurone & Muscle, Inst NeuroMyoGene, Inserm U1315,CNRS 5261, Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Chazaud, B (corresponding author), Univ Claude Bernard Lyon 1, Unite Physiopathol & Genet Neurone & Muscle, Inst NeuroMyoGene, Inserm U1315,CNRS 5261, Lyon, France.	benedicte.chazaud@inserm.fr			AFM-Telethon	AFM-Telethon(Association Francaise contre les Myopathies)	G.J. is currently supported by the AFM-Telethon.	Boada-Romero E, 2020, NAT REV MOL CELL BIO, V21, P398, DOI 10.1038/s41580-020-0232-1; Bonnefoy F, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02586; Dejani NN, 2018, P NATL ACAD SCI USA, V115, pE8469, DOI 10.1073/pnas.1722016115; Maschalidi S, 2022, NATURE, V606, P776, DOI 10.1038/s41586-022-04754-6; Morioka S, 2019, IMMUNITY, V50, P1149, DOI 10.1016/j.immuni.2019.04.018; Morioka S, 2018, NATURE, V563, P714, DOI 10.1038/s41586-018-0735-5; Patsalos A, 2021, J EXP MED, V219, DOI 10.1084/jem.20210420; Rothlin CV, 2021, NAT REV IMMUNOL, V21, P292, DOI 10.1038/s41577-020-00456-0; Subramanian M, 2014, J CLIN INVEST, V124, P1296, DOI 10.1172/JCI72051; Tzelepis F, 2015, J CLIN INVEST, V125, P752, DOI 10.1172/JCI77014	10	0	0	8	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 12	2022	55	7					1156	1158		10.1016/j.immuni.2022.06.008	http://dx.doi.org/10.1016/j.immuni.2022.06.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3G7UF	35830825				2022-12-18	WOS:000831554100008
J	Malik, A; Jabri, B				Malik, Ankit; Jabri, Bana			Innate riddle of CD4(+) T cells and the control of enteric infections	IMMUNITY			English	Editorial Material							RECEPTOR; IL-15	Intra-epithelial T cells make up a significant proportion of immune cells in the body, yet their development and function remain an enigma. In this issue of Immunity, Parsa et al. (2022) describe the differentiation and cross -protective function of CD4(+) intra-epithelial T cells against enteric viruses.	[Malik, Ankit; Jabri, Bana] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA	University of Chicago	Jabri, B (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	bjabri@bsd.uchicago.edu			US National Institutes of Health [DK067180]; University of Chicago Center for Interdisciplinary Study of Inflammatory Intestinal Disorders (C-IID) Pilot & Feasibility Award [NIDDK P30 DK042086]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Center for Interdisciplinary Study of Inflammatory Intestinal Disorders (C-IID) Pilot & Feasibility Award	This work is supported by the US National Institutes of Health (DK067180) to B.J. and the University of Chicago Center for Interdisciplinary Study of Inflammatory Intestinal Disorders (C-IID) Pilot & Feasibility Award (NIDDK P30 DK042086) to A.M.	Barlan AU, 2011, VIROLOGY, V412, P306, DOI 10.1016/j.virol.2011.01.019; Bilate AM, 2020, IMMUNITY, V53, P1001, DOI 10.1016/j.immuni.2020.09.003; Dallari S, 2021, CELL HOST MICROBE, V29, P1014, DOI 10.1016/j.chom.2021.03.015; Guy-Grand D, 2013, J EXP MED, V210, P1839, DOI 10.1084/jem.20122588; Jabri B, 2015, NAT REV IMMUNOL, V15, P771, DOI 10.1038/nri3919; Liu RB, 2013, P NATL ACAD SCI USA, V110, P8158, DOI 10.1073/pnas.1301022110; London M, 2021, NAT IMMUNOL, V22, P449, DOI 10.1038/s41590-021-00883-8; McDonald BD, 2018, NAT REV IMMUNOL, V18, P514, DOI 10.1038/s41577-018-0013-7; Parsa R, 2022, IMMUNITY, V55, P1234, DOI 10.1016/j.immuni.2022.05.001; Sharma D, 2016, J CELL BIOL, V213, P617, DOI 10.1083/jcb.201602089	10	0	0	2	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 12	2022	55	7					1145	1147		10.1016/j.immuni.2022.06.017	http://dx.doi.org/10.1016/j.immuni.2022.06.017			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3G7UF	35830821				2022-12-18	WOS:000831554100004
J	Mueller, AL; Klein, SL				Mueller, Alice L.; Klein, Sabra L.			Of mice, men, women, and cancer	IMMUNITY			English	Editorial Material							SEX-DIFFERENCES	The prevalence and severity of cancers in non-reproductive tissues are greater in males than females, but the sex-specific factors contributing to this remain ill described. In this issue of Immunity, Yang et al. (2022) un-cover a mechanism of androgen signaling leading to an exhausted, terminally differentiated CD8(+) T cell phenotype in male mice.	[Mueller, Alice L.; Klein, Sabra L.] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Mueller, AL; Klein, SL (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.	alandfa1@jhu.edu; sklein2@jhu.edu						Dhakal S, 2022, J EXP MED, V219, DOI 10.1084/jem.20211486; Fuseini H, 2018, J IMMUNOL, V201, P1843, DOI 10.4049/jimmunol.1800293; Haupt S, 2021, NAT REV CANCER, V21, P393, DOI 10.1038/s41568-021-00348-y; Klein SL, 2020, BIOL SEX DIFFER, V11, DOI 10.1186/s13293-020-00301-y; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Mauvais-Jarvis F, 2020, LANCET, V396, P565, DOI 10.1016/S0140-6736(20)31561-0; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Scully EP, 2020, NAT REV IMMUNOL, V20, P442, DOI 10.1038/s41577-020-0348-8; vom Steeg LG, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008506; Yang C, 2022, IMMUNITY, V55, P1268, DOI 10.1016/j.immuni.2022.05.012	10	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 12	2022	55	7					1150	1152		10.1016/j.immuni.2022.06.009	http://dx.doi.org/10.1016/j.immuni.2022.06.009			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3G7UF	35830823				2022-12-18	WOS:000831554100006
J	Niederlova, V; Kazer, SW; Ordovas-Montanes, J				Niederlova, Veronika; Kazer, Samuel W.; Ordovas-Montanes, Jose			Are we there yet? An immune field trip through human embryonic development	IMMUNITY			English	Editorial Material								Technical, analytical, and ethical challenges have obscured our understanding of immune cell subset ontogeny during human fetal development. Recently published in Science, Suo et al. (2022) apply multiple single-cell and spatial tools to provide a comprehensive roadmap during human gestation.	[Niederlova, Veronika] Czech Acad Sci, Inst Mol Genet, Lab Adapt Immun, Prague, Czech Republic; [Niederlova, Veronika] Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague, Czech Republic; [Niederlova, Veronika; Kazer, Samuel W.; Ordovas-Montanes, Jose] Boston Childrens Hosp, Boston, MA 02115 USA; [Kazer, Samuel W.; Ordovas-Montanes, Jose] Harvard Med Sch, Boston, MA 02115 USA; [Kazer, Samuel W.; Ordovas-Montanes, Jose] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Kazer, Samuel W.; Ordovas-Montanes, Jose] Broad Inst, Cambridge, MA 02142 USA; [Ordovas-Montanes, Jose] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Charles University Prague; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Ordovas-Montanes, J (corresponding author), Boston Childrens Hosp, Boston, MA 02115 USA.; Ordovas-Montanes, J (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Ordovas-Montanes, J (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.; Ordovas-Montanes, J (corresponding author), Broad Inst, Cambridge, MA 02142 USA.; Ordovas-Montanes, J (corresponding author), Harvard Stem Cell Inst, Cambridge, MA 02138 USA.	jose.ordovas-montanes@childrens.harvard.edu	Niederlova, Veronika/HGA-7771-2022	Niederlova, Veronika/0000-0001-8768-9039				Cao JY, 2020, SCIENCE, V370, P808, DOI 10.1126/science.aba7721; Dann E, 2022, NAT BIOTECHNOL, V40, P245, DOI 10.1038/s41587-021-01033-z; Gayoso A, 2022, NAT BIOTECHNOL, V40, P163, DOI 10.1038/s41587-021-01206-w; Georgiev H, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22589-z; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; Lim AI, 2021, SCIENCE, V373, DOI 10.1126/science.abf3002; Park JE, 2020, SCIENCE, V368, P600, DOI 10.1126/science.aaz9330; Suo CQ, 2022, SCIENCE, V376, P1069, DOI 10.1126/science.abo0510; Werner Y, 2020, NAT NEUROSCI, V23, P351, DOI 10.1038/s41593-020-0585-y; Wesemann DR, 2013, NATURE, V501, DOI 10.1038/nature12496	10	0	0	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 12	2022	55	7					1153	1155		10.1016/j.immuni.2022.06.014	http://dx.doi.org/10.1016/j.immuni.2022.06.014			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3G7UF	35830824				2022-12-18	WOS:000831554100007
J	Snell, LM				Snell, Laura M.			CD4(+) progenitor cells sustain helper responses during chronic infection	IMMUNITY			English	Editorial Material							CD8(+) T-CELLS	How CD4(+) T cell responses are maintained during chronic infection is unknown. In this issue of Immunity, Xia et al. (2022) identify a progenitor T cell subset that gives rise to effector and follicular helper T cells to sustain antiviral responses.	[Snell, Laura M.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Snell, Laura M.] Indiana Univ Sch Med, Indiana Univ Simon Comprehens Canc Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Snell, LM (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.; Snell, LM (corresponding author), Indiana Univ Sch Med, Indiana Univ Simon Comprehens Canc Ctr, Indianapolis, IN 46202 USA.	lausnell@iu.edu		Snell, Laura/0000-0001-9890-6588				Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Hudson WH, 2019, IMMUNITY, V51, P1043, DOI 10.1016/j.immuni.2019.11.002; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Ng CT, 2013, CELL HOST MICROBE, V13, P652, DOI 10.1016/j.chom.2013.05.014; Snell LM, 2021, NAT IMMUNOL, V22, P1524, DOI 10.1038/s41590-021-01060-7; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Xia Yu, 2022, Immunity, V55, P1200, DOI 10.1016/j.immuni.2022.05.003; Zander R, 2022, IMMUNITY, V55, P475, DOI 10.1016/j.immuni.2022.01.018; Zander R, 2019, IMMUNITY, V51, P1028, DOI 10.1016/j.immuni.2019.10.009	10	0	0	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 12	2022	55	7					1143	1145		10.1016/j.immuni.2022.06.016	http://dx.doi.org/10.1016/j.immuni.2022.06.016			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3G7UF	35830820				2022-12-18	WOS:000831554100003
J	van der Veeken, J; Campbell, C; Pritykin, Y; Schizas, M; Verter, J; Hu, W; Wang, ZM; Matheis, F; Mucida, D; Charbonnier, LM; Chatila, TA; Rudensky, AY				van der Veeken, Joris; Campbell, Clarissa; Pritykin, Yuri; Schizas, Michail; Verter, Jacob; Hu, Wei; Wang, Zhong-Min; Matheis, Fanny; Mucida, Daniel; Charbonnier, Louis-Marie; Chatila, Talal A.; Rudensky, Alexander Y.			Genetic tracing reveals transcription factor Foxp3-dependent and Foxp3-independent functionality of peripherally induced Treg cells	IMMUNITY			English	Article							REGULATORY T-CELLS; TGF-BETA; FACTOR FOXP3; C-MAF; DIFFERENTIATION; GENERATION; RECEPTOR; INDUCTION; T(H)17; ROR-GAMMA-T(+)	Regulatory T (Treg) cells expressing the transcription factor Foxp3 are an essential suppressive T cell lineage of dual origin: Foxp3 induction in thymocytes and mature CD4(+) T cells gives rise to thymic (tTreg) and peripheral (pTreg) Treg cells, respectively. While tTreg cells suppress autoimmunity, pTreg cells enforce tolerance to food and commensal microbiota. However, the role of Foxp3 in pTreg cells and the mechanisms supporting their differentiation remain poorly understood. Here, we used genetic tracing to identify microbiota-induced pTreg cells and found that many of their distinguishing features were Foxp3 independent. Lineage-committed, microbiota-dependent pTreg-like cells persisted in the colon in the absence of Foxp3. While Foxp3 was critical for the suppression of a Th17 cell program, colitis, and mastocytosis, pTreg cells suppressed colonic effector T cell expansion in a Foxp3-independent manner. Thus, Foxp3 and the tolerogenic signals that precede and promote its expression independently confer distinct facets of pTreg functionality.	[van der Veeken, Joris; Campbell, Clarissa; Schizas, Michail; Verter, Jacob; Hu, Wei; Wang, Zhong-Min; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, 1275 York Ave, New York, NY 10021 USA; [van der Veeken, Joris; Campbell, Clarissa; Schizas, Michail; Verter, Jacob; Hu, Wei; Wang, Zhong-Min; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Immunol Program, 1275 York Ave, New York, NY 10021 USA; [van der Veeken, Joris; Campbell, Clarissa; Schizas, Michail; Verter, Jacob; Hu, Wei; Wang, Zhong-Min; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, 1275 York Ave, New York, NY 10021 USA; [van der Veeken, Joris] Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Vienna, Austria; [Campbell, Clarissa] Austrian Acad Sci, Res Ctr Mol Med, CeMM, Vienna, Austria; [Pritykin, Yuri] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ USA; [Pritykin, Yuri] Princeton Univ, Dept Comp Sci, Princeton, NJ 08544 USA; [Wang, Zhong-Min] Mem Sloan Kettering Canc Ctr, Gerstner Sloan Kettering Grad Sch Biomed Sci, 1275 York Ave, New York, NY 10021 USA; [Matheis, Fanny; Mucida, Daniel] Rockefeller Univ, Lab Mucosal Immunol, 1230 York Ave, New York, NY 10021 USA; [Chatila, Talal A.] Boston Childrens Hosp, Div Immunol, Boston, MA USA; [Charbonnier, Louis-Marie] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Princeton University; Princeton University; Memorial Sloan Kettering Cancer Center; Rockefeller University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	van der Veeken, J; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, 1275 York Ave, New York, NY 10021 USA.; van der Veeken, J; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Immunol Program, 1275 York Ave, New York, NY 10021 USA.; van der Veeken, J; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Ludwig Ctr, 1275 York Ave, New York, NY 10021 USA.; van der Veeken, J (corresponding author), Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Vienna, Austria.	joris.van.der.veeken@imp.ac.at; rudenska@mskcc.org	Wang, Zhongmin/GLU-9473-2022	Wang, Zhongmin/0000-0002-5538-1969; van der Veeken, Joris/0000-0001-7299-2174; Campbell, Clarissa/0000-0002-1918-0318; Pritykin, Yury/0000-0001-6589-981X; Hu, Wei/0000-0002-0392-6939; Matheis, Fanny/0000-0001-9971-3315	NIH [R01AI034206, R01AI153174]; NIH/NCI [P30 CA008748]; AACR-Bristol-Myers Squibb Immuno-oncology Research Fellowship [19-4015-PRIT]; Ludwig Center at MSKCC; Cycle for Survival; Marie-Josee and Henry R. Kravis Center for Molecular Oncology	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AACR-Bristol-Myers Squibb Immuno-oncology Research Fellowship; Ludwig Center at MSKCC; Cycle for Survival; Marie-Josee and Henry R. Kravis Center for Molecular Oncology	We thank all members of the Rudensky lab for discussions and Bruno Moltedo and Jesse Green for help with LLC experiments. This study was supported by NIH grants R01AI034206, R01AI153174, and NIH/NCI Grant P30 CA008748; AACR-Bristol-Myers Squibb Immuno-oncology Research Fellowship 19-4015-PRIT; and the Ludwig Center at MSKCC. A.Y.R. is an HHMI investigator. We acknowledge the use of the MSKCC Single Cell Research Initiative and the Integrated Genomics Operation Core, funded by NIH/NCI Grant P30 CA008748, Cycle for Survival, and the Marie-Jose ' e and Henry R. Kravis Center for Molecular Oncology.	Aguilera-Lizarraga J, 2022, ACTA CLIN BELG, V77, P889, DOI 10.1080/17843286.2021.1996069; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Arvey A, 2014, NAT IMMUNOL, V15, P580, DOI 10.1038/ni.2868; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Campbell C, 2020, NATURE, V581, P475, DOI 10.1038/s41586-020-2193-0; Campbell C, 2018, IMMUNITY, V48, P1245, DOI 10.1016/j.immuni.2018.04.013; Chai JN, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal5068; Charbonnier LM, 2019, NAT IMMUNOL, V20, P1208, DOI 10.1038/s41590-019-0442-x; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cobbold SP, 2004, J IMMUNOL, V172, P6003, DOI 10.4049/jimmunol.172.10.6003; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gaublomme JT, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.009; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gottschalk RA, 2012, J IMMUNOL, V188, P976, DOI 10.4049/jimmunol.1102964; Hang SY, 2019, NATURE, V576, P143, DOI 10.1038/s41586-019-1785-z; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Hemmers S, 2019, J EXP MED, V216, P2466, DOI 10.1084/jem.20190993; Hu W, 2021, NAT IMMUNOL, V22, P1163, DOI 10.1038/s41590-021-01001-4; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kim BS, 2017, CELL REP, V21, P195, DOI 10.1016/j.celrep.2017.09.021; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kim KS, 2016, SCIENCE, V351, P858, DOI 10.1126/science.aac5560; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Liston A, 2008, P NATL ACAD SCI USA, V105, P11903, DOI 10.1073/pnas.0801506105; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Neumann C, 2019, NAT IMMUNOL, V20, P471, DOI 10.1038/s41590-019-0316-2; Nutsch K, 2016, CELL REP, V17, P206, DOI 10.1016/j.celrep.2016.08.092; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Omenetti S, 2019, IMMUNITY, V51, P77, DOI 10.1016/j.immuni.2019.05.004; Pratama A, 2020, J EXP MED, V217, DOI 10.1084/jem.20190428; Schambach F, 2007, EUR J IMMUNOL, V37, P2396, DOI 10.1002/eji.200737621; Schnell A, 2021, CELL, V184, P6281, DOI 10.1016/j.cell.2021.11.018; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Sledzinska A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001674; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Song XY, 2020, NATURE, V577, P410, DOI 10.1038/s41586-019-1865-0; Stoeckius M, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1603-1; Sturm G, 2020, BIOINFORMATICS, V36, P4817, DOI 10.1093/bioinformatics/btaa611; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Szurek E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141161; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; van der Veeken J, 2020, IMMUNITY, V53, P971, DOI 10.1016/j.immuni.2020.10.010; van Dijk D, 2018, CELL, V174, P716, DOI 10.1016/j.cell.2018.05.061; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Wheaton JD, 2017, J IMMUNOL, V199, P3931, DOI 10.4049/jimmunol.1701134; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	67	0	0	13	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 12	2022	55	7					1173	+		10.1016/j.immuni.2022.05.010	http://dx.doi.org/10.1016/j.immuni.2022.05.010			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3G7UF	35700740				2022-12-18	WOS:000831554100010
J	Zhao, M; Ren, KQ; Xiong, XW; Xin, Y; Zou, YJ; Maynard, JC; Kim, A; Battist, AP; Koneripalli, N; Wang, YS; Chen, QY; Xin, RY; Yang, CY; Huang, R; Yu, JH; Huang, Z; Zhang, ZD; Wang, HG; Wang, DY; Xiao, YH; Salgado, OC; Jarjour, NN; Hogquist, KA; Revelo, XS; Burlingame, AL; Gao, X; von Moltke, J; Lin, ZY; Ruan, HB				Zhao, Ming; Ren, Kaiqun; Xiong, Xiwen; Xin, Yue; Zou, Yujie; Maynard, Jason C.; Kim, Angela; Battist, Alexander P.; Koneripalli, Navya; Wang, Yusu; Chen, Qianyue; Xin, Ruyue; Yang, Chenyan; Huang, Rong; Yu, Jiahui; Huang, Zan; Zhang, Zengdi; Wang, Haiguang; Wang, Daoyuan; Xiao, Yihui; Salgado, Oscar C.; Jarjour, Nicholas N.; Hogquist, Kristin A.; Revelo, Xavier S.; Burlingame, Alma L.; Gao, Xiang; Moltke, Jakob von; Lin, Zhaoyu; Ruan, Hai-Bin			Epithelial STAT6 O-GlcNAcylation drives a concerted anti-helminth alarmin response dependent on tuft cell hyperplasia and Gasdermin C (vol 55, pg 623, 2022)	IMMUNITY			English	Correction												linzy@nju.edu.cn; hruan@umn.edu		Jarjour, Nicholas/0000-0001-9400-4448; Revelo, Xavier/0000-0002-2754-509X				Zhao M, 2022, IMMUNITY, V55, P623, DOI 10.1016/j.immuni.2022.03.009	1	0	0	6	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 12	2022	55	7					1327	1327		10.1016/j.immuni.2022.06.011	http://dx.doi.org/10.1016/j.immuni.2022.06.011			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3D3AD	35830826	Green Accepted, Bronze			2022-12-18	WOS:000829177900007
J	Caronni, N; Ostuni, R				Caronni, Nicoletta; Ostuni, Renato			Drugging inflammation: Easier NSAID than done	IMMUNITY			English	Editorial Material								In this issue of Immunity, Eisenstein, Hiliard, et al., uncover a novel mechanism of some widely used non-steroidal anti-inflammatory drugs (NSAIDs): activation of the antioxidant transcription factor NRF2 in myeloid immune cells.	[Caronni, Nicoletta; Ostuni, Renato] IRCCS San Raffaele Sci Inst, San Raffaele Telethon Inst Gene Therapy SR Tiget, Milan, Italy; [Ostuni, Renato] Univ Vita Salute San Raffaele, Milan, Italy	Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Ostuni, R (corresponding author), IRCCS San Raffaele Sci Inst, San Raffaele Telethon Inst Gene Therapy SR Tiget, Milan, Italy.; Ostuni, R (corresponding author), Univ Vita Salute San Raffaele, Milan, Italy.	ostuni.renato@hsr.it			European Research Council (ERC-StG) [759532]; Italian Telethon Foundation (SR-Tiget Grant Award); Italian Association for Cancer Research (AIRC) [MFAG 20247, 22737]; Italian Ministry of Health [GR-201602362156]; Fondazione Umberto Veronesi (FUV)	European Research Council (ERC-StG)(European Research Council (ERC)); Italian Telethon Foundation (SR-Tiget Grant Award)(Fondazione Telethon); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy); Fondazione Umberto Veronesi (FUV)(Fondazione Umberto Veronesi)	Research in the R.O. lab is supported by the European Research Council (ERC-StG 759532, X-TAM), the Italian Telethon Foundation (SR-Tiget Grant Award), the Italian Association for Cancer Research (AIRC MFAG 20247 and AIRC 5x1000 special program 22737), and the Italian Ministry of Health (GR-201602362156). N.C. is supported by a fellowship from Fondazione Umberto Veronesi (FUV).	Bell CR, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-29606-9; Caronni N, 2021, IMMUNOL REV, V300, P220, DOI 10.1111/imr.12944; Cilenti F, 2021, IMMUNITY, V54, P1665, DOI 10.1016/j.immuni.2021.05.016; de la Vega MR, 2018, CANCER CELL, V34, P21, DOI 10.1016/j.ccell.2018.03.022; Eisenstein A, 2022, IMMUNITY, V55, P1082, DOI 10.1016/j.immuni.2022.04.015; Li HZ, 2022, CANCER CELL, V40, P36, DOI 10.1016/j.ccell.2021.11.002; Luan HH, 2019, CELL, V178, P1231, DOI 10.1016/j.cell.2019.07.033; Nikolos F, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-29026-9; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Perkins DJ, 2018, NAT IMMUNOL, V19, P1309, DOI 10.1038/s41590-018-0243-7; Suzuki T, 2019, CELL REP, V28, P746, DOI 10.1016/j.celrep.2019.06.047	11	0	0	4	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 14	2022	55	6					973	975		10.1016/j.immuni.2022.05.009	http://dx.doi.org/10.1016/j.immuni.2022.05.009			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	2U6UT	35704999				2022-12-18	WOS:000823293900006
J	Manfroi, B; Fillatreau, S				Manfroi, Benoit; Fillatreau, Simon			Regulatory B cells gain muscles with a leucine-rich diet	IMMUNITY			English	Editorial Material								Regulatory B cells infiltrate the microenvironment of solid tumors. However, their identification and charac-terization remain incomplete. In this issue of Immunity, Wang and colleagues characterize a new subset of leucine-induced regulatory B cells involved in colorectal cancer (CRC) immunoevasion in mice and humans.	[Manfroi, Benoit; Fillatreau, Simon] Ctr Natl Rech Sci CNRS UMR 8253, Inst Necker Enfants Malad, Inst Natl Sante & Rech Med INSERM U 1151, Paris, France; [Fillatreau, Simon] Univ Paris Cite, Fac Med, Paris, France; [Fillatreau, Simon] Hop Necker Enfants Malad, AP HP, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Manfroi, B; Fillatreau, S (corresponding author), Ctr Natl Rech Sci CNRS UMR 8253, Inst Necker Enfants Malad, Inst Natl Sante & Rech Med INSERM U 1151, Paris, France.; Fillatreau, S (corresponding author), Univ Paris Cite, Fac Med, Paris, France.; Fillatreau, S (corresponding author), Hop Necker Enfants Malad, AP HP, Paris, France.	benoit.manfroi@inserm.fr; simon.fillatreau@inserm.fr		Manfroi, Benoit/0000-0002-4105-4684				Ai LS, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-5086-y; Almquist DR, 2020, BIODRUGS, V34, P349, DOI 10.1007/s40259-020-00420-3; Kos K, 2021, ANNU REV CANC BIOL, V5, P291, DOI 10.1146/annurev-cancerbio-042920-104912; Laumont CM, 2022, NAT REV CANCER, V22, P414, DOI 10.1038/s41568-022-00466-1; Li RH, 2010, MOL CELL BIOL, V30, P2147, DOI 10.1128/MCB.01614-09; Michaud D, 2021, IMMUNOL REV, V299, P74, DOI 10.1111/imr.12939; Morse MA, 2020, ONCOLOGIST, V25, P33, DOI 10.1634/theoncologist.2019-0176; Passarelli MC, 2022, NAT CELL BIOL, V24, P307, DOI 10.1038/s41556-022-00856-5; Rondanelli M, 2021, FRONT NUTR, V7, DOI 10.3389/fnut.2020.622391; Wang ZJ, 2022, IMMUNITY, V55, P998, DOI 10.1016/j.immuni.2022.04.003	10	0	0	2	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 14	2022	55	6					970	972		10.1016/j.immuni.2022.05.011	http://dx.doi.org/10.1016/j.immuni.2022.05.011			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	2U6UT	35704998				2022-12-18	WOS:000823293900005
J	Prentzell, MT; Opitz, CA				Prentzell, Mirja Tamara; Opitz, Christiane A.			cDC1 to cDC2: "Everything I do, Ido1 it for you"	IMMUNITY			English	Editorial Material							ARYL-HYDROCARBON RECEPTOR; DENDRITIC CELLS	Distinct dendritic cell (DC) subsets exert specific functions in immune regulation, but their communication with each other has remained elusive. In this issue of Immunity, Gargaro et al. identify the IDO1-Kyn-AHR axis as a metabolic signaling pathway through which conventional DC subsets communicate and induce tolerogenicity.	[Prentzell, Mirja Tamara; Opitz, Christiane A.] German Consortium Translat Canc Res DKTK, Metab Crosstalk Canc, Heidelberg, Germany; [Prentzell, Mirja Tamara; Opitz, Christiane A.] German Canc Res Ctr, Heidelberg, Germany; [Prentzell, Mirja Tamara] Heidelberg Univ, Fac Biosci, Heidelberg, Germany; [Opitz, Christiane A.] Univ Hosp Heidelberg, Natl Ctr Tumor Dis, Dept Neurol, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Opitz, CA (corresponding author), German Consortium Translat Canc Res DKTK, Metab Crosstalk Canc, Heidelberg, Germany.; Opitz, CA (corresponding author), German Canc Res Ctr, Heidelberg, Germany.; Opitz, CA (corresponding author), Univ Hosp Heidelberg, Natl Ctr Tumor Dis, Dept Neurol, Heidelberg, Germany.	c.opitz@dkfz-heidelberg.de						Esser C, 2015, PHARMACOL REV, V67, P259, DOI 10.1124/pr.114.009001; Gargaro M, 2022, IMMUNITY, V55, P1032, DOI 10.1016/j.immuni.2022.05.013; Goudot C, 2017, IMMUNITY, V47, P582, DOI 10.1016/j.immuni.2017.08.016; Grohmann U, 2000, J IMMUNOL, V165, P1357, DOI 10.4049/jimmunol.165.3.1357; Kvedaraite E, 2022, SCI IMMUNOL, V7, DOI 10.1126/sciimmunol.abm9409; Liu H, 2014, IMMUNOL CELL BIOL, V92, P200, DOI 10.1038/icb.2013.65; Lukas D, 2017, P NATL ACAD SCI USA, V114, pE1480, DOI 10.1073/pnas.1615065114; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Sadik A, 2020, CELL, V182, P1252, DOI 10.1016/j.cell.2020.07.038; Vogel CFA, 2008, BIOCHEM BIOPH RES CO, V375, P331, DOI 10.1016/j.bbrc.2008.07.156	10	0	0	9	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 14	2022	55	6					967	970		10.1016/j.immuni.2022.05.015	http://dx.doi.org/10.1016/j.immuni.2022.05.015			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	2U6UT	35704997				2022-12-18	WOS:000823293900004
J	Rivera, CA; Lennon-Dumenil, AM				Rivera, Claudia A.; Lennon-Dumenil, Ana-Maria			Dendritic cells (cross)dress for success	IMMUNITY			English	Editorial Material							ACTIVATION; MECHANISM; ANTIGENS		[Rivera, Claudia A.; Lennon-Dumenil, Ana-Maria] PSL Res Univ, Inst Curie, INSERM U932, F-75005 Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite	Lennon-Dumenil, AM (corresponding author), PSL Res Univ, Inst Curie, INSERM U932, F-75005 Paris, France.	amlennon@curie.fr		Rivera, Claudia A/0000-0002-9926-1475	ARC Foundation for Cancer Research; INSERM; Institut Curie; DCBIOL Labex [ANR-10-IDEX-0001-02-PSL, ANR-11-LABX-0043]	ARC Foundation for Cancer Research; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Curie; DCBIOL Labex	C.A.R. received funding from ARC Foundation for Cancer Research. A.-M.L.-D. received funding from INSERM, Institut Curie, and the DCBIOL Labex (ANR-10-IDEX-0001-02-PSL and ANR-11-LABX-0043).	Campana S, 2015, IMMUNOL LETT, V168, P349, DOI 10.1016/j.imlet.2015.11.002; Das Mohapatra A, 2020, CANCER IMMUNOL RES, V8, P1287, DOI 10.1158/2326-6066.CIR-20-0248; Dolan BP, 2006, J IMMUNOL, V177, P6018, DOI 10.4049/jimmunol.177.9.6018; Duong E, 2022, IMMUNITY, V55, P308, DOI 10.1016/j.immuni.2021.10.020; Kvedaraite E, 2022, SCI IMMUNOL, V7, DOI 10.1126/sciimmunol.abm9409; MacNabb BW, 2022, IMMUNITY, V55, P982, DOI 10.1016/j.immuni.2022.04.016; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Wakim LM, 2011, NATURE, V471, P629, DOI 10.1038/nature09863; Yewdell JW, 2005, ANNU REV IMMUNOL, V23, P651, DOI 10.1146/annurev.immunol.23.021704.115702; Zeng FR, 2018, SEMIN IMMUNOPATHOL, V40, P477, DOI 10.1007/s00281-018-0679-8	10	0	0	5	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 14	2022	55	6					965	967		10.1016/j.immuni.2022.05.016	http://dx.doi.org/10.1016/j.immuni.2022.05.016			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	2U6UT	35704996				2022-12-18	WOS:000823293900003
J	Roy, R; Ramamoorthy, S; Shapiro, BD; Kaileh, M; Hernandez, D; Sarantopoulou, D; Arepalli, S; Boller, SR; Singh, A; Bektas, A; Kim, J; Moore, AZ; Tanaka, T; McKelvey, J; Zukley, L; Nguyen, C; Wallace, T; Dunn, C; Wersto, R; Wood, W; Piao, Y; Becker, KG; Coletta, C; De, S; Sen, JM; Battle, A; Weng, NP; Grosschedl, R; Ferrucci, L; Sen, R				Roy, Roshni; Ramamoorthy, Senthilkumar; Shapiro, Benjamin D.; Kaileh, Mary; Hernandez, Dena; Sarantopoulou, Dimitra; Arepalli, Sampath; Boller, So Ren; Singh, Amit; Bektas, Arsun; Kim, Jaekwan; Moore, Ann Zenobia; Tanaka, Toshiko; McKelvey, Julia; Zukley, Linda; Nguyen, Cuong; Wallace, Tonya; Dunn, Christopher; Wersto, Robert; Wood, William; Piao, Yulan; Becker, Kevin G.; Coletta, Christopher; De, Supriyo; Sen, Jyoti Misra; Battle, Alexis; Weng, Nan-ping; Grosschedl, Rudolf; Ferrucci, Luigi; Sen, Ranjan			DNA methylation signatures reveal that distinct combinations of transcription factors specify human immune cell epigenetic identity (vol 54, pg 2465, 2021)	IMMUNITY			English	Correction												senranja@grc.nia.nih.gov; senranja@grc.nia.nih.gov		Dunn, Christopher/0000-0001-7899-0110				Roy R, 2021, IMMUNITY, V54, P2465, DOI 10.1016/j.immuni.2021.10.001	1	0	0	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 14	2022	55	6					1135	1135		10.1016/j.immuni.2022.05.006	http://dx.doi.org/10.1016/j.immuni.2022.05.006			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3F2TY	35704994	Bronze			2022-12-18	WOS:000830524400007
J	Schneider, KM; Thaiss, CA				Schneider, Kai Markus; Thaiss, Christoph A.			When the brain feels the bugs	IMMUNITY			English	Editorial Material								The microbiome modulates brain function, but the precise routes of gut-brain communication remain unclear. In a recent issue of Science, Gabanyi et al. discover that hypothalamic GABAergic neurons directly recognize microbial muropeptides via NOD2, leading to reduced neuronal activity, loss of appetite, and aberrant thermoregulation.	[Schneider, Kai Markus; Thaiss, Christoph A.] Univ Penn, Dept Microbiol, Inst Immunol, Philadelphia, PA 19104 USA; [Schneider, Kai Markus; Thaiss, Christoph A.] Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Thaiss, CA (corresponding author), Univ Penn, Dept Microbiol, Inst Immunol, Philadelphia, PA 19104 USA.; Thaiss, CA (corresponding author), Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA.	thaiss@pennmedicine.upenn.edu			NIH [DP2-AG-067492, R01-DK-129691, P30-DK050306, P30-AR-069589, P30-DK-019525]; Human Frontier Science Program; Pew Biomedical Scholarship; Agilent Early Career Professor Award; IDSA Foundation; Thyssen Foundation; German Research Foundation (DFG)	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); Pew Biomedical Scholarship; Agilent Early Career Professor Award; IDSA Foundation; Thyssen Foundation; German Research Foundation (DFG)(German Research Foundation (DFG))	Work in the Thaiss lab is supported by the NIH (DP2-AG-067492, R01-DK-129691, P30-DK050306, P30-AR-069589, P30-DK-019525); the Human Frontier Science Program; a Pew Biomedical Scholarship; the Edward Mallinckrodt, Jr. Foundation; the Agilent Early Career Professor Award; the IDSA Foundation; and the Thyssen Foundation. K.M.S. is supported by a fellowship from the German Research Foundation (DFG).	Arentsen T, 2018, BRAIN BEHAV IMMUN, V67, P345, DOI 10.1016/j.bbi.2017.09.014; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Betley JN, 2015, NATURE, V521, P180, DOI 10.1038/nature14416; Chen YM, 2015, CELL, V160, P829, DOI 10.1016/j.cell.2015.01.033; Gabanyi I, 2022, SCIENCE, V376, P263, DOI 10.1126/science.abj3986; Grimes CL, 2012, J AM CHEM SOC, V134, P13535, DOI 10.1021/ja303883c; Morais LH, 2021, NAT REV MICROBIOL, V19, P241, DOI 10.1038/s41579-020-00460-0; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Pusceddu MM, 2019, J PHYSIOL-LONDON, V597, P5777, DOI 10.1113/JP278640; Saper CB, 2014, CURR BIOL, V24, pR1111, DOI 10.1016/j.cub.2014.10.023; Thaiss CA, 2016, NATURE, V535, P65, DOI 10.1038/nature18847	11	0	0	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 14	2022	55	6					976	978		10.1016/j.immuni.2022.05.008	http://dx.doi.org/10.1016/j.immuni.2022.05.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	2U6UT	35705000				2022-12-18	WOS:000823293900007
J	Hughes, EJ; Tobin, DM				Hughes, Erika J.; Tobin, David M.			Decoding the tuberculous granuloma	IMMUNITY			English	Editorial Material								In this issue of Immunity, Gideon et al. (2022) couple sophisticated single-cell analyses with detailed in vivo measurements of Mycobacterium tuberculosis granulomas to define the cellular and transcriptional properties of a successful host immune response during tuberculosis.	[Hughes, Erika J.] Duke Univ, Univ Program Genet & Genom, Sch Med, Durham, NC 27710 USA; [Hughes, Erika J.; Tobin, David M.] Duke Univ, Dept Mol Genet & Microbiol, Sch Med, Durham, NC 27710 USA; [Tobin, David M.] Duke Univ, Dept Immunol, Sch Med, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Tobin, DM (corresponding author), Duke Univ, Dept Mol Genet & Microbiol, Sch Med, Durham, NC 27710 USA.; Tobin, DM (corresponding author), Duke Univ, Dept Immunol, Sch Med, Durham, NC 27710 USA.	david.tobin@duke.edu			NIH [AI130236, AI125517, AI166304, AI157405]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants AI130236, AI125517, and AI166304 (D.M.T.) and AI157405 (E.J.H.) .	Bohrer AC, 2021, J EXP MED, V218, DOI 10.1084/jem.20210469; Cronan MR, 2021, CELL, V184, P1757, DOI 10.1016/j.cell.2021.02.046; Cronan MR, 2016, IMMUNITY, V45, P861, DOI 10.1016/j.immuni.2016.09.014; Esaulova E, 2021, CELL HOST MICROBE, V29, P165, DOI 10.1016/j.chom.2020.11.013; Gideon HP, 2022, IMMUNITY, V55, P827, DOI 10.1016/j.immuni.2022.04.004; Huang L, 2018, J EXP MED, V215, P1135, DOI 10.1084/jem.20172020; Lin PL, 2014, NAT MED, V20, P75, DOI 10.1038/nm.3412; Marakalala MJ, 2016, NAT MED, V22, P531, DOI 10.1038/nm.4073; McCaffrey EF, 2022, NAT IMMUNOL, V23, P318, DOI 10.1038/s41590-021-01121-x; Pagan AJ, 2018, ANNU REV IMMUNOL, V36, P639, DOI 10.1146/annurev-immunol-032712-100022	10	0	0	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 10	2022	55	5					819	821		10.1016/j.immuni.2022.04.009	http://dx.doi.org/10.1016/j.immuni.2022.04.009			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1P7FS	35545030				2022-12-18	WOS:000802171100006
J	Koh, JY; Shin, EC				Koh, June-Young; Shin, Eui-Cheol			KIRs mark killers suppressing autoimmunity	IMMUNITY			English	Editorial Material							T-HELPER-CELLS; RECEPTOR; EXPRESS	Identification of regulatory CD8(+) T cells that suppress pathological immune responses is an importunate pursuit. In a recent issue of Science, Li et al. demonstrated that human KIR(+)CD8(+) T cells suppress autoimmunity by eliminating pathogenic CD4(+) T cells.	[Koh, June-Young; Shin, Eui-Cheol] Korea Adv Inst Sci & Technol KAIST, Grad Sch Med Sci & Engn, Daejeon 34141, South Korea; [Shin, Eui-Cheol] Inst Basic Sci IBS, Korea Virus Res Inst, Ctr Viral Immunol, Daejeon 34126, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Institute for Basic Science - Korea (IBS)	Shin, EC (corresponding author), Korea Adv Inst Sci & Technol KAIST, Grad Sch Med Sci & Engn, Daejeon 34141, South Korea.; Shin, EC (corresponding author), Inst Basic Sci IBS, Korea Virus Res Inst, Ctr Viral Immunol, Daejeon 34126, South Korea.	ecshin@kaist.ac.kr			Institute for Basic Science (IBS) , Republic of Korea [IBS-R801-D2]	Institute for Basic Science (IBS) , Republic of Korea	This work was supported by the Institute for Basic Science (IBS) , Republic of Korea, under project code IBS-R801-D2.	Bjorkstrom NK, 2012, BLOOD, V120, P3455, DOI 10.1182/blood-2012-03-416867; CANTOR H, 1978, J EXP MED, V148, P871, DOI 10.1084/jem.148.4.871; Huard B, 2000, NATURE, V403, P325, DOI 10.1038/35002105; Kim HJ, 2011, SEMIN IMMUNOL, V23, P446, DOI 10.1016/j.smim.2011.06.001; Kim HJ, 2011, P NATL ACAD SCI USA, V108, P2010, DOI 10.1073/pnas.1018974108; Kim HJ, 2010, NATURE, V467, P328, DOI 10.1038/nature09370; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Li J, 2022, SCIENCE, V376, P265, DOI 10.1126/science.abi9591; Mishra S, 2021, J EXP MED, V218, DOI 10.1084/jem.20200030; Vivier E, 2004, NAT REV IMMUNOL, V4, P190, DOI 10.1038/nri1306	10	0	0	3	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 10	2022	55	5					735	737		10.1016/j.immuni.2022.04.014	http://dx.doi.org/10.1016/j.immuni.2022.04.014			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1P7FS	35545025				2022-12-18	WOS:000802171100001
J	McCarville, JL; Ayres, JS				McCarville, Justin L.; Ayres, Janelle S.			Virulence triggered allergies Pseudomonas gets the Las laugh	IMMUNITY			English	Editorial Material							BACTERIA	The mechanisms of how infectious diseases contribute to allergy remain unanswered. In this issue of Immunity, Agaronyan et al. (2022) show that Pseudomonas aeruginosa drives immune deviation through induction of type 2 immune responses, resulting in niche remodeling that incites allergic responses to innocuous antigens.	[McCarville, Justin L.; Ayres, Janelle S.] Salk Inst Biol Studies, Nomis Ctr Immunobiol & Microbial Pathogenesis, Gene Express Lab, Mol & Syst Physiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA	Salk Institute	Ayres, JS (corresponding author), Salk Inst Biol Studies, Nomis Ctr Immunobiol & Microbial Pathogenesis, Gene Express Lab, Mol & Syst Physiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jayres@salk.edu			NIH [R01AI114929, DP1 AI144249]; Canadian Institutes of Health Research fellowship	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research fellowship(Canadian Institutes of Health Research (CIHR))	J.S.A. is supported by a NIH Pioneer award (DP1 AI144249) and a NIH grant (R01AI114929) . J.L.M. is supported by a Canadian Institutes of Health Research fellowship.	Agaronyan K, 2022, IMMUNITY, V55, P895, DOI 10.1016/j.immuni.2022.04.001; Aguilera-Lizarraga J, 2021, NATURE, V590, P151, DOI 10.1038/s41586-020-03118-2; Amoah AS, 2013, J ALLERGY CLIN IMMUN, V132, P639, DOI 10.1016/j.jaci.2013.04.023; ASHERSON GL, 1965, IMMUNOLOGY, V9, P205; Bouziat R, 2017, SCIENCE, V356, P44, DOI 10.1126/science.aah5298; Caminero A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09037-9; Caminero A, 2016, GASTROENTEROLOGY, V151, P670, DOI 10.1053/j.gastro.2016.06.041; Edwards MR, 2017, J ALLERGY CLIN IMMUN, V140, P909, DOI 10.1016/j.jaci.2017.07.025; Gieseck RL, 2018, NAT REV IMMUNOL, V18, P62, DOI 10.1038/nri.2017.90; Stefka AT, 2014, P NATL ACAD SCI USA, V111, P13145, DOI 10.1073/pnas.1412008111	10	0	0	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 10	2022	55	5					824	826		10.1016/j.immuni.2022.04.011	http://dx.doi.org/10.1016/j.immuni.2022.04.011			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1P7FS	35545032				2022-12-18	WOS:000802171100008
J	Neher, JJ				Neher, J. Jonas			InFlamiN' the brain in Alzheimer's disease	IMMUNITY			English	Editorial Material								Although consistently implicated, the exact role of interferon (IFN) signaling in Alzheimer's disease remains largely unexplored. Roy et al. now demonstrate that type I IFNs may drive cognitive dysfunction through acting not only on microglia but, surprisingly, also on neurons.	[Neher, J. Jonas] German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany; [Neher, J. Jonas] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cellular Neurol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Neher, JJ (corresponding author), German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany.; Neher, JJ (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cellular Neurol, Tubingen, Germany.	jonas.neher@dzne.de						Chen Y, 2021, J EXP MED, V218, DOI 10.1084/jem.20202717; Decout A, 2021, NAT REV IMMUNOL, V21, P548, DOI 10.1038/s41577-021-00524-z; Deczkowska A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00769-0; Huang YT, 2021, NAT IMMUNOL, V22, P586, DOI 10.1038/s41590-021-00913-5; Olah M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19737-2; Rexach JE, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108398; Roy ER, 2022, IMMUNITY, V55, P879, DOI 10.1016/j.immuni.2022.03.018; Roy ER, 2020, J CLIN INVEST, V130, P1912, DOI 10.1172/JCI133737; Scott-Hewitt N, 2020, EMBO J, V39, DOI 10.15252/embj.2020105380	9	0	0	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 10	2022	55	5					821	823		10.1016/j.immuni.2022.04.008	http://dx.doi.org/10.1016/j.immuni.2022.04.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1P7FS	35545031				2022-12-18	WOS:000802171100007
J	Brooks, DG; Ohashi, PS				Brooks, David G.; Ohashi, Pamela S.			DC1s shield Tpex cells to bolster PD-1 blockade	IMMUNITY			English	Editorial Material							T-CELLS	Responsiveness to PD-1 blockade depends on a cell subset known as Tpex cells, but how these cells are sustained is less understood. In this issue of Immunity, Dahling et al. show how dendritic cells form a niche for Tpex preservation.	[Brooks, David G.; Ohashi, Pamela S.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [Brooks, David G.; Ohashi, Pamela S.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Brooks, DG; Ohashi, PS (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada.; Brooks, DG; Ohashi, PS (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada.	dbrooks@uhnresearch.ca; pam.ohashi@uhnresearch.ca			Canadian Institutes of Health Research (CIHR) Foundation Grant [FDN148386]; National Institutes of Health (NIH) [AI085043]; Canadian Cancer Society (CCSRI) Innovation Award [706230]; Terry Fox (TFRI) New Frontiers Grant; CIHR Foundation Grant [FDN 143220]; Canadian Cancer Society [706152]; OICR-translational research initiative [108796]; Sco-tiabank Research Chair; TFRI [1060]	Canadian Institutes of Health Research (CIHR) Foundation Grant(Canadian Institutes of Health Research (CIHR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Cancer Society (CCSRI) Innovation Award; Terry Fox (TFRI) New Frontiers Grant; CIHR Foundation Grant(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); OICR-translational research initiative; Sco-tiabank Research Chair; TFRI	D.G.B. is supported by the Canadian Institutes of Health Research (CIHR) Foundation Grant FDN148386, the National Institutes of Health (NIH) grant AI085043 (D.G.B) , the Canadian Cancer Society (CCSRI) Innovation Award No. 706230, Terry Fox (TFRI) New Frontiers Grant and the Sco-tiabank Research Chair. P.S.O. is funded by a CIHR Foundation Grant FDN 143220, Canadian Cancer Society 706152, TFRI 1060, and the OICR-translational research initiative 108796.	Dahling S, 2022, IMMUNITY, V55, P656, DOI 10.1016/j.immuni.2022.03.006; Hui EF, 2017, SCIENCE, V355, P1428, DOI 10.1126/science.aaf1292; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Kamphorst AO, 2017, SCIENCE, V355, P1423, DOI 10.1126/science.aaf0683; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Mueller SN, 2007, P NATL ACAD SCI USA, V104, P15430, DOI 10.1073/pnas.0702579104; Snell LM, 2018, IMMUNITY, V49, P378, DOI 10.1016/j.immuni.2018.08.002; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593	8	0	0	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 12	2022	55	4					577	579		10.1016/j.immuni.2022.03.017	http://dx.doi.org/10.1016/j.immuni.2022.03.017			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0W2LH	35417669				2022-12-18	WOS:000788864600002
J	Cho, DH; Choi, GB				Cho, Daniel H.; Choi, Gloria B.			Fungus packs a punch in the gut	IMMUNITY			English	Editorial Material							COMMENSAL FUNGI	The impact of intestinal fungi on host physiology and their mechanisms of interaction are incompletely understood. In a recent issue of Cell, Leonardi et al. (2022) showed that mucosal fungi induce intestinal Th17 cells to produce IL-22 and IL-17A. IL-22 acts on the gut epithelium to protect barrier integrity, whereas IL-17 acts on IL-17RA(+) neurons to enhance sociability.	[Cho, Daniel H.; Choi, Gloria B.] MIT, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Cho, Daniel H.; Choi, Gloria B.] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT)	Choi, GB (corresponding author), MIT, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Choi, GB (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	gbchoi@mit.edu						de Lima KA, 2020, NAT IMMUNOL, V21, P1421, DOI 10.1038/s41590-020-0776-4; Chen CC, 2017, NATURE, V542, P43, DOI 10.1038/nature20818; Fan Y, 2021, NAT REV MICROBIOL, V19, P55, DOI 10.1038/s41579-020-0433-9; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Jiang TT, 2017, CELL HOST MICROBE, V22, P809, DOI 10.1016/j.chom.2017.10.013; Leonardi I, 2022, CELL, V185, P831, DOI 10.1016/j.cell.2022.01.017; Ost KS, 2021, NATURE, V596, P114, DOI 10.1038/s41586-021-03722-w; Pappas PC, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.26; Reed MD, 2020, NATURE, V577, P249, DOI 10.1038/s41586-019-1843-6; Ribeiro M, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aay5199	10	0	0	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 12	2022	55	4					586	588		10.1016/j.immuni.2022.03.012	http://dx.doi.org/10.1016/j.immuni.2022.03.012			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0W2LH	35417672				2022-12-18	WOS:000788864600005
J	Hawerkamp, HC; Fallon, PG				Hawerkamp, Heike C.; Fallon, Padraic G.			Expelliarmus helminthus! Harry Helminth and the Goblet of Alarmins	IMMUNITY			English	Editorial Material							IMMUNITY; RESPONSES	Epithelial cells (tuft and goblet cells) interact with immune cells on the "inside"while secreting effector molecules into the topological "outside."In this issue of Immunity, Zhao et al. investigate an interleukin-33 (IL-33) secretion mechanism in goblet cells dependent on O-GlcNAcylation and gasdermin pores facilitating worm expulsion.	[Hawerkamp, Heike C.; Fallon, Padraic G.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Med, Dublin 2, Ireland	Trinity College Dublin	Hawerkamp, HC; Fallon, PG (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Med, Dublin 2, Ireland.	hawerkah@tcd.ie; pfallon@tcd.ie		Hawerkamp, Heike C./0000-0002-3990-8230				Chang YH, 2020, J BIOMED SCI, V27, DOI 10.1186/s12929-020-00648-9; Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Harris NL, 2017, IMMUNITY, V47, P1024, DOI 10.1016/j.immuni.2017.11.015; Knoop KA, 2018, MUCOSAL IMMUNOL, V11, P1551, DOI 10.1038/s41385-018-0039-y; Schneider C, 2019, NAT REV IMMUNOL, V19, P584, DOI 10.1038/s41577-019-0176-x; Schwartz C, 2016, EUR J IMMUNOL, V46, P1091, DOI 10.1002/eji.201545780; Ualiyeva S, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abj0474; Zhao M, 2022, IMMUNITY, V55, P623, DOI 10.1016/j.immuni.2022.03.009; Zou J, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.751533	10	0	0	4	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 12	2022	55	4					575	577		10.1016/j.immuni.2022.03.014	http://dx.doi.org/10.1016/j.immuni.2022.03.014			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0W2LH	35417668				2022-12-18	WOS:000788864600001
J	Lenti, E; Genovese, L; Bianchessi, S; Maurizio, A; Sain, SB; di Lillo, A; Mattavelli, G; Harel, I; Bernassola, F; Hehlgans, T; Pfeffer, K; Crosti, M; Abrignani, S; Evans, SM; Sitia, G; Guimaraes-Camboa, N; Russo, V; van de Pavert, SA; Garcia-Manteiga, JM; Brendolan, A				Lenti, Elisa; Genovese, Luca; Bianchessi, Silvia; Maurizio, Aurora; Sain, Simona Baghai; di Lillo, Alessia; Mattavelli, Greta; Harel, Itamar; Bernassola, Francesca; Hehlgans, Thomas; Pfeffer, Klaus; Crosti, Mariacristina; Abrignani, Sergio; Evans, Sylvia M.; Sitia, Giovanni; Guimaraes-Camboa, Nuno; Russo, Vincenzo; van de Pavert, Serge A.; Garcia-Manteiga, Jose Manuel; Brendolan, Andrea			Fate mapping and scRNA sequencing reveal origin and diversity of lymph node stromal precursors	IMMUNITY			English	Article							FIBROBLASTIC RETICULAR CELLS; NEURAL CREST; ENDOTHELIAL-CELLS; ORGANIZER; NETWORKS; ORGANOGENESIS; ACTIVATION; DYNAMICS; PATHWAY; ATLAS	Lymph node (LN) stromal cells play a crucial role in LN development and in supporting adaptive immune responses. However, their origin, differentiation pathways, and transcriptional programs are still elusive. Here, we used lineage-tracing approaches and single-cell transcriptome analyses to determine origin, transcriptional profile, and composition of LN stromal and endothelial progenitors. Our results showed that all major stromal cell subsets and a large proportion of blood endothelial cells originate from embryonic Hoxb6(+) progenitors of the lateral plate mesoderm (LPM), whereas lymphatic endothelial cells arise from Pax3(+) progenitors of the paraxial mesoderm (PXM). Single-cell RNA sequencing revealed the existence of different Cd34(+) and Cxcl13(+) stromal cell subsets and showed that embryonic LNs contain proliferating progenitors possibly representing the amplifying populations for terminally differentiated cells. Taken together, our work identifies the earliest embryonic sources of LN stromal and endothelial cells and demonstrates that stromal diversity begins already during LN development.	[Lenti, Elisa; Genovese, Luca; Bianchessi, Silvia; di Lillo, Alessia; Mattavelli, Greta; Russo, Vincenzo; Brendolan, Andrea] IRCCS San Raffaele Sci Inst, Div Expt Oncol, Milan, Italy; [Maurizio, Aurora; Sain, Simona Baghai; Garcia-Manteiga, Jose Manuel] IRCCS San Raffaele Sci Inst, Ctr Omics Sci, Milan, Italy; [Harel, Itamar] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Genet, Edmond J Safra Campus, IL-9190401 Jerusalem, Israel; [Bernassola, Francesca] Univ Roma Tor Vergata, Dept Expt Med, TOR, I-00133 Rome, Italy; [Hehlgans, Thomas] Univ Regensburg, Leibniz Inst Immunotherapy LIT, Chair Immunol, D-93053 Regensburg, Germany; [Pfeffer, Klaus] Univ Hosp Dusseldorf, Inst Med Microbiol & Hosp Hyg, D-40225 Dusseldorf, Germany; [Crosti, Mariacristina; Abrignani, Sergio] Ist Nazl Genet Mol Romeo & Enrica Invernizzi, INGM, Milan, Italy; [Abrignani, Sergio] Univ Milan, Dept Clin Sci & Community Hlth DISCCO, Milan, Italy; [Evans, Sylvia M.] Univ Calif San Diego, Skaggs Sch Pharm, La Jolla, CA 92093 USA; [Sitia, Giovanni] IRCCS San Raffaele Sci Inst, Div Immunol Transplantat & Infect Dis, Milan, Italy; [Guimaraes-Camboa, Nuno] Goethe Univ, Inst Cardiovasc Regenerat, D-60590 Frankfurt, Germany; [Guimaraes-Camboa, Nuno] German Ctr Cardiovasc Res, Partner Site Frankfurt Rhine Main, Berlin, Germany; [van de Pavert, Serge A.] Aix Marseille Univ, Ctr Immunol Marseille Luminy CIML, CNRS, INSERM, Marseille, France	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Hebrew University of Jerusalem; University of Rome Tor Vergata; University of Regensburg; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Milan; University of California System; University of California San Diego; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Goethe University Frankfurt; German Centre for Cardiovascular Research; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Brendolan, A (corresponding author), IRCCS San Raffaele Sci Inst, Div Expt Oncol, Milan, Italy.	brendolan.andrea@hsr.it	van de Pavert, Serge A./A-7307-2008	van de Pavert, Serge A./0000-0002-7147-4380; Lenti, Elisa/0000-0002-4462-3213; Harel, Itamar/0000-0001-9749-8279; di Lillo, Alessia/0000-0003-1798-4846; Abrignani, Sergio/0000-0002-0794-3285; Baghai Sain, Simona/0000-0002-2357-7027	Italian Association for Cancer Research (AIRC) [14511, 19867]; BSF-NSF [2020611]; NIH	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); BSF-NSF; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors are grateful to the lab members for technical assistance and help-ful suggestions. We are grateful to Susan Mackem for providing the Hoxb6-CreERT mice. This work was supported by fundings from Italian Association for Cancer Research (AIRC) grants IG# 14511 and 19867 to A.B., BSF-NSF 2020611 to I.H., and NIH to S.M.E.	Acton SE, 2012, IMMUNITY, V37, P276, DOI 10.1016/j.immuni.2012.05.022; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Benezech C, 2012, IMMUNITY, V37, P721, DOI 10.1016/j.immuni.2012.06.010; Benezech C, 2010, J IMMUNOL, V184, P4521, DOI 10.4049/jimmunol.0903113; Betancur P, 2010, ANNU REV CELL DEV BI, V26, P581, DOI 10.1146/annurev.cellbio.042308.113245; Bovay E, 2018, J EXP MED, V215, P2760, DOI 10.1084/jem.20180217; Brown FD, 2019, NAT IMMUNOL, V20, P1668, DOI 10.1038/s41590-019-0515-x; Buckingham M, 2014, DEV CELL, V28, P225, DOI 10.1016/j.devcel.2013.12.020; Buckley CD, 2015, ANNU REV IMMUNOL, V33, P715, DOI 10.1146/annurev-immunol-032713-120252; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Camara A, 2019, IMMUNITY, V50, P1467, DOI 10.1016/j.immuni.2019.05.008; Castagnaro L, 2013, IMMUNITY, V38, P782, DOI 10.1016/j.immuni.2012.12.005; Cording S, 2014, MUCOSAL IMMUNOL, V7, P359, DOI 10.1038/mi.2013.54; Denton AE, 2019, J EXP MED, V216, P2242, DOI 10.1084/jem.20181705; Derti A, 2012, GENOME RES, V22, P1173, DOI 10.1101/gr.132563.111; Dijkstra KK, 2018, CELL, V174, P1586, DOI 10.1016/j.cell.2018.07.009; Engleka KA, 2005, DEV BIOL, V280, P396, DOI 10.1016/j.ydbio.2005.02.002; Fletcher AL, 2011, TRENDS IMMUNOL, V32, P12, DOI 10.1016/j.it.2010.11.002; Foster K, 2008, J IMMUNOL, V180, P3183, DOI 10.4049/jimmunol.180.5.3183; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Goldman O, 2014, STEM CELL REP, V3, P556, DOI 10.1016/j.stemcr.2014.08.009; Gutierrez-Miranda L, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.577584; Han L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17968-x; Hutcheson DA, 2009, GENE DEV, V23, P997, DOI 10.1101/gad.1769009; Jarjour M, 2014, J EXP MED, V211, P1109, DOI 10.1084/jem.20132409; Kim S, 2019, NAT REV MATER, V4, P355, DOI 10.1038/s41578-019-0100-9; Kiselev VY, 2018, NAT METHODS, V15, P359, DOI 10.1038/nmeth.4644; Kobayashi Y, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00316; Koning JJ, 2020, CURR OPIN IMMUNOL, V64, P20, DOI 10.1016/j.coi.2020.03.003; Koning JJ, 2016, J IMMUNOL, V197, P2686, DOI 10.4049/jimmunol.1501162; Lenti E, 2019, STEM CELL REP, V12, P1260, DOI 10.1016/j.stemcr.2019.04.021; Lenti E, 2016, J CLIN INVEST, V126, P2452, DOI 10.1172/JCI82956; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Martinez VG, 2019, CELL REP, V29, P2810, DOI 10.1016/j.celrep.2019.10.103; Matsuda M, 2020, NATURE, V580, P124, DOI 10.1038/s41586-020-2144-9; Mayeuf-Louchart A, 2014, P NATL ACAD SCI USA, V111, P8844, DOI 10.1073/pnas.1407606111; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Muhl L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17740-1; Nazareth EJP, 2013, NAT METHODS, V10, P1225, DOI [10.1038/nmeth.2684, 10.1038/NMETH.2684]; Nguyen MT, 2009, DEV DYNAM, V238, P467, DOI 10.1002/dvdy.21846; Onder L, 2017, IMMUNITY, V47, P80, DOI 10.1016/j.immuni.2017.05.008; Onder L, 2013, J EXP MED, V210, P465, DOI 10.1084/jem.20121462; Perez-Shibayama C, 2019, IMMUNOL REV, V289, P31, DOI 10.1111/imr.12748; Pezoldt J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06423-7; Plein A, 2018, NATURE, V562, P223, DOI 10.1038/s41586-018-0552-x; Prummel KD, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.175059; Rodda LB, 2018, IMMUNITY, V48, P1014, DOI 10.1016/j.immuni.2018.04.006; Schaeuble K, 2017, CELL REP, V21, P2500, DOI 10.1016/j.celrep.2017.10.119; Sebo ZL, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.166801; Sitnik KM, 2016, CELL REP, V14, P2375, DOI 10.1016/j.celrep.2016.02.033; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Smith T, 2017, GENOME RES, V27, P491, DOI 10.1101/gr.209601.116; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stone OA, 2019, DEV CELL, V50, P247, DOI 10.1016/j.devcel.2019.04.034; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sun YF, 2007, DEV BIOL, V304, P286, DOI 10.1016/j.ydbio.2006.12.048; Tani S, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22031404; Tani S, 2020, EXP MOL MED, V52, P1166, DOI 10.1038/s12276-020-0482-1; Thierry GR, 2019, IMMUNOL REV, V289, P42, DOI 10.1111/imr.12750; Vanlandewijck M, 2018, NATURE, V554, P475, DOI 10.1038/nature25739; Wasteson P, 2008, DEVELOPMENT, V135, P1823, DOI 10.1242/dev.020958; Wimmer N, 2012, J IMMUNOL, V188, P3426, DOI 10.4049/jimmunol.1103324; Yang L, 2006, DEVELOPMENT, V133, P1575, DOI 10.1242/dev.02322; Zakany J, 2007, CURR OPIN GENET DEV, V17, P359, DOI 10.1016/j.gde.2007.05.011; Zhuang SW, 2013, GENE EXPR PATTERNS, V13, P407, DOI 10.1016/j.gep.2013.07.001	67	0	0	3	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 12	2022	55	4					606	+		10.1016/j.immuni.2022.03.002	http://dx.doi.org/10.1016/j.immuni.2022.03.002			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0W2LH	35358427				2022-12-18	WOS:000788864600008
J	Lopes, A; Goldszmid, RS				Lopes, Amelie; Goldszmid, Romina S.			Microbes-myeloid-tumor: a colonic triad against T cells	IMMUNITY			English	Editorial Material								Immune checkpoint blockade has dramatically improved cancer therapy but remains ineffective for most colorectal tumors. In this issue of Immunity, Peuker et al. describe a microbiota-myeloid-tumor cell crosstalk that inhibits CD8(+) T cells and promotes colorectal cancer progression.	[Lopes, Amelie; Goldszmid, Romina S.] NCI, Inflammatory Cell Dynam Sect, Lab Integrat Canc Immunol, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Goldszmid, RS (corresponding author), NCI, Inflammatory Cell Dynam Sect, Lab Integrat Canc Immunol, Ctr Canc Res, Bethesda, MD 20892 USA.	rgoldszmid@mail.nih.gov			Intramural Research Program of the NIH (NCI, Center for Cancer Research)	Intramural Research Program of the NIH (NCI, Center for Cancer Research)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the NIH (NCI, Center for Cancer Research) .	Bruni D, 2020, NAT REV CANCER, V20, P662, DOI 10.1038/s41568-020-0285-7; Chung L, 2018, CELL HOST MICROBE, V23, P203, DOI [10.1016/j.chom.2018.01.007, 10.1016/j.chom.2018.02.004]; Drewes JL, 2016, BRIT J CANCER, V115, P273, DOI 10.1038/bjc.2016.189; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Lopes A, 2020, INT J CANCER, V146, P3147, DOI 10.1002/ijc.32920; Mima K, 2015, JAMA ONCOL, V1, P653, DOI 10.1001/jamaoncol.2015.1377; Ni L, 2017, MOL CANCER THER, V16, P1203, DOI 10.1158/1535-7163.MCT-16-0761; Peuker K, 2022, IMMUNITY, V55, P701, DOI 10.1016/j.immuni.2022.03.008; Peuker K, 2016, NAT MED, V22, P506, DOI 10.1038/nm.4072; Picard E, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00369	10	0	0	2	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 12	2022	55	4					582	585		10.1016/j.immuni.2022.03.011	http://dx.doi.org/10.1016/j.immuni.2022.03.011			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0W2LH	35417671				2022-12-18	WOS:000788864600004
J	Patel, MA; Tavazoie, SF				Patel, Mira A.; Tavazoie, Sohail F.			RIP(K)ing away immunotherapy resistance	IMMUNITY			English	Editorial Material							CHECKPOINT; APOPTOSIS	Interferon signaling mediates resistance to immune checkpoint blockade therapy, but the underlying mechanisms are poorly understood. In this issue of Immunity, Cucolo et al. identify RIPK1 as an interferon-stimulated gene with potent effects on cell extrinsic and intrinsic immunotherapy resistance.	[Patel, Mira A.; Tavazoie, Sohail F.] Rockefeller Univ, Lab Syst Canc Biol, 1230 York Ave, New York, NY 10065 USA	Rockefeller University	Patel, MA; Tavazoie, SF (corresponding author), Rockefeller Univ, Lab Syst Canc Biol, 1230 York Ave, New York, NY 10065 USA.	mpatel@rockefeller.edu; stavazoie@rockefeller.edu						Benci JL, 2019, CELL, V178, P933, DOI 10.1016/j.cell.2019.07.019; Benci JL, 2016, CELL, V167, P1540, DOI 10.1016/j.cell.2016.11.022; Chen PL, 2016, CANCER DISCOV, V6, P827, DOI 10.1158/2159-8290.CD-15-1545; Cucolo L, 2022, IMMUNITY, V55, P671, DOI 10.1016/j.immuni.2022.03.007; Dannappel M, 2014, NATURE, V513, P90, DOI 10.1038/nature13608; Jacquelot N, 2019, CELL RES, V29, P846, DOI 10.1038/s41422-019-0224-x; Kalbasi A, 2020, NAT REV IMMUNOL, V20, P25, DOI 10.1038/s41577-019-0218-4; Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Pai CCS, 2019, IMMUNITY, V50, P477, DOI 10.1016/j.immuni.2019.01.006	10	0	0	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 12	2022	55	4					580	582		10.1016/j.immuni.2022.03.010	http://dx.doi.org/10.1016/j.immuni.2022.03.010			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0W2LH	35417670				2022-12-18	WOS:000788864600003
J	He, YK; Vinuesa, CG				He, Yuke; Vinuesa, Carola G.			Monocytes asphyxiate germinal centers	IMMUNITY			English	Editorial Material							B-CELLS; INFECTION	Some bacteria and parasites, such as Salmonella, actively disrupt germinal centers and elicit only low affinity antibodies, but the mechanisms by which microbes alter these responses is poorly understood. In this issue of Immunity, Biram et al. (2022) uncover a mechanism by which Salmonella recruits Sca-1+ monocytes to germinal centers and impairs metabolic adaptation.	[He, Yuke; Vinuesa, Carola G.] Shanghai Jiao Tong Univ SJTUSM, Sch Med, Renji Hosp, Dept Rheumatol,Ctr Personalised Immunol CACPI, Shanghai 200001, Peoples R China; [Vinuesa, Carola G.] Francis Crick Inst, 1 Midland Rd, London NW1 1AT, England; [Vinuesa, Carola G.] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol & Infect, 131 Garran Rd, Acton, ACT 2601, Australia	Shanghai Jiao Tong University; Francis Crick Institute; Australian National University; John Curtin School of Medical Research	Vinuesa, CG (corresponding author), Shanghai Jiao Tong Univ SJTUSM, Sch Med, Renji Hosp, Dept Rheumatol,Ctr Personalised Immunol CACPI, Shanghai 200001, Peoples R China.; Vinuesa, CG (corresponding author), Francis Crick Inst, 1 Midland Rd, London NW1 1AT, England.; Vinuesa, CG (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol & Infect, 131 Garran Rd, Acton, ACT 2601, Australia.	carola.vinuesa@crick.ac.uk	He, Yuke/GXF-6551-2022	He, Yuke/0000-0002-6716-198X				Biram A, 2022, IMMUNITY, V55, P442, DOI 10.1016/j.immuni.2022.01.013; Chen DY, 2021, NAT IMMUNOL, V22, P904, DOI 10.1038/s41590-021-00936-y; Cho SH, 2016, NATURE, V537, P234, DOI 10.1038/nature19334; Elsner RA, 2020, IMMUNITY, V53, P1136, DOI 10.1016/j.immuni.2020.11.006; Jenks SA, 2018, IMMUNITY, V49, P725, DOI 10.1016/j.immuni.2018.08.015; MacNamara KC, 2011, J IMMUNOL, V186, P1032, DOI 10.4049/jimmunol.1001893; Song WZ, 2022, IMMUNITY, V55, P290, DOI 10.1016/j.immuni.2022.01.002; St John AL, 2009, NAT MED, V15, P1259, DOI 10.1038/nm.2036; Weisel FJ, 2020, NAT IMMUNOL, V21, P331, DOI 10.1038/s41590-020-0598-4; Woodruff MC, 2020, NAT IMMUNOL, V21, P1506, DOI 10.1038/s41590-020-00814-z	10	0	0	7	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 8	2022	55	3					385	387		10.1016/j.immuni.2022.02.007	http://dx.doi.org/10.1016/j.immuni.2022.02.007			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0Z4IZ	35263564				2022-12-18	WOS:000791044400004
J	Hu, XH; Liu, XS				Hu, Xihao; Liu, X. Shirley			A high-resolution view of intra-tumoral B cell immunity	IMMUNITY			English	Editorial Material							IMMUNOTHERAPY; SURVIVAL	In this issue of Immunity , Meylan et al. (2022) uses spatial transcriptomics to examine B cell immunity within intratumoral tertiary lymphoid structures (TLSs). They find that B cells expand and mature into plasma cells (PCs) within the TLS, migrate along fibroblastic tracks to tumor beds, and produce IgG antibodies that target cancer cells.	[Hu, Xihao; Liu, X. Shirley] GV20 Therapeut, Cambridge, MA 02142 USA		Hu, XH (corresponding author), GV20 Therapeut, Cambridge, MA 02142 USA.	xihao_hu@gv20therapeutics.com; xsliu@gv20therapeutics.com						Bolotin DA, 2017, NAT BIOTECHNOL, V35, P908, DOI 10.1038/nbt.3979; Cabrita R, 2020, NATURE, V577, P561, DOI 10.1038/s41586-019-1914-8; Disis ML, 1997, J CLIN ONCOL, V15, P3363, DOI 10.1200/JCO.1997.15.11.3363; Gao Y, 2020, NAT CELL BIOL, V22, P1064, DOI 10.1038/s41556-020-0562-4; Helmink BA, 2020, NATURE, V577, P549, DOI 10.1038/s41586-019-1922-8; Hu XH, 2019, NAT GENET, V51, P560, DOI 10.1038/s41588-018-0339-x; Meylan M, 2022, IMMUNITY, V55, P527, DOI 10.1016/j.immuni.2022.02.001; Petitprez F, 2020, NATURE, V577, P556, DOI 10.1038/s41586-019-1906-8; Shalapour S, 2021, SEMIN IMMUNOL, V52, DOI 10.1016/j.smim.2021.101479; Zhang J, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0681-3	10	0	0	6	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 8	2022	55	3					387	389		10.1016/j.immuni.2022.02.009	http://dx.doi.org/10.1016/j.immuni.2022.02.009			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0Z4IZ	35263565				2022-12-18	WOS:000791044400005
J	Reynolds, G; Tirard, A; Villani, AC				Reynolds, Gary; Tirard, Alice; Villani, Alexandra-Chloe			Plasmacytoid dendritic cells: Welcome back to the DC fold	IMMUNITY			English	Editorial Material							DISTINCT	The presumed common origin of plasmacytoid and conventional dendritic cells has been the contentious subject of recent debate. In this issue of Immunity, Feng et al. employed an inducible cell barcoding system to track clonal relationships and uncovered a surprising close developmental relationship between cDC1s and pDCs.	[Reynolds, Gary] Newcastle Univ, Translat & Clin Res Inst, Fac Med Sci, Newcastle, NSW, Australia; [Reynolds, Gary; Tirard, Alice; Villani, Alexandra-Chloe] Massachusetts Gen Hosp, Dept Med, Ctr Immunol & Inflammatory Dis, Ctr Canc Res, Boston, MA 02129 USA; [Reynolds, Gary; Tirard, Alice; Villani, Alexandra-Chloe] Broad Inst MIT & Harvard, Cambridge, MA 02138 USA; [Reynolds, Gary; Villani, Alexandra-Chloe] Harvard Med Sch, Boston, MA 02115 USA	University of Newcastle; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School	Villani, AC (corresponding author), Massachusetts Gen Hosp, Dept Med, Ctr Immunol & Inflammatory Dis, Ctr Canc Res, Boston, MA 02129 USA.; Villani, AC (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02138 USA.; Villani, AC (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	avillani@mgh.harvard.edu						Batta K, 2021, LEUKEMIA, V35, P3299, DOI 10.1038/s41375-021-01228-y; Bigley V, 2016, CURR OPIN ALLERGY CL, V16, P530, DOI 10.1097/ACI.0000000000000322; Cabeza-Cabrerizo M, 2021, ANNU REV IMMUNOL, V39, P131, DOI 10.1146/annurev-immunol-061020-053707; Dress RJ, 2019, NAT IMMUNOL, V20, P852, DOI 10.1038/s41590-019-0420-3; Feng J, 2022, IMMUNITY, V55, P405, DOI 10.1016/j.immuni.2022.01.016; Matsui T, 2009, J IMMUNOL, V182, P6815, DOI 10.4049/jimmunol.0802008; Rodrigues PF, 2018, NAT IMMUNOL, V19, P711, DOI 10.1038/s41590-018-0136-9; See P, 2017, SCIENCE, V356, DOI 10.1126/science.aag3009; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573	10	0	0	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 8	2022	55	3					380	+		10.1016/j.immuni.2022.02.011	http://dx.doi.org/10.1016/j.immuni.2022.02.011			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0Z4IZ	35263562				2022-12-18	WOS:000791044400002
J	Robertson, SJ; Best, SM				Robertson, Shelly J.; Best, Sonja M.			The domiNO effect turns macrophage activation deadly	IMMUNITY			English	Editorial Material								Macrophage activation is essential for effective immunity to infection but can also contribute to disease through incompletely understood mechanisms. In this issue of Immunity, Simpson et al. reveal that death of activated macrophages integrates extrinsic and intrinsic pathways of apoptosis that contribute to damaging host responses.	[Robertson, Shelly J.; Best, Sonja M.] NIAID, Virol Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Best, SM (corresponding author), NIAID, Virol Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.	sbest@niaid.nih.gov			Division of Intramural Research, National Institutes of Health, National Institute of Allergy and Infectious Diseases	Division of Intramural Research, National Institutes of Health, National Institute of Allergy and Infectious Diseases	This work was funded by the Division of Intramural Research, National Institutes of Health, National Institute of Allergy and Infectious Diseases. Thank you to Ryan Kissinger for his work in medical illustration for Figure 1.	Anderton H, 2020, NAT REV RHEUMATOL, V16, P496, DOI 10.1038/s41584-020-0455-8; Carrington EM, 2017, CELL DEATH DIFFER, V24, P878, DOI 10.1038/cdd.2017.30; Di Domizio J, 2022, NATURE, V603, P145, DOI 10.1038/s41586-022-04421-w; Diamond MS, 2022, NAT IMMUNOL, V23, P165, DOI 10.1038/s41590-021-01091-0; Henry CM, 2017, MOL CELL, V65, P715, DOI 10.1016/j.molcel.2017.01.022; Karki Rajendra, 2021, Cell, V184, P149, DOI [10.1101/2020.10.29.361048, 10.1016/j.cell.2020.11.025]; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; McArthur K, 2018, SCIENCE, V359, P883, DOI 10.1126/science.aao6047; Schroder K, 2006, IMMUNOBIOLOGY, V211, P511, DOI 10.1016/j.imbio.2006.05.007; Simpson DS, 2022, IMMUNITY, V55, P423, DOI 10.1016/j.immuni.2022.01.003	10	0	0	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 8	2022	55	3					382	384		10.1016/j.immuni.2022.02.010	http://dx.doi.org/10.1016/j.immuni.2022.02.010			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0Z4IZ	35263563	Green Published			2022-12-18	WOS:000791044400003
J	Tangye, SG; Warnatz, K				Tangye, Stuart G.; Warnatz, Klaus			"Are you gonna go my way?" Decisions at the Tfh-B cell interface	IMMUNITY			English	Editorial Material							HELPER-CELLS	The generation of memory B cells and plasma cells is complex and involves inputs from the microenvironment, notably from T follicular helper cells. In last month's issue of Immunity, Yeh et al. and Song et al. refine our understanding of the B cell intrinsic and extrinsic requirements to generate effective humoral immunity in response to foreign antigens.	[Tangye, Stuart G.] Garvan Inst Med Res, Darlinghurst, NSW, Australia; [Tangye, Stuart G.] Univ New South Wales, Fac Med & Hlth, St Vincents Clin Sch, Darlinghurst, NSW, Australia; [Warnatz, Klaus] Univ Freiburg, Fac Med, Med Ctr, Dept Rheumatol & Clin Immunol, Freiburg, Germany; [Warnatz, Klaus] Univ Freiburg, Fac Med, Med Ctr, Ctr Chron Immunodeficiency CCI, Freiburg, Germany	Garvan Institute of Medical Research; University of New South Wales Sydney; University of Freiburg; University of Freiburg	Tangye, SG (corresponding author), Garvan Inst Med Res, Darlinghurst, NSW, Australia.; Tangye, SG (corresponding author), Univ New South Wales, Fac Med & Hlth, St Vincents Clin Sch, Darlinghurst, NSW, Australia.; Warnatz, K (corresponding author), Univ Freiburg, Fac Med, Med Ctr, Dept Rheumatol & Clin Immunol, Freiburg, Germany.; Warnatz, K (corresponding author), Univ Freiburg, Fac Med, Med Ctr, Ctr Chron Immunodeficiency CCI, Freiburg, Germany.	s.tangye@garvan.org.au; klaus.warnatz@uniklinik-freiburg.de						Cancro MP, 2020, ANNU REV IMMUNOL, V38, P315, DOI 10.1146/annurev-immunol-092419-031130; Crotty S, 2019, IMMUNITY, V50, P1132, DOI 10.1016/j.immuni.2019.04.011; Keller B, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abh0891; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001; Moriyama S, 2014, J EXP MED, V211, P1297, DOI 10.1084/jem.20131666; Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136; Sanz I, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02458; Song WZ, 2022, IMMUNITY, V55, P290, DOI 10.1016/j.immuni.2022.01.002; Warnatz K., 2002, BLOOD; Yeh CH, 2022, IMMUNITY, V55, P272, DOI 10.1016/j.immuni.2021.12.015; Zheng B, 1996, J EXP MED, V184, P1083, DOI 10.1084/jem.184.3.1083	12	0	0	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 8	2022	55	3					377	379		10.1016/j.immuni.2022.02.002	http://dx.doi.org/10.1016/j.immuni.2022.02.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0Z4IZ	35180377				2022-12-18	WOS:000791044400001
J	Barreby, E; Aouadi, M				Barreby, Emelie; Aouadi, Myriam			To be or not to be a hepatic niche macrophage	IMMUNITY			English	Editorial Material								While single-cell analyses have improved our understanding of liver macrophage heterogeneity, their localization and cellular interactions remain unclear. In a recent issue of Cell, Guilliams et al. provide strategies to localize liver macrophage populations and their communication with neighboring cells during health and disease.	[Barreby, Emelie; Aouadi, Myriam] Karolinska Univ Hosp, Ctr Infect Med CIM, Karolinska Inst, Dept Med Huddinge, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Aouadi, M (corresponding author), Karolinska Univ Hosp, Ctr Infect Med CIM, Karolinska Inst, Dept Med Huddinge, Stockholm, Sweden.	myriam.aouadi@ki.se						Bleriot C, 2021, IMMUNITY, V54, P2101, DOI 10.1016/j.immuni.2021.08.006; Bonnardel J, 2019, IMMUNITY, V51, P638, DOI 10.1016/j.immuni.2019.08.017; Daemen S, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2020.108626; Guilliams M, 2022, CELL, V185, P379, DOI 10.1016/j.cell.2021.12.018; Halpern KB, 2017, NATURE, V542, P352, DOI 10.1038/nature21065; Jin HW, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23197-7; Ramachandran P, 2019, NATURE, V575, P512, DOI 10.1038/s41586-019-1631-3; Remmerie A, 2020, IMMUNITY, V53, P641, DOI 10.1016/j.immuni.2020.08.004; Sakai M, 2019, IMMUNITY, V51, P655, DOI 10.1016/j.immuni.2019.09.002; Zwicker C, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.690813	10	0	0	3	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 8	2022	55	2					198	200		10.1016/j.immuni.2022.01.008	http://dx.doi.org/10.1016/j.immuni.2022.01.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YX7WH	35139350				2022-12-18	WOS:000754308000006
J	Bonsignori, M; Marcotrigiano, J				Bonsignori, Mattia; Marcotrigiano, Joseph			HCV neutralization goes elite	IMMUNITY			English	Editorial Material								A vaccine remains the most promising option to eradicate HCV. In this issue of Immunity, Weber et al. identified HCV elite neutralizers, isolated exceptionally potent and broad VH1-69 CD81-binding site neutralizing antibodies that used a shared mode of antigen recognition, and developed a computational approach that predicted mutations relevant to gain-of-function for this bnAb class, which can inform immunogen designs.	[Bonsignori, Mattia] NIAID, Translat Immunobiol Unit, Lab Infect Dis, NIH, Bethesda, MD 20892 USA; [Marcotrigiano, Joseph] NIAID, Struct Virol Sect, Lab Infect Dis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Bonsignori, M (corresponding author), NIAID, Translat Immunobiol Unit, Lab Infect Dis, NIH, Bethesda, MD 20892 USA.; Marcotrigiano, J (corresponding author), NIAID, Struct Virol Sect, Lab Infect Dis, NIH, Bethesda, MD 20892 USA.	mattia.bonsignori@nih.gov; joseph.marcotrigiano@nih.gov						Bankwitz D, 2021, GUT, V70, P1734, DOI 10.1136/gutjnl-2020-321190; Chen F, 2021, IMMUNITY, V54, P781, DOI 10.1016/j.immuni.2021.02.013; Chen F, 2019, CURR OPIN VIROL, V34, P149, DOI 10.1016/j.coviro.2019.02.004; Keck ML, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01194; Kumar A, 2021, NATURE, V598, P521, DOI 10.1038/s41586-021-03913-5; Page K, 2021, NEW ENGL J MED, V384, P541, DOI 10.1056/NEJMoa2023345; Ryerson AB, 2020, MMWR-MORBID MORTAL W, V69, P399, DOI 10.15585/mmwr.mm6914a2; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Tzarum N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01315; Weber T, 2022, IMMUNITY, V55, P341, DOI 10.1016/j.immuni.2021.12.003	10	0	0	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 8	2022	55	2					195	197		10.1016/j.immuni.2022.01.010	http://dx.doi.org/10.1016/j.immuni.2022.01.010			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YX7WH	35139349				2022-12-18	WOS:000754308000005
J	Kreutmair, S; Becher, B				Kreutmair, Stefanie; Becher, Burkhard			Response to Are NKT cells a useful predictor of COVID-19 severity?	IMMUNITY			English	Letter									[Kreutmair, Stefanie; Becher, Burkhard] Univ Zurich, Inst Expt Immunol, CH-5057 Zurich, Switzerland	University of Zurich	Becher, B (corresponding author), Univ Zurich, Inst Expt Immunol, CH-5057 Zurich, Switzerland.	becher@immunology.uzh.ch	Becher, Burkhard/ABE-4225-2020; Kreutmair, Stefanie/AAE-6952-2022; Kreutmair, Stefanie/GOK-2757-2022	Becher, Burkhard/0000-0002-1541-7867; Kreutmair, Stefanie/0000-0001-8466-6675; 				Flament H, 2021, EUR J IMMUNOL, V51, P298, DOI 10.1038/s41590-021-00870-z; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Koay HF, 2022, IMMUNITY, V55, P185, DOI 10.1016/j.immuni.2022.01.005; Kreutmair S, 2021, IMMUNITY, V54, P1578, DOI 10.1016/j.immuni.2021.05.002; Li MY, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.580237; Notarbartolo S, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abg5021; Odak I, 2020, EBIOMEDICINE, V57, DOI 10.1016/j.ebiom.2020.102885; Parrot T, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abe1670; Zhang JY, 2020, NAT IMMUNOL, V21, P1107, DOI 10.1038/s41590-020-0762-x; Zingaropoli MA, 2021, CLIN IMMUNOL, V222, DOI 10.1016/j.clim.2020.108630	10	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 8	2022	55	2					188	189		10.1016/j.immuni.2022.01.012	http://dx.doi.org/10.1016/j.immuni.2022.01.012			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YX7WH	35065711	Green Published, Bronze			2022-12-18	WOS:000754308000002
J	Kreutmair, S; Unger, S; Nunez, NG; Ingelfinger, F; Alberti, C; De Feo, D; Krishnarajah, S; Kauffmann, M; Friebel, E; Babaei, S; Gaborit, B; Lutz, M; Jurado, NP; Malek, NP; Goepel, S; Rosenberger, P; Haberle, HA; Al-Hajj, S; Ayoub, I; Nilsson, J; Claassen, M; Liblau, R; Martin-Blondel, G; Bitzer, M; Roquilly, A; Becher, B				Kreutmair, Stefanie; Unger, Susanne; Nunez, Nicolas Gonzalo; Ingelfinger, Florian; Alberti, Chiara; De Feo, Donatella; Krishnarajah, Sinduya; Kauffmann, Manuel; Friebel, Ekaterina; Babaei, Sepideh; Gaborit, Benjamin; Lutz, Mirjam; Jurado, Nicole Puertas; Malek, Nisar P.; Goepel, Siri; Rosenberger, Peter; Haberle, Helene A.; Al-Hajj, Sally; Ayoub, Ikram; Nilsson, Jakob; Claassen, Manfred; Liblau, Roland; Martin-Blondel, Guillaume; Bitzer, Michael; Roquilly, Antoine; Becher, Burkhard			Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia (vol 54, pg 1578, 2021)	IMMUNITY			English	Correction												becher@immunology.uzh.ch	Kreutmair, Stefanie/AAE-6952-2022; Martin-Blondel, Guillaume/K-6762-2014; Kreutmair, Stefanie/GOK-2757-2022; Becher, Burkhard/ABE-4225-2020	Kreutmair, Stefanie/0000-0001-8466-6675; Martin-Blondel, Guillaume/0000-0002-8363-7028; Becher, Burkhard/0000-0002-1541-7867; Ingelfinger, Florian/0000-0001-6890-9753; Krishnarajah, Sinduya/0000-0003-2348-1751				Notarbartolo S, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abg5021	1	0	0	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 8	2022	55	2					366	375		10.1016/j.immuni.2022.01.015	http://dx.doi.org/10.1016/j.immuni.2022.01.015			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YX7UM	35139354	Green Published, hybrid			2022-12-18	WOS:000754303300001
J	Smole, U; Hammad, H				Smole, Ursula; Hammad, Hamida			IFN-gamma(g)uarding the niche-Keeping ILC2 in check	IMMUNITY			English	Editorial Material							INTERLEUKIN-33; INTERFERON; ACTIVATION	The causal signals and the relevance of group 2 innate lymphoid cell (ILC2) dynamic redistribution during inflammation remain unknown. In this issue of Immunity, Cautivo et al. show that type 2 immunity drives ILC2 accumulation at non-adventitial "parenchymal'' sites, allowing balanced responses in inflamed tissues.	[Smole, Ursula; Hammad, Hamida] VIB UGent Ctr Inflammat Res, Lab Immunoregulat & Mucosal Immunol, B-9052 Ghent, Belgium; [Smole, Ursula; Hammad, Hamida] Univ Ghent, Dept Internal Med & Pediat, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Hammad, H (corresponding author), VIB UGent Ctr Inflammat Res, Lab Immunoregulat & Mucosal Immunol, B-9052 Ghent, Belgium.; Hammad, H (corresponding author), Univ Ghent, Dept Internal Med & Pediat, B-9000 Ghent, Belgium.	hamida.hammad@ugent.be						Cautivo KM, 2022, IMMUNITY, V55, P254, DOI 10.1016/j.immuni.2021.12.014; Dahlgren MW, 2019, IMMUNITY, V50, P707, DOI 10.1016/j.immuni.2019.02.002; de Kleer IM, 2016, IMMUNITY, V45, P1285, DOI 10.1016/j.immuni.2016.10.031; Germain RN, 2019, CURR OPIN IMMUNOL, V56, P76, DOI 10.1016/j.coi.2018.11.001; Han MY, 2017, AM J RESP CELL MOL, V56, P242, DOI 10.1165/rcmb.2016-0056OC; Matha L, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.679509; Molofsky AB, 2015, IMMUNITY, V43, P161, DOI 10.1016/j.immuni.2015.05.019; Moro K, 2016, NAT IMMUNOL, V17, P76, DOI 10.1038/ni.3309; Ricardo-Gonzalez RR, 2020, J EXP MED, V217, DOI 10.1084/jem.20191172; Vu LD, 2019, AM J RESP CRIT CARE, V200, P1414, DOI 10.1164/rccm.201812-2366OC	10	0	0	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 8	2022	55	2					190	192		10.1016/j.immuni.2022.01.007	http://dx.doi.org/10.1016/j.immuni.2022.01.007			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YX7WH	35139347				2022-12-18	WOS:000754308000003
J	Cohen, JA; Kaplan, DH				Cohen, Jonathan A.; Kaplan, Daniel H.			Inflammatory thoughts can upset your guts	IMMUNITY			English	Editorial Material							IMMUNITY; CELLS	Peripheral neurons and immune cells interact to modulate inflammation, but whether the brain can control this process is unknown. In a recent issue of Cell, Koren et al. (2021) show that peripheral inflammation is encoded in the insular cortex and that later re-activation of these neurons triggers inflammation.	[Cohen, Jonathan A.; Kaplan, Daniel H.] Univ Pittsburgh, Dept Dermatol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kaplan, DH (corresponding author), Univ Pittsburgh, Dept Dermatol, Pittsburgh, PA 15261 USA.	dankaplan@pitt.edu			NIH [R01AR077341]; National Psoriasis Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Psoriasis Foundation	ACKNOWLEGMENTS The authors received funding from the NIH R01AR077341 (D.H.K.) and the National Psoriasis Foundation (J.A.C.) .	Baral P, 2019, NAT REV IMMUNOL, V19, P433, DOI 10.1038/s41577-019-0147-2; Chu C, 2020, IMMUNITY, V52, P464, DOI 10.1016/j.immuni.2020.02.017; Huh JR, 2020, NAT REV IMMUNOL, V20, P217, DOI 10.1038/s41577-019-0247-z; Koren T, 2021, CELL, V184, P5902, DOI 10.1016/j.cell.2021.10.013; Naik S, 2017, NATURE, V550, P475, DOI 10.1038/nature24271; Netea MG, 2017, CELL HOST MICROBE, V21, P297, DOI 10.1016/j.chom.2017.02.003; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Pavlov VA, 2017, NAT NEUROSCI, V20, P156, DOI 10.1038/nn.4477; Zhang SQ, 2021, CELL, V184, P2151, DOI 10.1016/j.cell.2021.03.002	9	0	0	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 11	2022	55	1					11	13		10.1016/j.immuni.2021.12.011	http://dx.doi.org/10.1016/j.immuni.2021.12.011			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YI0BU	35021052				2022-12-18	WOS:000743523600005
J	de Candia, P; Matarese, G				de Candia, Paola; Matarese, Giuseppe			The folate way to T cell fate	IMMUNITY			English	Editorial Material							METABOLISM	The role of folate-dependent one carbon (1C) metabolism in CD4(+) T cell polarization is incompletely understood. In this issue of Immunity, Sugiura et al. (2021) provide evidence that blocking the 1C metabolic enzyme MTHFD2 may curb pro-inflammatory CD4(+)T cells, while redirecting them toward a regulatory T cell phenotype.	[de Candia, Paola; Matarese, Giuseppe] Univ Napoli Federico II, Treg Cell Lab, Dipartimento Med Mol & Biotecnol Med, Naples, Italy; [Matarese, Giuseppe] CNR, Lab Immunol, Ist Endocrinol & Oncol Sperimentale G Salvatore, Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR)	de Candia, P; Matarese, G (corresponding author), Univ Napoli Federico II, Treg Cell Lab, Dipartimento Med Mol & Biotecnol Med, Naples, Italy.; Matarese, G (corresponding author), CNR, Lab Immunol, Ist Endocrinol & Oncol Sperimentale G Salvatore, Naples, Italy.	paola.decandia@unina.it; giuseppe.matarese@unina.it	de Candia, Paola/HGC-8826-2022; Matarese, Giuseppe/AAO-4077-2021	de Candia, Paola/0000-0003-4767-446X; Matarese, Giuseppe/0000-0001-9429-0616	Fondazione Italiana Sclerosi Multipla (FISM) [2016/R/18, 2018/S/5]; Progetti di Rilevante Interesse Nazionale (PRIN) [2017 K55HLC 001]; Ministero della Salute [RF-2019-12371111]; FISM [2018/R/4]	Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); Progetti di Rilevante Interesse Nazionale (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Ministero della Salute(Ministry of Health, Italy); FISM(Fondazione Italiana Sclerosi Multipla (FISM))	G.M. is funded by Fondazione Italiana Sclerosi Multipla (FISM; grants 2016/R/18 and 2018/S/5), Progetti di Rilevante Interesse Nazionale (PRIN; grant 2017 K55HLC 001), and Ministero della Salute (grant RF-2019-12371111). P.d.C. is supported by FISM (grant 2018/R/4). The authors would like to thank Dr. Silvia Garavelli for assistance with creating the illustration in Figure 1 and Dr. Claudio Procaccini for critical reading of the manuscript.	Bantug GR, 2018, NAT REV IMMUNOL, V18, P19, DOI 10.1038/nri.2017.99; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Ducker GS, 2017, CELL METAB, V25, P27, DOI 10.1016/j.cmet.2016.08.009; Gaublomme JT, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.009; Nilsson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4128; Procaccini C, 2021, IMMUNITY, V54, P1543, DOI 10.1016/j.immuni.2021.04.014; Ron-Harel N, 2016, CELL METAB, V24, P104, DOI 10.1016/j.cmet.2016.06.007; Sheppard NG, 2015, SCI REP-UK, V5, DOI 10.1038/srep15029; Sugiura A., 2021, IMMUNITY, DOI DOI 10.1016/J.IMMUNI.2021.10.011; Ziegler SF, 2016, NAT REV IMMUNOL, V16, P403, DOI 10.1038/nri.2016.53	10	0	0	3	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 11	2022	55	1					1	+		10.1016/j.immuni.2021.12.009	http://dx.doi.org/10.1016/j.immuni.2021.12.009			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YI0BU	35021051				2022-12-18	WOS:000743523600001
J	Dopico, XC; Hedestam, GBK				Dopico, Xaquin Castro; Hedestam, Gunilla B. Karlsson			A family matter: Anti-viral antibody responses	IMMUNITY			English	Editorial Material							SEQUENCE	The immune response is an amalgam of heritable and non-heritable effects, although the contribution of each is generally unknown. In this issue of Immunity, Venkataraman et al. report heritable traits that govern antiviral antibody epitope specificity and breadth controlled by the MHC class II region, indicating that your genes influence which pathogen-derived epitopes your B cells target during viral infections.	[Dopico, Xaquin Castro; Hedestam, Gunilla B. Karlsson] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden	Karolinska Institutet	Hedestam, GBK (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden.	gunilla.karlsson.hedestam@ki.se						Avnir Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep20842; Collins AM, 2020, CURR OPIN SYST BIOL, V24, P100, DOI 10.1016/j.coisb.2020.10.011; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Huszthy PC, 2019, P NATL ACAD SCI USA, V116, P25850, DOI 10.1073/pnas.1902836116; Jonsson S, 2017, NAT GENET, V49, P1182, DOI 10.1038/ng.3897; Levin LI, 2005, JAMA-J AM MED ASSOC, V293, P2496, DOI 10.1001/jama.293.20.2496; Venkataraman T, 2022, IMMUNITY, V55, P174, DOI 10.1016/j.immuni.2021.12.004; Watson CT, 2017, TRENDS IMMUNOL, V38, P459, DOI 10.1016/j.it.2017.04.003; Watson CT, 2013, AM J HUM GENET, V92, P530, DOI 10.1016/j.ajhg.2013.03.004; Xu GJ, 2015, SCIENCE, V348, DOI 10.1126/science.aaa0698	10	0	0	3	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 11	2022	55	1					8	10		10.1016/j.immuni.2021.12.008	http://dx.doi.org/10.1016/j.immuni.2021.12.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YI0BU	35021059				2022-12-18	WOS:000743523600004
J	Zengeler, KE; Lukens, JR				Zengeler, Kristine E.; Lukens, John R.			Maternal inflammation is hard for offspring to stomach	IMMUNITY			English	Editorial Material							IMMUNE ACTIVATION; BRAIN-DEVELOPMENT	Individuals with neurodevelopmental disorders often experience comorbid gastrointestinal distress and dysregulated immune responses, yet the underlying mechanisms remain unclear. In this issue of Immunity, Kim et al. utilize a murine maternal immune activation model of autism and find that inflammation can alter the microbiota of mothers, which postnatally primes offspring CD4(+) T cells and increases susceptibility to intestinal inflammation.	[Zengeler, Kristine E.; Lukens, John R.] Univ Virginia, Ctr Brain Immunol & Glia BIG, Dept Neurosci, Charlottesville, VA 22908 USA; [Zengeler, Kristine E.; Lukens, John R.] Univ Virginia, Neurosci Grad Program, Charlottesville, VA 22908 USA; [Zengeler, Kristine E.; Lukens, John R.] Univ Virginia, Sch Med, Cell & Mol Biol Training Program, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia	Zengeler, KE; Lukens, JR (corresponding author), Univ Virginia, Ctr Brain Immunol & Glia BIG, Dept Neurosci, Charlottesville, VA 22908 USA.; Zengeler, KE; Lukens, JR (corresponding author), Univ Virginia, Neurosci Grad Program, Charlottesville, VA 22908 USA.; Zengeler, KE; Lukens, JR (corresponding author), Univ Virginia, Sch Med, Cell & Mol Biol Training Program, Charlottesville, VA 22908 USA.	Kez9hf@virginia.edu; jrl7n@virginia.edu		Zengeler, Kristine/0000-0003-4023-0313				de Lima KA, 2020, NAT IMMUNOL, V21, P1421, DOI 10.1038/s41590-020-0776-4; Choi GB, 2016, SCIENCE, V351, P933, DOI 10.1126/science.aad0314; Hsiao EY, 2014, HARVARD REV PSYCHIAT, V22, P104, DOI 10.1097/HRP.0000000000000029; Kim E., 2021, IMMUNITY, V55, P145; Kim S, 2017, NATURE, V549, P528, DOI 10.1038/nature23910; Knuesel I, 2014, NAT REV NEUROL, V10, P643, DOI 10.1038/nrneurol.2014.187; Lammert CR, 2018, J IMMUNOL, V201, P845, DOI 10.4049/jimmunol.1701755; McElhanon BO, 2014, PEDIATRICS, V133, P872, DOI 10.1542/peds.2013-3995; Reed MD, 2020, NATURE, V577, P249, DOI 10.1038/s41586-019-1843-6; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007	10	0	0	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 11	2022	55	1					6	+		10.1016/j.immuni.2021.12.005	http://dx.doi.org/10.1016/j.immuni.2021.12.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YI0BU	35021058				2022-12-18	WOS:000743523600003
J	Berzofsky, JA				Berzofsky, Jay A.			Thomas Alexander Waldmann Obituary	IMMUNITY			English	Biographical-Item									[Berzofsky, Jay A.] NCI, Vaccine Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Berzofsky, JA (corresponding author), NCI, Vaccine Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	berzofsj@mail.nih.gov						WALDMANN TA, PUBLCIATION LIST	1	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2021	54	12					2671	2672		10.1016/j.immuni.2021.11.012	http://dx.doi.org/10.1016/j.immuni.2021.11.012		DEC 2021	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XQ6GW	34910932	Bronze			2022-12-18	WOS:000731645300001
J	Kariko, K; Weissman, D				Kariko, Katalin; Weissman, Drew			Meet the authors: Katalin Kariko and Drew Weissman	IMMUNITY			English	Editorial Material																			0	0	0	4	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2021	54	12					2673	2675		10.1016/j.immuni.2021.11.011	http://dx.doi.org/10.1016/j.immuni.2021.11.011		DEC 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XQ6GW	34910933	Bronze			2022-12-18	WOS:000731645300002
J	King, C				King, Cecile			Tfh cells set the stage for tumor control	IMMUNITY			English	Editorial Material							B-CELLS		[King, Cecile] UNSW Sydney, Fac Sci, Sch Biotechnol & Biomol Sci, Sydney, NSW 2033, Australia	University of New South Wales Sydney	King, C (corresponding author), UNSW Sydney, Fac Sci, Sch Biotechnol & Biomol Sci, Sydney, NSW 2033, Australia.	c.king@unsw.edu.au						Domblides C, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.698604; Fridman WH, 2021, J EXP MED, V218, DOI 10.1084/jem.20200851; Helmink BA, 2020, NATURE, V577, P549, DOI 10.1038/s41586-019-1922-8; Kroemer G, 2018, NAT REV IMMUNOL, V18, P87, DOI 10.1038/nri.2018.4; Meckiff BJ, 2020, CELL, V183, P1340, DOI 10.1016/j.cell.2020.10.001; Orange M, 2016, INTEGR CANCER THER, V15, P502, DOI 10.1177/1534735416649916; Overacre-Delgoffe AE, 2021, IMMUNITY, V54, P2812, DOI 10.1016/j.immuni.2021.11.003; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Petitprez F, 2020, NATURE, V577, P556, DOI 10.1038/s41586-019-1906-8; Whary MT, 2004, COMPARATIVE MED, V54, P128	10	0	0	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2021	54	12					2690	2692		10.1016/j.immuni.2021.11.013	http://dx.doi.org/10.1016/j.immuni.2021.11.013		DEC 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XQ6GW	34910936				2022-12-18	WOS:000731645300006
J	Stalls, V; Acharya, P				Stalls, Victoria; Acharya, Priyamvada			How to train your antibody to fight malaria	IMMUNITY			English	Editorial Material									[Stalls, Victoria; Acharya, Priyamvada] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC 27708 USA; [Acharya, Priyamvada] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Acharya, Priyamvada] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Acharya, P (corresponding author), Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC 27708 USA.; Acharya, P (corresponding author), Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA.; Acharya, P (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	priyamvada.acharya@duke.edu						Francica JR, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9030272; Gaudinski MR, 2021, NEW ENGL J MED, V385, P803, DOI 10.1056/NEJMoa2034031; Jelinkova L, 2021, NPJ VACCINES, V6, DOI 10.1038/s41541-020-00274-4; Kisalu NK, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.143958; Kisalu NK, 2018, NAT MED, V24, P408, DOI 10.1038/nm.4512; Kratochvil S, 2021, IMMUNITY, V54, P2859, DOI 10.1016/j.immuni.2021.10.017; Laurens MB, 2020, HUM VACC IMMUNOTHER, V16, P480, DOI 10.1080/21645515.2019.1669415; Raghunandan R, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03181-0; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Wang LT, 2020, IMMUNITY, V53, P733, DOI 10.1016/j.immuni.2020.08.014	10	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2021	54	12					2692	2694		10.1016/j.immuni.2021.11.007	http://dx.doi.org/10.1016/j.immuni.2021.11.007		DEC 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XQ6GW	34910937				2022-12-18	WOS:000731645300007
J	Turley, JL; Lavelle, EC				Turley, Joanna L.; Lavelle, Ed C.			Fatballs foster fabulous follicles	IMMUNITY			English	Editorial Material									[Turley, Joanna L.; Lavelle, Ed C.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Adjuvant Res Grp, Sch Biochem & Immunol, Dublin D02R590 2, Ireland	Trinity College Dublin	Lavelle, EC (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Adjuvant Res Grp, Sch Biochem & Immunol, Dublin D02R590 2, Ireland.	lavellee@tcd.ie		Turley, Joanna L./0000-0002-7293-0675				Alameh MG, 2021, IMMUNITY, V54, P2877, DOI 10.1016/j.immuni.2021.11.001; Arunachalam PS, 2021, NATURE, V596, P410, DOI 10.1038/s41586-021-03791-x; Earle KA, 2021, VACCINE, V39, P4423, DOI 10.1016/j.vaccine.2021.05.063; Hassett KJ, 2019, MOL THER-NUCL ACIDS, V15, P1, DOI 10.1016/j.omtn.2019.01.013; Hou XC, 2021, NAT REV MATER, V6, P1078, DOI 10.1038/s41578-021-00358-0; Juno JA, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0995-0; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Ng S, 2019, NAT MED, V25, P962, DOI 10.1038/s41591-019-0463-x; Swaminathan G, 2016, SCI REP-UK, V6, DOI 10.1038/srep34215	9	0	0	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2021	54	12					2695	2697		10.1016/j.immuni.2021.11.009	http://dx.doi.org/10.1016/j.immuni.2021.11.009		DEC 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XQ6GW	34910938	Bronze, Green Published			2022-12-18	WOS:000731645300008
J	Chen, A; Diehl, GE				Chen, Amanda; Diehl, Gretchen E.			T cells in harmony: Aligning the TCR repertoire pool to identify microbiota recognizing T cells	IMMUNITY			English	Editorial Material								Microbiota-specific T cell responses have been identified for select microbes, but individual T cell receptor repertoire differences make characterizing responses across populations difficult. In this issue of Immunity, Muschaweck et al. establish a system allowing for reproducible responses between individual mice, a powerful tool for characterizing microbiota directed immunity.	[Chen, Amanda; Diehl, Gretchen E.] Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA; [Chen, Amanda; Diehl, Gretchen E.] Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Diehl, GE (corresponding author), Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA.; Diehl, GE (corresponding author), Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, New York, NY 10065 USA.	diehlg1@mskcc.org						Ansaldo E, 2019, SCIENCE, V364, P1179, DOI 10.1126/science.aaw7479; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Li MO, 2016, NAT REV IMMUNOL, V16, P220, DOI 10.1038/nri.2016.26; Muschaweck M, 2021, IMMUNITY, V54, P2565, DOI 10.1016/j.immuni.2021.08.014; POWRIE F, 1994, J EXP MED, V179, P589, DOI 10.1084/jem.179.2.589; Saldana-Morales FB, 2021, GUT MICROBES, V13, DOI 10.1080/19490976.2021.1916376; Wegorzewska MM, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau9079; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279	10	0	0	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 9	2021	54	11					2437	2439		10.1016/j.immuni.2021.10.008	http://dx.doi.org/10.1016/j.immuni.2021.10.008		NOV 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WX1LS	34758332	Bronze			2022-12-18	WOS:000718366000001
J	Labuda, J; Harrison, OJ				Labuda, Jasmine; Harrison, Oliver J.			sLRP1'in up retinol keeps the gut SAAfe	IMMUNITY			English	Editorial Material							VITAMIN-A; ACID	Retinol is shuttled to myeloid cells for conversion to retinoic acid, but the receptor facilitating uptake of SAA:retinol complexes on myeloid cells is unknown. In a recent issue of Science, Bang et al. (2021) use genetic and biochemical approaches to reveal this critical receptor to be LRP1 and show that this axis is essential for intestinal innate and adaptive immune responses.	[Labuda, Jasmine; Harrison, Oliver J.] Benaroya Res Inst, Ctr Fundamental Immunol, 1201 9th Ave, Seattle, WA 98101 USA; [Harrison, Oliver J.] Univ Washington, Dept Immunol, 750 Republican St, Seattle, WA 98108 USA	Benaroya Research Institute; University of Washington; University of Washington Seattle	Harrison, OJ (corresponding author), Benaroya Res Inst, Ctr Fundamental Immunol, 1201 9th Ave, Seattle, WA 98101 USA.; Harrison, OJ (corresponding author), Univ Washington, Dept Immunol, 750 Republican St, Seattle, WA 98108 USA.	oharrison@benaroyaresearch.org						Bang YJ, 2021, SCIENCE, V373, P1323, DOI 10.1126/science.abf9232; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Lee JY, 2020, CELL, V180, P79, DOI 10.1016/j.cell.2019.11.026; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Sherwin JC, 2012, T ROY SOC TROP MED H, V106, P205, DOI 10.1016/j.trstmh.2012.01.004; Stephensen CB, 2001, ANNU REV NUTR, V21, P167, DOI 10.1146/annurev.nutr.21.1.167	9	0	0	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 9	2021	54	11					2447	2449		10.1016/j.immuni.2021.10.013	http://dx.doi.org/10.1016/j.immuni.2021.10.013		NOV 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WX1LS	34758336	Bronze			2022-12-18	WOS:000718366000005
J	Sozmen, EG; Akassoglou, K				Sozmen, Elif G.; Akassoglou, Katerina			Coagulation and immunity: Caught in the fibrin web	IMMUNITY			English	Editorial Material								In this issue of Immunity, Vega-Perez et al. (2021) reveal the formation of a dynamic multicellular aggregate within a fibrin scaffold consisting of large peritoneal macrophages, B1 cells, neutrophils, and monocytes during antibacterial immunity in the peritoneum. Anticoagulants targeting thrombin or peritoneal macrophage depletion by clodronate impaired efficient control of E. coli infection.	[Sozmen, Elif G.; Akassoglou, Katerina] Ctr Neurovasc Brain Immunol Gladstone, San Francisco, CA 94158 USA; [Sozmen, Elif G.; Akassoglou, Katerina] UCSF, San Francisco, CA 94158 USA; [Sozmen, Elif G.; Akassoglou, Katerina] Gladstone Inst, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Sozmen, Elif G.; Akassoglou, Katerina] Univ Calif San Francisco, Weill Inst Neurosci, Dept Neurol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Akassoglou, K (corresponding author), Ctr Neurovasc Brain Immunol Gladstone, San Francisco, CA 94158 USA.; Akassoglou, K (corresponding author), UCSF, San Francisco, CA 94158 USA.; Akassoglou, K (corresponding author), Gladstone Inst, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.; Akassoglou, K (corresponding author), Univ Calif San Francisco, Weill Inst Neurosci, Dept Neurol, San Francisco, CA 94158 USA.	kakassoglou@gladstone.ucsf.edu						Bugge TH, 1996, CELL, V87, P709, DOI 10.1016/S0092-8674(00)81390-2; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Davalos D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2230; Davalos D, 2012, SEMIN IMMUNOPATHOL, V34, P43, DOI 10.1007/s00281-011-0290-8; Esmon CT, 2003, J THROMB HAEMOST, V1, P1343, DOI 10.1046/j.1538-7836.2003.00261.x; Luyendyk JP, 2019, BLOOD, V133, P511, DOI 10.1182/blood-2018-07-818211; NELSON DS, 1963, LANCET, V2, P175; Petersen MA, 2018, NAT REV NEUROSCI, V19, P283, DOI 10.1038/nrn.2018.13; Vega-Perez A, 2021, IMMUNITY, V54, P2578, DOI 10.1016/j.immuni.2021.10.007; Zhang N, 2019, J EXP MED, V216, P1291, DOI 10.1084/jem.20182024	10	0	0	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 9	2021	54	11					2439	2441		10.1016/j.immuni.2021.10.016	http://dx.doi.org/10.1016/j.immuni.2021.10.016		NOV 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WX1LS	34758333	Bronze, Green Accepted			2022-12-18	WOS:000718366000002
J	Huang, YN; Peng, KR; Popejoy, AB; Hu, JT; Nowicki, TS; Gold, SM; Quintana-Murci, L; Fuentes-Guajardo, M; Shugay, M; Greiff, V; Burkhardt, AM; Alachkar, H; Mangul, S				Huang, Yu-Ning; Peng, Kerui; Popejoy, Alice B.; Hu, Jieting; Nowicki, Theodore Scott; Gold, Stefan M.; Quintana-Murci, Lluis; Fuentes-Guajardo, Macarena; Shugay, Mikhail; Greiff, Victor; Burkhardt, Amanda M.; Alachkar, Houda; Mangul, Serghei			Ancestral diversity is limited in published T cell receptor sequencing studies	IMMUNITY			English	Letter									[Huang, Yu-Ning; Peng, Kerui; Burkhardt, Amanda M.; Alachkar, Houda; Mangul, Serghei] Univ Southern Calif, Sch Pharm, Dept Clin Pharm, Los Angeles, CA 90089 USA; [Popejoy, Alice B.] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Hu, Jieting] Univ Southern Calif, Keck Sch Med, Dept Translat Genom, Los Angeles, CA 90033 USA; [Nowicki, Theodore Scott] Univ Calif Los Angeles, Div Pediat Hematol Oncol, Dept Pediat, Los Angeles, CA 90095 USA; [Gold, Stefan M.] Univ Klinkum Hamburg Eppendorf, Inst Neuroimmunol & Multiple Sclerosis, D-20246 Hamburg, Germany; [Gold, Stefan M.] Charite Univ Med Berlin, Dept Psychiat, Campus Benjamin Franklin, D-12203 Berlin, Germany; [Gold, Stefan M.] Charite Univ Med Berlin, Med Dept, Campus Benjamin Franklin, D-12203 Berlin, Germany; [Quintana-Murci, Lluis] Inst Pasteur, CNRS UMR2000, Human Evolutionary Genet Unit, F-75015 Paris, France; [Quintana-Murci, Lluis] Coll France, Dept Human Genom & Evolut, F-75231 Paris, France; [Fuentes-Guajardo, Macarena] Univ Tarapaca, Fac Ciencias Salud, Dept Tecnol Med, Arica 1000009, Chile; [Shugay, Mikhail] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Shugay, Mikhail] Pirogov Russian Natl Res Med Univ, Moscow 117997, Russia; [Greiff, Victor] Univ Oslo, Dept Immunol, N-0372 Oslo, Norway; [Greiff, Victor] Oslo Univ Hosp, N-0372 Oslo, Norway	University of Southern California; Stanford University; University of Southern California; University of California System; University of California Los Angeles; University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; PSL Research University Paris; College de France; Universidad de Tarapaca; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Pirogov Russian National Research Medical University; University of Oslo; University of Oslo	Mangul, S (corresponding author), Univ Southern Calif, Sch Pharm, Dept Clin Pharm, Los Angeles, CA 90089 USA.	serghei.mangul@gmail.com	Quintana-Murci, Lluis/AAB-7468-2022; Shugay, Mikhail/O-1073-2016	Peng, Kerui/0000-0002-9362-4618; Huang, Yu-Ning/0000-0003-1697-4267; Shugay, Mikhail/0000-0001-7826-7942; Popejoy, Alice B/0000-0003-4976-0628; Greiff, Victor/0000-0003-2622-5032	National Science Foundation [2041984]; Ministry of Science and Higher Education of the Russian Federation [075-15-2020807]; Deutsche Forschungsgemeinschaft [KFO296, GO1357/8-2, FR1720/8-2]; University of Southern California School of Pharmacy Seed Fund; Norris Cancer Center IRG-ACS pilot fund; STOP Cancer pilot fund; Ming Hsieh Institute foundation; NIH-NCI [1R01CA24838101A1]; NIH [5P30CA014089-45]	National Science Foundation(National Science Foundation (NSF)); Ministry of Science and Higher Education of the Russian Federation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Southern California School of Pharmacy Seed Fund; Norris Cancer Center IRG-ACS pilot fund; STOP Cancer pilot fund; Ming Hsieh Institute foundation; NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	S.M. is partially supported by National Science Foundation grant 2041984. M.S. is supported by the Ministry of Science and Higher Education of the Russian Federation grant no. 075-15-2020807. S.M.G. acknowledges support by the Deutsche Forschungsgemeinschaft (KFO296 Fetomaternal Immune Cross-Talk, grants GO1357/8-2 and FR1720/8-2). H.A. is supported by University of Southern California School of Pharmacy Seed Fund, The Norris Cancer Center IRG-ACS pilot fund, STOP Cancer pilot fund, The Ming Hsieh Institute foundation grants, NIH-NCI 1R01CA24838101A1, and in part by NIH grant 5P30CA014089-45. We thank all the authors of the surveyed studies (Dr. Anastasia A. Minervina, Dr. Mikhail V. Pogorelyy, Dr. Grigory A. Efimov, Dr. Zheming Lu, Dr. Yang Ke, Dr. Xiao Liu, Dr. Mascha Binder, Dr. DmitriyM. Chudakov, Dr. Nathalie Bedard, Dr. Jun S. Liu, Dr. Michelle Miron, Dr. Maura Rossetti, Dr. Satu Mustjoki, Dr. Atsunari Kawashima, Dr. Matthew A. Brown, Dr. Jorge Correale, and Dr. Tae Jin Kim) who shared the information of the study participants with us.	Bradley P, 2019, ANNU REV IMMUNOL, V37, P547, DOI 10.1146/annurev-immunol-042718-041757; Jorde LB, 2020, JAMA-J AM MED ASSOC, V323, P1089, DOI 10.1001/jama.2020.0517; Morales J, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1396-2; Nemat-Gorgani N, 2019, J IMMUNOL, V202, P2636, DOI 10.4049/jimmunol.1801586; Oni-Orisan A, 2021, NEW ENGL J MED, V384, P1163, DOI 10.1056/NEJMms2031080; Peng KR, 2021, NAT METHODS, V18, P588, DOI 10.1038/s41592-021-01169-5; Peterson RE, 2019, CELL, V179, P589, DOI 10.1016/j.cell.2019.08.051; Pilishvili T, 2021, MMWR-MORBID MORTAL W, V70, P753, DOI [10.15585/mmwr.mm7020e2, 10.15585/mmwr.mm7020e2externalicon]; Popejoy AB, 2020, AM J HUM GENET, V107, P72, DOI 10.1016/j.ajhg.2020.05.005	10	0	0	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 12	2021	54	10					2177	2179		10.1016/j.immuni.2021.09.015	http://dx.doi.org/10.1016/j.immuni.2021.09.015		OCT 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WG2VB	34644550	Bronze			2022-12-18	WOS:000706854100003
J	Ordovas-Montanes, J; Gerlach, C; Moraes-Vieira, P; Vento-Tormo, R; Zhang, C; Jurado, KA				Ordovas-Montanes, Jose; Gerlach, Carmen; Moraes-Vieira, Pedro; Vento-Tormo, Roser; Zhang, Conggang; Jurado, Kellie Ann			Navigating COVID-19: Starting a lab during the pandemic	IMMUNITY			English	Editorial Material								For new principal investigators, the first years are key to getting a laboratory off the ground and running. COVID-19 has changed the world, bringing on unforeseen difficulties and challenges at every level. We asked these investigators to share their experiences in navigating the unique environment since the start of the pandemic-what has changed in their vision for their laboratory, how they have adapted, and what advice they can share with others in a similar situation.	[Ordovas-Montanes, Jose] Boston Childrens Hosp, Boston, MA 02215 USA; [Gerlach, Carmen] Karolinska Inst, Solna, Sweden; [Moraes-Vieira, Pedro] Univ Estadual Campinas, Sao Paulo, Brazil; [Vento-Tormo, Roser] Wellcome Sanger Inst, Hinxton, England; [Zhang, Conggang] Tsinghua Univ, Beijing, Peoples R China; [Jurado, Kellie Ann] Univ Penn, Philadelphia, PA 19104 USA	Harvard University; Boston Children's Hospital; Karolinska Institutet; Universidade Estadual de Campinas; Wellcome Trust Sanger Institute; Tsinghua University; University of Pennsylvania	Ordovas-Montanes, J (corresponding author), Boston Childrens Hosp, Boston, MA 02215 USA.		Moraes-Vieira, Pedro/C-8701-2014	Moraes-Vieira, Pedro/0000-0002-8263-786X; Gerlach, Carmen/0000-0001-7889-2393	NIAID NIH HHS [R25 AI147376] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))			0	0	0	3	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 12	2021	54	10					2169	2171						3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WG2VB	34644549	Bronze, Green Published			2022-12-18	WOS:000706854100001
J	Stojanovic, A; Cerwenka, A				Stojanovic, Ana; Cerwenka, Adelheid			ILC1-like NK cells as matchmakers for DC-T cell interactions	IMMUNITY			English	Editorial Material							CONVERSION	Both innate and adaptive immunity are orchestrated by multiple cell types, specialized cell lineages, and their spatiotemporal encounters. It is thought that adaptive-like NK cell responses to viral infection mainly involve circulating bona fide NK cells. In this issue of Immunity, Flommersfeld et al. (2021) identify a splenic-resident ILC1-like NK cell subset that facilitates CD8(+) T cell-DC interactions during anti-viral defense.	[Stojanovic, Ana; Cerwenka, Adelheid] Heidelberg Univ, Mannheim Inst Innate Immunosci MI3, Med Fac Mannheim, Dept Immunobiochem, Mannheim, Germany; [Cerwenka, Adelheid] Heidelberg Univ, Med Fac Mannheim, European Ctr Angiosci ECAS, Mannheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Cerwenka, A (corresponding author), Heidelberg Univ, Mannheim Inst Innate Immunosci MI3, Med Fac Mannheim, Dept Immunobiochem, Mannheim, Germany.; Cerwenka, A (corresponding author), Heidelberg Univ, Med Fac Mannheim, European Ctr Angiosci ECAS, Mannheim, Germany.	adelheid.cerwenka@medma.uni-heidelberg.de		Cerwenka, Adelheid/0000-0001-6977-3536	German Research Foundation [SFB1366, 394046768-SFB 1366, TRR179, SFB-TRR156, SPP 1937 (CE 140/2-2)]; state of Baden-W_urttemberg Foundation; European Commission [MSCA-MC-ITN765104]	German Research Foundation(German Research Foundation (DFG)); state of Baden-W_urttemberg Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grants from: the German Research Foundation SFB1366 (Project number 394046768-SFB 1366; C02) to A.C., TRR179 (TP07) to A.C., SFB-TRR156 (B10N) to A.C., and SPP 1937 (CE 140/2-2) to A.S. and A.C.; the state of Baden-W_urttemberg Foundation for special program ``Angioformatics single cell platform'' to A.C.; and a network grant of the European Commission (H2020-ll Article Immunity 52, 1075-1087, June 16, 2020 1085 MSCA-MC-ITN765104-MATURE-NK) to A.C.	Amon L, 2019, INT REV CEL MOL BIO, V349, P55, DOI 10.1016/bs.ircmb.2019.10.001; Ataide MA, 2020, NAT IMMUNOL, V21, P1397, DOI 10.1038/s41590-020-0786-2; Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Cortez VS, 2017, NAT IMMUNOL, V18, P995, DOI 10.1038/ni.3809; Flommersfeld S, 2021, IMMUNITY, V54, P2288, DOI 10.1016/j.immuni.2021.08.002; Gao YL, 2017, NAT IMMUNOL, V18, P1004, DOI 10.1038/ni.3800; Lau CM, 2018, NAT IMMUNOL, V19, P963, DOI 10.1038/s41590-018-0176-1; Park E, 2019, ELIFE, V8, DOI 10.7554/eLife.47605; Riggan L, 2019, TRENDS IMMUNOL, V40, P909, DOI 10.1016/j.it.2019.08.005; Weizman OE, 2019, NAT IMMUNOL, V20, P1004, DOI 10.1038/s41590-019-0430-1	10	0	0	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 12	2021	54	10					2185	2187		10.1016/j.immuni.2021.09.007	http://dx.doi.org/10.1016/j.immuni.2021.09.007		OCT 2021	4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WG2VB	34644553	Bronze			2022-12-18	WOS:000706854100006
J	Chen, S; Wang, D				Chen, Sheng; Wang, Di			Intestinal-derived HDL: The portal guardian of the liver	IMMUNITY			English	Editorial Material								The trafficking and function of intestine-derived high-density lipoprotein (HDL) have not been identified. In a recent issue of Science, Han et al. (2021) find that intestine-derived HDL neutralizes intestinal-leaked LPS in the portal vein, serving as a host disease tolerance strategy to restrain liver damage of enteric origin under physiological conditions.	[Chen, Sheng; Wang, Di] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China; [Chen, Sheng] Zhejiang Univ, Key Lab Canc Prevent & Intervent, Affiliated Hosp 2, Dept Colorectal Surg & Oncol,Minist Educ,Sch Med, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Wang, D (corresponding author), Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China.	diwang@zju.edu.cn		Chen, Sheng/0000-0002-5186-5069	National Natural Science Foundation of China [81730047, 81930042, 82025017, 31800759]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	D.W. is supported by the National Natural Science Foundation of China (81730047, 81930042, 82025017, and 31800759).	Albillos A, 2020, J HEPATOL, V72, P558, DOI 10.1016/j.jhep.2019.10.003; Brunham LR, 2006, J CLIN INVEST, V116, P1052, DOI 10.1172/JCI27352; Davidson WS, 2009, ARTERIOSCL THROM VAS, V29, P870, DOI 10.1161/ATVBAHA.109.186031; Han YH, 2021, SCIENCE, V373, P410, DOI 10.1126/science.abe6729; Ko CW, 2020, NAT REV GASTRO HEPAT, V17, P169, DOI 10.1038/s41575-019-0250-7; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Pironi L, 2019, CLIN LIVER DIS, V23, P279, DOI 10.1016/j.cld.2018.12.009; Pownall HJ, 2021, NAT REV CARDIOL, V18, P712, DOI 10.1038/s41569-021-00538-z; Tall AR, 2015, NAT REV IMMUNOL, V15, P104, DOI 10.1038/nri3793; Tripathi A, 2018, NAT REV GASTRO HEPAT, V15, P397, DOI 10.1038/s41575-018-0011-z	10	0	0	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 14	2021	54	9					1903	1905		10.1016/j.immuni.2021.08.010	http://dx.doi.org/10.1016/j.immuni.2021.08.010		SEP 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UQ0VB	34525332	Bronze			2022-12-18	WOS:000695789800001
J	De Ponti, FF; Scott, CL				De Ponti, Federico F.; Scott, Charlotte L.			In matters of the heart, (cellular) communication is key	IMMUNITY			English	Editorial Material							RESIDENT CARDIAC MACROPHAGES	To maintain cardiac output, the failing heart undergoes significant remodeling. However, the mechanisms regulating this remain unclear. In this issue of Immunity, Zaman et al. and Wong, Mohan, and Kopecky et al. uncover an interaction between resident cardiac macrophages and cardiomyocytes governing this process.	[De Ponti, Federico F.; Scott, Charlotte L.] VIB Ctr Inflammat Res, Lab Myeloid Cell Biol Tissue Damage & Inflammat, Ghent, Belgium; [De Ponti, Federico F.; Scott, Charlotte L.] Univ Ghent, Dept Biomed Mol Biol, Fac Sci, Ghent, Belgium; [Scott, Charlotte L.] Univ Limerick, Bernal Inst, Dept Chem Sci, Castletroy, Co Limerick, Ireland	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; University of Limerick	Scott, CL (corresponding author), VIB Ctr Inflammat Res, Lab Myeloid Cell Biol Tissue Damage & Inflammat, Ghent, Belgium.; Scott, CL (corresponding author), Univ Ghent, Dept Biomed Mol Biol, Fac Sci, Ghent, Belgium.; Scott, CL (corresponding author), Univ Limerick, Bernal Inst, Dept Chem Sci, Castletroy, Co Limerick, Ireland.	charlotte.scott@ugent.be			ERC [851908]; FWO [3G000519, 3G001219]; UGent BOF starting grant; Fondation ACTERIA; Chan Zuckerberg Initiative (Liver seed network)	ERC(European Research Council (ERC)European Commission); FWO(FWO); UGent BOF starting grant; Fondation ACTERIA; Chan Zuckerberg Initiative (Liver seed network)	Figure was created with BioRender. C.L.S. is a Francqui Professor and her lab is funded by an ERC starting grant (MyeFattyLiver; 851908), two FWO project grants (3G000519 and 3G001219), a UGent BOF starting grant, a grant from Fondation ACTERIA, and the Chan Zuckerberg Initiative (Liver seed network).	Bajpai G, 2018, NAT MED, V24, P1234, DOI 10.1038/s41591-018-0059-x; Dick SA, 2019, NAT IMMUNOL, V20, P29, DOI [10.1038/s41590-018-0272-2, 10.1038/s41590-019-0363-8]; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Guilliams M, 2017, NAT REV IMMUNOL, V17, P451, DOI 10.1038/nri.2017.42; Lavine KJ, 2014, P NATL ACAD SCI USA, V111, P16029, DOI 10.1073/pnas.1406508111; Leid J, 2016, CIRC RES, V118, P1498, DOI 10.1161/CIRCRESAHA.115.308270; Rizzo G., 2020, SINGLE CELL TRANSCRI; Sansonetti M, 2020, BASIC RES CARDIOL, V115, DOI 10.1007/s00395-020-00836-6; Wong NR, 2021, IMMUNITY, V54, P2072, DOI 10.1016/j.immuni.2021.07.003; Zaman Rysa, 2021, Immunity, V54, P2057, DOI 10.1016/j.immuni.2021.07.006; Zwicker C, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.690813	11	0	0	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 14	2021	54	9					1906	1908		10.1016/j.immuni.2021.08.004	http://dx.doi.org/10.1016/j.immuni.2021.08.004		SEP 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UQ0VB	34525333	Bronze			2022-12-18	WOS:000695789800002
J	Gonzalez, JC; Wang, TT				Gonzalez, Joseph C.; Wang, Taia T.			Illuminating the Fc dependence of SARS-CoV-2 neutralization	IMMUNITY			English	Editorial Material								Monoclonal antibodies show efficacy in treating COVID-19, but the functional requirements for protection are unclear. In this issue of Immunity, Ullah et al. (2021) develop a stable SARS-CoV-2 reporter virus and use bioluminescence imaging to longitudinally monitor infection and assess neutralizing monoclonal antibody interventions in mice. They find that antibody-mediated protection depends on the Fc domain and Fc-gamma receptor-expressing immune cells.	[Gonzalez, Joseph C.; Wang, Taia T.] Stanford Univ, Div Infect Dis, Dept Med, Stanford, CA 94305 USA; [Gonzalez, Joseph C.] Stanford Univ, Immunol Interdept Program, Stanford, CA 94305 USA; [Wang, Taia T.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Wang, Taia T.] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA	Stanford University; Stanford University; Stanford University	Wang, TT (corresponding author), Stanford Univ, Div Infect Dis, Dept Med, Stanford, CA 94305 USA.; Wang, TT (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.; Wang, TT (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.	taiawang@stanford.edu			Stanford University School of Medicine; Searle Scholars Program; NIH/NIAID [U19AI1118 25, R01AI139119]; NIH [5T32AI0072 90]; Chan Zuckerberg Biohub	Stanford University School of Medicine; Searle Scholars Program; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chan Zuckerberg Biohub	This work was supported by Stanford University School of Medicine, the Chan Zuckerberg Biohub, Searle Scholars Program, NIH/NIAID U19AI1118 25, NIH/NIAID R01AI139119, and NIH 5T32AI0072 90.	Chakraborty S., 2021, DIV EARLY ANT RESP D, DOI [10.1101/2021.05.25.445649, DOI 10.1101/2021.05.25.445649, 10.1016/S0140-6736(20)30183-5]; Chakraborty S, 2021, NAT IMMUNOL, V22, P67, DOI [10.1038/s41590-020-00828-7, 10.1101/2020.05.15.20103341]; Jennewein MF, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109353; McCray PB, 2007, J VIROL, V81, P813, DOI 10.1128/JVI.02012-06; Ravetch J., 2021, RES SQ; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Stamatatos L, 2021, SCIENCE, V372, P1413, DOI 10.1126/science.abg9175; Ullah Irfan, 2021, bioRxiv, DOI 10.1101/2021.03.22.436337; Winkler ES, 2021, CELL, V184, P1804, DOI 10.1016/j.cell.2021.02.026; Winkler ES, 2020, NAT IMMUNOL, V21, P1327, DOI 10.1038/s41590-020-0778-2	10	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 14	2021	54	9					1912	1914		10.1016/j.immuni.2021.08.024	http://dx.doi.org/10.1016/j.immuni.2021.08.024		SEP 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UQ0VB	34464594	Green Published, Bronze			2022-12-18	WOS:000695789800004
J	Lianos, KSA; Fletcher, AL				Lianos, Krystal S. A.; Fletcher, Anne L.			Fibroblasts: The B's knees of follicular lymphoma	IMMUNITY			English	Editorial Material								Fibroblasts are the immunological architects of lymph nodes. In this issue of Immunity, Mourcin et al. describe the human tonsil fibroblast landscape and predicted T and B cell interactions. Transcriptomic changes in follicular lymphoma could provide untapped clinical targets.	[Lianos, Krystal S. A.; Fletcher, Anne L.] Monash Univ, Monash Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Fletcher, Anne L.] Univ Birmingham, Inst Immunol & Immunotherapy, Edgbaston B15 2TT, England	Monash University; University of Birmingham	Fletcher, AL (corresponding author), Monash Univ, Monash Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.; Fletcher, AL (corresponding author), Univ Birmingham, Inst Immunol & Immunotherapy, Edgbaston B15 2TT, England.	anne.l.fletcher@monash.edu			National Health and Medical Research Council of Australia [APP2004253]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by Ideas grant APP2004253 from the National Health and Medical Research Council of Australia.	Desmots F, 2019, CLIN CANCER RES, V25, P735, DOI 10.1158/1078-0432.CCR-18-1153; Dumontet E, 2021, BLOOD, V138, P57, DOI 10.1182/blood.2020008791; Huet S, 2018, LANCET ONCOL, V19, P549, DOI 10.1016/S1470-2045(18)30102-5; Knoblich K, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005046; Lutge M, 2021, IMMUNOL REV, V302, P32, DOI 10.1111/imr.12981; Mourcin F, 2021, IMMUNITY, V54, P1788, DOI 10.1016/j.immuni.2021.05.019; Pikor NB, 2020, NAT IMMUNOL, V21, P649, DOI 10.1038/s41590-020-0672-y; Riedel A, 2016, NAT IMMUNOL, V17, P1118, DOI 10.1038/ni.3492; Rodda LB, 2018, IMMUNITY, V48, P1014, DOI 10.1016/j.immuni.2018.04.006	9	0	0	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 10	2021	54	8					1628	1630		10.1016/j.immuni.2021.07.016	http://dx.doi.org/10.1016/j.immuni.2021.07.016		AUG 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TZ6OI	34380060	Bronze			2022-12-18	WOS:000684589700003
J	Romanov, A; Sharma, S				Romanov, Artem; Sharma, Sonia			Smooth-talking T cells leave asthma breathless	IMMUNITY			English	Editorial Material							RELEASE	The plasma membrane channel PANX1 mediates release of bio-active adenine nucleotides; however, its function in immune cells is unknown. In this issue of Immunity, Medina et al. show that PANX1 mediates adenosine-dependent communication between regulatory and effector CD4(+) T cells during allergic airway inflammation.	[Romanov, Artem; Sharma, Sonia] La Jolla Inst Immunol, La Jolla, CA 92037 USA	La Jolla Institute for Immunology	Sharma, S (corresponding author), La Jolla Inst Immunol, La Jolla, CA 92037 USA.	soniasharma@lji.org			La Jolla Institute for Immunology (LJI) Tullie; Rickie Families SPARK Award; NIH/NCI [R01CA256133]	La Jolla Institute for Immunology (LJI) Tullie; Rickie Families SPARK Award; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. Araujo (La Jolla Institute) for generating Figure 1 with A.R. A.R. is supported by a La Jolla Institute for Immunology (LJI) Tullie and Rickie Families SPARK Award; S.S. is supported by NIH/NCI R01CA256133.	Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chiu YH, 2014, CHANNELS, V8, P1, DOI 10.4161/chan.27545; Clark K, 2012, P NATL ACAD SCI USA, V109, P16986, DOI 10.1073/pnas.1215450109; Dhanwani R, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba3688; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Lasley RD, 2011, BBA-BIOMEMBRANES, V1808, P1284, DOI 10.1016/j.bbamem.2010.09.019; Linden J, 2019, ANNU REV IMMUNOL, V37, P325, DOI 10.1146/annurev-immunol-051116-052406; Lohman AW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8965; Medina CB, 2021, IMMUNITY, V54, P1715, DOI 10.1016/j.immuni.2021.06.014; Wang YP, 2018, SIGNAL TRANSDUCT TAR, V3, DOI 10.1038/s41392-018-0024-7	10	0	0	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 10	2021	54	8					1623	1625		10.1016/j.immuni.2021.07.011	http://dx.doi.org/10.1016/j.immuni.2021.07.011		AUG 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TZ6OI	34380058	Bronze			2022-12-18	WOS:000684589700001
J	Di Gioia, M; Zanoni, I				Di Gioia, Marco; Zanoni, Ivan			Aged vasculature drives neutrophils mad	IMMUNITY			English	Editorial Material								Inflammaging drives age-related pathologies. In this issue of Immunity, Barkaway et al. illustrate how aged endothelial cells and mast cells promote reverse migration of neutrophils from inflamed tissue back into circulation, causing tissue damage at distal sites.	[Di Gioia, Marco; Zanoni, Ivan] Harvard Med Sch, Boston, MA 02115 USA; [Di Gioia, Marco; Zanoni, Ivan] Boston Childrens Hosp, Div Immunol, Div Gastroenterol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Zanoni, I (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Zanoni, I (corresponding author), Boston Childrens Hosp, Div Immunol, Div Gastroenterol, Boston, MA 02115 USA.	ivan.zanoni@childrens.harvard.edu	Di Gioia, Marco/AAC-4192-2019	Di Gioia, Marco/0000-0001-9499-5771				Ballesteros I, 2020, CELL, V183, P1282, DOI 10.1016/j.cell.2020.10.003; Barkaway A., 2021, Immunity, V54; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Lord JM, 2014, LANCET, V384, P1455, DOI 10.1016/S0140-6736(14)60687-5; Meizlish ML, 2021, ANNU REV IMMUNOL, V39, P557, DOI 10.1146/annurev-immunol-061020-053734; Nikolich-Zugich J, 2018, NAT IMMUNOL, V19, P10, DOI 10.1038/s41590-017-0006-x; Owen-Woods C, 2020, J CLIN INVEST, V130, P2301, DOI 10.1172/JCI133661; Wang J, 2017, SCIENCE, V358, P111, DOI 10.1126/science.aam9690	10	0	0	3	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 13	2021	54	7					1369	1371		10.1016/j.immuni.2021.06.010	http://dx.doi.org/10.1016/j.immuni.2021.06.010		JUL 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TI4ZW	34260883	Bronze			2022-12-18	WOS:000672812100004
J	Kim, S; Bagadia, P; Anderson, DA; Liu, TT; Huang, XA; Theisen, DJ; O'Connor, KW; Ohara, RA; Iwata, A; Murphy, TL; Murphy, KM				Kim, Sunkyung; Bagadia, Prachi; Anderson, David A., III; Liu, Tian-Tian; Huang, Xiao; Theisen, Derek J.; O'Connor, Kevin W.; Ohara, Ray A.; Iwata, Arifumi; Murphy, Theresa L.; Murphy, Kenneth M.			High Amount of Transcription Factor IRF8 Engages AP1-IRF Composite Elements in Enhancers to Direct Type 1 Conventional Dendritic Cell Identity (vol 53, 759.e1, 2020)	IMMUNITY			English	Correction												kmurphy@wustl.edu						KIM SY, 2020, IMMUNITY, V53	1	0	0	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 13	2021	54	7					1622	1622		10.1016/j.immuni.2021.05.018	http://dx.doi.org/10.1016/j.immuni.2021.05.018		JUL 2021	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TI4ZW	34260888	Bronze			2022-12-18	WOS:000672812100022
J	Makdissi, N; Mass, E				Makdissi, Nikola; Mass, Elvira			Of myeloid cells and fibroblasts-A love story	IMMUNITY			English	Editorial Material							LAIR-1	The interaction between myeloid cells and the extracellular matrix is important for tissue homeostasis and pathophysiology. In this issue of Immunity, Keerthivasan et al. reveal crosstalk dependent on the collagen receptor LAIR1 that regulates the dynamics of monocytes and macrophages during steady-state and cancer.	[Makdissi, Nikola; Mass, Elvira] Univ Bonn, Dev Biol Immune Syst, Life & Med Sci LIMES Inst, D-53115 Bonn, Germany	University of Bonn	Mass, E (corresponding author), Univ Bonn, Dev Biol Immune Syst, Life & Med Sci LIMES Inst, D-53115 Bonn, Germany.	elvira.mass@uni-bonn.de	Mass, Elvira/AAH-3805-2019	Mass, Elvira/0000-0003-2318-2356				Brondijk THC, 2010, BLOOD, V115, P1364, DOI 10.1182/blood-2009-10-246322; Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964; Guilliams M, 2020, IMMUNITY, V52, P434, DOI 10.1016/j.immuni.2020.02.015; Guo N, 2020, CURR RES TRANSL MED, V68, P119, DOI 10.1016/j.retram.2020.05.003; Keerthivasan S, 2021, IMMUNITY, V54, P1511, DOI 10.1016/j.immuni.2021.06.012; Khalaji S, 2017, SCI REP-UK, V7, DOI 10.1038/srep46532; Schultz HS, 2015, J IMMUNOL, V194, P3169, DOI 10.4049/jimmunol.1402800; Schurch CM, 2020, CELL, V182, P1341, DOI 10.1016/j.cell.2020.07.005; Zheng P, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.571516; Zhou X, 2018, CELL, V172, P744, DOI 10.1016/j.cell.2018.01.015	10	0	0	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 13	2021	54	7					1371	1373		10.1016/j.immuni.2021.06.016	http://dx.doi.org/10.1016/j.immuni.2021.06.016		JUL 2021	4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TI4ZW	34260884	Bronze			2022-12-18	WOS:000672812100023
J	Zarate-Potes, A; Dierking, K				Zarate-Potes, Alejandra; Dierking, Katja			Guard proteins keep watch at epithelial walls	IMMUNITY			English	Editorial Material							TRANSLATIONAL INHIBITION; IMMUNITY	Cells can detect pathogens through guard proteins that sense disturbances in core cellular processes, but the exact mechanisms often remain elusive. In this issue of Immunity, Orzalli et al. identify Bcl-2 family members as guard proteins that detect virus-induced translational inhibition and induce pyroptosis in human keratinocytes.	[Zarate-Potes, Alejandra] Univ Lancaster, Div Biomed & Life Sci, Lancaster LA1 4YE, England; [Dierking, Katja] Christian Albrechts Univ Kiel, Dept Evolutionary Ecol & Genet, D-24118 Kiel, Germany	Lancaster University; University of Kiel	Dierking, K (corresponding author), Christian Albrechts Univ Kiel, Dept Evolutionary Ecol & Genet, D-24118 Kiel, Germany.	kdierking@zoologie.uni-kiel.de		Zarate-Potes, Alejandra/0000-0001-9643-4214				Boyer L, 2011, IMMUNITY, V35, P536, DOI 10.1016/j.immuni.2011.08.015; Dunbar TL, 2012, CELL HOST MICROBE, V11, P375, DOI 10.1016/j.chom.2012.02.008; Fischer NL, 2020, NAT MICROBIOL, V5, P14, DOI 10.1038/s41564-019-0623-2; McEwan DL, 2012, CELL HOST MICROBE, V11, P364, DOI 10.1016/j.chom.2012.02.007; Orzalli MH, 2021, IMMUNITY, V54, P1447, DOI 10.1016/j.immuni.2021.04.012; Robinson KS, 2020, SCIENCE, V370, P1182, DOI 10.1126/science.aay2002; Shi JJ, 2017, TRENDS BIOCHEM SCI, V42, P245, DOI 10.1016/j.tibs.2016.10.004; Singh R, 2019, NAT REV MOL CELL BIO, V20, P175, DOI 10.1038/s41580-018-0089-8; Stern-Ginossar N, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a033001; Zhang ZB, 2020, NATURE, V579, P415, DOI 10.1038/s41586-020-2071-9	10	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 13	2021	54	7					1366	1368		10.1016/j.immuni.2021.06.004	http://dx.doi.org/10.1016/j.immuni.2021.06.004		JUL 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TI4ZW	34260882	Bronze, Green Accepted			2022-12-18	WOS:000672812100003
J	Suber, T; Camiolo, MJ; Ray, A				Suber, Tomeka; Camiolo, Matthew J.; Ray, Anuradha			A no-Wnt situation for alveolar macrophage self-renewal	IMMUNITY			English	Editorial Material							CELLS	Alveolar macrophages (AMs) are central to defense against respiratory pathogens. Impediments in restoring AMs after infection increase the risk for superinfection, which is associated with significant morbidity and mortality worldwide. In this issue of Immunity, Zhu et al. report a Wnt-beta-catenin-HIF-1 alpha axis in AMs that promotes an inflammatory phenotype while restricting proliferation and self-renewal.	[Suber, Tomeka; Camiolo, Matthew J.; Ray, Anuradha] Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA; [Camiolo, Matthew J.] Univ Pittsburgh, Med Ctr, Ctr Syst Immunol, Pittsburgh, PA USA; [Ray, Anuradha] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ray, A (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA.; Ray, A (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA.	raya@pitt.edu		Suber, Tomeka/0000-0002-7062-0278	Swedish Research Council (VR) [K2015-68X-2276501-6, 2018-02533]; Formas [FR2016/0005]; Cancerfonden [19 0395 Pj]; Wallenberg Academy Fellow program [2019.0315]	Swedish Research Council (VR)(Swedish Research Council); Formas(Swedish Research Council Formas); Cancerfonden(Swedish Cancer Society); Wallenberg Academy Fellow program	E.J.V. was supported by grants from the Swedish Research Council (VR) grants K2015-68X-2276501-6 and 2018-02533, Formas grant no. FR2016/0005, Cancerfonden (19 0395 Pj), and the Wallenberg Academy Fellow program (2019.0315)	Byrne AJ, 2015, THORAX, V70, P1189, DOI 10.1136/thoraxjnl-2015-207020; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Codo AC, 2020, CELL METAB, V32, P498, DOI 10.1016/j.cmet.2020.07.015; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Guillon A, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.133042; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Zhu BB, 2021, IMMUNITY, V54, P1200, DOI 10.1016/j.immuni.2021.04.001	9	0	0	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 8	2021	54	6					1099	1101		10.1016/j.immuni.2021.05.013	http://dx.doi.org/10.1016/j.immuni.2021.05.013		JUN 2021	4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SP7ZL	34107266	Bronze			2022-12-18	WOS:000659882900002
J	Wu, T; Wu, L				Wu, Tao; Wu, Li			Dendritic cell fate determination revealed by "SISter'' assays	IMMUNITY			English	Editorial Material								Establishing the connection between cell fate and fate-related genes in a single progenitor cell is a challenge. In this issue of Immunity, Tian et al. tackled this challenge by designing SIS-seq and SIS-Skew assays and identified Bcor as a negative regulator for dendritic cell differentiation.	[Wu, Tao; Wu, Li] Tsinghua Univ, Inst Immunol, Beijing 100084, Peoples R China; [Wu, Tao; Wu, Li] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Wu, Li] Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Wu, Li] Beijing Key Lab Immunol Res Chron Dis, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University	Wu, L (corresponding author), Tsinghua Univ, Inst Immunol, Beijing 100084, Peoples R China.; Wu, L (corresponding author), Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China.; Wu, L (corresponding author), Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China.; Wu, L (corresponding author), Beijing Key Lab Immunol Res Chron Dis, Beijing 100084, Peoples R China.	wuli@tsinghua.edu.cn			NIH [T32-AI060525, F31-AI149866, AI081759, AI150151, AI145828, AI145296]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	A.I.W. is supported by NIH T32-AI060525 and NIH F31-AI149866, and C.B.C. is supported by NIH AI081759, AI150151, AI145828, and AI145296.	Carrelha J, 2018, NATURE, V554, P106, DOI 10.1038/nature25455; Ghosh HS, 2014, J EXP MED, V211, P1623, DOI 10.1084/jem.20132121; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Ji ZC, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw430; Lin DS, 2021, NAT CELL BIOL, V23, P219, DOI 10.1038/s41556-021-00636-7; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Nutt SL, 2020, IMMUNITY, V52, P942, DOI 10.1016/j.immuni.2020.05.005; Rodriguez-Fraticelli AE, 2018, NATURE, V553, P212, DOI 10.1038/nature25168; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Tian LY, 2021, IMMUNITY, V54, P1338, DOI 10.1016/j.immuni.2021.03.012	10	0	0	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 8	2021	54	6					1104	1106		10.1016/j.immuni.2021.05.012	http://dx.doi.org/10.1016/j.immuni.2021.05.012		JUN 2021	4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SP7ZL	34107268	Bronze			2022-12-18	WOS:000659882900004
J	Afzali, B; Kemper, C				Afzali, Behdad; Kemper, Claudia			Fibroblast tissue priming-not so nice to C you!	IMMUNITY			English	Editorial Material							IMMUNITY	The molecular mechanisms explaining why relapses of inflammatory arthritis occur at previously affected sites are unknown. In this issue of Immunity, Friscic et al. propose that local fibroblasts perpetuate inflammation after priming through cell-intrinsic complement C3, which reprograms their bioenergetics and activates the inflammasome.	[Afzali, Behdad] NIDDK, Immunoregulat Sect, Kidney Dis Branch, NIH, Bethesda, MD 20892 USA; [Kemper, Claudia] NHLBI, Complement & Inflammat Res Sect, NIH, Bldg 10, Bethesda, MD 20892 USA; [Kemper, Claudia] Univ Lubeck, Inst System Inflammat Res, Lubeck, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Lubeck	Afzali, B (corresponding author), NIDDK, Immunoregulat Sect, Kidney Dis Branch, NIH, Bethesda, MD 20892 USA.; Kemper, C (corresponding author), NHLBI, Complement & Inflammat Res Sect, NIH, Bldg 10, Bethesda, MD 20892 USA.; Kemper, C (corresponding author), Univ Lubeck, Inst System Inflammat Res, Lubeck, Germany.	behdad.afzali@nih.gov; claudia.kemper@nih.gov	Afzali, Behdad/H-8565-2013	Afzali, Behdad/0000-0003-2968-1156	Intramural Research Program of the NIH; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [ZIA/DK075149]; National Heart, Lung, and Blood Institute (NHLBI) [ZIA/Hl006223]	Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the Intramural Research Program of the NIH, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (project number ZIA/DK075149 to B.A.) and the National Heart, Lung, and Blood Institute (NHLBI) (project number ZIA/Hl006223 to C.K.).	Arbore G, 2016, SCIENCE, V352, DOI 10.1126/science.aad1210; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Friscic J, 2021, IMMUNITY, V54, P1002, DOI 10.1016/j.immuni.2021.03.003; Kolev M, 2020, IMMUNITY, V52, P513, DOI 10.1016/j.immuni.2020.02.006; Kolev M, 2015, IMMUNITY, V42, P1033, DOI 10.1016/j.immuni.2015.05.024; Liszewski MK, 2013, IMMUNITY, V39, P1143, DOI 10.1016/j.immuni.2013.10.018; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Verschoor A, 2016, IMMUNOL REV, V274, P112, DOI 10.1111/imr.12473; Yan BY, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abg0833	10	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 11	2021	54	5					847	850		10.1016/j.immuni.2021.04.010	http://dx.doi.org/10.1016/j.immuni.2021.04.010		MAY 2021	5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SE4BY	33979581	Bronze			2022-12-18	WOS:000652019500002
J	Cheemalavagu, N; Gottschalk, RA				Cheemalavagu, Neha; Gottschalk, Rachel A.			Time will tell: The temporal code of immune threats	IMMUNITY			English	Editorial Material								Activation of NF-kappa B is a common downstream consequence of inflammatory stimulation, yet it achieves stimulus-specific transcriptional responses. In this issue of Immunity, Adelaja et al. use single-cell imaging and computational approaches to understand temporal features of NF-kappa B dynamics that transmit information about immune threats.	[Cheemalavagu, Neha; Gottschalk, Rachel A.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA; [Cheemalavagu, Neha; Gottschalk, Rachel A.] Univ Pittsburgh, Ctr Syst Immunol, Pittsburgh, PA 15260 USA; [Cheemalavagu, Neha] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gottschalk, RA (corresponding author), Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA.; Gottschalk, RA (corresponding author), Univ Pittsburgh, Ctr Syst Immunol, Pittsburgh, PA 15260 USA.	rachel.gottschalk@pitt.edu			NIH [T32AI089443]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	N.C. is supported by NIH training grant T32AI089443.	Adelaja A, 2021, IMMUNITY, V54, P916, DOI 10.1016/j.immuni.2021.04.011; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Cheong R, 2011, SCIENCE, V334, P354, DOI 10.1126/science.1204553; Lane K, 2017, CELL SYST, V4, P458, DOI 10.1016/j.cels.2017.03.010; Lee REC, 2014, MOL CELL, V53, P867, DOI 10.1016/j.molcel.2014.01.026; Martin EW, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aax7195; Pandey S, 2020, CELL SYST, V11, P495, DOI 10.1016/j.cels.2020.10.001; Selimkhanov J, 2014, SCIENCE, V346, P1370, DOI 10.1126/science.1254933; Sen S, 2020, CELL SYST, V10, P169, DOI 10.1016/j.cels.2019.12.004; Sung MH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004764	10	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 11	2021	54	5					845	847		10.1016/j.immuni.2021.04.018	http://dx.doi.org/10.1016/j.immuni.2021.04.018		MAY 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SE4BY	33979580	Bronze			2022-12-18	WOS:000652019500001
J	Stakenborg, N; Boeckxstaens, GE				Stakenborg, Nathalie; Boeckxstaens, Guy E.			Shining light on the neuro-immune axis in the gut	IMMUNITY			English	Editorial Material							MAINTENANCE THERAPY; VEDOLIZUMAB; INDUCTION	In this issue of Immunity, Schiller et al. report that local sympathetic nerve activation decreases endothelial expression of the adhesion molecule MAdCAM-1, reducing immune cell infiltration and colitis-induced inflammation. These findings suggest that local sympathetic stimulation provides a key gateway for regulating organ homeostasis.	[Stakenborg, Nathalie; Boeckxstaens, Guy E.] Univ Leuven, Ctr Intestinal Neuroimmune Interact, Translat Res Ctr GI Disorders TARGID, Dept Chron Dis Metab & Ageing,KU Leuven, Leuven, Belgium	KU Leuven	Boeckxstaens, GE (corresponding author), Univ Leuven, Ctr Intestinal Neuroimmune Interact, Translat Res Ctr GI Disorders TARGID, Dept Chron Dis Metab & Ageing,KU Leuven, Leuven, Belgium.	guy.boeckxstaens@kuleuven.be			European Research Council (ERC) [ERC-833816-NEU-MACS]; FWO [12V3619N]	European Research Council (ERC)(European Research Council (ERC)European Commission); FWO(FWO)	G.E.B. is supported by the European Research Council (ERC) advanced grant (ERC-833816-NEU-MACS). N.S. (12V3619N) is supported by a postdoctoral research fellowship of FWO.	Asano K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8802; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Feagan BG, 2013, NEW ENGL J MED, V369, P699, DOI 10.1056/NEJMoa1215734; Gabanyi I, 2016, CELL, V164, P378, DOI 10.1016/j.cell.2015.12.023; Koopman FA, 2016, P NATL ACAD SCI USA, V113, P8284, DOI 10.1073/pnas.1605635113; Sandborn WJ, 2013, NEW ENGL J MED, V369, P711, DOI 10.1056/NEJMoa1215739; Schiller M, 2021, IMMUNITY, V54, P1022, DOI 10.1016/j.immuni.2021.04.007; Sinniger V, 2020, NEUROGASTROENT MOTIL, V32, DOI 10.1111/nmo.13911; Willemze RA, 2018, NEUROGASTROENT MOTIL, V30, DOI 10.1111/nmo.13163	9	0	0	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 11	2021	54	5					850	852		10.1016/j.immuni.2021.04.016	http://dx.doi.org/10.1016/j.immuni.2021.04.016		MAY 2021	4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SE4BY	33979582	Green Accepted, Bronze			2022-12-18	WOS:000652019500003
J	Usmani, SM; Mempel, TR				Usmani, Shariq M.; Mempel, Thorsten R.			Cancer cells relax and resist cytotoxic attack	IMMUNITY			English	Editorial Material								When it comes to cancer evading the immune response, antigen presentation usually gets all the attention. In this issue of Immunity, Tello-Lafoz et al. reveal that cancer cells have another card up their sleeve: by regulating gene expression to "soften'' their actin cytoskeleton, cancer cells limit susceptibility to lymphocyte-mediated cytotoxic attack.	[Usmani, Shariq M.; Mempel, Thorsten R.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Mempel, TR (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02115 USA.	tmempel@mgh.harvard.edu						Basu R, 2016, CELL, V165, P100, DOI 10.1016/j.cell.2016.01.021; Er EE, 2018, NAT CELL BIOL, V20, P966, DOI 10.1038/s41556-018-0138-8; Huse M, 2017, NAT REV IMMUNOL, V17, P679, DOI 10.1038/nri.2017.74; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Murooka TT, 2012, NATURE, V490, P283, DOI 10.1038/nature11398; Stolp B, 2009, CELL HOST MICROBE, V6, P174, DOI 10.1016/j.chom.2009.06.004; Tello-Lafoz M, 2021, IMMUNITY, V54, P1037, DOI 10.1016/j.immuni.2021.02.020; Thiery J, 2011, NAT IMMUNOL, V12, P770, DOI 10.1038/ni.2050; Usmani SM, 2019, CELL HOST MICROBE, V25, P73, DOI 10.1016/j.chom.2018.12.008; Van den Broeke C, 2010, TRENDS CELL BIOL, V20, P160, DOI 10.1016/j.tcb.2009.12.005	10	0	0	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 11	2021	54	5					853	855		10.1016/j.immuni.2021.04.017	http://dx.doi.org/10.1016/j.immuni.2021.04.017		MAY 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SE4BY	33979583	Bronze			2022-12-18	WOS:000652019500004
J	Cieri, N; Wu, CJ				Cieri, Nicoletta; Wu, Catherine J.			Splice it up: Atypical transcripts to boost leukemia immunotherapy	IMMUNITY			English	Editorial Material								Neoantigens are prime targets for cancer immunotherapy, but their identification in low mutational burden malignancies remains challenging. In this issue of Immunity, Ehx et al. show that atypical transcripts, and particularly retained introns, expand the spectrum of leukemia immunotherapy targets.	[Cieri, Nicoletta; Wu, Catherine J.] Harvard Med Sch, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA; [Cieri, Nicoletta; Wu, Catherine J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Wu, Catherine J.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Wu, Catherine J.] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Wu, CJ (corresponding author), Harvard Med Sch, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA.; Wu, CJ (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Wu, CJ (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.; Wu, CJ (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	cwu@partners.org		Cieri, Nicoletta/0000-0003-1340-6272				Blass E, 2021, NAT REV CLIN ONCOL, V18, P215, DOI 10.1038/s41571-020-00460-2; Coulie PG, 2014, NAT REV CANCER, V14, P135, DOI 10.1038/nrc3670; Dvinge H, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0168-9; Ehx G, 2021, IMMUNITY, V54, P737, DOI 10.1016/j.immuni.2021.03.001; Griss J, 2016, NAT METHODS, V13, P651, DOI 10.1038/NMETH.3902; Jayasinghe RG, 2018, CELL REP, V23, P270, DOI 10.1016/j.celrep.2018.03.052; Kahles A, 2018, CANCER CELL, V34, P211, DOI 10.1016/j.ccell.2018.07.001; Lavallee VP, 2015, NAT GENET, V47, P1030, DOI 10.1038/ng.3371; Ouspenskaia T., 2020, 1000 NOVEL UNANNOTAT, DOI [10.1101/2020.02.12.945840, DOI 10.1101/2020.02.12.945840]; Smart AC, 2018, NAT BIOTECHNOL, V36, P1056, DOI 10.1038/nbt.4239	10	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 13	2021	54	4					608	610		10.1016/j.immuni.2021.03.016	http://dx.doi.org/10.1016/j.immuni.2021.03.016		APR 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RN1GO	33852826	Bronze			2022-12-18	WOS:000640102800003
J	Kwon, AHK; Liddelow, SA				Kwon, Alice H. K.; Liddelow, Shane A.			Astrocytes have a license to kill inflammatory T cells	IMMUNITY			English	Editorial Material								Microbiome-induced interferon signaling through gut-derived natural killer cells is integral to minimize peripheral inflammatory responses in the brain and spinal cord. In a recent issue of Nature, Sanmarco, Wheeler, et al. define how interferon signaling induces LAMP1(+)TRAIL(+) astrocytes, which cause death of inflammatory T cells, mitigating degeneration in a mouse model of demyealination.	[Kwon, Alice H. K.] NYU, Sch Med, Skirball Inst, Mol Pathogenesis Program,Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Liddelow, Shane A.] NYU, Dept Neurosci & Physiol, Grossman Sch Med, 550 1St Ave, New York, NY 10016 USA; [Liddelow, Shane A.] NYU, Dept Ophthalmol, Grossman Sch Med, 550 1St Ave, New York, NY 10016 USA; [Liddelow, Shane A.] NYU, Neurosci Inst, Grossman Sch Med, 550 1St Ave, New York, NY 10016 USA	New York University; New York University; New York University; New York University	Kwon, AHK (corresponding author), NYU, Sch Med, Skirball Inst, Mol Pathogenesis Program,Kimmel Ctr Biol & Med, New York, NY 10016 USA.; Liddelow, SA (corresponding author), NYU, Dept Neurosci & Physiol, Grossman Sch Med, 550 1St Ave, New York, NY 10016 USA.; Liddelow, SA (corresponding author), NYU, Dept Ophthalmol, Grossman Sch Med, 550 1St Ave, New York, NY 10016 USA.; Liddelow, SA (corresponding author), NYU, Neurosci Inst, Grossman Sch Med, 550 1St Ave, New York, NY 10016 USA.	alice.kwon@nyulangone.org; shane.liddelow@nyulangone.org		Liddelow, Shane/0000-0002-0840-1437				de Saint Basile G, 2010, NAT REV IMMUNOL, V10, P568, DOI 10.1038/nri2803; Duffy SS, 2014, MULT SCLER INT, V2014, DOI 10.1155/2014/285245; Ganal SC, 2012, IMMUNITY, V37, P171, DOI 10.1016/j.immuni.2012.05.020; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Nicholas E., 2016, LANCET NEUROL, V18, P88; Rothhammer V, 2018, NATURE, V557, P724, DOI 10.1038/s41586-018-0119-x; Sanmarco LM, 2021, NATURE, V590, P473, DOI 10.1038/s41586-020-03116-4; Tomura M, 2008, P NATL ACAD SCI USA, V105, P10871, DOI 10.1073/pnas.0802278105; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714	10	0	0	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 13	2021	54	4					614	616		10.1016/j.immuni.2021.03.015	http://dx.doi.org/10.1016/j.immuni.2021.03.015		APR 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RN1GO	33852828	Bronze			2022-12-18	WOS:000640102800005
J	Larsen, SB; Naik, S				Larsen, Samantha B.; Naik, Shruti			A neu(ronal) player joins the T regulatory game	IMMUNITY			English	Editorial Material							NEURONS; POPULATION; CELLS	The enteric nervous system is surfacing as a key regulator of intestinal immunity and a liaison of host-commensal interactions. In this issue, Yan et al. identify neuronal interleukin-6 as a potent modulator of regulatory T (Treg) cells in the intestine. This neuroimmune dialog is further refined by commensal microbiota, which impact the enteric nervous system and consequently the intestinal Treg cell pool.	[Larsen, Samantha B.] New York Univ Langone Hlth, Neurosci Inst, 550 First Ave, New York, NY 10016 USA; [Naik, Shruti] New York Univ Langone Hlth, Dept Pathol, Dept Med, Ronald O Perelman Dept Dermatol, 550 First Ave, New York, NY 10016 USA; [Naik, Shruti] New York Univ Langone Hlth, Perlmutter Canc Ctr, 550 First Ave, New York, NY 10016 USA	New York University; New York University; New York University	Naik, S (corresponding author), New York Univ Langone Hlth, Dept Pathol, Dept Med, Ronald O Perelman Dept Dermatol, 550 First Ave, New York, NY 10016 USA.; Naik, S (corresponding author), New York Univ Langone Hlth, Perlmutter Canc Ctr, 550 First Ave, New York, NY 10016 USA.	shruti.naik@nylangone.org						Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Gabanyi I, 2016, CELL, V164, P378, DOI 10.1016/j.cell.2015.12.023; Huang SY, 2021, CELL, V184, P441, DOI 10.1016/j.cell.2020.11.028; Muller PA, 2014, CELL, V158, P300, DOI 10.1016/j.cell.2014.04.050; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Yan YQ, 2021, IMMUNITY, V54, P499, DOI 10.1016/j.immuni.2021.02.002; Yissachar N, 2017, CELL, V168, P1135, DOI 10.1016/j.cell.2017.02.009; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021	9	0	0	2	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 9	2021	54	3					404	406		10.1016/j.immuni.2021.02.016	http://dx.doi.org/10.1016/j.immuni.2021.02.016		MAR 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RU	33691130	Bronze			2022-12-18	WOS:000627409300008
J	Murphy, PM; Lenardo, MJ				Murphy, Philip M.; Lenardo, Michael J.			Ulrich Siebenlist (1951-2020) Obituary	IMMUNITY			English	Biographical-Item									[Murphy, Philip M.] NIAID, Lab Mol Immunol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Lenardo, Michael J.] NIAID, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Murphy, PM (corresponding author), NIAID, Lab Mol Immunol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	pmm@nih.gov						SIEBENLIST U, PUBLICATION LIST	1	0	0	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 9	2021	54	3					391	392		10.1016/j.immuni.2021.02.009	http://dx.doi.org/10.1016/j.immuni.2021.02.009		MAR 2021	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RU	33691124	Bronze			2022-12-18	WOS:000627409300002
J	Wang, AA; Gommerman, JL				Wang, Angela A.; Gommerman, Jennifer L.			A totally OSM gift to astrocytes relieves inflammation	IMMUNITY			English	Editorial Material								Dectin-1 is known for promoting anti-fungal responses through the signaling molecule Card9. In this issue of Immunity, Deerhake et al. now report that during autoimmune neuroinflammation, Dectin-1 can promote a neuroprotective feed-forward pathway through Card9-independent upregulation of Oncostatin M.	[Wang, Angela A.; Gommerman, Jennifer L.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada	University of Toronto	Wang, AA; Gommerman, JL (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada.	angelaar.wang@mail.utoronto.ca; jen.gommerman@utoronto.ca						Jordao MJC, 2019, SCIENCE, V363, P365, DOI 10.1126/science.aat7554; Deerhake ME, 2021, IMMUNITY, V54, P484, DOI 10.1016/j.immuni.2021.01.004; Houben E, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01165; Itoh N, 2018, P NATL ACAD SCI USA, V115, pE302, DOI 10.1073/pnas.1716032115; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Li R, 2018, NAT IMMUNOL, V19, P696, DOI 10.1038/s41590-018-0135-x; Mishra MK, 2016, NAT REV NEUROL, V12, P539, DOI 10.1038/nrneurol.2016.110; Ramaglia V., 2021, ANN REV IMMUNOL; Tone K, 2019, EUR J IMMUNOL, V49, P2127, DOI 10.1002/eji.201847536; Ye XC, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-019-1693-z	10	0	0	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 9	2021	54	3					401	403		10.1016/j.immuni.2021.02.011	http://dx.doi.org/10.1016/j.immuni.2021.02.011		MAR 2021	4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RU	33691129	Bronze			2022-12-18	WOS:000627409300007
J	Yi, F; Klebanoff, CA				Yi, Fei; Klebanoff, Christopher A.			Erasing iatrogenic neoantigens from in vivo CRISPR screens	IMMUNITY			English	Editorial Material							IMMUNOTHERAPY; DISCOVERY	In vivo genetic screens using CRISPR-Cas9 are a powerful tool to resolve the molecular determinants of response and resistance to cancer immunotherapies; however, vector immunogenicity can introduce artifact. In this issue of Immunity, Dubrot et al. report a strategy to "erase'' vector-associated neoantigens, enabling a more physiologic assessment of tumor-immune cell interactions in immunocompetent hosts.	[Yi, Fei; Klebanoff, Christopher A.] Mem Sloan Kettering Canc Ctr, Immunooncol Serv, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Yi, Fei; Klebanoff, Christopher A.] MSKCC, Ctr Cell Engn, New York, NY 10065 USA; [Klebanoff, Christopher A.] Parker Inst Canc Immunotherapy, New York, NY 10065 USA; [Klebanoff, Christopher A.] Weill Cornell Med Coll, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Klebanoff, CA (corresponding author), Mem Sloan Kettering Canc Ctr, Immunooncol Serv, Human Oncol & Pathogenesis Program, New York, NY 10065 USA.; Klebanoff, CA (corresponding author), MSKCC, Ctr Cell Engn, New York, NY 10065 USA.; Klebanoff, CA (corresponding author), Parker Inst Canc Immunotherapy, New York, NY 10065 USA.; Klebanoff, CA (corresponding author), Weill Cornell Med Coll, New York, NY 10065 USA.	klebanoc@mskcc.org			NIH/NCI [R37 CA259177-01, P30 CA008748]; Damon Runyon Cancer Research Foundation [CI-96-18]; Parker Institute for Cancer Immunotherapy; Cancer Research Institute [CRI3176]	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Damon Runyon Cancer Research Foundation; Parker Institute for Cancer Immunotherapy; Cancer Research Institute	This work was supported in part by NIH/NCI R37 CA259177-01 and P30 CA008748, the Damon Runyon Cancer Research Foundation CI-96-18, the Parker Institute for Cancer Immunotherapy, and the Cancer Research Institute CRI3176 (C.A.K.).	[Anonymous], TITLE ERROR, DOI 10.1016/j.bbi.2019.12.019; Chandran SS, 2019, IMMUNOL REV, V290, P127, DOI 10.1111/imr.12772; Dong MB, 2019, CELL, V178, P1189, DOI 10.1016/j.cell.2019.07.044; Hu JH, 2018, MOL THER-METH CLIN D, V9, P203, DOI 10.1016/j.omtm.2018.02.009; Ishizuka JJ, 2019, NATURE, V565, P43, DOI 10.1038/s41586-018-0768-9; Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270; Patel SJ, 2017, NATURE, V548, P537, DOI 10.1038/nature23477; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Shifrut E, 2018, CELL, V175, P1958, DOI 10.1016/j.cell.2018.10.024; Zhou PH, 2014, NATURE, V506, P52, DOI 10.1038/nature12988	10	0	0	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 9	2021	54	3					406	408		10.1016/j.immuni.2021.02.017	http://dx.doi.org/10.1016/j.immuni.2021.02.017		MAR 2021	4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RU	33691131	Bronze			2022-12-18	WOS:000627409300009
J	Abelin, JG; Harjanto, D; Malloy, M; Suri, P; Colson, T; Goulding, SP; Creech, AL; Serrano, LR; Nasir, G; Nasrullah, Y; McGann, CD; Velez, D; Ting, YS; Poran, A; Rothenberg, DA; Chhangawala, S; Rubinsteyn, A; Hammerbacher, J; Gaynor, RB; Fritsch, EF; Greshock, J; Oslund, RC; Barthelme, D; Addona, TA; Arieta, CM; Rooney, MS				Abelin, Jennifer G.; Harjanto, Dewi; Malloy, Matthew; Suri, Prerna; Colson, Tyler; Goulding, Scott P.; Creech, Amanda L.; Serrano, Lia R.; Nasir, Gibran; Nasrullah, Yusuf; McGann, Christopher D.; Velez, Diana; Ting, Ying S.; Poran, Asaf; Rothenberg, Daniel A.; Chhangawala, Sagar; Rubinsteyn, Alex; Hammerbacher, Jeff; Gaynor, Richard B.; Fritsch, Edward F.; Greshock, Joel; Oslund, Rob C.; Barthelme, Dominik; Addona, Terri A.; Arieta, Christina M.; Rooney, Michael S.			Defining HLA-II ligand processing and binding rules with mass spectrometry enhances cancer epitope prediction (vol 51, 766.e1, 2019)	IMMUNITY			English	Correction												mrooney@neontherapeutics.com						Abelin JG, 2019, IMMUNITY, V51, P766, DOI 10.1016/j.immuni.2019.08.012	1	0	0	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 9	2021	54	2					388	388		10.1016/j.immuni.2020.12.005	http://dx.doi.org/10.1016/j.immuni.2020.12.005		FEB 2021	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RE	33567264				2022-12-18	WOS:000627407700020
J	Wong, AC; Levy, M				Wong, Andrea C.; Levy, Maayan			Microbial memories	IMMUNITY			English	Editorial Material							HOST	The microbiota impedes pathogen invasion of the intestinal ecosystem, a phenomenon termed colonization resistance. In an upcoming issue of Cell, Stacy et al. describe host-initiated metabolite pathways that functionally alter the microbiota after primary infection, thereby augmenting colonization resistance to subsequent infection.	[Wong, Andrea C.; Levy, Maayan] Univ Penn, Dept Microbiol, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Levy, M (corresponding author), Univ Penn, Dept Microbiol, Sch Med, Philadelphia, PA 19104 USA.	maayanle@pennmedicine.upenn.edu						Baumler AJ, 2016, NATURE, V535, P85, DOI 10.1038/nature18849; Forte E, 2016, SCI REP-UK, V6, DOI 10.1038/srep23788; Grosheva I, 2020, GASTROENTEROLOGY, V159, P1807, DOI 10.1053/j.gastro.2020.07.003; Levy M, 2015, CELL, V163, P1428, DOI 10.1016/j.cell.2015.10.048; Netea MG, 2019, CELL HOST MICROBE, V25, P13, DOI 10.1016/j.chom.2018.12.006; Rosshart SP, 2017, CELL, V171, P1015, DOI 10.1016/j.cell.2017.09.016; Sassone-Corsi M, 2015, J IMMUNOL, V194, P4081, DOI 10.4049/jimmunol.1403169; Sencio V, 2020, CELL REP, V30, P2934, DOI 10.1016/j.celrep.2020.02.013; Stacy A, 2021, CELL, V184, P615, DOI 10.1016/j.cell.2020.12.011; Thaiss CA, 2016, NATURE, V540, P544, DOI 10.1038/nature20796	10	0	0	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 9	2021	54	2					201	204		10.1016/j.immuni.2021.01.009	http://dx.doi.org/10.1016/j.immuni.2021.01.009		FEB 2021	5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RE	33567260	Bronze			2022-12-18	WOS:000627407700005
J	Louis, TL; Chang, JT				Louis, Tiani L.; Chang, John T.			Clone Wars: Survival of the Fittest CD8(+) Trm Cells	IMMUNITY			English	Editorial Material							MEMORY T-CELLS; RESIDENT MEMORY	In this issue of Immunity, Hirai et al. illuminate competition for the cytokine TGF beta as a key regulator of CD8(+) tissue-resident memory T cell persistence and occupancy in the skin epidermal niche.	[Louis, Tiani L.; Chang, John T.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Chang, John T.] Vet Affairs San Diego Healthcare Syst, Dept Med, San Diego, CA 92161 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Chang, JT (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.; Chang, JT (corresponding author), Vet Affairs San Diego Healthcare Syst, Dept Med, San Diego, CA 92161 USA.	changj@ucsd.edu						Beura LK, 2018, NAT IMMUNOL, V19, P173, DOI 10.1038/s41590-017-0029-3; Hirai T, 2021, IMMUNITY, V54, P84, DOI 10.1016/j.immuni.2020.10.022; Hirai T, 2019, IMMUNITY, V50, P1249, DOI 10.1016/j.immuni.2019.03.002; Kurd NS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aaz6894; Mackay LK, 2015, IMMUNITY, V43, P1101, DOI 10.1016/j.immuni.2015.11.008; Mani V, 2019, SCIENCE, V366, P202, DOI 10.1126/science.aav5728; Milner JJ, 2020, IMMUNITY, V52, P808, DOI 10.1016/j.immuni.2020.04.007; Mohammed J, 2016, NAT IMMUNOL, V17, P414, DOI 10.1038/ni.3396; Nath AP, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210495; Park SL, 2018, NAT IMMUNOL, V19, P183, DOI 10.1038/s41590-017-0027-5	10	0	0	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 12	2021	54	1					4	6		10.1016/j.immuni.2020.12.015	http://dx.doi.org/10.1016/j.immuni.2020.12.015		JAN 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PS3GL	33440136	Bronze			2022-12-18	WOS:000607814000002
J	Weinberg, SE; Chandel, NS				Weinberg, Samuel E.; Chandel, Navdeep S.			Targeting Bacteria within Us to Diminish Infection and Autoimmunity	IMMUNITY			English	Editorial Material							ANTIBIOTICS	Antibiotics improve clinical outcomes independent of their antibacterial effects. In this issue of Immunity, Almeida et al. and Colaco et al. demonstrate that antibiotic impairment of mitochondrial ribosomes modulates both T-cell-dependent inflammation and host tolerance to infection.	[Weinberg, Samuel E.] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Chandel, Navdeep S.] Northwestern Univ, Feinberg Sch Med, Dept Med Biochem & Mol Genet, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Chandel, NS (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med Biochem & Mol Genet, Chicago, IL 60611 USA.	nav@northwestern.edu	Weinberg, Sam/ABD-5721-2021	Weinberg, Sam/0000-0002-9532-7051				Almeida L, 2021, IMMUNITY, V54, P68, DOI 10.1016/j.immuni.2020.11.001; Ayres JS, 2020, CELL, V181, P250, DOI 10.1016/j.cell.2020.03.036; Colaco HG, 2021, IMMUNITY, V54, P53, DOI 10.1016/j.immuni.2020.09.011; Huen S.C., 2020, BIORXIV, DOI [10.1101/2020.10.05, DOI 10.1101/2020.10.05]; Kaufmann U, 2019, CELL METAB, V29, P1104, DOI 10.1016/j.cmet.2019.01.019; Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007; Leach KL, 2007, MOL CELL, V26, P393, DOI 10.1016/j.molcel.2007.04.005; Luan HH, 2019, CELL, V178, P1231, DOI 10.1016/j.cell.2019.07.033; Moullan N, 2015, CELL REP, V10, P1681, DOI 10.1016/j.celrep.2015.02.034; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Wu L, 2020, CELL, V182, P641, DOI 10.1016/j.cell.2020.06.014	11	0	0	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 12	2021	54	1					1	3		10.1016/j.immuni.2020.12.006	http://dx.doi.org/10.1016/j.immuni.2020.12.006		JAN 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PS3GL	33440134	Bronze			2022-12-18	WOS:000607814000001
J	Yu, LW; Hsiao, EY				Yu, Lewis W.; Hsiao, Elaine Y.			IL-33 Changes Our "Gut Feelings" about Serotonin	IMMUNITY			English	Editorial Material							INTERLEUKIN-33	Many studies highlight direct interactions between immune cells and enteric neurons, but whether immune signals can indirectly modulate enteric function through neurotransmitter regulation is poorly understood. In this issue of Immunity, Chen et al. reveal how IL-33 induces intestinal serotonin to promote gut motility.	[Yu, Lewis W.; Hsiao, Elaine Y.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Hsiao, EY (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA.	ehsiao@g.ucla.edu						Chen ZJ, 2021, IMMUNITY, V54, P151, DOI 10.1016/j.immuni.2020.10.014; Furness JB, 2013, NAT REV GASTRO HEPAT, V10, P729, DOI 10.1038/nrgastro.2013.180; Herr N, 2017, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00048; Kee SA, 2020, J IMMUNOL, V204; Liew FY, 2016, NAT REV IMMUNOL, V16, P676, DOI 10.1038/nri.2016.95; Liu BY, 2016, P NATL ACAD SCI USA, V113, pE7572, DOI 10.1073/pnas.1606608113; Putney James W, 2012, Adv Biol Regul, V52, P152; Reverchon F, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006322; Sjoberg LC, 2015, ALLERGY, V70, P514, DOI 10.1111/all.12590; Wang SJ, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180027	10	0	0	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 12	2021	54	1					9	11		10.1016/j.immuni.2020.12.007	http://dx.doi.org/10.1016/j.immuni.2020.12.007		JAN 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PS3GL	33440138	Bronze			2022-12-18	WOS:000607814000004
J	Kee, BL				Kee, Barbara L.			It's a Phase That EBF1 Is Going Through	IMMUNITY			English	Editorial Material								EBF1 is a pioneer transcription factor involved in B lymphocyte specification. In this issue of Immunity, Wang et al. localize EBF1's pioneering activity to a prion-like domain that mediates recruitment of the nucleosome remodeler Brg1 and FUS-assisted liquid-liquid phase separation.	[Kee, Barbara L.] Univ Chicago, Dept Pathol, Comm Immunol, 924 E 57th St, Chicago, IL 60637 USA; [Kee, Barbara L.] Univ Chicago, Dept Pathol, Comm Canc Biol, 924 E 57th St, Chicago, IL 60637 USA; [Kee, Barbara L.] Univ Chicago, Dept Pathol, Comm Genet, 924 E 57th St, Chicago, IL 60637 USA; [Kee, Barbara L.] Univ Chicago, Dept Pathol, Comm Genom, 924 E 57th St, Chicago, IL 60637 USA; [Kee, Barbara L.] Univ Chicago, Dept Pathol, Comm Syst Biol, 924 E 57th St, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago	Kee, BL (corresponding author), Univ Chicago, Dept Pathol, Comm Immunol, 924 E 57th St, Chicago, IL 60637 USA.; Kee, BL (corresponding author), Univ Chicago, Dept Pathol, Comm Canc Biol, 924 E 57th St, Chicago, IL 60637 USA.; Kee, BL (corresponding author), Univ Chicago, Dept Pathol, Comm Genet, 924 E 57th St, Chicago, IL 60637 USA.; Kee, BL (corresponding author), Univ Chicago, Dept Pathol, Comm Genom, 924 E 57th St, Chicago, IL 60637 USA.; Kee, BL (corresponding author), Univ Chicago, Dept Pathol, Comm Syst Biol, 924 E 57th St, Chicago, IL 60637 USA.	bkee@bsd.uchicago.edu						Boller S, 2016, IMMUNITY, V44, P527, DOI 10.1016/j.immuni.2016.02.021; Boller S, 2014, IMMUNOL REV, V261, P102, DOI 10.1111/imr.12206; Bossen C, 2015, NAT IMMUNOL, V16, P775, DOI 10.1038/ni.3170; Boulay G, 2017, CELL, V171, P163, DOI 10.1016/j.cell.2017.07.036; Li R, 2018, GENE DEV, V32, P96, DOI 10.1101/gad.309583.117; Linden M, 2019, EMBO REP, V20, DOI 10.15252/embr.201845766; Schwartz JC, 2015, ANNU REV BIOCHEM, V84, P355, DOI 10.1146/annurev-biochem-060614-034325; Takaku M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0897-0; Wang J, 2018, CELL, V174, P688, DOI 10.1016/j.cell.2018.06.006; Wang Y, 2020, CLIM DYNAM, V53, P1	10	0	0	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2020	53	6					1123	1125		10.1016/j.immuni.2020.11.013	http://dx.doi.org/10.1016/j.immuni.2020.11.013			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9JT	33326760	Bronze			2022-12-18	WOS:000599363300001
J	Turner, JA; Stephen-Victor, E; Wang, S; Rivas, MN; Abdel-Gadir, A; Harb, H; Cui, Y; Fanny, M; Charbonnier, LM; Fong, JJH; Benamar, M; Wang, L; Burton, OT; Bansal, K; Bry, L; Zhu, CS; Li, QZ; Clement, RL; Oettgen, HC; Crestani, E; Rachid, R; Sage, PT; Chatila, TA				Turner, Jacob A.; Stephen-Victor, Emmanuel; Wang, Sen; Rivas, Magali Noval; Abdel-Gadir, Azza; Harb, Hani; Cui, Ye; Fanny, Manoussa; Charbonnier, Louis-Marie; Fong, Jason Jun Hung; Benamar, Mehdi; Wang, Leighanne; Burton, Oliver T.; Bansal, Kushagra; Bry, Lynn; Zhu, Chengsong; Li, Quan-Zhen; Clement, Rachel L.; Oettgen, Hans C.; Crestani, Elena; Rachid, Rima; Sage, Peter T.; Chatila, Talal A.			Regulatory T Cell-Derived TGF-beta 1 Controls Multiple Checkpoints Governing Allergy and Autoimmunity (vol 53, pg 1202, 2020)	IMMUNITY			English	Correction												talal.chatila@childrens.harvard.edu	Harb, Hani/J-6517-2019; Stephen Victor, Emmanuel/HDN-0252-2022; Harb, Hani/HGB-7333-2022	Harb, Hani/0000-0001-8218-2538; Stephen Victor, Emmanuel/0000-0001-5049-7017; Harb, Hani/0000-0001-8218-2538				Turner JA, 2020, IMMUNITY, V53, P1202, DOI [10.1016/j.immuni.2020.10.002, 10.1016/j.immuni.2020.11.011]	1	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2020	53	6					1331	1332		10.1016/j.immuni.2020.11.011	http://dx.doi.org/10.1016/j.immuni.2020.11.011			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9JT		Green Accepted, Bronze			2022-12-18	WOS:000599363300019
J	Minhas, PS; Durairaj, AS; Andreasson, KI				Minhas, Paras Singh; Durairaj, Aarooran Sivakumaran; Andreasson, Katrin I.			The Dueling Duo: IL10 and TNF Face Off in Microglial Recovery from Endotoxin Challenge	IMMUNITY			English	Editorial Material							PATHWAY	The molecular mechanisms that restore microglial quiescence after acute stimulation remain largely unexplored, unlike those that drive microglial activation. In this issue of Immunity, Shemer et al. discover that the microglial IL-10 receptor counteracts the pro-inflammatory effects of TNF to allow restoration of microglial quiescence after peripheral endotoxin challenge.	[Minhas, Paras Singh; Durairaj, Aarooran Sivakumaran; Andreasson, Katrin I.] Stanford Univ, Dept Neurol, Stanford, CA 94305 USA; [Andreasson, Katrin I.] Stanford Univ, Wu Tsai Neurosci Inst, Stanford, CA 94305 USA; [Andreasson, Katrin I.] Stanford Univ, Program Immunol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Andreasson, KI (corresponding author), Stanford Univ, Dept Neurol, Stanford, CA 94305 USA.; Andreasson, KI (corresponding author), Stanford Univ, Wu Tsai Neurosci Inst, Stanford, CA 94305 USA.; Andreasson, KI (corresponding author), Stanford Univ, Program Immunol, Stanford, CA 94305 USA.	kandreas@stanford.edu						Baik SH, 2019, CELL METAB, V30, P493, DOI 10.1016/j.cmet.2019.06.005; Bohlen CJ, 2017, NEURON, V94, P759, DOI 10.1016/j.neuron.2017.04.043; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Riley JK, 1999, J BIOL CHEM, V274, P16513, DOI 10.1074/jbc.274.23.16513; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Salter MW, 2017, NAT MED, V23, P1018, DOI 10.1038/nm.4397; Shemer A, 2020, IMMUNITY, V53, P1033, DOI 10.1016/j.immuni.2020.09.018; Skelly DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069123; Varatharaj A, 2017, BRAIN BEHAV IMMUN, V60, P1, DOI 10.1016/j.bbi.2016.03.010	12	0	0	3	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2020	53	5					897	899		10.1016/j.immuni.2020.10.016	http://dx.doi.org/10.1016/j.immuni.2020.10.016			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9ED	33207212	Bronze			2022-12-18	WOS:000599348200002
J	Higgins, MK				Higgins, Matthew K.			Staging an Antibody Contest to Fight Malaria	IMMUNITY			English	Editorial Material							INFECTION	In this issue of Immunity, Wang et al. report isolation of a human antibody derived from volunteers immunized during a malaria vaccine trial. This antibody binds a novel epitope and proves potent at preventing mosquito transmission of the malaria parasite.	[Higgins, Matthew K.] Univ Oxford, Dept Biochem, South Parks Rd, Oxford OX1 3QU, England	University of Oxford	Higgins, MK (corresponding author), Univ Oxford, Dept Biochem, South Parks Rd, Oxford OX1 3QU, England.	matthew.higgins@bioch.ox.ac.uk						Cockburn IA, 2018, NAT IMMUNOL, V19, P1199, DOI 10.1038/s41590-018-0228-6; Imkeller K, 2018, SCIENCE, V360, P1358, DOI 10.1126/science.aar5304; Julien JP, 2019, NAT REV IMMUNOL, V19, P761, DOI 10.1038/s41577-019-0209-5; Kisalu NK, 2018, NAT MED, V24, P408, DOI 10.1038/nm.4512; McNamara HA, 2020, CELL HOST MICROBE, V28, P572, DOI 10.1016/j.chom.2020.07.001; Murugan R, 2020, NAT MED, V26, P1135, DOI 10.1038/s41591-020-0881-9; Oyen D, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau8529; Tan J, 2018, NAT MED, V24, P401, DOI 10.1038/nm.4513; Triller G, 2017, IMMUNITY, V47, P1197, DOI 10.1016/j.immuni.2017.11.007; Wang LT, 2020, IMMUNITY, V53, P733, DOI 10.1016/j.immuni.2020.08.014	10	0	0	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 13	2020	53	4					697	699		10.1016/j.immuni.2020.09.004	http://dx.doi.org/10.1016/j.immuni.2020.09.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OF2RX	33053324	Bronze			2022-12-18	WOS:000581062800001
J	Philip, M				Philip, Mary			CD226 Throttles up CD8(+) T Cell Antitumor Activity	IMMUNITY			English	Editorial Material							ACTIVATION; LYMPHOCYTES	In this issue of Immunity, Weulersse et al. and Braun et al. explain how CD226 expression loss on CD8(+) T cells impairs TCR-driven activation, and thereby anti-tumor effector responses, tantamount to taking the CD8(+) T cell's foot off the gas pedal.	[Philip, Mary] Vanderbilt Univ, Med Ctr, Div Hematol & Oncol, Dept Med, Nashville, TN 37232 USA; [Philip, Mary] Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Philip, M (corresponding author), Vanderbilt Univ, Med Ctr, Div Hematol & Oncol, Dept Med, Nashville, TN 37232 USA.; Philip, M (corresponding author), Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA.	mary.philip@vumc.org			V Foundation Scholar Award; Vanderbilt Digestive Disease Research Center Pilot Award [NIH NIDDK P30DK05840406]; Vanderbilt-Ingram Cancer Center Breast Cancer SPORE Career Enhancement Award (NIH) [NCI P50CA098131]	V Foundation Scholar Award; Vanderbilt Digestive Disease Research Center Pilot Award; Vanderbilt-Ingram Cancer Center Breast Cancer SPORE Career Enhancement Award (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	M.P. is supported by a V Foundation Scholar Award, a Vanderbilt Digestive Disease Research Center Pilot Award (NIH NIDDK P30DK05840406), and a Vanderbilt-Ingram Cancer Center Breast Cancer SPORE Career Enhancement Award (NIH, NCI P50CA098131).	BURNS GF, 1985, J EXP MED, V161, P1063, DOI 10.1084/jem.161.5.1063; Effern M, 2020, IMMUNITY, V53, P564, DOI 10.1016/j.immuni.2020.07.007; Gilfillan S, 2008, J EXP MED, V205, P2965, DOI 10.1084/jem.20081752; Haslam A, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.2535; Huang ZY, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00564; Miller CH, 2020, NAT IMMUNOL, V21, P567, DOI 10.1038/s41590-020-0653-1; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Shibuya K, 1999, IMMUNITY, V11, P615, DOI 10.1016/S1074-7613(00)80136-3; Weulersse M, 2020, IMMUNITY, V53, P824, DOI 10.1016/j.immuni.2020.09.006; Yost KE, 2019, NAT MED, V25, P1251, DOI 10.1038/s41591-019-0522-3; Zhang ZG, 2015, J EXP MED, V212, P2165, DOI 10.1084/jem.20150792	12	0	0	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 13	2020	53	4					704	706		10.1016/j.immuni.2020.09.013	http://dx.doi.org/10.1016/j.immuni.2020.09.013			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OF2RX	33053327	Bronze			2022-12-18	WOS:000581062800004
J	Robinson, MJ; Harris, NL				Robinson, Marcus J.; Harris, Nicola L.			A Dangerous Liaison with a Conscience	IMMUNITY			English	Editorial Material							CELLS	The contribution of the immunoglobulin E (IgE)-mast cell response to allergy portrays the axis as a villain with malicious intent. A new study from Starkl et al. tells a different story, highlighting a more worthwhile purpose of protecting us against bacterial toxins.	[Robinson, Marcus J.; Harris, Nicola L.] Monash Univ, Alfred Med Res & Educ Precinct, Dept Immunol & Pathol, Level 6,Burnet Tower,89 Commercial Rd, Melbourne, Vic 3004, Australia	Monash University	Harris, NL (corresponding author), Monash Univ, Alfred Med Res & Educ Precinct, Dept Immunol & Pathol, Level 6,Burnet Tower,89 Commercial Rd, Melbourne, Vic 3004, Australia.	nicola.harris@monash.edu						Bluth MH, 2007, SCAND J IMMUNOL, V65, P376, DOI 10.1111/j.1365-3083.2007.01904.x; Cook-Mills JM, 2019, J ALLERGY CLIN IMMUN, V144, P404, DOI 10.1016/j.jaci.2019.06.014; Gowthaman U, 2019, SCIENCE, V365, P883, DOI 10.1126/science.aaw6433; Kitaura J, 2003, P NATL ACAD SCI USA, V100, P12911, DOI 10.1073/pnas.1735525100; Marichal T, 2013, IMMUNITY, V39, P963, DOI 10.1016/j.immuni.2013.10.005; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; Nakamura Y, 2013, NATURE, V503, P397, DOI 10.1038/nature12655; Nordengrun M, 2018, INT J MED MICROBIOL, V308, P738, DOI 10.1016/j.ijmm.2018.04.003; Palm NW, 2013, IMMUNITY, V39, P976, DOI 10.1016/j.immuni.2013.10.006; Starkl P, 2020, IMMUNITY, V53, P793, DOI 10.1016/j.immuni.2020.08.002	10	0	0	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 13	2020	53	4					702	704		10.1016/j.immuni.2020.09.012	http://dx.doi.org/10.1016/j.immuni.2020.09.012			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OF2RX	33053326	Bronze			2022-12-18	WOS:000581062800003
J	Satoh-Takayama, N; Ohno, H				Satoh-Takayama, Naoko; Ohno, Hiroshi			Unraveling the Heterogeneity and Specialization of ILCs	IMMUNITY			English	Editorial Material							INNATE LYMPHOID-CELLS	In this issue of Immunity, Zeis et al. report the generation of a single-cell atlas of lung innate lymphoid cells (ILCs). Their findings provide insight into the how ILCs are locally maintained, revealing in situ differentiation and diversification as mechanisms of ILC renewal and function.	[Satoh-Takayama, Naoko; Ohno, Hiroshi] RIKEN, Lab Intestinal Ecosyst, Ctr Integrat Med Sci, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan; [Satoh-Takayama, Naoko; Ohno, Hiroshi] Yokohama City Univ, Grad Sch Med Life Sci, Immunobiol Lab, Tsurumi Ku, 1-7-29 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan; [Ohno, Hiroshi] Chiba Univ, Grad Sch Med, Lab Immune Regulat, Chuo Ku, 1-8-1 Inohana, Chiba, Chiba 2608670, Japan; [Ohno, Hiroshi] Kanagawa Inst Ind Sci & Technol, Intestinal Microbiota Project, Takatsu Ku, 3-2-1 Sakado, Kawasaki, Kanagawa 2130012, Japan	RIKEN; Yokohama City University; Chiba University; Kanagawa Academy Science & Technology	Satoh-Takayama, N (corresponding author), RIKEN, Lab Intestinal Ecosyst, Ctr Integrat Med Sci, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.; Satoh-Takayama, N (corresponding author), Yokohama City Univ, Grad Sch Med Life Sci, Immunobiol Lab, Tsurumi Ku, 1-7-29 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	naoko.satoh@riken.jp			Japan Society for the Promotion of Science KAKENHI [18K07189, 16H05207]; Yakult Bioscience Foundation; Japan Agency for Medical Research; Core Research for Evolutional Science and Technology [JP18gm0710009]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Yakult Bioscience Foundation; Japan Agency for Medical Research; Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST))	N. S.-T. has been supported by the Japan Society for the Promotion of Science KAKENHI (18K07189) and by the Yakult Bioscience Foundation. H. O. is supported by the Japan Society for the Promotion of Science KAKENHI (16H05207), Japan Agency for Medical Research, and the Core Research for Evolutional Science and Technology (JP18gm0710009).	Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Hams E, 2014, P NATL ACAD SCI USA, V111, P367, DOI 10.1073/pnas.1315854111; Huang YF, 2018, SCIENCE, V359, P114, DOI 10.1126/science.aam5809; Monticelli LA, 2015, P NATL ACAD SCI USA, V112, P10762, DOI 10.1073/pnas.1509070112; Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4; Saberkari Hamidreza, 2013, J Med Signals Sens, V3, P139; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Yu Y, 2016, NATURE, V539, P102, DOI 10.1038/nature20105; Zeis P, 2020, IMMUNITY, V53, P775, DOI 10.1016/j.immuni.2020.09.002	10	0	0	2	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 13	2020	53	4					699	701		10.1016/j.immuni.2020.09.017	http://dx.doi.org/10.1016/j.immuni.2020.09.017			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OF2RX	33053325	Bronze			2022-12-18	WOS:000581062800002
J	Locatelli, G; Engelhardt, B				Locatelli, Giuseppe; Engelhardt, Britta			Microglia Get a Little Help from "Th"'-eir Friends	IMMUNITY			English	Editorial Material							ANTIGEN; CELLS	The presence of CD4+ T cells in the healthy brain parenchyma remains controversial due to the barrier function of the glia limitans. Pasciuto, Burton, Roca et al. in Cell describe the dynamic recruitment of CD4(+) T cells within the brain parenchyma, their unexpected contribution to microglial maturation, and, ultimately, their influence on behavior.	[Locatelli, Giuseppe; Engelhardt, Britta] Univ Bern, Theodor Kocher Inst, Bern, Switzerland	University of Bern	Engelhardt, B (corresponding author), Univ Bern, Theodor Kocher Inst, Bern, Switzerland.	bengel@tki.unibe.ch		Locatelli, Giuseppe/0000-0002-2179-4407				Alferink J, 1998, SCIENCE, V282, P1338, DOI 10.1126/science.282.5392.1338; Braniste V, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009759; Engelhardt B, 2016, ACTA NEUROPATHOL, V132, P317, DOI 10.1007/s00401-016-1606-5; Ero C, 2018, FRONT NEUROINFORM, V12, DOI 10.3389/fninf.2018.00084; Korin B, 2017, NAT NEUROSCI, V20, P1300, DOI 10.1038/nn.4610; Na SY, 2008, BRAIN, V131, P2353, DOI 10.1093/brain/awn148; Pasciuto E, 2020, CELL, V182, P625, DOI 10.1016/j.cell.2020.06.026; Radjavi A, 2014, BRAIN BEHAV IMMUN, V35, P58, DOI 10.1016/j.bbi.2013.08.013	8	0	0	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2020	53	3					484	486		10.1016/j.immuni.2020.08.011	http://dx.doi.org/10.1016/j.immuni.2020.08.011			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NO9KZ	32937150	Bronze			2022-12-18	WOS:000569806100006
J	Ross, SH; Cantrell, DA				Ross, Sarah H.; Cantrell, Doreen A.			Of Mosaicism and Mechanisms: How JAK1 Goes Awry	IMMUNITY			English	Editorial Material							STAT PATHWAY	Personalized medicines require understanding the molecular causes of disease. In this issue of Immunity, Gruber et al. reveal that a gain-of-function JAK1 genetic variant results in a mutant protein with mosaic expression that drives multi-organ immune dysregulation via kinase dependent and independent mechanisms. The work highlights how biochemistry can inform therapies to resolve complex immune disorders.	[Ross, Sarah H.] Babraham Inst, Lymphocyte Signaling & Dev, Cambridge CB22 3AT, England; [Cantrell, Doreen A.] Univ Dundee, Sch Life Sci, Div Cell Signaling & Immunol, Dundee DD1 5EH, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Dundee	Cantrell, DA (corresponding author), Univ Dundee, Sch Life Sci, Div Cell Signaling & Immunol, Dundee DD1 5EH, Scotland.	d.a.cantrell@dundee.ac.uk		Ross, Sarah/0000-0001-7302-6875				Babon JJ, 2014, BIOCHEM J, V462, P1, DOI 10.1042/BJ20140712; Gruber CN, 2020, IMMUNITY, V53, P672, DOI 10.1016/j.immuni.2020.07.006; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; O'Shea JJ, 2015, ANNU REV MED, V66, P311, DOI 10.1146/annurev-med-051113-024537; Ross SH, 2016, IMMUNITY, V45, P685, DOI 10.1016/j.immuni.2016.07.022; Schwartz DM, 2017, NAT REV DRUG DISCOV, V16, P843, DOI 10.1038/nrd.2017.201; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; WILKS AF, 1991, MOL CELL BIOL, V11, P2057, DOI 10.1128/MCB.11.4.2057; Wolf T, 2020, NAT IMMUNOL, V21, P927, DOI 10.1038/s41590-020-0714-5	10	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2020	53	3					481	484		10.1016/j.immuni.2020.08.010	http://dx.doi.org/10.1016/j.immuni.2020.08.010			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NO9KZ	32937149	Bronze, Green Published, Green Submitted			2022-12-18	WOS:000569806100005
J	Doyle, SL				Doyle, Sarah L.			The Persistence of Privilege for a Healthy Retina	IMMUNITY			English	Editorial Material							DEGENERATION; GENETICS	A minor haplotype of chromosome 10q26 accounts for much of the genetic risk of age-related macular degeneration (AMD). In this issue of Immunity, Beguier et al. demonstrate that carriers of the 10q26 AMD-risk haplotype overexpress the peptidase HTRA1, which in turns results in mononuclear phagocyte persistence in an immune privileged site and pathogenic inflammation.	[Doyle, Sarah L.] Trinity Coll Dublin, Sch Med, Dept Clin Med, Dublin 2, Ireland; [Doyle, Sarah L.] Trinity Coll Dublin, Trinity Coll, Inst Neurosci, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin	Doyle, SL (corresponding author), Trinity Coll Dublin, Sch Med, Dept Clin Med, Dublin 2, Ireland.; Doyle, SL (corresponding author), Trinity Coll Dublin, Trinity Coll, Inst Neurosci, Dublin 2, Ireland.	sarah.doyle@tcd.ie						Beguier F., 2020, IMMUNITY, V53; Calippe B, 2017, IMMUNITY, V46, P261, DOI 10.1016/j.immuni.2017.01.006; Chen CY, 2018, MATRIX BIOL, V70, P84, DOI 10.1016/j.matbio.2018.03.013; DeAngelis MM, 2017, HUM MOL GENET, V26, pR45, DOI 10.1093/hmg/ddx228; Fritsche LG, 2014, ANNU REV GENOM HUM G, V15, P151, DOI 10.1146/annurev-genom-090413-025610; Fujita N, 2011, INVEST OPHTH VIS SCI, V52, P9310, DOI 10.1167/iovs.10-7050; Lin MK, 2018, AGING CELL, V17, DOI 10.1111/acel.12710; McDonald JF, 2003, BIOCHEMISTRY-US, V42, P10001, DOI 10.1021/bi0341408; Sennlaub F, 2013, EMBO MOL MED, V5, P1775, DOI 10.1002/emmm.201302692; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811	10	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2020	53	2					240	242		10.1016/j.immuni.2020.07.022	http://dx.doi.org/10.1016/j.immuni.2020.07.022			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NC4NX	32814022	Bronze			2022-12-18	WOS:000561190600004
J	Khatwani, N; Turk, MJ				Khatwani, Nikhil; Turk, Mary Jo			Oncogenes Feed Treg Cells without Calling CD8s to the Table	IMMUNITY			English	Editorial Material							T-CELLS; SURVIVAL	Metabolic support for regulatory T (Treg) cells in noninflamed tumors is not well understood. In this issue of Immunity, Kumagai et. al. show how oncogene-driven fatty-acid synthesis favors Treg cells over effector T cells and how this imbalance can be overcome.	[Khatwani, Nikhil; Turk, Mary Jo] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Lebanon, NH 03766 USA; [Turk, Mary Jo] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Lebanon, NH 03766 USA	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Turk, MJ (corresponding author), Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Lebanon, NH 03766 USA.; Turk, MJ (corresponding author), Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Lebanon, NH 03766 USA.	mary.jo.turk@dartmouth.edu			NIH [R01CA225028, CA214062, CA205965]; Knights of the York Cross of Honor Philanthropic Fund	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Knights of the York Cross of Honor Philanthropic Fund	M.J.T. is supported by NIH R01CA225028, CA214062, and CA205965; the Knights of the York Cross of Honor Philanthropic Fund; and the O. Ross McIntyre, M.D. Endowment.	[Anonymous], TITLE ERROR, DOI 10.1016/j.bbi.2019.12.019; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Pan YD, 2017, NATURE, V543, P252, DOI 10.1038/nature21379; Plitas G, 2020, ANNU REV CANC BIOL, V4, P459, DOI 10.1146/annurev-cancerbio-030419-033428; Shabaneh TB, 2018, CANCER RES, V78, P5038, DOI 10.1158/0008-5472.CAN-18-0365; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Steinberg SM, 2017, CANCER RES, V77, P1599, DOI 10.1158/0008-5472.CAN-16-1755; Wang HP, 2020, NAT IMMUNOL, V21, P298, DOI 10.1038/s41590-019-0589-5	10	0	0	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 14	2020	53	1					13	15		10.1016/j.immuni.2020.06.020	http://dx.doi.org/10.1016/j.immuni.2020.06.020			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MN8UK	32668223	Bronze			2022-12-18	WOS:000551116800005
J	Haberman, ER; Domingos, AI				Haberman, Emma R.; Domingos, Ana I.			Illuminating Neuroimmunity: A Humoral Brain	IMMUNITY			English	Editorial Material							CELLS; STRESS	The hypothalamic-pituitary-adrenal axis modulates immunity in response to stress. In a recent report in the May 14, 2020 issue of Nature, Zhang et al. use optogenetic tools to investigate whether the splenic immune response is directly controlled by descending neuronal circuits activated in response to stress.	[Haberman, Emma R.; Domingos, Ana I.] Univ Oxford, Dept Physiol Anat & Genet, Parks Rd, Oxford OX1 3PT, England	University of Oxford	Domingos, AI (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Parks Rd, Oxford OX1 3PT, England.	ana.domingos@dpag.ox.ac.uk		Haberman, Emma/0000-0002-6936-1870; Domingos, Ana/0000-0002-7938-4814				Benko AL, 2014, MOL CELL ENDOCRINOL, V382, P881, DOI 10.1016/j.mce.2013.11.001; Blanc-Lapierre A, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00269; Dhabhar FS, 2009, NEUROIMMUNOMODULAT, V16, P300, DOI 10.1159/000216188; Gruver-Yates AL, 2014, ENDOCRINOLOGY, V155, P463, DOI 10.1210/en.2013-1473; Harle G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18401-y; Kooijman S., 2015, AM J PHYSIOL-HEART C, V15, P309; McCarron MJ, 2017, BLOOD, V129, P2749, DOI 10.1182/blood-2017-01-761643; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Silberman DM, 2003, J NEUROIMMUNOL, V144, P53, DOI 10.1016/j.jneuroim.2003.08.031; Zhang X, 2020, NATURE, V581, P204, DOI 10.1038/s41586-020-2235-7	10	0	0	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2020	52	6					900	902						3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MA4MT	32553178	Bronze			2022-12-18	WOS:000541890000006
J	Nakamura, K; Smyth, MJ				Nakamura, Kyohei; Smyth, Mark J.			Natural Killers out of Thin Air	IMMUNITY			English	Editorial Material							NK CELLS	The regulatory mechanisms controlling natural killer (NK) cells in the tumor microenvironment remain unknown. In this issue, Ni. et al. provide evidence that the transcription factor HIF-1 alpha acts as a key negative regulator of NK cell metabolic fitness in the tumor microenvironment that critically impedes NK cell anti-tumor immune responses.	[Nakamura, Kyohei; Smyth, Mark J.] QIMR Berghofer Med Res Inst, Herston, Qld 4006, Australia	QIMR Berghofer Medical Research Institute	Smyth, MJ (corresponding author), QIMR Berghofer Med Res Inst, Herston, Qld 4006, Australia.	mark.smyth@qimrberghofer.edu.au	Nakamura, Kyohei/AAH-4823-2019	Nakamura, Kyohei/0000-0002-6631-9028				Barry KC, 2018, NAT MED, V24, P1178, DOI 10.1038/s41591-018-0085-8; Cerdeira AS, 2013, J IMMUNOL, V190, P3939, DOI 10.4049/jimmunol.1202582; Fallah J, 2019, CURR ONCOL REP, V21, DOI 10.1007/s11912-019-0752-z; Gotthardt D, 2016, CANCER DISCOV, V6, P414, DOI 10.1158/2159-8290.CD-15-0732; Krzywinska E, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01599-w; Liu EL, 2020, NEW ENGL J MED, V382, P545, DOI 10.1056/NEJMoa1910607; Nakamura K, 2017, IMMUNOL CELL BIOL, V95, P325, DOI 10.1038/icb.2016.126; Ni J, 2020, IMMUNITY, V52, P1075, DOI 10.1016/j.immuni.2020.05.001; Noman MZ, 2015, AM J PHYSIOL-CELL PH, V309, pC569, DOI 10.1152/ajpcell.00207.2015; Zheng XH, 2019, NAT IMMUNOL, V20, P1656, DOI 10.1038/s41590-019-0511-1	10	0	0	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2020	52	6					895	897		10.1016/j.immuni.2020.05.007	http://dx.doi.org/10.1016/j.immuni.2020.05.007			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MA4MT	32553176	Bronze			2022-12-18	WOS:000541890000004
J	Webb, LM; Wojno, EDT				Webb, Lauren M.; Wojno, Elia D. Tait			Exercising Immunity: Interleukin-13 Flexes Muscle	IMMUNITY			English	Editorial Material							INNATE LYMPHOID-CELLS; SKELETAL-MUSCLE	Endurance exercise drives physiological changes in the muscle to optimize performance. In a recent study in Science, Knudsen et al. report a role for the type 2 cytokine interleukin-13 in orchestrating metabolic reprogramming that drives adaptation to endurance exercise.	[Webb, Lauren M.; Wojno, Elia D. Tait] Univ Washington, Dept Immunol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Wojno, EDT (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	etwojno@uw.edu						Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Cardoso V, 2017, NATURE, V549, P277, DOI 10.1038/nature23469; Henrique JS, 2018, EXP GERONTOL, V110, P284, DOI 10.1016/j.exger.2018.06.025; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Klose CSN, 2017, NATURE, V549, P282, DOI 10.1038/nature23676; Knudsen NH, 2020, SCIENCE, V368, P488, DOI 10.1126/science.aat3987; Kuswanto W, 2016, IMMUNITY, V44, P355, DOI 10.1016/j.immuni.2016.01.009; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Varga T, 2016, IMMUNITY, V45, P1038, DOI 10.1016/j.immuni.2016.10.016; Wallrapp A, 2017, NATURE, V549, P351, DOI 10.1038/nature24029	10	0	0	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2020	52	6					902	904		10.1016/j.immuni.2020.05.012	http://dx.doi.org/10.1016/j.immuni.2020.05.012			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MA4MT	32553179	Bronze			2022-12-18	WOS:000541890000007
J	Kazmierski, J; Goffinet, C				Kazmierski, Julia; Goffinet, Christine			Alert from a Distant Neighbor: Spread of Antiviral Immunity through Anion Channels	IMMUNITY			English	Editorial Material							GMP-AMP SYNTHASE; SENSOR; CGAMP	Cytosolic DNA detection via the DNA sensor cGAS initiates a major cell-intrinsic response to infection and malignancies. In this issue of Immunity, Zhou et al. (2020) report that the catalytic product of cGAS, cGAMP, can alert bystander cells over large distances through its cell-to-cell transmission via volume-regulated anion channels.	[Kazmierski, Julia; Goffinet, Christine] Charite Univ Med Berlin, Campus Charite Mitte, Inst Virol, Charitepl 1, D-10117 Berlin, Germany; [Kazmierski, Julia; Goffinet, Christine] Berlin Inst Hlth, D-10178 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health	Goffinet, C (corresponding author), Charite Univ Med Berlin, Campus Charite Mitte, Inst Virol, Charitepl 1, D-10117 Berlin, Germany.; Goffinet, C (corresponding author), Berlin Inst Hlth, D-10178 Berlin, Germany.	christine.goffinet@charite.de	Goffinet, Christine/L-4878-2019	Goffinet, Christine/0000-0002-3959-004X; Kazmierski, Julia/0000-0002-7962-2165	Deutsche Forschungsgemeinschaft (DFG) [1923, GO2153/4]; Berlin Institute of Health (BIH); Center of Infection Biology and Immunity (ZIBI); Charite' PhD Program	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Berlin Institute of Health (BIH); Center of Infection Biology and Immunity (ZIBI); Charite' PhD Program	Works in the authors' laboratory is supported by funding from Deutsche Forschungsgemeinschaft (DFG) (Priority Programm 1923 "Innate Sensing and Restriction of Retroviruses,'' GO2153/4) and from the Berlin Institute of Health (BIH) to C.G. J.K. is supported by the Center of Infection Biology and Immunity (ZIBI) and Charite ' PhD Program. Figure 1 was created with BioRender.com.	Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; Bridgeman A, 2015, SCIENCE, V349, P1228, DOI 10.1126/science.aab3632; Carozza JA, 2020, NAT CANCER, V1, P184, DOI 10.1038/s43018-020-0028-4; Chen LY, 2019, BIOL CHEM, V400, P1481, DOI 10.1515/hsz-2019-0189; Eaglesham JB, 2019, NATURE, V566, P259, DOI 10.1038/s41586-019-0928-6; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Gentili M, 2015, SCIENCE, V349, P1232, DOI 10.1126/science.aab3628; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Xu ST, 2016, CELL HOST MICROBE, V20, P443, DOI 10.1016/j.chom.2016.09.003; Zhou C, 2020, IMMUNITY, V52, P767, DOI 10.1016/j.immuni.2020.03.016	10	0	1	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2020	52	5					719	721		10.1016/j.immuni.2020.04.017	http://dx.doi.org/10.1016/j.immuni.2020.04.017			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR0EZ	32433941	Bronze			2022-12-18	WOS:000535371100001
J	Avishai, E; Rolls, A				Avishai, Eden; Rolls, Asya			Something Else to Stress about: Perinatal Stress Attenuates CD8(+) T Cell Activity in Adults	IMMUNITY			English	Editorial Material								Early-life stress has adverse health effects, but the underlying mechanisms are unclear. Hong et al. demonstrate that perinatal exposure to glucocorticoids in mice reprograms the neuroendocrine stress pathway. This results in reduced glucocorticoid levels in adults, leading to attenuated anti-tumor and anti-bacterial CD8(+) T cell responses.	[Avishai, Eden; Rolls, Asya] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Rolls, A (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel.	rolls.asya@gmail.com		Rolls, Asya/0000-0001-5862-4287				Armaiz-Pena GN, 2009, BRAIN BEHAV IMMUN, V23, P10, DOI 10.1016/j.bbi.2008.06.007; Bohacek J, 2013, NEUROPSYCHOPHARMACOL, V38, P220, DOI 10.1038/npp.2012.110; Dantzer R, 2018, PHYSIOL REV, V98, P477, DOI 10.1152/physrev.00039.2016; Dhabhar FS, 2014, IMMUNOL RES, V58, P193, DOI 10.1007/s12026-014-8517-0; Heidt T, 2014, NAT MED, V20, P754, DOI 10.1038/nm.3589; Henriksen RE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137304; Hong JY, 2020, CELL, V180, P847, DOI 10.1016/j.cell.2020.02.018; Kelly-Irving M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-767; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; van Bodegom M, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00087	10	0	0	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 14	2020	52	4					580	582		10.1016/j.immuni.2020.03.014	http://dx.doi.org/10.1016/j.immuni.2020.03.014			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LE5TM	32294404	Green Published, Bronze			2022-12-18	WOS:000526782600004
J	de Pablos-Aragoneses, A; Valiente, M				de Pablos-Aragoneses, Ana; Valiente, Manuel			An Inbred Ecosystem that Supports Medulloblastoma	IMMUNITY			English	Editorial Material							INJURY	In a recent issue of Cell, Yao et al. use a unique genetic strategy to study sonic hedgehog-medulloblastoma. Their results reveal a complex network in the tumor microenvironment involving the trans-differentiation of cancer cells into astrocytes to fuel tumor growth.	[de Pablos-Aragoneses, Ana; Valiente, Manuel] Spanish Natl Canc Res Ctr, Brain Metastasis Grp, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO)	Valiente, M (corresponding author), Spanish Natl Canc Res Ctr, Brain Metastasis Grp, Madrid, Spain.	mvaliente@cnio.es			MINECO grants MINECO-Retos [SAF2017-89643-R]; Bristol-Myers Squibb-Melanoma Research Alliance Young Investigator Award [498103]; Fundacion Ramon Areces [CIVP19S8163]; Worldwide Cancer Research [19-0177]; H2020-FETOPEN [828972]; Clinic and Laboratory Integration Program CRI Award [54545]; AECC Coordinated Translational Groups 2017 [GCTRA16015SEOA]; LAB AECC 2019 [LABAE19002VALI]; La Caixa INPhINIT Fellowship [LCF/BQ/DI19/11730044]; Ramon y Cajal Investigator [RYC-2013-13365]; EMBO YIP [4053]	MINECO grants MINECO-Retos; Bristol-Myers Squibb-Melanoma Research Alliance Young Investigator Award; Fundacion Ramon Areces; Worldwide Cancer Research; H2020-FETOPEN; Clinic and Laboratory Integration Program CRI Award; AECC Coordinated Translational Groups 2017; LAB AECC 2019; La Caixa INPhINIT Fellowship; Ramon y Cajal Investigator(Spanish Government); EMBO YIP(European Molecular Biology Organization (EMBO))	Researchin the Brain Metastasis Group is supported by MINECO grants MINECO-Retos SAF2017-89643-R (M.V.), Bristol-Myers Squibb-Melanoma Research Alliance Young Investigator Award 2017 (498103) (M.V.), Fundacion Ramon Areces (CIVP19S8163) (M.V.), Worldwide Cancer Research (19-0177) (M.V.), H2020-FETOPEN (828972) (M.V.), Clinic and Laboratory Integration Program CRI Award 2018 (54545) (M.V.), AECC Coordinated Translational Groups 2017 (GCTRA16015SEOA) (M.V.), LAB AECC 2019 (LABAE19002VALI) (M.V.), and La Caixa INPhINIT Fellowship (LCF/BQ/DI19/11730044) (A.d.P.-A.). M.V.is a Ramon y Cajal Investigator (RYC-2013-13365) and EMBO YIP (4053).	Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Benner EJ, 2013, NATURE, V497, P369, DOI 10.1038/nature12069; Hovestadt V, 2020, NAT REV CANCER, V20, P42, DOI 10.1038/s41568-019-0223-8; Khakh BS, 2015, NAT NEUROSCI, V18, P942, DOI 10.1038/nn.4043; Muzumdar MD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12685; Priego N, 2018, NAT MED, V24, P1024, DOI 10.1038/s41591-018-0044-4; Shekhani MT, 2013, AM J STEM CELLS, V2, P52; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Yao MJ, 2020, CELL, V180, P502, DOI 10.1016/j.cell.2019.12.024; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	10	0	0	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2020	52	3					431	433		10.1016/j.immuni.2020.02.010	http://dx.doi.org/10.1016/j.immuni.2020.02.010			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KV6NX	32187514	Bronze			2022-12-18	WOS:000520600200006
